Reduced size self-delivering RNAI compounds

Abstract

The present invention relates to RNAi constructs with minimal double-stranded regions, and their use in gene silencing. RNAi constructs associated with the invention include a double stranded region of 8-14 nucleotides and a variety of chemical modifications, and are highly effective in gene silencing. The RNAi constructs may be, for instance, miRNA constructs that are miRNA modulators.

Description

FIELD OF INVENTION

The invention pertains to the field of RNA interference (RNAi). The invention more specifically relates to nucleic acid molecules with improved in vivo delivery properties without the use of a delivering agent and their use in efficient gene silencing.

BACKGROUND OF INVENTION

Complementary oligonucleotide sequences are promising therapeutic agents and useful research tools in elucidating gene functions. However, prior art oligonucleotide molecules suffer from several problems that may impede their clinical development, and frequently make it difficult to achieve intended efficient inhibition of gene expression (including protein synthesis) using such compositions in vivo.

A major problem has been the delivery of these compounds to cells and tissues. Conventional double-stranded RNAi compounds, 19-29 bases long, form a highly negatively-charged rigid helix of approximately 1.5 by 10-15 nm in size. This rod type molecule cannot get through the cell-membrane and as a result has very limited efficacy both in vitro and in vivo. As a result, all conventional RNAi compounds require some kind of a delivery vehicle to promote their tissue distribution and cellular uptake. This is considered to be a major limitation of the RNAi technology.

There have been previous attempts to apply chemical modifications to oligonucleotides to improve their cellular uptake properties. One such modification was the attachment of a cholesterol molecule to the oligonucleotide. A first report on this approach was by Letsinger et al., in 1989. Subsequently, ISIS Pharmaceuticals, Inc. (Carlsbad, Calif.) reported on more advanced techniques in attaching the cholesterol molecule to the oligonucleotide (Manoharan, 1992).

With the discovery of siRNAs in the late nineties, similar types of modifications were attempted on these molecules to enhance their delivery profiles. Cholesterol molecules conjugated to slightly modified (Soutschek, 2004) and heavily modified (Wolfrum, 2007) siRNAs appeared in the literature. Yamada et al., 2008 also reported on the use of advanced linker chemistries which further improved cholesterol mediated uptake of siRNAs. In spite of all this effort, the uptake of these types of compounds appears to be inhibited in the presence of biological fluids resulting in highly limited efficacy in gene silencing in vivo, limiting the applicability of these compounds in a clinical setting.

Therefore, it would be of great benefit to improve upon the prior art oligonucleotides by designing oligonucleotides that have improved delivery properties in vivo and are clinically meaningful.

SUMMARY OF INVENTION

Described herein are asymmetric chemically modified nucleic acid molecules with minimal double stranded regions, and the use of such molecules in gene expression modulation. RNAi molecules associated with the invention contain single stranded regions and double stranded regions, and can contain a variety of chemical modifications within both the single stranded and double stranded regions of the molecule. Additionally, the RNAi molecules can be attached to a hydrophobic conjugate such as a conventional and advanced sterol-type molecule. This new class of RNAi molecules has superior efficacy both in vitro and in vivo than previously described RNAi molecules.

Aspects of the invention relate to an isolated nucleic acid molecule having a guide strand of 18-23 nucleotides in length that has complementarity to a miRNA sequence and a passenger strand of 8-16 nucleotides in length. The guide strand and the passenger strand form the nucleic acid molecule such that the nucleic acid has a double stranded region and a single stranded region, wherein the single stranded region is the 3′ end of the guide strand and is 2-13 nucleotides in length and comprises at least two phosphorothioate modifications. At least 50% of the pyrimidines in the nucleic acid molecule are modified.

In some embodiments the nucleotide in position one of the guide strand has a 2′-O-methyl modification. For example, the nucleotide in position one of the guide strand may be a 5P-2′O-methyl U.

In other embodiments, at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 98% or 99% of the pyrimidines in the nucleic acid molecule are modified. 100% of the pyrimidines in the nucleic acid molecule are modified in other embodiments. The modified pyrimidines may be, for instance, 2′fluoro or 2′O methyl modified.

In some embodiments at least one U or C includes a hydrophobic modification. In other embodiments a plurality of U's and/or C's include a hydrophobic modification. The hydrophobic modification may be, for instance, a methyl or ethyl hydrophobic base modification.

The guide strand may include a number of phosphate backbone modifications, such as phosphorothioate modifications. The guide strand contains 6-8 phosphorothioate modifications in some embodiments. In other embodiments the 3′ terminal 10 nucleotides of the guide strand include at least eight phosphorothioate modifications. In yet other embodiments the guide strand includes 4-14 phosphate modifications. These modifications may be on the single stranded region, the double stranded region or both.

The nucleic acid molecule includes a single stranded and a double stranded region. The single stranded region of the guide strand, in some embodiments, is 6 nucleotides long. In other embodiments the single stranded region of the guide strand is 8 nucleotides long. The double stranded region may be 12-14 or 13 nucleotides long in other embodiments.

Optionally, the double stranded nucleic acid molecule has one end that is blunt or includes a one nucleotide overhang.

The passenger strand is linked at the 3′ end to a lipophilic group according to some embodiments. The lipophilic group may be a sterol, such as cholesterol.

The isolated double stranded nucleic acid molecule in some embodiments is an miRNA mimic. The miRNA sequence to which the guide strand is complementary in the miRNA mimic is a miRNA recognition element. In some embodiments the miRNA mimic is a mimic of an miRNA selected from the group consisting of miR21, miR 139, miR 7, miR29, miR 122, miR 302-367 cluster, miR 221, miR-96, miR 126, miR 225 and miR 206.

In other embodiments the isolated double stranded nucleic acid molecule is an miRNA inhibitor. The miRNA sequence to which the guide strand is complementary in the miRNA inhibitor is an antisense strand of a mature miRNA. In some embodiments the guide strand is at least 50% chemically modified. In other embodiments the mature miRNA is miR 17-92.

According to aspects of the invention, a method for modulating miRNA-mediated gene expression in a mammalian cell is provided. The method involves contacting the mammalian cell with an isolated double stranded nucleic acid molecule described herein in an effective amount to modulate miRNA-mediated gene expression. In some embodiments miRNA-mediated gene expression in the mammalian cell is reduced. In other embodiments miRNA-mediated gene expression in the mammalian cell is increased. The mammalian cell may contacted with the isolated nucleic acid in vivo, ex vivo, or in vitro.

The invention also involves in other aspects a method for modulating miRNA-mediated gene expression in a stem cell. The method involves contacting the stem cell with an isolated double stranded nucleic acid molecule described herein in an effective amount to modulate miRNA-mediated gene expression in the stem cell. The methods are useful for example in promoting or inhibiting stem cell differentiation, tissue remodeling, organ preservation etc.

Each of the limitations of the invention can encompass various embodiments of the invention. It is, therefore, anticipated that each of the limitations of the invention involving any one element or combinations of elements can be included in each aspect of the invention. This invention is not limited in its application to the details of construction and the arrangement of components set forth in the following description or illustrated in the drawings. The invention is capable of other embodiments and of being practiced or of being carried out in various ways.

BRIEF DESCRIPTION OF DRAWINGS

The accompanying drawings are not intended to be drawn to scale. In the drawings, each identical or nearly identical component that is illustrated in various figures is represented by a like numeral. For purposes of clarity, not every component may be labeled in every drawing. In the drawings:

FIGS. 1A-1D are a schematic depicting proposed structures of asymmetric double stranded RNA molecules (adsRNA). Bold lines represent sequences carrying modification patterns compatible with RISC loading. Striped lines represent polynucleotides carrying modifications compatible with passenger strands. Plain lines represent a single stranded polynucleotide with modification patterns optimized for cell interaction and uptake. FIG. 1A depicts adsRNA with extended guide or passenger strands; FIG. 1B depicts adsRNA with length variations of a cell penetrating polynucleotide; FIG. 1C depicts adsRNA with 3′ and 5′ conjugates; FIG. 1D depicts adsRNAs with mismatches.

FIG. 2 is a schematic depicting asymmetric dsRNA molecules with different chemical modification patterns. Several examples of chemical modifications that might be used to increase hydrophobicity are shown including 4-pyridyl, 2-pyridyl, isobutyl and indolyl based position 5 uridine modifications.

FIG. 3 is a schematic depicting the use of dsRNA binding domains, protamine (or other Arg rich peptides), spermidine or similar chemical structures to block duplex charge to facilitate cellular entry.

FIG. 4 is a schematic depicting positively charged chemicals that might be used for polynucleotide charge blockage.

FIG. 5 is a schematic depicting examples of structural and chemical compositions of single stranded RISC entering polynucleotides. The combination of one or more modifications including 2′d, 2′Ome, 2′F, hydrophobic and phosphorothioate modifications can be used to optimize single strand entry into the RISC.

FIG. 6 is a schematic depicting examples of structural and chemical composition of RISC substrate inhibitors. Combinations of one or more chemical modifications can be used to mediate efficient uptake and efficient binding to preloaded RISC complex.

FIGS. 7A-7D are a schematic depicting structures of polynucleotides with sterol type molecules attached, where R represent a polycarbonic tail of 9 carbons or longer. FIG. 7A depicts an adsRNA molecule; FIG. 7B depicts an siRNA molecule of approximately 17-30 bp long; FIG. 7C depicts a RISC entering strand; FIG. 7D depicts a substrate analog strand. Chemical modification patterns, as depicted in FIGS. 7A-7D, can be optimized to promote desired function.

FIG. 8 is a schematic depicting examples of naturally occurring phytosterols with a polycarbon chain that is longer than 8, attached at position 17. More than 250 different types of phytosterols are known.

FIG. 9 is a schematic depicting examples of sterol-like structures, with variations in the size of the polycarbon chains attached at position 17.

FIG. 10 presents schematics and graphs demonstrating that the percentage of liver uptake and plasma clearance of lipid emulsions containing sterol type molecules is directly affected by the size of the polycarbon chain attached at position 17. This figure is adapted from Martins et al, Journal of Lipid Research (1998).

FIGS. 11A-11C are a schematic depicting micelle formation. FIG. 11A depicts a polynucleotide with a hydrophobic conjugate; FIG. 11B depicts linoleic acid; FIG. 11C depicts a micelle formed from a mixture of polynucleotides containing hydrophobic conjugates combined with fatty acids.

FIG. 12 is a schematic depicting how alteration in lipid composition can affect pharmacokinetic behavior and tissue distribution of hydrophobically modified and/or hydrophobically conjugated polynucleotides. In particular, use of lipid mixtures enriched in linoleic acid and cardiolipin results in preferential uptake by cardiomyocites.

FIG. 13 is a schematic showing examples of RNAi constructs and controls used to target MAP4K4 expression. RNAi construct 12083 corresponds to SEQ ID NOs:597 and 598. RNAi construct 12089 corresponds to SEQ ID NO:599.

FIG. 14 is a graph showing MAP4K4 expression following transfection with RNAi constructs associated with the invention. RNAi constructs tested were: 12083 (Nicked), 12085 (13 nt Duplex), 12089 (No Stem Pairing) and 12134 (13 nt miniRNA). Results of transfection were compared to an untransfected control sample. RNAi construct 12083 corresponds to SEQ ID NOs:597 and 598. RNAi construct 12085 corresponds to SEQ ID NOs:600 and 601. RNAi construct 12089 corresponds to SEQ ID NO:599. RNAi construct 12134 corresponds to SEQ ID NOs:602 and 603.

FIG. 15 is a graph showing expression of MAP4K4 24 hours post-transfection with RNAi constructs associated with the invention. RNAi constructs tested were: 11546 (MAP4K4 rxRNA), 12083 (MAP4K4 Nicked Construct), 12134 (12 bp soloRNA) and 12241 (14/3/14 soloRNA). Results of transfection were compared to a filler control sample. RNAi construct 11546 corresponds to SEQ ID NOs:604 and 605. RNAi construct 12083 corresponds to SEQ ID NOs:597 and 598. RNAi construct 12134 corresponds to SEQ ID NOs:602 and 603. RNAi construct 12241 corresponds to SEQ ID NOs:606 and 607.

FIG. 16 presents a graph and several tables comparing parameters associated with silencing of MAP4K4 expression following transfection with RNAi constructs associated with the invention. The rxRNA construct corresponds to SEQ ID NOs:604 and 605. The 14-3-14 soloRNA construct corresponds to SEQ ID NOs:606 and 607. The 13/19 duplex (nicked construct) corresponds to SEQ ID NOs:597 and 598. The 12-bp soloRNA construct corresponds to SEQ ID NOs:602 and 603.

FIG. 17 is a schematic showing examples of RNAi constructs and controls used to target SOD1 expression. The 12084 RNAi construct corresponds to SEQ ID NOs:612 and 613.

FIG. 18 is a graph showing SOD1 expression following transfection with RNAi constructs associated with the invention. RNAi constructs tested were: 12084 (Nicked), 12086 (13 nt Duplex), 12090 (No Stem Pairing) and 12035 (13 nt MiniRNA). Results of transfection were compared to an untransfected control sample. The 12084 RNAi construct corresponds to SEQ ID NOs:612 and 613. The 12086 RNAi construct corresponds to SEQ ID NOs:608 and 609. The 12035 RNAi construct corresponds to SEQ ID NOs:610 and 611.

FIG. 19 is a graph showing expression of SOD1 24 hours post-transfection with RNAi constructs associated with the invention. RNAi constructs tested were: 10015 (SOD1 rxRNA) and 12084 (SOD1 Nicked Construct). Results of transfection were compared to a filler control sample. The 10015 RNAi construct corresponds to SEQ ID NOs:614 and 615. The 12084 RNAi construct corresponds to SEQ ID NOs:612 and 613.

FIG. 20 is a schematic indicating that RNA molecules with double stranded regions that are less than 10 nucleotides are not cleaved by Dicer.

FIG. 21 is a schematic revealing a hypothetical RNAi model for RNA induced gene silencing.

FIG. 22 is a graph showing chemical optimization of asymmetric RNAi compounds. The presence of chemical modifications, in particular 2′F UC, phosphorothioate modifications on the guide strand, and complete CU 2′OMe modification of the passenger strands results in development of functional compounds. Silencing of MAP4K4 following lipid-mediated transfection is shown using RNAi molecules with specific modifications. RNAi molecules tested had sense strands that were 13 nucleotides long and contained the following modifications: unmodified; C and U 2′OMe; C and U 2′OMe and 3′ Chl; rxRNA 2′OMe pattern; or full 2′OMe, except base 1. Additionally, the guide (anti-sense) strands of the RNAi molecules tested contained the following modifications: unmodified; unmodified with 5′P; C and U 2′F; C and U 2′F with 8 PS 3′ end; and unmodified (17 nt length). Results for rxRNA 12/10 Duplex and negative controls are also shown.

FIG. 23 demonstrates that the chemical modifications described herein significantly increase in vitro efficacy in un-assisted delivery of RNAi molecules in HeLa cells. The structure and sequence of the compounds were not altered; only the chemical modification patterns of the molecules were modified. Compounds lacking 2′F, 2′O-me, phosphorothioate modification, or cholesterol conjugates were completely inactive in passive uptake. A combination of all 4 of these types of modifications produced the highest levels of activity (compound 12386).

FIG. 24 is a graph showing MAP4K4 expression in Hela cells following passive uptake transfection of: NT Accell modified siRNA, MAP4K4 Accell siRNA, Non-Chl nanoRNA (12379) and sd-nanoRNA (12386).

FIG. 25 is a graph showing expression of MAP4K4 in HeLa cells following passive uptake transfection of various concentrations of RNA molecules containing the following parameters: Nano Lead with no 3′Chl; Nano Lead; Accell MAP4K4; 21mer GS with 8 PS tail; 21mer GS with 12 PS tail; and 25mer GS with 12 PS tail.

FIG. 26 is a graph demonstrating that reduction in oligonucleotide content increases the efficacy of unassisted uptake. Similar chemical modifications were applied to asymmetric compounds, traditional siRNA compounds and 25 mer RNAi compounds. The asymmetric small compounds demonstrated the most significant efficacy.

FIGS. 27A and 27B are graphs demonstrating the importance of phosphorothioate content for un-assisted delivery. FIG. 27A demonstrates the results of a systematic screen that revealed that the presence of at least 2-12 phosphorothioates in the guide strand significantly improves uptake; in some embodiments, 4-8 phosphorothioate modifications were found to be preferred. FIG. 27B reveals that the presence or absence of phosphorothioate modifications in the sense strand did not alter efficacy.

FIG. 28 is a graph showing expression of MAP4K4 in primary mouse hepatocytes following passive uptake transfection of: Accell Media-Ctrl-UTC; MM APOB Alnylam; Active APOB Alnylam; nanoRNA without chl; nanoRNA MAP4K4; Mouse MAP4K4 Accell Smartpool; DY547 Accell Control; Luc Ctrl rxRNA with Dy547; MAP4K4 rxRNA with DY547; and AS Strand Alone (nano).

FIG. 29 is a graph showing expression of ApoB in mouse primary hepatocytes following passive uptake transfection of: Accell Media-Ctrl-UTC; MM APOB Alnylam; Active APOB Alnylam; nanoRNA without chl; nanoRNA MAP4K4; Mouse MAP4K4 Accell Smartpool; DY547 Accell Control; Luc Ctrl rxRNA with Dy547; MAP4K4 rxRNA with DY547; and AS Strand Alone (nano).

FIG. 30 is a graph showing expression of MAP4K4 in primary human hepatocytes following passive uptake transfection of: 11550 MAP4K4 rxRNA; 12544 MM MAP4K4 nanoRNA; 12539 Active MAP4K4 nanoRNA; Accell Media; and UTC.

FIG. 31 is a graph showing ApoB expression in primary human hepatoctyes following passive uptake transfection of: 12505 Active ApoB chol-siRNA; 12506 MM ApoB chol-siRNA; Accell Media; and UTC.

FIG. 32 is an image depicting localization of sd-rxRNA^nano localization.

FIG. 33 is an image depicting localization of Chol-siRNA (Alnylam).

FIG. 34 is a schematic of 1^st generation (G1) sd-rxRNA^nano molecules associated with the invention indicating regions that are targeted for modification, and functions associated with different regions of the molecules.

FIG. 35 depicts modification patterns that were screened for optimization of sd-rxRNA^nano (G1). The modifications that were screened included, on the guide strand, lengths of 19, 21 and 25 nucleotides, phosphorothioate modifications of 0-18 nucleotides, and replacement of 2′F modifications with 2′OMe, 5 Methyl C and/or ribo Thymidine modifications. Modifications on the sense strand that were screened included nucleotide lengths of 11, 13 and 19 nucleotides, phosphorothiote modifications of 0-4 nucleotides and 2′OMe modifications.

FIG. 36 is a schematic depicting modifications of sd-rxRNA^nano that were screened for optimization.

FIG. 37 is a graph showing percent MAP4K4 expression in Hek293 cells following transfection of: Risc Free siRNA; rxRNA; Nano (unmodified); GS alone; Nano Lead (no Chl); Nano (GS: (3) 2′OMe at positions 1, 18, and 19, 8 PS, 19 nt); Nano (GS: (3) 2′OMe at positions 1, 18, and 19, 8 PS, 21 nt); Nano (GS: (3) 2′OMe at positions 1, 18, and 19, 12 PS, 21 nt); and Nano (GS: (3) 2′OMe at positions 1, 18, and 19, 12 PS, 25 nt);

FIG. 38 is a graph showing percent MAP4K4 expression in HeLa cells following passive uptake transfection of: GS alone; Nano Lead; Nano (GS: (3) 2′OMe at positions 1, 18, and 19, 8 PS, 19 nt); Nano (GS: (3) 2′OMe at positions 1, 18, and 19, 8 PS, 21 nt); Nano (GS: (3) 2′OMe at positions 1, 18, and 19, 12 PS, 21 nt); Nano (GS: (3) 2′OMe at positions 1, 18, and 19, 12 PS, 25 nt).

FIG. 39 is a graph showing percent MAP4K4 expression in Hek293 cells following lipid mediated transfection of: Guide Strand alone (GS: 8PS, 19 nt); Guide Strand alone (GS: 18PS, 19 nt); Nano (GS: no PS, 19 nt); Nano (GS: 2 PS, 19 nt); Nano (GS: 4 PS, 19 nt); Nano (GS: 6 PS, 19 nt); Nano Lead (GS: 8 PS, 19 nt); Nano (GS: 10 PS, 19 nt); Nano (GS: 12 PS, 19 nt); and Nano (GS: 18 PS, 19 nt).

FIG. 40 is a graph showing percent MAP4K4 expression in Hek293 cells following lipid mediated transfection of: Guide Strand alone (GS: 8PS, 19 nt); Guide Strand alone (GS: 18PS, 19 nt); Nano (GS: no PS, 19 nt); Nano (GS: 2 PS, 19 nt); Nano (GS: 4 PS, 19 nt); Nano (GS: 6 PS, 19 nt); Nano Lead (GS: 8 PS, 19 nt); Nano (GS: 10 PS, 19 nt); Nano (GS: 12 PS, 19 nt); and Nano (GS: 18 PS, 19 nt).

FIG. 41 is a graph showing percent MAP4K4 expression in HeLa cells following passive uptake transfection of: Nano Lead (no Chl); Guide Strand alone (18 PS); Nano (GS: 0 PS, 19 nt); Nano (GS: 2 PS, 19 nt); Nano (GS: 4 PS, 19 nt); Nano (GS: 6 PS, 19 nt); Nano Lead (GS: 8 PS, 19 nt); Nano (GS: 10 PS, 19 nt); Nano (GS: 12 PS, 19 nt); and Nano (GS: 18 PS, 19 nt).

FIG. 42 is a graph showing percent MAP4K4 expression in HeLa cells following passive uptake transfection of: Nano Lead (no Chl); Guide Strand alone (18 PS); Nano (GS: 0 PS, 19 nt); Nano (GS: 2 PS, 19 nt); Nano (GS: 4 PS, 19 nt); Nano (GS: 6 PS, 19 nt); Nano Lead (GS: 8 PS, 19 nt); Nano (GS: 10 PS, 19 nt); Nano (GS: 12 PS, 19 nt); and Nano (GS: 18 PS, 19 nt).

FIG. 43 is a schematic depicting guide strand chemical modifications that were screened for optimization.

FIG. 44 is a graph showing percent MAP4K4 expression in Hek293 cells following reverse transfection of: RISC free siRNA; GS only (2′F C and Us); GS only (2′OMe C and Us); Nano Lead (2′F C and Us); nano (GS: (3) 2′OMe, positions 16-18); nano (GS: (3) 2′OMe, positions 16, 17 and 19); nano (GS: (4) 2′OMe, positions 11, 16-18); nano (GS: (10) 2′OMe,C and Us); nano (GS: (6) 2′OMe, positions 1 and 5-9); nano (GS: (3) 2′OMe, positions 1, 18 and 19); and nano (GS: (5) 2′OMe Cs).

FIG. 45 is a graph demonstrating efficacy of various chemical modification patterns. In particular, 2-OMe modification in positions 1 and 11-18 was well tolerated. 2′OMe modifications in the seed area resulted in a slight reduction of efficacy (but were still highly efficient). Ribo-modifications in the seed were well tolerated. This data enabled the generation of self delivering compounds with reduced or no 2′F modifications. This is significant because 2′F modifications may be associated with toxicity in vivo.

FIG. 46 is a schematic depicting sense strand modifications.

FIG. 47 is a graph demonstrating sense strand length optimization. A sense strand length between 10-15 bases was found to be optimal in this assay. Increasing sense strand length resulted in a reduction of passive uptake of these compounds but may be tolerated for other compounds. Sense strands containing LNA modification demonstrated similar efficacy to non-LNA containing compounds. In some embodiments, the addition of LNA or other thermodynamically stabilizing compounds can be beneficial, resulting in converting non-functional sequences into functional sequences.

FIG. 48 is a graph showing percent MAP4K4 expression in HeLa cells following passive uptake transfection of: Guide Strand Alone (2′F C and U); Nano Lead; Nano Lead (No Chl); Nano (SS: 11 nt 2′OMe C and Us, Chl); Nano (SS: lint, complete 2′OMe, Chl); Nano (SS: 19 nt, 2′OMe C and Us, Chl); Nano (SS: 19 nt, 2′OMe C and Us, no Chl).

FIG. 49 is a graph showing percent MAP4K4 expression in HeLa cells following passive uptake transfection of: Nano Lead (No Chl); Nano (SS no PS); Nano Lead (SS:2 PS); Nano (SS:4 PS).

FIG. 50 is a schematic depicting a sd-rxRNA^nano second generation (GII) lead molecule.

FIG. 51 presents a graph indicating EC50 values for MAP4K4 silencing in the presence of sd-rxRNA, and images depicting localization of DY547-labeled rxRNA^ori and DY547-labeled sd-rxRNA.

FIG. 52 is a graph showing percent MAP4K4 expression in HeLa cells in the presence of optimized sd-rxRNA molecules.

FIG. 53 is a graph depicting the relevance of chemistry content in optimization of sd-rxRNA efficacy.

FIG. 54 presents schematics of sterol-type molecules and a graph revealing that sd-rxRNA compounds are fully functional with a variety of linker chemistries. GII asymmetric compounds were synthesized with sterol type molecules attached through TEG and amino caproic acid linkers. Both linkers showed identical potency. This functionality independent of linker chemistry indicates a significant difference between the molecules described herein and previously described molecules, and offers significant advantages for the molecules described herein in terms of scale up and synthesis.

FIG. 55 demonstrates the stability of chemically modified sd-rxRNA compounds in human serum in comparison to non modified RNA. The oligonucleotides were incubated in 75% serum at 37° C. for the number of hours indicated. The level of degradation was determined by running the samples on non-denaturing gels and staining with SYBGR.

FIG. 56 is a graph depicting optimization of cellular uptake of sd-rxRNA through minimizing oligonucleotide content.

FIG. 57 is a graph showing percent MAP4K4 expression after spontaneous cellular uptake of sd-rxRNA in mouse PEC-derived macrophages, and phase and fluorescent images showing localization of sd-rxRNA.

FIG. 58 is a graph showing percent MAP4K4 expression after spontaneous cellular uptake of sd-rxRNA (targeting) and sd-rxRNA (mismatch) in mouse primary hepatocytes, and phase and fluorescent images showing localization of sd-rxRNA.

FIG. 59 presents images depicting localization of DY547-labeled sd-rxRNA delivered to RPE cells with no formulation.

FIG. 60 is a graph showing silencing of MAP4K4 expression in RPE cells treated with sd-rxRNA^nano without formulation.

FIG. 61 presents a graph and schematics of RNAi compounds showing the chemical/structural composition of highly effective sd-rxRNA compounds. Highly effective compounds were found to have the following characteristics: anti sense strands of 17-21 nucleotides, sense strands of 10-15 nucleotides, single-stranded regions that contained 2-12 phosphorothioate modifications, preferentially 6-8 phosphorothioate modifications, and sense strands in which the majority of nucleotides were 2′OMe modified, with or without phosphorothioate modification. Any linker chemistry can be used to attach these molecules to hydrophobic moieties such as cholesterol at the 3′ end of the sense strand. Version GIIa-b of these RNA compounds demonstrate that elimination of 2′F content has no impact on efficacy.

FIG. 62 presents a graph and schematics of RNAi compounds demonstrating the superior performance of sd-rxRNA compounds compared to compounds published by Wolfrum et. al. Nature Biotech, 2007. Both generation I and II compounds (GI and GIIa) developed herein show great efficacy. By contrast, when the chemistry described in Wolfrum et al. (all oligos contain cholesterol conjugated to the 3′ end of the sense strand) was applied to the same sequence in a context of conventional siRNA (19 bp duplex with two overhang) the compound was practically inactive. These data emphasize the significance of the combination of chemical modifications and asymmetrical molecules described herein, producing highly effective RNA compounds.

FIG. 63 presents images showing that sd-rxRNA accumulates inside cells while other less effective conjugate RNAs accumulate on the surface of cells.

FIG. 64 presents images showing that sd-rxRNA molecules, but not other molecules, are internalized into cells within minutes.

FIGS. 65A-65F present images demonstrating that sd-rxRNA compounds have drastically better cellular and tissue uptake characteristics when compared to conventional cholesterol conjugated siRNAs (such as those published by Soucheck et al). FIG. 65A-65B compare uptake in RPE cells, FIG. 65C-65D compare uptake upon local administration to skin and FIG. 65E-65F compare uptake by the liver upon systemic administration. The level of uptake is at least an order of magnitude higher for the sd-rxRNA compounds relative to the regular siRNA-cholesterol compounds.

FIG. 66 presents images depicting localization of rxRNA^ori and sd-rxRNA following local delivery.

FIG. 67 presents images depicting localization of sd-rxRNA and other conjugate RNAs following local delivery.

FIG. 68 presents a graph revealing the results of a screen performed with sd-rxRNAGII chemistry to identify functional compounds targeting the SPP1 gene. Multiple effective compounds were identified, with 14131 being the most effective. The compounds were added to A-549 cells and the level of the ratio of SPP 1/PPM was determined by B-DNA after 48 hours.

FIG. 69 presents a graph and several images demonstrating efficient cellular uptake of sd-rxRNA within minutes of exposure. This is a unique characteristics of the sd-rxRNA compounds described herein, not observed with any other RNAi compounds. The Soutschek et al. compound was used as a negative control.

FIG. 70 presents a graph and several images demonstrating efficient uptake and silencing of sd-rxRNA compounds in multiple cell types with multiple sequences. In each case silencing was confirmed by looking at target gene expression using a Branched DNA assay.

FIG. 71 presents a graph revealing that sd-rxRNA is active in the presence and absence of serum. A slight reduction in efficacy (2-5 fold) was observed in the presence of serum. This minimal reduction in efficacy in the presence of serum differentiates the sd-rxRNA compounds described herein from previously described RNAi compounds, which had a greater reduction in efficacy, and thus creates a foundation for in vivo efficacy of the sd-rxRNA molecules described herein.

FIG. 72 presents images demonstrating efficient tissue penetration and cellular uptake upon single intradermal injection of sd-rxRNA compounds described herein. This represents a model for local delivery of sd-rxRNA compounds as well as an effective demonstration of delivery of sd-rxRNA compounds and silencing of genes in dermatological applications.

FIG. 73 presents images and a graph demonstrating efficient cellular uptake and in vivo silencing with sd-rxRNA following intradermal injection.

FIG. 74 presents graphs demonstrating that sd-rxRNA compounds have improved blood clearance and induce effective gene silencing in vivo in the liver upon systemic administration.

FIG. 75 presents a graph demonstrating that the presence of 5-Methyl C in an RNAi compound resulted in an increase in potency of lipid mediated transfection, demonstrating that hydrophobic modification of Cs and Us in the content of RNAi compounds can be beneficial. In some embodiments, these types of modifications can be used in the context of 2′ ribose modified bases to insure optimal stability and efficacy.

FIG. 76 presents a graph showing percent MAP4K4 expression in HeLa cells following passive uptake transfection of: Guide strand alone; Nano Lead; Nano Lead (No cholesterol); Guide Strand w/5MeC and 2′F Us Alone; Nano Lead w/GS 5MeC and 2′F Us; Nano Lead w/GS riboT and 5 Methyl Cs; and Nano Lead w/Guide dT and 5 Methyl Cs.

FIG. 77 presents images comparing localization of sd-rxRNA and other RNA conjugates following systemic delivery to the liver.

FIG. 78A presents schematics demonstrating 5-uridyl modifications with improved hydrophobicity characteristics. Incorporation of such modifications into sd-rxRNA compounds can increase cellular and tissue uptake properties. FIG. 78B presents a new type of RNAi compound modification which can be applied to compounds to improve cellular uptake and pharmacokinetic behavior. This type of modification, when applied to sd-rxRNA compounds, may contribute to making such compounds orally available.

FIG. 79 presents schematics revealing the structures of synthesized modified sterol type molecules, where the length and structure of the C17 attached tail is modified. Without wishing to be bound by any theory, the length of the C17 attached tail may contribute to improving in vitro and in vivo efficacy of sd-rxRNA compounds.

FIG. 80 presents a schematic demonstrating the lithocholic acid route to long side chain cholesterols.

FIG. 81 presents a schematic demonstrating a route to 5-uridyl phosphoramidite synthesis.

FIG. 82 presents a schematic demonstrating synthesis of tri-functional hydroxyprolinol linker for 3′-cholesterol attachment.

FIG. 83 presents a schematic demonstrating synthesis of solid support for the manufacture of a shorter asymmetric RNAi compound strand.

FIG. 84 demonstrates SPPI sd-rxRNA compound selection. Sd-rxRNA compounds targeting SPP1 were added to A549 cells (using passive transfection) and the level of SPP1 expression was evaluated after 48 hours. Several novel compounds effective in SPP1 silencing were identified, the most potent of which was compound 14131.

FIG. 85 demonstrates independent validation of sd-rxRNA compounds 14116, 14121, 14131, 14134, 14139, 14149, and 14152 efficacy in SPP1 silencing.

FIG. 86 demonstrates results of sd-rxRNA compound screens to identify sd-rxRNA compounds functional in CTGF knockdown.

FIG. 87 demonstrates results of sd-rxRNA compound screens to identify sd-rxRNA functional in CTGF knockdown.

FIG. 88 demonstrates a systematic screen identifying the minimal length of the asymmetric compounds. The passenger strand of 10-19 bases was hybridized to a guide strand of 17-25 bases. In this assay, compounds with duplex regions as short as 10 bases were found to be effective in inducing.

FIG. 89 demonstrates that positioning of the sense strand relative to the guide strand is critical for RNAi Activity. In this assay, a blunt end was found to be optimal, a 3′ overhang was tolerated, and a 5′ overhang resulted in complete loss of functionality.

FIG. 90 demonstrates that the guide strand, which has homology to the target only at nucleotides 2-17, resulted in effective RNAi when hybridized with sense strands of different lengths. The compounds were introduced into HeLa cells via lipid mediated transfection.

FIG. 91 is a schematic depicting a panel of sterol-type molecules which can be used as a hydrophobic entity in place of cholesterol. In some instances, the use of sterol-type molecules comprising longer chains results in generation of sd-rxRNA compounds with significantly better cellular uptake and tissue distribution properties.

FIG. 92 presents schematics depicting a panel of hydrophobic molecules which might be used as a hydrophobic entity in place of cholesterol. These list just provides representative examples; any small molecule with substantial hydrophobicity can be used.

DETAILED DESCRIPTION

Aspects of the invention relate to methods and compositions involved in gene silencing. The invention is based at least in part on the surprising discovery that asymmetric nucleic acid molecules with a double stranded region of a minimal length such as 8-14 nucleotides, are effective in silencing gene expression. Molecules with such a short double stranded region have not previously been demonstrated to be effective in mediating RNA interference. It had previously been assumed that that there must be a double stranded region of 19 nucleotides or greater. The molecules described herein are optimized through chemical modification, and in some instances through attachment of hydrophobic conjugates.

The invention is based at least in part on another surprising discovery that asymmetric nucleic acid molecules with reduced double stranded regions are much more effectively taken up by cells compared to conventional siRNAs. These molecules are highly efficient in silencing of target gene expression and offer significant advantages over previously described RNAi molecules including high activity in the presence of serum, efficient self delivery, compatibility with a wide variety of linkers, and reduced presence or complete absence of chemical modifications that are associated with toxicity.

In contrast to single-stranded polynucleotides, duplex polynucleotides have been difficult to deliver to a cell as they have rigid structures and a large number of negative charges which makes membrane transfer difficult. Unexpectedly, it was found that the polynucleotides of the present invention, although partially double-stranded, are recognized in vivo as single-stranded and, as such, are capable of efficiently being delivered across cell membranes. As a result the polynucleotides of the invention are capable in many instances of self delivery. Thus, the polynucleotides of the invention may be formulated in a manner similar to conventional RNAi agents or they may be delivered to the cell or subject alone (or with non-delivery type carriers) and allowed to self deliver. In one embodiment of the present invention, self delivering asymmetric double-stranded RNA molecules are provided in which one portion of the molecule resembles a conventional RNA duplex and a second portion of the molecule is single stranded.

The polynucleotides of the invention are referred to herein as isolated double stranded or duplex nucleic acids, oligonucleotides or polynucleotides, nano molecules, nano RNA, sd-rxRNA^nano, sd-rxRNA or RNA molecules of the invention.

The oligonucleotides of the invention in some aspects have a combination of asymmetric structures including a double stranded region and a single stranded region of 5 nucleotides or longer, specific chemical modification patterns and are conjugated to lipophilic or hydrophobic molecules. This new class of RNAi like compounds have superior efficacy in vitro and in vivo. Based on the data described herein it is believed that the reduction in the size of the rigid duplex region in combination with phosphorothioate modifications applied to a single stranded region are new and important for achieving the observed superior efficacy. Thus, the RNA molecules described herein are different in both structure and composition as well as in vitro and in vivo activity.

In a preferred embodiment the RNAi compounds of the invention comprise an asymmetric compound comprising a duplex region (required for efficient RISC entry of 10-15 bases long) and single stranded region of 4-12 nucleotides long; with a 13 nucleotide duplex. A 6 nucleotide single stranded region is preferred in some embodiments. The single stranded region of the new RNAi compounds also comprises 2-12 phosphorothioate internucleotide linkages (referred to as phosphorothioate modifications). 6-8 phosphorothioate internucleotide linkages are preferred in some embodiments. Additionally, the RNAi compounds of the invention also include a unique chemical modification pattern, which provides stability and is compatible with RISC entry. The combination of these elements has resulted in unexpected properties which are highly useful for delivery of RNAi reagents in vitro and in vivo.

The chemically modification pattern, which provides stability and is compatible with RISC entry includes modifications to the sense, or passenger, strand as well as the antisense, or guide, strand. For instance the passenger strand can be modified with any chemical entities which confirm stability and do not interfere with activity. Such modifications include 2′ ribo modifications (O-methyl, 2′ F, 2 deoxy and others) and backbone modification like phosphorothioate modifications. A preferred chemical modification pattern in the passenger strand includes O-methyl modification of C and U nucleotides within the passenger strand or alternatively the passenger strand may be completely O-methyl modified.

The guide strand, for example, may also be modified by any chemical modification which confirms stability without interfering with RISC entry. A preferred chemical modification pattern in the guide strand includes the majority of C and U nucleotides being 2′F modified and the 5′end being phosphorylated. Another preferred chemical modification pattern in the guide strand includes 2′Omethyl modification of position 1 and C/U in positions 11-18 and 5′end chemical phosphorylation. Yet another preferred chemical modification pattern in the guide strand includes 2′Omethyl modification of position 1 and C/U in positions 11-18 and 5′ end chemical phosphorylation and 2′F modification of C/U in positions 2-10.

It was surprisingly discovered according to the invention that the above-described chemical modification patterns of the oligonucleotides of the invention are well tolerated and actually improved efficacy of asymmetric RNAi compounds. See, for instance, FIG. 22.

It was also demonstrated experimentally herein that the combination of modifications to RNAi when used together in a polynucleotide results in the achievement of optimal efficacy in passive uptake of the RNAi. Elimination of any of the described components (Guide strand stabilization, phosphorothioate stretch, sense strand stabilization and hydrophobic conjugate) or increase in size results in sub-optimal efficacy and in some instances complete lost of efficacy. The combination of elements results in development of compound, which is fully active following passive delivery to cells such as HeLa cells. (FIG. 23). The degree to which the combination of elements results in efficient self delivery of RNAi molecules was completely unexpected.

The data shown in FIGS. 26, 27 and 43 demonstrated the importance of the various modifications to the RNAi in achieving stabilization and activity. For instance, FIG. 26 demonstrates that use off asymmetric configuration is important in getting efficacy in passive uptake. When the same chemical composition is applied to compounds of traditional configurations (19-21 bases duplex and 25 mer duplex) the efficacy was drastically decreased in a length dependent manner. FIG. 27 demonstrated a systematic screen of the impact of phosphorothioate chemical modifications on activity. The sequence, structure, stabilization chemical modifications, hydrophobic conjugate were kept constant and compound phosphorothioate content was varied (from 0 to 18 PS bond). Both compounds having no phosphorothioate linkages and having 18 phosphorothioate linkages were completely inactive in passive uptake. Compounds having 2-16 phosphorothioate linkages were active, with compounds having 4-10 phosphorothioate being the most active compounds.

The data in the Examples presented below demonstrates high efficacy of the oligonucleotides of the invention both in vitro in variety of cell types (supporting data) and in vivo upon local and systemic administration. For instance, the data compares the ability of several competitive RNAi molecules having different chemistries to silence a gene. Comparison of sd-rxRNA (oligonucleotides of the invention) with RNAs described in Soucheck et al. and Wolfrum at al., as applied to the same targeting region, demonstrated that only sd-rxRNA chemistry showed a significant functionality in passive uptake. The composition of the invention achieved EC50 values of 10-50 pM. This level of efficacy is un-attainable with conventional chemistries like those described in Sauthceck at al and Accell. Similar comparisons were made in other systems, such as in vitro (RPE cell line), in vivo upon local administration (wounded skin) and systemic (50 mg/kg) as well as other genes (FIGS. 65 and 68). In each case the oligonucleotides of the invention achieved better results. FIG. 64 includes data demonstrating efficient cellular uptake and resulting silencing by sd-rxRNA compounds only after 1 minute of exposure. Such an efficacy is unique to this composition and have not been seen with other types of molecules in this class. FIG. 70 demonstrates efficient uptake and silencing of sd-rxRNA compounds in multiple cell types with multiple sequences. The sd-rxRNA compounds are also active in cells in presence and absence of serum and other biological liquids. FIG. 71 demonstrates only a slight reduction in activity in the presence of serum. This ability to function in biologically aggressive environment effectively further differentiates sd-rxRNA compounds from other compounds described previously in this group, like Accell and Soucheck et al, in which uptake is drastically inhibited in a presence of serum.

Significant amounts of data also demonstrate the in vivo efficacy of the compounds of the invention. For instance FIGS. 72-74 involve multiple routes of in vivo delivery of the compounds of the invention resulting in significant activity. FIG. 72, for example, demonstrates efficient tissue penetration and cellular uptake upon single intradermal injection. This is a model for local delivery of sd-rxRNA compounds as well as an effective delivery mode for sd-rxRNA compounds and silencing genes in any dermatology applications. FIG. 73 demonstrated efficient tissue penetration, cellular uptake and silencing upon local in vivo intradermal injection of sd-rxRNA compounds. The data of FIG. 74 demonstrate that sd-rxRNA compounds result in highly effective liver uptake upon IV administration. Comparison to Souicheck at al molecule showed that the level of liver uptake at identical dose level was quite surprisingly, at least 50 fold higher with the sd-rxRNA compound than the Souicheck at al molecule.

The sd-rxRNA can be further improved in some instances by improving the hydrophobicity of compounds using of novel types of chemistries. For example one chemistry is related to use of hydrophobic base modifications. Any base in any position might be modified, as long as modification results in an increase of the partition coefficient of the base. The preferred locations for modification chemistries are positions 4 and 5 of the pyrimidines. Preferably the base modification is a methyl or ethyl modification. The major advantage of these positions is (a) ease of synthesis and (b) lack of interference with base-pairing and A form helix formation, which are essential for RISC complex loading and target recognition. Examples of these chemistries is shown in FIGS. 75-83. A version of sd-rxRNA compounds where multiple deoxy Uridines are present without interfering with overall compound efficacy was used. In addition major improvement in tissue distribution and cellular uptake might be obtained by optimizing the structure of the hydrophobic conjugate. In some of the preferred embodiment the structure of sterol is modified to alter (increase/decrease) C17 attached chain. This type of modification results in significant increase in cellular uptake and improvement of tissue uptake prosperities in vivo.

This invention is not limited in its application to the details of construction and the arrangement of components set forth in the following description or illustrated in the drawings. The invention is capable of other embodiments and of being practiced or of being carried out in various ways. Also, the phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting. The use of “including,” “comprising,” or “having,” “containing,” “involving,” and variations thereof herein, is meant to encompass the items listed thereafter and equivalents thereof as well as additional items.

Thus, aspects of the invention relate to isolated double stranded nucleic acid molecules comprising a guide (antisense) strand and a passenger (sense) strand. As used herein, the term “double-stranded” refers to one or more nucleic acid molecules in which at least a portion of the nucleomonomers are complementary and hydrogen bond to form a double-stranded region. In some embodiments, the length of the guide strand ranges from 16-29 nucleotides long. In certain embodiments, the guide strand is 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, or 29 nucleotides long. The guide strand has complementarity to a target gene. Complementarity between the guide strand and the target gene may exist over any portion of the guide strand. Complementarity as used herein may be perfect complementarity or less than perfect complementarity as long as the guide strand is sufficiently complementary to the target that it mediates RNAi. In some embodiments complementarity refers to less than 25%, 20%, 15%, 10%, 5%, 4%, 3%, 2%, or 1% mismatch between the guide strand and the target. Perfect complementarity refers to 100% complementarity. Thus the invention has the advantage of being able to tolerate sequence variations that might be expected due to genetic mutation, strain polymorphism, or evolutionary divergence. For example, siRNA sequences with insertions, deletions, and single point mutations relative to the target sequence have also been found to be effective for inhibition. Moreover, not all positions of a siRNA contribute equally to target recognition. Mismatches in the center of the siRNA are most critical and essentially abolish target RNA cleavage. Mismatches upstream of the center or upstream of the cleavage site referencing the antisense strand are tolerated but significantly reduce target RNA cleavage. Mismatches downstream of the center or cleavage site referencing the antisense strand, preferably located near the 3′ end of the antisense strand, e.g. 1, 2, 3, 4, 5 or 6 nucleotides from the 3′ end of the antisense strand, are tolerated and reduce target RNA cleavage only slightly.

While not wishing to be bound by any particular theory, in some embodiments, the guide strand is at least 16 nucleotides in length and anchors the Argonaute protein in RISC. In some embodiments, when the guide strand loads into RISC it has a defined seed region and target mRNA cleavage takes place across from position 10-11 of the guide strand. In some embodiments, the 5′ end of the guide strand is or is able to be phosphorylated. The nucleic acid molecules described herein may be referred to as minimum trigger RNA.

In some embodiments, the length of the passenger strand ranges from 8-14 nucleotides long. In certain embodiments, the passenger strand is 8, 9, 10, 11, 12, 13 or 14 nucleotides long. The passenger strand has complementarity to the guide strand. Complementarity between the passenger strand and the guide strand can exist over any portion of the passenger or guide strand. In some embodiments, there is 100% complementarity between the guide and passenger strands within the double stranded region of the molecule.

Aspects of the invention relate to double stranded nucleic acid molecules with minimal double stranded regions. In some embodiments the region of the molecule that is double stranded ranges from 8-14 nucleotides long. In certain embodiments, the region of the molecule that is double stranded is 8, 9, 10, 11, 12, 13 or 14 nucleotides long. In certain embodiments the double stranded region is 13 nucleotides long. There can be 100% complementarity between the guide and passenger strands, or there may be one or more mismatches between the guide and passenger strands. In some embodiments, on one end of the double stranded molecule, the molecule is either blunt-ended or has a one-nucleotide overhang. The single stranded region of the molecule is in some embodiments between 4-12 nucleotides long. For example the single stranded region can be 4, 5, 6, 7, 8, 9, 10, 11 or 12 nucleotides long. However, in certain embodiments, the single stranded region can also be less than 4 or greater than 12 nucleotides long. In certain embodiments, the single stranded region is 6 nucleotides long.

RNAi constructs associated with the invention can have a thermodynamic stability (ΔG) of less than −13 kkal/mol. In some embodiments, the thermodynamic stability (ΔG) is less than −20 kkal/mol. In some embodiments there is a loss of efficacy when (ΔG) goes below −21 kkal/mol. In some embodiments a (ΔG) value higher than −13 kkal/mol is compatible with aspects of the invention. Without wishing to be bound by any theory, in some embodiments a molecule with a relatively higher (ΔG) value may become active at a relatively higher concentration, while a molecule with a relatively lower (ΔG) value may become active at a relatively lower concentration. In some embodiments, the (ΔG) value may be higher than −9 kkcal/mol. The gene silencing effects mediated by the RNAi constructs associated with the invention, containing minimal double stranded regions, are unexpected because molecules of almost identical design but lower thermodynamic stability have been demonstrated to be inactive (Rana et al 2004).

Without wishing to be bound by any theory, results described herein suggest that a stretch of 8-10 bp of dsRNA or dsDNA will be structurally recognized by protein components of RISC or co-factors of RISC. Additionally, there is a free energy requirement for the triggering compound that it may be either sensed by the protein components and/or stable enough to interact with such components so that it may be loaded into the Argonaute protein. If optimal thermodynamics are present and there is a double stranded portion that is preferably at least 8 nucleotides then the duplex will be recognized and loaded into the RNAi machinery.

In some embodiments, thermodynamic stability is increased through the use of LNA bases. In some embodiments, additional chemical modifications are introduced. Several non-limiting examples of chemical modifications include: 5′ Phosphate, 2′-O-methyl, 2′-O-ethyl, 2′-fluoro, ribothymidine, C-5 propynyl-dC (pdC) and C-5 propynyl-dU (pdU); C-5 propynyl-C (pC) and C-5 propynyl-U (pU); 5-methyl C, 5-methyl U, 5-methyl dC, 5-methyl dU methoxy, (2,6-diaminopurine), 5′-Dimethoxytrityl-N4-ethyl-2′-deoxyCytidine and MGB (minor groove binder). It should be appreciated that more than one chemical modification can be combined within the same molecule.

Molecules associated with the invention are optimized for increased potency and/or reduced toxicity. For example, nucleotide length of the guide and/or passenger strand, and/or the number of phosphorothioate modifications in the guide and/or passenger strand, can in some aspects influence potency of the RNA molecule, while replacing 2′-fluoro (2′F) modifications with 2′-O-methyl (2′OMe) modifications can in some aspects influence toxicity of the molecule. Specifically, reduction in 2′F content of a molecule is predicted to reduce toxicity of the molecule. The Examples section presents molecules in which 2′F modifications have been eliminated, offering an advantage over previously described RNAi compounds due to a predicted reduction in toxicity. Furthermore, the number of phosphorothioate modifications in an RNA molecule can influence the uptake of the molecule into a cell, for example the efficiency of passive uptake of the molecule into a cell. Preferred embodiments of molecules described herein have no 2′F modification and yet are characterized by equal efficacy in cellular uptake and tissue penetration. Such molecules represent a significant improvement over prior art, such as molecules described by Accell and Wolfrum, which are heavily modified with extensive use of 2′F.

In some embodiments, a guide strand is approximately 18-19 nucleotides in length and has approximately 2-14 phosphate modifications. For example, a guide strand can contain 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 or more than 14 nucleotides that are phosphate-modified. The guide strand may contain one or more modifications that confer increased stability without interfering with RISC entry. The phosphate modified nucleotides, such as phosphorothioate modified nucleotides, can be at the 3′ end, 5′ end or spread throughout the guide strand. In some embodiments, the 3′ terminal 10 nucleotides of the guide strand contains 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 phosphorothioate modified nucleotides. The guide strand can also contain 2′F and/or 2′OMe modifications, which can be located throughout the molecule. In some embodiments, the nucleotide in position one of the guide strand (the nucleotide in the most 5′ position of the guide strand) is 2′OMe modified and/or phosphorylated. C and U nucleotides within the guide strand can be 2′F modified. For example, C and U nucleotides in positions 2-10 of a 19 nt guide strand (or corresponding positions in a guide strand of a different length) can be 2′F modified. C and U nucleotides within the guide strand can also be 2′OMe modified. For example, C and U nucleotides in positions 11-18 of a 19 nt guide strand (or corresponding positions in a guide strand of a different length) can be 2′OMe modified. In some embodiments, the nucleotide at the most 3′ end of the guide strand is unmodified. In certain embodiments, the majority of Cs and Us within the guide strand are 2′F modified and the 5′ end of the guide strand is phosphorylated. In other embodiments, position 1 and the Cs or Us in positions 11-18 are 2′OMe modified and the 5′ end of the guide strand is phosphorylated. In other embodiments, position 1 and the Cs or Us in positions 11-18 are 2′OMe modified, the 5′ end of the guide strand is phosphorylated, and the Cs or Us in position 2-10 are 2′F modified.

In some aspects, an optimal passenger strand is approximately 11-14 nucleotides in length. The passenger strand may contain modifications that confer increased stability. One or more nucleotides in the passenger strand can be 2′OMe modified. In some embodiments, one or more of the C and/or U nucleotides in the passenger strand is 2′OMe modified, or all of the C and U nucleotides in the passenger strand are 2′OMe modified. In certain embodiments, all of the nucleotides in the passenger strand are 2′OMe modified. One or more of the nucleotides on the passenger strand can also be phosphate-modified such as phosphorothioate modified. The passenger strand can also contain 2′ ribo, 2′F and 2 deoxy modifications or any combination of the above. As demonstrated in the Examples, chemical modification patterns on both the guide and passenger strand are well tolerated and a combination of chemical modifications is shown herein to lead to increased efficacy and self-delivery of RNA molecules.

Aspects of the invention relate to RNAi constructs that have extended single-stranded regions relative to double stranded regions, as compared to molecules that have been used previously for RNAi. The single stranded region of the molecules may be modified to promote cellular uptake or gene silencing. In some embodiments, phosphorothioate modification of the single stranded region influences cellular uptake and/or gene silencing. The region of the guide strand that is phosphorothioate modified can include nucleotides within both the single stranded and double stranded regions of the molecule. In some embodiments, the single stranded region includes 2-12 phosphorothioate modifications. For example, the single stranded region can include 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12 phosphorothioate modifications. In some instances, the single stranded region contains 6-8 phosphorothioate modifications.

Molecules associated with the invention are also optimized for cellular uptake. In RNA molecules described herein, the guide and/or passenger strands can be attached to a conjugate. In certain embodiments the conjugate is hydrophobic. The hydrophobic conjugate can be a small molecule with a partition coefficient that is higher than 10. The conjugate can be a sterol-type molecule such as cholesterol, or a molecule with an increased length polycarbon chain attached to C17, and the presence of a conjugate can influence the ability of an RNA molecule to be taken into a cell with or without a lipid transfection reagent. The conjugate can be attached to the passenger or guide strand through a hydrophobic linker. In some embodiments, a hydrophobic linker is 5-12C in length, and/or is hydroxypyrrolidine-based. In some embodiments, a hydrophobic conjugate is attached to the passenger strand and the CU residues of either the passenger and/or guide strand are modified. In some embodiments, at least 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90% or 95% of the CU residues on the passenger strand and/or the guide strand are modified. In some aspects, molecules associated with the invention are self-delivering (sd). As used herein, “self-delivery” refers to the ability of a molecule to be delivered into a cell without the need for an additional delivery vehicle such as a transfection reagent.

Aspects of the invention relate to selecting molecules for use in RNAi. Based on the data described herein, molecules that have a double stranded region of 8-14 nucleotides can be selected for use in RNAi. In some embodiments, molecules are selected based on their thermodynamic stability (ΔG). In some embodiments, molecules will be selected that have a (ΔG) of less than −13 kkal/mol. For example, the (ΔG) value may be −13, −14, −15, −16, −17, −18, −19, −21, −22 or less than −22 kkal/mol. In other embodiments, the (ΔG) value may be higher than −13 kkal/mol. For example, the (ΔG) value may be −12, ×11, ×10, ×9, ×8, ×7 or more than −7 kkal/mol. It should be appreciated that ΔG can be calculated using any method known in the art. In some embodiments ΔG is calculated using Mfold, available through the Mfold internet site (mfold.bioinfo.rpi.edu/cgi-bin/rna-forml.cgi). Methods for calculating ΔG are described in, and are incorporated by reference from, the following references: Zuker, M. (2003) Nucleic Acids Res., 31(13):3406-15; Mathews, D. H., Sabina, J., Zuker, M. and Turner, D. H. (1999) J. Mol. Biol. 288:911-940; Mathews, D. H., Disney, M. D., Childs, J. L., Schroeder, S. J., Zuker, M., and Turner, D. H. (2004) Proc. Natl. Acad. Sci. 101:7287-7292; Duan, S., Mathews, D. H., and Turner, D. H. (2006) Biochemistry 45:9819-9832; Wuchty, S., Fontana, W., Hofacker, I. L., and Schuster, P. (1999) Biopolymers 49:145-165.

Aspects of the invention relate to using nucleic acid molecules described herein, with minimal double stranded regions and/or with a (4G) of less than −13 kkal/mol, for gene silencing. RNAi molecules can be administered in vivo or in vitro, and gene silencing effects can be achieved in vivo or in vitro.

In certain embodiments, the polynucleotide contains 5′- and/or 3′-end overhangs. The number and/or sequence of nucleotides overhang on one end of the polynucleotide may be the same or different from the other end of the polynucleotide. In certain embodiments, one or more of the overhang nucleotides may contain chemical modification(s), such as phosphorothioate or 2′-OMe modification.

In certain embodiments, the polynucleotide is unmodified. In other embodiments, at least one nucleotide is modified. In further embodiments, the modification includes a 2′-H or 2′-modified ribose sugar at the 2nd nucleotide from the 5′-end of the guide sequence. The “2nd nucleotide” is defined as the second nucleotide from the 5′-end of the polynucleotide.

As used herein, “2′-modified ribose sugar” includes those ribose sugars that do not have a 2′-OH group. “2′-modified ribose sugar” does not include 2′-deoxyribose (found in unmodified canonical DNA nucleotides). For example, the 2′-modified ribose sugar may be 2′-0-alkyl nucleotides, 2′-deoxy-2′-fluoro nucleotides, 2′-deoxy nucleotides, or combination thereof.

In certain embodiments, the 2′-modified nucleotides are pyrimidine nucleotides (e.g., C/U). Examples of 2′-O-alkyl nucleotides include 2′-O-methyl nucleotides, or 2′-O-allyl nucleotides.

In certain embodiments, the miniRNA polynucleotide of the invention with the above-referenced 5′-end modification exhibits significantly (e.g., at least about 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90% or more) less “off-target” gene silencing when compared to similar constructs without the specified 5′-end modification, thus greatly improving the overall specificity of the RNAi reagent or therapeutics.

As used herein, “off-target” gene silencing refers to unintended gene silencing due to, for example, spurious sequence homology between the antisense (guide) sequence and the unintended target mRNA sequence.

According to this aspect of the invention, certain guide strand modifications further increase nuclease stability, and/or lower interferon induction, without significantly decreasing RNAi activity (or no decrease in RNAi activity at all).

In some embodiments, the 5′-stem sequence may comprise a 2′-modified ribose sugar, such as 2′-O-methyl modified nucleotide, at the 2^nd nucleotide on the 5′-end of the polynucleotide and, in some embodiments, no other modified nucleotides. The hairpin structure having such modification may have enhanced target specificity or reduced off-target silencing compared to a similar construct without the 2′-O-methyl modification at said position.

Certain combinations of specific 5′-stem sequence and 3′-stem sequence modifications may result in further unexpected advantages, as partly manifested by enhanced ability to inhibit target gene expression, enhanced serum stability, and/or increased target specificity, etc.

In certain embodiments, the guide strand comprises a 2′-O-methyl modified nucleotide at the 2^nd nucleotide on the 5′-end of the guide strand and no other modified nucleotides.

In other aspects, the miniRNA structures of the present invention mediates sequence-dependent gene silencing by a microRNA mechanism. As used herein, the term “microRNA” (“miRNA”), also referred to in the art as “small temporal RNAs” (“stRNAs”), refers to a small (10-50 nucleotide) RNA which are genetically encoded (e.g., by viral, mammalian, or plant genomes) and are capable of directing or mediating RNA silencing. An “miRNA disorder” shall refer to a disease or disorder characterized by an aberrant expression or activity of an miRNA.

miRNAs are important modulators of cellular homeostasis and differention. Reduced levels of miRNA expreression or excessive expression of miRNA have been shown to be involved in many diseases. microRNAs are involved in down-regulating target genes in critical pathways, such as development and cancer, in mice, worms and mammals. In particular significant reduction of different miRNA expression is related to tumor development and progression. Gene silencing through a microRNA mechanism is achieved by specific yet, in some cases, imperfect base-pairing of the miRNA and its target messenger RNA (mRNA). Various mechanisms may be used in microRNA-mediated down-regulation of target mRNA expression.

miRNAs are noncoding RNAs of approximately 22 nucleotides which can regulate gene expression at the post transcriptional or translational level during plant and animal development. One common feature of miRNAs is that they are all excised from an approximately 70 nucleotide precursor RNA stem-loop termed pre-miRNA, probably by Dicer, an RNase III-type enzyme, or a homolog thereof. Naturally-occurring miRNAs are expressed by endogenous genes in vivo and are processed from a hairpin or stem-loop precursor (pre-miRNA or pri-miRNAs) by Dicer or other RNAses. miRNAs can exist transiently in vivo as a double-stranded duplex but only one strand is taken up by the RISC complex to direct gene silencing.

In some embodiments a version of sd-rxRNA compounds, which are effective in cellular uptake and modulating miRNA activity are described. Essentially the compounds are similar to RISC entering version but large strand chemical modification patterns are optimized in the way to block cleavage and act as an effective inhibitor of the RISC action. For example, the compound might be completely or mostly O-methyl modified with the PS content described previously. For these types of compounds the 5′ phosphorylation is not necessary. The presence of double stranded region is preferred as it is promotes cellular uptake and efficient RISC loading.

Finding a way to modulate miRNA expression is an important unresolved problem in miRNA based drug development. The invention describes novel miRNA modulating compounds (miRNA mimics and miRNA inhibitors). The miRNA modulating compounds of the invention have the same basic structural properties described herein for self delivering RNA. Exemplary, non-limiting, sequences of the miRNA modulating compounds of the invention are shown in Tables 4-5.

In general, the miRNA modulating compounds have two strands, a guide (or antisense) strand that is 18-23 bases long and a passenger (or sense) strand that is 8-16 bases long. The size difference of the two strands results in a double stranded and a single strand region of the molecule. In some embodiments the single stranded region is substantially modified, for example, with phosphorothioates. The presence of this phosphorothioated region is believed to be important for improved PK/PD, tissue distribution and cellular uptake properties of these molecules.

In some instances it is preferred that the first position of the guide strand has a 2′O-methyl modification such as a 5P-2 o-methyl U. The presence of this modification in the guide strand further promotes the association with and loading into RISC complex.

Preferably both strands of the miRNA modulators are extensively modified, as described herein. For instance many of the pyrimidines are preferably 2′ modified. These modifications contribute to the stability of the molecule.

Additionally the overall hydrophobicity of the miRNA modulating compounds of the invention is increased to enhance cellular entry. This may be accomplished through the presence of some hydrophobic modification in the bases. For instance, position 5 or 4 of uridines and cytidine may include hydrophobic base modifications. These modifications increase and promote RISC association, stability, specificity and cellular entry. An example of a preferred hydrophobic base modification is methyl or ethyl. The presence of these type of modifications appear to not interfere with RISC entry of the miRNA modulating compounds and actually seem to promotes RISC entry.

In addition to hydrophobic base modification, other hydrophobic moieties may be linked to the molecule. A preferred location for linkage of hydrophobic moieties is the 3′ end position of the passenger strand.

The compounds of the invention having these structural properties are excellent modulators of miRNA expression in vivo. Administration of these compounds is expected to mimic natural miRNA expression in a targeted cells or inhibit undesirable miRNA, depending on the specificity of the guide strand. These compounds are useful in modulating miRNA level and activity in many tissues, such as brain, spinal cord, tumors, liver, lung, kidney skin, heart, vasculature, and spleen. Additionally these compounds may be used ex vivo and in primary, dentritic or stem cells to modulate cellular properties prior to introduction or reintroduction of the cells into a subject. For instance they may be used in dendritic cells or primary tumors to help with a cancer vaccine development. The compounds may be used in stem cells or tissues or organs ex vivo or in vitro to promote or stop stem cells differentiation, tissue remodeling, organ preservation and many other applications.

The miRNA modulating compounds of the invention are miRNA mimics or miRNA inhibitors. An miRNA mimic as used herein refers to a double stranded nucleic acid having a guide strand that has a nucleic acid sequence that is similar, or in some cases identical, to a guide strand of a naturally occurring mature miRNA. Naturally occurring miRNA are processed from long nucleic acids having secondary structural properties (referred to as pri-miRNA and pre-miRNA) to produce naturally occurring mature miRNA. The mature miRNA is a double stranded molecule of about 22 nucleotides in length having a guide strand that binds to an miRNA recognition element (MRE) in the 3′ untranslated region (UTR) of a target mRNA (in a RISC complex) and suppresses its translation or initiates degradation of the mRNA.

The miRNA mimic of the invention includes a guide strand that is identical to or similar to the sequence of a guide strand of a naturally occurring mature miRNA. Identical to the sequence, as used herein refers to the same nucleic acid bases in the nucleotide as are found in the mature miRNA. Similar to the sequence, in this context, refers to a nucleic acid molecule having a sequence which is less than identical but at least 75% homologous to the mature miRNA. In some instances “similar to the sequence” refers to a sequence which is less than identical but at least 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% homologous to the mature miRNA. In some cases the sequence of the miRNA mimic may include the same bases, but the base of the mimic may be modified, i.e. hydrophobically modified. In other cases the mimic may include one or more different bases or nucleotides than the naturally occurring mature miRNA.

The guide strand of the miRNA mimic is complementary to a miRNA recognition element (MRE). “Complementary to a miRNA recognition element” as used herein refers to base complementarity between at least 6 or 7 nucleotides of the miRNA mimic guide strand (preferably the 5′ end of the guide strand) and the MRE. The region of complementarity is referred to as the seed region. In some embodiments the seed region or region of complementarity is 6, 7, 8, 9, 10, 11, 12 or 13 nucleotides in length. The complementarity of the seed region may be perfect (100%) or may be less i.e. greater than 90%, 95%, 96%, 97%, 98%, or 99%, but preferably is 100%. The complementarity between the entire miRNA and the MRE may be greater than 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99%.

The miRNA mimics of the invention are useful for mimicking the activity of any naturally occurring miRNA. Non-limiting examples include: miR21, miR 139, miR 7, miR29, miR 122, miR 302-367 cluster, miR 221, miR-96, miR 126, miR 225 and miR 206.

An miRNA inhibitor as used herein refers to a double stranded nucleic acid having a guide strand that has a nucleic acid sequence that is complementary to a guide strand or antisense strand of a naturally occurring mature miRNA. “Complementary to an antisense strand of a naturally occurring mature miRNA” as used herein refers to base complementarity between the guide strand of the inhibitor and the antisense strand of the naturally occurring mature miRNA. In some embodiments the complementarity may be perfect (100%) or may be less than perfect i.e. greater than 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% complementarity. The guide strand of the miRNA inhibitor is extensively chemically modified (i.e. with O-methyls or other modification), to prevent its entry into RISC. The association of the miRNA inhibitor guide strand with the naturally occurring (or miRNA mimic guide strand) miRNA loaded RISC is enhanced by the chemical modifications and sequence complementarily, such that it competes for binding with the naturally occurring mRNA.

The structure and function of miRNAs has been the subject of extensive research and several miRNAs have been sequenced and investigated regarding their function in human disease. Some non-limiting examples of known human miRNAs, the expression of which can be modulated with agents and methods provided herein are let-7, let-7a-1, let-7a-2, let-7a-3, let-7b, let-7c, let-7d, let-7e, let-7f-1, let-7f-2, let-7g, let-7i, mir-1, mir-10, mir-100, mir-101, mir-101-1, mir-101-2, mir-103, mir-103-1, mir-103-2, mir-105, mir-105-1, mir-105-2, mir-106a, mir-106b, mir-107, mir-10a, mir-10b, mir-1-1, mir-1-2, mir-124, mir-124-1, mir-124-2, mir-124-3, mir-125, mir-125a, mir-125b-1, mir-125b-2, mir-128, mir-128a, mir-128b, mir-129, mir-129-1, mir-129-2, mir-130, mir-130a, mir-130b, mir-132, mir-132, mir-133, mir-133a-1, mir-133a-2, mir-133b, mir-135, mir-135a-1, mir-135a-2, mir-135b, mir-138, mir-138-1, mir-138-2, mir-141, mir-146, mir-146a, mir-146b, mir-147, mir-147a, mir-147b, mir-148, mir-148a, mir-148b, mir-15, mir-151, mir-152, mir-153, mir-153-1, mir-153-2, mir-154, mir-154, mir-15a, mir-15b, mir-16-1, mir-16-2, mir-17, mir-181, mir-181a-1, mir-181a-2, mir-181b-1, mir-181b-2, mir-181c, mir-181d, mir-188, mir-188, mir-18a, mir-18b, mir-19, mir-190, mir-190, mir-190b, mir-192, mir-192, mir-193, mir-193a, mir-193b, mir-194, mir-194-1, mir-194-2, mir-195, mir-196, mir-196a-1, mir-196a-2, mir-196b, mir-199, mir-199a-1, mir-199a-2, mir-199b, mir-19a, mir-19b-1, mir-19b-2, mir-200a, mir-200b, mir-200c, mir-204, mir-204, mir-206, mir-208, mir-208, mir-208b, mir-20a, mir-20b, mir-211, mir-212, mir-215, mir-216, mir-216a, mir-216b, mir-218, mir-218-1, mir-218-2, mir-219, mir-219-1, mir-219-2, mir-220, mir-220, mir-220b, mir-221, mir-221, mir-222, mir-23, mir-23a, mir-23b, mir-24, mir-24-1, mir-24-2, mir-25, mir-25, mir-26, mir-26a-1, mir-26a-2, mir-26b, mir-27, mir-27a, mir-27b, mir-28, mir-28, mir-29, mir-290, mir-29a, mir-29b-1, mir-29b-2, mir-29c, mir-30, mir-300, mir-301a, mir-301b, mir-302, mir-302a, mir-302b, mir-302c, mir-302d, mir-30a, mir-30b, mir-30c-1, mir-30c-2, mir-30d, mir-30e, mir-323, mir-329, mir-329-1, mir-329-2, mir-33, mir-33a, mir-33b, mir-34, mir-34a, mir-34b, mir-34c, mir-365, mir-365-1, mir-365-2, mir-368, mir-369, mir-371, mir-372, mir-374, mir-374a, mir-374b, mir-376a-1, mir-376a-2, mir-376b, mir-376c, mir-377, mir-379, mir-379, mir-380, mir-381, mir-382, mir-409, mir-410, mir-411, mir-421, mir-429, mir-449, mir-449a, mir-449b, mir-450, mir-450a-1, mir-450a-2, mir-450b, mir-453, mir-487a, mir-487b, mir-494, mir-495, mir-496, mir-500, mir-500, mir-501, mir-502, mir-506, mir-506, mir-507, mir-508, mir-509, mir-509-1, mir-509-2, mir-509-3, mir-510, mir-511, mir-511-1, mir-511-2, mir-512, mir-512-1, mir-512-2, mir-513, mir-513-1, mir-513-2, mir-514-1, mir-514-2, mir-514-3, mir-515, mir-515-1, mir-515-2, mir-516a-1, mir-516a-2, mir-516b-1, mir-516b-2, mir-517a, mir-517b, mir-517c, mir-518a-1, mir-518a-2, mir-518b, mir-518c, mir-518d, mir-518e, mir-518f, mir-519a-1, mir-519a-2, mir-519b, mir-519c, mir-519d, mir-519e, mir-520a, mir-520b, mir-520c, mir-520d, mir-520e, mir-520f, mir-520g, mir-520h, mir-521-1, mir-521-2, mir-522, mir-523, mir-524, mir-525, mir-526a-1, mir-526a-2, mir-526b, mir-527, mir-532, mir-539, mir-543, mir-545, mir-548, mir-548a-1, mir-548a-2, mir-548a-3, mir-548b, mir-548c, mir-548d-1, mir-548d-2, mir-550, mir-550-1, mir-550-2, mir-551, mir-551a, mir-551b, mir-570, mir-579, mir-603, mir-655, mir-656, mir-660, mir-7, mir-7-1, mir-7-2, mir-7-3, mir-758, mir-8, mir-891, mir-891a, mir-891b, mir-892, mir-892a, mir-892b, mir-9, mir-9-1, mir-9-2, mir-92a-1, mir-92a-2, mir-92b, mir-93, mir-9-3, mir-941, mir-941-1, mir-941-2, mir-941-3, mir-941-4, mir-95, mir-95, mir-98, mir-99, mir-99a, mir-99b. Sequence, structural information, and functions of these and other miRNAs are well known to those of skill in the art and are described, for example, in the miRBase database, Release 16, September 2010, accessible at www.mirbase.org, and described in more detail in “miRBase: tools for microRNA genomics” by Griffiths-Jones S, Saini H K, van Dongen S, Enright A J, Nucleic Acids Res. 2008 36:D154-D158; “miRBase: microRNA sequences, targets and gene nomenclature” by Griffiths-Jones S, Grocock R J, van Dongen S, Bateman A, Enright A J, Nucleic Acids Res. 2006 34:D140-D144; and “The miRNA Registry” by Griffiths-Jones S, Nucleic Acids Res. 2004 32:D109-D111. The entire contents of miRBase, Release 16, September 2010, and the three references provided immediately above are incorporated herein in their entirety by reference for disclosure of miRNA sequences, structure, and function.

In some embodiments, the miRNA that is modulated using an agent or method provided herein is an miRNA that is implicated or known to be involved in the pathogenesis or the progression of a human disease, for example, in a cancer or neoplastic disease. MiRNAs implicated or known to be involved in the pathogenesis or the progression of a human disease are well known to those of skill in the art and include, but are not limited to the miRNAs described in the Human MiRNA & Disease Database (HMDD), Release January 2011, accessible at 202.38.126.151/hmdd/mirna/md/, and described in more detail in Lu M, Zhang Q, Deng M, Miao J, Guo Y, et al. (2008) An Analysis of Human MicroRNA and Disease Associations. PLoS ONE 3(10): e3420; the mir2disease base, Release March 2011, accessible at www.mir2disease.org, and described in more detail in Jiang Q., Wang Y., Hao Y., Juan L., Teng M., Zhang X., Li M., Wang G., Liu Y., (2009) miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res 37:D98-104; the entire contents of each database and reference are incorporated herein by reference.

In some embodiments, an miRNA modulating agent or method is provided that targets a particular miRNA or a particular miRNA cluster. For example, in some embodiments, the target miRNA is mir139 (e.g., miRBase accession: MI0000261). Mir139 has been described to act as a tumor suppressor and aberrant expression of mir139 has been reported to be associated with leukemia, for example, chronic lymphocytic leukemia, and with certain carcinomas, for example, adenocarcinoma, epithelial ovarian carcinoma, gastric carcinoma, and non-small cell lung carcinoma. In some embodiments, a miRNA modulating agent or method provided herein is useful for the alleviation of a disease or condition associated with aberrant mir139.

In some embodiments, the target miRNA is let-7 (e.g., miRBase accession: MI0000060-MI0000068). Let-7 has been reported to act as a tumor suppressor and aberrant expression of let-7 has been reported to be associated with tumorigenesis and tumor progression. In some embodiments, a let-7 mimic as provided herein is introduced into a neoplastic cell or tissue, for example, into a tumor cell or tumor tissue to alleviate tumor growth and/or any associated disease or condition. In some embodiments, introduction of a let-7 mimic into a tumor results in tumor regression.

In some embodiments, the target miRNA is mir-29 (e.g., miRBase accession: MI0000087, MI0000105, MI0000107). Aberrant expression of mir-29 has been reported to be associated with abnormal cell or tissue proliferation. For example, lack of miR-29a and/or miR-29b is implicated in progression of HCV infection, fibrosis or neuron remodeling and degeneration during Alzeheimer's disease. In some embodiments, introduction of a mir-29 mimic into an affected cell or tissue of a diseased subject is of therapeutic benefit in neurological disorders, liver and pulmonary fibrosis, HCV or other liver infection, cardiac hypertension and other indications with a reported involvement of mir-29. In some embodiments, introduction of a mir-29 mimic, as provided herein, for example, of a mir-29b mimic, can result in PDPN downregulation, which is involved in glioblastoma progression. In some embodiments, introduction of a mir-29 mimic as provided herein into a glioblastoma cell or tissue, for example, brain tissue of a glioblastoma patient, results in arrest or delay of tumor progression, tumor regression, or an alleviation of the disease state.

In some embodiments, the target miRNA is mir-133 (e.g., miRBase accession: MI0000450, MI0000451, MI0000822). Aberrant expression of miR-133 has been reported to be associated with CTGF downregulation as well as downregulation of molecular signaling pathways implicated in fibrosis. In some embodiments, a mir-133 mimic provided herein is used as an anti-fibrotic agent.

In some embodiments, the target miRNA is a miRNA of the mir-302-367 cluster, comprising mir-302a-mir302d and mir-367 (e.g., miRBase accession: MI0000738, MI0000772, MI0000773, MI0000775). Aberrant expression of the miRNA 302-367 cluster has been reported to be associated with inhibition of HDac2-regulated reprogramming of somatic cells into pluripotent stem cells. In some embodiments, introduction of a mimic of a miRNA in the miRNA 302-367 cluster into somatic stem cells supports or enhances the reprogramming of the somatic cells into pluripotent stem cells, which can be used for regenerative medicine approaches, and organ and tissue development.

In some embodiments, the target miRNA is mir-221 (e.g., miRBase accession: MI0000298). Mir-221 has been reported to act as a tumor suppressor, and aberrant expression of mir-221 has been reported to be associated with glioblastoma progression. In some embodiments, introduction, e.g., by direct ingection or intrabrain infusion of a mir-221 mimic provided herein is used to treat or alleviate a symptom observed in glioblastoma patients.

In some embodiments, the target miRNA is mir-96 (e.g., miRBase accession: MI0000098). Mir-96 has been reported to be involved in hair growth regulation and aberrant expression of mir-96 has been reported to be associated with alopecia, for example, or chemotherapy-induced alopecia. In some embodiments, a mir-96 mimic as provided herein is used to treat alopecia.

In some embodiments, the target miRNA is mir-126, mir-335, or mir-206 (e.g., miRBase accession: MI0000471, MI0000816, MI0000490). These miRNAs are potent suppressors of tumor metastasis formation or maturation. For example, mir-126 has been reported to suppress endothelium cellular recruitment and, thus, metastasis maturation. In some embodiment, introduction of a mir-126, mir-335, or mir-206 mimic as provided herein into a primary tumor, or systemic administration to a subject having a tumor results in a partial or complete inhibition of metastasis formation.

In some embodiments, the target miRNA is a miRNA of the mir-17-92 cluster, comprising mir-17, mir-18a, mir-19a, mir-20a, mir-19b-1, and mir-92a-1 (e.g., miRBase accession: MI0000071, MI0000072, MI0000073, MI0000076, MI0000074, MI0000093). The mir-17-92 cluster has been reported to act as an oncogene and overexpression of the cluster, or of any member of the cluster has been reported to be associated with tumorigenesis. In some embodiments, a miRNA inhibitory agent targeting the mir-17-92 cluster as provided herein is administered to a tumor cell or tissue, or systemically, to a patient diagnosed with or suspected to have a tumor. Another pathway that uses small RNAs as sequence-specific regulators is the RNA interference (RNAi) pathway, which is an evolutionarily conserved response to the presence of double-stranded RNA (dsRNA) in the cell. The dsRNAs are cleaved into −20-base pair (bp) duplexes of small-interfering RNAs (siRNAs) by Dicer. These small RNAs get assembled into multiprotein effector complexes called RNA-induced silencing complexes (RISCs). The siRNAs then guide the cleavage of target mRNAs with perfect complementarity.

Some aspects of biogenesis, protein complexes, and function are shared between the siRNA pathway and the miRNA pathway. The subject single-stranded polynucleotides may mimic the dsRNA in the siRNA mechanism, or the microRNA in the miRNA mechanism.

In certain embodiments, the modified RNAi constructs may have improved stability in serum and/or cerebral spinal fluid compared to an unmodified RNAi constructs having the same sequence.

In certain embodiments, the structure of the RNAi construct does not induce interferon response in primary cells, such as mammalian primary cells, including primary cells from human, mouse and other rodents, and other non-human mammals. In certain embodiments, the RNAi construct may also be used to inhibit expression of a target gene in an invertebrate organism.

To further increase the stability of the subject constructs in vivo, the 3′-end of the hairpin structure may be blocked by protective group(s). For example, protective groups such as inverted nucleotides, inverted abasic moieties, or amino-end modified nucleotides may be used. Inverted nucleotides may comprise an inverted deoxynucleotide. Inverted abasic moieties may comprise an inverted deoxyabasic moiety, such as a 3′, 3′-linked or 5′, 5′-linked deoxyabasic moiety.

The RNAi constructs of the invention are capable of inhibiting the synthesis of any target protein encoded by target gene(s). The invention includes methods to inhibit expression of a target gene either in a cell in vitro, or in vivo. As such, the RNAi constructs of the invention are useful for treating a patient with a disease characterized by the overexpression of a target gene.

The target gene can be endogenous or exogenous (e.g., introduced into a cell by a virus or using recombinant DNA technology) to a cell. Such methods may include introduction of RNA into a cell in an amount sufficient to inhibit expression of the target gene. By way of example, such an RNA molecule may have a guide strand that is complementary to the nucleotide sequence of the target gene, such that the composition inhibits expression of the target gene.

The invention also relates to vectors expressing the nucleic acids of the invention, and cells comprising such vectors or the nucleic acids. The cell may be a mammalian cell in vivo or in culture, such as a human cell.

The invention further relates to compositions comprising the subject RNAi constructs, and a pharmaceutically acceptable carrier or diluent.

Another aspect of the invention provides a method for inhibiting the expression of a target gene in a mammalian cell, comprising contacting the mammalian cell with any of the subject RNAi constructs.

The method may be carried out in vitro, ex vivo, or in vivo, in, for example, mammalian cells in culture, such as a human cell in culture.

The target cells (e.g., mammalian cell) may be contacted in the presence of a delivery reagent, such as a lipid (e.g., a cationic lipid) or a liposome.

Another aspect of the invention provides a method for inhibiting the expression of a target gene in a mammalian cell, comprising contacting the mammalian cell with a vector expressing the subject RNAi constructs.

In one aspect of the invention, a longer duplex polynucleotide is provided, including a first polynucleotide that ranges in size from about 16 to about 30 nucleotides; a second polynucleotide that ranges in size from about 26 to about 46 nucleotides, wherein the first polynucleotide (the antisense strand) is complementary to both the second polynucleotide (the sense strand) and a target gene, and wherein both polynucleotides form a duplex and wherein the first polynucleotide contains a single stranded region longer than 6 bases in length and is modified with alternative chemical modification pattern, and/or includes a conjugate moiety that facilitates cellular delivery. In this embodiment, between about 40% to about 90% of the nucleotides of the passenger strand between about 40% to about 90% of the nucleotides of the guide strand, and between about 40% to about 90% of the nucleotides of the single stranded region of the first polynucleotide are chemically modified nucleotides.

In an embodiment, the chemically modified nucleotide in the polynucleotide duplex may be any chemically modified nucleotide known in the art, such as those discussed in detail above. In a particular embodiment, the chemically modified nucleotide is selected from the group consisting of 2′ F modified nucleotides, 2′-O-methyl modified and 2′deoxy nucleotides. In another particular embodiment, the chemically modified nucleotides results from “hydrophobic modifications” of the nucleotide base. In another particular embodiment, the chemically modified nucleotides are phosphorothioates. In an additional particular embodiment, chemically modified nucleotides are combination of phosphorothioates, 2′-O-methyl, 2′deoxy, hydrophobic modifications and phosphorothioates. As these groups of modifications refer to modification of the ribose ring, back bone and nucleotide, it is feasible that some modified nucleotides will carry a combination of all three modification types.

In another embodiment, the chemical modification is not the same across the various regions of the duplex. In a particular embodiment, the first polynucleotide (the passenger strand), has a large number of diverse chemical modifications in various positions. For this polynucleotide up to 90% of nucleotides might be chemically modified and/or have mismatches introduced.

In another embodiment, chemical modifications of the first or second polynucleotide include, but not limited to, 5′ position modification of Uridine and Cytosine (4-pyridyl, 2-pyridyl, indolyl, phenyl (C₆H₅OH); tryptophanyl (C8H6N)CH2CH(NH2)CO), isobutyl, butyl, aminobenzyl; phenyl; naphthyl, etc), where the chemical modification might alter base pairing capabilities of a nucleotide. For the guide strand an important feature of this aspect of the invention is the position of the chemical modification relative to the 5′ end of the antisense and sequence. For example, chemical phosphorylation of the 5′ end of the guide strand is usually beneficial for efficacy. 0-methyl modifications in the seed region of the sense strand (position 2-7 relative to the 5′ end) are not generally well tolerated, whereas 2′F and deoxy are well tolerated. The mid part of the guide strand and the 3′ end of the guide strand are more permissive in a type of chemical modifications applied. Deoxy modifications are not tolerated at the 3′ end of the guide strand.

A unique feature of this aspect of the invention involves the use of hydrophobic modification on the bases. In one embodiment, the hydrophobic modifications are preferably positioned near the 5′ end of the guide strand, in other embodiments, they localized in the middle of the guides strand, in other embodiment they localized at the 3′ end of the guide strand and yet in another embodiment they are distributed thought the whole length of the polynucleotide. The same type of patterns is applicable to the passenger strand of the duplex.

The other part of the molecule is a single stranded region. The single stranded region is expected to range from 7 to 40 nucleotides.

In one embodiment, the single stranded region of the first polynucleotide contains modifications selected from the group consisting of between 40% and 90% hydrophobic base modifications, between 40%-90% phosphorothioates, between 40%-90% modification of the ribose moiety, and any combination of the preceding.

Efficiency of guide strand (first polynucleotide) loading into the RISC complex might be altered for heavily modified polynucleotides, so in one embodiment, the duplex polynucleotide includes a mismatch between nucleotide 9, 11, 12, 13, or 14 on the guide strand (first polynucleotide) and the opposite nucleotide on the sense strand (second polynucleotide) to promote efficient guide strand loading.

More detailed aspects of the invention are described in the sections below.

Duplex Characteristics

Double-stranded oligonucleotides of the invention may be formed by two separate complementary nucleic acid strands. Duplex formation can occur either inside or outside the cell containing the target gene.

As used herein, the term “duplex” includes the region of the double-stranded nucleic acid molecule(s) that is (are) hydrogen bonded to a complementary sequence. Double-stranded oligonucleotides of the invention may comprise a nucleotide sequence that is sense to a target gene and a complementary sequence that is antisense to the target gene. The sense and antisense nucleotide sequences correspond to the target gene sequence, e.g., are identical or are sufficiently identical to effect target gene inhibition (e.g., are about at least about 98% identical, 96% identical, 94%, 90% identical, 85% identical, or 80% identical) to the target gene sequence.

In certain embodiments, the double-stranded oligonucleotide of the invention is double-stranded over its entire length, i.e., with no overhanging single-stranded sequence at either end of the molecule, i.e., is blunt-ended. In other embodiments, the individual nucleic acid molecules can be of different lengths. In other words, a double-stranded oligonucleotide of the invention is not double-stranded over its entire length. For instance, when two separate nucleic acid molecules are used, one of the molecules, e.g., the first molecule comprising an antisense sequence, can be longer than the second molecule hybridizing thereto (leaving a portion of the molecule single-stranded). Likewise, when a single nucleic acid molecule is used a portion of the molecule at either end can remain single-stranded.

In one embodiment, a double-stranded oligonucleotide of the invention contains mismatches and/or loops or bulges, but is double-stranded over at least about 70% of the length of the oligonucleotide. In another embodiment, a double-stranded oligonucleotide of the invention is double-stranded over at least about 80% of the length of the oligonucleotide. In another embodiment, a double-stranded oligonucleotide of the invention is double-stranded over at least about 90%-95% of the length of the oligonucleotide. In another embodiment, a double-stranded oligonucleotide of the invention is double-stranded over at least about 96%-98% of the length of the oligonucleotide. In certain embodiments, the double-stranded oligonucleotide of the invention contains at least or up to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, or 15 mismatches.

Modifications

The nucleotides of the invention may be modified at various locations, including the sugar moiety, the phosphodiester linkage, and/or the base.

Sugar moieties include natural, unmodified sugars, e.g., monosaccharide (such as pentose, e.g., ribose, deoxyribose), modified sugars and sugar analogs. In general, possible modifications of nucleomonomers, particularly of a sugar moiety, include, for example, replacement of one or more of the hydroxyl groups with a halogen, a heteroatom, an aliphatic group, or the functionalization of the hydroxyl group as an ether, an amine, a thiol, or the like.

One particularly useful group of modified nucleomonomers are 2′-O-methyl nucleotides. Such 2′-O-methyl nucleotides may be referred to as “methylated,” and the corresponding nucleotides may be made from unmethylated nucleotides followed by alkylation or directly from methylated nucleotide reagents. Modified nucleomonomers may be used in combination with unmodified nucleomonomers. For example, an oligonucleotide of the invention may contain both methylated and unmethylated nucleomonomers.

Some exemplary modified nucleomonomers include sugar- or backbone-modified ribonucleotides. Modified ribonucleotides may contain a non-naturally occurring base (instead of a naturally occurring base), such as uridines or cytidines modified at the 5′-position, e.g., 5′-(2-amino)propyl uridine and 5′-bromo uridine; adenosines and guanosines modified at the 8-position, e.g., 8-bromo guanosine; deaza nucleotides, e.g., 7-deaza-adenosine; and N-alkylated nucleotides, e.g., N6-methyl adenosine. Also, sugar-modified ribonucleotides may have the 2′-OH group replaced by a H, alxoxy (or OR), R or alkyl, halogen, SH, SR, amino (such as NH₂, NHR, NR₂,), or CN group, wherein R is lower alkyl, alkenyl, or alkynyl.

Modified ribonucleotides may also have the phosphodiester group connecting to adjacent ribonucleotides replaced by a modified group, e.g., of phosphorothioate group. More generally, the various nucleotide modifications may be combined.

Although the antisense (guide) strand may be substantially identical to at least a portion of the target gene (or genes), at least with respect to the base pairing properties, the sequence need not be perfectly identical to be useful, e.g., to inhibit expression of a target gene's phenotype. Generally, higher homology can be used to compensate for the use of a shorter antisense gene. In some cases, the antisense strand generally will be substantially identical (although in antisense orientation) to the target gene.

The use of 2′-O-methyl modified RNA may also be beneficial in circumstances in which it is desirable to minimize cellular stress responses. RNA having 2′-O-methyl nucleomonomers may not be recognized by cellular machinery that is thought to recognize unmodified RNA. The use of 2′-O-methylated or partially 2′-O-methylated RNA may avoid the interferon response to double-stranded nucleic acids, while maintaining target RNA inhibition. This may be useful, for example, for avoiding the interferon or other cellular stress responses, both in short RNAi (e.g., siRNA) sequences that induce the interferon response, and in longer RNAi sequences that may induce the interferon response.

Overall, modified sugars may include D-ribose, 2′-O-alkyl (including 2′-O-methyl and 2′-O-ethyl), i.e., 2′-alkoxy, 2′-amino, 2′-S-alkyl, 2′-halo (including 2′-fluoro), 2′-methoxyethoxy, 2′-allyloxy (—OCH₂CH═CH₂), 2′-propargyl, 2′-propyl, ethynyl, ethenyl, propenyl, and cyano and the like. In one embodiment, the sugar moiety can be a hexose and incorporated into an oligonucleotide as described (Augustyns, K., et al., Nucl. Acids. Res. 18:4711 (1992)). Exemplary nucleomonomers can be found, e.g., in U.S. Pat. No. 5,849,902, incorporated by reference herein.

The term “alkyl” includes saturated aliphatic groups, including straight-chain alkyl groups (e.g., methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, etc.), branched-chain alkyl groups (isopropyl, tert-butyl, isobutyl, etc.), cycloalkyl (alicyclic) groups (cyclopropyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl), alkyl substituted cycloalkyl groups, and cycloalkyl substituted alkyl groups. In certain embodiments, a straight chain or branched chain alkyl has 6 or fewer carbon atoms in its backbone (e.g., C₁-C₆ for straight chain, C₃-C₆ for branched chain), and more preferably 4 or fewer. Likewise, preferred cycloalkyls have from 3-8 carbon atoms in their ring structure, and more preferably have 5 or 6 carbons in the ring structure. The term C₁-C₆ includes alkyl groups containing 1 to 6 carbon atoms.

Moreover, unless otherwise specified, the term alkyl includes both “unsubstituted alkyls” and “substituted alkyls,” the latter of which refers to alkyl moieties having independently selected substituents replacing a hydrogen on one or more carbons of the hydrocarbon backbone. Such substituents can include, for example, alkenyl, alkynyl, halogen, hydroxyl, alkylcarbonyloxy, arylcarbonyloxy, alkoxycarbonyloxy, aryloxycarbonyloxy, carboxylate, alkyl carbonyl, arylcarbonyl, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkylthiocarbonyl, alkoxyl, phosphate, phosphonato, phosphinato, cyano, amino (including alkyl amino, dialkylamino, arylamino, diarylamino, and alkylarylamino), acylamino (including alkylcarbonylamino, arylcarbonylamino, carbamoyl and ureido), amidino, imino, sulfhydryl, alkylthio, arylthio, thiocarboxylate, sulfates, alkylsulfinyl, sulfonato, sulfamoyl, sulfonamido, nitro, trifluoromethyl, cyano, azido, heterocyclyl, alkylaryl, or an aromatic or heteroaromatic moiety. Cycloalkyls can be further substituted, e.g., with the substituents described above. An “alkylaryl” or an “arylalkyl” moiety is an alkyl substituted with an aryl (e.g., phenylmethyl (benzyl)). The term “alkyl” also includes the side chains of natural and unnatural amino acids. The term “n-alkyl” means a straight chain (i.e., unbranched) unsubstituted alkyl group.

The term “alkenyl” includes unsaturated aliphatic groups analogous in length and possible substitution to the alkyls described above, but that contain at least one double bond. For example, the term “alkenyl” includes straight-chain alkenyl groups (e.g., ethylenyl, propenyl, butenyl, pentenyl, hexenyl, heptenyl, octenyl, nonenyl, decenyl, etc.), branched-chain alkenyl groups, cycloalkenyl (alicyclic) groups (cyclopropenyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, cyclooctenyl), alkyl or alkenyl substituted cycloalkenyl groups, and cycloalkyl or cycloalkenyl substituted alkenyl groups. In certain embodiments, a straight chain or branched chain alkenyl group has 6 or fewer carbon atoms in its backbone (e.g., C₂-C₆ for straight chain, C₃-C₆ for branched chain). Likewise, cycloalkenyl groups may have from 3-8 carbon atoms in their ring structure, and more preferably have 5 or 6 carbons in the ring structure. The term C₂-C₆ includes alkenyl groups containing 2 to 6 carbon atoms.

Moreover, unless otherwise specified, the term alkenyl includes both “unsubstituted alkenyls” and “substituted alkenyls,” the latter of which refers to alkenyl moieties having independently selected substituents replacing a hydrogen on one or more carbons of the hydrocarbon backbone. Such substituents can include, for example, alkyl groups, alkynyl groups, halogens, hydroxyl, alkylcarbonyloxy, arylcarbonyloxy, alkoxycarbonyloxy, aryloxycarbonyloxy, carboxylate, alkylcarbonyl, arylcarbonyl, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkylthiocarbonyl, alkoxyl, phosphate, phosphonato, phosphinato, cyano, amino (including alkyl amino, dialkylamino, arylamino, diarylamino, and alkylarylamino), acylamino (including alkylcarbonylamino, arylcarbonylamino, carbamoyl and ureido), amidino, imino, sulfhydryl, alkylthio, arylthio, thiocarboxylate, sulfates, alkylsulfinyl, sulfonato, sulfamoyl, sulfonamido, nitro, trifluoromethyl, cyano, azido, heterocyclyl, alkylaryl, or an aromatic or heteroaromatic moiety.

The term “alkynyl” includes unsaturated aliphatic groups analogous in length and possible substitution to the alkyls described above, but which contain at least one triple bond. For example, the term “alkynyl” includes straight-chain alkynyl groups (e.g., ethynyl, propynyl, butynyl, pentynyl, hexynyl, heptynyl, octynyl, nonynyl, decynyl, etc.), branched-chain alkynyl groups, and cycloalkyl or cycloalkenyl substituted alkynyl groups. In certain embodiments, a straight chain or branched chain alkynyl group has 6 or fewer carbon atoms in its backbone (e.g., C₂-C₆ for straight chain, C₃-C₆ for branched chain). The term C₂-C₆ includes alkynyl groups containing 2 to 6 carbon atoms.

Moreover, unless otherwise specified, the term alkynyl includes both “unsubstituted alkynyls” and “substituted alkynyls,” the latter of which refers to alkynyl moieties having independently selected substituents replacing a hydrogen on one or more carbons of the hydrocarbon backbone. Such substituents can include, for example, alkyl groups, alkynyl groups, halogens, hydroxyl, alkylcarbonyloxy, arylcarbonyloxy, alkoxycarbonyloxy, aryloxycarbonyloxy, carboxylate, alkylcarbonyl, arylcarbonyl, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkylthiocarbonyl, alkoxyl, phosphate, phosphonato, phosphinato, cyano, amino (including alkyl amino, dialkylamino, arylamino, diarylamino, and alkylarylamino), acylamino (including alkylcarbonylamino, arylcarbonylamino, carbamoyl and ureido), amidino, imino, sulfhydryl, alkylthio, arylthio, thiocarboxylate, sulfates, alkylsulfinyl, sulfonato, sulfamoyl, sulfonamido, nitro, trifluoromethyl, cyano, azido, heterocyclyl, alkylaryl, or an aromatic or heteroaromatic moiety.

Unless the number of carbons is otherwise specified, “lower alkyl” as used herein means an alkyl group, as defined above, but having from one to five carbon atoms in its backbone structure. “Lower alkenyl” and “lower alkynyl” have chain lengths of, for example, 2-5 carbon atoms.

The term “alkoxy” includes substituted and unsubstituted alkyl, alkenyl, and alkynyl groups covalently linked to an oxygen atom. Examples of alkoxy groups include methoxy, ethoxy, isopropyloxy, propoxy, butoxy, and pentoxy groups. Examples of substituted alkoxy groups include halogenated alkoxy groups. The alkoxy groups can be substituted with independently selected groups such as alkenyl, alkynyl, halogen, hydroxyl, alkylcarbonyloxy, arylcarbonyloxy, alkoxycarbonyloxy, aryloxycarbonyloxy, carboxylate, alkylcarbonyl, arylcarbonyl, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkylthiocarbonyl, alkoxyl, phosphate, phosphonato, phosphinato, cyano, amino (including alkyl amino, dialkylamino, arylamino, diarylamino, and alkylarylamino), acylamino (including alkylcarbonylamino, arylcarbonylamino, carbamoyl and ureido), amidino, imino, sulffiydryl, alkylthio, arylthio, thiocarboxylate, sulfates, alkylsulfmyl, sulfonato, sulfamoyl, sulfonamido, nitro, trifluoromethyl, cyano, azido, heterocyclyl, alkylaryl, or an aromatic or heteroaromatic moieties. Examples of halogen substituted alkoxy groups include, but are not limited to, fluoromethoxy, difluoromethoxy, trifluoromethoxy, chloromethoxy, dichloromethoxy, trichloromethoxy, etc.

The term “heteroatom” includes atoms of any element other than carbon or hydrogen. Preferred heteroatoms are nitrogen, oxygen, sulfur and phosphorus.

The term “hydroxy” or “hydroxyl” includes groups with an —OH or —O⁻ (with an appropriate counterion).

The term “halogen” includes fluorine, bromine, chlorine, iodine, etc. The term “perhalogenated” generally refers to a moiety wherein all hydrogens are replaced by halogen atoms.

The term “substituted” includes independently selected substituents which can be placed on the moiety and which allow the molecule to perform its intended function. Examples of sub stituents include alkyl, alkenyl, alkynyl, aryl, (CR′R″)_0-3NR′R″, (CR′R″)_0-3CN, NO₂, halogen, (CR′R″)_0-3C(halogen)₃, (CR′R″)_0-3CH(halogen)₂, (CR′R″)_0-3CH₂(halogen), (CR′R″)_0-3CONR′R″, (CR′R″)_0-3S(O)_1-2NR′R″, (CR′R″)_0-3CHO, (CR′R″)_0-3O(CR′R″)_0-3H, (CR′R″)_0-3S(O)_0-2R′, (CR′R″)_0-3O(CR′R″)_0-3H, (CR′R″)_0-3COR′, (CR′R″)_0-3CO₂R′, or (CR′R″)_0-3OR′ groups; wherein each R′ and R″ are each independently hydrogen, a C₁-C₅ alkyl, C₂-C₅ alkenyl, C₂-C₅ alkynyl, or aryl group, or R′ and R″ taken together are a benzylidene group or a —(CH₂)₂O(CH₂)₂— group.

The term “amine” or “amino” includes compounds or moieties in which a nitrogen atom is covalently bonded to at least one carbon or heteroatom. The term “alkyl amino” includes groups and compounds wherein the nitrogen is bound to at least one additional alkyl group. The term “dialkyl amino” includes groups wherein the nitrogen atom is bound to at least two additional alkyl groups.

The term “ether” includes compounds or moieties which contain an oxygen bonded to two different carbon atoms or heteroatoms. For example, the term includes “alkoxyalkyl,” which refers to an alkyl, alkenyl, or alkynyl group covalently bonded to an oxygen atom which is covalently bonded to another alkyl group.

The term “base” includes the known purine and pyrimidine heterocyclic bases, deazapurines, and analogs (including heterocyclic substituted analogs, e.g., aminoethyoxy phenoxazine), derivatives (e.g., 1-alkyl-, 1-alkenyl-, heteroaromatic- and 1-alkynyl derivatives) and tautomers thereof. Examples of purines include adenine, guanine, inosine, diaminopurine, and xanthine and analogs (e.g., 8-oxo-N⁶-methyladenine or 7-diazaxanthine) and derivatives thereof. Pyrimidines include, for example, thymine, uracil, and cytosine, and their analogs (e.g., 5-methylcytosine, 5-methyluracil, 5-(1-propynyl)uracil, 5-(1-propynyl)cytosine and 4,4-ethanocytosine). Other examples of suitable bases include non-purinyl and non-pyrimidinyl bases such as 2-aminopyridine and triazines.

In a preferred embodiment, the nucleomonomers of an oligonucleotide of the invention are RNA nucleotides. In another preferred embodiment, the nucleomonomers of an oligonucleotide of the invention are modified RNA nucleotides. Thus, the oligunucleotides contain modified RNA nucleotides.

The term “nucleoside” includes bases which are covalently attached to a sugar moiety, preferably ribose or deoxyribose. Examples of preferred nucleosides include ribonucleosides and deoxyribonucleosides. Nucleosides also include bases linked to amino acids or amino acid analogs which may comprise free carboxyl groups, free amino groups, or protecting groups. Suitable protecting groups are well known in the art (see P. G. M. Wuts and T. W. Greene, “Protective Groups in Organic Synthesis”, 2^nd Ed., Wiley-Interscience, New York, 1999).

The term “nucleotide” includes nucleosides which further comprise a phosphate group or a phosphate analog.

As used herein, the term “linkage” includes a naturally occurring, unmodified phosphodiester moiety (—O—(PO²⁻)—O—) that covalently couples adjacent nucleomonomers. As used herein, the term “substitute linkage” includes any analog or derivative of the native phosphodiester group that covalently couples adjacent nucleomonomers. Substitute linkages include phosphodiester analogs, e.g., phosphorothioate, phosphorodithioate, and P-ethyoxyphosphodiester, P-ethoxyphosphodiester, P-alkyloxyphosphotriester, methylphosphonate, and nonphosphorus containing linkages, e.g., acetals and amides. Such substitute linkages are known in the art (e.g., Bjergarde et al. 1991. Nucleic Acids Res. 19:5843; Caruthers et al. 1991. Nucleosides Nucleotides. 10:47). In certain embodiments, non-hydrolizable linkages are preferred, such as phosphorothiate linkages.

In certain embodiments, oligonucleotides of the invention comprise hydrophobically modified nucleotides or “hydrophobic modifications.” As used herein “hydrophobic modifications” refers to bases that are modified such that (1) overall hydrophobicity of the base is significantly increased, and/or (2) the base is still capable of forming close to regular Watson-Crick interaction. Several non-limiting examples of base modifications include 5-position uridine and cytidine modifications such as methyl, ethyl, phenyl, 4-pyridyl, 2-pyridyl, indolyl, and isobutyl, phenyl (C6H5OH); tryptophanyl (C8H6N)CH2CH(NH2)CO), butyl, aminobenzyl; and naphthyl.

In certain embodiments, oligonucleotides of the invention comprise 3′ and 5′ termini (except for circular oligonucleotides). In one embodiment, the 3′ and 5′ termini of an oligonucleotide can be substantially protected from nucleases e.g., by modifying the 3′ or 5′ linkages (e.g., U.S. Pat. No. 5,849,902 and WO 98/13526). For example, oligonucleotides can be made resistant by the inclusion of a “blocking group.” The term “blocking group” as used herein refers to substituents (e.g., other than OH groups) that can be attached to oligonucleotides or nucleomonomers, either as protecting groups or coupling groups for synthesis (e.g., FITC, propyl (CH₂—CH₂—CH₃), glycol (—O—CH₂—CH₂—O—) phosphate (PO₃²⁻), hydrogen phosphonate, or phosphoramidite). “Blocking groups” also include “end blocking groups” or “exonuclease blocking groups” which protect the 5′ and 3′ termini of the oligonucleotide, including modified nucleotides and non-nucleotide exonuclease resistant structures.

Exemplary end-blocking groups include cap structures (e.g., a 7-methylguanosine cap), inverted nucleomonomers, e.g., with 3′-3′ or 5′-5′ end inversions (see, e.g., Ortiagao et al. 1992. Antisense Res. Dev. 2:129), methylphosphonate, phosphoramidite, non-nucleotide groups (e.g., non-nucleotide linkers, amino linkers, conjugates) and the like. The 3′ terminal nucleomonomer can comprise a modified sugar moiety. The 3′ terminal nucleomonomer comprises a 3′-O that can optionally be substituted by a blocking group that prevents 3′-exonuclease degradation of the oligonucleotide. For example, the 3′-hydroxyl can be esterified to a nucleotide through a 3′→3′ internucleotide linkage. For example, the alkyloxy radical can be methoxy, ethoxy, or isopropoxy, and preferably, ethoxy. Optionally, the 3′→3′ linked nucleotide at the 3′ terminus can be linked by a substitute linkage. To reduce nuclease degradation, the 5′ most 3′→5′ linkage can be a modified linkage, e.g., a phosphorothioate or a P-alkyloxyphosphotriester linkage. Preferably, the two 5′ most 3′→5′ linkages are modified linkages. Optionally, the 5′ terminal hydroxy moiety can be esterified with a phosphorus containing moiety, e.g., phosphate, phosphorothioate, or P-ethoxyphosphate.

Another type of conjugates that can be attached to the end (3′ or 5′ end), the loop region, or any other parts of the miniRNA might include a sterol, sterol type molecule, peptide, small molecule, protein, etc. In some embodiments, a miniRNA may contain more than one conjugates (same or different chemical nature). In some embodiments, the conjugate is cholesterol.

Another way to increase target gene specificity, or to reduce off-target silencing effect, is to introduce a 2′-modification (such as the 2′-O methyl modification) at a position corresponding to the second 5′-end nucleotide of the guide sequence. This allows the positioning of this 2′-modification in the Dicer-resistant hairpin structure, thus enabling one to design better RNAi constructs with less or no off-target silencing.

In one embodiment, a hairpin polynucleotide of the invention can comprise one nucleic acid portion which is DNA and one nucleic acid portion which is RNA. Antisense (guide) sequences of the invention can be “chimeric oligonucleotides” which comprise an RNA-like and a DNA-like region.

The language “RNase H activating region” includes a region of an oligonucleotide, e.g., a chimeric oligonucleotide, that is capable of recruiting RNase H to cleave the target RNA strand to which the oligonucleotide binds. Typically, the RNase activating region contains a minimal core (of at least about 3-5, typically between about 3-12, more typically, between about 5-12, and more preferably between about 5-10 contiguous nucleomonomers) of DNA or DNA-like nucleomonomers. (See, e.g., U.S. Pat. No. 5,849,902). Preferably, the RNase H activating region comprises about nine contiguous deoxyribose containing nucleomonomers.

The language “non-activating region” includes a region of an antisense sequence, e.g., a chimeric oligonucleotide, that does not recruit or activate RNase H. Preferably, a non-activating region does not comprise phosphorothioate DNA. The oligonucleotides of the invention comprise at least one non-activating region. In one embodiment, the non-activating region can be stabilized against nucleases or can provide specificity for the target by being complementary to the target and forming hydrogen bonds with the target nucleic acid molecule, which is to be bound by the oligonucleotide.

In one embodiment, at least a portion of the contiguous polynucleotides are linked by a substitute linkage, e.g., a phosphorothioate linkage.

In certain embodiments, most or all of the nucleotides beyond the guide sequence (2′-modified or not) are linked by phosphorothioate linkages. Such constructs tend to have improved pharmacokinetics due to their higher affinity for serum proteins. The phosphorothioate linkages in the non-guide sequence portion of the polynucleotide generally do not interfere with guide strand activity, once the latter is loaded into RISC.

Antisense (guide) sequences of the present invention may include “morpholino oligonucleotides.” Morpholino oligonucleotides are non-ionic and function by an RNase H-independent mechanism. Each of the 4 genetic bases (Adenine, Cytosine, Guanine, and Thymine/Uracil) of the morpholino oligonucleotides is linked to a 6-membered morpholine ring. Morpholino oligonucleotides are made by joining the 4 different subunit types by, e.g., non-ionic phosphorodiamidate inter-subunit linkages. Morpholino oligonucleotides have many advantages including: complete resistance to nucleases (Antisense & Nucl. Acid Drug Dev. 1996. 6:267); predictable targeting (Biochemica Biophysica Acta. 1999. 1489:141); reliable activity in cells (Antisense & Nucl. Acid Drug Dev. 1997. 7:63); excellent sequence specificity (Antisense & Nucl. Acid Drug Dev. 1997. 7:151); minimal non-antisense activity (Biochemica Biophysica Acta. 1999. 1489:141); and simple osmotic or scrape delivery (Antisense & Nucl. Acid Drug Dev. 1997. 7:291). Morpholino oligonucleotides are also preferred because of their non-toxicity at high doses. A discussion of the preparation of morpholino oligonucleotides can be found in Antisense & Nucl. Acid Drug Dev. 1997. 7:187.

The chemical modifications described herein are believed, based on the data described herein, to promote single stranded polynucleotide loading into the RISC. Single stranded polynucleotides have been shown to be active in loading into RISC and inducing gene silencing. However, the level of activity for single stranded polynucleotides appears to be 2 to 4 orders of magnitude lower when compared to a duplex polynucleotide.

The present invention provides a description of the chemical modification patterns, which may (a) significantly increase stability of the single stranded polynucleotide (b) promote efficient loading of the polynucleotide into the RISC complex and (c) improve uptake of the single stranded nucleotide by the cell. FIG. 5 provides some non-limiting examples of the chemical modification patterns which may be beneficial for achieving single stranded polynucleotide efficacy inside the cell. The chemical modification patterns may include combination of ribose, backbone, hydrophobic nucleoside and conjugate type of modifications. In addition, in some of the embodiments, the 5′ end of the single polynucleotide may be chemically phosphorylated.

In yet another embodiment, the present invention provides a description of the chemical modifications patterns, which improve functionality of RISC inhibiting polynucleotides. Single stranded polynucleotides have been shown to inhibit activity of a preloaded RISC complex through the substrate competition mechanism. For these types of molecules, conventionally called antagomers, the activity usually requires high concentration and in vivo delivery is not very effective. The present invention provides a description of the chemical modification patterns, which may (a) significantly increase stability of the single stranded polynucleotide (b) promote efficient recognition of the polynucleotide by the RISC as a substrate and/or (c) improve uptake of the single stranded nucleotide by the cell. FIG. 6 provides some non-limiting examples of the chemical modification patterns that may be beneficial for achieving single stranded polynucleotide efficacy inside the cell. The chemical modification patterns may include combination of ribose, backbone, hydrophobic nucleoside and conjugate type of modifications.

The modifications provided by the present invention are applicable to all polynucleotides. This includes single stranded RISC entering polynucleotides, single stranded RISC inhibiting polynucleotides, conventional duplexed polynucleotides of variable length (15-40 bp),asymmetric duplexed polynucleotides, and the like. Polynucleotides may be modified with wide variety of chemical modification patterns, including 5′ end, ribose, backbone and hydrophobic nucleoside modifications.

Synthesis

Oligonucleotides of the invention can be synthesized by any method known in the art, e.g., using enzymatic synthesis and/or chemical synthesis. The oligonucleotides can be synthesized in vitro (e.g., using enzymatic synthesis and chemical synthesis) or in vivo (using recombinant DNA technology well known in the art).

In a preferred embodiment, chemical synthesis is used for modified polynucleotides. Chemical synthesis of linear oligonucleotides is well known in the art and can be achieved by solution or solid phase techniques. Preferably, synthesis is by solid phase methods. Oligonucleotides can be made by any of several different synthetic procedures including the phosphoramidite, phosphite triester, H-phosphonate, and phosphotriester methods, typically by automated synthesis methods.

Oligonucleotide synthesis protocols are well known in the art and can be found, e.g., in U.S. Pat. No. 5,830,653; WO 98/13526; Stec et al. 1984. J. Am. Chem. Soc. 106:6077; Stec et al. 1985. J. Org. Chem. 50:3908; Stec et al. J. Chromatog. 1985. 326:263; LaPlanche et al. 1986. Nucl. Acid. Res. 1986. 14:9081; Fasman G. D., 1989. Practical Handbook of Biochemistry and Molecular Biology. 1989. CRC Press, Boca Raton, Fla.; Lamone. 1993. Biochem. Soc. Trans. 21:1; U.S. Pat. Nos. 5,013,830; 5,214,135; 5,525,719; Kawasaki et al. 1993. J. Med. Chem. 36:831; WO 92/03568; U.S. Pat. Nos. 5,276,019; and 5,264,423.

The synthesis method selected can depend on the length of the desired oligonucleotide and such choice is within the skill of the ordinary artisan. For example, the phosphoramidite and phosphite triester method can produce oligonucleotides having 175 or more nucleotides, while the H-phosphonate method works well for oligonucleotides of less than 100 nucleotides. If modified bases are incorporated into the oligonucleotide, and particularly if modified phosphodiester linkages are used, then the synthetic procedures are altered as needed according to known procedures. In this regard, Uhlmann et al. (1990, Chemical Reviews 90:543-584) provide references and outline procedures for making oligonucleotides with modified bases and modified phosphodiester linkages. Other exemplary methods for making oligonucleotides are taught in Sonveaux. 1994. “Protecting Groups in Oligonucleotide Synthesis”; Agrawal. Methods in Molecular Biology 26:1. Exemplary synthesis methods are also taught in “Oligonucleotide Synthesis—A Practical Approach” (Gait, M. J. IRL Press at Oxford University Press. 1984). Moreover, linear oligonucleotides of defined sequence, including some sequences with modified nucleotides, are readily available from several commercial sources.

The oligonucleotides may be purified by polyacrylamide gel electrophoresis, or by any of a number of chromatographic methods, including gel chromatography and high pressure liquid chromatography. To confirm a nucleotide sequence, especially unmodified nucleotide sequences, oligonucleotides may be subjected to DNA sequencing by any of the known procedures, including Maxam and Gilbert sequencing, Sanger sequencing, capillary electrophoresis sequencing, the wandering spot sequencing procedure or by using selective chemical degradation of oligonucleotides bound to Hybond paper. Sequences of short oligonucleotides can also be analyzed by laser desorption mass spectroscopy or by fast atom bombardment (McNeal, et al., 1982, J. Am. Chem. Soc. 104:976; Viari, et al., 1987, Biomed. Environ. Mass Spectrom. 14:83; Grotjahn et al., 1982, Nuc. Acid Res. 10:4671). Sequencing methods are also available for RNA oligonucleotides.

The quality of oligonucleotides synthesized can be verified by testing the oligonucleotide by capillary electrophoresis and denaturing strong anion HPLC (SAX-HPLC) using, e.g., the method of Bergot and Egan. 1992. J. Chrom. 599:35.

Other exemplary synthesis techniques are well known in the art (see, e.g., Sambrook et al., Molecular Cloning: a Laboratory Manual, Second Edition (1989); DNA Cloning, Volumes I and II (DN Glover Ed. 1985); Oligonucleotide Synthesis (M J Gait Ed, 1984; Nucleic Acid Hybridisation (B D Hames and S J Higgins eds. 1984); A Practical Guide to Molecular Cloning (1984); or the series, Methods in Enzymology (Academic Press, Inc.)).

In certain embodiments, the subject RNAi constructs or at least portions thereof are transcribed from expression vectors encoding the subject constructs. Any art recognized vectors may be use for this purpose. The transcribed RNAi constructs may be isolated and purified, before desired modifications (such as replacing an unmodified sense strand with a modified one, etc.) are carried out.

Delivery/Carrier

Uptake of Oligonucleotides by Cells

Oligonucleotides and oligonucleotide compositions are contacted with (i.e., brought into contact with, also referred to herein as administered or delivered to) and taken up by one or more cells or a cell lysate. The term “cells” includes prokaryotic and eukaryotic cells, preferably vertebrate cells, and, more preferably, mammalian cells. In a preferred embodiment, the oligonucleotide compositions of the invention are contacted with human cells.

Oligonucleotide compositions of the invention can be contacted with cells in vitro, e.g., in a test tube or culture dish, (and may or may not be introduced into a subject) or in vivo, e.g., in a subject such as a mammalian subject. Oligonucleotides are taken up by cells at a slow rate by endocytosis, but endocytosed oligonucleotides are generally sequestered and not available, e.g., for hybridization to a target nucleic acid molecule. In one embodiment, cellular uptake can be facilitated by electroporation or calcium phosphate precipitation. However, these procedures are only useful for in vitro or ex vivo embodiments, are not convenient and, in some cases, are associated with cell toxicity.

In another embodiment, delivery of oligonucleotides into cells can be enhanced by suitable art recognized methods including calcium phosphate, DMSO, glycerol or dextran, electroporation, or by transfection, e.g., using cationic, anionic, or neutral lipid compositions or liposomes using methods known in the art (see e.g., WO 90/14074; WO 91/16024; WO 91/17424; U.S. Pat. No. 4,897,355; Bergan et al. 1993. Nucleic Acids Research. 21:3567). Enhanced delivery of oligonucleotides can also be mediated by the use of vectors (See e.g., Shi, Y. 2003. Trends Genet 2003 Jan. 19:9; Reichhart J M et al. Genesis. 2002. 34(1-2):1604, Yu et al. 2002. Proc. Natl. Acad Sci. USA 99:6047; Sui et al. 2002. Proc. Natl. Acad Sci. USA 99:5515) viruses, polyamine or polycation conjugates using compounds such as polylysine, protamine, or Ni, N12-bis (ethyl) spermine (see, e.g., Bartzatt, R. et al. 1989. Biotechnol. Appl. Biochem. 11:133; Wagner E. et al. 1992. Proc. Natl. Acad. Sci. 88:4255).

In certain embodiments, the miniRNA of the invention may be delivered by using various beta-glucan containing particles, such as those described in US 2005/0281781 A1, WO 2006/007372, and WO 2007/050643 (all incorporated herein by reference). In certain embodiments, the beta-glucan particle is derived from yeast. In certain embodiments, the payload trapping molecule is a polymer, such as those with a molecular weight of at least about 1000 Da, 10,000 Da, 50,000 Da, 100 kDa, 500 kDa, etc. Preferred polymers include (without limitation) cationic polymers, chitosans, or PEI (polyethylenimine), etc.

Such beta-glucan based delivery system may be formulated for oral delivery, where the orally delivered beta-glucan/miniRNA constructs may be engulfed by macrophages or other related phagocytic cells, which may in turn release the miniRNA constructs in selected in vivo sites. Alternatively or in addition, the miniRNA may changes the expression of certain macrophage target genes.

The optimal protocol for uptake of oligonucleotides will depend upon a number of factors, the most crucial being the type of cells that are being used. Other factors that are important in uptake include, but are not limited to, the nature and concentration of the oligonucleotide, the confluence of the cells, the type of culture the cells are in (e.g., a suspension culture or plated) and the type of media in which the cells are grown.

Encapsulating Agents

Encapsulating agents entrap oligonucleotides within vesicles. In another embodiment of the invention, an oligonucleotide may be associated with a carrier or vehicle, e.g., liposomes or micelles, although other carriers could be used, as would be appreciated by one skilled in the art. Liposomes are vesicles made of a lipid bilayer having a structure similar to biological membranes. Such carriers are used to facilitate the cellular uptake or targeting of the oligonucleotide, or improve the oligonucleotide's pharmacokinetic or toxicologic properties.

For example, the oligonucleotides of the present invention may also be administered encapsulated in liposomes, pharmaceutical compositions wherein the active ingredient is contained either dispersed or variously present in corpuscles consisting of aqueous concentric layers adherent to lipidic layers. The oligonucleotides, depending upon solubility, may be present both in the aqueous layer and in the lipidic layer, or in what is generally termed a liposomic suspension. The hydrophobic layer, generally but not exclusively, comprises phopholipids such as lecithin and sphingomyelin, steroids such as cholesterol, more or less ionic surfactants such as diacetylphosphate, stearylamine, or phosphatidic acid, or other materials of a hydrophobic nature. The diameters of the liposomes generally range from about 15 nm to about 5 microns.

A “hydrophobic modified polynucleotide” as used herein is a polynucleotide of the invention(i.e. sd-rxRNA) that has at least one modification that renders the polynucleotide more hydrophobic than the polynucleotide was prior to modification. The modification may be achieved by attaching (covalently or non-covalently) a hydrophobic molecule to the polynucleotide. In some instances the hydrophobic molecule is or includes a lipophilic group.

The term “lipophilic group” means a group that has a higher affinity for lipids than its affinity for water. Examples of lipophilic groups include, but are not limited to, cholesterol, a cholesteryl or modified cholesteryl residue, adamantine, dihydrotesterone, long chain alkyl, long chain alkenyl, long chain alkynyl, olely-lithocholic, cholenic, oleoyl-cholenic, palmityl, heptadecyl, myrisityl, bile acids, cholic acid or taurocholic acid, deoxycholate, oleyl litocholic acid, oleoyl cholenic acid, glycolipids, phospholipids, sphingolipids, isoprenoids, such as steroids, vitamins, such as vitamin E, fatty acids either saturated or unsaturated, fatty acid esters, such as triglycerides, pyrenes, porphyrines, Texaphyrine, adamantane, acridines, biotin, coumarin, fluorescein, rhodamine, Texas-Red, digoxygenin, dimethoxytrityl, t-butyldimethylsilyl, t-butyldiphenylsilyl, cyanine dyes (e.g. Cy3 or Cy5), Hoechst 33258 dye, psoralen, or ibuprofen. The cholesterol moiety may be reduced (e.g. as in cholestan) or may be substituted (e.g. by halogen). A combination of different lipophilic groups in one molecule is also possible.

The hydrophobic molecule may be attached at various positions of the polynucleotide. As described above, the hydrophobic molecule may be linked to the terminal residue of the polynucleotide such as the 3′ of 5′-end of the polynucleotide. Alternatively, it may be linked to an internal nucleotide or a nucleotide on a branch of the polynucleotide. The hydrophobic molecule may be attached, for instance to a 2′-position of the nucleotide. The hydrophobic molecule may also be linked to the heterocyclic base, the sugar or the backbone of a nucleotide of the polynucleotide.

The hydrophobic molecule may be connected to the polynucleotide by a linker moiety. Optionally the linker moiety is a non-nucleotidic linker moiety. Non-nucleotidic linkers are e.g. abasic residues (dSpacer), oligoethyleneglycol, such as triethyleneglycol (spacer 9) or hexaethylenegylcol (spacer 18), or alkane-diol, such as butanediol. The spacer units are preferably linked by phosphodiester or phosphorothioate bonds. The linker units may appear just once in the molecule or may be incorporated several times, e.g. via phosphodiester, phosphorothioate, methylphosphonate, or amide linkages.

Typical conjugation protocols involve the synthesis of polynucleotides bearing an aminolinker at one or more positions of the sequence, however, a linker is not required. The amino group is then reacted with the molecule being conjugated using appropriate coupling or activating reagents. The conjugation reaction may be performed either with the polynucleotide still bound to a solid support or following cleavage of the polynucleotide in solution phase. Purification of the modified polynucleotide by HPLC typically results in a pure material.

In some embodiments the hydrophobic molecule is a sterol type conjugate, a PhytoSterol conjugate, cholesterol conjugate, sterol type conjugate with altered side chain length, fatty acid conjugate, any other hydrophobic group conjugate, and/or hydrophobic modifications of the internal nucleoside, which provide sufficient hydrophobicity to be incorporated into micelles.

For purposes of the present invention, the term “sterols”, refers or steroid alcohols are a subgroup of steroids with a hydroxyl group at the 3-position of the A-ring. They are amphipathic lipids synthesized from acetyl-coenzyme A via the HMG-CoA reductase pathway. The overall molecule is quite flat. The hydroxyl group on the A ring is polar. The rest of the aliphatic chain is non-polar. Usually sterols are considered to have an 8 carbon chain at position 17.

For purposes of the present invention, the term “sterol type molecules”, refers to steroid alcohols, which are similar in structure to sterols. The main difference is the structure of the ring and number of carbons in a position 21 attached side chain.

For purposes of the present invention, the term “PhytoSterols” (also called plant sterols) are a group of steroid alcohols, phytochemicals naturally occurring in plants. There are more then 200 different known PhytoSterols

For purposes of the present invention, the term “Sterol side chain” refers to a chemical composition of a side chain attached at the position 17 of sterol-type molecule. In a standard definition sterols are limited to a 4 ring structure carrying a 8 carbon chain at position 17. In this invention, the sterol type molecules with side chain longer and shorter than conventional are described. The side chain may branched or contain double back bones.

Thus, sterols useful in the invention, for example, include cholesterols, as well as unique sterols in which position 17 has attached side chain of 2-7 or longer then 9 carbons. In a particular embodiment, the length of the polycarbon tail is varied between 5 and 9 carbons. FIG. 9 demonstrates that there is a correlation between plasma clearance, liver uptake and the length of the polycarbon chain. Such conjugates may have significantly better in vivo efficacy, in particular delivery to liver. These types of molecules are expected to work at concentrations 5 to 9 fold lower then oligonucleotides conjugated to conventional cholesterols.

Alternatively the polynucleotide may be bound to a protein, peptide or positively charged chemical that functions as the hydrophobic molecule. The proteins may be selected from the group consisting of protamine, dsRNA binding domain, and arginine rich peptides. Exemplary positively charged chemicals include spermine, spermidine, cadaverine, and putrescine.

In another embodiment hydrophobic molecule conjugates may demonstrate even higher efficacy when it is combined with optimal chemical modification patterns of the polynucleotide (as described herein in detail), containing but not limited to hydrophobic modifications, phosphorothioate modifications, and 2′ ribo modifications.

In another embodiment the sterol type molecule may be a naturally occurring PhytoSterols such as those shown in FIG. 8. The polycarbon chain may be longer than 9 and may be linear, branched and/or contain double bonds. Some PhytoSterol containing polynucleotide conjugates may be significantly more potent and active in delivery of polynucleotides to various tissues. Some PhytoSterols may demonstrate tissue preference and thus be used as a way to delivery RNAi specifically to particular tissues.

Targeting Agents

The delivery of oligonucleotides can also be improved by targeting the oligonucleotides to a cellular receptor. The targeting moieties can be conjugated to the oligonucleotides or attached to a carrier group (i.e., poly(L-lysine) or liposomes) linked to the oligonucleotides. This method is well suited to cells that display specific receptor-mediated endocytosis.

For instance, oligonucleotide conjugates to 6-phosphomannosylated proteins are internalized 20-fold more efficiently by cells expressing mannose 6-phosphate specific receptors than free oligonucleotides. The oligonucleotides may also be coupled to a ligand for a cellular receptor using a biodegradable linker. In another example, the delivery construct is mannosylated streptavidin which forms a tight complex with biotinylated oligonucleotides. Mannosylated streptavidin was found to increase 20-fold the internalization of biotinylated oligonucleotides. (Vlassov et al. 1994. Biochimica et Biophysica Acta 1197:95-108).

In addition specific ligands can be conjugated to the polylysine component of polylysine-based delivery systems. For example, transferrin-polylysine, adenovirus-polylysine, and influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides-polylysine conjugates greatly enhance receptor-mediated DNA delivery in eucaryotic cells. Mannosylated glycoprotein conjugated to poly(L-lysine) in aveolar macrophages has been employed to enhance the cellular uptake of oligonucleotides. Liang et al. 1999. Pharmazie 54:559-566.

Because malignant cells have an increased need for essential nutrients such as folic acid and transferrin, these nutrients can be used to target oligonucleotides to cancerous cells. For example, when folic acid is linked to poly(L-lysine) enhanced oligonucleotide uptake is seen in promyelocytic leukaemia (HL-60) cells and human melanoma (M-14) cells. Ginobbi et al. 1997. Anticancer Res. 17:29. In another example, liposomes coated with maleylated bovine serum albumin, folic acid, or ferric protoporphyrin IX, show enhanced cellular uptake of oligonucleotides in murine macrophages, KB cells, and 2.2.15 human hepatoma cells. Liang et al. 1999. Pharmazie 54:559-566.

Liposomes naturally accumulate in the liver, spleen, and reticuloendothelial system (so-called, passive targeting). By coupling liposomes to various ligands such as antibodies are protein A, they can be actively targeted to specific cell populations. For example, protein A-bearing liposomes may be pretreated with H-2K specific antibodies which are targeted to the mouse major histocompatibility complex-encoded H-2K protein expressed on L cells. (Vlassov et al. 1994. Biochimica et Biophysica Acta 1197:95-108).

Other in vitro and/or in vivo delivery of RNAi reagents are known in the art, and can be used to deliver the subject RNAi constructs. See, for example, U.S. patent application publications 20080152661, 20080112916, 20080107694, 20080038296, 20070231392, 20060240093, 20060178327, 20060008910, 20050265957, 20050064595, 20050042227, 20050037496, 20050026286, 20040162235, 20040072785, 20040063654, 20030157030, WO 2008/036825, WO04/065601, and AU2004206255B2, just to name a few (all incorporated by reference).

Administration

The optimal course of administration or delivery of the oligonucleotides may vary depending upon the desired result and/or on the subject to be treated. As used herein “administration” refers to contacting cells with oligonucleotides and can be performed in vitro or in vivo. The dosage of oligonucleotides may be adjusted to optimally reduce expression of a protein translated from a target nucleic acid molecule, e.g., as measured by a readout of RNA stability or by a therapeutic response, without undue experimentation.

For example, expression of the protein encoded by the nucleic acid target can be measured to determine whether or not the dosage regimen needs to be adjusted accordingly. In addition, an increase or decrease in RNA or protein levels in a cell or produced by a cell can be measured using any art recognized technique. By determining whether transcription has been decreased, the effectiveness of the oligonucleotide in inducing the cleavage of a target RNA can be determined.

Any of the above-described oligonucleotide compositions can be used alone or in conjunction with a pharmaceutically acceptable carrier. As used herein, “pharmaceutically acceptable carrier” includes appropriate solvents, dispersion media, coatings, antibacterial and antifungal agents, isotonic and absorption delaying agents, and the like. The use of such media and agents for pharmaceutical active substances is well known in the art. Except insofar as any conventional media or agent is incompatible with the active ingredient, it can be used in the therapeutic compositions. Supplementary active ingredients can also be incorporated into the compositions.

Oligonucleotides may be incorporated into liposomes or liposomes modified with polyethylene glycol or admixed with cationic lipids for parenteral administration. Incorporation of additional substances into the liposome, for example, antibodies reactive against membrane proteins found on specific target cells, can help target the oligonucleotides to specific cell types.

Moreover, the present invention provides for administering the subject oligonucleotides with an osmotic pump providing continuous infusion of such oligonucleotides, for example, as described in Rataiczak et al. (1992 Proc. Natl. Acad. Sci. USA 89:11823-11827). Such osmotic pumps are commercially available, e.g., from Alzet Inc. (Palo Alto, Calif.). Topical administration and parenteral administration in a cationic lipid carrier are preferred.

With respect to in vivo applications, the formulations of the present invention can be administered to a patient in a variety of forms adapted to the chosen route of administration, e.g., parenterally, orally, or intraperitoneally. Parenteral administration, which is preferred, includes administration by the following routes: intravenous; intramuscular; interstitially; intraarterially; subcutaneous; intra ocular; intrasynovial; trans epithelial, including transdermal; pulmonary via inhalation; ophthalmic; sublingual and buccal; topically, including ophthalmic; dermal; ocular; rectal; and nasal inhalation via insufflation.

Pharmaceutical preparations for parenteral administration include aqueous solutions of the active compounds in water-soluble or water-dispersible form. In addition, suspensions of the active compounds as appropriate oily injection suspensions may be administered. Suitable lipophilic solvents or vehicles include fatty oils, for example, sesame oil, or synthetic fatty acid esters, for example, ethyl oleate or triglycerides. Aqueous injection suspensions may contain substances which increase the viscosity of the suspension include, for example, sodium carboxymethyl cellulose, sorbitol, or dextran, optionally, the suspension may also contain stabilizers. The oligonucleotides of the invention can be formulated in liquid solutions, preferably in physiologically compatible buffers such as Hank's solution or Ringer's solution. In addition, the oligonucleotides may be formulated in solid form and redissolved or suspended immediately prior to use. Lyophilized forms are also included in the invention.

Pharmaceutical preparations for topical administration include transdermal patches, ointments, lotions, creams, gels, drops, sprays, suppositories, liquids and powders. In addition, conventional pharmaceutical carriers, aqueous, powder or oily bases, or thickeners may be used in pharmaceutical preparations for topical administration.

Pharmaceutical preparations for oral administration include powders or granules, suspensions or solutions in water or non-aqueous media, capsules, sachets or tablets. In addition, thickeners, flavoring agents, diluents, emulsifiers, dispersing aids, or binders may be used in pharmaceutical preparations for oral administration.

For transmucosal or transdermal administration, penetrants appropriate to the barrier to be permeated are used in the formulation. Such penetrants are known in the art, and include, for example, for transmucosal administration bile salts and fusidic acid derivatives, and detergents. Transmucosal administration may be through nasal sprays or using suppositories. For oral administration, the oligonucleotides are formulated into conventional oral administration forms such as capsules, tablets, and tonics. For topical administration, the oligonucleotides of the invention are formulated into ointments, salves, gels, or creams as known in the art.

Drug delivery vehicles can be chosen e.g., for in vitro, for systemic, or for topical administration. These vehicles can be designed to serve as a slow release reservoir or to deliver their contents directly to the target cell. An advantage of using some direct delivery drug vehicles is that multiple molecules are delivered per uptake. Such vehicles have been shown to increase the circulation half-life of drugs that would otherwise be rapidly cleared from the blood stream. Some examples of such specialized drug delivery vehicles which fall into this category are liposomes, hydrogels, cyclodextrins, biodegradable nanocapsules, and bioadhesive microspheres.

The described oligonucleotides may be administered systemically to a subject. Systemic absorption refers to the entry of drugs into the blood stream followed by distribution throughout the entire body. Administration routes which lead to systemic absorption include: intravenous, subcutaneous, intraperitoneal, and intranasal. Each of these administration routes delivers the oligonucleotide to accessible diseased cells. Following subcutaneous administration, the therapeutic agent drains into local lymph nodes and proceeds through the lymphatic network into the circulation. The rate of entry into the circulation has been shown to be a function of molecular weight or size. The use of a liposome or other drug carrier localizes the oligonucleotide at the lymph node. The oligonucleotide can be modified to diffuse into the cell, or the liposome can directly participate in the delivery of either the unmodified or modified oligonucleotide into the cell.

The chosen method of delivery will result in entry into cells. Preferred delivery methods include liposomes (10-400 nm), hydrogels, controlled-release polymers, and other pharmaceutically applicable vehicles, and microinjection or electroporation (for ex vivo treatments).

The pharmaceutical preparations of the present invention may be prepared and formulated as emulsions. Emulsions are usually heterogeneous systems of one liquid dispersed in another in the form of droplets usually exceeding 0.1 μm in diameter. The emulsions of the present invention may contain excipients such as emulsifiers, stabilizers, dyes, fats, oils, waxes, fatty acids, fatty alcohols, fatty esters, humectants, hydrophilic colloids, preservatives, and anti-oxidants may also be present in emulsions as needed. These excipients may be present as a solution in either the aqueous phase, oily phase or itself as a separate phase.

Examples of naturally occurring emulsifiers that may be used in emulsion formulations of the present invention include lanolin, beeswax, phosphatides, lecithin and acacia. Finely divided solids have also been used as good emulsifiers especially in combination with surfactants and in viscous preparations. Examples of finely divided solids that may be used as emulsifiers include polar inorganic solids, such as heavy metal hydroxides, nonswelling clays such as bentonite, attapulgite, hectorite, kaolin, montrnorillonite, colloidal aluminum silicate and colloidal magnesium aluminum silicate, pigments and nonpolar solids such as carbon or glyceryl tristearate.

Examples of preservatives that may be included in the emulsion formulations include methyl paraben, propyl paraben, quaternary ammonium salts, benzalkonium chloride, esters of p-hydroxybenzoic acid, and boric acid. Examples of antioxidants that may be included in the emulsion formulations include free radical scavengers such as tocopherols, alkyl gallates, butylated hydroxyanisole, butylated hydroxytoluene, or reducing agents such as ascorbic acid and sodium metabisulfite, and antioxidant synergists such as citric acid, tartaric acid, and lecithin.

In one embodiment, the compositions of oligonucleotides are formulated as microemulsions. A microemulsion is a system of water, oil and amphiphile which is a single optically isotropic and thermodynamically stable liquid solution. Typically microemulsions are prepared by first dispersing an oil in an aqueous surfactant solution and then adding a sufficient amount of a 4th component, generally an intermediate chain-length alcohol to form a transparent system.

Surfactants that may be used in the preparation of microemulsions include, but are not limited to, ionic surfactants, non-ionic surfactants, Brij 96, polyoxyethylene oleyl ethers, polyglycerol fatty acid esters, tetraglycerol monolaurate (ML310), tetraglycerol monooleate (MO310), hexaglycerol monooleate (PO310), hexaglycerol pentaoleate (PO500), decaglycerol monocaprate (MCA750), decaglycerol monooleate (MO750), decaglycerol sequioleate (S0750), decaglycerol decaoleate (DA0750), alone or in combination with cosurfactants. The cosurfactant, usually a short-chain alcohol such as ethanol, 1-propanol, and 1-butanol, serves to increase the interfacial fluidity by penetrating into the surfactant film and consequently creating a disordered film because of the void space generated among surfactant molecules.

Microemulsions may, however, be prepared without the use of cosurfactants and alcohol-free self-emulsifying microemulsion systems are known in the art. The aqueous phase may typically be, but is not limited to, water, an aqueous solution of the drug, glycerol, PEG300, PEG400, polyglycerols, propylene glycols, and derivatives of ethylene glycol. The oil phase may include, but is not limited to, materials such as Captex 300, Captex 355, Capmul MCM, fatty acid esters, medium chain (C₈-C₁₂) mono, di, and tri-glycerides, polyoxyethylated glyceryl fatty acid esters, fatty alcohols, polyglycolized glycerides, saturated polyglycolized C₈-C₁₀ glycerides, vegetable oils and silicone oil.

Microemulsions are particularly of interest from the standpoint of drug solubilization and the enhanced absorption of drugs. Lipid based microemulsions (both oil/water and water/oil) have been proposed to enhance the oral bioavailability of drugs.

Microemulsions offer improved drug solubilization, protection of drug from enzymatic hydrolysis, possible enhancement of drug absorption due to surfactant-induced alterations in membrane fluidity and permeability, ease of preparation, ease of oral administration over solid dosage forms, improved clinical potency, and decreased toxicity (Constantinides et al., Pharmaceutical Research, 1994, 11:1385; Ho et al., J. Pharm. Sci., 1996, 85:138-143). Microemulsions have also been effective in the transdermal delivery of active components in both cosmetic and pharmaceutical applications. It is expected that the microemulsion compositions and formulations of the present invention will facilitate the increased systemic absorption of oligonucleotides from the gastrointestinal tract, as well as improve the local cellular uptake of oligonucleotides within the gastrointestinal tract, vagina, buccal cavity and other areas of administration.

In an embodiment, the present invention employs various penetration enhancers to affect the efficient delivery of nucleic acids, particularly oligonucleotides, to the skin of animals. Even non-lipophilic drugs may cross cell membranes if the membrane to be crossed is treated with a penetration enhancer. In addition to increasing the diffusion of non-lipophilic drugs across cell membranes, penetration enhancers also act to enhance the permeability of lipophilic drugs.

Five categories of penetration enhancers that may be used in the present invention include: surfactants, fatty acids, bile salts, chelating agents, and non-chelating non-surfactants. Other agents may be utilized to enhance the penetration of the administered oligonucleotides include: glycols such as ethylene glycol and propylene glycol, pyrrols such as 2-15 pyrrol, azones, and terpenes such as limonene, and menthone.

The oligonucleotides, especially in lipid formulations, can also be administered by coating a medical device, for example, a catheter, such as an angioplasty balloon catheter, with a cationic lipid formulation. Coating may be achieved, for example, by dipping the medical device into a lipid formulation or a mixture of a lipid formulation and a suitable solvent, for example, an aqueous-based buffer, an aqueous solvent, ethanol, methylene chloride, chloroform and the like. An amount of the formulation will naturally adhere to the surface of the device which is subsequently administered to a patient, as appropriate. Alternatively, a lyophilized mixture of a lipid formulation may be specifically bound to the surface of the device. Such binding techniques are described, for example, in K. Ishihara et al., Journal of Biomedical Materials Research, Vol. 27, pp. 1309-1314 (1993), the disclosures of which are incorporated herein by reference in their entirety.

The useful dosage to be administered and the particular mode of administration will vary depending upon such factors as the cell type, or for in vivo use, the age, weight and the particular animal and region thereof to be treated, the particular oligonucleotide and delivery method used, the therapeutic or diagnostic use contemplated, and the form of the formulation, for example, suspension, emulsion, micelle or liposome, as will be readily apparent to those skilled in the art. Typically, dosage is administered at lower levels and increased until the desired effect is achieved. When lipids are used to deliver the oligonucleotides, the amount of lipid compound that is administered can vary and generally depends upon the amount of oligonucleotide agent being administered. For example, the weight ratio of lipid compound to oligonucleotide agent is preferably from about 1:1 to about 15:1, with a weight ratio of about 5:1 to about 10:1 being more preferred. Generally, the amount of cationic lipid compound which is administered will vary from between about 0.1 milligram (mg) to about 1 gram (g). By way of general guidance, typically between about 0.1 mg and about 10 mg of the particular oligonucleotide agent, and about 1 mg to about 100 mg of the lipid compositions, each per kilogram of patient body weight, is administered, although higher and lower amounts can be used.

The agents of the invention are administered to subjects or contacted with cells in a biologically compatible form suitable for pharmaceutical administration. By “biologically compatible form suitable for administration” is meant that the oligonucleotide is administered in a form in which any toxic effects are outweighed by the therapeutic effects of the oligonucleotide. In one embodiment, oligonucleotides can be administered to subjects. Examples of subjects include mammals, e.g., humans and other primates; cows, pigs, horses, and farming (agricultural) animals; dogs, cats, and other domesticated pets; mice, rats, and transgenic non-human animals.

Administration of an active amount of an oligonucleotide of the present invention is defined as an amount effective, at dosages and for periods of time necessary to achieve the desired result. For example, an active amount of an oligonucleotide may vary according to factors such as the type of cell, the oligonucleotide used, and for in vivo uses the disease state, age, sex, and weight of the individual, and the ability of the oligonucleotide to elicit a desired response in the individual. Establishment of therapeutic levels of oligonucleotides within the cell is dependent upon the rates of uptake and efflux or degradation. Decreasing the degree of degradation prolongs the intracellular half-life of the oligonucleotide. Thus, chemically-modified oligonucleotides, e.g., with modification of the phosphate backbone, may require different dosing.

The exact dosage of an oligonucleotide and number of doses administered will depend upon the data generated experimentally and in clinical trials. Several factors such as the desired effect, the delivery vehicle, disease indication, and the route of administration, will affect the dosage. Dosages can be readily determined by one of ordinary skill in the art and formulated into the subject pharmaceutical compositions. Preferably, the duration of treatment will extend at least through the course of the disease symptoms.

Dosage regim may be adjusted to provide the optimum therapeutic response. For example, the oligonucleotide may be repeatedly administered, e.g., several doses may be administered daily or the dose may be proportionally reduced as indicated by the exigencies of the therapeutic situation. One of ordinary skill in the art will readily be able to determine appropriate doses and schedules of administration of the subject oligonucleotides, whether the oligonucleotides are to be administered to cells or to subjects.

Physical methods of introducing nucleic acids include injection of a solution containing the nucleic acid, bombardment by particles covered by the nucleic acid, soaking the cell or organism in a solution of the nucleic acid, or electroporation of cell membranes in the presence of the nucleic acid. A viral construct packaged into a viral particle would accomplish both efficient introduction of an expression construct into the cell and transcription of nucleic acid encoded by the expression construct. Other methods known in the art for introducing nucleic acids to cells may be used, such as lipid-mediated carrier transport, chemical-mediated transport, such as calcium phosphate, and the like. Thus the nucleic acid may be introduced along with components that perform one or more of the following activities: enhance nucleic acid uptake by the cell, inhibit annealing of single strands, stabilize the single strands, or other-wise increase inhibition of the target gene.

Nucleic acid may be directly introduced into the cell (i.e., intracellularly); or introduced extracellularly into a cavity, interstitial space, into the circulation of an organism, introduced orally or by inhalation, or may be introduced by bathing a cell or organism in a solution containing the nucleic acid. Vascular or extravascular circulation, the blood or lymph system, and the cerebrospinal fluid are sites where the nucleic acid may be introduced.

The cell with the target gene may be derived from or contained in any organism. The organism may a plant, animal, protozoan, bacterium, virus, or fungus. The plant may be a monocot, dicot or gymnosperm; the animal may be a vertebrate or invertebrate. Preferred microbes are those used in agriculture or by industry, and those that are pathogenic for plants or animals.

Alternatively, vectors, e.g., transgenes encoding a siRNA of the invention can be engineered into a host cell or transgenic animal using art recognized techniques.

Another use for the nucleic acids of the present invention (or vectors or transgenes encoding same) is a functional analysis to be carried out in eukaryotic cells, or eukaryotic non-human organisms, preferably mammalian cells or organisms and most preferably human cells, e.g. cell lines such as HeLa or 293 or rodents, e.g. rats and mice. By administering a suitable nucleic acid of the invention which is sufficiently complementary to a target mRNA sequence to direct target-specific RNA interference, a specific knockout or knockdown phenotype can be obtained in a target cell, e.g. in cell culture or in a target organism.

Thus, a further subject matter of the invention is a eukaryotic cell or a eukaryotic non-human organism exhibiting a target gene-specific knockout or knockdown phenotype comprising a fully or at least partially deficient expression of at least one endogenous target gene wherein said cell or organism is transfected with at least one vector comprising DNA encoding an RNAi agent capable of inhibiting the expression of the target gene. It should be noted that the present invention allows a target-specific knockout or knockdown of several different endogenous genes due to the specificity of the RNAi agent.

Gene-specific knockout or knockdown phenotypes of cells or non-human organisms, particularly of human cells or non-human mammals may be used in analytic to procedures, e.g. in the functional and/or phenotypical analysis of complex physiological processes such as analysis of gene expression profiles and/or proteomes. Preferably the analysis is carried out by high throughput methods using oligonucleotide based chips.

Therapeutic Use

By inhibiting the expression of a gene, the oligonucleotide compositions of the present invention can be used to treat any disease involving the expression of a protein. Examples of diseases that can be treated by oligonucleotide compositions, just to illustrate, include: cancer, retinopathies, autoimmune diseases, inflammatory diseases (i.e., ICAM-1 related disorders, Psoriasis, Ulcerative Colitus, Crohn's disease), viral diseases (i.e., HIV, Hepatitis C), miRNA disorders, and cardiovascular diseases.

In one embodiment, in vitro treatment of cells with oligonucleotides can be used for ex vivo therapy of cells removed from a subject (e.g., for treatment of leukemia or viral infection) or for treatment of cells which did not originate in the subject, but are to be administered to the subject (e.g., to eliminate transplantation antigen expression on cells to be transplanted into a subject). In addition, in vitro treatment of cells can be used in non-therapeutic settings, e.g., to evaluate gene function, to study gene regulation and protein synthesis or to evaluate improvements made to oligonucleotides designed to modulate gene expression or protein synthesis. In vivo treatment of cells can be useful in certain clinical settings where it is desirable to inhibit the expression of a protein. There are numerous medical conditions for which antisense therapy is reported to be suitable (see, e.g., U.S. Pat. No. 5,830,653) as well as respiratory syncytial virus infection (WO 95/22,553) influenza virus (WO 94/23,028), and malignancies (WO 94/08,003). Other examples of clinical uses of antisense sequences are reviewed, e.g., in Glaser. 1996. Genetic Engineering News 16:1. Exemplary targets for cleavage by oligonucleotides include, e.g., protein kinase Ca, ICAM-1, c-raf kinase, p53, c-myb, and the bcr/abl fusion gene found in chronic myelogenous leukemia.

The subject nucleic acids can be used in RNAi-based therapy in any animal having RNAi pathway, such as human, non-human primate, non-human mammal, non-human vertebrates, rodents (mice, rats, hamsters, rabbits, etc.), domestic livestock animals, pets (cats, dogs, etc.), Xenopus, fish, insects (Drosophila, etc.), and worms (C. elegans), etc.

The invention provides methods for inhibiting or preventing in a subject, a disease or condition associated with an aberrant or unwanted target gene expression or activity, by administering to the subject a nucleic acid of the invention. If appropriate, subjects are first treated with a priming agent so as to be more responsive to the subsequent RNAi therapy. Subjects at risk for a disease which is caused or contributed to by aberrant or unwanted target gene expression or activity can be identified by, for example, any or a combination of diagnostic or prognostic assays known in the art. Administration of a prophylactic agent can occur prior to the manifestation of symptoms characteristic of the target gene aberrancy, such that a disease or disorder is prevented or, alternatively, delayed in its progression. Depending on the type of target gene aberrancy, for example, a target gene, target gene agonist or target gene antagonist agent can be used for treating the subject.

In another aspect, the invention pertains to methods of modulating target gene expression, protein expression or activity for therapeutic purposes. Accordingly, in an exemplary embodiment, the methods of the invention involve contacting a cell capable of expressing target gene with a nucleic acid of the invention that is specific for the target gene or protein (e.g., is specific for the mRNA encoded by said gene or specifying the amino acid sequence of said protein) such that expression or one or more of the activities of target protein is modulated. These methods can be performed in vitro (e.g., by culturing the cell with the agent), in vivo (e.g., by administering the agent to a subject), or ex vivo. The subjects may be first treated with a priming agent so as to be more responsive to the subsequent RNAi therapy if desired. As such, the present invention provides methods of treating a subject afflicted with a disease or disorder characterized by aberrant or unwanted expression or activity of a target gene polypeptide or nucleic acid molecule. Inhibition of target gene activity is desirable in situations in which target gene is abnormally unregulated and/or in which decreased target gene activity is likely to have a beneficial effect.

Thus the therapeutic agents of the invention can be administered to subjects to treat (prophylactically or therapeutically) disorders associated with aberrant or unwanted target gene activity. In conjunction with such treatment, pharmacogenomics (i.e., the study of the relationship between an individual's genotype and that individual's response to a foreign compound or drug) may be considered. Differences in metabolism of therapeutics can lead to severe toxicity or therapeutic failure by altering the relation between dose and blood concentration of the pharmacologically active drug. Thus, a physician or clinician may consider applying knowledge obtained in relevant pharmacogenomics studies in determining whether to administer a therapeutic agent as well as tailoring the dosage and/or therapeutic regimen of treatment with a therapeutic agent. Pharmacogenomics deals with clinically significant hereditary variations in the response to drugs due to altered drug disposition and abnormal action in affected persons.

For the purposes of the invention, ranges may be expressed herein as from “about” one particular value, and/or to “about” another particular value. When such a range is expressed, another embodiment includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent “about,” it will be understood that the particular value forms another embodiment. It will be further understood that the endpoints of each of the ranges are significant both in relation to the other endpoint, and independently of the other endpoint.

Moreover, for the purposes of the present invention, the term “a” or “an” entity refers to one or more of that entity; for example, “a protein” or “a nucleic acid molecule” refers to one or more of those compounds or at least one compound. As such, the terms “a” (or “an”), “one or more” and “at least one” can be used interchangeably herein. It is also to be noted that the terms “comprising”, “including”, and “having” can be used interchangeably. Furthermore, a compound “selected from the group consisting of” refers to one or more of the compounds in the list that follows, including mixtures (i.e., combinations) of two or more of the compounds. According to the present invention, an isolated, or biologically pure, protein or nucleic acid molecule is a compound that has been removed from its natural milieu. As such, “isolated” and “biologically pure” do not necessarily reflect the extent to which the compound has been purified. An isolated compound of the present invention can be obtained from its natural source, can be produced using molecular biology techniques or can be produced by chemical synthesis.

The present invention is further illustrated by the following Examples, which in no way should be construed as further limiting. The entire contents of all of the references (including literature references, issued patents, published patent applications, and co-pending patent applications) cited throughout this application are hereby expressly incorporated by reference.

EXAMPLES

Example 1: Inhibition of Gene Expression Using Minimum Length Trigger RNAs

Transfection of Minimum Length Trigger (mlt) RNA

mltRNA constructs were chemically synthesized (Integrated DNA Technologies, Coralville, Iowa) and transfected into HEK293 cells (ATCC, Manassas, Va.) using the Lipofectamine RNAiMAX (Invitrogen, Carlsbad, Calif.) reagent according to manufacturer's instructions. In brief, RNA was diluted to a 12× concentration and then combined with a 12× concentration of Lipofectamine RNAiMAX to complex. The RNA and transfection reagent were allowed to complex at room temperature for 20 minutes and make a 6× concentration. While complexing, HEK293 cells were washed, trypsinized and counted. The cells were diluted to a concentration recommended by the manufacturer and previously described conditions which was at 1×10⁵cells/ml. When RNA had completed complexing with the RNAiMAX transfection reagent, 20 ul of the complexes were added to the appropriate well of the 96-well plate in triplicate. Cells were added to each well (100 ul volume) to make the final cell count per well at 1×10⁴ cells/well. The volume of cells diluted the 6× concentration of complex to 1× which was equal to a concentration noted (between 10-0.05 nM). Cells were incubated for 24 or 48 hours under normal growth conditions.

After 24 or 48 hour incubation cells were lysed and gene silencing activity was measured using the QuantiGene assay (Panomics, Freemont, Calif.) which employs bDNA hybridization technology. The assay was carried out according to manufacturer's instructions.

ΔG Calculation

ΔG was calculated using Mfold, available through the Mfold internet site (mfold.bioinfarpi.edu/cgi-bin/rna-forml.cgi). Methods for calculating ΔG are described in, and are incorporated by reference from, the following references: Zuker, M. (2003) Nucleic Acids Res., 31(13):3406-15; Mathews, D. H., Sabina, J., Zuker, M. and Turner, D. H. (1999) J. Mol. Biol. 288:911-940; Mathews, D. H., Disney, M. D., Childs, J. L., Schroeder, S. J., Zuker, M., and Turner, D. H. (2004) Proc. Natl. Acad. Sci. 101:7287-7292; Duan, S., Mathews, D. H., and Turner, D. H. (2006) Biochemistry 45:9819-9832; Wuchty, S., Fontana, W., Hofacker, I. L., and Schuster, P. (1999) Biopolymers 49:145-165.

Example 2: Optimization of sd-rxRNA^nano Molecules for Gene Silencing

Asymmetric double stranded RNAi molecules, with minimal double stranded regions, were developed herein and are highly effective at gene silencing. These molecules can contain a variety of chemical modifications on the sense and/or anti-sense strands, and can be conjugated to sterol-like compounds such as cholesterol.

FIGS. 1-3 present schematics of RNAi molecules associated with the invention. In the asymmetric molecules, which contain a sense and anti-sense strand, either of the strands can be the longer strand. Either strand can also contain a single-stranded region. There can also be mismatches between the sense and anti-sense strand, as indicated in FIG. 1D. Preferably, one end of the double-stranded molecule is either blunt-ended or contains a short overhang such as an overhang of one nucleotide. FIG. 2 indicates types of chemical modifications applied to the sense and anti-sense strands including 2′F, 2′OMe, hydrophobic modifications and phosphorothioate modifications. Preferably, the single stranded region of the molecule contains multiple phosphorothioate modifications. Hydrophobicity of molecules can be increased using such compounds as 4-pyridyl at 5-U, 2-pyridyl at 5-U, isobutyl at 5-U and indolyl at 5-U (FIG. 2). Proteins or peptides such as protamine (or other Arg rich peptides), spermidine or other similar chemical structures can also be used to block duplex charge and facilitate cellular entry (FIG. 3). Increased hydrophobicity can be achieved through either covalent or non-covalent modifications. Several positively charged chemicals, which might be used for polynucleotide charge blockage are depicted in FIG. 4.

Chemical modifications of polynucleotides, such as the guide strand in a duplex molecule, can facilitate RISC entry. FIG. 5 depicts single stranded polynucleotides, representing a guide strand in a duplex molecule, with a variety of chemical modifications including 2′d, 2′OMe, 2′F, hydrophobic modifications, phosphorothioate modifications, and attachment of conjugates such as “X” in FIG. 5, where X can be a small molecule with high affinity to a PAZ domain, or sterol-type entity. Similarly, FIG. 6 depicts single stranded polynucleotides, representing a passenger strand in a duplex molecule, with proposed structural and chemical compositions of RISC substrate inhibitors. Combinations of chemical modifications can ensure efficient uptake and efficient binding to preloaded RISC complexes.

FIG. 7 depicts structures of polynucleotides with sterol-type molecules attached, where R represents a polycarbonic tail of 9 carbons or longer. FIG. 8 presents examples of naturally occurring phytosterols with a polycarbon chain longer than 8 attached at position 17. More than 250 different types of phytosterols are known. FIG. 9 presents examples of sterol-like structures with variations in the sizes of the polycarbon chains attached at position 17. FIG. 91 presents further examples of sterol-type molecules that can be used as a hydrophobic entity in place of cholesterol. FIG. 92 presents further examples of hydrophobic molecules that might be used as hydrophobic entities in place of cholestesterol. Optimization of such characteristics can improve uptake properties of the RNAi molecules. FIG. 10 presents data adapted from Martins et al. (J Lipid Research), showing that the percentage of liver uptake and plasma clearance of lipid emulsions containing sterol-type molecules is directly affected by the size of the attached polycarbon chain at position 17. FIG. 11 depicts a micelle formed from a mixture of polynucleotides attached to hydrophobic conjugates and fatty acids. FIG. 12 describes how alteration in lipid composition can affect pharmacokinetic behavior and tissue distribution of hydrophobically modified and/or hydrophobically conjugated polynucleotides. In particular, the use of lipid mixtures that are enriched in linoleic acid and cardiolipin results in preferential uptake by cardiomyocites.

FIG. 13 depicts examples of RNAi constructs and controls designed to target MAP4K4 expression. FIGS. 14 and 15 reveal that RNAi constructs with minimal duplex regions (such as duplex regions of approximately 13 nucleotides) are effective in mediating RNA silencing in cell culture. Parameters associated with these RNA molecules are shown in FIG. 16. FIG. 17 depicts examples of RNAi constructs and controls designed to target SOD1 expression. FIGS. 18 and 19 reveal the results of gene silencing experiments using these RNAi molecules to target SOD1 in cells. FIG. 20 presents a schematic indicating that RNA molecules with double stranded regions that are less than 10 nucleotides are not cleaved by Dicer, and FIG. 21 presents a schematic of a hypothetical RNAi model for RNA induced gene silencing.

The RNA molecules described herein were subject to a variety of chemical modifications on the sense and antisense strands, and the effects of such modifications were observed. RNAi molecules were synthesized and optimized through testing of a variety of modifications. In first generation optimization, the sense (passenger) and anti-sense (guide) strands of the sd-rxRNA^nano molecules were modified for example through incorporation of C and U 2′OMe modifications, 2′F modifications, phosphorothioate modifications, phosphorylation, and conjugation of cholesterol. Molecules were tested for inhibition of MAP4K4 expression in cells including HeLa, primary mouse hepatocytes and primary human hepatocytes through both lipid-mediated and passive uptake transfection.

FIG. 22 reveals that chemical modifications can enhance gene silencing. In particular, modifying the guide strand with 2′F UC modifications, and with a stretch of phosphorothioate modifications, combined with complete CU O′Me modification of the passenger strands, resulted in molecules that were highly effective in gene silencing. The effect of chemical modification on in vitro efficacy in un-assisted delivery in HeLa cells was also examined. FIG. 23 reveals that compounds lacking any of 2′F, 2′OMe, a stretch of phosphorothioate modifications, or cholesterol conjugates, were completely inactive in passive uptake. A combination of all 4 types of chemical modifications, for example in compound 12386, was found to be highly effective in gene silencing. FIG. 24 also shows the effectiveness of compound 12386 in gene silencing.

Optimization of the length of the oligonucleotide was also investigated. FIGS. 25 and 26 reveal that oligonucleotides with a length of 21 nucleotides were more effective than oligonucletides with a length of 25 nucleotides, indicating that reduction in the size of an RNA molecule can improve efficiency, potentially by assisting in its uptake. Screening was also conducted to optimize the size of the duplex region of double stranded RNA molecules. FIG. 88 reveals that compounds with duplexes of 10 nucleotides were effective in inducing gene silencing. Positioning of the sense strand relative to the guide strand can also be critical for silencing gene expression (FIG. 89). In this assay, a blunt end was found to be most effective. 3′ overhangs were tolerated, but 5′ overhangs resulted in a complete loss of functionality. The guide strand can be effective in gene silencing when hybiridized to a sense strand of varying lengths (FIG. 90). In this assay presented in FIG. 90, the compounds were introduced into HeLa cells via lipid mediated transfection.

The importance of phosphorothioate content of the RNA molecule for unassisted delivery was also investigated. FIG. 27 presents the results of a systematic screen that identified that the presence of at least 2-12 phosphorothioates in the guide strand as being highly advantageous for achieving uptake, with 4-8 being the preferred number. FIG. 27 also shows that presence or absence of phosphorothioate modifications in the sense strand did not alter efficacy.

FIGS. 28-29 reveal the effects of passive uptake of RNA compounds on gene silencing in primary mouse hepatocytes. nanoRNA molecules were found to be highly effective, especially at a concentration of 1 μM (FIG. 28). FIGS. 30 and 31 reveal that the RNA compounds associated with the invention were also effective in gene silencing following passive uptake in primary human hepatocytes. The cellular localization of the RNA molecules associated with the invention was examined and compared to the localization of Chol-siRNA (Alnylam) molecules, as shown in FIGS. 32 and 33.

A summary of 1^st generation sd-rxRNA molecules is presented in FIG. 21. Chemical modifications were introduced into the RNA molecules, at least in part, to increase potency, such as through optimization of nucleotide length and phosphorothioate content, to reduce toxicity, such as through replacing 2′F modifications on the guide strand with other modifications, to improve delivery such as by adding or conjugating the RNA molecules to linker and sterol modalities, and to improve the ease of manufacturing the RNA molecules. FIG. 35 presents schematic depictions of some of the chemical modifications that were screened in 1s^t generation molecules. Parameters that were optimized for the guide strand included nucleotide length (e.g., 19, 21 and 25 nucleotides), phosphorothioate content (e.g., 0-18 phosphorothioate linkages) and replacement of 2′F groups with 2′OMe and 5 Me C or riboThymidine. Parameters that were optimized for the sense strand included nucleotide length (e.g., 11, 13 and 19 nucleotides), phosphorothioate content (e.g., 0-4 phosphorothioate linkages), and 2′OMe modifications. FIG. 36 summarizes parameters that were screened. For example, the nucleotide length and the phosphorothioate tail length were modified and screened for optimization, as were the additions of 2′OMe C and U modifications. Guide strand length and the length of the phosphorothioate modified stretch of nucleotides were found to influence efficacy (FIGS. 37-38). Phosphorothioate modifications were tolerated in the guide strand and were found to influence passive uptake (FIGS. 39-42).

FIG. 43 presents a schematic revealing guide strand chemical modifications that were screened. FIGS. 44 and 45 reveal that 2′OMe modifications were tolerated in the 3′ end of the guide strand. In particular, 2′OMe modifications in positions 1 and 11-18 were well tolerated. The 2′OMe modifications in the seed area were tolerated but resulted in slight reduction of efficacy. Ribo-modifications in the seed were also well tolerated. These data indicate that the molecules associated with the invention offer the significant advantage of having reduced or no 2′F modification content. This is advantageous because 2′F modifications are thought to generate toxicity in vivo. In some instances, a complete substitution of 2′F modifications with 2′OMe was found to lead to some reduction in potency. However, the 2′OMe substituted molecules were still very active. A molecule with 50% reduction in 2′F content (including at positions 11, 16-18 which were changed to 2′OMe modifications), was found to have comparable efficacy to a compound with complete 2′F C and U modification. 2′OMe modification in position was found in some instances to reduce efficacy, although this can be at least partially compensated by 2′OMe modification in position 1 (with chemical phosphate). In some instances, 5 Me C and/or ribothymidine substitution for 2′F modifications led to a reduction in passive uptake efficacy, but increased potency in lipid mediated transfections compared to 2′F modifications. Optimization results for lipid mediated transfection were not necessarily the same as for passive uptake.

Modifications to the sense strand were also developed and tested, as depicted in FIG. 46. FIG. 47 reveals that in some instances, a sense strand length between 10-15 bases was found to be optimal. For the molecules tested in FIG. 47, an increase in the sense strand length resulted in reduction of passive uptake, however an increase in sense strand length may be tolerated for some compounds. FIG. 47 also reveals that LNA modification of the sense strand demonstrated similar efficacy to non-LNA containing compounds. In general, the addition of LNA or other thermodynamically stabilizing compounds has been found to be beneficial, in some instances resulting in converting non-functional sequences to functional sequences. FIG. 48 also presents data on sense strand length optimization, while FIG. 49 shows that phosphorothioate modification of the sense strand is not required for passive uptake.

Based on the above-described optimization experiments, 2^nd generation RNA molecules were developed. As shown in FIG. 50, these molecules contained reduced phosphorothioate modification content and reduced 2′F modification content, relative to 1^st generation RNA molecules. Significantly, these RNA molecules exhibit spontaneous cellular uptake and efficacy without a delivery vehicle (FIG. 51). These molecules can achieve self-delivery (i.e., with no transfection reagent) and following self-delivery can exhibit nanomolar activity in cell culture. These molecules can also be delivered using lipid-mediated transfection, and exhibit picomolar activity levels following transfection. Significantly, these molecules exhibit highly efficient uptake, 95% by most cells in cell culture, and are stable for more than three days in the presence of 100% human serum. These molecules are also highly specific and exhibit little or no immune induction. FIGS. 52 and 53 reveal the significance of chemical modifications and the configurations of such modifications in influencing the properties of the RNA molecules associated with the invention.

Linker chemistry was also tested in conjunction with the RNA molecules associated with the invention. As depicted in FIG. 54, 2^nd generation RNA molecules were synthesized with sterol-type molecules attached through TEG and amino caproic acid linkers. Both linkers showed identical potency. This functionality of the RNA molecules, independent of linker chemistry offers additional advantages in terms of scale up and synthesis and demonstrates that the mechanism of function of these RNA molecules is very different from other previously described RNA molecules.

Stability of the chemically modified sd-rxRNA molecules described herein in human serum is shown in FIG. 55 in comparison to unmodified RNA. The duplex molecules were incubated in 75% serum at 37° C. for the indicated periods of time. The level of degradation was determined by running the samples on non-denaturing gels and staining with SYBGR.

FIGS. 56 and 57 present data on cellular uptake of the sd-rxRNA molecules. FIG. 56 shows that minimizing the length of the RNA molecule is importance for cellular uptake, while FIG. 57 presents data showing target gene silencing after spontaneous cellular uptake in mouse PEC-derived macrophages. FIG. 58 demonstrates spontaneous uptake and target gene silencing in primary cells. FIG. 59 shows the results of delivery of sd-rxRNA molecules associated with the invention to RPE cells with no formulation. Imaging with Hoechst and DY547 reveals the clear presence of a signal representing the RNA molecule in the sd-rxRNA sample, while no signal is detectable in the other samples including the samples competing a competing conjugate, an rxRNA, and an untransfected control. FIG. 60 reveals silencing of target gene expression in RPE cells treated with sd-rxRNA molecules associated with the invention following 24-48 hours without any transfection formulation.

FIG. 61 shows further optimization of the chemical/structural composition of sd-rxRNA compounds. In some instances, preferred properties included an antisense strand that was 17-21 nucleotides long, a sense strand that was 10-15 nucleotides long, phosphorothioate modification of 2-12 nucleotides within the single stranded region of the molecule, preferentially phosphorothioate modification of 6-8 nucleotides within the single stranded region, and 2′OMe modification at the majority of positions within the sense strand, with or without phosphorothioate modification. Any linker chemistry can be used to attach the hydrophobic moiety, such as cholesterol, to the 3′ end of the sense strand. Version GIIb molecules, as shown in FIG. 61, have no 2′F modifications. Significantly, there is was no impact on efficacy in these molecules.

FIG. 62 demonstrates the superior performance of sd-rxRNA compounds compared to compounds published by Wolfrum et. al. Nature Biotech, 2007. Both generation I and II compounds (GI and GIIa) developed herein show great efficacy in reducing target gene expression. By contrast, when the chemistry described in Wolfrum et al. (all oligos contain cholesterol conjugated to the 3′ end of the sense strand) was applied to the same sequence in a context of conventional siRNA (19 bp duplex with two overhang) the compound was practically inactive. These data emphasize the significance of the combination of chemical modifications and assymetrical molecules described herein, producing highly effective RNA compounds.

FIG. 63 shows localization of sd-rxRNA molecules developed herein compared to localization of other RNA molecules such as those described in Soutschek et al. (2004) Nature, 432:173. sd-rxRNA molecules accumulate inside the cells whereas competing conjugate RNAs accumulate on the surface of cells. Significantly, FIG. 64 shows that sd-rxRNA molecules, but not competitor molecules such as those described in Soutschek et al. are internalized within minutes. FIG. 65 compares localization of sd-rxRNA molecules compared to regular siRNA-cholesterol, as described in Soutschek et al. A signal representing the RNA molecule is clearly detected for the sd-rxRNA molecule in tissue culture RPE cells, following local delivery to compromised skin, and following systemic delivery where uptake to the liver is seen. In each case, no signal is detected for the regular siRNA-cholesterol molecule. The sd-rxRNA molecule thus has drastically better cellular and tissue uptake characteristics when compared to conventional cholesterol conjugated siRNAs such as those described in Soutschek et al. The level of uptake is at least order of magnitude higher and is due at least in part to the unique combination of chemistries and conjugated structure. Superior delivery of sd-rxRNA relative to previously described RNA molecules is also demonstrated in FIGS. 66 and 67.

Based on the analysis of 2^nd generation RNA molecules associated with the invention, a screen was performed to identify functional molecules for targeting the SPP1/PPIB gene. As revealed in FIG. 68, several effective molecules were identified, with 14131 being the most effective. The compounds were added to A-549 cells and then the level of SPP1/PPM ratio was determined by B-DNA after 48 hours.

FIG. 69 reveals efficient cellular uptake of sd-rxRNA within minutes of exposure. This is a unique characteristics of these molecules, not observed with any other RNAi compounds. Compounds described in Soutschek et al. were used as negative controls. FIG. 70 reveals that the uptake and gene silencing of the sd-rxRNA is effective in multiple different cell types including SH-SY5Y neuroblastoma derived cells, ARPE-19 (retinal pigment epithelium) cells, primary hepatocytes, and primary macrophages. In each case silencing was confirmed by looking at target gene expression by a Branched DNA assay.

FIG. 70 reveals that sd-rxRNA is active in the presence or absence of serum. While a slight reduction in efficacy (2-5 fold) was observed in the presence of serum, this small reduction in efficacy in the presence of serum differentiate the sd-rxRNA molecules from previously described molecules which exhibited a larger reduction in efficacy in the presence of serum. This demonstrated level of efficacy in the presence of serum creates a foundation for in vivo efficacy.

FIG. 72 reveals efficient tissue penetration and cellular uptake upon single intradermal injection. This data indicates the potential of the sd-rxRNA compounds described herein for silencing genes in any dermatology applications, and also represents a model for local delivery of sd-rxRNA compounds. FIG. 73 also demonstrates efficient cellular uptake and in vivo silencing with sd-rxRNA following intradermal injection. Silencing is determined as the level of MAP4K4 knockdown in several individual biopsies taken from the site of injection as compared to biopsies taken from a site injected with a negative control. FIG. 74 reveals that sd-rxRNA compounds has improved blood clearance and induced effective gene silencing in vivo in the liver upon systemic administration. In comparison to the RNA molecules described by Soutschek et al., the level of liver uptake at identical dose level is at least 50 fold higher with the sd-rxRNA molecules. The uptake results in productive silencing. sd-rxRNA compounds are also characterized by improved blood clearance kinetics.

The effect of 5-Methly C modifications was also examined. FIG. 75 demonstrates that the presence of 5-Methyl C in an RNAi molecule resulted in increased potency in lipid mediated transfection. This suggests that hydrophobic modification of Cs and Us in an RNAi molecule can be beneficial. These types of modifications can also be used in the context 2′ ribose modified bases to ensure optimal stability and efficacy. FIG. 76 presents data showing that incorporation of 5-Methyl C and/or ribothymidine in the guide strand can in some instances reduce efficacy.

FIG. 77 reveals that sd-rxRNA molecules are more effective than competitor molecules such as molecules described in Soutschek et al., in systemic delivery to the liver. A signal representing the RNA molecule is clearly visible in the sample containing sd-rxRNA, while no signal representing the RNA molecule is visible in the sample containing the competitor RNA molecule.

The addition of hydrophobic conjugates to the sd-rxRNA molecules was also explored (FIGS. 78-83). FIG. 78 presents schematics demonstrating 5-uridyl modifications with improved hydrophobicity characteristics. Incorporation of such modifications into sd-rxRNA compounds can increase cellular and tissue uptake properties. FIG. 78B presents a new type of RNAi compound modification which can be applied to compounds to improve cellular uptake and pharmacokinetic behavior. Significantly, this type of modification, when applied to sd-rxRNA compounds, may contribute to making such compounds orally available. FIG. 79 presents schematics revealing the structures of synthesized modified sterol-type molecules, where the length and structure of the C17 attached tail is modified. Without wishing to be bound by any theory, the length of the C17 attached tail may contribute to improving in vitro and in vivo efficacy of sd-rxRNA compounds.

FIG. 80 presents a schematic demonstrating the lithocholic acid route to long side chain cholesterols. FIG. 81 presents a schematic demonstrating a route to 5-uridyl phosphoramidite synthesis. FIG. 82 presents a schematic demonstrating synthesis of tri-functional hydroxyprolinol linker for 3′-cholesterol attachment. FIG. 83 presents a schematic demonstrating synthesis of solid support for the manufacture of a shorter asymmetric RNAi compound strand.

A screen was conducted to identify compounds that could effectively silence expression of SPP1 (Osteopontin). Compounds targeting SPP1 were added to A549 cells (using passive transfection), and the level of SPP1 expression was evaluated at 48 hours. Several novel compounds effective in SPP1 silencing were identified. Compounds that were effective in silencing of SPP1 included 14116, 14121, 14131, 14134, 14139, 14149, and 14152 (FIGS. 84-86). The most potent compound in this assay was 14131 (FIG. 84). The efficacy of these sd-rxRNA compounds in silencing SPP1 expression was independently validated (FIG. 85).

A similar screen was conducted to identify compounds that could effectively silence expression of CTGF (FIGS. 86-87). Compounds that were effective in silencing of CTGF included 14017, 14013, 14016, 14022, 14025, 14027.

Methods

• Transfection of sd-rxRNA^nano
• Lipid Mediated Transfection

sd-rxRNA^nano constructs were chemically synthesized (Dharmacon, Lafayette, Colo.) and transfected into HEK293 cells (ATCC, Manassas, Va.) using Lipofectamine RNAiMAX (Invitrogen, Carlsbad, Calif.) according to the manufacturer's instructions. In brief, RNA was diluted to a 12× concentration in Opti-MEM®1 Reduced Serum Media (Invitrogen, Carlsbad, Calif.) and then combined with a 12× concentration of Lipofectamine RNAiMAX. The RNA and transfection reagent were allowed to complex at room temperature for 20 minutes and make a 6× concentration. While complexing, HEK293 cells were washed, trypsinized and counted. The cells were diluted to a concentration recommended by the manufacturer and previously described of 1×10⁵ cells/ml. When RNA had completed complexing with the RNAiMAX transfection reagent, 20 ul of the complexes were added to the appropriate well of the 96-well plate in triplicate. Cells were added to each well (100 ul volume) to make the final cell count per well 1×10⁴ cells/well. The volume of cells diluted the 6× concentration of complex to 1× (between 10-0.05 nM). Cells were incubated for 24 or 48 hours under normal growth conditions. After 24 or 48 hour incubation, cells were lysed and gene silencing activity was measured using the QuantiGene assay (Panomics, Freemont, Calif.) which employs bDNA hybridization technology. The assay was carried out according to manufacturer's instructions.

Passive Uptake Transfection

Sd-rXRNA^nano constructs were chemically synthesized (Dharmacon, Lafayette, Colo.). 24 hours prior to transfection, HeLa cells (ATCC, Manassas, Va.) were plated at 1×10⁴ cells/well in a 96 well plate under normal growth conditions (DMEM, 10% FBS and 1% Penicillin and Streptomycin). Prior to transfection of HeLa cells, Sd-rXRNA^nano were diluted to a final concentration of 0.01 uM to 1 uM in Accell siRNA Delivery Media (Dharmacon, Lafayette, Colo.). Normal growth media was aspirated off cells and 100 uL of Accell Delivery media containing the appropriate concentration of sd-rxRNAnano was applied to the cells. 48 hours post transfection, delivery media was aspirated off the cells and normal growth media was applied to cells for an additional 24 hours.

After 48 or 72 hour incubation, cells were lysed and gene silencing activity was measured using the QuantiGene assay (Panomics, Freemont, Calif.) according to manufacturer's instructions.

TABLE 1
	Oligo	Accession		Gene
ID Number	Number	number	Gene Name	Symbol
APOB-10167-20-12138	12138	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
APOB-10167-20-12139	12139	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
MAP4K4-2931-13-12266	12266	NM_004834	Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4-2931-16-12293	12293	NM_004834	Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4-2931-16-12383	12383	NM_004834	Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4-2931-16-12384	12384	NM_004834	Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4-2931-16-12385	12385	NM_004834	Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4-2931-16-12386	12386	NM_004834	Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4-2931-16-12387	12387	NM_004834	Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4-2931-15-12388	12388	NM_004834	Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4-2931-13-12432	12432	NM_004834	Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4-2931-13-12266.2	12266.2	NM_004834	Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
APOB--21-12434	12434	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
APOB--21-12435	12435	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
MAP4K4-2931-16-12451	12451	NM_004834	Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4-2931-16-12452	12452	NM_004834	Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4-2931-16-12453	12453	NM_004834	Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4-2931-17-12454	12454	NM_004834	Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4-2931-17-12455	12455	NM_004834	Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4-2931-19-12456	12456	NM_004834	Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
--27-12480	12480
--27-12481	12481
APOB-10167-21-12505	12505	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
APOB-10167-21-12506	12506	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
MAP4K4-2931-16-12539	12539	NM_004834	Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
APOB-10167-21-12505.2	12505.2	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
APOB-10167-21-12506.2	12506.2	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
MAP4K4--13-12565	12565			MAP4K4
MAP4K4-2931-16-12386.2	12386.2	NM_004834	Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4-2931-13-12815	12815	NM_004834	Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
APOB--13-12957	12957	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
MAP4K4--16-12983	12983		Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4--16-12984	12984		Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4--16-12985	12985		Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4--16-12986	12986		Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4--16-12987	12987		Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4--16-12988	12988		Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4--16-12989	12989		Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4--16-12990	12990		Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4--16-12991	12991		Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4--16-12992	12992		Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4--16-12993	12993		Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4--16-12994	12994		Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4--16-12995	12995		Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4-2931-19-13012	13012	NM_004834	Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
MAP4K4-2931-19-13016	13016	NM_004834	Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
PPIB--13-13021	13021	NM_000942	Peptidylprolyl Isomerase B	PPIB
			(cyclophilin B)
pGL3-1172-13-13038	13038	U47296	Cloning vector pGL3-Control	pGL3
pGL3-1172-13-13040	13040	U47296	Cloning vector pGL3-Control	pGL3
--16-13047	13047
SOD1-530-13-13090	13090	NM_000454	Superoxide Dismutase 1, soluble	SOD1
			(amyotrophic lateral sclerosis 1
			(adult))
SOD1-523-13-13091	13091	NM_000454	Superoxide Dismutase 1, soluble	SOD1
			(amyotrophic lateral sclerosis 1
			(adult))
SOD1-535-13-13092	13092	NM_000454	Superoxide Dismutase 1, soluble	SOD1
			(amyotrophic lateral sclerosis 1
			(adult))
SOD1-536-13-13093	13093	NM_000454	Superoxide Dismutase 1, soluble	SOD1
			(amyotrophic lateral sclerosis 1
			(adult))
SOD1-396-13-13094	13094	NM_000454	Superoxide Dismutase 1, soluble	SOD1
			(amyotrophic lateral sclerosis 1
			(adult))
SOD1-385-13-13095	13095	NM_000454	Superoxide Dismutase 1, soluble	SOD1
			(amyotrophic lateral sclerosis 1
			(adult))
SOD1-195-13-13096	13096	NM_000454	Superoxide Dismutase 1, soluble	SOD1
			(amyotrophic lateral sclerosis 1
			(adult))
APOB-4314-13-13115	13115	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
APOB-3384-13-13116	13116	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
APOB-3547-13-13117	13117	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
APOB-4318-13-13118	13118	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
APOB-3741-13-13119	13119	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
PPIB--16-13136	13136	NM_000942	Peptidylprolyl Isomerase B	PPIB
			(cyclophilin B)
APOB-4314-15-13154	13154	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
APOB-3547-15-13155	13155	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
APOB-4318-15-13157	13157	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
APOB-3741-15-13158	13158	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
APOB--13-13159	13159	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
APOB--15-13160	13160	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
SOD1-530-16-13163	13163	NM_000454	Superoxide Dismutase 1, soluble	SOD1
			(amyotrophic lateral sclerosis 1
			(adult))
SOD1-523-16-13164	13164	NM_000454	Superoxide Dismutase 1, soluble	SOD1
			(amyotrophic lateral sclerosis 1
			(adult))
SOD1-535-16-13165	13165	NM_000454	Superoxide Dismutase 1, soluble	SOD1
			(amyotrophic lateral sclerosis 1
			(adult))
SOD1-536-16-13166	13166	NM_000454	Superoxide Dismutase 1, soluble	SOD1
			(amyotrophic lateral sclerosis 1
			(adult))
SOD1-396-16-13167	13167	NM_000454	Superoxide Dismutase 1, soluble	SOD1
			(amyotrophic lateral sclerosis 1
			(adult))
SOD1-385-16-13168	13168	NM_000454	Superoxide Dismutase 1, soluble	SOD1
			(amyotrophic lateral sclerosis 1
			(adult))
SOD1-195-16-13169	13169	NM_000454	Superoxide Dismutase 1, soluble	SOD1
			(amyotrophic lateral sclerosis 1
			(adult))
pGL3-1172-16-13170	13170	U47296	Cloning vector pGL3-Control	pGL3
pGL3-1172-16-13171	13171	U47296	Cloning vector pGL3-Control	pGL3
MAP4k4-2931-19-13189	13189	NM_004834	Mitogen-Activated Protein Kinase	MAP4k4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
CTGF-1222-13-13190	13190	NM_001901.2	connective tissue growth factor	CTGF
CTGF-813-13-13192	13192	NM_001901.2	connective tissue growth factor	CTGF
CTGF-747-13-13194	13194	NM_001901.2	connective tissue growth factor	CTGF
CTGF-817-13-13196	13196	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1174-13-13198	13198	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1005-13-13200	13200	NM_001901.2	connective tissue growth factor	CTGF
CTGF-814-13-13202	13202	NM_001901.2	connective tissue growth factor	CTGF
CTGF-816-13-13204	13204	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1001-13-13206	13206	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1173-13-13208	13208	NM_001901.2	connective tissue growth factor	CTGF
CTGF-749-13-13210	13210	NM_001901.2	connective tissue growth factor	CTGF
CTGF-792-13-13212	13212	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1162-13-13214	13214	NM_001901.2	connective tissue growth factor	CTGF
CTGF-811-13-13216	13216	NM_001901.2	connective tissue growth factor	CTGF
CTGF-797-13-13218	13218	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1175-13-13220	13220	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1172-13-13222	13222	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1177-13-13224	13224	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1176-13-13226	13226	NM_001901.2	connective tissue growth factor	CTGF
CTGF-812-13-13228	13228	NM_001901.2	connective tissue growth factor	CTGF
CTGF-745-13-13230	13230	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1230-13-13232	13232	NM_001901.2	connective tissue growth factor	CTGF
CTGF-920-13-13234	13234	NM_001901.2	connective tissue growth factor	CTGF
CTGF-679-13-13236	13236	NM_001901.2	connective tissue growth factor	CTGF
CTGF-992-13-13238	13238	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1045-13-13240	13240	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1231-13-13242	13242	NM_001901.2	connective tissue growth factor	CTGF
CTGF-991-13-13244	13244	NM_001901.2	connective tissue growth factor	CTGF
CTGF-998-13-13246	13246	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1049-13-13248	13248	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1044-13-13250	13250	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1327-13-13252	13252	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1196-13-13254	13254	NM_001901.2	connective tissue growth factor	CTGF
CTGF-562-13-13256	13256	NM_001901.2	connective tissue growth factor	CTGF
CTGF-752-13-13258	13258	NM_001901.2	connective tissue growth factor	CTGF
CTGF-994-13-13260	13260	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1040-13-13262	13262	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1984-13-13264	13264	NM_001901.2	connective tissue growth factor	CTGF
CTGF-2195-13-13266	13266	NM_001901.2	connective tissue growth factor	CTGF
CTGF-2043-13-13268	13268	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1892-13-13270	13270	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1567-13-13272	13272	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1780-13-13274	13274	NM_001901.2	connective tissue growth factor	CTGF
CTGF-2162-13-13276	13276	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1034-13-13278	13278	NM_001901.2	connective tissue growth factor	CTGF
CTGF-2264-13-13280	13280	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1032-13-13282	13282	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1535-13-13284	13284	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1694-13-13286	13286	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1588-13-13288	13288	NM_001901.2	connective tissue growth factor	CTGF
CTGF-928-13-13290	13290	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1133-13-13292	13292	NM_001901.2	connective tissue growth factor	CTGF
CTGF-912-13-13294	13294	NM_001901.2	connective tissue growth factor	CTGF
CTGF-753-13-13296	13296	NM_001901.2	connective tissue growth factor	CTGF
CTGF-918-13-13298	13298	NM_001901.2	connective tissue growth factor	CTGF
CTGF-744-13-13300	13300	NM_001901.2	connective tissue growth factor	CTGF
CTGF-466-13-13302	13302	NM_001901.2	connective tissue growth factor	CTGF
CTGF-917-13-13304	13304	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1038-13-13306	13306	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1048-13-13308	13308	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1235-13-13310	13310	NM_001901.2	connective tissue growth factor	CTGF
CTGF-868-13-13312	13312	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1131-13-13314	13314	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1043-13-13316	13316	NM_001901.2	connective tissue growth factor	CTGF
CTGF-751-13-13318	13318	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1227-13-13320	13320	NM_001901.2	connective tissue growth factor	CTGF
CTGF-867-13-13322	13322	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1128-13-13324	13324	NM_001901.2	connective tissue growth factor	CTGF
CTGF-756-13-13326	13326	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1234-13-13328	13328	NM_001901.2	connective tissue growth factor	CTGF
CTGF-916-13-13330	13330	NM_001901.2	connective tissue growth factor	CTGF
CTGF-925-13-13332	13332	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1225-13-13334	13334	NM_001901.2	connective tissue growth factor	CTGF
CTGF-445-13-13336	13336	NM_001901.2	connective tissue growth factor	CTGF
CTGF-446-13-13338	13338	NM_001901.2	connective tissue growth factor	CTGF
CTGF-913-13-13340	13340	NM_001901.2	connective tissue growth factor	CTGF
CTGF-997-13-13342	13342	NM_001901.2	connective tissue growth factor	CTGF
CTGF-277-13-13344	13344	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1052-13-13346	13346	NM_001901.2	connective tissue growth factor	CTGF
CTGF-887-13-13348	13348	NM_001901.2	connective tissue growth factor	CTGF
CTGF-914-13-13350	13350	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1039-13-13352	13352	NM_001901.2	connective tissue growth factor	CTGF
CTGF-754-13-13354	13354	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1130-13-13356	13356	NM_001901.2	connective tissue growth factor	CTGF
CTGF-919-13-13358	13358	NM_001901.2	connective tissue growth factor	CTGF
CTGF-922-13-13360	13360	NM_001901.2	connective tissue growth factor	CTGF
CTGF-746-13-13362	13362	NM_001901.2	connective tissue growth factor	CTGF
CTGF-993-13-13364	13364	NM_001901.2	connective tissue growth factor	CTGF
CTGF-825-13-13366	13366	NM_001901.2	connective tissue growth factor	CTGF
CTGF-926-13-13368	13368	NM_001901.2	connective tissue growth factor	CTGF
CTGF-923-13-13370	13370	NM_001901.2	connective tissue growth factor	CTGF
CTGF-866-13-13372	13372	NM_001901.2	connective tissue growth factor	CTGF
CTGF-563-13-13374	13374	NM_001901.2	connective tissue growth factor	CTGF
CTGF-823-13-13376	13376	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1233-13-13378	13378	NM_001901.2	connective tissue growth factor	CTGF
CTGF-924-13-13380	13380	NM_001901.2	connective tissue growth factor	CTGF
CTGF-921-13-13382	13382	NM_001901.2	connective tissue growth factor	CTGF
CTGF-443-13-13384	13384	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1041-13-13386	13386	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1042-13-13388	13388	NM_001901.2	connective tissue growth factor	CTGF
CTGF-755-13-13390	13390	NM_001901.2	connective tissue growth factor	CTGF
CTGF-467-13-13392	13392	NM_001901.2	connective tissue growth factor	CTGF
CTGF-995-13-13394	13394	NM_001901.2	connective tissue growth factor	CTGF
CTGF-927-13-13396	13396	NM_001901.2	connective tissue growth factor	CTGF
SPP1-1025-13-13398	13398	NM_000582.2	Osteopontin	SPP1
SPP1-1049-13-13400	13400	NM_000582.2	Osteopontin	SPP1
SPP1-1051-13-13402	13402	NM_000582.2	Osteopontin	SPP1
SPP1-1048-13-13404	13404	NM_000582.2	Osteopontin	SPP1
SPP1-1050-13-13406	13406	NM_000582.2	Osteopontin	SPP1
SPP1-1047-13-13408	13408	NM_000582.2	Osteopontin	SPP1
SPP1-800-13-13410	13410	NM_000582.2	Osteopontin	SPP1
SPP1-492-13-13412	13412	NM_000582.2	Osteopontin	SPP1
SPP1-612-13-13414	13414	NM_000582.2	Osteopontin	SPP1
SPP1-481-13-13416	13416	NM_000582.2	Osteopontin	SPP1
SPP1-614-13-13418	13418	NM_000582.2	Osteopontin	SPP1
SPP1-951-13-13420	13420	NM_000582.2	Osteopontin	SPP1
SPP1-482-13-13422	13422	NM_000582.2	Osteopontin	SPP1
SPP1-856-13-13424	13424	NM_000582.2	Osteopontin	SPP1
SPP1-857-13-13426	13426	NM_000582.2	Osteopontin	SPP1
SPP1-365-13-13428	13428	NM_000582.2	Osteopontin	SPP1
SPP1-359-13-13430	13430	NM_000582.2	Osteopontin	SPP1
SPP1-357-13-13432	13432	NM_000582.2	Osteopontin	SPP1
SPP1-858-13-13434	13434	NM_000582.2	Osteopontin	SPP1
SPP1-1012-13-13436	13436	NM_000582.2	Osteopontin	SPP1
SPP1-1014-13-13438	13438	NM_000582.2	Osteopontin	SPP1
SPP1-356-13-13440	13440	NM_000582.2	Osteopontin	SPP1
SPP1-368-13-13442	13442	NM_000582.2	Osteopontin	SPP1
SPP1-1011-13-13444	13444	NM_000582.2	Osteopontin	SPP1
SPP1-754-13-13446	13446	NM_000582.2	Osteopontin	SPP1
SPP1-1021-13-13448	13448	NM_000582.2	Osteopontin	SPP1
SPP1-1330-13-13450	13450	NM_000582.2	Osteopontin	SPP1
SPP1-346-13-13452	13452	NM_000582.2	Osteopontin	SPP1
SPP1-869-13-13454	13454	NM_000582.2	Osteopontin	SPP1
SPP1-701-13-13456	13456	NM_000582.2	Osteopontin	SPP1
SPP1-896-13-13458	13458	NM_000582.2	Osteopontin	SPP1
SPP1-1035-13-13460	13460	NM_000582.2	Osteopontin	SPP1
SPP1-1170-13-13462	13462	NM_000582.2	Osteopontin	SPP1
SPP1-1282-13-13464	13464	NM_000582.2	Osteopontin	SPP1
SPP1-1537-13-13466	13466	NM_000582.2	Osteopontin	SPP1
SPP1-692-13-13468	13468	NM_000582.2	Osteopontin	SPP1
SPP1-840-13-13470	13470	NM_000582.2	Osteopontin	SPP1
SPP1-1163-13-13472	13472	NM_000582.2	Osteopontin	SPP1
SPP1-789-13-13474	13474	NM_000582.2	Osteopontin	SPP1
SPP1-841-13-13476	13476	NM_000582.2	Osteopontin	SPP1
SPP1-852-13-13478	13478	NM_000582.2	Osteopontin	SPP1
SPP1-209-13-13480	13480	NM_000582.2	Osteopontin	SPP1
SPP1-1276-13-13482	13482	NM_000582.2	Osteopontin	SPP1
SPP1-137-13-13484	13484	NM_000582.2	Osteopontin	SPP1
SPP1-711-13-13486	13486	NM_000582.2	Osteopontin	SPP1
SPP1-582-13-13488	13488	NM_000582.2	Osteopontin	SPP1
SPP1-839-13-13490	13490	NM_000582.2	Osteopontin	SPP1
SPP1-1091-13-13492	13492	NM_000582.2	Osteopontin	SPP1
SPP1-884-13-13494	13494	NM_000582.2	Osteopontin	SPP1
SPP1-903-13-13496	13496	NM_000582.2	Osteopontin	SPP1
SPP1-1090-13-13498	13498	NM_000582.2	Osteopontin	SPP1
SPP1-474-13-13500	13500	NM_000582.2	Osteopontin	SPP1
SPP1-575-13-13502	13502	NM_000582.2	Osteopontin	SPP1
SPP1-671-13-13504	13504	NM_000582.2	Osteopontin	SPP1
SPP1-924-13-13506	13506	NM_000582.2	Osteopontin	SPP1
SPP1-1185-13-13508	13508	NM_000582.2	Osteopontin	SPP1
SPP1-1221-13-13510	13510	NM_000582.2	Osteopontin	SPP1
SPP1-347-13-13512	13512	NM_000582.2	Osteopontin	SPP1
SPP1-634-13-13514	13514	NM_000582.2	Osteopontin	SPP1
SPP1-877-13-13516	13516	NM_000582.2	Osteopontin	SPP1
SPP1-1033-13-13518	13518	NM_000582.2	Osteopontin	SPP1
SPP1-714-13-13520	13520	NM_000582.2	Osteopontin	SPP1
SPP1-791-13-13522	13522	NM_000582.2	Osteopontin	SPP1
SPP1-813-13-13524	13524	NM_000582.2	Osteopontin	SPP1
SPP1-939-13-13526	13526	NM_000582.2	Osteopontin	SPP1
SPP1-1161-13-13528	13528	NM_000582.2	Osteopontin	SPP1
SPP1-1164-13-13530	13530	NM_000582.2	Osteopontin	SPP1
SPP1-1190-13-13532	13532	NM_000582.2	Osteopontin	SPP1
SPP1-1333-13-13534	13534	NM_000582.2	Osteopontin	SPP1
SPP1-537-13-13536	13536	NM_000582.2	Osteopontin	SPP1
SPP1-684-13-13538	13538	NM_000582.2	Osteopontin	SPP1
SPP1-707-13-13540	13540	NM_000582.2	Osteopontin	SPP1
SPP1-799-13-13542	13542	NM_000582.2	Osteopontin	SPP1
SPP1-853-13-13544	13544	NM_000582.2	Osteopontin	SPP1
SPP1-888-13-13546	13546	NM_000582.2	Osteopontin	SPP1
SPP1-1194-13-13548	13548	NM_000582.2	Osteopontin	SPP1
SPP1-1279-13-13550	13550	NM_000582.2	Osteopontin	SPP1
SPP1-1300-13-13552	13552	NM_000582.2	Osteopontin	SPP1
SPP1-1510-13-13554	13554	NM_000582.2	Osteopontin	SPP1
SPP1-1543-13-13556	13556	NM_000582.2	Osteopontin	SPP1
SPP1-434-13-13558	13558	NM_000582.2	Osteopontin	SPP1
SPP1-600-13-13560	13560	NM_000582.2	Osteopontin	SPP1
SPP1-863-13-13562	13562	NM_000582.2	Osteopontin	SPP1
SPP1-902-13-13564	13564	NM_000582.2	Osteopontin	SPP1
SPP1-921-13-13566	13566	NM_000582.2	Osteopontin	SPP1
SPP1-154-13-13568	13568	NM_000582.2	Osteopontin	SPP1
SPP1-217-13-13570	13570	NM_000582.2	Osteopontin	SPP1
SPP1-816-13-13572	13572	NM_000582.2	Osteopontin	SPP1
SPP1-882-13-13574	13574	NM_000582.2	Osteopontin	SPP1
SPP1-932-13-13576	13576	NM_000582.2	Osteopontin	SPP1
SPP1-1509-13-13578	13578	NM_000582.2	Osteopontin	SPP1
SPP1-157-13-13580	13580	NM_000582.2	Osteopontin	SPP1
SPP1-350-13-13582	13582	NM_000582.2	Osteopontin	SPP1
SPP1-511-13-13584	13584	NM_000582.2	Osteopontin	SPP1
SPP1-605-13-13586	13586	NM_000582.2	Osteopontin	SPP1
SPP1-811-13-13588	13588	NM_000582.2	Osteopontin	SPP1
SPP1-892-13-13590	13590	NM_000582.2	Osteopontin	SPP1
SPP1-922-13-13592	13592	NM_000582.2	Osteopontin	SPP1
SPP1-1169-13-13594	13594	NM_000582.2	Osteopontin	SPP1
SPP1-1182-13-13596	13596	NM_000582.2	Osteopontin	SPP1
SPP1-1539-13-13598	13598	NM_000582.2	Osteopontin	SPP1
SPP1-1541-13-13600	13600	NM_000582.2	Osteopontin	SPP1
SPP1-427-13-13602	13602	NM_000582.2	Osteopontin	SPP1
SPP1-533-13-13604	13604	NM_000582.2	Osteopontin	SPP1
APOB--13-13763	13763	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
APOB--13-13764	13764	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
MAP4K4--16-13766	13766			MAP4K4
PPIB--13-13767	13767	NM_000942	peptidylprolyl isomerase B	PPIB
			(cyclophilin B)
PPIB--15-13768	13768	NM_000942	peptidylprolyl isomerase B	PPIB
			(cyclophilin B)
PPIB--17-13769	13769	NM_000942	peptidylprolyl isomerase B	PPIB
			(cyclophilin B)
MAP4K4--16-13939	13939			MAP4K4
APOB-4314-16-13940	13940	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
APOB-4314-17-13941	13941	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
APOB--16-13942	13942	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
APOB--18-13943	13943	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
APOB--17-13944	13944	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
APOB--19-13945	13945	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
APOB-4314-16-13946	13946	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
APOB-4314-17-13947	13947	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
APOB--16-13948	13948	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
APOB--17-13949	13949	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
APOB--16-13950	13950	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
APOB--18-13951	13951	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
APOB--17-13952	13952	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
APOB--19-13953	13953	NM_000384	Apolipoprotein B (including	APOB
			Ag(x) antigen)
MAP4K4--16-13766.2	13766.2			MAP4K4
CTGF-1222-16-13980	13980	NM_001901.2	connective tissue growth factor	CTGF
CTGF-813-16-13981	13981	NM_001901.2	connective tissue growth factor	CTGF
CTGF-747-16-13982	13982	NM_001901.2	connective tissue growth factor	CTGF
CTGF-817-16-13983	13983	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1174-16-13984	13984	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1005-16-13985	13985	NM_001901.2	connective tissue growth factor	CTGF
CTGF-814-16-13986	13986	NM_001901.2	connective tissue growth factor	CTGF
CTGF-816-16-13987	13987	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1001-16-13988	13988	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1173-16-13989	13989	NM_001901.2	connective tissue growth factor	CTGF
CTGF-749-16-13990	13990	NM_001901.2	connective tissue growth factor	CTGF
CTGF-792-16-13991	13991	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1162-16-13992	13992	NM_001901.2	connective tissue growth factor	CTGF
CTGF-811-16-13993	13993	NM_001901.2	connective tissue growth factor	CTGF
CTGF-797-16-13994	13994	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1175-16-13995	13995	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1172-16-13996	13996	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1177-16-13997	13997	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1176-16-13998	13998	NM_001901.2	connective tissue growth factor	CTGF
CTGF-812-16-13999	13999	NM_001901.2	connective tissue growth factor	CTGF
CTGF-745-16-14000	14000	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1230-16-14001	14001	NM_001901.2	connective tissue growth factor	CTGF
CTGF-920-16-14002	14002	NM_001901.2	connective tissue growth factor	CTGF
CTGF-679-16-14003	14003	NM_001901.2	connective tissue growth factor	CTGF
CTGF-992-16-14004	14004	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1045-16-14005	14005	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1231-16-14006	14006	NM_001901.2	connective tissue growth factor	CTGF
CTGF-991-16-14007	14007	NM_001901.2	connective tissue growth factor	CTGF
CTGF-998-16-14008	14008	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1049-16-14009	14009	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1044-16-14010	14010	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1327-16-14011	14011	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1196-16-14012	14012	NM_001901.2	connective tissue growth factor	CTGF
CTGF-562-16-14013	14013	NM_001901.2	connective tissue growth factor	CTGF
CTGF-752-16-14014	14014	NM_001901.2	connective tissue growth factor	CTGF
CTGF-994-16-14015	14015	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1040-16-14016	14016	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1984-16-14017	14017	NM_001901.2	connective tissue growth factor	CTGF
CTGF-2195-16-14018	14018	NM_001901.2	connective tissue growth factor	CTGF
CTGF-2043-16-14019	14019	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1892-16-14020	14020	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1567-16-14021	14021	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1780-16-14022	14022	NM_001901.2	connective tissue growth factor	CTGF
CTGF-2162-16-14023	14023	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1034-16-14024	14024	NM_001901.2	connective tissue growth factor	CTGF
CTGF-2264-16-14025	14025	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1032-16-14026	14026	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1535-16-14027	14027	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1694-16-14028	14028	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1588-16-14029	14029	NM_001901.2	connective tissue growth factor	CTGF
CTGF-928-16-14030	14030	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1133-16-14031	14031	NM_001901.2	connective tissue growth factor	CTGF
CTGF-912-16-14032	14032	NM_001901.2	connective tissue growth factor	CTGF
CTGF-753-16-14033	14033	NM_001901.2	connective tissue growth factor	CTGF
CTGF-918-16-14034	14034	NM_001901.2	connective tissue growth factor	CTGF
CTGF-744-16-14035	14035	NM_001901.2	connective tissue growth factor	CTGF
CTGF-466-16-14036	14036	NM_001901.2	connective tissue growth factor	CTGF
CTGF-917-16-14037	14037	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1038-16-14038	14038	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1048-16-14039	14039	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1235-16-14040	14040	NM_001901.2	connective tissue growth factor	CTGF
CTGF-868-16-14041	14041	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1131-16-14042	14042	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1043-16-14043	14043	NM_001901.2	connective tissue growth factor	CTGF
CTGF-751-16-14044	14044	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1227-16-14045	14045	NM_001901.2	connective tissue growth factor	CTGF
CTGF-867-16-14046	14046	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1128-16-14047	14047	NM_001901.2	connective tissue growth factor	CTGF
CTGF-756-16-14048	14048	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1234-16-14049	14049	NM_001901.2	connective tissue growth factor	CTGF
CTGF-916-16-14050	14050	NM_001901.2	connective tissue growth factor	CTGF
CTGF-925-16-14051	14051	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1225-16-14052	14052	NM_001901.2	connective tissue growth factor	CTGF
CTGF-445-16-14053	14053	NM_001901.2	connective tissue growth factor	CTGF
CTGF-446-16-14054	14054	NM_001901.2	connective tissue growth factor	CTGF
CTGF-913-16-14055	14055	NM_001901.2	connective tissue growth factor	CTGF
CTGF-997-16-14056	14056	NM_001901.2	connective tissue growth factor	CTGF
CTGF-277-16-14057	14057	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1052-16-14058	14058	NM_001901.2	connective tissue growth factor	CTGF
CTGF-887-16-14059	14059	NM_001901.2	connective tissue growth factor	CTGF
CTGF-914-16-14060	14060	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1039-16-14061	14061	NM_001901.2	connective tissue growth factor	CTGF
CTGF-754-16-14062	14062	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1130-16-14063	14063	NM_001901.2	connective tissue growth factor	CTGF
CTGF-919-16-14064	14064	NM_001901.2	connective tissue growth factor	CTGF
CTGF-922-16-14065	14065	NM_001901.2	connective tissue growth factor	CTGF
CTGF-746-16-14066	14066	NM_001901.2	connective tissue growth factor	CTGF
CTGF-993-16-14067	14067	NM_001901.2	connective tissue growth factor	CTGF
CTGF-825-16-14068	14068	NM_001901.2	connective tissue growth factor	CTGF
CTGF-926-16-14069	14069	NM_001901.2	connective tissue growth factor	CTGF
CTGF-923-16-14070	14070	NM_001901.2	connective tissue growth factor	CTGF
CTGF-866-16-14071	14071	NM_001901.2	connective tissue growth factor	CTGF
CTGF-563-16-14072	14072	NM_001901.2	connective tissue growth factor	CTGF
CTGF-823-16-14073	14073	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1233-16-14074	14074	NM_001901.2	connective tissue growth factor	CTGF
CTGF-924-16-14075	14075	NM_001901.2	connective tissue growth factor	CTGF
CTGF-921-16-14076	14076	NM_001901.2	connective tissue growth factor	CTGF
CTGF-443-16-14077	14077	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1041-16-14078	14078	NM_001901.2	connective tissue growth factor	CTGF
CTGF-1042-16-14079	14079	NM_001901.2	connective tissue growth factor	CTGF
CTGF-755-16-14080	14080	NM_001901.2	connective tissue growth factor	CTGF
CTGF-467-16-14081	14081	NM_001901.2	connective tissue growth factor	CTGF
CTGF-995-16-14082	14082	NM_001901.2	connective tissue growth factor	CTGF
CTGF-927-16-14083	14083	NM_001901.2	connective tissue growth factor	CTGF
SPP1-1091-16-14131	14131	NM_000582.2	Osteopontin	SPP1
PPIB--16-14188	14188	NM_000942	peptidylprolyl isomerase B	PPIB
			(cyclophilin B)
PPIB--17-14189	14189	NM_000942	peptidylprolyl isomerase B	PPIB
			(cyclophilin B)
PPIB--18-14190	14190	NM_000942	peptidylprolyl isomerase B	PPIB
			(cyclophilin B)
pGL3-1172-16-14386	14386	U47296	Cloning vector pGL3-Control	pGL3
pGL3-1172-16-14387	14387	U47296	Cloning vector pGL3-Control	pGL3
MAP4K4-2931-25-14390	14390	NM_004834	Mitogen-Activated Protein Kinase	MAP4K4
			Kinase Kinase Kinase 4
			(MAP4K4), transcript variant 1
miR-122--23-14391	14391			miR-122
	14084	NM_000582.2	Osteopontin	SPP1
	14085	NM_000582.2	Osteopontin	SPP1
	14086	NM_000582.2	Osteopontin	SPP1
	14087	NM_000582.2	Osteopontin	SPP1
	14088	NM_000582.2	Osteopontin	SPP1
	14089	NM_000582.2	Osteopontin	SPP1
	14090	NM_000582.2	Osteopontin	SPP1
	14091	NM_000582.2	Osteopontin	SPP1
	14092	NM_000582.2	Osteopontin	SPP1
	14093	NM_000582.2	Osteopontin	SPP1
	14094	NM_000582.2	Osteopontin	SPP1
	14095	NM_000582.2	Osteopontin	SPP1
	14096	NM_000582.2	Osteopontin	SPP1
	14097	NM_000582.2	Osteopontin	SPP1
	14098	NM_000582.2	Osteopontin	SPP1
	14099	NM_000582.2	Osteopontin	SPP1
	14100	NM_000582.2	Osteopontin	SPP1
	14101	NM_000582.2	Osteopontin	SPP1
	14102	NM_000582.2	Osteopontin	SPP1
	14103	NM_000582.2	Osteopontin	SPP1
	14104	NM_000582.2	Osteopontin	SPP1
	14105	NM_000582.2	Osteopontin	SPP1
	14106	NM_000582.2	Osteopontin	SPP1
	14107	NM_000582.2	Osteopontin	SPP1
	14108	NM_000582.2	Osteopontin	SPP1
	14109	NM_000582.2	Osteopontin	SPP1
	14110	NM_000582.2	Osteopontin	SPP1
	14111	NM_000582.2	Osteopontin	SPP1
	14112	NM_000582.2	Osteopontin	SPP1
	14113	NM_000582.2	Osteopontin	SPP1
	14114	NM_000582.2	Osteopontin	SPP1
	14115	NM_000582.2	Osteopontin	SPP1
	14116	NM_000582.2	Osteopontin	SPP1
	14117	NM_000582.2	Osteopontin	SPP1
	14118	NM_000582.2	Osteopontin	SPP1
	14119	NM_000582.2	Osteopontin	SPP1
	14120	NM_000582.2	Osteopontin	SPP1
	14121	NM_000582.2	Osteopontin	SPP1
	14122	NM_000582.2	Osteopontin	SPP1
	14123	NM_000582.2	Osteopontin	SPP1
	14124	NM_000582.2	Osteopontin	SPP1
	14125	NM_000582.2	Osteopontin	SPP1
	14126	NM_000582.2	Osteopontin	SPP1
	14127	NM_000582.2	Osteopontin	SPP1
	14128	NM_000582.2	Osteopontin	SPP1
	14129	NM_000582.2	Osteopontin	SPP1
	14130	NM_000582.2	Osteopontin	SPP1
	14132	NM_000582.2	Osteopontin	SPP1
	14133	NM_000582.2	Osteopontin	SPP1
	14134	NM_000582.2	Osteopontin	SPP1
	14135	NM_000582.2	Osteopontin	SPP1
	14136	NM_000582.2	Osteopontin	SPP1
	14137	NM_000582.2	Osteopontin	SPP1
	14138	NM_000582.2	Osteopontin	SPP1
	14139	NM_000582.2	Osteopontin	SPP1
	14140	NM_000582.2	Osteopontin	SPP1
	14141	NM_000582.2	Osteopontin	SPP1
	14142	NM_000582.2	Osteopontin	SPP1
	14143	NM_000582.2	Osteopontin	SPP1
	14144	NM_000582.2	Osteopontin	SPP1
	14145	NM_000582.2	Osteopontin	SPP1
	14146	NM_000582.2	Osteopontin	SPP1
	14147	NM_000582.2	Osteopontin	SPP1
	14148	NM_000582.2	Osteopontin	SPP1
	14149	NM_000582.2	Osteopontin	SPP1
	14150	NM_000582.2	Osteopontin	SPP1
	14151	NM_000582.2	Osteopontin	SPP1
	14152	NM_000582.2	Osteopontin	SPP1
	14153	NM_000582.2	Osteopontin	SPP1
	14154	NM_000582.2	Osteopontin	SPP1
	14155	NM_000582.2	Osteopontin	SPP1
	14156	NM_000582.2	Osteopontin	SPP1
	14157	NM_000582.2	Osteopontin	SPP1
	14158	NM_000582.2	Osteopontin	SPP1
	14159	NM_000582.2	Osteopontin	SPP1
	14160	NM_000582.2	Osteopontin	SPP1
	14161	NM_000582.2	Osteopontin	SPP1
	14162	NM_000582.2	Osteopontin	SPP1
	14163	NM_000582.2	Osteopontin	SPP1
	14164	NM_000582.2	Osteopontin	SPP1
	14165	NM_000582.2	Osteopontin	SPP1
	14166	NM_000582.2	Osteopontin	SPP1
	14167	NM_000582.2	Osteopontin	SPP1
	14168	NM_000582.2	Osteopontin	SPP1
	14169	NM_000582.2	Osteopontin	SPP1
	14170	NM_000582.2	Osteopontin	SPP1
	14171	NM_000582.2	Osteopontin	SPP1
	14172	NM_000582.2	Osteopontin	SPP1
	14173	NM_000582.2	Osteopontin	SPP1
	14174	NM_000582.2	Osteopontin	SPP1
	14175	NM_000582.2	Osteopontin	SPP1
	14176	NM_000582.2	Osteopontin	SPP1
	14177	NM_000582.2	Osteopontin	SPP1
	14178	NM_000582.2	Osteopontin	SPP1
	14179	NM_000582.2	Osteopontin	SPP1
	14180	NM_000582.2	Osteopontin	SPP1
	14181	NM_000582.2	Osteopontin	SPP1
	14182	NM_000582.2	Osteopontin	SPP1
	14183	NM_000582.2	Osteopontin	SPP1
	14184	NM_000582.2	Osteopontin	SPP1
	14185	NM_000582.2	Osteopontin	SPP1
	14186	NM_000582.2	Osteopontin	SPP1
	14187	NM_000582.2	Osteopontin	SPP1

TABLE 2
					SEQ
	Oligo				ID
ID Number	#	AntiSense Backbone	AntiSense Chemistry	AntiSense Sequence	NO:
APOB-10167-20-	12138	ooooooooooooooooooo	00000000000000000000m	AUUGGUAUUCAGUGUGAUG	1
12138
APOB-10167-20-	12139	ooooooooooooooooooo	00000000000000000000m	AUUCGUAUUGAGUCUGAUC	2
12139
MAP4K4-2931-	12293	ooooooooooooooooooo	Pf000fffff0f0000fff0	UAGACUUCCACAGAACUCU	3
16-12293
MAP4K4-2931-	12383	ooooooooooooooooooo	0000000000000000000	UAGACUUCCACAGAACUCU	4
16-12383
MAP4K4-2931-	12384	ooooooooooooooooooo	P0000000000000000000	UAGACUUCCACAGAACUCU	5
16-12384
MAP4K4-2931-	12385	ooooooooooooooooooo	Pf000fffff0f0000fff0	UAGACUUCCACAGAACUCU	6
16-12385
MAP4K4-2931-	12386	oooooooooosssssssso	Pf000fffff0f0000fff0	UAGACUUCCACAGAACUCU	7
16-12386
MAP4K4-2931-	12387	oooooooooosssssssso	P0000000000000000000	UAGACUUCCACAGAACUCU	8
16-12387
MAP4K4-2931-	12388	ooooooooooooooooo	00000000000000000	UAGACUUCCACAGAACU	9
15-12388
APOB--21-12434	12434	ooooooooooooooooooo	00000000000000000000m	AUUGGUAUUCAGUGUGAUG	10
		oo		AC
APOB--21-12435	12435	ooooooooooooooooooo	00000000000000000000m	AUUCGUAUUGAGUCUGAUC
		oo		AC	11
MAP4K4-2931-	12451	oooooooooosssssssso	Pf000fffff0f0000ffmm	UAGACUUCCACAGAACUCU	12
16-12451
MAP4K4-2931-	12452	oooooooooosssssssso	Pm000fffff0000ffmm	UAGACUUCCACAGAACUCU	13
16-12452
MAP4K4-2931-	12453	oooooosssssssssssso	Pm000fffff0f0000ffmm	UAGACUUCCACAGAACUCU	14
16-12453
MAP4K4-2931-	12454	oooooooooooosssssssso	Pm000fffff0f0000ffffmm	UAGACUUCCACAGAACUCUU	15
17-12454				C
MAP4K4-2931-	12455	oooooooosssssssssssso	Pm000fffff0f0000ffffmm	UAGACUUCCACAGAACUCUU	16
17-12455				C
MAP4K4-2931-	12456	oooooooooooosssssssss	Pm000fffff0f0000ffffff	UAGACUUCCACAGAACUCUU	17
19-12456		ssso	00mm	CAAAG
APOB-10167-21-	12505	ooooooooooooooooooo	00000000000000000000m	AUUGGUAUUCAGUGUGAUG	18
12505		os		AC
APOB-10167-21-	12506	ooooooooooooooooooo	00000000000000000000m	AUUCGUAUUGAGUCUGAUC	19
12506		os		AC
MAP4K4-2931-	12539	ooooooooooossssssss	Pf000fffff0f0000fff0	UAGACUUCCACAGAACUCU	20
16-12539
APOB-10167-21-	12505.2	ooooooooooooooooooo	00000000000000000000m	AUUGGUAUUCAGUGUGAUG	21
12505.2		oo		AC
APOB-10167-21-	12506.2	ooooooooooooooooooo	00000000000000000000m	AUUCGUAUUGAGUCUGAUC	22
12506.2		oo		AC
MAP4K4-2931-	12386.2	oooooooooosssssssso	Pf000fffff0f0000fff0	UAGACUUCCACAGAACUCU	23
16-12386.2
MAP4K4--16-	12983	oooooooooooosssssso	Pm000fffff0m0000mmm0	uagacuuccacagaacucu	24
12983
MAP4K4--16-	12984	oooooooooooossssss	Pm000fffff0m0000mmm0	uagacuuccacagaacucu	25
12984
MAP4K4--16-	12985	oooooooooooosssssso	Pm000fffff0m0000mmm0	uagacuuccacagaacucu	26
12985
MAP4K4--16-	12986	oooooooooosssssssso	Pf000fffff0f0000fff0	UAGACUUCCACAGAACUCU	27
12986
MAP4K4--16-	12987	ooooooooooooossssss	P0000f00ff0m0000m0m0	UagacUUccacagaacUcU	28
12987
MAP4K4--16-	12988	ooooooooooooossssss	P0000f00ff0m0000m0m0	UagacUUccacagaacUcu	29
12988
MAP4K4--16-	12989	ooooooooooooossssss	P0000ff0ff0m0000m0m0	UagacuUccacagaacUcu	30
12989
MAP4K4--16-	12990	ooooooooooooossssss	Pf0000ff000000000m00	uagaCuuCCaCagaaCuCu	31
12990
MAP4K4--16-	12991	ooooooooooooossssss	Pf0000fff00m00000mm0	uagaCuucCacagaaCucu	32
12991
MAP4K4--16-	12992	ooooooooooooossssss	Pf000fffff0000000m00	uagacuuccaCagaaCuCu	33
12992
MAP4K4--16-	12993	ooooooooooooossssss	P0000000000000000000	UagaCUUCCaCagaaCUCU	34
12993
MAP4K4--16-	12994	ooooooooooooossssss	P0000f0f0f0000000m00	UagacUuCcaCagaaCuCu	35
12994
MAP4K4--16-	12995	oooooooooooosssssso	Pf000fffff0000000000	uagacuuccaCagaaCUCU	36
12995
--16-13047	13047	oooooooooooossssss	Pm000000000m0000mm	UAGACUUCCACAGAACUCU	37
			m0
PP1B-16-13136	13136	oooooooooooossssss	Pm0fffff0f00mm000mm0	UGUUUUUGUAGCCAAAUCC	38
SOD1-530-16-	13163	oooooooooooosssssso	Pm0ffffffff0mmmmm0m0	UACUUUCUUCAUUUCCACC	39
13163
SOD1-523-16-	13164	oooooooooooosssssso	Pmff0fffff0fmmmm0mm0	UUCAUUUCCACCUUUGCCC	40
13164
SOD1-535-16-	13165	oooooooooooosssssso	Pmfff0f0ffffmmmm0mm0	CUUUGUACUUUCUUCAUUU	41
13165
SOD1-536-16-	13166	oooooooooooosssssso	Pmffff0f0fffmmmmm0m0	UCUUUGUACUUUCUUCAUU	42
13166
SOD1-396-16-	13167	oooooooooooosssssso	Pmf00f00ff0f0mm0mmm0	UCAGCAGUCACAUUGCCCA	43
13167
SOD1-385-16-	13168	oooooooooooosssssso	Pmff0fff000fmmmm00m0	AUUGCCCAAGUCUCCAACA	44
13168
SOD1-195-16-	13169	oooooooooooosssssso	Pmfff0fff0000mm00m00	UUCUGCUCGAAAUUGAUGA	45
13169
pGL3-1172-16-	13170	oooooooooooosssssso	Pm00ff0f0ffm0ff00mm0	AAAUCGUAUUUGUCAAUCA	46
13170
pGL3-1172-16-	13171	ooooooooooooossssss	Pm00ff0f0ffm0ff00mm0	AAAUCGUAUUUGUCAAUCA	47
13171
MAP4k4-2931-	13189	ooooooooooooooooooo	0000000000000000000	UAGACUUCCACAGAACUCU	48
19-13189
MAP4K4--16-	13766	oooooooooooosssssso	Pm000fffff0m0000mmm0	UAGACUUCCACAGAACUCU	49
13766
MAP4K4--16-	13939	oooooooooooosssssso	m000f0ffff0m0m00m0m	UAGACAUCCUACACAGCAC	50
13939
APOB-4314-16-	13940	oooooooooooosssssso	Pm0fffffff000mmmmm00	UGUUUCUCCAGAUCCUUGC	51
13940
APOB-4314-17-	13941	oooooooooooosssssso	Pm0fffffff000mmmmm00	UGUUUCUCCAGAUCCUUGC	52
13941
APOB--16-13942	13942	oooooooooooosssssso	Pm00f000f000mmm0mm	UAGCAGAUGAGUCCAUUUG	53
			m0
APOB--18-13943	13943	oooooooooooooooossss	Pm00f000f000mmm0mm	UAGCAGAUGAGUCCAUUUG	54
		sso	m00000	GAGA
APOB--17-13944	13944	oooooooooooosssssso	Pm00f000f000mmm0mm	UAGCAGAUGAGUCCAUUUG	55
			mo
APOB--19-13945	13945	oooooooooooooooossss	Pm00f000f000mmm0mm	UAGCAGAUGAGUCCAUUUG	56
		sso	m00000	GAGA
APOB-4314-16-	13946	oooooooooooosssssso	Pmf0ff0ffffmmm000mm0	AUGUUGUUUCUCCAGAUCC	57
13946
APOB-4314-17-	13947	oooooooooooosssssso	Pmf0ff0ffffmmm000mm0	AUGUUGUUUCUCCAGAUCC	58
13947
APOB--16-13948	13948	oooooooooooosssssso	Pm0fff000000mmmm0m0	UGUUUGAGGGACUCUGUGA	59
		o
APOB--17-13949	13949	oooooooooooosssssso	Pm0fff000000mmmm0m0	UGUUUGAGGGACUCUGUGA	60
		o
APOB--16-13950	13950	oooooooooooosssssso	Pmff00f0fff00m0m00m0	AUUGGUAUUCAGUGUGAUG	61
APOB--18-13951	13951	oooooooooooooooossss	Pmff00f0fff00m0m00m00	AUUGGUAUUCAGUGUGAUG	62
		sso	m00	ACAC
APOB--17-13952	13952	oooooooooooosssssso	Pmff00f0fff00m0m00m0	AUUGGUAUUCAGUGUGAUG	63
APOB--19-13953	13953	oooooooooooooooossss	Pmff00f0fff00m0m00m00	AUUGGUAUUCAGUGUGAUG	64
		sso	m00	ACAC
MAP4K4--16-	13766.2	oooooooooooosssssso	Pm000fffff0m0000mmm0	UAGACUUCCACAGAACUCU	65
13766.2
CTGF-1222-16-	13980	oooooooooooosssssso	Pm0f0ffffffm0m00m0m0	UACAUCUUCCUGUAGUACA	66
13980
CTGF-813-16-	13981	oooooooooooosssssso	Pm0f0ffff0mmmm0m000	AGGCGCUCCACUCUGUGGU	67
13981
CTGF-747-16-	13982	oooooooooooosssssso	Pm0ffffff00mm0m0000	UGUCUUCCAGUCGGUAAGC	68
13982
CTGF-817-16-	13983	oooooooooooosssssso	Pm00f000f0fmmm0mmm	GAACAGGCGCUCCACUCUG	69
13983			m0
CTGF-1174-16-	13984	oooooooooooosssssso	Pm00ff0f00f00m000m00	CAGUUGUAAUGGCAGGCAC	70
13984
CTGF-1005-16-	13985	oooooooooooosssssso	Pmff000000mmm000mm0	AGCCAGAAAGCUCAAACUU	71
13985
CTGF-814-16-	13986	oooooooooooosssssso	Pm000f0ffff0mmmm0m00	CAGGCGCUCCACUCUGUGG	72
13986
CTGF-816-16-	13987	oooooooooooosssssso	Pm0f000f0ffmm0mmmm0	AACAGGCGCUCCACUCUGU	73
13987			0
CTGF-1001-16-	13988	oooooooooooosssssso	Pm0000fff000mmm00m0	AGAAAGCUCAAACUUGAUA	74
13988
CTGF-1173-16-	13989	oooooooooooosssssso	Pmff0f00f00m000m0m0	AGUUGUAAUGGCAGGCACA	75
13989
CTGF-749-16-	13990	oooooooooooosssssso	Pmf0ffffff00mm00m00	CGUGUCUUCCAGUCGGUAA	76
13990
CTGF-792-16-	13991	oooooooooooosssssso	Pm00ff000f00mm00mmm	GGACCAGGCAGUUGGCUCU	77
13991			0
CTGF-1162-16-	13992	oooooooooooosssssso	Pm000f0f000mmmm00m0	CAGGCACAGGUCUUGAUGA	78
13992			0
CTGF-811-16-	13993	oooooooooooosssssso	Pmf0ffff0ffmm0m00mm0	GCGCUCCACUCUGUGGUCU	79
13993
CTGF-797-16-	13994	oooooooooooosssssso	Pm0fff000ff000m00mm0	GGUCUGGACCAGGCAGUUG	80
13994
CTGF-1175-16-	13995	oooooooooooosssssso	Pmf00ff0f00m00m000m0	ACAGUUGUAAUGGCAGGCA	81
13995
CTGF-1172-16-	13996	oooooooooooosssssso	Pmff0f00f00m000m0m00	GUUGUAAUGGCAGGCACAG	82
13996
CTGF-1177-16-	13997	oooooooooooosssssso	Pm00f00ff0f00m00m000	GGACAGUUGUAAUGGCAGG	83
13997
CTGF-1176-16-	13998	oooooooooooosssssso	Pm0f00ff0f00m00m0000	GACAGUUGUAAUGGCAGGC	84
13998
CTGF-812-16-	13999	oooooooooooosssssso	Pm0f0ffff0fmmm0m00m0	GGCGCUCCACUCUGUGGUC	85
13999
CTGF-745-16-	14000	oooooooooooosssssso	Pmfffff00ff00m000mm0	UCUUCCAGUCGGUAAGCCG	86
14000
CTGF-1230-16-	14001	oooooooooooosssssso	Pm0fffff0f0m0mmmmmm	UGUCUCCGUACAUCUUCCU	87
14001			0
CTGF-920-16-	14002	oooooooooooosssssso	Pmffff0f0000mmm00m0	AGCUUCGCAAGGCCUGACC	88
14002
CTGF-679-16-	14003	oooooooooooosssssso	Pm0ffffff0f00m0mmmm0	CACUCCUCGCAGCAUUUCC	89
14003
CTGF-992-16-	14004	oooooooooooosssssso	Pm00fff00f000mmm0000	AAACUUGAUAGGCUUGGAG	90
14004
CTGF-1045-16-	14005	oooooooooooosssssso	Pmffff0f0000mmm00mm0	ACUCCACAGAAUUUAGCUC	91
14005
CTGF-1231-16-	14006	oooooooooooosssssso	Pmf0fffff0f0m0mmmmm0	AUGUCUCCGUACAUCUUCC	92
14006
CTGF-991-16-	14007	oooooooooooosssssso	Pm0fff00f000mmm00000	AACUUGAUAGGCUUGGAGA	93
14007
CTGF-998-16-	14008	oooooooooooosssssso	Pm00fff000fmm00m0000	AAGCUCAAACUUGAUAGGC	94
14008
CTGF-1049-16-	14009	oooooooooooosssssso	Pmf0f0ffff0m0000mmm0	ACAUACUCCACAGAAUUUA	95
14009
CTGF-1044-16-	14010	oooooooooooosssssso	Pmfff0f0000mmm00mmm	CUCCACAGAAUUUAGCUCG	96
14010			0
CTGF-1327-16-	14011	oooooooooooosssssso	Pm0f0ff0ff0000mm0mm0	UGUGCUACUGAAAUCAUUU	97
14011
CTGF-1196-16-	14012	oooooooooooosssssso	Pm0000f0ff0mm0mmmm	AAAGAUGUCAUUGUCUCCG	98
14012			m0
CTGF-562-16-	14013	oooooooooooosssssso	Pmf0f0ff00f0mmm0m000	GUGCACUGGUACUUGCAGC	99
14013
CTGF-752-16-	14014	oooooooooooosssssso	Pm00f0f0fffmmm00mm00	AAACGUGUCUUCCAGUCGG	100
14014
CTGF-994-16-	14015	oooooooooooosssssso	Pmf000fff00m000mmm00	UCAAACUUGAUAGGCUUGG	101
14015
CTGF-1040-16-	14016	oooooooooooosssssso	Pmf0000fff00mmm00m00	ACAGAAUUUAGCUCGGUAU	102
14016
CTGF-1984-16-	14017	oooooooooooosssssso	Pmf0f0ffff0mmm0m00m0	UUACAUUCUACCUAUGGUG	103
14017
CTGF-2195-16-	14018	oooooooooooosssssso	Pm00ff00ff00mm0m0m00	AAACUGAUCAGCUAUAUAG	104
14018
CTGF-2043-16-	14019	oooooooooooosssssso	Pm0fff000f0000mmmmm	UAUCUGAGCAGAAUUUCCA	105
14019			0
CTGF-1892-16-	14020	oooooooooooosssssso	Pmf00fff000m00mm0m00	UUAACUUAGAUAACUGUAC	106
14020
CTGF-1567-16-	14021	oooooooooooosssssso	Pm0ff0fff0f0m0000m00	UAUUACUCGUAUAAGAUGC	107
14021
CTGF-1780-16-	14022	oooooooooooosssssso	Pm00ff0fff00mmm00mm0	AAGCUGUCCAGUCUAAUCG	108
14022
CTGF-2162-16-	14023	oooooooooooosssssso	Pm00f00000fm0mmm0m	UAAUAAAGGCCAUUUGUUC	109
14023			m0
CTGF-1034-16-	14024	oooooooooooosssssso	Pmff00fff00m0m0mmmm	UUUAGCUCGGUAUGUCUUC	110
14024			0
CTGF-2264-16-	14025	oooooooooooosssssso	Pmf0fffff00m000m0000	ACACUCUCAACAAAUAAAC	111
14025
CTGF-1032-16-	14026	oooooooooooosssssso	Pm00fff00f0m0mmmmm0	UAGCUCGGUAUGUCUUCAU	112
14026			0
CTGF-1535-16-	14027	oooooooooooosssssso	Pm00fffffff0mm00m0m0	UAACCUUUCUGCUGGUACC	113
14027
CTGF-1694-16-	14028	oooooooooooosssssso	Pmf000000f00mmm00mm	UUAAGGAACAACUUGACUC	114
14028			0
CTGF-1588-16-	14029	oooooooooooosssssso	Pmf0f0ffff000m00m000	UUACACUUCAAAUAGCAGG	115
14029
CTGF-928-16-	14030	oooooooooooosssssso	Pmff000ff00mmmm0m00	UCCAGGUCAGCUUCGCAAG	116
14030			0
CTGF-1133-16-	14031	oooooooooooosssssso	Pmffffff0f00mmmm0mm0	CUUCUUCAUGACCUCGCCG	117
14031
CTGF-912-16-	14032	oooooooooooosssssso	Pm000fff00fm0m0m0m00	AAGGCCUGACCAUGCACAG	118
14032
CTGF-753-16-	14033	oooooooooooosssssso	Pm000f0f0ffmmmm00mm	CAAACGUGUCUUCCAGUCG	119
14033			0
CTGF-918-16-	14034	oooooooooooosssssso	Pmfff0f0000mmm00mm0	CUUCGCAAGGCCUGACCAU	120
14034			0
CTGF-744-16-	14035	oooooooooooosssssso	Pmffff00ff00m000mm00	CUUCCAGUCGGUAAGCCGC	121
14035
CTGF-466-16-	14036	oooooooooooosssssso	Pmf00ffff0f00mm00mm0	CCGAUCUUGCGGUUGGCCG	122
14036
CTGF-917-16-	14037	oooooooooooosssssso	Pmff0f0000fmm00mm0m	UUCGCAAGGCCUGACCAUG	123
14037			0
CTGF-1038-16-	14038	oooooooooooosssssso	Pm00fff00fmm0m0m00	AGAAUUUAGCUCGGUAUGU	124
14038
CTGF-1048-16-	14039	oooooooooooosssssso	Pm0f0ffff0f0000mmm00	CAUACUCCACAGAAUUUAG	125
14039
CTGF-1235-16-	14040	oooooooooooosssssso	Pm0ff0f0fffmmm0m0m0	UGCCAUGUCUCCGUACAUC	126
14040
CTGF-868-16-	14041	oooooooooooosssssso	Pm000f0ff0fm0mm00m00	GAGGCGUUGUCAUUGGUAA	127
14041
CTGF-1131-16-	14042	oooooooooooosssssso	Pmffff0f00fmmm0mm0m	UCUUCAUGACCUCGCCGUC	128
14042			0
CTGF-1043-16-	14043	oooooooooooosssssso	Pmff0f0000fmm00mmm0	UCCACAGAAUUUAGCUCGG	129
14043			0
CTGF-751-16-	14044	oooooooooooosssssso	Pm0f0f0ffffmm00mm000	AACGUGUCUUCCAGUCGGU	130
14044
CTGF-1227-16-	14045	oooooooooooosssssso	Pmfff0f0f0fmmmmmm0m	CUCCGUACAUCUUCCUGUA	131
14045			0
CTGF-867-16-	14046	oooooooooooosssssso	Pm0f0ff0ff0mm00m000	AGGCGUUGUCAUUGGUAAC	132
14046
CTGF-1128-16-	14047	oooooooooooosssssso	Pmf0f00ffff0mm0mm000	UCAUGACCUCGCCGUCAGG	133
14047
CTGF-756-16-	14048	oooooooooooosssssso	Pm0ff000f0f0mmmmmm0	GGCCAAACGUGUCUUCCAG	134
14048			0
CTGF-1234-16-	14049	oooooooooooosssssso	Pmff0f0ffffmm0m0mm0	GCCAUGUCUCCGUACAUCU	135
14049
CTGF-916-16-	14050	oooooooooooosssssso	Pmf0f0000ffm00mm0m00	UCGCAAGGCCUGACCAUGC	136
14050
CTGF-925-16-	14051	oooooooooooosssssso	Pm0ff00fffmm0000m0	AGGUCAGCUUCGCAAGGCC	137
14051
CTGF-1225-16-	14052	oooooooooooosssssso	Pmf0f0f0fffmmmm0m000	CCGUACAUCUUCCUGUAGU	138
14052
CTGF-445-16-	14053	oooooooooooosssssso	Pm00ff0000fm0m000000	GAGCCGAAGUCACAGAAGA	139
14053
CTGF-446-16-	14054	oooooooooooosssssso	Pm000ff0000mm0m00000	GGAGCCGAAGUCACAGAAG	140
14054
CTGF-913-16-	14055	oooooooooooosssssso	Pm0000fff00mm0m0m0m	CAAGGCCUGACCAUGCACA	141
14055			0
CTGF-997-16-	14056	oooooooooooosssssso	Pmfff000ffm00m000m0	AGCUCAAACUUGAUAGGCU	142
14056
CTGF-277-16-	14057	oooooooooooosssssso	Pmf0f00ffff00mm00m00	CUGCAGUUCUGGCCGACGG	143
14057
CTGF-1052-16-	14058	oooooooooooosssssso	Pm0f0f0f0ffmm0m00000	GGUACAUACUCCACAGAAU	144
14058
CTGF-887-16-	14059	oooooooooooosssssso	Pmf0fffffff00mmm0m00	CUGCUUCUCUAGCCUGCAG	145
14059
CTGF-914-16-	14060	oooooooooooosssssso	Pmf0000fff00mm0m0m00	GCAAGGCCUGACCAUGCAC	146
14060
CTGF-1039-16-	14061	oooooooooooosssssso	Pm0000fff00mmm00m0m	CAGAAUUUAGCUCGGUAUG	147
14061			0
CTGF-754-16-	14062	oooooooooooosssssso	Pmf000f0f0fmmmmm00m	CCAAACGUGUCUUCCAGUC	148
14062			0
CTGF-1130-16-	14063	oooooooooooosssssso	Pmfff0f00ffmmmm0mm0	CUUCAUGACCUCGCCGUCA	149
14063
CTGF-919-16-	14064	oooooooooooosssssso	Pmffff0f0000mmm00mm0	GCUUCGCAAGGCCUGACCA	150
14064
CTGF-922-16-	14065	oooooooooooosssssso	Pmf00ffffM000mmm00	UCAGCUUCGCAAGGCCUGA	151
14065
CTGF-746-16-	14066	oooooooooooosssssso	Pmffffff00fm0m000m0	GUCUUCCAGUCGGUAAGCC	152
14066
CTGF-993-16-	14067	oooooooooooosssssso	Pm000fff00f000mmm000	CAAACUUGAUAGGCUUGGA	153
14067
CTGF-825-16-	14068	oooooooooooosssssso	Pm0ffff0000m000m0m0	AGGUCUUGGAACAGGCGCU	154
14068
CTGF-926-16-	14069	oooooooooooosssssso	Pm000ff00ffmmm00000	CAGGUCAGCUUCGCAAGGC	155
14069
CTGF-923-16-	14070	oooooooooooosssssso	Pmff00ffff0m0000mmm0	GUCAGCUUCGCAAGGCCUG	156
14070
CTGF-866-16-	14071	oooooooooooosssssso	Pm0fffff0ff0mm00m00m0	GGCGUUGUCAUUGGUAACC	157
14071
CTGF-563-16-	14072	oooooooooooosssssso	Pmffff0ff00m0mmm0m00	CGUGCACUGGUACUUGCAG	158
14072
CTGF-823-16-	14073	oooooooooooosssssso	Pmffff0000f000m0mmm0	GUCUUGGAACAGGCGCUCC	159
14073
CTGF-1233-16-	14074	oooooooooooosssssso	Pmf0f0fffff0m0m0mmm0	CCAUGUCUCCGUACAUCUU	160
14074
CTGF-924-16-	14075	oooooooooooosssssso	Pm0ff00ffffffm0000mm0	GGUCAGCUUCGCAAGGCCU	161
14075
CTGF-921-16-	14076	oooooooooooosssssso	Pm00ffff0f0000mmm000	CAGCUUCGCAAGGCCUGAC	162
14076
CTGF-443-16-	14077	oooooooooooosssssso	Pmff0000ffffm00000000	GCCGAAGUCACAGAAGAGG	163
14077
CTGF-1041-16-	14078	oooooooooooosssssso	Pm0f0000fffff0mmm00m0	CACAGAAUUUAGCUCGGUA	164
14078
CTGF-1042-16-	14079	oooooooooooosssssso	Pmffff0000ffm00mmm000	CCACAGAAUUUAGCUCGGU	165
14079
CTGF-755-16-	14080	oooooooooooosssssso	Pmff000f0f0mmmmmm00	GCCAAACGUGUCUUCCAGU	166
14080			0
CTGF-467-16-	14081	oooooooooooosssssso	Pmffff00ffff0m0mm00m0	GCCGAUCUUGCGGUUGGCC	167
14081
CTGF-995-16-	14082	oooooooooooosssssso	Pmff000fffff0m000mmm0	CUCAAACUUGAUAGGCUUG	168
14082
CTGF-927-16-	14083	oooooooooooosssssso	Pmf000ff00fmmm0m0000	CCAGGUCAGCUUCGCAAGG	169
14083
SPP1-1091-16-	14131	oooooooooooosssssso	Pmff00ff000m0m0000m0	UUUGACUAAAUGCAAAGUG	170
14131
PP113-16-14188	14188	ooooooooooooossssss	Pm0fffff0f00mm000mm0	UGUUUUUGUAGCCAAAUCC	171
PP113-17-14189	14189	ooooooooooooossssss	Pm0fffff0f00mm000mm0	UGUUUUUGUAGCCAAAUCC	172
PP113-18-14190	14190	ooooooooooooossssss	Pm0fffff0f00mm000mm0	UGUUUUUGUAGCCAAAUCC	173
pGL3-1172-16-	14386	oooooooooooosssssso	Pm00ff0f0ffm0mm00mm0	AAAUCGUAUUUGUCAAUCA	174
14386
pGL3-1172-16-	14387	oooooooooooosssssso	Pm00ff0f0ffm0mm00mm0	AAAUCGUAUUUGUCAAUCA	175
14387
miR-122--23-	14391
14391
	14084	oooooooooooosssssso	Pmff00fff0f000000m00	UCUAAUUCAUGAGAAAUAC	616
	14085	oooooooooooosssssso	Pm00ff00fffm000000m0	UAAUUGACCUCAGAAGAUG	617
	14086	oooooooooooosssssso	Pmff00ff00fmmm000000	UUUAAUUGACCUCAGAAGA	618
	14087	oooooooooooosssssso	Pm0ff00ffff000000m00	AAUUGACCUCAGAAGAUGC	619
	14088	oooooooooooosssssso	Pmf00ff00ffmm0000000	UUAAUUGACCUCAGAAGAU	620
	14089	oooooooooooosssssso	Pmff00ffff000000m0m0	AUUGACCUCAGAAGAUGCA	621
	14090	oooooooooooosssssso	Pmf0fff00ff00mmm0mm0	UCAUCCAGCUGACUCGUUU	622
	14091	oooooooooooosssssso	Pm0fff0ff0000m00m00	AGAUUCAUCAGAAUGGUGA	623
	14092	oooooooooooosssssso	Pm00ffff00fmm0m000m0	UGACCUCAGUCCAUAAACC	624
	14093	oooooooooooosssssso	Pm0100f0000mmm0mm00	AAUGGUGAGACUCAUCAGA	625
			0
	14094	oooooooooooosssssso	Pmff00ffff00mmm0m000	UUUGACCUCAGUCCAUAAA	626
	14095	oooooooooooosssssso	Pmff0f00ff0m0000mmm0	UUCAUGGCUGUGAAAUUCA	627
	14096	oooooooooooosssssso	Pm00f00f0000mmm0mm0	GAAUGGUGAGACUCAUCAG	628
			0
	14097	oooooooooooosssssso	Pm00ffffff0mmm0m0m00	UGGCUUUCCGCUUAUAUAA	629
	14098	oooooooooooosssssso	Pmf00ffffff0mmm0m0m0	UUGGCUUUCCGCUUAUAUA	630
	14099	oooooooooooosssssso	Pmf0fff0f0f00mm0m000	UCAUCCAUGUGGUCAUGGC	631
	14100	oooooooooooosssssso	Pmf0f00ff0f00mmmmm00	AUGUGGUCAUGGCUUUCGU	632
	14101	oooooooooooosssssso	Pmf00ff0f00mmmmm0m	GUGGUCAUGGCUUUCGUUG	633
			m0
	14102	oooooooooooosssssso	Pmff00fffffmmmm0m00	AUUGGCUUUCCGCUUAUAU	634
	14103	oooooooooooosssssso	Pm00f0f0000mmmm000m	AAAUACGAAAUUUCAGGUG	635
			0
	14104	oooooooooooosssssso	Pm000f0f0000mmmm000	AGAAAUACGAAAUUUCAGG	636
	14105	oooooooooooosssssso	Pm00ff0f00fmmmm0mm0	UGGUCAUGGCUUUCGUUGG	637
			0
	14106	oooooooooooosssssso	Pmf0ff0fff0m0m00mm00	AUAUCAUCCAUGUGGUCAU	638
	14107	oooooooooooosssssso	Pm0f0f0000fmmm000m0	AAUACGAAAUUUCAGGUGU	639
			0
	14108	oooooooooooosssssso	Pm0ff000000mm0mmm00	AAUCAGAAGGCGCGUUCAG	640
	14109	oooooooooooosssssso	Pmfff0f000000m0m0000	AUUCAUGAGAAAUACGAAA	641
	14110	oooooooooooosssssso	Pmf0fff0f0000000m000	CUAUUCAUGAGAGAAUAAC	642
	14111	oooooooooooosssssso	Pmfff0ff000mmm0mmm0	UUUCGUUGGACUUACUUGG	643
			0
	14112	oooooooooooosssssso	Pmf0fffff0fm0mm00mm0	UUGCUCUCAUCAUUGGCUU	644
	14113	oooooooooooosssssso	Pmff00fffffmmmmmmm0	UUCAACUCCUCGCUUUCCA	645
	14114	oooooooooooosssssso	Pm00ff0ff00mm0m0mm0	UGACUAUCAAUCACAUCGG	646
			0
	14115	oooooooooooosssssso	Pm0f0f0ff0mmm00mmm0	AGAUGCACUAUCUAAUUCA	647
	14116	oooooooooooosssssso	Pm0f000f0f0m0mmm00m	AAUAGAUACACAUUCAACC	648
			0
	14117	oooooooooooosssssso	Pmffffff0f0000m000m0	UUCUUCUAUAGAAUGAACA	649
	14118	oooooooooooosssssso	Pm0ff0ff000m00mm0m00	AAUUGCUGGACAACCGUGG	650
	14119	oooooooooooosssssso	Pmf0ffffff0m0m0m0000	UCGCUUUCCAUGUGUGAGG	651
	14120	oooooooooooosssssso	Pm00fff000fm0mmm0m0	UAAUCUGGACUGCUUGUGG	652
			0
	14121	oooooooooooosssssso	Pmf0f0fff00mm00m0000	ACACAUUCAACCAAUAAAC	653
	14122	oooooooooooosssssso	Pmfff0ffff0m00mm0mm0	ACUCGUUUCAUAACUGUCC	654
	14123	oooooooooooosssssso	Pmf00fff000mm0mmm0m	AUAAUCUGGACUGCUUGUG	655
			0
	14124	oooooooooooosssssso	Pmffff0fff0m0m00mmm0	UUUCCGCUUAUAUAAUCUG	656
	14125	oooooooooooosssssso	Pm0fff00ff00m0m00m00	UGUUUAACUGGUAUGGCAC	657
	14126	oooooooooooosssssso	Pm0f0000f000m0m000m0	UAUAGAAUGAACAUAGACA	658
	14127	oooooooooooosssssso	Pmffffff00fm0m0mmm0	UUUCCUUGGUCGGCGUUUG	659
	14128	oooooooooooosssssso	Pmf0f0f0ff0mmm00mmm	GUAUGCACCAUUCAACUCC	660
			0
	14129	oooooooooooosssssso	Pmf00ff0ff0m0m0m0mm0	UCGGCCAUCAUAUGUGUCU	661
	14130	oooooooooooosssssso	Pm0fff000ff0mmm0m000	AAUCUGGACUGCUUGUGGC	662
	14132	oooooooooooosssssso	Pmf0ff0000f0mmm0mm0	ACAUCGGAAUGCUCAUUGC	663
			0
	14133	oooooooooooosssssso	Pm00fffff00mm0mm00m0	AAGUUCCUGACUAUCAAUC	664
	14134	oooooooooooosssssso	Pmf00ff000f0m0000m00	UUGACUAAAUGCAAAGUGA	665
	14135	oooooooooooosssssso	Pm0fff0ff000mm00m00	AGACUCAUCAGACUGGUGA	666
	14136	oooooooooooosssssso	Pmf0f0f0f0fmm0mm0m00	UCAUAUGUGUCUACUGUGG	667
	14137	oooooooooooosssssso	Pmf0fffff0fmm0m00m00	AUGUCCUCGUCUGUAGCAU	668
	14138	oooooooooooosssssso	Pm00fff0f00mm00mmmm	GAAUUCACGGCUGACUUUG	669
			0
	14139	oooooooooooosssssso	Pmf0fffff000mmm000m0	UUAUUUCCAGACUCAAAUA	670
	14140	oooooooooooosssssso	Pm000ff0f000mm000mm	GAAGCCACAAACUAAACUA	671
			0
	14141	oooooooooooosssssso	Pmffff0ff000mmm0mmm	CUUUCGUUGGACUUACUUG	672
			0
	14142	oooooooooooosssssso	Pmfff0f0000mmmmmm00	GUCUGCGAAACUUCUUAGA	673
			0
	14143	oooooooooooosssssso	Pm0f0fff0ff0mmmmm0m	AAUGCUCAUUGCUCUCAUC	674
			0
	14144	oooooooooooosssssso	Pmf0f0ff0ffm00mmm0m0	AUGCACUAUCUAAUUCAUG	675
	14145	oooooooooooosssssso	Pmff0f0f0f0mm0mmm000	CUUGUAUGCACCAUUCAAC	676
	14146	oooooooooooosssssso	Pm00fff0fffm0m00mm00	UGACUCGUUUCAUAACUGU	677
	14147	oooooooooooosssssso	Pmff00f0fffm00mm0mm0	UUCAGCACUCUGGUCAUCC	678
	14148	oooooooooooosssssso	Pm00fff0f00mm0m00000	AAAUUCAUGGCUGUGGAAU	679
	14149	oooooooooooosssssso	Pmf0fff00ff00m000mm0	ACAUUCAACCAAUAAACUG	680
	14150	oooooooooooosssssso	Pm0f0f0fff00mm00m000	UACACAUUCAACCAAUAAA	681
	14151	oooooooooooosssssso	Pmff00ff0ffmmm000mm0	AUUAGUUAUUUCCAGACUC	682
	14152	oooooooooooosssssso	Pmffff0fff0m00000000	UUUCUAUUCAUGAGAGAAU	683
	14153	oooooooooooosssssso	Pmff00ff0ff00m000mm0	UUCGGUUGCUGGCAGGUCC	684
	14154	oooooooooooosssssso	Pm0f0f0f0000m00m0mm	CAUGUGUGAGGUGAUGUCC	685
			0
	14155	oooooooooooosssssso	Pmf0ff0fff00mmmmmm0	GCACCAUUCAACUCCUCGC	686
			0
	14156	oooooooooooosssssso	Pm0fff00ff00mmm0mmm	CAUCCAGCUGACUCGUUUC	687
			0
	14157	oooooooooooosssssso	Pmfffff0fff0m0m00mm0	CUUUCCGCUUAUAUAAUCU	688
	14158	oooooooooooosssssso	Pm0ff0f0ff0000m0mmm0	AAUCACAUCGGAAUGCUCA	689
	14159	oooooooooooosssssso	Pmf0f0ff00fm0mmmmm0	ACACAUUAGUUAUUUCCAG	690
			0
	14160	oooooooooooosssssso	Pmfff0f0000m000m0m00	UUCUAUAGAAUGAACAUAG	691
	14161	oooooooooooosssssso	Pm0f00f00f00mmm0m0m	UACAGUGAUAGUUUGCAUU	692
			0
	14162	oooooooooooosssssso	Pmf000f00ff00m0mm0m0	AUAAGCAAUUGACACCACC	693
	14163	oooooooooooosssssso	Pmff0ff00ff0mm000m00	UUUAUUAAUUGCUGGACAA	694
	14164	oooooooooooosssssso	Pmf0ff0000fmmmm0000	UCAUCAGAGUCGUUCGAGU	695
	14165	oooooooooooosssssso	Pmf000ff0f0mm0mm0mm	AUAAACCACACUAUCACCU	696
			0
	14166	oooooooooooosssssso	Pmf0ff0ff00mmmmmm0	UCAUCAUUGGCUUUCCGCU	697
			m0
	14167	oooooooooooosssssso	Pmfffff00fm0mm00mm0	AGUUCCUGACUAUCAAUCA	698
	14168	oooooooooooosssssso	Pmfffff00ff00mmmm0000	UUCACGGCUGACUUUGGAA	699
	14169	oooooooooooosssssso	Pmffff0f00f00m000mm0	UUCUCAUGGUAGUGAGUUU	700
	14170	oooooooooooosssssso	Pm0ff00fff0mmm00mm00	AAUCAGCCUGUUUAACUGG	701
	14171	oooooooooooosssssso	Pm0ffff00f0mmmm00mm	GGUUUCAGCACUCUGGUCA	702
			0
	14172	oooooooooooosssssso	Pmff0000f0fmm0mm0mm	AUCGGAAUGCUCAUUGCUC	703
			0
	14173	oooooooooooosssssso	Pm00ff0f0000mmm0m00	UGGCUGUGGAAUUCACGGC	704
			0
	14174	oooooooooooosssssso	Pm000f00ff00m0mm0mm	UAAGCAAUUGACACCACCA	705
			0
	14175	oooooooooooosssssso	Pm00fffff0f00m00m000	CAAUUCUCAUGGUAGUGAG	706
	14176	oooooooooooosssssso	Pm00fffff0fm000mmm00	UGGCUUUCGUUGGACUUAC	707
	14177	oooooooooooosssssso	Pm0ff00100fm00mmm0m	AAUCAGUGACCAGUUCAUC	708
			0
	14178	oooooooooooosssssso	Pmfff0f000mm0m0mm00	AGUCCAUAAACCACACUAU	709
	14179	oooooooooooosssssso	Pm00f0ffff00mm0mmm00	CAGCACUCUGGUCAUCCAG	710
	14180	oooooooooooosssssso	Pm0ff00ff0f0mm0000m0	UAUCAAUCACAUCGGAAUG	711
	14181	oooooooooooosssssso	Pmfff0f00ff00mmmm000	AUUCACGGCUGACUUUGGA	712
	14182	oooooooooooosssssso	Pmf000f0f0f0mmm00mm	AUAGAUACACAUUCAACCA	713
			0
	14183	oooooooooooosssssso	Pmffff000ffm000m0000	UUUCCAGACUCAAAUAGAU	714
	14184	oooooooooooosssssso	Pmf00ff0ff000m00mm00	UUAAUUGCUGGACAACCGU	715
	14185	oooooooooooosssssso	Pm0ff00ff0fm000m00m0	UAUUAAUUGCUGGACAACC	716
	14186	oooooooooooosssssso	Pmff0fff000mm00m000	AGUCGUUCGAGUCAAUGGA	717
	14187	oooooooooooosssssso	Pmff0ff00f000mmm0m00	GUUGCUGGCAGGUCCGUGG	718
Antisense backbone, chemistry, and sequence information.
o: phosphodiester;
s: phosphorothioate;
P: 5′ phosphorylation;
0: 2′-OH;
F: 2′-fluoro;
m: 2′ O-methyl;
+: LNA modification.
Capital letters in the sequence signify riobonucleotides, lower case letters signify deoxyribonucleotides.

TABLE 3
Sense backbone, chemistry, and sequence information.
		OHang				SEQ
	Oligo	Sense	Sense			ID
ID Number	Number	Chem.	Backbone	Sense Chemistry	Sense Sequence	NO:
APOB-10167-	12138	chl	ooooooooooooo	00000000000000000	GUCAUCACACUGAA	176
20-12138			ooooooso	000	UACCAAU
APOB-10167-	12139	chl	ooooooooooooo	00000000000000000	GUGAUCAGACUCAA	177
20-12139			ooooooso	000	UACGAAU
MAP4K4-2931-	12266	chl	oooooooooosso	mm0m00000mmm0	CUGUGGAAGUCUA	178
13-12266
MAP4K4-2931-	12293	chl	oooooooooosso	mm0m00000mmm0	CUGUGGAAGUCUA	179
16-12293
MAP4K4-2931-	12383	chl	ooooooooooooo	mm0m00000mmm0	CUGUGGAAGUCUA	180
16-12383
MAP4K4-2931-	12384	chl	ooooooooooooo	mm0m00000mmm0	CUGUGGAAGUCUA	181
16-12384
MAP4K4-2931-	12385	chl	ooooooooooooo	mm0m00000mmm0	CUGUGGAAGUCUA	182
16-12385
MAP4K4-2931-	12386	chl	oooooooooosso	0mm0m00000mmm0	CUGUGGAAGUCUA	183
16-12386
MAP4K4-2931-	12387	chl	ooooooooooooo	mm0m00000mmm0	CUGUGGAAGUCUA	184
16-12387
MAP4K4-2931-	12388	chl	ooooooooooooo	mm0m00000mmm0	CUGUGGAAGUCUA	185
15-12388
MAP4K4-2931-	12432	chl	ooooooooooooo	DY547mm0m00000mmm	CUGUGGAAGUCUA	186
13-12432				0
MAP4K4-2931-	12266.2	chl	oooooooooooss	mm0m00000mmm0	CUGUGGAAGUCUA	187
13-12266.2
APOB--21-	12434	chl	ooooooooooooo	00000000000000000	GUCAUCACACUGAA	188
12434			ooooooso	000	UACCAAU
APOB--21-	12435	chl	ooooooooooooo	DY547000000000000	GUGAUCAGACUCAA	189
12435			ooooooso	00000000	UACGAAU
MAP4K4-2931-	12451	chl	oooooooooooss	0mm0m00000mmm0	CUGUGGAAGUCUA	190
16-12451
MAP4K4-2931-	12452	chl	oooooooooooss	mm0m00000mmm0	CUGUGGAAGUCUA	191
16-12452
MAP4K4-2931-	12453	chl	oooooooooooss	mm0m00000mmm0	CUGUGGAAGUCUA	192
16-12453
MAP4K4-2931-	12454	chl	oooooooooooss	0mm0m00000mmm0	CUGUGGAAGUCUA	193
17-12454
MAP4K4-2931-	12455	chl	oooooooooooss	mm0m00000mmm0	CUGUGGAAGUCUA	194
17-12455
MAP4K4-2931-	12456	chl	oooooooooooss	mm0m00000mmm0	CUGUGGAAGUCUA	195
19-12456
--27-12480	12480	chl	ooooooooooooo	DY547mm0f000f0055	UCAUAGGUAACCUC	196
			oooooooooooss	f5f00mm00000m000	UGGUUGAAAGUGA
			o
--27-12481	12481	chl	ooooooooooooo	DY547mm05f05000f0	CGGCUACAGGUGCU	197
			oooooooooooss	5ff0m00000000m00	UAUGAAGAAAGUA
			o
APOB-10167-	12505	chl	ooooooooooooo	00000000000000000	GUCAUCACACUGAA	198
21-12505			ooooooos	0000	UACCAAU
APOB-10167-	12506	chl	ooooooooooooo	00000000000000000	GUGAUCAGACUCAA	199
21-12506			ooooooos	0000	UACGAAU
MAP4K4-2931-	12539	chl	oooooooooooss	DY547mm0m00000mmm	CUGUGGAAGUCUA	200
16-12539				0
APOB-10167-	12505.2	chl	ooooooooooooo	00000000000000000	GUCAUCACACUGAA	201
21-12505.2			ooooooso	000	UACCAAU
APOB-10167-	12506.2	chl	ooooooooooooo	00000000000000000	GUGAUCAGACUCAA	202
21-12506.2			ooooooso	000	UACGAAU
MAP4K4--13-	12565	Chl	ooooooooooooo	m0m0000m0mmm0	UGUAGGAUGUCUA	203
12565
MAP4K4-2931-	12386.2	chl	ooooooooooooo	0mm0m00000mmm0	CUGUGGAAGUCUA	204
16-12386.2
MAP4K4-2931-	12815	chl	ooooooooooooo	m0m0m0m0m0m0m0m0m	CUGUGGAAGUCUA	205
13-12815				0m0m0m0m0
APOB--13-	12957	Chl	oooooooooooss	0mmmmmmmmmmmmm	ACUGAAUACCAAU	206
12957		TEG
MAP4K4--16-	12983	chl	oooooooooooss	mm0m00000mmm0	CUGUGGAAGUCUA	207
12983
MAP4K4--16-	12984	Chl	ooooooooooooo	mm0m00000mmm0	CUGUGGAAGUCUA	208
12984			o
MAP4K4--16-	12985	chl	oooooooooosso	mmmmmmmmmmmmm	CUGUGGAAGUCUA	209
12985
MAP4K4--16-	12986	chl	oooooooooosso	mmmmmmmmmmmmm	CUGUGGAAGUCUA	210
12986
MAP4K4--16-	12987	chl	oooooooooosso	mm0m00000mmm0	CUGUGGAAGUCUA	211
12987
MAP4K4--16-	12988	chl	oooooooooosso	mm0m00000mmm0	CUGUGGAAGUCUA	212
12988
MAP4K4--16-	12989	chl	oooooooooosso	mm0m00000mmm0	CUGUGGAAGUCUA	213
12989
MAP4K4--16-	12990	chl	oooooooooosso	mm0m00000mmm0	CUGUGGAAGUCUA	214
12990
MAP4K4--16-	12991	chl	oooooooooosso	mm0m00000mmm0	CUGUGGAAGUCUA	215
12991
MAP4K4--16-	12992	chl	oooooooooosso	mm0m00000mmm0	CUGUGGAAGUCUA	216
12992
MAP4K4--16-	12993	chl	oooooooooosso	mm0m00000mmm0	CUGUGGAAGUCUA	217
12993
MAP4K4--16-	12994	chl	oooooooooosso	mm0m00000mmm0	CUGUGGAAGUCUA	218
12994
MAP4K4--16-	12995	chl	oooooooooosso	mm0m00000mmm0	CUGUGGAAGUCUA	219
12995
MAP4K4-2931-	13012	chl	ooooooooooooo	00000000000000000	AGAGUUCUGUGGAA	220
19-13012			oooooo	0000	GUCUA
MAP4K4-2931-	13016	chl	ooooooooooooo	DY547000000000000	AGAGUUCUGUGGAA	221
19-13016			oooooo	000000000	GUCUA
PPIB--13-	13021	Chl	ooooooooooooo	0mmm00mm0m000	AUUUGGCUACAAA	222
13021
pGL3-1172-	13038	chl	ooooooooooooo	00m000m0m00mmm	ACAAAUACGAUUU	223
13-13038
pGL3-1172-	13040	chl	ooooooooooooo	DY5470m000m0m00mm	ACAAAUACGAUUU	224
13-13040				m
--16-13047	13047	Chl	ooooooooooooo	mm0m00000mmm0	CUGUGGAAGUCUA	225
			o
SOD1-530-13-	13090	chl	ooooooooooooo	00m00000000m0	AAUGAAGAAAGUA	226
13090
SOD1-523-13-	13091	chl	ooooooooooooo	000m00000m000	AGGUGGAAAUGAA	227
13091
SOD1-535-13-	13092	chl	ooooooooooooo	000000m0m0000	AGAAAGUACAAAG	228
13092
SOD1-536-13-	13093	chl	ooooooooooooo	00000m0m00000	GAAAGUACAAAGA	229
13093
SOD1-396-13-	13094	chl	ooooooooooooo	0m0m00mm0mm00	AUGUGACUGCUGA	230
13094
SOD1-385-13-	13095	chl	ooooooooooooo	000mmm000m00m	AGACUUGGGCAAU	231
13095
SOD1-195-13-	13096	chl	ooooooooooooo	0mmmm000m0000	AUUUCGAGCAGAA	232
13096
APOB-4314-	13115	Chl	ooooooooooooo	0mmm0000000m0	AUCUGGAGAAACA	233
13-13115
APOB-3384-	13116	Chl	ooooooooooooo	mm0000m000000	UCAGAACAAGAAA	234
13-13116
APOB-3547-	13117	Chl	ooooooooooooo	00mmm0mmm0mm0	GACUCAUCUGCUA	235
13-13117
APOB-4318-	13118	Chl	ooooooooooooo	0000000m00m0m	GGAGAAACAACAU	236
13-13118
APOB-3741-	13119	Chl	ooooooooooooo	00mmmmmm000m0	AGUCCCUCAAACA	237
13-13119
PPIB--16-	13136	Chl	ooooooooooooo	00mm0m00000m0	GGCUACAAAAACA	238
13136			o
APOB-4314-	13154	chl	ooooooooooooo	000mmm0000000m0	AGAUCUGGAGAAAC	239
15-13154			o		A
APOB-3547-	13155	chl	ooooooooooooo	m000mmm0mmm0mm0	UGGACUCAUCUGCU	240
15-13155			o		A
APOB-4318-	13157	chl	ooooooooooooo	mm0000000m00m0m	CUGGAGAAACAACA	241
15-13157			o		U
APOB-3741-	13158	chl	ooooooooooooo	0000mmmmmm0000m0	AGAGUCCCUCAAAC	242
15-13158			o		A
APOB--13-	13159	chl	000000000000	0mm000m0mm00m	ACUGAAUACCAAU	243
13159
APOB--15-	13160	chl	ooooooooooooo	0m0mm000m0mm00m	ACACUGAAUACCAA	244
13160			o		U
SOD1-530-16-	13163	chl	ooooooooooooo	00m00000000m0	AAUGAAGAAAGUA	245
13163
SOD1-523-16-	13164	chl	ooooooooooooo	000m00000m000	AGGUGGAAAUGAA	246
13164
SOD1-535-16-	13165	chl	ooooooooooooo	000000m0m0000	AGAAAGUACAAAG	247
13165
SOD1-536-16-	13166	chl	ooooooooooooo	00000m0m00000	GAAAGUACAAAGA	248
13166
SOD1-396-16-	13167	chl	ooooooooooooo	0m0m00mm0mm00	AUGUGACUGCUGA	249
13167
SOD1-385-16-	13168	chl	ooooooooooooo	000mmm000m00m	AGACUUGGGCAAU	250
13168
SOD1-195-16-	13169	chl	ooooooooooooo	0mmmm000m0000	AUUUCGAGCAGAA	251
13169
pGL3-1172-	13170	chl	ooooooooooooo	0m000m0m00mmm	ACAAAUACGAUUU	252
16-13170
pGL3-1172-	13171	chl	ooooooooooooo	DY5470m000m0m00mm	ACAAAUACGAUUU	253
16-13171				m
MAP4k4-2931-	13189	chl	ooooooooooooo	00000000000000000	AGAGUUCUGUGGAA	254
19-13189			oooooo	0000	GUCUA
CTGF-1222-	13190	Chl	ooooooooooooo	0m0000000m0m0	ACAGGAAGAUGUA	255
13-13190
CTGF-813-13-	13192	Chl	ooooooooooooo	000m0000m0mmm	GAGUGGAGCGCCU	256
13192
CTGF-747-13-	13194	Chl	ooooooooooooo	m00mm000000m0	CGACUGGAAGACA	257
13194
CTGF-817-13-	13196	Chl	ooooooooooooo	0000m0mmm0mmm	GGAGCGCCUGUUC	258
13196
CTGF-1174-	13198	Chl	ooooooooooooo	0mm0mm0m00mm0	GCCAUUACAACUG	259
13-13198
CTGF-1005-	13200	Chl	ooooooooooooo	000mmmmmm00mm	GAGCUUUCUGGCU	260
13-13200
CTGF-814-13-	13202	Chl	ooooooooooooo	00m0000m0mmm0	AGUGGAGCGCCUG	261
13202
CTGF-816-13-	13204	Chl	ooooooooooooo	m0000m0mmm0mm	UGGAGCGCCUGUU	262
13204
CTGF-1001-	13206	Chl	ooooooooooooo	0mmm000mmmmmm	GUUUGAGCUUUCU	263
13-13206
CTGF-1173-	13208	Chl	ooooooooooooo	m0mm0mm0m00mm	UGCCAUUACAACU	264
13-13208
CTGF-749-13-	13210	Chl	ooooooooooooo	0mm000000m0m0	ACUGGAAGACACG	265
13210
CTGF-792-13-	13212	Chl	ooooooooooooo	00mm0mmm00mmm	AACUGCCUGGUCC	266
13212
CTGF-1162-	13214	Chl	ooooooooooooo	000mmm0m0mmm0	AGACCUGUGCCUG	267
13-13214
CTGF-811-13-	13216	Chl	ooooooooooooo	m0000m0000m0m	CAGAGUGGAGCGC	268
13216
CTGF-797-13-	13218	Chl	ooooooooooooo	mmm00mmm000mm	CCUGGUCCAGACC	269
13218
CTGF-1175-	13220	Chl	ooooooooooooo	mm0mm0m00mm0m	CCAUUACAACUGU	270
13-13220
CTGF-1172-	13222	Chl	ooooooooooooo	mm0mm0mm0m0m	CUGCCAUUACAAC	271
13-13222
CTGF-1177-	13224	Chl	ooooooooooooo	0mm0m00mm0mmm	AUUACAACUGUCC	272
13-13224
CTGF-1176-	13226	Chl	ooooooooooooo	m0mm0m00mm0mm	CAUUACAACUGUC	273
13-13226
CTGF-812-13-	13228	Chl	ooooooooooooo	0000m0000m0mm	AGAGUGGAGCGCC	274
13228
CTGF-745-13-	13230	Chl	ooooooooooooo	0mm00mm000000	ACCGACUGGAAGA	275
13230
CTGF-1230-	13232	Chl	ooooooooooooo	0m0m0m00000m0	AUGUACGGAGACA	276
13-13232
CTGF-920-13-	13234	Chl	ooooooooooooo	0mmmm0m0000mm	GCCUUGCGAAGCU	277
13234
CTGF-679-13-	13236	Chl	ooooooooooooo	0mm0m000000m0	GCUGCGAGGAGUG	278
13236
CTGF-992-13-	13238	Chl	ooooooooooooo	0mmm0mm000mmm	GCCUAUCAAGUUU	279
13238
CTGF-1045-	13240	Chl	ooooooooooooo	00mmmm0m0000m	AAUUCUGUGGAGU	280
13-13240
CTGF-1231-	13242	Chl	ooooooooooooo	m0m0m00000m0m	UGUACGGAGACAU	281
13-13242
CTGF-991-13-	13244	Chl	ooooooooooooo	00mmm0mm000mm	AGCCUAUCAAGUU	282
13244
CTGF-998-13-	13246	Chl	ooooooooooooo	m000mmm000mmm	CAAGUUUGAGCUU	283
13246
CTGF-1049-	13248	Chl	ooooooooooooo	mm0m0000m0m0m	CUGUGGAGUAUGU	284
13-13248
CTGF-1044-	13250	Chl	ooooooooooooo	000mmmm0m0000	AAAUUCUGUGGAG	285
13-13250
CTGF-1327-	13252	Chl	ooooooooooooo	mmmm00m00m0m0	UUUCAGUAGCACA	286
13-13252
CTGF-1196-	13254	Chl	ooooooooooooo	m00m00m0mmmmm	CAAUGACAUCUUU	287
13-13254
CTGF-562-13-	13256	Chl	ooooooooooooo	00m0mm00m0m0m	AGUACCAGUGCAC	288
13256
CTGF-752-13-	13258	Chl	ooooooooooooo	000000m0m0mmm	GGAAGACACGUUU	289
13258
CTGF-994-13-	13260	Chl	ooooooooooooo	mm0mm000mmm00	CUAUCAAGUUUGA	290
13260
CTGF-1040-	13262	Chl	ooooooooooooo	00mm000mmmm0m	AGCUAAAUUCUGU	291
13-13262
CTGF-1984-	13264	Chl	ooooooooooooo	000m0000m0m00	AGGUAGAAUGUAA	292
13-13264
CTGF-2195-	13266	Chl	ooooooooooooo	00mm00mm00mmm	AGCUGAUCAGUUU	293
13-13266
CTGF-2043-	13268	Chl	ooooooooooooo	mmmm0mmm000m0	UUCUGCUCAGAUA	294
13-13268
CTGF-1892-	13270	Chl	ooooooooooooo	mm0mmm000mm00	UUAUCUAAGUUAA	295
13-13270
CTGF-1567-	13272	Chl	ooooooooooooo	m0m0m000m00m0	UAUACGAGUAAUA	296
13-13272
CTGF-1780-	13274	Chl	ooooooooooooo	00mm000m00mmm	GACUGGACAGCUU	297
13-13274
CTGF-2162-	13276	Chl	ooooooooooooo	0m00mmmmm0mm0	AUGGCCUUUAUUA	298
13-13276
CTGF-1034-	13278	Chl	ooooooooooooo	0m0mm000mm000	AUACCGAGCUAAA	299
13-13278
CTGF-2264-	13280	Chl	ooooooooooooo	mm0mm00000m0m	UUGUUGAGAGUGU	300
13-13280
CTGF-1032-	13282	Chl	ooooooooooooo	0m0m0mm000mm0	ACAUACCGAGCUA	301
13-13282
CTGF-1535-	13284	Chl	ooooooooooooo	00m0000000mm0	AGCAGAAAGGUUA	302
13-13284
CTGF-1694-	13286	Chl	ooooooooooooo	00mm0mmmmmm00	AGUUGUUCCUUAA	303
13-13286
CTGF-1588-	13288	Chl	ooooooooooooo	0mmm0000m0m00	AUUUGAAGUGUAA	304
13-13288
CTGF-928-13-	13290	Chl	ooooooooooooo	000mm00mmm000	AAGCUGACCUGGA	305
13290
CTGF-1133-	13292	Chl	ooooooooooooo	00mm0m0000000	GGUCAUGAAGAAG	306
13-13292
CTGF-912-13-	13294	Chl	ooooooooooooo	0m00mm000mmmm	AUGGUCAGGCCUU	307
13294
CTGF-753-13-	13296	Chl	ooooooooooooo	00000m0m0mmm0	GAAGACACGUUUG	308
13296
CTGF-918-13-	13298	Chl	ooooooooooooo	000mmmm0m0000	AGGCCUUGCGAAG	309
13298
CTGF-744-13-	13300	Chl	ooooooooooooo	m0mm0mm00000	UACCGACUGGAAG	310
13300
CTGF-466-13-	13302	Chl	ooooooooooooo	0mm0m0000mm0	ACCGCAAGAUCGG	311
13302
CTGF-917-13-	13304	Chl	ooooooooooooo	m000mmmm0m000	CAGGCCUUGCGAA	312
13304
CTGF-1038-	13306	Chl	ooooooooooooo	m000mm000mmmm	CGAGCUAAAUUCU	313
13-13306
CTGF-1048-	13308	Chl	ooooooooooooo	mmm0m0000m0m0	UCUGUGGAGUAUG	314
13-13308
CTGF-1235-	13310	Chl	ooooooooooooo	m00000m0m00m0	CGGAGACAUGGCA	315
13-13310
CTGF-868-13-	13312	Chl	ooooooooooooo	0m00m00m0mmmm	AUGACAACGCCUC	316
13312
CTGF-1131-	13314	Chl	ooooooooooooo	0000mm0m00000	GAGGUCAUGAAGA	317
13-13314
CTGF-1043-	13316	Chl	ooooooooooooo	m000mmmm0m000	UAAAUUCUGUGGA	318
13-13316
CTGF-751-13-	13318	Chl	ooooooooooooo	m000000m0m0mm	UGGAAGACACGUU	319
13318
CTGF-1227-	13320	Chl	ooooooooooooo	0000m0m0m0000	AAGAUGUACGGAG	320
13-13320
CTGF-867-13-	13322	Chl	ooooooooooooo	00m00m00m0mmm	AAUGACAACGCCU	321
13322
CTGF-1128-	13324	Chl	ooooooooooooo	00m0000mm0m00	GGCGAGGUCAUGA	322
13-13324
CTGF-756-13-	13326	Chl	ooooooooooooo	00m0m0mmm00mm	GACACGUUUGGCC	323
13326
CTGF-1234-	13328	Chl	ooooooooooooo	0m00000m0m00m	ACGGAGACAUGGC	324
13-13328
CTGF-916-13-	13330	Chl	ooooooooooooo	mm000mmmm0m00	UCAGGCCUUGCGA	325
13330
CTGF-925-13-	13332	Chl	ooooooooooooo	0m0000mm00mmm	GCGAAGCUGACCU	326
13332
CTGF-1225-	13334	Chl	ooooooooooooo	000000m0m0m00	GGAAGAUGUACGG	327
13-13334
CTGF-445-13-	13336	Chl	ooooooooooooo	0m00mmmm00mmm	GUGACUUCGGCUC	328
13336
CTGF-446-13-	13338	Chl	ooooooooooooo	m00mmmm00mmmm	UGACUUCGGCUCC	329
13338
CTGF-913-13-	13340	Chl	ooooooooooooo	m00mm000mmmm0	UGGUCAGGCCUUG	330
13340
CTGF-997-13-	13342	Chl	ooooooooooooo	mm000mmm000mm	UCAAGUUUGAGCU	331
13342
CTGF-277-13-	13344	Chl	ooooooooooooo	0mm0000mm0m00	GCCAGAACUGCAG	332
13344
CTGF-1052-	13346	Chl	ooooooooooooo	m0000m0m0m0mm	UGGAGUAUGUACC	333
13-13346
CTGF-887-13-	13348	Chl	ooooooooooooo	0mm0000000m00	GCUAGAGAAGCAG	334
13348
CTGF-914-13-	13350	Chl	ooooooooooooo	00mm000mmmm0m	GGUCAGGCCUUGC	335
13350
CTGF-1039-	13352	Chl	ooooooooooooo	000mm000mmmm0	GAGCUAAAUUCUG	336
13-13352
CTGF-754-13-	13354	Chl	ooooooooooooo	0000m0m0mmm00	AAGACACGUUUGG	337
13354
CTGF-1130-	13356	Chl	ooooooooooooo	m0000mm0m0000	CGAGGUCAUGAAG	338
13-13356
CTGF-919-13-	13358	Chl	ooooooooooooo	00mmmm0m0000m	GGCCUUGCGAAGC	339
13358
CTGF-922-13-	13360	Chl	ooooooooooooo	mmm0m0000mm00	CUUGCGAAGCUGA	340
13360
CTGF-746-13-	13362	Chl	ooooooooooooo	mm00mm000000m	CCGACUGGAAGAC	341
13362
CTGF-993-13-	13364	Chl	ooooooooooooo	mmm0mm000mmm0	CCUAUCAAGUUUG	342
13364
CTGF-825-13-	13366	Chl	ooooooooooooo	m0mmmm0000mmm	UGUUCCAAGACCU	343
13366
CTGF-926-13-	13368	Chl	ooooooooooooo	m0000mm00mmm0	CGAAGCUGACCUG	344
13368
CTGF-923-13-	13370	Chl	ooooooooooooo	mm0m0000mm00m	UUGCGAAGCUGAC	345
13370
CTGF-866-13-	13372	Chl	ooooooooooooo	m00m00m00m0mm	CAAUGACAACGCC	346
13372
CTGF-563-13-	13374	Chl	ooooooooooooo	0m0mm00m0m0m0	GUACCAGUGCACG	347
13374
CTGF-823-13-	13376	Chl	ooooooooooooo	mmm0mmmm0000m	CCUGUUCCAAGAC	348
13376
CTGF-1233-	13378	Chl	ooooooooooooo	m0m00000m0m00	UACGGAGACAUGG	349
13-13378
CTGF-924-13-	13380	Chl	ooooooooooooo	m0m0000mm00mm	UGCGAAGCUGACC	350
13380
CTGF-921-13-	13382	Chl	ooooooooooooo	mmmm0m0000mm0	CCUUGCGAAGCUG	351
13382
CTGF-443-13-	13384	Chl	ooooooooooooo	mm0m00mmmm00m	CUGUGACUUCGGC	352
13384
CTGF-1041-	13386	Chl	ooooooooooooo	0mm000mmmm0m0	GCUAAAUUCUGUG	353
13-13386
CTGF-1042-	13388	Chl	ooooooooooooo	mm000mmmm0m00	CUAAAUUCUGUGG	354
13-13388
CTGF-755-13-	13390	Chl	ooooooooooooo	000m0m0mmm00m	AGACACGUUUGGC	355
13390
CTGF-467-13-	13392	Chl	ooooooooooooo	mm0m0000mm00m	CCGCAAGAUCGGC	356
13392
CTGF-995-13-	13394	Chl	ooooooooooooo	m0mm000mmm000	UAUCAAGUUUGAG	357
13394
CTGF-927-13-	13396	Chl	ooooooooooooo	0000mm00mmm00	GAAGCUGACCUGG	358
13396
SPP1-1025-	13398	Chl	ooooooooooooo	mmm0m000mm000	CUCAUGAAUUAGA	359
13-13398
SPP1-1049-	13400	Chl	ooooooooooooo	mm0000mm00mm0	CUGAGGUCAAUUA	360
13-13400
SPP1-1051-	13402	Chl	ooooooooooooo	0000mm00mm000	GAGGUCAAUUAAA	361
13-13402
SPP1-1048-	13404	Chl	ooooooooooooo	mmm0000mm00mm	UCUGAGGUCAAUU	362
13-13404
SPP1-1050-	13406	Chl	ooooooooooooo	m0000mm00mm00	UGAGGUCAAUUAA	363
13-13406
SPP1-1047-	13408	Chl	ooooooooooooo	mmmm0000mm00m	UUCUGAGGUCAAU	364
13-13408
SPP1-800-13-	13410	Chl	ooooooooooooo	0mm00mm000m00	GUCAGCUGGAUGA	365
13410
SPP1-492-13-	13412	Chl	ooooooooooooo	mmmm00m000mmm	UUCUGAUGAAUCU	366
13412
SPP1-612-13-	13414	Chl	ooooooooooooo	m000mm0000mm0	UGGACUGAGGUCA	367
13414
SPP1-481-13-	13416	Chl	ooooooooooooo	000mmmm0mm0mm	GAGUCUCACCAUU	368
13416
SPP1-614-13-	13418	Chl	ooooooooooooo	00mm0000mm000	GACUGAGGUCAAA	369
13418
SPP1-951-13-	13420	Chl	ooooooooooooo	mm0m00mm0m000	UCACAGCCAUGAA	370
13420
SPP1-482-13-	13422	Chl	ooooooooooooo	00mmmm0mm0mmm	AGUCUCACCAUUC	371
13422
SPP1-856-13-	13424	Chl	ooooooooooooo	000m000000mm0	AAGCGGAAAGCCA	372
13424
SPP1-857-13-	13426	Chl	ooooooooooooo	00m000000mm00	AGCGGAAAGCCAA	373
13426
SPP1-365-13-	13428	Chl	ooooooooooooo	0mm0m0m000m00	ACCACAUGGAUGA	374
13428
SPP1-359-13-	13430	Chl	ooooooooooooo	0mm0m00mm0m0m	GCCAUGACCACAU	375
13430
SPP1-357-13-	13432	Chl	ooooooooooooo	000mm0m00mm0m	AAGCCAUGACCAC	376
13432
SPP1-858-13-	13434	Chl	ooooooooooooo	0m000000mm00m	GCGGAAAGCCAAU	377
13434
SPP1-1012-	13436	Chl	ooooooooooooo	000mmmm0m0mmm	AAAUUUCGUAUUU	378
13-13436
SPP1-1014-	13438	Chl	ooooooooooooo	0mmmm0m0mmmmm	AUUUCGUAUUUCU	379
13-13438
SPP1-356-13-	13440	Chl	ooooooooooooo	0000mm0m00mm0	AAAGCCAUGACCA	380
13440
SPP1-368-13-	13442	Chl	ooooooooooooo	0m0m000m00m0m	ACAUGGAUGAUAU	381
13442
SPP1-1011-	13444	Chl	ooooooooooooo	0000mmmm0m0mm	GAAAUUUCGUAUU	382
13-13444
SPP1-754-13-	13446	Chl	ooooooooooooo	0m0mmmmmm00mm	GCGCCUUCUGAUU	383
13446
SPP1-1021-	13448	Chl	ooooooooooooo	0mmmmmm0m000m	AUUUCUCAUGAAU	384
13-13448
SPP1-1330-	13450	Chl	ooooooooooooo	mmmmm0m000m00	CUCUCAUGAAUAG	385
13-13450
SPP1-346-13-	13452	Chl	ooooooooooooo	000mmm00m0000	AAGUCCAACGAAA	386
13452
SPP1-869-13-	13454	Chl	ooooooooooooo	0m00m00000m00	AUGAUGAGAGCAA	387
13454
SPP1-701-13-	13456	Chl	ooooooooooooo	0m000000mm000	GCGAGGAGUUGAA	388
13456
SPP1-896-13-	13458	Chl	ooooooooooooo	m00mm00m00mm0	UGAUUGAUAGUCA	389
13458
SPP1-1035-	13460	Chl	ooooooooooooo	000m00m0m0mmm	AGAUAGUGCAUCU	390
13-13460
SPP1-1170-	13462	Chl	ooooooooooooo	0m0m0m0mmm0mm	AUGUGUAUCUAUU	391
13-13462
SPP1-1282-	13464	Chl	ooooooooooooo	mmmm0m0000000	UUCUAUAGAAGAA	392
13-13464
SPP1-1537-	13466	Chl	ooooooooooooo	mm0mmm00m00mm	UUGUCCAGCAAUU	393
13-13466
SPP1-692-13-	13468	Chl	ooooooooooooo	0m0m000000m00	ACAUGGAAAGCGA	394
13468
SPP1-840-13-	13470	Chl	ooooooooooooo	0m00mmm000mm0	GCAGUCCAGAUUA	395
13470
SPP1-1163-	13472	Chl	ooooooooooooo	m00mm000m0m0m	UGGUUGAAUGUGU	396
13-13472
SPP1-789-13-	13474	Chl	ooooooooooooo	mm0m0000m000m	UUAUGAAACGAGU	397
13474
SPP1-841-13-	13476	Chl	ooooooooooooo	m00mmm000mm0m	CAGUCCAGAUUAU	398
13476
SPP1-852-13-	13478	Chl	ooooooooooooo	0m0m000m00000	AUAUAAGCGGAAA	399
13478
SPP1-209-13-	13480	Chl	ooooooooooooo	m0mm00mm000m0	UACCAGUUAAACA	400
13480
SPP1-1276-	13482	Chl	ooooooooooooo	m0mmm0mmmm0m0	UGUUCAUUCUAUA	401
13-13482
SPP1-137-13-	13484	Chl	ooooooooooooo	mm00mm0000000	CCGACCAAGGAAA	402
13484
SPP1-711-13-	13486	Chl	ooooooooooooo	000m00m0m0m0m	GAAUGGUGCAUAC	403
13486
SPP1-582-13-	13488	Chl	ooooooooooooo	0m0m00m00mm00	AUAUGAUGGCCGA	404
13488
SPP1-839-13-	13490	Chl	ooooooooooooo	00m00mmm000mm	AGCAGUCCAGAUU	405
13490
SPP1-1091-	13492	Chl	ooooooooooooo	0m0mmm00mm000	GCAUUUAGUCAAA	406
13-13492
SPP1-884-13-	13494	Chl	ooooooooooooo	00m0mmmm00m0m	AGCAUUCCGAUGU	407
13494
SPP1-903-13-	13496	Chl	ooooooooooooo	m00mm00000mmm	UAGUCAGGAACUU	408
13496
SPP1-1090-	13498	Chl	ooooooooooooo	m0m0mmm00mm00	UGCAUUUAGUCAA	409
13-13498
SPP1-474-13-	13500	Chl	ooooooooooooo	0mmm00m000mmm	GUCUGAUGAGUCU	410
13500
SPP1-575-13-	13502	Chl	ooooooooooooo	m000m0m0m0m00	UAGACACAUAUGA	411
13502
SPP1-671-13-	13504	Chl	ooooooooooooo	m000m00000m0m	CAGACGAGGACAU	412
13504
SPP1-924-13-	13506	Chl	ooooooooooooo	m00mm0m000mmm	CAGCCGUGAAUUC	413
13506
SPP1-1185-	13508	Chl	ooooooooooooo	00mmm00000m00	AGUCUGGAAAUAA	414
13-13508
SPP1-1221-	13510	Chl	ooooooooooooo	00mmm0m00mmmm	AGUUUGUGGCUUC	415
13-13510
SPP1-347-13-	13512	Chl	ooooooooooooo	00mmm00m00000	AGUCCAACGAAAG	416
13512
SPP1-634-13-	13514	Chl	ooooooooooooo	000mmmm0m000m	AAGUUUCGCAGAC	417
13514
SPP1-877-13-	13516	Chl	ooooooooooooo	00m00m000m0mm	AGCAAUGAGCAUU	418
13516
SPP1-1033-	13518	Chl	ooooooooooooo	mm000m00m0m0m	UUAGAUAGUGCAU	419
13-13518
SPP1-714-13-	13520	Chl	ooooooooooooo	m00m0m0m0m000	UGGUGCAUACAAG	420
13520
SPP1-791-13-	13522	Chl	ooooooooooooo	0m0000m000mm0	AUGAAACGAGUCA	421
13522
SPP1-813-13-	13524	Chl	ooooooooooooo	mm0000m0mm000	CCAGAGUGCUGAA	422
13524
SPP1-939-13-	13526	Chl	ooooooooooooo	m00mm0m000mmm	CAGCCAUGAAUUU	423
13526
SPP1-1161-	13528	Chl	ooooooooooooo	0mm00mm000m0m	AUUGGUUGAAUGU	424
13-13528
SPP1-1164-	13530	Chl	ooooooooooooo	00mm000m0m0m0	GGUUGAAUGUGUA	425
13-13530
SPP1-1190-	13532	Chl	ooooooooooooo	00000m00mm00m	GGAAAUAACUAAU	426
13-13532
SPP1-1333-	13534	Chl	ooooooooooooo	mm0m000m00000	UCAUGAAUAGAAA	427
13-13534
SPP1-537-13-	13536	Chl	ooooooooooooo	0mm00m00mm000	GCCAGCAACCGAA	428
13536
SPP1-684-13-	13538	Chl	ooooooooooooo	m0mmmm0m0m0m0	CACCUCACACAUG	429
13538
SPP1-707-13-	13540	Chl	ooooooooooooo	00mm000m00m0m	AGUUGAAUGGUGC	430
13540
SPP1-799-13-	13542	Chl	ooooooooooooo	00mm00mm000m0	AGUCAGCUGGAUG	431
13542
SPP1-853-13-	13544	Chl	ooooooooooooo	m0m000m000000	UAUAAGCGGAAAG	432
13544
SPP1-888-13-	13546	Chl	ooooooooooooo	mmmm00m0m00mm	UUCCGAUGUGAUU	433
13546
SPP1-1194-	13548	Chl	ooooooooooooo	0m00mm00m0m0m	AUAACUAAUGUGU	434
13-13548
SPP1-1279-	13550	Chl	ooooooooooooo	mm0mmmm0m0000	UCAUUCUAUAGAA	435
13-13550
SPP1-1300-	13552	Chl	ooooooooooooo	00mm0mm0mm0m0	AACUAUCACUGUA	436
13-13552
SPP1-1510-	13554	Chl	ooooooooooooo	0mm00mm0mmm0m	GUCAAUUGCUUAU	437
13-13554
SPP1-1543-	13556	Chl	ooooooooooooo	00m00mm00m000	AGCAAUUAAUAAA	438
13-13556
SPP1-434-13-	13558	Chl	ooooooooooooo	0m00mmmm00m00	ACGACUCUGAUGA	439
13558
SPP1-600-13-	13560	Chl	ooooooooooooo	m00m0m00mmm0m	UAGUGUGGUUUAU	440
13560
SPP1-863-13-	13562	Chl	ooooooooooooo	000mm00m00m00	AAGCCAAUGAUGA	441
13562
SPP1-902-13-	13564	Chl	ooooooooooooo	0m00mm00000mm	AUAGUCAGGAACU	442
13564
SPP1-921-13-	13566	Chl	ooooooooooooo	00mm00mm0m000	AGUCAGCCGUGAA	443
13566
SPP1-154-13-	13568	Chl	ooooooooooooo	0mm0mm0m00000	ACUACCAUGAGAA	444
13568
SPP1-217-13-	13570	Chl	ooooooooooooo	000m000mm00mm	AAACAGGCUGAUU	445
13570
SPP1-816-13-	13572	Chl	ooooooooooooo	000m0mm0000mm	GAGUGCUGAAACC	446
13572
SPP1-882-13-	13574	Chl	ooooooooooooo	m000m0mmmm00m	UGAGCAUUCCGAU	447
13574
SPP1-932-13-	13576	Chl	ooooooooooooo	00mmmm0m00mm0	AAUUCCACAGCCA	448
13576
SPP1-1509-	13578	Chl	ooooooooooooo	m0mm00mm0mmm0	UGUCAAUUGCUUA	449
13-13578
SPP1-157-13-	13580	Chl	ooooooooooooo	0mm0m00000mm0	ACCAUGAGAAUUG	450
13580
SPP1-350-13-	13582	Chl	ooooooooooooo	mm00m00000mm0	CCAACGAAAGCCA	451
13582
SPP1-511-13-	13584	Chl	ooooooooooooo	mm00mm0mm00mm	CUGGUCACUGAUU	452
13584
SPP1-605-13-	13586	Chl	ooooooooooooo	m00mmm0m000mm	UGGUUUAUGGACU	453
13586
SPP1-811-13-	13588	Chl	ooooooooooooo	00mm0000m0mm0	GACCAGAGUGCUG	454
13588
SPP1-892-13-	13590	Chl	ooooooooooooo	00m0m00mm00m0	GAUGUGAUUGAUA	455
13590
SPP1-922-13-	13592	Chl	ooooooooooooo	0mm00mm0m000m	GUCAGCCGUGAAU	456
13592
SPP1-1169-	13594	Chl	ooooooooooooo	00m0m0m0mmm0m	AAUGUGUAUCUAU	457
13-13594
SPP1-1182-	13596	Chl	ooooooooooooo	mm000mmm00000	UUGAGUCUGGAAA	458
13-13596
SPP1-1539-	13598	Chl	ooooooooooooo	0mmm00m00mm00	GUCCAGCAAUUAA	459
13-13598
SPP1-1541-	13600	Chl	ooooooooooooo	mm00m00mm00m0	CCAGCAAUUAAUA	460
13-13600
SPP1-427-13-	13602	Chl	ooooooooooooo	00mmm000m00mm	GACUCGAACGACU	461
13602
SPP1-533-13-	13604	Chl	ooooooooooooo	0mmm0mm00m00m	ACCUGCCAGCAAC	462
13604
APOB--13-	13763	Chl	ooooooooooooo	0m+00+m0+m0+m	ACtGAaUAcCAaU	463
13763		TEG
APOB--13-	13764	Chl	ooooooooooooo	0mm000m0mm00m	ACUGAAUACCAAU	464
13764		TEG
MAP4K4--16-	13766	Chl	ooooooooooooo	DY547mm0m00000mmm	CUGUGGAAGUCUA	465
13766				0
PPIB--13-	13767	Chl	ooooooooooooo	mmmmmmmmmmmmm	GGCUACAAAAACA	466
13767
PPIB--15-	13768	Chl	ooooooooooooo	mm00mm0m00000m0	UUGGCUACAAAAAC	467
13768			oo		A
PPIB--17-	13769	Chl	ooooooooooooo	0mmm00mm0m00000m0	AUUUGGCUACAAAA	468
13769			oooo		ACA
MAP4K4--16-	13939	Chl	ooooooooooooo	m0m0000m0mmm0	UGUAGGAUGUCUA	469
13939
APOB-4314-	13940	Chl	ooooooooooooo	0mmm0000000m0	AUCUGGAGAAACA	470
16-13940
APOB-4314-	13941	Chl	ooooooooooooo	000mmm0000000m0	AGAUCUGGAGAAAC	471
17-13941			oo		A
APOB--16-	13942	Chl	ooooooooooooo	00mmm0mmm0mm0	GACUCAUCUGCUA	472
13942
APOB--18-	13943	Chl	ooooooooooooo	00mmm0mmm0mm0	GACUCAUCUGCUA	473
13943
APOB--17-	13944	Chl	ooooooooooooo	m000mmm0mmm0mm0	UGGACUCAUCUGCU	474
13944			oo		A
APOB--19-	13945	Chl	ooooooooooooo	m000mmm0mmm0mm0	UGGACUCAUCUGCU	475
13945			oo		A
APOB-4314-	13946	Chl	ooooooooooooo	0000000m00m0m	GGAGAAACAACAU	476
16-13946
APOB-4314-	13947	Chl	ooooooooooooo	mm0000000m00m0m	CUGGAGAAACAACA	477
17-13947			oo		U
APOB--16-	13948	Chl	ooooooooooooo	00mmmmmm000m0	AGUCCCUCAAACA	478
13948
APOB--17-	13949	Chl	ooooooooooooo	0000mmmmmm000m0	AGAGUCCCUCAAAC	479
13949			oo		A
APOB--16-	13950	Chl	ooooooooooooo	0mm000m0mm00m	ACUGAAUACCAAU	480
13950
APOB--18-	13951	Chl	ooooooooooooo	0mm000m0mm00m	ACUGAAUACCAAU	481
13951
APOB--17-	13952	Chl	ooooooooooooo	0m0mm000m0mm00m	ACACUGAAUACCAA	482
13952			oo		U
APOB--19-	13953	Chl	ooooooooooooo	0m0mm000m0mm00m	ACACUGAAUACCAA	483
13953			oo		U
MAP4K4--16-	13766.2	Chl	ooooooooooooo	DY547mm0m00000mmm	CUGUGGAAGUCUA	484
13766.2				0
CTGF-1222-	13980	Chl	ooooooooooooo	0m0000000m0m0	ACAGGAAGAUGUA	485
16-13980
CTGF-813-16-	13981	Chl	ooooooooooooo	000m0000mmmm	GAGUGGAGCGCCU	486
13981
CTGF-747-16-	13982	Chl	ooooooooooooo	m0mm000000m0	CGACUGGAAGACA	487
13982
CTGF-817-16-	13983	Chl	ooooooooooooo	0000mmmm0mmm	GGAGCGCCUGUUC	488
13983
CTGF-1174-	13984	Chl	ooooooooooooo	0mm0mm0m00mm0	GCCAUUACAACUG	489
16-13984
CTGF-1005-	13985	Chl	ooooooooooooo	000mmmmmm00mm	GAGCUUUCUGGCU	490
16-13985
CTGF-814-16-	13986	Chl	ooooooooooooo	00m0000mmmm0	AGUGGAGCGCCUG	491
13986
CTGF-816-16-	13987	Chl	ooooooooooooo	m0000mmmm0mm	UGGAGCGCCUGUU	492
13987
CTGF-1001-	13988	Chl	ooooooooooooo	0mmm000mmmmmm	GUUUGAGCUUUCU	493
16-13988
CTGF-1173-	13989	Chl	ooooooooooooo	m0mm0mm0m00mm	UGCCAUUACAACU	494
16-13989
CTGF-749-16-	13990	Chl	ooooooooooooo	0mm000000m0m	ACUGGAAGACACG	495
13990
CTGF-792-16-	13991	Chl	ooooooooooooo	00mm0mmm00mmm	AACUGCCUGGUCC	496
13991
CTGF-1162-	13992	Chl	ooooooooooooo	000mmm0m0mmm0	AGACCUGUGCCUG	497
16-13992
CTGF-811-16-	13993	Chl	ooooooooooooo	m0000m0000mm	CAGAGUGGAGCGC	498
13993
CTGF-797-16-	13994	Chl	ooooooooooooo	mmm00mmm000mm	CCUGGUCCAGACC	499
13994
CTGF-1175-	13995	Chl	ooooooooooooo	mm0mm0m00mm0m	CCAUUACAACUGU	500
16-13995
CTGF-1172-	13996	Chl	ooooooooooooo	mm0mm0mm0m00m	CUGCCAUUACAAC	501
16-13996
CTGF-1177-	13997	Chl	ooooooooooooo	0mm0m00mm0mmm	AUUACAACUGUCC	502
16-13997
CTGF-1176-	13998	Chl	ooooooooooooo	m0mm0m00mm0mm	CAUUACAACUGUC	503
16-13998
CTGF-812-16-	13999	Chl	ooooooooooooo	0000m0000mmm	AGAGUGGAGCGCC	504
13999
CTGF-745-16-	14000	Chl	ooooooooooooo	0mm0mm000000	ACCGACUGGAAGA	505
14000
CTGF-1230-	14001	Chl	ooooooooooooo	0m0m0m0000m0	AUGUACGGAGACA	506
16-14001
CTGF-920-16-	14002	Chl	ooooooooooooo	0mmmm0m000mm	GCCUUGCGAAGCU	507
14002
CTGF-679-16-	14003	Chl	ooooooooooooo	0mm0m00000m0	GCUGCGAGGAGUG	508
14003
CTGF-992-16-	14004	Chl	ooooooooooooo	0mmm0mm000mmm	GCCUAUCAAGUUU	509
14004
CTGF-1045-	14005	Chl	ooooooooooooo	00mmmm0m0000m	AAUUCUGUGGAGU	510
16-14005
CTGF-1231-	14006	Chl	ooooooooooooo	m0m0m0000m0m	UGUACGGAGACAU	511
16-14006
CTGF-991-16-	14007	Chl	ooooooooooooo	00mmm0mm000mm	AGCCUAUCAAGUU	512
14007
CTGF-998-16-	14008	Chl	ooooooooooooo	m000mmm000mmm	CAAGUUUGAGCUU	513
14008
CTGF-1049-	14009	Chl	ooooooooooooo	mm0m0000m0m0m	CUGUGGAGUAUGU	514
16-14009
CTGF-1044-	14010	Chl	ooooooooooooo	000mmmm0m0000	AAAUUCUGUGGAG	515
16-14010
CTGF-1327-	14011	Chl	ooooooooooooo	mmmm00m00m0m0	UUUCAGUAGCACA	516
16-14011
CTGF-1196-	14012	Chl	ooooooooooooo	m00m00m0mmmmm	CAAUGACAUCUUU	517
16-14012
CTGF-562-16-	14013	Chl	ooooooooooooo	00m0mm00m0m0m	AGUACCAGUGCAC	518
14013
CTGF-752-16-	14014	Chl	ooooooooooooo	000000m0mmmm	GGAAGACACGUUU	519
14014
CTGF-994-16-	14015	Chl	ooooooooooooo	mm0mm000mmm00	CUAUCAAGUUUGA	520
14015
CTGF-1040-	14016	Chl	ooooooooooooo	00mm000mmmm0m	AGCUAAAUUCUGU	521
16-14016
CTGF-1984-	14017	Chl	ooooooooooooo	000m0000m0m00	AGGUAGAAUGUAA	522
16-14017
CTGF-2195-	14018	Chl	ooooooooooooo	00mm00mm00mmm	AGCUGAUCAGUUU	523
16-14018
CTGF-2043-	14019	Chl	ooooooooooooo	mmmm0mmm000m0	UUCUGCUCAGAUA	524
16-14019
CTGF-1892-	14020	Chl	ooooooooooooo	mm0mmm000mm00	UUAUCUAAGUUAA	525
16-14020
CTGF-1567-	14021	Chl	ooooooooooooo	m0m0m00m00m0	UAUACGAGUAAUA	526
16-14021
CTGF-1780-	14022	Chl	ooooooooooooo	00mm000m00mmm	GACUGGACAGCUU	527
16-14022
CTGF-2162-	14023	Chl	ooooooooooooo	0m00mmmmm0mm0	AUGGCCUUUAUUA	528
16-14023
CTGF-1034-	14024	Chl	ooooooooooooo	0m0mm00mm000	AUACCGAGCUAAA	529
16-14024
CTGF-2264-	14025	Chl	ooooooooooooo	mm0mm00000m0m	UUGUUGAGAGUGU	530
16-14025
CTGF-1032-	14026	Chl	ooooooooooooo	0m0m0mm00mm0	ACAUACCGAGCUA	531
16-14026
CTGF-1535-	14027	Chl	ooooooooooooo	00m0000000mm0	AGCAGAAAGGUUA	532
16-14027
CTGF-1694-	14028	Chl	ooooooooooooo	00mm0mmmmmm00	AGUUGUUCCUUAA	533
16-14028
CTGF-1588-	14029	Chl	ooooooooooooo	0mmm0000m0m00	AUUUGAAGUGUAA	534
16-14029
CTGF-928-16-	14030	Chl	ooooooooooooo	000mm00mmm000	AAGCUGACCUGGA	535
14030
CTGF-1133-	14031	Chl	ooooooooooooo	00mm0m0000000	GGUCAUGAAGAAG	536
16-14031
CTGF-912-16-	14032	Chl	ooooooooooooo	0m00mm000mmmm	AUGGUCAGGCCUU	537
14032
CTGF-753-16-	14033	Chl	ooooooooooooo	00000m0mmmm0	GAAGACACGUUUG	538
14033
CTGF-918-16-	14034	Chl	ooooooooooooo	000mmmm0m000	AGGCCUUGCGAAG	539
14034
CTGF-744-16-	14035	Chl	ooooooooooooo	m0mm0mm00000	UACCGACUGGAAG	540
14035
CTGF-466-16-	14036	Chl	ooooooooooooo	0mmm0000mm0	ACCGCAAGAUCGG	541
14036
CTGF-917-16-	14037	Chl	ooooooooooooo	m000mmmm0m00	CAGGCCUUGCGAA	542
14037
CTGF-1038-	14038	Chl	ooooooooooooo	m00mm000mmmm	CGAGCUAAAUUCU	543
16-14038
CTGF-1048-	14039	Chl	ooooooooooooo	mmm0m0000m0m0	UCUGUGGAGUAUG	544
16-14039
CTGF-1235-	14040	Chl	ooooooooooooo	m0000m0m00m0	CGGAGACAUGGCA	545
16-14040
CTGF-868-16-	14041	Chl	ooooooooooooo	0m00m00mmmmm	AUGACAACGCCUC	546
14041
CTGF-1131-	14042	Chl	ooooooooooooo	0000mm0m00000	GAGGUCAUGAAGA	547
16-14042
CTGF-1043-	14043	Chl	ooooooooooooo	m000mmmm0m000	UAAAUUCUGUGGA	548
16-14043
CTGF-751-16-	14044	Chl	ooooooooooooo	m000000m0mmm	UGGAAGACACGUU	549
14044
CTGF-1227-	14045	Chl	ooooooooooooo	0000m0m0m000	AAGAUGUACGGAG	550
16-14045
CTGF-867-16-	14046	Chl	ooooooooooooo	00m00m00mmmm	AAUGACAACGCCU	551
14046
CTGF-1128-	14047	Chl	ooooooooooooo	00m000mm0m00	GGCGAGGUCAUGA	552
16-14047
CTGF-756-16-	14048	Chl	ooooooooooooo	00m0m0mmm00mm	GACACGUUUGGCC	553
14048
CTGF-1234-	14049	Chl	ooooooooooooo	0m00000m0m00m	ACGGAGACAUGGC	554
16-14049
CTGF-916-16-	14050	Chl	ooooooooooooo	mm000mmmm0m00	UCAGGCCUUGCGA	555
14050
CTGF-925-16-	14051	Chl	ooooooooooooo	0m0000mm00mmm	GCGAAGCUGACCU	556
14051
CTGF-1225-	14052	Chl	ooooooooooooo	000000m0m0m00	GGAAGAUGUACGG	557
16-14052
CTGF-445-16-	14053	Chl	ooooooooooooo	0m00mmmm00mmm	GUGACUUCGGCUC	558
14053
CTGF-446-16-	14054	Chl	ooooooooooooo	m00mmmm00mmmm	UGACUUCGGCUCC	559
14054
CTGF-913-16-	14055	Chl	ooooooooooooo	m00mm000mmmm0	UGGUCAGGCCUUG	560
14055
CTGF-997-16-	14056	Chl	ooooooooooooo	mm000mmm000mm	UCAAGUUUGAGCU	561
14056
CTGF-277-16-	14057	Chl	ooooooooooooo	0mm0000mm0m00	GCCAGAACUGCAG	562
14057
CTGF-1052-	14058	Chl	ooooooooooooo	m0000m0m0m0mm	UGGAGUAUGUACC	563
16-14058
CTGF-887-16-	14059	Chl	ooooooooooooo	0mm0000000m00	GCUAGAGAAGCAG	564
14059
CTGF-914-16-	14060	Chl	ooooooooooooo	00mm000mmmm0m	GGUCAGGCCUUGC	565
14060
CTGF-1039-	14061	Chl	ooooooooooooo	000mm000mmmm0	GAGCUAAAUUCUG	566
16-14061
CTGF-754-16-	14062	Chl	ooooooooooooo	0000m0m0mmm00	AAGACACGUUUGG	567
14062
CTGF-1130-	14063	Chl	ooooooooooooo	m0000mm0m0000	CGAGGUCAUGAAG	568
16-14063
CTGF-919-16-	14064	Chl	ooooooooooooo	00mmmm0m0000m	GGCCUUGCGAAGC	569
14064
CTGF-922-16-	14065	Chl	ooooooooooooo	mmm0m0000mm00	CUUGCGAAGCUGA	570
14065
CTGF-746-16-	14066	Chl	ooooooooooooo	mm00mm000000m	CCGACUGGAAGAC	571
14066
CTGF-993-16-	14067	Chl	ooooooooooooo	mmm0mm000mmm0	CCUAUCAAGUUUG	572
14067
CTGF-825-16-	14068	Chl	ooooooooooooo	m0mmmm0000mmm	UGUUCCAAGACCU	573
14068
CTGF-926-16-	14069	Chl	ooooooooooooo	m0000mm00mmm0	CGAAGCUGACCUG	574
14069
CTGF-923-16-	14070	Chl	ooooooooooooo	mm0m0000mm00m	UUGCGAAGCUGAC	575
14070
CTGF-866-16-	14071	Chl	ooooooooooooo	m00m00m00m0mm	CAAUGACAACGCC	576
14071
CTGF-563-16-	14072	Chl	ooooooooooooo	0m0mm00m0m0m0	GUACCAGUGCACG	577
14072
CTGF-823-16-	14073	Chl	ooooooooooooo	mmm0mmmm0000m	CCUGUUCCAAGAC	578
14073
CTGF-1233-	14074	Chl	ooooooooooooo	m0m00000m0m00	UACGGAGACAUGG	579
16-14074
CTGF-924-16-	14075	Chl	ooooooooooooo	m0m0000mm00mm	UGCGAAGCUGACC	580
14075
CTGF-921-16-	14076	Chl	ooooooooooooo	mmmm0m0000mm0	CCUUGCGAAGCUG	581
14076
CTGF-443-16-	14077	Chl	ooooooooooooo	mm0m00mmmm00m	CUGUGACUUCGGC	582
14077
CTGF-1041-	14078	Chl	ooooooooooooo	0mm000mmmm0m0	GCUAAAUUCUGUG	583
16-14078
CTGF-1042-	14079	Chl	ooooooooooooo	mm000mmmm0m00	CUAAAUUCUGUGG	584
16-14079
CTGF-755-16-	14080	Chl	ooooooooooooo	000m0m0mmm00m	AGACACGUUUGGC	585
14080
CTGF-467-16-	14081	Chl	ooooooooooooo	mm0m0000mm00m	CCGCAAGAUCGGC	586
14081
CTGF-995-16-	14082	Chl	ooooooooooooo	m0mm000mmm000	UAUCAAGUUUGAG	587
14082
CTGF-927-16-	14083	Chl	ooooooooooooo	0000mm00mmm00	GAAGCUGACCUGG	588
14083
SPP1-1091-	14131	Chl	ooooooooooooo	0m0mmm00mm000	GCAUUUAGUCAAA	589
16-14131
PPIB--16-	14188	Chl	ooooooooooooo	mmmmmmmmmmmmm	GGCUACAAAAACA	590
14188
PPIB--17-	14189	Chl	ooooooooooooo	mm00mm0m00000m0	UUGGCUACAAAAAC	591
14189			oo		A
PPIB--18-	14190	Chl	ooooooooooooo	0mmm00mm0m00000m0	AUUUGGCUACAAAA	592
14190			oooo		ACA
pGL3-1172-	14386	chl	ooooooooooooo	0m000m0m00mmm	ACAAAUACGAUUU	593
16-14386
pGL3-1172-	14387	chl	ooooooooooooo	DY5470m000m0m00mm	ACAAAUACGAUUU	594
16-14387				m
MAP4K4-2931-	14390	Chl	ooooooooooooo	Pmmmmmmmmmmmm000m	CUUUGAAGAGUUCU	595
25-14390			oooooooooooo	mmmmmmmmm	GUGGAAGUCUA
miR-122--23-	14391	Chl	ssooooooooooo	mmmmmmmmmmmmmmmmm	ACAAACACCAUUGU	596
14391			oooooossss	mmmmmm	CACACUCCA
	14084	Chl	ooooooooooooo	mmm0m000mm000	CUCAUGAAUUAGA	719
	14085	Chl	ooooooooooooo	mm0000mm00mm0	CUGAGGUCAAUUA	720
	14086	Chl	ooooooooooooo	0000mm00mm000	GAGGUCAAUUAAA	721
	14087	Chl	ooooooooooooo	mmm0000mm00mm	UCUGAGGUCAAUU	722
	14088	Chl	ooooooooooooo	m0000mm00mm00	UGAGGUCAAUUAA	723
	14089	Chl	ooooooooooooo	mmmm0000mm00m	UUCUGAGGUCAAU	724
	14090	Chl	ooooooooooooo	0mm00mm000m00	GUCAGCUGGAUGA	725
	14091	Chl	ooooooooooooo	mmmm00m000mmm	UUCUGAUGAAUCU	726
	14092	Chl	ooooooooooooo	m000mm0000mm0	UGGACUGAGGUCA	727
	14093	Chl	ooooooooooooo	000mmmm0mm0mm	GAGUCUCACCAUU	728
	14094	Chl	ooooooooooooo	00mm0000mm000	GACUGAGGUCAAA	729
	14095	Chl	ooooooooooooo	mm0m00mm0m000	UCACAGCCAUGAA	730
	14096	Chl	ooooooooooooo	00mmmm0mm0mmm	AGUCUCACCAUUC	731
	14097	Chl	ooooooooooooo	000m00000mm0	AAGCGGAAAGCCA	732
	14098	Chl	ooooooooooooo	00m00000mm00	AGCGGAAAGCCAA	733
	14099	Chl	ooooooooooooo	0mm0m0m000m00	ACCACAUGGAUGA	734
	14100	Chl	ooooooooooooo	0mm0m00mm0m0m	GCCAUGACCACAU	735
	14101	Chl	ooooooooooooo	000mm0m00mm0m	AAGCCAUGACCAC	736
	14102	Chl	ooooooooooooo	0m00000mm00m	GCGGAAAGCCAAU	737
	14103	Chl	ooooooooooooo	000mmmmm0mmm	AAAUUUCGUAUUU	738
	14104	Chl	ooooooooooooo	0mmmmm0mmmmm	AUUUCGUAUUUCU	739
	14105	Chl	ooooooooooooo	0000mm0m00mm0	AAAGCCAUGACCA	740
	14106	Chl	ooooooooooooo	0m0m000m00m0m	ACAUGGAUGAUAU	741
	14107	Chl	ooooooooooooo	0000mmmmm0mm	GAAAUUUCGUAUU	742
	14108	Chl	ooooooooooooo	0mmmmmmm00mm	GCGCCUUCUGAUU	743
	14109	Chl	ooooooooooooo	0mmmmmm0m000m	AUUUCUCAUGAAU	744
	14110	Chl	ooooooooooooo	mmmmm0m000m00	CUCUCAUGAAUAG	745
	14111	Chl	ooooooooooooo	000mmm00m000	AAGUCCAACGAAA	746
	14112	Chl	ooooooooooooo	0m00m00000m00	AUGAUGAGAGCAA	747
	14113	Chl	ooooooooooooo	0m00000mm000	GCGAGGAGUUGAA	748
	14114	Chl	ooooooooooooo	m00mm00m00mm0	UGAUUGAUAGUCA	749
	14115	Chl	ooooooooooooo	000m00m0m0mmm	AGAUAGUGCAUCU	750
	14116	Chl	ooooooooooooo	0m0m0m0mmm0mm	AUGUGUAUCUAUU	751
	14117	Chl	ooooooooooooo	mmmm0m0000000	UUCUAUAGAAGAA	752
	14118	Chl	ooooooooooooo	mm0mmm00m00mm	UUGUCCAGCAAUU	753
	14119	Chl	ooooooooooooo	0m0m000000m0	ACAUGGAAAGCGA	754
	14120	Chl	ooooooooooooo	0m00mmm000mm0	GCAGUCCAGAUUA	755
	14121	Chl	ooooooooooooo	m00mm000m0m0m	UGGUUGAAUGUGU	756
	14122	Chl	ooooooooooooo	mm0m0000m00m	UUAUGAAACGAGU	757
	14123	Chl	ooooooooooooo	m00mmm000mm0m	CAGUCCAGAUUAU	758
	14124	Chl	ooooooooooooo	0m0m000m0000	AUAUAAGCGGAAA	759
	14125	Chl	ooooooooooooo	m0mm00mm000m0	UACCAGUUAAACA	760
	14126	Chl	ooooooooooooo	m0mmm0mmmm0m0	UGUUCAUUCUAUA	761
	14127	Chl	ooooooooooooo	mm0mm0000000	CCGACCAAGGAAA	762
	14128	Chl	ooooooooooooo	000m00m0m0m0m	GAAUGGUGCAUAC	763
	14129	Chl	ooooooooooooo	0m0m00m00mm0	AUAUGAUGGCCGA	764
	14130	Chl	ooooooooooooo	00m00mmm000mm	AGCAGUCCAGAUU	765
	14132	Chl	ooooooooooooo	00m0mmmm0m0m	AGCAUUCCGAUGU	766
	14133	Chl	ooooooooooooo	m00mm00000mmm	UAGUCAGGAACUU	767
	14134	Chl	ooooooooooooo	m0m0mmm00mm00	UGCAUUUAGUCAA	768
	14135	Chl	ooooooooooooo	0mmm00m000mmm	GUCUGAUGAGUCU	769
	14136	Chl	ooooooooooooo	m000m0m0m0m00	UAGACACAUAUGA	770
	14137	Chl	ooooooooooooo	m000m0000m0m	CAGACGAGGACAU	771
	14138	Chl	ooooooooooooo	m00mmm000mmm	CAGCCGUGAAUUC	772
	14139	Chl	ooooooooooooo	00mmm00000m00	AGUCUGGAAAUAA	773
	14140	Chl	ooooooooooooo	00mmm0m00mmmm	AGUUUGUGGCUUC	774
	14141	Chl	ooooooooooooo	00mmm00m0000	AGUCCAACGAAAG	775
	14142	Chl	ooooooooooooo	000mmmmm000m	AAGUUUCGCAGAC	776
	14143	Chl	ooooooooooooo	00m00m000m0mm	AGCAAUGAGCAUU	777
	14144	Chl	ooooooooooooo	mm000m00m0m0m	UUAGAUAGUGCAU	778
	14145	Chl	ooooooooooooo	m00m0m0m0m000	UGGUGCAUACAAG	779
	14146	Chl	ooooooooooooo	0m0000m00mm0	AUGAAACGAGUCA	780
	14147	Chl	ooooooooooooo	mm0000m0mm000	CCAGAGUGCUGAA	781
	14148	Chl	ooooooooooooo	m00mm0m000mmm	CAGCCAUGAAUUU	782
	14149	Chl	ooooooooooooo	0mm00mm000m0m	AUUGGUUGAAUGU	783
	14150	Chl	ooooooooooooo	00mm000m0m0m0	GGUUGAAUGUGUA	784
	14151	Chl	ooooooooooooo	00000m00mm00m	GGAAAUAACUAAU	785
	14152	Chl	ooooooooooooo	mm0m000m00000	UCAUGAAUAGAAA	786
	14153	Chl	ooooooooooooo	0mm00m00mm00	GCCAGCAACCGAA	787
	14154	Chl	ooooooooooooo	m0mmmm0m0m0m0	CACCUCACACAUG	788
	14155	Chl	ooooooooooooo	00mm000m00m0m	AGUUGAAUGGUGC	789
	14156	Chl	ooooooooooooo	00mm00mm000m0	AGUCAGCUGGAUG	790
	14157	Chl	ooooooooooooo	m0m000m00000	UAUAAGCGGAAAG	791
	14158	Chl	ooooooooooooo	mmmm0m0m00mm	UUCCGAUGUGAUU	792
	14159	Chl	ooooooooooooo	0m00mm00m0m0m	AUAACUAAUGUGU	793
	14160	Chl	ooooooooooooo	mm0mmmm0m0000	UCAUUCUAUAGAA	794
	14161	Chl	ooooooooooooo	00mm0mm0mm0m0	AACUAUCACUGUA	795
	14162	Chl	ooooooooooooo	0mm00mm0mmm0m	GUCAAUUGCUUAU	796
	14163	Chl	ooooooooooooo	00m00mm00m000	AGCAAUUAAUAAA	797
	14164	Chl	ooooooooooooo	0m0mmmm00m00	ACGACUCUGAUGA	798
	14165	Chl	ooooooooooooo	m00m0m00mmm0m	UAGUGUGGUUUAU	799
	14166	Chl	ooooooooooooo	000mm00m00m00	AAGCCAAUGAUGA	800
	14167	Chl	ooooooooooooo	0m00mm00000mm	AUAGUCAGGAACU	801
	14168	Chl	ooooooooooooo	00mm00mmm000	AGUCAGCCGUGAA	802
	14169	Chl	ooooooooooooo	0mm0mm0m00000	ACUACCAUGAGAA	803
	14170	Chl	ooooooooooooo	000m000mm00mm	AAACAGGCUGAUU	804
	14171	Chl	ooooooooooooo	000m0mm0000mm	GAGUGCUGAAACC	805
	14172	Chl	ooooooooooooo	m000m0mmmm0m	UGAGCAUUCCGAU	806
	14173	Chl	ooooooooooooo	00mmmm0m00mm0	AAUUCCACAGCCA	807
	14174	Chl	ooooooooooooo	m0mm00mm0mmm0	UGUCAAUUGCUUA	808
	14175	Chl	ooooooooooooo	0mm0m00000mm0	ACCAUGAGAAUUG	809
	14176	Chl	ooooooooooooo	mm00m0000mm0	CCAACGAAAGCCA	810
	14177	Chl	ooooooooooooo	mm00mm0mm00mm	CUGGUCACUGAUU	811
	14178	Chl	ooooooooooooo	m00mmm0m000mm	UGGUUUAUGGACU	812
	14179	Chl	ooooooooooooo	00mm0000m0mm0	GACCAGAGUGCUG	813
	14180	Chl	ooooooooooooo	00m0m00mm00m0	GAUGUGAUUGAUA	814
	14181	Chl	ooooooooooooo	0mm00mmm000m	GUCAGCCGUGAAU	815
	14182	Chl	ooooooooooooo	00m0m0m0mmm0m	AAUGUGUAUCUAU	816
	14183	Chl	ooooooooooooo	mm000mmm00000	UUGAGUCUGGAAA	817
	14184	Chl	ooooooooooooo	0mmm00m00mm00	GUCCAGCAAUUAA	818
	14185	Chl	ooooooooooooo	mm00m00mm00m0	CCAGCAAUUAAUA	819
	14186	Chl	ooooooooooooo	00mmm00m0mm	GACUCGAACGACU	820
	14187	Chl	ooooooooooooo	0mmm0mm00m00m	ACCUGCCAGCAAC	821
o: phosphodiester; s: phosphorothioate; P: 5′ phosphorylation; 0: 2′-OH; F: 2′-fluoro; m: 2′ O-methyl; +: LNA modification. Capital letters in the sequence signify ribonucleotides, lower case letters signify deoxyribonucleotides.

TABLE 4
sd-rxRNA miRNA designs
	SEQ	mIRNA Sequence	SEQ ID	sd-rxRNA	SEQ	sd-rxRNA
mIRNA Name	ID NO	mature	NO	Antisense	ID NO	Sense
hsa-let-7a	822	UGAGGUAGUAGGUUGUA	823	UGAGGUAGUAGG	824	AACCUACUACC
MIMAT0000062		UAGUU		UUGUAUAG		UCA
hsa-let-7a*	825	CUAUACAAUCUACUGUC	826	CUAUACAAUCUA	827	AGUAGAUUGUA
MIMAT0004481		UUUC		CUGUCUUU		UAG
hsa-let-7a-2*	828	CUGUACAGCCUCCUAGC	829	CUGUACAGCCUC	830	AGGAGGCUGUA
MIMAT0010195		UUUCC		CUAGCUUU		CAG
hsa-let-7b	831	UGAGGUAGUAGGUUGUG	832	UGAGGUAGUAGG	833	AACCUACUACC
MIMAT0000063		UGGUU		UUGUGUGG		UCA
hsa-let-7b*	834	CUAUACAACCUACUGCC	835	CUAUACAACCUA	836	AGUAGGUUGUA
MIMAT0004482		UUCCC		CUGCCUUC		UAG
hsa-let-7c	837	UGAGGUAGUAGGUUGUA	838	UGAGGUAGUAGG	839	AACCUACUACC
MIMAT0000064		UGGUU		UUGUAUGG		UCA
hsa-let-7c*	840	UAGAGUUACACCCUGGG	841	UAGAGUUACACC	842	AGGGUGUAACU
MIMAT0004483		AGUUA		CUGGGAGU		CUA
hsa-let-7d	843	AGAGGUAGUAGGUUGCA	844	AGAGGUAGUAGG	845	AACCUACUACC
MIMAT0000065		UAGUU		UUGCAUAG		UCU
hsa-let-7d*	846	CUAUACGACCUGCUGCC	847	CUAUACGACCUG	848	AGCAGGUCGUA
MIMAT0004484		UUUCU		CUGCCUUU		UAG
hsa-let-7e	849	UGAGGUAGGAGGUUGUA	850	UGAGGUAGGAGG	851	AACCUCCUACC
MIMAT0000066		UAGUU		UUGUAUAG		UCA
hsa-let-7e*	852	CUAUACGGCCUCCUAGC	853	CUAUACGGCCUC	854	AGGAGGCCGUA
MIMAT0004485		UUUCC		CUAGCUUU		UAG
hsa-let-7f	855	UGAGGUAGUAGAUUGUA	856	UGAGGUAGUAGA	857	AAUCUACUACC
MIMAT0000067		UAGUU		UUGUAUAG		UCA
hsa-let-7f-1*	858	CUAUACAAUCUAUUGCC	859	CUAUACAAUCUA	860	AAUAGAUUGUA
MIMAT0004486		UUCCC		UUGCCUUC		UAG
hsa-let-7f-2*	861	CUAUACAGUCUACUGUC	862	CUAUACAGUCUA	863	AGUAGACUGUA
MIMAT0004487		UUUCC		CUGUCUUU		UAG
hsa-let-7g	864	UGAGGUAGUAGUUUGUA	865	UGAGGUAGUAGU	866	AAACUACUACC
MIMAT0000414		CAGUU		UUGUACAG		UCA
hsa-let-7g*	867	CUGUACAGGCCACUGCC	868	CUGUACAGGCCA	869	AGUGGCCUGUA
MIMAT0004584		UUGC		CUGCCUUG		CAG
hsa-let-7i	870	UGAGGUAGUAGUUUGUG	871	UGAGGUAGUAGU	872	AAACUACUACC
MIMAT0000415		CUGUU		UUGUGCUG		UCA
hsa-let-7i*	873	CUGCGCAAGCUACUGCC	874	CUGCGCAAGCUA	875	AGUAGCUUGCG
MIMAT0004585		UUGCU		CUGCCUUG		CAG
hsa-miR-1	876	UGGAAUGUAAAGAAGUA	877	UGGAAUGUAAAG	878	UUCUUUACAUU
MIMAT0000416		UGUAU		AAGUAUGU		CCA
hsa-miR-100	879	AACCCGUAGAUCCGAAC	880	AACCCGUAGAUC	881	CGGAUCUACGG
MIMAT0000098		UUGUG		CGAACUUG		GUU
hsa-miR-100*	882	CAAGCUUGUAUCUAUAG	883	CAAGCUUGUAUC	884	UAGAUACAAGC
MIMAT0004512		GUAUG		UAUAGGUA		UUG
hsa-miR-101	885	UACAGUACUGUGAUAAC	886	UACAGUACUGUG	887	AUCACAGUACU
MIMAT0000099		UGAA		AUAACUGA		GUA
hsa-miR-101*	888	CAGUUAUCACAGUGCUG	889	CAGUUAUCACAG	890	CACUGUGAUAA
MIMAT0004513		AUGCU		UGCUGAUG		CUG
hsa-miR-103	891	AGCAGCAUUGUACAGGG	892	AGCAGCAUUGUA	893	UGUACAAUGCU
MIMAT0000101		CUAUGA		CAGGGCUA		GCU
hsa-miR-103-2*	894	AGCUUCUUUACAGUGCU	895	AGCUUCUUUACA	896	ACUGUAAAGAA
MIMAT0009196		GCCUUG		GUGCUGCC		GCU
hsa-miR-103-as	897	UCAUAGCCCUGUACAAU	898	UCAUAGCCCUGU	899	GUACAGGGCUA
MIMAT0007402		GCUGCU		ACAAUGCU		UGA
hsa-miR-105	900	UCAAAUGCUCAGACUCC	901	UCAAAUGCUCAG	902	GUCUGAGCAUU
MIMAT0000102		UGUGGU		ACUCCUGU		UGA
hsa-miR-105*	903	ACGGAUGUUUGAGCAUG	904	ACGGAUGUUUGA	905	GCUCAAACAUC
MIMAT0004516		UGCUA		GCAUGUGC		CGU
hsa-miR-106a	906	AAAAGUGCUUACAGUGC	907	AAAAGUGCUUAC	908	CUGUAAGCACU
MIMAT0000103		AGGUAG		AGUGCAGG		UUU
hsa-miR-106a*	909	CUGCAAUGUAAGCACUU	910	CUGCAAUGUAAG	911	UGCUUACAUUG
MIMAT0004517		CUUAC		CACUUCUU		CAG
hsa-miR-106b	912	UAAAGUGCUGACAGUGC	913	UAAAGUGCUGAC	914	CUGUCAGCACU
MIMAT0000680		AGAU		AGUGCAGA		UUA
hsa-miR-106b*	915	CCGCACUGUGGGUACUU	916	CCGCACUGUGGG	917	UACCCACAGUG
MIMAT0004672		GCUGC		UACUUGCU		CGG
hsa-miR-107	918	AGCAGCAUUGUACAGGG	919	AGCAGCAUUGUA	920	UGUACAAUGCU
MIMAT0000104		CUAUCA		CAGGGCUA		GCU
hsa-miR-10a	921	UACCCUGUAGAUCCGAA	922	UACCCUGUAGAU	923	GGAUCUACAGG
MIMAT0000253		UUUGUG		CCGAAUUU		GUA
hsa-miR-10a*	924	CAAAUUCGUAUCUAGGG	925	CAAAUUCGUAUC	926	UAGAUACGAAU
MIMAT0004555		GAAUA		UAGGGGAA		UUG
hsa-miR-10b	927	UACCCUGUAGAACCGAA	928	UACCCUGUAGAA	929	GGUUCUACAGG
MIMAT0000254		UUUGUG		CCGAAUUU		GUA
hsa-miR-10b*	930	ACAGAUUCGAUUCUAGG	931	ACAGAUUCGAUU	932	AGAAUCGAAUC
MIMAT0004556		GGAAU		CUAGGGGA		UGU
hsa-miR-1178	933	UUGCUCACUGUUCUUCC	934	UUGCUCACUGUU	935	AGAACAGUGAG
MIMAT0005823		CUAG		CUUCCCUA		CAA
hsa-miR-1179	936	AAGCAUUCUUUCAUUGG	937	AAGCAUUCUUUC	938	AUGAAAGAAUG
MIMAT0005824		UUGG		AUUGGUUG		CUU
hsa-miR-1180	939	UUUCCGGCUCGCGUGGG	940	UUUCCGGCUCGC	941	ACGCGAGCCGG
MIMAT0005825		UGUGU		GUGGGUGU		AAA
hsa-miR-1181	942	CCGUCGCCGCCACCCGA	943	CCGUCGCCGCCA	944	GGUGGCGGCGA
MIMAT0005826		GCCG		CCCGAGCC		CGG
hsa-miR-1182	945	GAGGGUCUUGGGAGGGA	946	GAGGGUCUUGGG	947	CUCCCAAGACC
MIMAT0005827		UGUGAC		AGGGAUGU		CUC
hsa-miR-1183	948	CACUGUAGGUGAUGGUG	949	CACUGUAGGUGA	950	CAUCACCUACA
MIMAT0005828		AGAGUGGGCA		UGGUGAGA		GUG
hsa-miR-1184	951	CCUGCAGCGACUUGAUG	952	CCUGCAGCGACU	953	CAAGUCGCUGC
MIMAT0005829		GCUUCC		UGAUGGCU		AGG
hsa-miR-1185	954	AGAGGAUACCCUUUGUA	955	AGAGGAUACCCU	956	AAAGGGUAUCC
MIMAT0005798		UGUU		UUGUAUGU		UCU
hsa-miR-1193	957	GGGAUGGUAGACCGGUG	958	GGGAUGGUAGAC	959	CGGUCUACCAU
MIMAT0015049		ACGUGC		CGGUGACG		CCC
hsa-miR-1197	960	UAGGACACAUGGUCUAC	961	UAGGACACAUGG	962	GACCAUGUGUC
MIMAT0005955		UUCU		UCUACUUC		CUA
hsa-miR-1200	963	CUCCUGAGCCAUUCUGA	964	CUCCUGAGCCAU	965	GAAUGGCUCAG
MIMAT0005863		GCCUC		UCUGAGCC		GAG
hsa-miR-1202	966	GUGCCAGCUGCAGUGGG	967	GUGCCAGCUGCA	968	ACUGCAGCUGG
MIMAT0005865		GGAG		GUGGGGGA		CAC
hsa-miR-1203	969	CCCGGAGCCAGGAUGCA	970	CCCGGAGCCAGG	971	AUCCUGGCUCC
MIMAT0005866		GCUC		AUGCAGCU		GGG
hsa-miR-1204	972	UCGUGGCCUGGUCUCCA	973	UCGUGGCCUGGU	974	AGACCAGGCCA
MIMAT0005868		UUAU		CUCCAUUA		CGA
hsa-miR-1205	975	UCUGCAGGGUUUGCUUU	976	UCUGCAGGGUUU	977	GCAAACCCUGC
MIMAT0005869		GAG		GCUUUGAG		AGA
hsa-miR-1206	978	UGUUCAUGUAGAUGUUU	979	UGUUCAUGUAGA	980	CAUCUACAUGA
MIMAT0005870		AAGC		UGUUUAAG		ACA
hsa-miR-1207-	981	UCAGCUGGCCCUCAUUU	982	UCAGCUGGCCCU	983	UGAGGGCCAGC
3p		C		CAUUUC		UGA
MIMAT0005872
hsa-miR-1207-	984	UGGCAGGGAGGCUGGGA	985	UGGCAGGGAGGC	986	CAGCCUCCCUG
5p		GGGG		UGGGAGGG		CCA
MIMAT0005871
hsa-miR-1208	987	UCACUGUUCAGACAGGC	988	UCACUGUUCAGA	989	UGUCUGAACAG
MIMAT0005873		GGA		CAGGCGGA		UGA
hsa-miR-122	990	UGGAGUGUGACAAUGGU	991	UGGAGUGUGACA	992	AUUGUCACACU
MIMAT0000421		GUUUG		AUGGUGUU		CCA
hsa-miR-122*	993	AACGCCAUUAUCACACU	994	AACGCCAUUAUC	995	GUGAUAAUGGC
MIMAT0004590		AAAUA		ACACUAAA		GUU
hsa-miR-1224-	996	CCCCACCUCCUCUCUCC	997	CCCCACCUCCUC	998	GAGAGGAGGUG
3p		UCAG		UCUCCUCA		GGG
MIMAT0005459
hsa-miR-1224-	999	GUGAGGACUCGGGAGGU	1000	GUGAGGACUCGG	1001	UCCCGAGUCCU
5p		GG		GAGGUGG		CAC
MIMAT0005458
hsa-miR-1225-	1002	UGAGCCCCUGUGCCGCC	1003	UGAGCCCCUGUG	1004	GGCACAGGGGC
3p		CCCAG		CCGCCCCC		UCA
MIMAT0005573
hsa-miR-1225-	1005	GUGGGUACGGCCCAGUG	1006	GUGGGUACGGCC	1007	UGGGCCGUACC
5p		GGGGG		CAGUGGGG		CAC
MIMAT0005572
hsa-miR-1226	1008	UCACCAGCCCUGUGUUC	1009	UCACCAGCCCUG	1010	CACAGGGCUGG
MIMAT0005577		CCUAG		UGUUCCCU		UGA
hsa-miR-1226*	1011	GUGAGGGCAUGCAGGCC	1012	GUGAGGGCAUGC	1013	CUGCAUGCCCU
MIMAT0005576		UGGAUGGGG		AGGCCUGG		CAC
hsa-miR-1227	1014	CGUGCCACCCUUUUCCC	1015	CGUGCCACCCUU	1016	AAAAGGGUGGC
MIMAT0005580		CAG		UUCCCCAG		ACG
hsa-miR-1228	1017	UCACACCUGCCUCGCCC	1018	UCACACCUGCCU	1019	CGAGGCAGGUG
MIMAT0005583		CCC		CGCCCCCC		UGA
hsa-miR-1228*	1020	GUGGGCGGGGGCAGGUG	1021	GUGGGCGGGGGC	1022	CUGCCCCCGCC
MIMAT0005582		UGUG		AGGUGUGU		CAC
hsa-miR-1229	1023	CUCUCACCACUGCCCUC	1024	CUCUCACCACUG	1025	GGCAGUGGUGA
MIMAT0005584		CCACAG		CCCUCCCA		GAG
hsa-miR-1231	1026	GUGUCUGGGCGGACAGC	1027	GUGUCUGGGCGG	1028	GUCCGCCCAGA
MIMAT0005586		UGC		ACAGCUGC		CAC
hsa-miR-1233	1029	UGAGCCCUGUCCUCCCG	1030	UGAGCCCUGUCC	1031	GAGGACAGGGC
MIMAT0005588		CAG		UCCCGCAG		UCA
hsa-miR-1234	1032	UCGGCCUGACCACCCAC	1033	UCGGCCUGACCA	1034	GGUGGUCAGGC
MIMAT0005589		CCCAC		CCCACCCC		CGA
hsa-miR-1236	1035	CCUCUUCCCCUUGUCUC	1036	CCUCUUCCCCUU	1037	ACAAGGGGAAG
MIMAT0005591		UCCAG		GUCUCUCC		AGG
hsa-miR-1237	1038	UCCUUCUGCUCCGUCCC	1039	UCCUUCUGCUCC	1040	ACGGAGCAGAA
MIMAT0005592		CCAG		GUCCCCCA		GGA
hsa-miR-1238	1041	CUUCCUCGUCUGUCUGC	1042	CUUCCUCGUCUG	1043	GACAGACGAGG
MIMAT0005593		CCC		UCUGCCCC		AAG
hsa-miR-124	1044	UAAGGCACGCGGUGAAU	1045	UAAGGCACGCGG	1046	CACCGCGUGCC
MIMAT0000422		GCC		UGAAUGCC		UUA
hsa-miR-124*	1047	CGUGUUCACAGCGGACC	1048	CGUGUUCACAGC	1049	CCGCUGUGAAC
MIMAT0004591		UUGAU		GGACCUUG		ACG
hsa-miR-1243	1050	AACUGGAUCAAUUAUAG	1051	AACUGGAUCAAU	1052	UAAUUGAUCCA
MIMAT0005894		GAGUG		UAUAGGAG		GUU
hsa-miR-1244	1053	AAGUAGUUGGUUUGUAU	1054	AAGUAGUUGGUU	1055	CAAACCAACUA
MIMAT0005896		GAGAUGGUU		UGUAUGAG		CUU
hsa-miR-1245	1056	AAGUGAUCUAAAGGCCU	1057	AAGUGAUCUAAA	1058	CCUUUAGAUCA
MIMAT0005897		ACAU		GGCCUACA		CUU
hsa-miR-1246	1059	AAUGGAUUUUUGGAGCA	1060	AAUGGAUUUUUG	1061	UCCAAAAAUCC
MIMAT0005898		GG		GAGCAGG		AUU
hsa-miR-1247	1062	ACCCGUCCCGUUCGUCC	1063	ACCCGUCCCGUU	1064	CGAACGGGACG
MIMAT0005899		CCGGA		CGUCCCCG		GGU
hsa-miR-1248	1065	ACCUUCUUGUAUAAGCA	1066	ACCUUCUUGUAU	1067	UUAUACAAGAA
MIMAT0005900		CUGUGCUAAA		AAGCACUG		GGU
hsa-miR-1249	1068	ACGCCCUUCCCCCCCUU	1069	ACGCCCUUCCCC	1070	GGGGGGAAGGG
MIMAT0005901		CUUCA		CCCUUCUU		CGU
hsa-miR-1250	1071	ACGGUGCUGGAUGUGGC	1072	ACGGUGCUGGAU	1073	ACAUCCAGCAC
MIMAT0005902		CUUU		GUGGCCUU		CGU
hsa-miR-1251	1074	ACUCUAGCUGCCAAAGG	1075	ACUCUAGCUGCC	1076	UUGGCAGCUAG
MIMAT0005903		CGCU		AAAGGCGC		AGU
hsa-miR-1252	1077	AGAAGGAAAUUGAAUUC	1078	AGAAGGAAAUUG	1079	UUCAAUUUCCU
MIMAT0005944		AUUUA		AAUUCAUU		UCU
hsa-miR-1253	1080	AGAGAAGAAGAUCAGCC	1081	AGAGAAGAAGAU	1082	UGAUCUUCUUC
MIMAT0005904		UGCA		CAGCCUGC		UCU
hsa-miR-1254	1083	AGCCUGGAAGCUGGAGC	1084	AGCCUGGAAGCU	1085	CCAGCUUCCAG
MIMAT0005905		CUGCAGU		GGAGCCUG		GCU
hsa-miR-1255a	1086	AGGAUGAGCAAAGAAAG	1087	AGGAUGAGCAAA	1088	UCUUUGCUCAU
MIMAT0005906		UAGAUU		GAAAGUAG		CCU
hsa-miR-1255b	1089	CGGAUGAGCAAAGAAAG	1090	CGGAUGAGCAAA	1091	UCUUUGCUCAU
MIMAT0005945		UGGUU		GAAAGUGG		CCG
hsa-miR-1256	1092	AGGCAUUGACUUCUCAC	1093	AGGCAUUGACUU	1094	AGAAGUCAAUG
MIMAT0005907		UAGCU		CUCACUAG		CCU
hsa-miR-1257	1095	AGUGAAUGAUGGGUUCU	1096	AGUGAAUGAUGG	1097	ACCCAUCAUUC
MIMAT0005908		GACC		GUUCUGAC		ACU
hsa-miR-1258	1098	AGUUAGGAUUAGGUCGU	1099	AGUUAGGAUUAG	1100	ACCUAAUCCUA
MIMAT0005909		GGAA		GUCGUGGA		ACU
hsa-miR-125a-	1101	ACAGGUGAGGUUCUUGG	1102	ACAGGUGAGGUU	1103	AGAACCUCACC
3p		GAGCC		CUUGGGAG		UGU
MIMAT0004602
hsa-miR-125a-	1104	UCCCUGAGACCCUUUAA	1105	UCCCUGAGACCC	1106	AAGGGUCUCAG
5p		CCUGUGA		UUUAACCU		GGA
MIMAT0000443
hsa-miR-125b	1107	UCCCUGAGACCCUAACU	1108	UCCCUGAGACCC	1109	UAGGGUCUCAG
MIMAT0000423		UGUGA		UAACUUGU		GGA
hsa-miR-125b-	1110	ACGGGUUAGGCUCUUGG	1111	ACGGGUUAGGCU	1112	AGAGCCUAACC
1*		GAGCU		CUUGGGAG		CGU
MIMAT0004592
hsa-miR-125b-	1113	UCACAAGUCAGGCUCUU	1114	UCACAAGUCAGG	1115	AGCCUGACUUG
2*		GGGAC		CUCUUGGG		UGA
MIMAT0004603
hsa-miR-126	1116	UCGUACCGUGAGUAAUA	1117	UCGUACCGUGAG	1118	UACUCACGGUA
MIMAT0000445		AUGCG		UAAUAAUG		CGA
hsa-miR-126*	1119	CAUUAUUACUUUUGGUA	1120	CAUUAUUACUUU	1121	CAAAAGUAAUA
MIMAT0000444		CGCG		UGGUACGC		AUG
hsa-miR-1260	1122	AUCCCACCUCUGCCACC	1123	AUCCCACCUCUG	1124	GGCAGAGGUGG
MIMAT0005911		A		CCACCA		GAU
hsa-miR-1260b	1125	AUCCCACCACUGCCACC	1126	AUCCCACCACUG	1127	GGCAGUGGUGG
MIMAT0015041		AU		CCACCAU		GAU
hsa-miR-1261	1128	AUGGAUAAGGCUUUGGC	1129	AUGGAUAAGGCU	1130	AAAGCCUUAUC
MIMAT0005913		UU		UUGGCUU		CAU
hsa-miR-1262	1131	AUGGGUGAAUUUGUAGA	1132	AUGGGUGAAUUU	1133	ACAAAUUCACC
MIMAT0005914		AGGAU		GUAGAAGG		CAU
hsa-miR-1263	1134	AUGGUACCCUGGCAUAC	1135	AUGGUACCCUGG	1136	UGCCAGGGUAC
MIMAT0005915		UGAGU		CAUACUGA		CAU
hsa-miR-1264	1137	CAAGUCUUAUUUGAGCA	1138	CAAGUCUUAUUU	1139	UCAAAUAAGAC
MIMAT0005791		CCUGUU		GAGCACCU		UUG
hsa-miR-1265	1140	CAGGAUGUGGUCAAGUG	1141	CAGGAUGUGGUC	1142	UUGACCACAUC
MIMAT0005918		UUGUU		AAGUGUUG		CUG
hsa-miR-1266	1143	CCUCAGGGCUGUAGAAC	1144	CCUCAGGGCUGU	1145	CUACAGCCCUG
MIMAT0005920		AGGGCU		AGAACAGG		AGG
hsa-miR-1267	1146	CCUGUUGAAGUGUAAUC	1147	CCUGUUGAAGUG	1148	UACACUUCAAC
MIMAT0005921		CCCA		UAAUCCCC		AGG
hsa-miR-1268	1149	CGGGCGUGGUGGUGGGG	1150	CGGGCGUGGUGG	1151	CACCACCACGC
MIMAT0005922		G		UGGGGG		CCG
hsa-miR-1269	1152	CUGGACUGAGCCGUGCU	1153	CUGGACUGAGCC	1154	ACGGCUCAGUC
MIMAT0005923		ACUGG		GUGCUACU		CAG
hsa-miR-1270	1155	CUGGAGAUAUGGAAGAG	1156	CUGGAGAUAUGG	1157	UUCCAUAUCUC
MIMAT0005924		CUGUGU		AAGAGCUG		CAG
hsa-miR-1271	1158	CUUGGCACCUAGCAAGC	1159	CUUGGCACCUAG	1160	UGCUAGGUGCC
MIMAT0005796		ACUCA		CAAGCACU		AAG
hsa-miR-1272	1161	GAUGAUGAUGGCAGCAA	1162	GAUGAUGAUGGC	1163	CUGCCAUCAUC
MIMAT0005925		AUUCUGAAA		AGCAAAUU		AUC
hsa-miR-1273	1164	GGGCGACAAAGCAAGAC	1165	GGGCGACAAAGC	1166	UUGCUUUGUCG
MIMAT0005926		UCUUUCUU		AAGACUCU		CCC
hsa-miR-1273c	1167	GGCGACAAAACGAGACC	1168	GGCGACAAAACG	1169	CUCGUUUUGUC
MIMAT0015017		CUGUC		AGACCCUG		GCC
hsa-miR-1273d	1170	GAACCCAUGAGGUUGAG	1171	GAACCCAUGAGG	1172	AACCUCAUGGG
MIMAT0015090		GCUGCAGU		UUGAGGCU		UUC
hsa-miR-1273e	1173	UUGCUUGAACCCAGGAA	1174	UUGCUUGAACCC	1175	CUGGGUUCAAG
MIMAT0018079		GUGGA		AGGAAGUG		CAA
hsa-miR-127-3p	1176	UCGGAUCCGUCUGAGCU	1177	UCGGAUCCGUCU	1178	UCAGACGGAUC
MIMAT0000446		UGGCU		GAGCUUGG		CGA
hsa-miR-1274a	1179	GUCCCUGUUCAGGCGCC	1180	GUCCCUGUUCAG	1181	GCCUGAACAGG
MIMAT0005927		A		GCGCCA		GAC
hsa-miR-1274b	1182	UCCCUGUUCGGGCGCCA	1183	UCCCUGUUCGGG	1184	CGCCCGAACAG
MIMAT0005938				CGCCA		GGA
hsa-miR-1275	1185	GUGGGGGAGAGGCUGUC	1186	GUGGGGGAGAGG	1187	AGCCUCUCCCC
MIMAT0005929				CUGUC		CAC
hsa-miR-127-5p	1188	CUGAAGCUCAGAGGGCU	1189	CUGAAGCUCAGA	1190	CCUCUGAGCUU
MIMAT0004604		CUGAU		GGGCUCUG		CAG
hsa-miR-1276	1191	UAAAGAGCCCUGUGGAG	1192	UAAAGAGCCCUG	1193	CACAGGGCUCU
MIMAT0005930		ACA		UGGAGACA		UUA
hsa-miR-1277	1194	UACGUAGAUAUAUAUGU	1195	UACGUAGAUAUA	1196	UAUAUAUCUAC
MIMAT0005933		AUUUU		UAUGUAUU		GUA
hsa-miR-1278	1197	UAGUACUGUGCAUAUCA	1198	UAGUACUGUGCA	1199	UAUGCACAGUA
MIMAT0005936		UCUAU		UAUCAUCU		CUA
hsa-miR-1279	1200	UCAUAUUGCUUCUUUCU	1201	UCAUAUUGCUUC	1202	AAGAAGCAAUA
MIMAT0005937				UUUCU		UGA
hsa-miR-128	1203	UCACAGUGAACCGGUCU	1204	UCACAGUGAACC	1205	CCGGUUCACUG
MIMAT0000424		CUUU		GGUCUCUU		UGA
hsa-miR-1280	1206	UCCCACCGCUGCCACCC	1207	UCCCACCGCUGC	1208	UGGCAGCGGUG
MIMAT0005946				CACCC		GGA
hsa-miR-1281	1209	UCGCCUCCUCCUCUCCC	1210	UCGCCUCCUCCU	1211	AGAGGAGGAGG
MIMAT0005939				CUCCC		CGA
hsa-miR-1282	1212	UCGUUUGCCUUUUUCUG	1213	UCGUUUGCCUUU	1214	AAAAAGGCAAA
MIMAT0005940		CUU		UUCUGCUU		CGA
hsa-miR-1283	1215	UCUACAAAGGAAAGCGC	1216	UCUACAAAGGAA	1217	CUUUCCUUUGU
MIMAT0005799		UUUCU		AGCGCUUU		AGA
hsa-miR-1284	1218	UCUAUACAGACCCUGGC	1219	UCUAUACAGACC	1220	AGGGUCUGUAU
MIMAT0005941		UUUUC		CUGGCUUU		AGA
hsa-miR-1285	1221	UCUGGGCAACAAAGUGA	1222	UCUGGGCAACAA	1223	CUUUGUUGCCC
MIMAT0005876		GACCU		AGUGAGAC		AGA
hsa-miR-1286	1224	UGCAGGACCAAGAUGAG	1225	UGCAGGACCAAG	1226	AUCUUGGUCCU
MIMAT0005877		CCCU		AUGAGCCC		GCA
hsa-miR-1287	1227	UGCUGGAUCAGUGGUUC	1228	UGCUGGAUCAGU	1229	CCACUGAUCCA
MIMAT0005878		GAGUC		GGUUCGAG		GCA
hsa-miR-1288	1230	UGGACUGCCCUGAUCUG	1231	UGGACUGCCCUG	1232	AUCAGGGCAGU
MIMAT0005942		GAGA		AUCUGGAG		CCA
hsa-miR-1289	1233	UGGAGUCCAGGAAUCUG	1234	UGGAGUCCAGGA	1235	AUUCCUGGACU
MIMAT0005879		CAUUUU		AUCUGCAU		CCA
hsa-miR-129*	1236	AAGCCCUUACCCCAAAA	1237	AAGCCCUUACCC	1238	UGGGGUAAGGG
MIMAT0004548		AGUAU		CAAAAAGU		CUU
hsa-miR-1290	1239	UGGAUUUUUGGAUCAGG	1240	UGGAUUUUUGGA	1241	GAUCCAAAAAU
MIMAT0005880		GA		UCAGGGA		CCA
hsa-miR-1291	1242	UGGCCCUGACUGAAGAC	1243	UGGCCCUGACUG	1244	UUCAGUCAGGG
MIMAT0005881		CAGCAGU		AAGACCAG		CCA
hsa-miR-1292	1245	UGGGAACGGGUUCCGGC	1246	UGGGAACGGGUU	1247	GGAACCCGUUC
MIMAT0005943		AGACGCUG		CCGGCAGA		CCA
hsa-miR-1293	1248	UGGGUGGUCUGGAGAUU	1249	UGGGUGGUCUGG	1250	CUCCAGACCAC
MIMAT0005883		UGUGC		AGAUUUGU		CCA
hsa-miR-129-3p	1251	AAGCCCUUACCCCAAAA	1252	AAGCCCUUACCC	1253	UGGGGUAAGGG
MIMAT0004605		AGCAU		CAAAAAGC		CUU
hsa-miR-1294	1254	UGUGAGGUUGGCAUUGU	1255	UGUGAGGUUGGC	1256	AUGCCAACCUC
MIMAT0005884		UGUCU		AUUGUUGU		ACA
hsa-miR-1295	1257	UUAGGCCGCAGAUCUGG	1258	UUAGGCCGCAGA	1259	GAUCUGCGGCC
MIMAT0005885		GUGA		UCUGGGUG		UAA
hsa-miR-129-5p	1260	CUUUUUGCGGUCUGGGC	1261	CUUUUUGCGGUC	1262	CAGACCGCAAA
MIMAT0000242		UUGC		UGGGCUUG		AAG
hsa-miR-1296	1263	UUAGGGCCCUGGCUCCA	1264	UUAGGGCCCUGG	1265	AGCCAGGGCCC
MIMAT0005794		UCUCC		CUCCAUCU		UAA
hsa-miR-1297	1266	UUCAAGUAAUUCAGGUG	1267	UUCAAGUAAUUC	1268	CUGAAUUACUU
MIMAT0005886				AGGUG		GAA
hsa-miR-1298	1269	UUCAUUCGGCUGUCCAG	1270	UUCAUUCGGCUG	1271	GACAGCCGAAU
MIMAT0005800		AUGUA		UCCAGAUG		GAA
hsa-miR-1299	1272	UUCUGGAAUUCUGUGUG	1273	UUCUGGAAUUCU	1274	ACAGAAUUCCA
MIMAT0005887		AGGGA		GUGUGAGG		GAA
hsa-miR-1301	1275	UUGCAGCUGCCUGGGAG	1276	UUGCAGCUGCCU	1277	CCAGGCAGCUG
MIMAT0005797		UGACUUC		GGGAGUGA		CAA
hsa-miR-1302	1278	UUGGGACAUACUUAUGC	1279	UUGGGACAUACU	1280	UAAGUAUGUCC
MIMAT0005890		UAAA		UAUGCUAA		CAA
hsa-miR-1303	1281	UUUAGAGACGGGGUCUU	1282	UUUAGAGACGGG	1283	ACCCCGUCUCU
MIMAT0005891		GCUCU		GUCUUGCU		AAA
hsa-miR-1304	1284	UUUGAGGCUACAGUGAG	1285	UUUGAGGCUACA	1286	ACUGUAGCCUC
MIMAT0005892		AUGUG		GUGAGAUG		AAA
hsa-miR-1305	1287	UUUUCAACUCUAAUGGG	1288	UUUUCAACUCUA	1289	AUUAGAGUUGA
MIMAT0005893		AGAGA		AUGGGAGA		AAA
hsa-miR-1306	1290	ACGUUGGCUCUGGUGGU	1291	ACGUUGGCUCUG	1292	ACCAGAGCCAA
MIMAT0005950		G		GUGGUG		CGU
hsa-miR-1307	1293	ACUCGGCGUGGCGUCGG	1294	ACUCGGCGUGGC	1295	ACGCCACGCCG
MIMAT0005951		UCGUG		GUCGGUCG		AGU
hsa-miR-130a	1296	CAGUGCAAUGUUAAAAG	1297	CAGUGCAAUGUU	1298	UUAACAUUGCA
MIMAT0000425		GGCAU		AAAAGGGC		CUG
hsa-miR-130a*	1299	UUCACAUUGUGCUACUG	1300	UUCACAUUGUGC	1301	UAGCACAAUGU
MIMAT0004593		UCUGC		UACUGUCU		GAA
hsa-miR-130b	1302	CAGUGCAAUGAUGAAAG	1303	CAGUGCAAUGAU	1304	UCAUCAUUGCA
MIMAT0000691		GGCAU		GAAAGGGC		CUG
hsa-miR-130b*	1305	ACUCUUUCCCUGUUGCA	1306	ACUCUUUCCCUG	1307	AACAGGGAAAG
MIMAT0004680		CUAC		UUGCACUA		AGU
hsa-miR-132	1308	UAACAGUCUACAGCCAU	1309	UAACAGUCUACA	1310	GCUGUAGACUG
MIMAT0000426		GGUCG		GCCAUGGU		UUA
hsa-miR-132*	1311	ACCGUGGCUUUCGAUUG	1312	ACCGUGGCUUUC	1313	UCGAAAGCCAC
MIMAT0004594		UUACU		GAUUGUUA		GGU
hsa-miR-1321	1314	CAGGGAGGUGAAUGUGA	1315	CAGGGAGGUGAA	1316	CAUUCACCUCC
MIMAT0005952		U		UGUGAU		CUG
hsa-miR-1322	1317	GAUGAUGCUGCUGAUGC	1318	GAUGAUGCUGCU	1319	UCAGCAGCAUC
MIMAT0005953		UG		GAUGCUG		AUC
hsa-miR-1323	1320	UCAAAACUGAGGGGCAU	1321	UCAAAACUGAGG	1322	CCCCUCAGUUU
MIMAT0005795		UUUCU		GGCAUUUU		UGA
hsa-miR-1324	1323	CCAGACAGAAUUCUAUG	1324	CCAGACAGAAUU	1325	AGAAUUCUGUC
MIMAT0005956		CACUUUC		CUAUGCAC		UGG
hsa-miR-133a	1326	UUUGGUCCCCUUCAACC	1327	UUUGGUCCCCUU	1328	UGAAGGGGACC
MIMAT0000427		AGCUG		CAACCAGC		AAA
hsa-miR-133b	1329	UUUGGUCCCCUUCAACC	1330	UUUGGUCCCCUU	1331	UGAAGGGGACC
MIMAT0000770		AGCUA		CAACCAGC		AAA
hsa-miR-134	1332	UGUGACUGGUUGACCAG	1333	UGUGACUGGUUG	1334	GUCAACCAGUC
MIMAT0000447		AGGGG		ACCAGAGG		ACA
hsa-miR-135a	1335	UAUGGCUUUUUAUUCCU	1336	UAUGGCUUUUUA	1337	AAUAAAAAGCC
MIMAT0000428		AUGUGA		UUCCUAUG		AUA
hsa-miR-135a*	1338	UAUAGGGAUUGGAGCCG	1339	UAUAGGGAUUGG	1340	CUCCAAUCCCU
MIMAT0004595		UGGCG		AGCCGUGG		AUA
hsa-miR-135b	1341	UAUGGCUUUUCAUUCCU	1342	UAUGGCUUUUCA	1343	AAUGAAAAGCC
MIMAT0000758		AUGUGA		UUCCUAUG		AUA
hsa-miR-135b*	1344	AUGUAGGGCUAAAAGCC	1345	AUGUAGGGCUAA	1346	UUUUAGCCCUA
MIMAT0004698		AUGGG		AAGCCAUG		CAU
hsa-miR-136	1347	ACUCCAUUUGUUUUGAU	1348	ACUCCAUUUGUU	1349	AAAACAAAUGG
MIMAT0000448		GAUGGA		UUGAUGAU		AGU
hsa-miR-136*	1350	CAUCAUCGUCUCAAAUG	1351	CAUCAUCGUCUC	1352	UUGAGACGAUG
MIMAT0004606		AGUCU		AAAUGAGU		AUG
hsa-miR-137	1353	UUAUUGCUUAAGAAUAC	1354	UUAUUGCUUAAG	1355	UUCUUAAGCAA
MIMAT0000429		GCGUAG		AAUACGCG		UAA
hsa-miR-138	1356	AGCUGGUGUUGUGAAUC	1357	AGCUGGUGUUGU	1358	UCACAACACCA
MIMAT0000430		AGGCCG		GAAUCAGG		GCU
hsa-miR-138-1*	1359	GCUACUUCACAACACCA	1360	GCUACUUCACAA	1361	UGUUGUGAAGU
MIMAT0004607		GGGCC		CACCAGGG		AGC
hsa-miR-138-2*	1362	GCUAUUUCACGACACCA	1363	GCUAUUUCACGA	1364	UGUCGUGAAAU
MIMAT0004596		GGGUU		CACCAGGG		AGC
hsa-miR-139-3p	1365	GGAGACGCGGCCCUGUU	1366	GGAGACGCGGCC	1367	AGGGCCGCGUC
MIMAT0004552		GGAGU		CUGUUGGA		UCC
hsa-miR-139-5p	1368	UCUACAGUGCACGUGUC	1369	UCUACAGUGCAC	1370	ACGUGCACUGU
MIMAT0000250		UCCAG		GUGUCUCC		AGA
hsa-miR-140-3p	1371	UACCACAGGGUAGAACC	1372	UACCACAGGGUA	1373	UCUACCCUGUG
MIMAT0004597		ACGG		GAACCACG		GUA
hsa-miR-140-5p	1374	CAGUGGUUUUACCCUAU	1375	CAGUGGUUUUAC	1376	GGGUAAAACCA
MIMAT0000431		GGUAG		CCUAUGGU		CUG
hsa-miR-141	1377	UAACACUGUCUGGUAAA	1378	UAACACUGUCUG	1379	ACCAGACAGUG
MIMAT0000432		GAUGG		GUAAAGAU		UUA
hsa-miR-141*	1380	CAUCUUCCAGUACAGUG	1381	CAUCUUCCAGUA	1382	UGUACUGGAAG
MIMAT0004598		UUGGA		CAGUGUUG		AUG
hsa-miR-142-3p	1383	UGUAGUGUUUCCUACUU	1384	UGUAGUGUUUCC	1385	UAGGAAACACU
MIMAT0000434		UAUGGA		UACUUUAU		ACA
hsa-miR-142-5p	1386	CAUAAAGUAGAAAGCAC	1387	CAUAAAGUAGAA	1388	CUUUCUACUUU
MIMAT0000433		UACU		AGCACUAC		AUG
hsa-miR-143	1389	UGAGAUGAAGCACUGUA	1390	UGAGAUGAAGCA	1391	AGUGCUUCAUC
MIMAT0000435		GCUC		CUGUAGCU		UCA
hsa-miR-143*	1392	GGUGCAGUGCUGCAUCU	1393	GGUGCAGUGCUG	1394	UGCAGCACUGC
MIMAT0004599		CUGGU		CAUCUCUG		ACC
hsa-miR-144	1395	UACAGUAUAGAUGAUGU	1396	UACAGUAUAGAU	1397	UCAUCUAUACU
MIMAT0000436		ACU		GAUGUACU		GUA
hsa-miR-144*	1398	GGAUAUCAUCAUAUACU	1399	GGAUAUCAUCAU	1400	AUAUGAUGAUA
MIMAT0004600		GUAAG		AUACUGUA		UCC
hsa-miR-145	1401	GUCCAGUUUUCCCAGGA	1402	GUCCAGUUUUCC	1403	UGGGAAAACUG
MIMAT0000437		AUCCCU		CAGGAAUC		GAC
hsa-miR-145*	1404	GGAUUCCUGGAAAUACU	1405	GGAUUCCUGGAA	1406	AUUUCCAGGAA
MIMAT0004601		GUUCU		AUACUGUU		UCC
hsa-miR-1468	1407	CUCCGUUUGCCUGUUUC	1408	CUCCGUUUGCCU	1409	ACAGGCAAACG
MIMAT0006789		GCUG		GUUUCGCU		GAG
hsa-miR-1469	1410	CUCGGCGCGGGGCGCGG	1411	CUCGGCGCGGGG	1412	CGCCCCGCGCC
MIMAT0007347		GCUCC		CGCGGGCU		GAG
hsa-miR-146a	1413	UGAGAACUGAAUUCCAU	1414	UGAGAACUGAAU	1415	GAAUUCAGUUC
MIMAT0000449		GGGUU		UCCAUGGG		UCA
hsa-miR-146a*	1416	CCUCUGAAAUUCAGUUC	1417	CCUCUGAAAUUC	1418	CUGAAUUUCAG
MIMAT0004608		UUCAG		AGUUCUUC		AGG
hsa-miR-146b-	1419	UGCCCUGUGGACUCAGU	1420	UGCCCUGUGGAC	1421	GAGUCCACAGG
3p		UCUGG		UCAGUUCU		GCA
MIMAT0004766
hsa-miR-146b-	1422	UGAGAACUGAAUUCCAU	1423	UGAGAACUGAAU	1424	GAAUUCAGUUC
5p		AGGCU		UCCAUAGG		UCA
MIMAT0002809
hsa-miR-147	1425	GUGUGUGGAAAUGCUUC	1426	GUGUGUGGAAAU	1427	GCAUUUCCACA
MIMAT0000251		UGC		GCUUCUGC		CAC
hsa-miR-1470	1428	GCCCUCCGCCCGUGCAC	1429	GCCCUCCGCCCG	1430	CACGGGCGGAG
MIMAT0007348		CCCG		UGCACCCC		GGC
hsa-miR-1471	1431	GCCCGCGUGUGGAGCCA	1432	GCCCGCGUGUGG	1433	CUCCACACGCG
MIMAT0007349		GGUGU		AGCCAGGU		GGC
hsa-miR-147b	1434	GUGUGCGGAAAUGCUUC	1435	GUGUGCGGAAAU	1436	GCAUUUCCGCA
MIMAT0004928		UGCUA		GCUUCUGC		CAC
hsa-miR-148a	1437	UCAGUGCACUACAGAAC	1438	UCAGUGCACUAC	1439	CUGUAGUGCAC
MIMAT0000243		UUUGU		AGAACUUU		UGA
hsa-miR-148a*	1440	AAAGUUCUGAGACACUC	1441	AAAGUUCUGAGA	1442	UGUCUCAGAAC
MIMAT0004549		CGACU		CACUCCGA		UUU
hsa-miR-148b	1443	UCAGUGCAUCACAGAAC	1444	UCAGUGCAUCAC	1445	CUGUGAUGCAC
MIMAT0000759		UUUGU		AGAACUUU		UGA
hsa-miR-148b*	1446	AAGUUCUGUUAUACACU	1447	AAGUUCUGUUAU	1448	GUAUAACAGAA
MIMAT0004699		CAGGC		ACACUCAG		CUU
hsa-miR-149	1449	UCUGGCUCCGUGUCUUC	1450	UCUGGCUCCGUG	1451	GACACGGAGCC
MIMAT0000450		ACUCCC		UCUUCACU		AGA
hsa-miR-149*	1452	AGGGAGGGACGGGGGCU	1453	AGGGAGGGACGG	1454	CCCCGUCCCUC
MIMAT0004609		GUGC		GGGCUGUG		CCU
hsa-miR-150	1455	UCUCCCAACCCUUGUAC	1456	UCUCCCAACCCU	1457	CAAGGGUUGGG
MIMAT0000451		CAGUG		UGUACCAG		AGA
hsa-miR-150*	1458	CUGGUACAGGCCUGGGG	1459	CUGGUACAGGCC	1460	CAGGCCUGUAC
MIMAT0004610		GACAG		UGGGGGAC		CAG
hsa-miR-151-3p	1461	CUAGACUGAAGCUCCUU	1462	CUAGACUGAAGC	1463	GAGCUUCAGUC
MIMAT0000757		GAGG		UCCUUGAG		UAG
hsa-miR-151-5p	1464	UCGAGGAGCUCACAGUC	1465	UCGAGGAGCUCA	1466	UGUGAGCUCCU
MIMAT0004697		UAGU		CAGUCUAG		CGA
hsa-miR-152	1467	UCAGUGCAUGACAGAAC	1468	UCAGUGCAUGAC	1469	CUGUCAUGCAC
MIMAT0000438		UUGG		AGAACUUG		UGA
hsa-miR-153	1470	UUGCAUAGUCACAAAAG	1471	UUGCAUAGUCAC	1472	UUGUGACUAUG
MIMAT0000439		UGAUC		AAAAGUGA		CAA
hsa-miR-1537	1473	AAAACCGUCUAGUUACA	1474	AAAACCGUCUAG	1475	AACUAGACGGU
MIMAT0007399		GUUGU		UUACAGUU		UUU
hsa-miR-1538	1476	CGGCCCGGGCUGCUGCU	1477	CGGCCCGGGCUG	1478	AGCAGCCCGGG
MIMAT0007400		GUUCCU		CUGCUGUU		CCG
hsa-miR-1539	1479	UCCUGCGCGUCCCAGAU	1480	UCCUGCGCGUCC	1481	UGGGACGCGCA
MIMAT0007401		GCCC		CAGAUGCC		GGA
hsa-miR-154	1482	UAGGUUAUCCGUGUUGC	1483	UAGGUUAUCCGU	1484	ACACGGAUAAC
MIMAT0000452		CUUCG		GUUGCCUU		CUA
hsa-miR-154*	1485	AAUCAUACACGGUUGAC	1486	AAUCAUACACGG	1487	AACCGUGUAUG
MIMAT0000453		CUAUU		UUGACCUA		AUU
hsa-miR-155	1488	UUAAUGCUAAUCGUGAU	1489	UUAAUGCUAAUC	1490	ACGAUUAGCAU
MIMAT0000646		AGGGGU		GUGAUAGG		UAA
hsa-miR-155*	1491	CUCCUACAUAUUAGCAU	1492	CUCCUACAUAUU	1493	CUAAUAUGUAG
MIMAT0004658		UAACA		AGCAUUAA		GAG
hsa-miR-15a	1494	UAGCAGCACAUAAUGGU	1495	UAGCAGCACAUA	1496	AUUAUGUGCUG
MIMAT0000068		UUGUG		AUGGUUUG		CUA
hsa-miR-15a*	1497	CAGGCCAUAUUGUGCUG	1498	CAGGCCAUAUUG	1499	CACAAUAUGGC
MIMAT0004488		CCUCA		UGCUGCCU		CUG
hsa-miR-15b	1500	UAGCAGCACAUCAUGGU	1501	UAGCAGCACAUC	1502	AUGAUGUGCUG
MIMAT0000417		UUACA		AUGGUUUA		CUA
hsa-miR-15b*	1503	CGAAUCAUUAUUUGCUG	1504	CGAAUCAUUAUU	1505	CAAAUAAUGAU
MIMAT0004586		CUCUA		UGCUGCUC		UCG
hsa-miR-16	1506	UAGCAGCACGUAAAUAU	1507	UAGCAGCACGUA	1508	UUUACGUGCUG
MIMAT0000069		UGGCG		AAUAUUGG		CUA
hsa-miR-16-1*	1509	CCAGUAUUAACUGUGCU	1510	CCAGUAUUAACU	1511	ACAGUUAAUAC
MIMAT0004489		GCUGA		GUGCUGCU		UGG
hsa-miR-16-2*	1512	CCAAUAUUACUGUGCUG	1513	CCAAUAUUACUG	1514	CACAGUAAUAU
MIMAT0004518		CUUUA		UGCUGCUU		UGG
hsa-miR-17	1515	CAAAGUGCUUACAGUGC	1516	CAAAGUGCUUAC	1517	CUGUAAGCACU
MIMAT0000070		AGGUAG		AGUGCAGG		UUG
hsa-miR-17*	1518	ACUGCAGUGAAGGCACU	1519	ACUGCAGUGAAG	1520	GCCUUCACUGC
MIMAT0000071		UGUAG		GCACUUGU		AGU
hsa-miR-181a	1521	AACAUUCAACGCUGUCG	1522	AACAUUCAACGC	1523	CAGCGUUGAAU
MIMAT0000256		GUGAGU		UGUCGGUG		GUU
hsa-miR-181a*	1524	ACCAUCGACCGUUGAUU	1525	ACCAUCGACCGU	1526	CAACGGUCGAU
MIMAT0000270		GUACC		UGAUUGUA		GGU
hsa-miR-181a-	1527	ACCACUGACCGUUGACU	1528	ACCACUGACCGU	1529	CAACGGUCAGU
2*		GUACC		UGACUGUA		GGU
MIMAT0004558
hsa-miR-181b	1530	AACAUUCAUUGCUGUCG	1531	AACAUUCAUUGC	1532	CAGCAAUGAAU
MIMAT0000257		GUGGGU		UGUCGGUG		GUU
hsa-miR-181c	1533	AACAUUCAACCUGUCGG	1534	AACAUUCAACCU	1535	ACAGGUUGAAU
MIMAT0000258		UGAGU		GUCGGUGA		GUU
hsa-miR-181c*	1536	AACCAUCGACCGUUGAG	1537	AACCAUCGACCG	1538	AACGGUCGAUG
MIMAT0004559		UGGAC		UUGAGUGG		GUU
hsa-miR-181d	1539	AACAUUCAUUGUUGUCG	1540	AACAUUCAUUGU	1541	CAACAAUGAAU
MIMAT0002821		GUGGGU		UGUCGGUG		GUU
hsa-miR-182	1542	UUUGGCAAUGGUAGAAC	1543	UUUGGCAAUGGU	1544	CUACCAUUGCC
MIMAT0000259		UCACACU		AGAACUCA		AAA
hsa-miR-182*	1545	UGGUUCUAGACUUGCCA	1546	UGGUUCUAGACU	1547	CAAGUCUAGAA
MIMAT0000260		ACUA		UGCCAACU		CCA
hsa-miR-1825	1548	UCCAGUGCCCUCCUCUC	1549	UCCAGUGCCCUC	1550	AGGAGGGCACU
MIMAT0006765		C		CUCUCC		GGA
hsa-miR-1827	1551	UGAGGCAGUAGAUUGAA	1552	UGAGGCAGUAGA	1553	AAUCUACUGCC
MIMAT0006767		U		UUGAAU		UCA
hsa-miR-183	1554	UAUGGCACUGGUAGAAU	1555	UAUGGCACUGGU	1556	CUACCAGUGCC
MIMAT0000261		UCACU		AGAAUUCA		AUA
hsa-miR-183*	1557	GUGAAUUACCGAAGGGC	1558	GUGAAUUACCGA	1559	CUUCGGUAAUU
MIMAT0004560		CAUAA		AGGGCCAU		CAC
hsa-miR-184	1560	UGGACGGAGAACUGAUA	1561	UGGACGGAGAAC	1562	CAGUUCUCCGU
MIMAT0000454		AGGGU		UGAUAAGG		CCA
hsa-miR-185	1563	UGGAGAGAAAGGCAGUU	1564	UGGAGAGAAAGG	1565	UGCCUUUCUCU
MIMAT0000455		CCUGA		CAGUUCCU		CCA
hsa-miR-185*	1566	AGGGGCUGGCUUUCCUC	1567	AGGGGCUGGCUU	1568	GAAAGCCAGCC
MIMAT0004611		UGGUC		UCCUCUGG		CCU
hsa-miR-186	1569	CAAAGAAUUCUCCUUUU	1570	CAAAGAAUUCUC	1571	AGGAGAAUUCU
MIMAT0000456		GGGCU		CUUUUGGG		UUG
hsa-miR-186*	1572	GCCCAAAGGUGAAUUUU	1573	GCCCAAAGGUGA	1574	AUUCACCUUUG
MIMAT0004612		UUGGG		AUUUUUUG		GGC
hsa-miR-187	1575	UCGUGUCUUGUGUUGCA	1576	UCGUGUCUUGUG	1577	AACACAAGACA
MIMAT0000262		GCCGG		UUGCAGCC		CGA
hsa-miR-187*	1578	GGCUACAACACAGGACC	1579	GGCUACAACACA	1580	CCUGUGUUGUA
MIMAT0004561		CGGGC		GGACCCGG		GCC
hsa-miR-188-3p	1581	CUCCCACAUGCAGGGUU	1582	CUCCCACAUGCA	1583	CCUGCAUGUGG
MIMAT0004613		UGCA		GGGUUUGC		GAG
hsa-miR-188-5p	1584	CAUCCCUUGCAUGGUGG	1585	CAUCCCUUGCAU	1586	CCAUGCAAGGG
MIMAT0000457		AGGG		GGUGGAGG		AUG
hsa-miR-18a	1587	UAAGGUGCAUCUAGUGC	1588	UAAGGUGCAUCU	1589	CUAGAUGCACC
MIMAT0000072		AGAUAG		AGUGCAGA		UUA
hsa-miR-18a*	1590	ACUGCCCUAAGUGCUCC	1591	ACUGCCCUAAGU	1592	GCACUUAGGGC
MIMAT0002891		UUCUGG		GCUCCUUC		AGU
hsa-miR-18b	1593	UAAGGUGCAUCUAGUGC	1594	UAAGGUGCAUCU	1595	CUAGAUGCACC
MIMAT0001412		AGUUAG		AGUGCAGU		UUA
hsa-miR-18b*	1596	UGCCCUAAAUGCCCCUU	1597	UGCCCUAAAUGC	1598	GGGCAUUUAGG
MIMAT0004751		CUGGC		CCCUUCUG		GCA
hsa-miR-190	1599	UGAUAUGUUUGAUAUAU	1600	UGAUAUGUUUGA	1601	UAUCAAACAUA
MIMAT0000458		UAGGU		UAUAUUAG		UCA
hsa-miR-1908	1602	CGGCGGGGACGGCGAUU	1603	CGGCGGGGACGG	1604	CGCCGUCCCCG
MIMAT0007881		GGUC		CGAUUGGU		CCG
hsa-miR-1909	1605	CGCAGGGGCCGGGUGCU	1606	CGCAGGGGCCGG	1607	ACCCGGCCCCU
MIMAT0007883		CACCG		GUGCUCAC		GCG
hsa-miR-1909*	1608	UGAGUGCCGGUGCCUGC	1609	UGAGUGCCGGUG	1610	GGCACCGGCAC
MIMAT0007882		CCUG		CCUGCCCU		UCA
hsa-miR-190b	1611	UGAUAUGUUUGAUAUUG	1612	UGAUAUGUUUGA	1613	UAUCAAACAUA
MIMAT0004929		GGUU		UAUUGGGU		UCA
hsa-miR-191	1614	CAACGGAAUCCCAAAAG	1615	CAACGGAAUCCC	1616	UUGGGAUUCCG
MIMAT0000440		CAGCUG		AAAAGCAG		UUG
hsa-miR-191*	1617	GCUGCGCUUGGAUUUCG	1618	GCUGCGCUUGGA	1619	AAUCCAAGCGC
MIMAT0001618		UCCCC		UUUCGUCC		AGC
hsa-miR-1910	1620	CCAGUCCUGUGCCUGCC	1621	CCAGUCCUGUGC	1622	AGGCACAGGAC
MIMAT0007884		GCCU		CUGCCGCC		UGG
hsa-miR-1911	1623	UGAGUACCGCCAUGUCU	1624	UGAGUACCGCCA	1625	CAUGGCGGUAC
MIMAT0007885		GUUGGG		UGUCUGUU		UCA
hsa-miR-1911*	1626	CACCAGGCAUUGUGGUC	1627	CACCAGGCAUUG	1628	CACAAUGCCUG
MIMAT0007886		UCC		UGGUCUCC		GUG
hsa-miR-1912	1629	UACCCAGAGCAUGCAGU	1630	UACCCAGAGCAU	1631	GCAUGCUCUGG
MIMAT0007887		GUGAA		GCAGUGUG		GUA
hsa-miR-1913	1632	UCUGCCCCCUCCGCUGC	1633	UCUGCCCCCUCC	1634	GCGGAGGGGGC
MIMAT0007888		UGCCA		GCUGCUGC		AGA
hsa-miR-1914	1635	CCCUGUGCCCGGCCCAC	1636	CCCUGUGCCCGG	1637	GGCCGGGCACA
MIMAT0007889		UUCUG		CCCACUUC		GGG
hsa-miR-1914*	1638	GGAGGGGUCCCGCACUG	1639	GGAGGGGUCCCG	1640	UGCGGGACCCC
MIMAT0007890		GGAGG		CACUGGGA		UCC
hsa-miR-1915	1641	CCCCAGGGCGACGCGGC	1642	CCCCAGGGCGAC	1643	GCGUCGCCCUG
MIMAT0007892		GGG		GCGGCGGG		GGG
hsa-miR-1915*	1644	ACCUUGCCUUGCUGCCC	1645	ACCUUGCCUUGC	1646	CAGCAAGGCAA
MIMAT0007891		GGGCC		UGCCCGGG		GGU
hsa-miR-192	1647	CUGACCUAUGAAUUGAC	1648	CUGACCUAUGAA	1649	AAUUCAUAGGU
MIMAT0000222		AGCC		UUGACAGC		CAG
hsa-miR-192*	1650	CUGCCAAUUCCAUAGGU	1651	CUGCCAAUUCCA	1652	UAUGGAAUUGG
MIMAT0004543		CACAG		UAGGUCAC		CAG
hsa-miR-193a-	1653	AACUGGCCUACAAAGUC	1654	AACUGGCCUACA	1655	UUUGUAGGCCA
3p		CCAGU		AAGUCCCA		GUU
MIMAT0000459
hsa-miR-193a-	1656	UGGGUCUUUGCGGGCGA	1657	UGGGUCUUUGCG	1658	CCCGCAAAGAC
5p		GAUGA		GGCGAGAU		CCA
MIMAT0004614
hsa-miR-193b	1659	AACUGGCCCUCAAAGUC	1660	AACUGGCCCUCA	1661	UUUGAGGGCCA
MIMAT0002819		CCGCU		AAGUCCCG		GUU
hsa-miR-193b*	1662	CGGGGUUUUGAGGGCGA	1663	CGGGGUUUUGAG	1664	CCCUCAAAACC
MIMAT0004767		GAUGA		GGCGAGAU		CCG
hsa-miR-194	1665	UGUAACAGCAACUCCAU	1666	UGUAACAGCAAC	1667	GAGUUGCUGUU
MIMAT0000460		GUGGA		UCCAUGUG		ACA
hsa-miR-194*	1668	CCAGUGGGGCUGCUGUU	1669	CCAGUGGGGCUG	1670	AGCAGCCCCAC
MIMAT0004671		AUCUG		CUGUUAUC		UGG
hsa-miR-195	1671	UAGCAGCACAGAAAUAU	1672	UAGCAGCACAGA	1673	UUUCUGUGCUG
MIMAT0000461		UGGC		AAUAUUGG		CUA
hsa-miR-195*	1674	CCAAUAUUGGCUGUGCU	1675	CCAAUAUUGGCU	1676	ACAGCCAAUAU
MIMAT0004615		GCUCC		GUGCUGCU		UGG
hsa-miR-196a	1677	UAGGUAGUUUCAUGUUG	1678	UAGGUAGUUUCA	1679	CAUGAAACUAC
MIMAT0000226		UUGGG		UGUUGUUG		CUA
hsa-miR-196a*	1680	CGGCAACAAGAAACUGC	1681	CGGCAACAAGAA	1682	GUUUCUUGUUG
MIMAT0004562		CUGAG		ACUGCCUG		CCG
hsa-miR-196b	1683	UAGGUAGUUUCCUGUUG	1684	UAGGUAGUUUCC	1685	CAGGAAACUAC
MIMAT0001080		UUGGG		UGUUGUUG		CUA
hsa-miR-196b*	1686	UCGACAGCACGACACUG	1687	UCGACAGCACGA	1688	UGUCGUGCUGU
MIMAT0009201		CCUUC		CACUGCCU		CGA
hsa-miR-197	1689	UUCACCACCUUCUCCAC	1690	UUCACCACCUUC	1691	GAGAAGGUGGU
MIMAT0000227		CCAGC		UCCACCCA		GAA
hsa-miR-1972	1692	UCAGGCCAGGCACAGUG	1693	UCAGGCCAGGCA	1694	UGUGCCUGGCC
MIMAT0009447		GCUCA		CAGUGGCU		UGA
hsa-miR-1973	1695	ACCGUGCAAAGGUAGCA	1696	ACCGUGCAAAGG	1697	UACCUUUGCAC
MIMAT0009448		UA		UAGCAUA		GGU
hsa-miR-1976	1698	CCUCCUGCCCUCCUUGC	1699	CCUCCUGCCCUC	1700	AGGAGGGCAGG
MIMAT0009451		UGU		CUUGCUGU		AGG
hsa-miR-198	1701	GGUCCAGAGGGGAGAUA	1702	GGUCCAGAGGGG	1703	CUCCCCUCUGG
MIMAT0000228		GGUUC		AGAUAGGU		ACC
hsa-miR-199a-	1704	ACAGUAGUCUGCACAUU	1705	ACAGUAGUCUGC	1706	GUGCAGACUAC
3p		GGUUA		ACAUUGGU		UGU
MIMAT0000232
hsa-miR-199a-	1707	CCCAGUGUUCAGACUAC	1708	CCCAGUGUUCAG	1709	GUCUGAACACU
5p		CUGUUC		ACUACCUG		GGG
MIMAT0000231
hsa-miR-199b-	1710	ACAGUAGUCUGCACAUU	1711	ACAGUAGUCUGC	1712	GUGCAGACUAC
3p		GGUUA		ACAUUGGU		UGU
MIMAT0004563
hsa-miR-199b-	1713	CCCAGUGUUUAGACUAU	1714	CCCAGUGUUUAG	1715	GUCUAAACACU
5p		CUGUUC		ACUAUCUG		GGG
MIMAT0000263
hsa-miR-19a	1716	UGUGCAAAUCUAUGCAA	1717	UGUGCAAAUCUA	1718	CAUAGAUUUGC
MIMAT0000073		AACUGA		UGCAAAAC		ACA
hsa-miR-19a*	1719	AGUUUUGCAUAGUUGCA	1720	AGUUUUGCAUAG	1721	AACUAUGCAAA
MIMAT0004490		CUACA		UUGCACUA		ACU
hsa-miR-19b	1722	UGUGCAAAUCCAUGCAA	1723	UGUGCAAAUCCA	1724	CAUGGAUUUGC
MIMAT0000074		AACUGA		UGCAAAAC		ACA
hsa-miR-19b-1*	1725	AGUUUUGCAGGUUUGCA	1726	AGUUUUGCAGGU	1727	AAACCUGCAAA
MIMAT0004491		UCCAGC		UUGCAUCC		ACU
hsa-miR-19b-2*	1728	AGUUUUGCAGGUUUGCA	1729	AGUUUUGCAGGU	1730	AAACCUGCAAA
MIMAT0004492		UUUCA		UUGCAUUU		ACU
hsa-miR-200a	1731	UAACACUGUCUGGUAAC	1732	UAACACUGUCUG	1733	ACCAGACAGUG
MIMAT0000682		GAUGU		GUAACGAU		UUA
hsa-miR-200a*	1734	CAUCUUACCGGACAGUG	1735	CAUCUUACCGGA	1736	UGUCCGGUAAG
MIMAT0001620		CUGGA		CAGUGCUG		AUG
hsa-miR-200b	1737	UAAUACUGCCUGGUAAU	1738	UAAUACUGCCUG	1739	ACCAGGCAGUA
MIMAT0000318		GAUGA		GUAAUGAU		UUA
hsa-miR-200b*	1740	CAUCUUACUGGGCAGCA	1741	CAUCUUACUGGG	1742	UGCCCAGUAAG
MIMAT0004571		UUGGA		CAGCAUUG		AUG
hsa-miR-200c	1743	UAAUACUGCCGGGUAAU	1744	UAAUACUGCCGG	1745	ACCCGGCAGUA
MIMAT0000617		GAUGGA		GUAAUGAU		UUA
hsa-miR-200c*	1746	CGUCUUACCCAGCAGUG	1747	CGUCUUACCCAG	1748	UGCUGGGUAAG
MIMAT0004657		UUUGG		CAGUGUUU		ACG
hsa-miR-202	1749	AGAGGUAUAGGGCAUGG	1750	AGAGGUAUAGGG	1751	UGCCCUAUACC
MIMAT0002811		GAA		CAUGGGAA		UCU
hsa-miR-202*	1752	UUCCUAUGCAUAUACUU	1753	UUCCUAUGCAUA	1754	UAUAUGCAUAG
MIMAT0002810		CUUUG		UACUUCUU		GAA
hsa-miR-203	1755	GUGAAAUGUUUAGGACC	1756	GUGAAAUGUUUA	1757	CCUAAACAUUU
MIMAT0000264		ACUAG		GGACCACU		CAC
hsa-miR-204	1758	UUCCCUUUGUCAUCCUA	1759	UUCCCUUUGUCA	1760	GAUGACAAAGG
MIMAT0000265		UGCCU		UCCUAUGC		GAA
hsa-miR-205	1761	UCCUUCAUUCCACCGGA	1762	UCCUUCAUUCCA	1763	GGUGGAAUGAA
MIMAT0000266		GUCUG		CCGGAGUC		GGA
hsa-miR-205*	1764	GAUUUCAGUGGAGUGAA	1765	GAUUUCAGUGGA	1766	ACUCCACUGAA
MIMAT0009197		GUUC		GUGAAGUU		AUC
hsa-miR-2052	1767	UGUUUUGAUAACAGUAA	1768	UGUUUUGAUAAC	1769	CUGUUAUCAAA
MIMAT0009977		UGU		AGUAAUGU		ACA
hsa-miR-2053	1770	GUGUUAAUUAAACCUCU	1771	GUGUUAAUUAAA	1772	GGUUUAAUUAA
MIMAT0009978		AUUUAC		CCUCUAUU		CAC
hsa-miR-2054	1773	CUGUAAUAUAAAUUUAA	1774	CUGUAAUAUAAA	1775	AAUUUAUAUUA
MIMAT0009979		UUUAUU		UUUAAUUU		CAG
hsa-miR-206	1776	UGGAAUGUAAGGAAGUG	1777	UGGAAUGUAAGG	1778	UUCCUUACAUU
MIMAT0000462		UGUGG		AAGUGUGU		CCA
hsa-miR-208a	1779	AUAAGACGAGCAAAAAG	1780	AUAAGACGAGCA	1781	UUUGCUCGUCU
MIMAT0000241		CUUGU		AAAAGCUU		UAU
hsa-miR-208b	1782	AUAAGACGAACAAAAGG	1783	AUAAGACGAACA	1784	UUUGUUCGUCU
MIMAT0004960		UUUGU		AAAGGUUU		UAU
hsa-miR-20a	1785	UAAAGUGCUUAUAGUGC	1786	UAAAGUGCUUAU	1787	CUAUAAGCACU
MIMAT0000075		AGGUAG		AGUGCAGG		UUA
hsa-miR-20a*	1788	ACUGCAUUAUGAGCACU	1789	ACUGCAUUAUGA	1790	GCUCAUAAUGC
MIMAT0004493		UAAAG		GCACUUAA		AGU
hsa-miR-20b	1791	CAAAGUGCUCAUAGUGC	1792	CAAAGUGCUCAU	1793	CUAUGAGCACU
MIMAT0001413		AGGUAG		AGUGCAGG		UUG
hsa-miR-20b*	1794	ACUGUAGUAUGGGCACU	1795	ACUGUAGUAUGG	1796	GCCCAUACUAC
MIMAT0004752		UCCAG		GCACUUCC		AGU
hsa-miR-21	1797	UAGCUUAUCAGACUGAU	1798	UAGCUUAUCAGA	1799	AGUCUGAUAAG
MIMAT0000076		GUUGA		CUGAUGUU		CUA
hsa-miR-21*	1800	CAACACCAGUCGAUGGG	1801	CAACACCAGUCG	1802	AUCGACUGGUG
MIMAT0004494		CUGU		AUGGGCUG		UUG
hsa-miR-210	1803	CUGUGCGUGUGACAGCG	1804	CUGUGCGUGUGA	1805	UGUCACACGCA
MIMAT0000267		GCUGA		CAGCGGCU		CAG
hsa-miR-211	1806	UUCCCUUUGUCAUCCUU	1807	UUCCCUUUGUCA	1808	GAUGACAAAGG
MIMAT0000268		CGCCU		UCCUUCGC		GAA
hsa-miR-2110	1809	UUGGGGAAACGGCCGCU	1810	UUGGGGAAACGG	1811	GGCCGUUUCCC
MIMAT0010133		GAGUG		CCGCUGAG		CAA
hsa-miR-2113	1812	AUUUGUGCUUGGCUCUG	1813	AUUUGUGCUUGG	1814	AGCCAAGCACA
MIMAT0009206		UCAC		CUCUGUCA		AAU
hsa-miR-2114	1815	UAGUCCCUUCCUUGAAG	1816	UAGUCCCUUCCU	1817	CAAGGAAGGGA
MIMAT0011156		CGGUC		UGAAGCGG		CUA
hsa-miR-2114*	1818	CGAGCCUCAAGCAAGGG	1819	CGAGCCUCAAGC	1820	UUGCUUGAGGC
MIMAT0011157		ACUU		AAGGGACU		UCG
hsa-miR-2115	1821	AGCUUCCAUGACUCCUG	1822	AGCUUCCAUGAC	1823	GAGUCAUGGAA
MIMAT0011158		AUGGA		UCCUGAUG		GCU
hsa-miR-2115*	1824	CAUCAGAAUUCAUGGAG	1825	CAUCAGAAUUCA	1826	CAUGAAUUCUG
MIMAT0011159		GCUAG		UGGAGGCU		AUG
hsa-miR-2116	1827	GGUUCUUAGCAUAGGAG	1828	GGUUCUUAGCAU	1829	CUAUGCUAAGA
MIMAT0011160		GUCU		AGGAGGUC		ACC
hsa-miR-2116*	1830	CCUCCCAUGCCAAGAAC	1831	CCUCCCAUGCCA	1832	CUUGGCAUGGG
MIMAT0011161		UCCC		AGAACUCC		AGG
hsa-miR-2117	1833	UGUUCUCUUUGCCAAGG	1834	UGUUCUCUUUGC	1835	UGGCAAAGAGA
MIMAT0011162		ACAG		CAAGGACA		ACA
hsa-miR-212	1836	UAACAGUCUCCAGUCAC	1837	UAACAGUCUCCA	1838	ACUGGAGACUG
MIMAT0000269		GGCC		GUCACGGC		UUA
hsa-miR-214	1839	ACAGCAGGCACAGACAG	1840	ACAGCAGGCACA	1841	UCUGUGCCUGC
MIMAT0000271		GCAGU		GACAGGCA		UGU
hsa-miR-214*	1842	UGCCUGUCUACACUUGC	1843	UGCCUGUCUACA	1844	AGUGUAGACAG
MIMAT0004564		UGUGC		CUUGCUGU		GCA
hsa-miR-215	1845	AUGACCUAUGAAUUGAC	1846	AUGACCUAUGAA	1847	AAUUCAUAGGU
MIMAT0000272		AGAC		UUGACAGA		CAU
hsa-miR-216a	1848	UAAUCUCAGCUGGCAAC	1849	UAAUCUCAGCUG	1850	GCCAGCUGAGA
MIMAT0000273		UGUGA		GCAACUGU		UUA
hsa-miR-216b	1851	AAAUCUCUGCAGGCAAA	1852	AAAUCUCUGCAG	1853	GCCUGCAGAGA
MIMAT0004959		UGUGA		GCAAAUGU		UUU
hsa-miR-217	1854	UACUGCAUCAGGAACUG	1855	UACUGCAUCAGG	1856	UUCCUGAUGCA
MIMAT0000274		AUUGGA		AACUGAUU		GUA
hsa-miR-218	1857	UUGUGCUUGAUCUAACC	1858	UUGUGCUUGAUC	1859	UAGAUCAAGCA
MIMAT0000275		AUGU		UAACCAUG		CAA
hsa-miR-218-1*	1860	AUGGUUCCGUCAAGCAC	1861	AUGGUUCCGUCA	1862	CUUGACGGAAC
MIMAT0004565		CAUGG		AGCACCAU		CAU
hsa-miR-218-2*	1863	CAUGGUUCUGUCAAGCA	1864	CAUGGUUCUGUC	1865	UUGACAGAACC
MIMAT0004566		CCGCG		AAGCACCG		AUG
hsa-miR-219-1-	1866	AGAGUUGAGUCUGGACG	1867	AGAGUUGAGUCU	1868	CCAGACUCAAC
3p		UCCCG		GGACGUCC		UCU
MIMAT0004567
hsa-miR-219-2-	1869	AGAAUUGUGGCUGGACA	1870	AGAAUUGUGGCU	1871	CCAGCCACAAU
3p		UCUGU		GGACAUCU		UCU
MIMAT0004675
hsa-miR-219-5p	1872	UGAUUGUCCAAACGCAA	1873	UGAUUGUCCAAA	1874	CGUUUGGACAA
MIMAT0000276		UUCU		CGCAAUUC		UCA
hsa-miR-22	1875	AAGCUGCCAGUUGAAGA	1876	AAGCUGCCAGUU	1877	UCAACUGGCAG
MIMAT0000077		ACUGU		GAAGAACU		CUU
hsa-miR-22*	1878	AGUUCUUCAGUGGCAAG	1879	AGUUCUUCAGUG	1880	GCCACUGAAGA
MIMAT0004495		CUUUA		GCAAGCUU		ACU
hsa-miR-221	1881	AGCUACAUUGUCUGCUG	1882	AGCUACAUUGUC	1883	CAGACAAUGUA
MIMAT0000278		GGUUUC		UGCUGGGU		GCU
hsa-miR-221*	1884	ACCUGGCAUACAAUGUA	1885	ACCUGGCAUACA	1886	AUUGUAUGCCA
MIMAT0004568		GAUUU		AUGUAGAU		GGU
hsa-miR-222	1887	AGCUACAUCUGGCUACU	1888	AGCUACAUCUGG	1889	AGCCAGAUGUA
MIMAT0000279		GGGU		CUACUGGG		GCU
hsa-miR-222*	1890	CUCAGUAGCCAGUGUAG	1891	CUCAGUAGCCAG	1892	CACUGGCUACU
MIMAT0004569		AUCCU		UGUAGAUC		GAG
hsa-miR-223	1893	UGUCAGUUUGUCAAAUA	1894	UGUCAGUUUGUC	1895	UUGACAAACUG
MIMAT0000280		CCCCA		AAAUACCC		ACA
hsa-miR-223*	1896	CGUGUAUUUGACAAGCU	1897	CGUGUAUUUGAC	1898	UUGUCAAAUAC
MIMAT0004570		GAGUU		AAGCUGAG		ACG
hsa-miR-224	1899	CAAGUCACUAGUGGUUC	1900	CAAGUCACUAGU	1901	CCACUAGUGAC
MIMAT0000281		CGUU		GGUUCCGU		UUG
hsa-miR-224*	1902	AAAAUGGUGCCCUAGUG	1903	AAAAUGGUGCCC	1904	UAGGGCACCAU
MIMAT0009198		ACUACA		UAGUGACU		UUU
hsa-miR-2276	1905	UCUGCAAGUGUCAGAGG	1906	UCUGCAAGUGUC	1907	CUGACACUUGC
MIMAT0011775		CGAGG		AGAGGCGA		AGA
hsa-miR-2277-	1908	UGACAGCGCCCUGCCUG	1909	UGACAGCGCCCU	1910	GCAGGGCGCUG
3p		GCUC		GCCUGGCU		UCA
MIMAT0011777
hsa-miR-2277-	1911	AGCGCGGGCUGAGCGCU	1912	AGCGCGGGCUGA	1913	GCUCAGCCCGC
5p		GCCAGUC		GCGCUGCC		GCU
MIMAT0017352
hsa-miR-2278	1914	GAGAGCAGUGUGUGUUG	1915	GAGAGCAGUGUG	1916	CACACACUGCU
MIMAT0011778		CCUGG		UGUUGCCU		CUC
hsa-miR-2355-	1917	AUUGUCCUUGCUGUUUG	1918	AUUGUCCUUGCU	1919	ACAGCAAGGAC
3p		GAGAU		GUUUGGAG		AAU
MIMAT0017950
hsa-miR-2355-	1920	AUCCCCAGAUACAAUGG	1921	AUCCCCAGAUAC	1922	UUGUAUCUGGG
5p		ACAA		AAUGGACA		GAU
MIMAT0016895
hsa-miR-23a	1923	AUCACAUUGCCAGGGAU	1924	AUCACAUUGCCA	1925	CCUGGCAAUGU
MIMAT0000078		UUCC		GGGAUUUC		GAU
hsa-miR-23a*	1926	GGGGUUCCUGGGGAUGG	1927	GGGGUUCCUGGG	1928	UCCCCAGGAAC
MIMAT0004496		GAUUU		GAUGGGAU		CCC
hsa-miR-23b	1929	AUCACAUUGCCAGGGAU	1930	AUCACAUUGCCA	1931	CCUGGCAAUGU
MIMAT0000418		UACC		GGGAUUAC		GAU
hsa-miR-23b*	1932	UGGGUUCCUGGCAUGCU	1933	UGGGUUCCUGGC	1934	AUGCCAGGAAC
MIMAT0004587		GAUUU		AUGCUGAU		CCA
hsa-miR-23c	1935	AUCACAUUGCCAGUGAU	1936	AUCACAUUGCCA	1937	ACUGGCAAUGU
MIMAT0018000		UACCC		GUGAUUAC		GAU
hsa-miR-24	1938	UGGCUCAGUUCAGCAGG	1939	UGGCUCAGUUCA	1940	GCUGAACUGAG
MIMAT0000080		AACAG		GCAGGAAC		CCA
hsa-miR-24-1*	1941	UGCCUACUGAGCUGAUA	1942	UGCCUACUGAGC	1943	CAGCUCAGUAG
MIMAT0000079		UCAGU		UGAUAUCA		GCA
hsa-miR-24-2*	1944	UGCCUACUGAGCUGAAA	1945	UGCCUACUGAGC	1946	CAGCUCAGUAG
MIMAT0004497		CACAG		UGAAACAC		GCA
hsa-miR-25	1947	CAUUGCACUUGUCUCGG	1948	CAUUGCACUUGU	1949	AGACAAGUGCA
MIMAT0000081		UCUGA		CUCGGUCU		AUG
hsa-miR-25*	1950	AGGCGGAGACUUGGGCA	1951	AGGCGGAGACUU	1952	CCAAGUCUCCG
MIMAT0004498		AUUG		GGGCAAUU		CCU
hsa-miR-26a	1953	UUCAAGUAAUCCAGGAU	1954	UUCAAGUAAUCC	1955	CUGGAUUACUU
MIMAT0000082		AGGCU		AGGAUAGG		GAA
hsa-miR-26a-1*	1956	CCUAUUCUUGGUUACUU	1957	CCUAUUCUUGGU	1958	UAACCAAGAAU
MIMAT0004499		GCACG		UACUUGCA		AGG
hsa-miR-26a-2*	1959	CCUAUUCUUGAUUACUU	1960	CCUAUUCUUGAU	1961	UAAUCAAGAAU
MIMAT0004681		GUUUC		UACUUGUU		AGG
hsa-miR-26b	1962	UUCAAGUAAUUCAGGAU	1963	UUCAAGUAAUUC	1964	CUGAAUUACUU
MIMAT0000083		AGGU		AGGAUAGG		GAA
hsa-miR-26b*	1965	CCUGUUCUCCAUUACUU	1966	CCUGUUCUCCAU	1967	UAAUGGAGAAC
MIMAT0004500		GGCUC		UACUUGGC		AGG
hsa-miR-27a	1968	UUCACAGUGGCUAAGUU	1969	UUCACAGUGGCU	1970	UUAGCCACUGU
MIMAT0000084		CCGC		AAGUUCCG		GAA
hsa-miR-27a*	1971	AGGGCUUAGCUGCUUGU	1972	AGGGCUUAGCUG	1973	AGCAGCUAAGC
MIMAT0004501		GAGCA		CUUGUGAG		CCU
hsa-miR-27b	1974	UUCACAGUGGCUAAGUU	1975	UUCACAGUGGCU	1976	UUAGCCACUGU
MIMAT0000419		CUGC		AAGUUCUG		GAA
hsa-miR-27b*	1977	AGAGCUUAGCUGAUUGG	1978	AGAGCUUAGCUG	1979	AUCAGCUAAGC
MIMAT0004588		UGAAC		AUUGGUGA		UCU
hsa-miR-28-3p	1980	CACUAGAUUGUGAGCUC	1981	CACUAGAUUGUG	1982	CUCACAAUCUA
MIMAT0004502		CUGGA		AGCUCCUG		GUG
hsa-miR-28-5p	1983	AAGGAGCUCACAGUCUA	1984	AAGGAGCUCACA	1985	ACUGUGAGCUC
MIMAT0000085		UUGAG		GUCUAUUG		CUU
hsa-miR-2861	1986	GGGGCCUGGCGGUGGGC	1987	GGGGCCUGGCGG	1988	CACCGCCAGGC
MIMAT0013802		GG		UGGGCGG		CCC
hsa-miR-2909	1989	GUUAGGGCCAACAUCUC	1990	GUUAGGGCCAAC	1991	AUGUUGGCCCU
MIMAT0013863		UUGG		AUCUCUUG		AAC
hsa-miR-296-3p	1992	GAGGGUUGGGUGGAGGC	1993	GAGGGUUGGGUG	1994	UCCACCCAACC
MIMAT0004679		UCUCC		GAGGCUCU		CUC
hsa-miR-296-5p	1995	AGGGCCCCCCCUCAAUC	1996	AGGGCCCCCCCU	1997	UGAGGGGGGGC
MIMAT0000690		CUGU		CAAUCCUG		CCU
hsa-miR-297	1998	AUGUAUGUGUGCAUGUG	1999	AUGUAUGUGUGC	2000	AUGCACACAUA
MIMAT0004450		CAUG		AUGUGCAU		CAU
hsa-miR-298	2001	AGCAGAAGCAGGGAGGU	2002	AGCAGAAGCAGG	2003	UCCCUGCUUCU
MIMAT0004901		UCUCCCA		GAGGUUCU		GCU
hsa-miR-299-3p	2004	UAUGUGGGAUGGUAAAC	2005	UAUGUGGGAUGG	2006	UACCAUCCCAC
MIMAT0000687		CGCUU		UAAACCGC		AUA
hsa-miR-299-5p	2007	UGGUUUACCGUCCCACA	2008	UGGUUUACCGUC	2009	GGGACGGUAAA
MIMAT0002890		UACAU		CCACAUAC		CCA
hsa-miR-29a	2010	UAGCACCAUCUGAAAUC	2011	UAGCACCAUCUG	2012	UUCAGAUGGUG
MIMAT0000086		GGUUA		AAAUCGGU		CUA
hsa-miR-29a*	2013	ACUGAUUUCUUUUGGUG	2014	ACUGAUUUCUUU	2015	CAAAAGAAAUC
MIMAT0004503		UUCAG		UGGUGUUC		AGU
hsa-miR-29b	2016	UAGCACCAUUUGAAAUC	2017	UAGCACCAUUUG	2018	UUCAAAUGGUG
MIMAT0000100		AGUGUU		AAAUCAGU		CUA
hsa-miR-29b-1*	2019	GCUGGUUUCAUAUGGUG	2020	GCUGGUUUCAUA	2021	CAUAUGAAACC
MIMAT0004514		GUUUAGA		UGGUGGUU		AGC
hsa-miR-29b-2*	2022	CUGGUUUCACAUGGUGG	2023	CUGGUUUCACAU	2024	CCAUGUGAAAC
MIMAT0004515		CUUAG		GGUGGCUU		CAG
hsa-miR-29c	2025	UAGCACCAUUUGAAAUC	2026	UAGCACCAUUUG	2027	UUCAAAUGGUG
MIMAT0000681		GGUUA		AAAUCGGU		CUA
hsa-miR-29c*	2028	UGACCGAUUUCUCCUGG	2029	UGACCGAUUUCU	2030	GGAGAAAUCGG
MIMAT0004673		UGUUC		CCUGGUGU		UCA
hsa-miR-300	2031	UAUACAAGGGCAGACUC	2032	UAUACAAGGGCA	2033	UCUGCCCUUGU
MIMAT0004903		UCUCU		GACUCUCU		AUA
hsa-miR-301a	2034	CAGUGCAAUAGUAUUGU	2035	CAGUGCAAUAGU	2036	AUACUAUUGCA
MIMAT0000688		CAAAGC		AUUGUCAA		CUG
hsa-miR-301b	2037	CAGUGCAAUGAUAUUGU	2038	CAGUGCAAUGAU	2039	AUAUCAUUGCA
MIMAT0004958		CAAAGC		AUUGUCAA		CUG
hsa-miR-302a	2040	UAAGUGCUUCCAUGUUU	2041	UAAGUGCUUCCA	2042	CAUGGAAGCAC
MIMAT0000684		UGGUGA		UGUUUUGG		UUA
hsa-miR-302a*	2043	ACUUAAACGUGGAUGUA	2044	ACUUAAACGUGG	2045	AUCCACGUUUA
MIMAT0000683		CUUGCU		AUGUACUU		AGU
hsa-miR-302b	2046	UAAGUGCUUCCAUGUUU	2047	UAAGUGCUUCCA	2048	CAUGGAAGCAC
MIMAT0000715		UAGUAG		UGUUUUAG		UUA
hsa-miR-302b*	2049	ACUUUAACAUGGAAGUG	2050	ACUUUAACAUGG	2051	UUCCAUGUUAA
MIMAT0000714		CUUUC		AAGUGCUU		AGU
hsa-miR-302c	2052	UAAGUGCUUCCAUGUUU	2053	UAAGUGCUUCCA	2054	CAUGGAAGCAC
MIMAT0000717		CAGUGG		UGUUUCAG		UUA
hsa-miR-302c*	2055	UUUAACAUGGGGGUACC	2056	UUUAACAUGGGG	2057	ACCCCCAUGUU
MIMAT0000716		UGCUG		GUACCUGC		AAA
hsa-miR-302d	2058	UAAGUGCUUCCAUGUUU	2059	UAAGUGCUUCCA	2060	CAUGGAAGCAC
MIMAT0000718		GAGUGU		UGUUUGAG		UUA
hsa-miR-302d*	2061	ACUUUAACAUGGAGGCA	2062	ACUUUAACAUGG	2063	CUCCAUGUUAA
MIMAT0004685		CUUGC		AGGCACUU		AGU
hsa-miR-302e	2064	UAAGUGCUUCCAUGCUU	2065	UAAGUGCUUCCA	2066	CAUGGAAGCAC
MIMAT0005931				UGCUU		UUA
hsa-miR-302f	2067	UAAUUGCUUCCAUGUUU	2068	UAAUUGCUUCCA	2069	CAUGGAAGCAA
MIMAT0005932				UGUUU		UUA
hsa-miR-3065-	2070	UCAGCACCAGGAUAUUG	2071	UCAGCACCAGGA	2072	UAUCCUGGUGC
3p		UUGGAG		UAUUGUUG		UGA
MIMAT0015378
hsa-miR-3065-	2073	UCAACAAAAUCACUGAU	2074	UCAACAAAAUCA	2075	AGUGAUUUUGU
5p		GCUGGA		CUGAUGCU		UGA
MIMAT0015066
hsa-miR-3074	2076	GAUAUCAGCUCAGUAGG	2077	GAUAUCAGCUCA	2078	ACUGAGCUGAU
MIMAT0015027		CACCG		GUAGGCAC		AUC
hsa-miR-30a	2079	UGUAAACAUCCUCGACU	2080	UGUAAACAUCCU	2081	CGAGGAUGUUU
MIMAT0000087		GGAAG		CGACUGGA		ACA
hsa-miR-30a*	2082	CUUUCAGUCGGAUGUUU	2083	CUUUCAGUCGGA	2084	CAUCCGACUGA
MIMAT0000088		GCAGC		UGUUUGCA		AAG
hsa-miR-30b	2085	UGUAAACAUCCUACACU	2086	UGUAAACAUCCU	2087	GUAGGAUGUUU
MIMAT0000420		CAGCU		ACACUCAG		ACA
hsa-miR-30b*	2088	CUGGGAGGUGGAUGUUU	2089	CUGGGAGGUGGA	2090	CAUCCACCUCC
MIMAT0004589		ACUUC		UGUUUACU		CAG
hsa-miR-30c	2091	UGUAAACAUCCUACACU	2092	UGUAAACAUCCU	2093	GUAGGAUGUUU
MIMAT0000244		CUCAGC		ACACUCUC		ACA
hsa-miR-30c-1*	2094	CUGGGAGAGGGUUGUUU	2095	CUGGGAGAGGGU	2096	CAACCCUCUCC
MIMAT0004674		ACUCC		UGUUUACU		CAG
hsa-miR-30c-2*	2097	CUGGGAGAAGGCUGUUU	2098	CUGGGAGAAGGC	2099	CAGCCUUCUCC
MIMAT0004550		ACUCU		UGUUUACU		CAG
hsa-miR-30d	2100	UGUAAACAUCCCCGACU	2101	UGUAAACAUCCC	2102	CGGGGAUGUUU
MIMAT0000245		GGAAG		CGACUGGA		ACA
hsa-miR-30d*	2103	CUUUCAGUCAGAUGUUU	2104	CUUUCAGUCAGA	2105	CAUCUGACUGA
MIMAT0004551		GCUGC		UGUUUGCU		AAG
hsa-miR-30e	2106	UGUAAACAUCCUUGACU	2107	UGUAAACAUCCU	2108	CAAGGAUGUUU
MIMAT0000692		GGAAG		UGACUGGA		ACA
hsa-miR-30e*	2109	CUUUCAGUCGGAUGUUU	2110	CUUUCAGUCGGA	2111	CAUCCGACUGA
MIMAT0000693		ACAGC		UGUUUACA		AAG
hsa-miR-31	2112	AGGCAAGAUGCUGGCAU	2113	AGGCAAGAUGCU	2114	CCAGCAUCUUG
MIMAT0000089		AGCU		GGCAUAGC		CCU
hsa-miR-31*	2115	UGCUAUGCCAACAUAUU	2116	UGCUAUGCCAAC	2117	AUGUUGGCAUA
MIMAT0004504		GCCAU		AUAUUGCC		GCA
hsa-miR-3115	2118	AUAUGGGUUUACUAGUU	2119	AUAUGGGUUUAC	2120	UAGUAAACCCA
MIMAT0014977		GGU		UAGUUGGU		UAU
hsa-miR-3116	2121	UGCCUGGAACAUAGUAG	2122	UGCCUGGAACAU	2123	CUAUGUUCCAG
MIMAT0014978		GGACU		AGUAGGGA		GCA
hsa-miR-3117	2124	AUAGGACUCAUAUAGUG	2125	AUAGGACUCAUA	2126	UAUAUGAGUCC
MIMAT0014979		CCAG		UAGUGCCA		UAU
hsa-miR-3118	2127	UGUGACUGCAUUAUGAA	2128	UGUGACUGCAUU	2129	AUAAUGCAGUC
MIMAT0014980		AAUUCU		AUGAAAAU		ACA
hsa-miR-3119	2130	UGGCUUUUAACUUUGAU	2131	UGGCUUUUAACU	2132	AAAGUUAAAAG
MIMAT0014981		GGC		UUGAUGGC		CCA
hsa-miR-3120	2133	CACAGCAAGUGUAGACA	2134	CACAGCAAGUGU	2135	CUACACUUGCU
MIMAT0014982		GGCA		AGACAGGC		GUG
hsa-miR-3121	2136	UAAAUAGAGUAGGCAAA	2137	UAAAUAGAGUAG	2138	GCCUACUCUAU
MIMAT0014983		GGACA		GCAAAGGA		UUA
hsa-miR-3122	2139	GUUGGGACAAGAGGACG	2140	GUUGGGACAAGA	2141	CCUCUUGUCCC
MIMAT0014984		GUCUU		GGACGGUC		AAC
hsa-miR-3123	2142	CAGAGAAUUGUUUAAUC	2143	CAGAGAAUUGUU	2144	UAAACAAUUCU
MIMAT0014985				UAAUC		CUG
hsa-miR-3124	2145	UUCGCGGGCGAAGGCAA	2146	UUCGCGGGCGAA	2147	CCUUCGCCCGC
MIMAT0014986		AGUC		GGCAAAGU		GAA
hsa-miR-3125	2148	UAGAGGAAGCUGUGGAG	2149	UAGAGGAAGCUG	2150	CACAGCUUCCU
MIMAT0014988		AGA		UGGAGAGA		CUA
hsa-miR-3126-	2151	CAUCUGGCAUCCGUCAC	2152	CAUCUGGCAUCC	2153	ACGGAUGCCAG
3p		ACAGA		GUCACACA		AUG
MIMAT0015377
hsa-miR-3126-	2154	UGAGGGACAGAUGCCAG	2155	UGAGGGACAGAU	2156	GCAUCUGUCCC
5p		AAGCA		GCCAGAAG		UCA
MIMAT0014989
hsa-miR-3127	2157	AUCAGGGCUUGUGGAAU	2158	AUCAGGGCUUGU	2159	CCACAAGCCCU
MIMAT0014990		GGGAAG		GGAAUGGG		GAU
hsa-miR-3128	2160	UCUGGCAAGUAAAAAAC	2161	UCUGGCAAGUAA	2162	UUUUACUUGCC
MIMAT0014991		UCUCAU		AAAACUCU		AGA
hsa-miR-3129	2163	GCAGUAGUGUAGAGAUU	2164	GCAGUAGUGUAG	2165	CUCUACACUAC
MIMAT0014992		GGUUU		AGAUUGGU		UGC
hsa-miR-3130-	2166	GCUGCACCGGAGACUGG	2167	GCUGCACCGGAG	2168	GUCUCCGGUGC
3p		GUAA		ACUGGGUA		AGC
MIMAT0014994
hsa-miR-3130-	2169	UACCCAGUCUCCGGUGC	2170	UACCCAGUCUCC	2171	CCGGAGACUGG
5p		AGCC		GGUGCAGC		GUA
MIMAT0014995
hsa-miR-3131	2172	UCGAGGACUGGUGGAAG	2173	UCGAGGACUGGU	2174	CCACCAGUCCU
MIMAT0014996		GGCCUU		GGAAGGGC		CGA
hsa-miR-3132	2175	UGGGUAGAGAAGGAGCU	2176	UGGGUAGAGAAG	2177	UCCUUCUCUAC
MIMAT0014997		CAGAGGA		GAGCUCAG		CCA
hsa-miR-3133	2178	UAAAGAACUCUUAAAAC	2179	UAAAGAACUCUU	2180	UUAAGAGUUCU
MIMAT0014998		CCAAU		AAAACCCA		UUA
hsa-miR-3134	2181	UGAUGGAUAAAAGACUA	2182	UGAUGGAUAAAA	2183	UCUUUUAUCCA
MIMAT0015000		CAUAUU		GACUACAU		UCA
hsa-miR-3135	2184	UGCCUAGGCUGAGACUG	2185	UGCCUAGGCUGA	2186	UCUCAGCCUAG
MIMAT0015001		CAGUG		GACUGCAG		GCA
hsa-miR-3136	2187	CUGACUGAAUAGGUAGG	2188	CUGACUGAAUAG	2189	ACCUAUUCAGU
MIMAT0015003		GUCAUU		GUAGGGUC		CAG
hsa-miR-3137	2190	UCUGUAGCCUGGGAGCA	2191	UCUGUAGCCUGG	2192	UCCCAGGCUAC
MIMAT0015005		AUGGGGU		GAGCAAUG		AGA
hsa-miR-3138	2193	UGUGGACAGUGAGGUAG	2194	UGUGGACAGUGA	2195	CCUCACUGUCC
MIMAT0015006		AGGGAGU		GGUAGAGG		ACA
hsa-miR-3139	2196	UAGGAGCUCAACAGAUG	2197	UAGGAGCUCAAC	2198	CUGUUGAGCUC
MIMAT0015007		CCUGUU		AGAUGCCU		CUA
hsa-miR-3140	2199	AGCUUUUGGGAAUUCAG	2200	AGCUUUUGGGAA	2201	AAUUCCCAAAA
MIMAT0015008		GUAGU		UUCAGGUA		GCU
hsa-miR-3141	2202	GAGGGCGGGUGGAGGAG	2203	GAGGGCGGGUGG	2204	CUCCACCCGCC
MIMAT0015010		GA		AGGAGGA		CUC
hsa-miR-3142	2205	AAGGCCUUUCUGAACCU	2206	AAGGCCUUUCUG	2207	UUCAGAAAGGC
MIMAT0015011		UCAGA		AACCUUCA		CUU
hsa-miR-3143	2208	AUAACAUUGUAAAGCGC	2209	AUAACAUUGUAA	2210	CUUUACAAUGU
MIMAT0015012		UUCUUUCG		AGCGCUUC		UAU
hsa-miR-3144-	2211	AUAUACCUGUUCGGUCU	2212	AUAUACCUGUUC	2213	CCGAACAGGUA
3p		CUUUA		GGUCUCUU		UAU
MIMAT0015015
hsa-miR-3144-	2214	AGGGGACCAAAGAGAUA	2215	AGGGGACCAAAG	2216	CUCUUUGGUCC
5p		UAUAG		AGAUAUAU		CCU
MIMAT0015014
hsa-miR-3145	2217	AGAUAUUUUGAGUGUUU	2218	AGAUAUUUUGAG	2219	CACUCAAAAUA
MIMAT0015016		GGAAUUG		UGUUUGGA		UCU
hsa-miR-3146	2220	CAUGCUAGGAUAGAAAG	2221	CAUGCUAGGAUA	2222	UCUAUCCUAGC
MIMAT0015018		AAUGG		GAAAGAAU		AUG
hsa-miR-3147	2223	GGUUGGGCAGUGAGGAG	2224	GGUUGGGCAGUG	2225	CUCACUGCCCA
MIMAT0015019		GGUGUGA		AGGAGGGU		ACC
hsa-miR-3148	2226	UGGAAAAAACUGGUGUG	2227	UGGAAAAAACUG	2228	ACCAGUUUUUU
MIMAT0015021		UGCUU		GUGUGUGC		CCA
hsa-miR-3149	2229	UUUGUAUGGAUAUGUGU	2230	UUUGUAUGGAUA	2231	CAUAUCCAUAC
MIMAT0015022		GUGUAU		UGUGUGUG		AAA
hsa-miR-3150	2232	CUGGGGAGAUCCUCGAG	2233	CUGGGGAGAUCC	2234	GAGGAUCUCCC
MIMAT0015023		GUUGG		UCGAGGUU		CAG
hsa-miR-3150b	2235	UGAGGAGAUCGUCGAGG	2236	UGAGGAGAUCGU	2237	CGACGAUCUCC
MIMAT0018194		UUGG		CGAGGUUG		UCA
hsa-miR-3151	2238	GGUGGGGCAAUGGGAUC	2239	GGUGGGGCAAUG	2240	CCCAUUGCCCC
MIMAT0015024		AGGU		GGAUCAGG		ACC
hsa-miR-3152	2241	UGUGUUAGAAUAGGGGC	2242	UGUGUUAGAAUA	2243	CCUAUUCUAAC
MIMAT0015025		AAUAA		GGGGCAAU		ACA
hsa-miR-3153	2244	GGGGAAAGCGAGUAGGG	2245	GGGGAAAGCGAG	2246	UACUCGCUUUC
MIMAT0015026		ACAUUU		UAGGGACA		CCC
hsa-miR-3154	2247	CAGAAGGGGAGUUGGGA	2248	CAGAAGGGGAGU	2249	CAACUCCCCUU
MIMAT0015028		GCAGA		UGGGAGCA		CUG
hsa-miR-3155	2250	CCAGGCUCUGCAGUGGG	2251	CCAGGCUCUGCA	2252	ACUGCAGAGCC
MIMAT0015029		AACU		GUGGGAAC		UGG
hsa-miR-3156	2253	AAAGAUCUGGAAGUGGG	2254	AAAGAUCUGGAA	2255	ACUUCCAGAUC
MIMAT0015030		AGACA		GUGGGAGA		UUU
hsa-miR-3157	2256	UUCAGCCAGGCUAGUGC	2257	UUCAGCCAGGCU	2258	CUAGCCUGGCU
MIMAT0015031		AGUCU		AGUGCAGU		GAA
hsa-miR-3158	2259	AAGGGCUUCCUCUCUGC	2260	AAGGGCUUCCUC	2261	GAGAGGAAGCC
MIMAT0015032		AGGAC		UCUGCAGG		CUU
hsa-miR-3159	2262	UAGGAUUACAAGUGUCG	2263	UAGGAUUACAAG	2264	CACUUGUAAUC
MIMAT0015033		GCCAC		UGUCGGCC		CUA
hsa-miR-3160	2265	AGAGCUGAGACUAGAAA	2266	AGAGCUGAGACU	2267	CUAGUCUCAGC
MIMAT0015034		GCCCA		AGAAAGCC		UCU
hsa-miR-3161	2268	CUGAUAAGAACAGAGGC	2269	CUGAUAAGAACA	2270	UCUGUUCUUAU
MIMAT0015035		CCAGAU		GAGGCCCA		CAG
hsa-miR-3162	2271	UUAGGGAGUAGAAGGGU	2272	UUAGGGAGUAGA	2273	CUUCUACUCCC
MIMAT0015036		GGGGAG		AGGGUGGG		UAA
hsa-miR-3163	2274	UAUAAAAUGAGGGCAGU	2275	UAUAAAAUGAGG	2276	GCCCUCAUUUU
MIMAT0015037		AAGAC		GCAGUAAG		AUA
hsa-miR-3164	2277	UGUGACUUUAAGGGAAA	2278	UGUGACUUUAAG	2279	CCCUUAAAGUC
MIMAT0015038		UGGCG		GGAAAUGG		ACA
hsa-miR-3165	2280	AGGUGGAUGCAAUGUGA	2281	AGGUGGAUGCAA	2282	CAUUGCAUCCA
MIMAT0015039		CCUCA		UGUGACCU		CCU
hsa-miR-3166	2283	CGCAGACAAUGCCUACU	2284	CGCAGACAAUGC	2285	AGGCAUUGUCU
MIMAT0015040		GGCCUA		CUACUGGC		GCG
hsa-miR-3167	2286	AGGAUUUCAGAAAUACU	2287	AGGAUUUCAGAA	2288	AUUUCUGAAAU
MIMAT0015042		GGUGU		AUACUGGU		CCU
hsa-miR-3168	2289	GAGUUCUACAGUCAGAC	2290	GAGUUCUACAGU	2291	UGACUGUAGAA
MIMAT0015043				CAGAC		CUC
hsa-miR-3169	2292	UAGGACUGUGCUUGGCA	2293	UAGGACUGUGCU	2294	CAAGCACAGUC
MIMAT0015044		CAUAG		UGGCACAU		CUA
hsa-miR-3170	2295	CUGGGGUUCUGAGACAG	2296	CUGGGGUUCUGA	2297	UCUCAGAACCC
MIMAT0015045		ACAGU		GACAGACA		CAG
hsa-miR-3171	2298	AGAUGUAUGGAAUCUGU	2299	AGAUGUAUGGAA	2300	GAUUCCAUACA
MIMAT0015046		AUAUAUC		UCUGUAUA		UCU
hsa-miR-3173	2301	AAAGGAGGAAAUAGGCA	2302	AAAGGAGGAAAU	2303	CUAUUUCCUCC
MIMAT0015048		GGCCA		AGGCAGGC		UUU
hsa-miR-3174	2304	UAGUGAGUUAGAGAUGC	2305	UAGUGAGUUAGA	2306	UCUCUAACUCA
MIMAT0015051		AGAGCC		GAUGCAGA		CUA
hsa-miR-3175	2307	CGGGGAGAGAACGCAGU	2308	CGGGGAGAGAAC	2309	GCGUUCUCUCC
MIMAT0015052		GACGU		GCAGUGAC		CCG
hsa-miR-3176	2310	ACUGGCCUGGGACUACC	2311	ACUGGCCUGGGA	2312	AGUCCCAGGCC
MIMAT0015053		GG		CUACCGG		AGU
hsa-miR-3177	2313	UGCACGGCACUGGGGAC	2314	UGCACGGCACUG	2315	CCCAGUGCCGU
MIMAT0015054		ACGU		GGGACACG		GCA
hsa-miR-3178	2316	GGGGCGCGGCCGGAUCG	2317	GGGGCGCGGCCG	2318	UCCGGCCGCGC
MIMAT0015055				GAUCG		CCC
hsa-miR-3179	2319	AGAAGGGGUGAAAUUUA	2320	AGAAGGGGUGAA	2321	AUUUCACCCCU
MIMAT0015056		AACGU		AUUUAAAC		UCU
hsa-miR-3180	2322	UGGGGCGGAGCUUCCGG	2323	UGGGGCGGAGCU	2324	GAAGCUCCGCC
MIMAT0018178		AG		UCCGGAG		CCA
hsa-miR-3180-	2325	UGGGGCGGAGCUUCCGG	2326	UGGGGCGGAGCU	2327	GAAGCUCCGCC
3p		AGGCC		UCCGGAGG		CCA
MIMAT0015058
hsa-miR-3180-	2328	CUUCCAGACGCUCCGCC	2329	CUUCCAGACGCU	2330	GGAGCGUCUGG
5p		CCACGUCG		CCGCCCCA		AAG
MIMAT0015057
hsa-miR-3181	2331	AUCGGGCCCUCGGCGCC	2332	AUCGGGCCCUCG	2333	GCCGAGGGCCC
MIMAT0015061		GG		GCGCCGG		GAU
hsa-miR-3182	2334	GCUUCUGUAGUGUAGUC	2335	GCUUCUGUAGUG	2336	UACACUACAGA
MIMAT0015062				UAGUC		AGC
hsa-miR-3183	2337	GCCUCUCUCGGAGUCGC	2338	GCCUCUCUCGGA	2339	ACUCCGAGAGA
MIMAT0015063		UCGGA		GUCGCUCG		GGC
hsa-miR-3184	2340	UGAGGGGCCUCAGACCG	2341	UGAGGGGCCUCA	2342	UCUGAGGCCCC
MIMAT0015064		AGCUUUU		GACCGAGC		UCA
hsa-miR-3185	2343	AGAAGAAGGCGGUCGGU	2344	AGAAGAAGGCGG	2345	GACCGCCUUCU
MIMAT0015065		CUGCGG		UCGGUCUG		UCU
hsa-miR-3186-	2346	UCACGCGGAGAGAUGGC	2347	UCACGCGGAGAG	2348	AUCUCUCCGCG
3p		UUUG		AUGGCUUU		UGA
MIMAT0015068
hsa-miR-3186-	2349	CAGGCGUCUGUCUACGU	2350	CAGGCGUCUGUC	2351	UAGACAGACGC
5p		GGCUU		UACGUGGC		CUG
MIMAT0015067
hsa-miR-3187	2352	UUGGCCAUGGGGCUGCG	2353	UUGGCCAUGGGG	2354	AGCCCCAUGGC
MIMAT0015069		CGG		CUGCGCGG		CAA
hsa-miR-3188	2355	AGAGGCUUUGUGCGGAU	2356	AGAGGCUUUGUG	2357	CGCACAAAGCC
MIMAT0015070		ACGGGG		CGGAUACG		UCU
hsa-miR-3189	2358	CCCUUGGGUCUGAUGGG	2359	CCCUUGGGUCUG	2360	AUCAGACCCAA
MIMAT0015071		GUAG		AUGGGGUA		GGG
hsa-miR-3190	2361	UGUGGAAGGUAGACGGC	2362	UGUGGAAGGUAG	2363	GUCUACCUUCC
MIMAT0015073		CAGAGA		ACGGCCAG		ACA
hsa-miR-3191	2364	UGGGGACGUAGCUGGCC	2365	UGGGGACGUAGC	2366	CAGCUACGUCC
MIMAT0015075		AGACAG		UGGCCAGA		CCA
hsa-miR-3192	2367	UCUGGGAGGUUGUAGCA	2368	UCUGGGAGGUUG	2369	UACAACCUCCC
MIMAT0015076		GUGGAA		UAGCAGUG		AGA
hsa-miR-3193	2370	UCCUGCGUAGGAUCUGA	2371	UCCUGCGUAGGA	2372	GAUCCUACGCA
MIMAT0015077		GGAGU		UCUGAGGA		GGA
hsa-miR-3194	2373	GGCCAGCCACCAGGAGG	2374	GGCCAGCCACCA	2375	CCUGGUGGCUG
MIMAT0015078		GCUG		GGAGGGCU		GCC
hsa-miR-3195	2376	CGCGCCGGGCCCGGGUU	2377	CGCGCCGGGCCC	2378	CCGGGCCCGGC
MIMAT0015079				GGGUU		GCG
hsa-miR-3196	2379	CGGGGCGGCAGGGGCCU	2380	CGGGGCGGCAGG	2381	CCCCUGCCGCC
MIMAT0015080		C		GGCCUC		CCG
hsa-miR-3197	2382	GGAGGCGCAGGCUCGGA	2383	GGAGGCGCAGGC	2384	GAGCCUGCGCC
MIMAT0015082		AAGGCG		UCGGAAAG		UCC
hsa-miR-3198	2385	GUGGAGUCCUGGGGAAU	2386	GUGGAGUCCUGG	2387	CCCCAGGACUC
MIMAT0015083		GGAGA		GGAAUGGA		CAC
hsa-miR-3199	2388	AGGGACUGCCUUAGGAG	2389	AGGGACUGCCUU	2390	CUAAGGCAGUC
MIMAT0015084		AAAGUU		AGGAGAAA		CCU
hsa-miR-32	2391	UAUUGCACAUUACUAAG	2392	UAUUGCACAUUA	2393	AGUAAUGUGCA
MIMAT0000090		UUGCA		CUAAGUUG		AUA
hsa-miR-32*	2394	CAAUUUAGUGUGUGUGA	2395	CAAUUUAGUGUG	2396	CACACACUAAA
MIMAT0004505		UAUUU		UGUGAUAU		UUG
hsa-miR-3200-	2397	CACCUUGCGCUACUCAG	2398	CACCUUGCGCUA	2399	AGUAGCGCAAG
3p		GUCUG		CUCAGGUC		GUG
MIMAT0015085
hsa-miR-3200-	2400	AAUCUGAGAAGGCGCAC	2401	AAUCUGAGAAGG	2402	CGCCUUCUCAG
5p		AAGGU		CGCACAAG		AUU
MIMAT0017392
hsa-miR-3201	2403	GGGAUAUGAAGAAAAAU	2404	GGGAUAUGAAGA	2405	UUUCUUCAUAU
MIMAT0015086				AAAAU		CCC
hsa-miR-3202	2406	UGGAAGGGAGAAGAGCU	2407	UGGAAGGGAGAA	2408	UCUUCUCCCUU
MIMAT0015089		UUAAU		GAGCUUUA		CCA
hsa-miR-320a	2409	AAAAGCUGGGUUGAGAG	2410	AAAAGCUGGGUU	2411	UCAACCCAGCU
MIMAT0000510		GGCGA		GAGAGGGC		UUU
hsa-miR-320b	2412	AAAAGCUGGGUUGAGAG	2413	AAAAGCUGGGUU	2414	UCAACCCAGCU
MIMAT0005792		GGCAA		GAGAGGGC		UUU
hsa-miR-320c	2415	AAAAGCUGGGUUGAGAG	2416	AAAAGCUGGGUU	2417	UCAACCCAGCU
MIMAT0005793		GGU		GAGAGGGU		UUU
hsa-miR-320d	2418	AAAAGCUGGGUUGAGAG	2419	AAAAGCUGGGUU	2420	UCAACCCAGCU
MIMAT0006764		GA		GAGAGGA		UUU
hsa-miR-320e	2421	AAAGCUGGGUUGAGAAG	2422	AAAGCUGGGUUG	2423	CUCAACCCAGC
MIMAT0015072		G		AGAAGG		UUU
hsa-miR-323-3p	2424	CACAUUACACGGUCGAC	2425	CACAUUACACGG	2426	GACCGUGUAAU
MIMAT0000755		CUCU		UCGACCUC		GUG
hsa-miR-323-5p	2427	AGGUGGUCCGUGGCGCG	2428	AGGUGGUCCGUG	2429	GCCACGGACCA
MIMAT0004696		UUCGC		GCGCGUUC		CCU
hsa-miR-323b-	2430	CCCAAUACACGGUCGAC	2431	CCCAAUACACGG	2432	GACCGUGUAUU
3p		CUCUU		UCGACCUC		GGG
MIMAT0015050
hsa-miR-323b-	2433	AGGUUGUCCGUGGUGAG	2434	AGGUUGUCCGUG	2435	ACCACGGACAA
5p		UUCGCA		GUGAGUUC		CCU
MIMAT0001630
hsa-miR-324-3p	2436	ACUGCCCCAGGUGCUGC	2437	ACUGCCCCAGGU	2438	GCACCUGGGGC
MIMAT0000762		UGG		GCUGCUGG		AGU
hsa-miR-324-5p	2439	CGCAUCCCCUAGGGCAU	2440	CGCAUCCCCUAG	2441	CCCUAGGGGAU
MIMAT0000761		UGGUGU		GGCAUUGG		GCG
hsa-miR-325	2442	CCUAGUAGGUGUCCAGU	2443	CCUAGUAGGUGU	2444	GGACACCUACU
MIMAT0000771		AAGUGU		CCAGUAAG		AGG
hsa-miR-326	2445	CCUCUGGGCCCUUCCUC	2446	CCUCUGGGCCCU	2447	GAAGGGCCCAG
MIMAT0000756		CAG		UCCUCCAG		AGG
hsa-miR-328	2448	CUGGCCCUCUCUGCCCU	2449	CUGGCCCUCUCU	2450	GCAGAGAGGGC
MIMAT0000752		UCCGU		GCCCUUCC		CAG
hsa-miR-329	2451	AACACACCUGGUUAACC	2452	AACACACCUGGU	2453	UAACCAGGUGU
MIMAT0001629		UCUUU		UAACCUCU		GUU
hsa-miR-330-3p	2454	GCAAAGCACACGGCCUG	2455	GCAAAGCACACG	2456	GCCGUGUGCUU
MIMAT0000751		CAGAGA		GCCUGCAG		UGC
hsa-miR-330-5p	2457	UCUCUGGGCCUGUGUCU	2458	UCUCUGGGCCUG	2459	CACAGGCCCAG
MIMAT0004693		UAGGC		UGUCUUAG		AGA
hsa-miR-331-3p	2460	GCCCCUGGGCCUAUCCU	2461	GCCCCUGGGCCU	2462	AUAGGCCCAGG
MIMAT0000760		AGAA		AUCCUAGA		GGC
hsa-miR-331-5p	2463	CUAGGUAUGGUCCCAGG	2464	CUAGGUAUGGUC	2465	GGGACCAUACC
MIMAT0004700		GAUCC		CCAGGGAU		UAG
hsa-miR-335	2466	UCAAGAGCAAUAACGAA	2467	UCAAGAGCAAUA	2468	GUUAUUGCUCU
MIMAT0000765		AAAUGU		ACGAAAAA		UGA
hsa-miR-335*	2469	UUUUUCAUUAUUGCUCC	2470	UUUUUCAUUAUU	2471	GCAAUAAUGAA
MIMAT0004703		UGACC		GCUCCUGA		AAA
hsa-miR-337-3p	2472	CUCCUAUAUGAUGCCUU	2473	CUCCUAUAUGAU	2474	GCAUCAUAUAG
MIMAT0000754		UCUUC		GCCUUUCU		GAG
hsa-miR-337-5p	2475	GAACGGCUUCAUACAGG	2476	GAACGGCUUCAU	2477	GUAUGAAGCCG
MIMAT0004695		AGUU		ACAGGAGU		UUC
hsa-miR-338-3p	2478	UCCAGCAUCAGUGAUUU	2479	UCCAGCAUCAGU	2480	UCACUGAUGCU
MIMAT0000763		UGUUG		GAUUUUGU		GGA
hsa-miR-338-5p	2481	AACAAUAUCCUGGUGCU	2482	AACAAUAUCCUG	2483	ACCAGGAUAUU
MIMAT0004701		GAGUG		GUGCUGAG		GUU
hsa-miR-339-3p	2484	UGAGCGCCUCGACGACA	2485	UGAGCGCCUCGA	2486	CGUCGAGGCGC
MIMAT0004702		GAGCCG		CGACAGAG		UCA
hsa-miR-339-5p	2487	UCCCUGUCCUCCAGGAG	2488	UCCCUGUCCUCC	2489	CUGGAGGACAG
MIMAT0000764		CUCACG		AGGAGCUC		GGA
hsa-miR-33a	2490	GUGCAUUGUAGUUGCAU	2491	GUGCAUUGUAGU	2492	CAACUACAAUG
MIMAT0000091		UGCA		UGCAUUGC		CAC
hsa-miR-33a*	2493	CAAUGUUUCCACAGUGC	2494	CAAUGUUUCCAC	2495	CUGUGGAAACA
MIMAT0004506		AUCAC		AGUGCAUC		UUG
hsa-miR-33b	2496	GUGCAUUGCUGUUGCAU	2497	GUGCAUUGCUGU	2498	CAACAGCAAUG
MIMAT0003301		UGC		UGCAUUGC		CAC
hsa-miR-33b*	2499	CAGUGCCUCGGCAGUGC	2500	CAGUGCCUCGGC	2501	CUGCCGAGGCA
MIMAT0004811		AGCCC		AGUGCAGC		CUG
hsa-miR-340	2502	UUAUAAAGCAAUGAGAC	2503	UUAUAAAGCAAU	2504	UCAUUGCUUUA
MIMAT0004692		UGAUU		GAGACUGA		UAA
hsa-miR-340*	2505	UCCGUCUCAGUUACUUU	2506	UCCGUCUCAGUU	2507	GUAACUGAGAC
MIMAT0000750		AUAGC		ACUUUAUA		GGA
hsa-miR-342-3p	2508	UCUCACACAGAAAUCGC	2509	UCUCACACAGAA	2510	AUUUCUGUGUG
MIMAT0000753		ACCCGU		AUCGCACC		AGA
hsa-miR-342-5p	2511	AGGGGUGCUAUCUGUGA	2512	AGGGGUGCUAUC	2513	CAGAUAGCACC
MIMAT0004694		UUGA		UGUGAUUG		CCU
hsa-miR-345	2514	GCUGACUCCUAGUCCAG	2515	GCUGACUCCUAG	2516	GACUAGGAGUC
MIMAT0000772		GGCUC		UCCAGGGC		AGC
hsa-miR-346	2517	UGUCUGCCCGCAUGCCU	2518	UGUCUGCCCGCA	2519	CAUGCGGGCAG
MIMAT0000773		GCCUCU		UGCCUGCC		ACA
hsa-miR-34a	2520	UGGCAGUGUCUUAGCUG	2521	UGGCAGUGUCUU	2522	CUAAGACACUG
MIMAT0000255		GUUGU		AGCUGGUU		CCA
hsa-miR-34a*	2523	CAAUCAGCAAGUAUACU	2524	CAAUCAGCAAGU	2525	AUACUUGCUGA
MIMAT0004557		GCCCU		AUACUGCC		UUG
hsa-miR-34b	2526	CAAUCACUAACUCCACU	2527	CAAUCACUAACU	2528	GGAGUUAGUGA
MIMAT0004676		GCCAU		CCACUGCC		UUG
hsa-miR-34b*	2529	UAGGCAGUGUCAUUAGC	2530	UAGGCAGUGUCA	2531	AAUGACACUGC
MIMAT0000685		UGAUUG		UUAGCUGA		CUA
hsa-miR-34c-3p	2532	AAUCACUAACCACACGG	2533	AAUCACUAACCA	2534	UGUGGUUAGUG
MIMAT0004677		CCAGG		CACGGCCA		AUU
hsa-miR-34c-5p	2535	AGGCAGUGUAGUUAGCU	2536	AGGCAGUGUAGU	2537	UAACUACACUG
MIMAT0000686		GAUUGC		UAGCUGAU		CCU
hsa-miR-3605-	2538	CCUCCGUGUUACCUGUC	2539	CCUCCGUGUUAC	2540	AGGUAACACGG
3p		CUCUAG		CUGUCCUC		AGG
MIMAT0017982
hsa-miR-3605-	2541	UGAGGAUGGAUAGCAAG	2542	UGAGGAUGGAUA	2543	GCUAUCCAUCC
5p		GAAGCC		GCAAGGAA		UCA
MIMAT0017981
hsa-miR-3606	2544	UUAGUGAAGGCUAUUUU	2545	UUAGUGAAGGCU	2546	AUAGCCUUCAC
MIMAT0017983		AAUU		AUUUUAAU		UAA
hsa-miR-3607-	2547	ACUGUAAACGCUUUCUG	2548	ACUGUAAACGCU	2549	AAAGCGUUUAC
3p		AUG		UUCUGAUG		AGU
MIMAT0017985
hsa-miR-3607-	2550	GCAUGUGAUGAAGCAAA	2551	GCAUGUGAUGAA	2552	GCUUCAUCACA
5p		UCAGU		GCAAAUCA		UGC
MIMAT0017984
hsa-miR-3609	2553	CAAAGUGAUGAGUAAUA	2554	CAAAGUGAUGAG	2555	UACUCAUCACU
MIMAT0017986		CUGGCUG		UAAUACUG		UUG
hsa-miR-3610	2556	GAAUCGGAAAGGAGGCG	2557	GAAUCGGAAAGG	2558	CUCCUUUCCGA
MIMAT0017987		CCG		AGGCGCCG		UUC
hsa-miR-3611	2559	UUGUGAAGAAAGAAAUU	2560	UUGUGAAGAAAG	2561	UUCUUUCUUCA
MIMAT0017988		CUUA		AAAUUCUU		CAA
hsa-miR-3612	2562	AGGAGGCAUCUUGAGAA	2563	AGGAGGCAUCUU	2564	UCAAGAUGCCU
MIMAT0017989		AUGGA		GAGAAAUG		CCU
hsa-miR-3613-	2565	ACAAAAAAAAAAGCCCA	2566	ACAAAAAAAAAA	2567	GCUUUUUUUUU
MIMAT0017991		ACCCUUC		GCCCAACC		UGU
hsa-miR-3613-	2568	UGUUGUACUUUUUUUUU	2569	UGUUGUACUUUU	2570	AAAAAAGUACA
5p		UGUUC		UUUUUUGU		ACA
MIMAT0017990
hsa-miR-361-3p	2571	UCCCCCAGGUGUGAUUC	2572	UCCCCCAGGUGU	2573	UCACACCUGGG
MIMAT0004682		UGAUUU		GAUUCUGA		GGA
hsa-miR-3614-	2574	UAGCCUUCAGAUCUUGG	2575	UAGCCUUCAGAU	2576	AGAUCUGAAGG
3p		UGUUUU		CUUGGUGU		CUA
MIMAT0017993
hsa-miR-3614-	2577	CCACUUGGAUCUGAAGG	2578	CCACUUGGAUCU	2579	UCAGAUCCAAG
5p		CUGCCC		GAAGGCUG		UGG
MIMAT0017992
hsa-miR-3615	2580	UCUCUCGGCUCCUCGCG	2581	UCUCUCGGCUCC	2582	GAGGAGCCGAG
MIMAT0017994		GCUC		UCGCGGCU		AGA
hsa-miR-361-5p	2583	UUAUCAGAAUCUCCAGG	2584	UUAUCAGAAUCU	2585	GGAGAUUCUGA
MIMAT0000703		GGUAC		CCAGGGGU		UAA
hsa-miR-3616-	2586	CGAGGGCAUUUCAUGAU	2587	CGAGGGCAUUUC	2588	AUGAAAUGCCC
3p		GCAGGC		AUGAUGCA		UCG
MIMAT0017996
hsa-miR-3616-	2589	AUGAAGUGCACUCAUGA	2590	AUGAAGUGCACU	2591	UGAGUGCACUU
5p		UAUGU		CAUGAUAU		CAU
MIMAT0017995
hsa-miR-3617	2592	AAAGACAUAGUUGCAAG	2593	AAAGACAUAGUU	2594	GCAACUAUGUC
MIMAT0017997		AUGGG		GCAAGAUG		UUU
hsa-miR-3618	2595	UGUCUACAUUAAUGAAA	2596	UGUCUACAUUAA	2597	CAUUAAUGUAG
MIMAT0017998		AGAGC		UGAAAAGA		ACA
hsa-miR-3619	2598	UCAGCAGGCAGGCUGGU	2599	UCAGCAGGCAGG	2600	AGCCUGCCUGC
MIMAT0017999		GCAGC		CUGGUGCA		UGA
hsa-miR-3620	2601	UCACCCUGCAUCCCGCA	2602	UCACCCUGCAUC	2603	GGGAUGCAGGG
MIMAT0018001		CCCAG		CCGCACCC		UGA
hsa-miR-3621	2604	CGCGGGUCGGGGUCUGC	2605	CGCGGGUCGGGG	2606	GACCCCGACCC
MIMAT0018002		AGG		UCUGCAGG		GCG
hsa-miR-3622a-	2607	UCACCUGACCUCCCAUG	2608	UCACCUGACCUC	2609	GGGAGGUCAGG
3p		CCUGU		CCAUGCCU		UGA
MIMAT0018004
hsa-miR-3622a-	2610	CAGGCACGGGAGCUCAG	2611	CAGGCACGGGAG	2612	AGCUCCCGUGC
5p		GUGAG		CUCAGGUG		CUG
MIMAT0018003
hsa-miR-3622b-	2613	UCACCUGAGCUCCCGUG	2614	UCACCUGAGCUC	2615	GGGAGCUCAGG
3p		CCUG		CCGUGCCU		UGA
MIMAT0018006
hsa-miR-3622b-	2616	AGGCAUGGGAGGUCAGG	2617	AGGCAUGGGAGG	2618	GACCUCCCAUG
5p		UGA		UCAGGUGA		CCU
MIMAT0018005
hsa-miR-362-3p	2619	AACACACCUAUUCAAGG	2620	AACACACCUAUU	2621	UGAAUAGGUGU
MIMAT0004683		AUUCA		CAAGGAUU		GUU
hsa-miR-362-5p	2622	AAUCCUUGGAACCUAGG	2623	AAUCCUUGGAAC	2624	AGGUUCCAAGG
MIMAT0000705		UGUGAGU		CUAGGUGU		AUU
hsa-miR-363	2625	AAUUGCACGGUAUCCAU	2626	AAUUGCACGGUA	2627	GAUACCGUGCA
MIMAT0000707		CUGUA		UCCAUCUG		AUU
hsa-miR-363*	2628	CGGGUGGAUCACGAUGC	2629	CGGGUGGAUCAC	2630	UCGUGAUCCAC
MIMAT0003385		AAUUU		GAUGCAAU		CCG
hsa-miR-3646	2631	AAAAUGAAAUGAGCCCA	2632	AAAAUGAAAUGA	2633	GCUCAUUUCAU
MIMAT0018065		GCCCA		GCCCAGCC		UUU
hsa-miR-3647-	2634	AGAAAAUUUUUGUGUGU	2635	AGAAAAUUUUUG	2636	CACAAAAAUUU
3p		CUGAUC		UGUGUCUG		UCU
MIMAT0018067
hsa-miR-3647-	2637	CUGAAGUGAUGAUUCAC	2638	CUGAAGUGAUGA	2639	AAUCAUCACUU
5p		AUUCAU		UUCACAUU		CAG
MIMAT0018066
hsa-miR-3648	2640	AGCCGCGGGGAUCGCCG	2641	AGCCGCGGGGAU	2642	CGAUCCCCGCG
MIMAT0018068		AGGG		CGCCGAGG		GCU
hsa-miR-3649	2643	AGGGACCUGAGUGUCUA	2644	AGGGACCUGAGU	2645	ACACUCAGGUC
MIMAT0018069		AG		GUCUAAG		CCU
hsa-miR-365	2646	UAAUGCCCCUAAAAAUC	2647	UAAUGCCCCUAA	2648	UUUUAGGGGCA
MIMAT0000710		CUUAU		AAAUCCUU		UUA
hsa-miR-365*	2649	AGGGACUUUCAGGGGCA	2650	AGGGACUUUCAG	2651	CCCUGAAAGUC
MIMAT0009199		GCUGU		GGGCAGCU		CCU
hsa-miR-3650	2652	AGGUGUGUCUGUAGAGU	2653	AGGUGUGUCUGU	2654	CUACAGACACA
MIMAT0018070		CC		AGAGUCC		CCU
hsa-miR-3651	2655	CAUAGCCCGGUCGCUGG	2656	CAUAGCCCGGUC	2657	GCGACCGGGCU
MIMAT0018071		UACAUGA		GCUGGUAC		AUG
hsa-miR-3652	2658	CGGCUGGAGGUGUGAGG	2659	CGGCUGGAGGUG	2660	CACACCUCCAG
MIMAT0018072		A		UGAGGA		CCG
hsa-miR-3653	2661	CUAAGAAGUUGACUGAA	2662	CUAAGAAGUUGA	2663	AGUCAACUUCU
MIMAT0018073		G		CUGAAG		UAG
hsa-miR-3654	2664	GACUGGACAAGCUGAGG	2665	GACUGGACAAGC	2666	CAGCUUGUCCA
MIMAT0018074		AA		UGAGGAA		GUC
hsa-miR-3655	2667	GCUUGUCGCUGCGGUGU	2668	GCUUGUCGCUGC	2669	CCGCAGCGACA
MIMAT0018075		UGCU		GGUGUUGC		AGC
hsa-miR-3656	2670	GGCGGGUGCGGGGGUGG	2671	GGCGGGUGCGGG	2672	CCCCCGCACCC
MIMAT0018076				GGUGG		GCC
hsa-miR-3657	2673	UGUGUCCCAUUAUUGGU	2674	UGUGUCCCAUUA	2675	AAUAAUGGGAC
MIMAT0018077		GAUU		UUGGUGAU		ACA
hsa-miR-3658	2676	UUUAAGAAAACACCAUG	2677	UUUAAGAAAACA	2678	GGUGUUUUCUU
MIMAT0018078		GAGAU		CCAUGGAG		AAA
hsa-miR-3659	2679	UGAGUGUUGUCUACGAG	2680	UGAGUGUUGUCU	2681	GUAGACAACAC
MIMAT0018080		GGCA		ACGAGGGC		UCA
hsa-miR-3660	2682	ACUGACAGGAGAGCAUU	2683	ACUGACAGGAGA	2684	GCUCUCCUGUC
MIMAT0018081		UUGA		GCAUUUUG		AGU
hsa-miR-3661	2685	UGACCUGGGACUCGGAC	2686	UGACCUGGGACU	2687	CGAGUCCCAGG
MIMAT0018082		AGCUG		CGGACAGC		UCA
hsa-miR-3662	2688	GAAAAUGAUGAGUAGUG	2689	GAAAAUGAUGAG	2690	UACUCAUCAUU
MIMAT0018083		ACUGAUG		UAGUGACU		UUC
hsa-miR-3663-	2691	UGAGCACCACACAGGCC	2692	UGAGCACCACAC	2693	CUGUGUGGUGC
3p		GGGCGC		AGGCCGGG		UCA
MIMAT0018085
hsa-miR-3663-	2694	GCUGGUCUGCGUGGUGC	2695	GCUGGUCUGCGU	2696	CCACGCAGACC
5p		UCGG		GGUGCUCG		AGC
MTMAT0018084
hsa-miR-3664	2697	AACUCUGUCUUCACUCA	2698	AACUCUGUCUUC	2699	GUGAAGACAGA
MIMAT0018086		UGAGU		ACUCAUGA		GUU
hsa-miR-3665	2700	AGCAGGUGCGGGGCGGC	2701	AGCAGGUGCGGG	2702	GCCCCGCACCU
MIMAT0018087		G		GCGGCG		GCU
hsa-miR-3666	2703	CAGUGCAAGUGUAGAUG	2704	CAGUGCAAGUGU	2705	CUACACUUGCA
MIMAT0018088		CCGA		AGAUGCCG		CUG
hsa-miR-3667-	2706	ACCUUCCUCUCCAUGGG	2707	ACCUUCCUCUCC	2708	AUGGAGAGGAA
3p		UCUUU		AUGGGUCU		GGU
MIMAT0018090
hsa-miR-3667-	2709	AAAGACCCAUUGAGGAG	2710	AAAGACCCAUUG	2711	CUCAAUGGGUC
5p		AAGGU		AGGAGAAG		UUU
MIMAT0018089
hsa-miR-3668	2712	AAUGUAGAGAUUGAUCA	2713	AAUGUAGAGAUU	2714	UCAAUCUCUAC
MIMAT0018091		AAAU		GAUCAAAA		AUU
hsa-miR-3669	2715	ACGGAAUAUGUAUACGG	2716	ACGGAAUAUGUA	2717	UAUACAUAUUC
MIMAT0018092		AAUAUA		UACGGAAU		CGU
hsa-miR-367	2718	AAUUGCACUUUAGCAAU	2719	AAUUGCACUUUA	2720	GCUAAAGUGCA
MIMAT0000719		GGUGA		GCAAUGGU		AUU
hsa-miR-367*	2721	ACUGUUGCUAAUAUGCA	2722	ACUGUUGCUAAU	2723	AUAUUAGCAAC
MIMAT0004686		ACUCU		AUGCAACU		AGU
hsa-miR-3670	2724	AGAGCUCACAGCUGUCC	2725	AGAGCUCACAGC	2726	CAGCUGUGAGC
MIMAT0018093		UUCUCUA		UGUCCUUC		UCU
hsa-miR-3671	2727	AUCAAAUAAGGACUAGU	2728	AUCAAAUAAGGA	2729	AGUCCUUAUUU
MIMAT0018094		CUGCA		CUAGUCUG		GAU
hsa-miR-3672	2730	AUGAGACUCAUGUAAAA	2731	AUGAGACUCAUG	2732	UACAUGAGUCU
MIMAT0018095		CAUCUU		UAAAACAU		CAU
hsa-miR-3673	2733	AUGGAAUGUAUAUACGG	2734	AUGGAAUGUAUA	2735	UAUAUACAUUC
MIMAT0018096		AAUA		UACGGAAU		CAU
hsa-miR-3674	2736	AUUGUAGAACCUAAGAU	2737	AUUGUAGAACCU	2738	UUAGGUUCUAC
MIMAT0018097		UGGCC		AAGAUUGG		AAU
hsa-miR-3675-	2739	CAUCUCUAAGGAACUCC	2740	CAUCUCUAAGGA	2741	GUUCCUUAGAG
3p		CCCAA		ACUCCCCC		AUG
MIMAT0018099
hsa-miR-3675-	2742	UAUGGGGCUUCUGUAGA	2743	UAUGGGGCUUCU	2744	ACAGAAGCCCC
5p		GAUUUC		GUAGAGAU		AUA
MIMAT0018098
hsa-miR-3676	2745	CCGUGUUUCCCCCACGC	2746	CCGUGUUUCCCC	2747	UGGGGGAAACA
MIMAT0018100		UUU		CACGCUUU		CGG
hsa-miR-3677	2748	CUCGUGGGCUCUGGCCA	2749	CUCGUGGGCUCU	2750	CCAGAGCCCAC
MIMAT0018101		CGGCC		GGCCACGG		GAG
hsa-miR-3678-	2751	CUGCAGAGUUUGUACGG	2752	CUGCAGAGUUUG	2753	UACAAACUCUG
3p		ACCGG		UACGGACC		CAG
MIMAT0018103
hsa-miR-3678-	2754	UCCGUACAAACUCUGCU	2755	UCCGUACAAACU	2756	AGAGUUUGUAC
5p		GUG		CUGCUGUG		GGA
MIMAT0018102
hsa-miR-3679-	2757	CUUCCCCCCAGUAAUCU	2758	CUUCCCCCCAGU	2759	UUACUGGGGGG
3p		UCAUC		AAUCUUCA		AAG
MIMAT0018105
hsa-miR-3679-	2760	UGAGGAUAUGGCAGGGA	2761	UGAGGAUAUGGC	2762	CUGCCAUAUCC
5p		AGGGGA		AGGGAAGG		UCA
MIMAT0018104
hsa-miR-3680	2763	GACUCACUCACAGGAUU	2764	GACUCACUCACA	2765	CCUGUGAGUGA
MIMAT0018106		GUGCA		GGAUUGUG		GUC
hsa-miR-3680*	2766	UUUUGCAUGACCCUGGG	2767	UUUUGCAUGACC	2768	AGGGUCAUGCA
MIMAT0018107		AGUAGG		CUGGGAGU		AAA
hsa-miR-3681	2769	UAGUGGAUGAUGCACUC	2770	UAGUGGAUGAUG	2771	UGCAUCAUCCA
MIMAT0018108		UGUGC		CACUCUGU		CUA
hsa-miR-3681*	2772	ACACAGUGCUUCAUCCA	2773	ACACAGUGCUUC	2774	AUGAAGCACUG
MIMAT0018109		CUACU		AUCCACUA		UGU
hsa-miR-3682	2775	UGAUGAUACAGGUGGAG	2776	UGAUGAUACAGG	2777	CACCUGUAUCA
MIMAT0018110		GUAG		UGGAGGUA		UCA
hsa-miR-3683	2778	UGCGACAUUGGAAGUAG	2779	UGCGACAUUGGA	2780	CUUCCAAUGUC
MIMAT0018111		UAUCA		AGUAGUAU		GCA
hsa-miR-3684	2781	UUAGACCUAGUACACGU	2782	UUAGACCUAGUA	2783	UGUACUAGGUC
MIMAT0018112		CCUU		CACGUCCU		UAA
hsa-miR-3685	2784	UUUCCUACCCUACCUGA	2785	UUUCCUACCCUA	2786	GGUAGGGUAGG
MIMAT0018113		AGACU		CCUGAAGA		AAA
hsa-miR-3686	2787	AUCUGUAAGAGAAAGUA	2788	AUCUGUAAGAGA	2789	UUUCUCUUACA
MIMAT0018114		AAUGA		AAGUAAAU		GAU
hsa-miR-3687	2790	CCCGGACAGGCGUUCGU	2791	CCCGGACAGGCG	2792	AACGCCUGUCC
MIMAT0018115		GCGACGU		UUCGUGCG		GGG
hsa-miR-3688	2793	UAUGGAAAGACUUUGCC	2794	UAUGGAAAGACU	2795	AAAGUCUUUCC
MIMAT0018116		ACUCU		UUGCCACU		AUA
hsa-miR-3689a-	2796	CUGGGAGGUGUGAUAUC	2797	CUGGGAGGUGUG	2798	AUCACACCUCC
3p		GUGGU		AUAUCGUG		CAG
MIMAT0018118
hsa-miR-3689a-	2799	UGUGAUAUCAUGGUUCC	2800	UGUGAUAUCAUG	2801	ACCAUGAUAUC
5p		UGGGA		GUUCCUGG		ACA
MIMAT0018117
hsa-miR-3689b	2802	UGUGAUAUCAUGGUUCC	2803	UGUGAUAUCAUG	2804	ACCAUGAUAUC
MIMAT0018180		UGGGA		GUUCCUGG		ACA
hsa-miR-3689b*	2805	CUGGGAGGUGUGAUAUU	2806	CUGGGAGGUGUG	2807	AUCACACCUCC
MIMAT0018181		GUGGU		AUAUUGUG		CAG
hsa-miR-3690	2808	ACCUGGACCCAGCGUAG	2809	ACCUGGACCCAG	2810	CGCUGGGUCCA
MIMAT0018119		ACAAAG		CGUAGACA		GGU
hsa-miR-3691	2811	AGUGGAUGAUGGAGACU	2812	AGUGGAUGAUGG	2813	CUCCAUCAUCC
MIMAT0018120		CGGUAC		AGACUCGG		ACU
hsa-miR-3692	2814	GUUCCACACUGACACUG	2815	GUUCCACACUGA	2816	UGUCAGUGUGG
MIMAT0018122		CAGAAGU		CACUGCAG		AAC
hsa-miR-3692*	2817	CCUGCUGGUCAGGAGUG	2818	CCUGCUGGUCAG	2819	UCCUGACCAGC
MIMAT0018121		GAUACUG		GAGUGGAU		AGG
hsa-miR-369-3p	2820	AAUAAUACAUGGUUGAU	2821	AAUAAUACAUGG	2822	AACCAUGUAUU
MIMAT0000721		CUUU		UUGAUCUU		AUU
hsa-miR-369-5p	2823	AGAUCGACCGUGUUAUA	2824	AGAUCGACCGUG	2825	AACACGGUCGA
MIMAT0001621		UUCGC		UUAUAUUC		UCU
hsa-miR-370	2826	GCCUGCUGGGGUGGAAC	2827	GCCUGCUGGGGU	2828	CCACCCCAGCA
MIMAT0000722		CUGGU		GGAACCUG		GGC
hsa-miR-3713	2829	GGUAUCCGUUUGGGGAU	2830	GGUAUCCGUUUG	2831	CCCAAACGGAU
MIMAT0018164		GGU		GGGAUGGU		ACC
hsa-miR-371-3p	2832	AAGUGCCGCCAUCUUUU	2833	AAGUGCCGCCAU	2834	AGAUGGCGGCA
MIMAT0000723		GAGUGU		CUUUUGAG		CUU
hsa-miR-3714	2835	GAAGGCAGCAGUGCUCC	2836	GAAGGCAGCAGU	2837	GCACUGCUGCC
MIMAT0018165		CCUGU		GCUCCCCU		UUC
hsa-miR-371-5p	2838	ACUCAAACUGUGGGGGC	2839	ACUCAAACUGUG	2840	CCCACAGUUUG
MIMAT0004687		ACU		GGGGCACU		AGU
hsa-miR-372	2841	AAAGUGCUGCGACAUUU	2842	AAAGUGCUGCGA	2843	UGUCGCAGCAC
MIMAT0000724		GAGCGU		CAUUUGAG		UUU
hsa-miR-373	2844	GAAGUGCUUCGAUUUUG	2845	GAAGUGCUUCGA	2846	AAUCGAAGCAC
MIMAT0000726		GGGUGU		UUUUGGGG		UUC
hsa-miR-373*	2847	ACUCAAAAUGGGGGCGC	2848	ACUCAAAAUGGG	2849	CCCCCAUUUUG
MIMAT0000725		UUUCC		GGCGCUUU		AGU
hsa-miR-374a	2850	UUAUAAUACAACCUGAU	2851	UUAUAAUACAAC	2852	AGGUUGUAUUA
MIMAT0000727		AAGUG		CUGAUAAG		UAA
hsa-miR-374a*	2853	CUUAUCAGAUUGUAUUG	2854	CUUAUCAGAUUG	2855	UACAAUCUGAU
MIMAT0004688		UAAUU		UAUUGUAA		AAG
hsa-miR-374b	2856	AUAUAAUACAACCUGCU	2857	AUAUAAUACAAC	2858	AGGUUGUAUUA
MIMAT0004955		AAGUG		CUGCUAAG		UAU
hsa-miR-374b*	2859	CUUAGCAGGUUGUAUUA	2860	CUUAGCAGGUUG	2861	UACAACCUGCU
MIMAT0004956		UCAUU		UAUUAUCA		AAG
hsa-miR-374c	2862	AUAAUACAACCUGCUAA	2863	AUAAUACAACCU	2864	GCAGGUUGUAU
MIMAT0018443		GUGCU		GCUAAGUG		UAU
hsa-miR-375	2865	UUUGUUCGUUCGGCUCG	2866	UUUGUUCGUUCG	2867	GCCGAACGAAC
MIMAT0000728		CGUGA		GCUCGCGU		AAA
hsa-miR-376a	2868	AUCAUAGAGGAAAAUCC	2869	AUCAUAGAGGAA	2870	UUUUCCUCUAU
MIMAT0000729		ACGU		AAUCCACG		GAU
hsa-miR-376a*	2871	GUAGAUUCUCCUUCUAU	2872	GUAGAUUCUCCU	2873	GAAGGAGAAUC
MIMAT0003386		GAGUA		UCUAUGAG		UAC
hsa-miR-376b	2874	AUCAUAGAGGAAAAUCC	2875	AUCAUAGAGGAA	2876	UUUUCCUCUAU
MIMAT0002172		AUGUU		AAUCCAUG		GAU
hsa-miR-376c	2877	AACAUAGAGGAAAUUCC	2878	AACAUAGAGGAA	2879	AUUUCCUCUAU
MIMAT0000720		ACGU		AUUCCACG		GUU
hsa-miR-377	2880	AUCACACAAAGGCAACU	2881	AUCACACAAAGG	2882	UGCCUUUGUGU
MIMAT0000730		UUUGU		CAACUUUU		GAU
hsa-miR-377*	2883	AGAGGUUGCCCUUGGUG	2884	AGAGGUUGCCCU	2885	CAAGGGCAACC
MIMAT0004689		AAUUC		UGGUGAAU		UCU
hsa-miR-378	2886	ACUGGACUUGGAGUCAG	2887	ACUGGACUUGGA	2888	ACUCCAAGUCC
MIMAT0000732		AAGG		GUCAGAAG		AGU
hsa-miR-378*	2889	CUCCUGACUCCAGGUCC	2890	CUCCUGACUCCA	2891	CCUGGAGUCAG
MIMAT0000731		UGUGU		GGUCCUGU		GAG
hsa-miR-378b	2892	ACUGGACUUGGAGGCAG	2893	ACUGGACUUGGA	2894	CCUCCAAGUCC
MIMAT0014999		AA		GGCAGAA		AGU
hsa-miR-378c	2895	ACUGGACUUGGAGUCAG	2896	ACUGGACUUGGA	2897	ACUCCAAGUCC
MIMAT0016847		AAGAGUGG		GUCAGAAG		AGU
hsa-miR-379	2898	UGGUAGACUAUGGAACG	2899	UGGUAGACUAUG	2900	UCCAUAGUCUA
MIMAT0000733		UAGG		GAACGUAG		CCA
hsa-miR-379*	2901	UAUGUAACAUGGUCCAC	2902	UAUGUAACAUGG	2903	GACCAUGUUAC
MIMAT0004690		UAACU		UCCACUAA		AUA
hsa-miR-380	2904	UAUGUAAUAUGGUCCAC	2905	UAUGUAAUAUGG	2906	GACCAUAUUAC
MIMAT0000735		AUCUU		UCCACAUC		AUA
hsa-miR-380*	2907	UGGUUGACCAUAGAACA	2908	UGGUUGACCAUA	2909	UCUAUGGUCAA
MIMAT0000734		UGCGC		GAACAUGC		CCA
hsa-miR-381	2910	UAUACAAGGGCAAGCUC	2911	UAUACAAGGGCA	2912	CUUGCCCUUGU
MIMAT0000736		UCUGU		AGCUCUCU		AUA
hsa-miR-382	2913	GAAGUUGUUCGUGGUGG	2914	GAAGUUGUUCGU	2915	CCACGAACAAC
MIMAT0000737		AUUCG		GGUGGAUU		UUC
hsa-miR-383	2916	AGAUCAGAAGGUGAUUG	2917	AGAUCAGAAGGU	2918	UCACCUUCUGA
MIMAT0000738		UGGCU		GAUUGUGG		UCU
hsa-miR-384	2919	AUUCCUAGAAAUUGUUC	2920	AUUCCUAGAAAU	2921	CAAUUUCUAGG
MIMAT0001075		AUA		UGUUCAUA		AAU
hsa-miR-3907	2922	AGGUGCUCCAGGCUGGC	2923	AGGUGCUCCAGG	2924	AGCCUGGAGCA
MIMAT0018179		UCACA		CUGGCUCA		CCU
hsa-miR-3908	2925	GAGCAAUGUAGGUAGAC	2926	GAGCAAUGUAGG	2927	UACCUACAUUG
MIMAT0018182		UGUUU		UAGACUGU		CUC
hsa-miR-3909	2928	UGUCCUCUAGGGCCUGC	2929	UGUCCUCUAGGG	2930	GGCCCUAGAGG
MIMAT0018183		AGUCU		CCUGCAGU		ACA
hsa-miR-3910	2931	AAAGGCAUAAAACCAAG	2932	AAAGGCAUAAAA	2933	GGUUUUAUGCC
MIMAT0018184		ACA		CCAAGACA		UUU
hsa-miR-3911	2934	UGUGUGGAUCCUGGAGG	2935	UGUGUGGAUCCU	2936	CCAGGAUCCAC
MIMAT0018185		AGGCA		GGAGGAGG		ACA
hsa-miR-3912	2937	UAACGCAUAAUAUGGAC	2938	UAACGCAUAAUA	2939	CAUAUUAUGCG
MIMAT0018186		AUGU		UGGACAUG		UUA
hsa-miR-3913	2940	UUUGGGACUGAUCUUGA	2941	UUUGGGACUGAU	2942	AGAUCAGUCCC
MIMAT0018187		UGUCU		CUUGAUGU		AAA
hsa-miR-3914	2943	AAGGAACCAGAAAAUGA	2944	AAGGAACCAGAA	2945	UUUUCUGGUUC
MIMAT0018188		GAAGU		AAUGAGAA		CUU
hsa-miR-3915	2946	UUGAGGAAAAGAUGGUC	2947	UUGAGGAAAAGA	2948	CAUCUUUUCCU
MIMAT0018189		UUAUU		UGGUCUUA		CAA
hsa-miR-3916	2949	AAGAGGAAGAAAUGGCU	2950	AAGAGGAAGAAA	2951	CAUUUCUUCCU
MIMAT0018190		GGUUCUCAG		UGGCUGGU		CUU
hsa-miR-3917	2952	GCUCGGACUGAGCAGGU	2953	GCUCGGACUGAG	2954	UGCUCAGUCCG
MIMAT0018191		GGG		CAGGUGGG		AGC
hsa-miR-3918	2955	ACAGGGCCGCAGAUGGA	2956	ACAGGGCCGCAG	2957	AUCUGCGGCCC
MIMAT0018192		GACU		AUGGAGAC		UGU
hsa-miR-3919	2958	GCAGAGAACAAAGGACU	2959	GCAGAGAACAAA	2960	CCUUUGUUCUC
MIMAT0018193		CAGU		GGACUCAG		UGC
hsa-miR-3920	2961	ACUGAUUAUCUUAACUC	2962	ACUGAUUAUCUU	2963	UUAAGAUAAUC
MIMAT0018195		UCUGA		AACUCUCU		AGU
hsa-miR-3921	2964	UCUCUGAGUACCAUAUG	2965	UCUCUGAGUACC	2966	AUGGUACUCAG
MIMAT0018196		CCUUGU		AUAUGCCU		AGA
hsa-miR-3922	2967	UCUGGCCUUGACUUGAC	2968	UCUGGCCUUGAC	2969	AAGUCAAGGCC
MIMAT0018197		UCUUU		UUGACUCU		AGA
hsa-miR-3923	2970	AACUAGUAAUGUUGGAU	2971	AACUAGUAAUGU	2972	CAACAUUACUA
MIMAT0018198		UAGGG		UGGAUUAG		GUU
hsa-miR-3924	2973	AUAUGUAUAUGUGACUG	2974	AUAUGUAUAUGU	2975	UCACAUAUACA
MIMAT0018199		CUACU		GACUGCUA		UAU
hsa-miR-3925	2976	AAGAGAACUGAAAGUGG	2977	AAGAGAACUGAA	2978	CUUUCAGUUCU
MIMAT0018200		AGCCU		AGUGGAGC		CUU
hsa-miR-3926	2979	UGGCCAAAAAGCAGGCA	2980	UGGCCAAAAAGC	2981	CUGCUUUUUGG
MIMAT0018201		GAGA		AGGCAGAG		CCA
hsa-miR-3927	2982	CAGGUAGAUAUUUGAUA	2983	CAGGUAGAUAUU	2984	CAAAUAUCUAC
MIMAT0018202		GGCAU		UGAUAGGC		CUG
hsa-miR-3928	2985	GGAGGAACCUUGGAGCU	2986	GGAGGAACCUUG	2987	UCCAAGGUUCC
MIMAT0018205		UCGGC		GAGCUUCG		UCC
hsa-miR-3929	2988	GAGGCUGAUGUGAGUAG	2989	GAGGCUGAUGUG	2990	CUCACAUCAGC
MIMAT0018206		ACCACU		AGUAGACC		CUC
hsa-miR-3934	2991	UCAGGUGUGGAAACUGA	2992	UCAGGUGUGGAA	2993	GUUUCCACACC
MIMAT0018349		GGCAG		ACUGAGGC		UGA
hsa-miR-3935	2994	UGUAGAUACGAGCACCA	2995	UGUAGAUACGAG	2996	UGCUCGUAUCU
MIMAT0018350		GCCAC		CACCAGCC		ACA
hsa-miR-3936	2997	UAAGGGGUGUAUGGCAG	2998	UAAGGGGUGUAU	2999	CCAUACACCCC
MIMAT0018351		AUGCA		GGCAGAUG		UUA
hsa-miR-3937	3000	ACAGGCGGCUGUAGCAA	3001	ACAGGCGGCUGU	3002	CUACAGCCGCC
MIMAT0018352		UGGGGG		AGCAAUGG		UGU
hsa-miR-3938	3003	AAUUCCCUUGUAGAUAA	3004	AAUUCCCUUGUA	3005	UCUACAAGGGA
MIMAT0018353		CCCGG		GAUAACCC		AUU
hsa-miR-3939	3006	UACGCGCAGACCACAGG	3007	UACGCGCAGACC	3008	GUGGUCUGCGC
MIMAT0018355		AUGUC		ACAGGAUG		GUA
hsa-miR-3940	3009	CAGCCCGGAUCCCAGCC	3010	CAGCCCGGAUCC	3011	UGGGAUCCGGG
MIMAT0018356		CACUU		CAGCCCAC		CUG
hsa-miR-3941	3012	UUACACACAACUGAGGA	3013	UUACACACAACU	3014	UCAGUUGUGUG
MIMAT0018357		UCAUA		GAGGAUCA		UAA
hsa-miR-3942	3015	AAGCAAUACUGUUACCU	3016	AAGCAAUACUGU	3017	UAACAGUAUUG
MIMAT0018358		GAAAU		UACCUGAA		CUU
hsa-miR-3943	3018	UAGCCCCCAGGCUUCAC	3019	UAGCCCCCAGGC	3020	AAGCCUGGGGG
MIMAT0018359		UUGGCG		UUCACUUG		CUA
hsa-miR-3944	3021	UUCGGGCUGGCCUGCUG	3022	UUCGGGCUGGCC	3023	CAGGCCAGCCC
MIMAT0018360		CUCCGG		UGCUGCUC		GAA
hsa-miR-3945	3024	AGGGCAUAGGAGAGGGU	3025	AGGGCAUAGGAG	3026	CUCUCCUAUGC
MIMAT0018361		UGAUAU		AGGGUUGA		CCU
hsa-miR-409-3p	3027	GAAUGUUGCUCGGUGAA	3028	GAAUGUUGCUCG	3029	ACCGAGCAACA
MIMAT0001639		CCCCU		GUGAACCC		UUC
hsa-miR-409-5p	3030	AGGUUACCCGAGCAACU	3031	AGGUUACCCGAG	3032	UGCUCGGGUAA
MIMAT0001638		UUGCAU		CAACUUUG		CCU
hsa-miR-410	3033	AAUAUAACACAGAUGGC	3034	AAUAUAACACAG	3035	AUCUGUGUUAU
MIMAT0002171		CUGU		AUGGCCUG		AUU
hsa-miR-411	3036	UAGUAGACCGUAUAGCG	3037	UAGUAGACCGUA	3038	UAUACGGUCUA
MIMAT0003329		UACG		UAGCGUAC		CUA
hsa-miR-411*	3039	UAUGUAACACGGUCCAC	3040	UAUGUAACACGG	3041	GACCGUGUUAC
MIMAT0004813		UAACC		UCCACUAA		AUA
hsa-miR-412	3042	ACUUCACCUGGUCCACU	3043	ACUUCACCUGGU	3044	GGACCAGGUGA
MIMAT0002170		AGCCGU		CCACUAGC		AGU
hsa-miR-421	3045	AUCAACAGACAUUAAUU	3046	AUCAACAGACAU	3047	UAAUGUCUGUU
MIMAT0003339		GGGCGC		UAAUUGGG		GAU
hsa-miR-422a	3048	ACUGGACUUAGGGUCAG	3049	ACUGGACUUAGG	3050	ACCCUAAGUCC
MIMAT0001339		AAGGC		GUCAGAAG		AGU
hsa-miR-423-3p	3051	AGCUCGGUCUGAGGCCC	3052	AGCUCGGUCUGA	3053	CCUCAGACCGA
MIMAT0001340		CUCAGU		GGCCCCUC		GCU
hsa-miR-423-5p	3054	UGAGGGGCAGAGAGCGA	3055	UGAGGGGCAGAG	3056	CUCUCUGCCCC
MIMAT0004748		GACUUU		AGCGAGAC		UCA
hsa-miR-424	3057	CAGCAGCAAUUCAUGUU	3058	CAGCAGCAAUUC	3059	AUGAAUUGCUG
MIMAT0001341		UUGAA		AUGUUUUG		CUG
hsa-miR-424*	3060	CAAAACGUGAGGCGCUG	3061	CAAAACGUGAGG	3062	CGCCUCACGUU
MIMAT0004749		CUAU		CGCUGCUA		UUG
hsa-miR-425	3063	AAUGACACGAUCACUCC	3064	AAUGACACGAUC	3065	GUGAUCGUGUC
MIMAT0003393		CGUUGA		ACUCCCGU		AUU
hsa-miR-425*	3066	AUCGGGAAUGUCGUGUC	3067	AUCGGGAAUGUC	3068	ACGACAUUCCC
MIMAT0001343		CGCCC		GUGUCCGC		GAU
hsa-miR-4251	3069	CCUGAGAAAAGGGCCAA	3070	CCUGAGAAAAGG	3071	GCCCUUUUCUC
MIMAT0016883				GCCAA		AGG
hsa-miR-4252	3072	GGCCACUGAGUCAGCAC	3073	GGCCACUGAGUC	3074	CUGACUCAGUG
MIMAT0016886		CA		AGCACCA		GCC
hsa-miR-4253	3075	AGGGCAUGUCCAGGGGG	3076	AGGGCAUGUCCA	3077	CCUGGACAUGC
MIMAT0016882		U		GGGGGU		CCU
hsa-miR-4254	3078	GCCUGGAGCUACUCCAC	3079	GCCUGGAGCUAC	3080	GAGUAGCUCCA
MIMAT0016884		CAUCUC		UCCACCAU		GGC
hsa-miR-4255	3081	CAGUGUUCAGAGAUGGA	3082	CAGUGUUCAGAG	3083	AUCUCUGAACA
MIMAT0016885				AUGGA		CUG
hsa-miR-4256	3084	AUCUGACCUGAUGAAGG	3085	AUCUGACCUGAU	3086	UCAUCAGGUCA
MIMAT0016877		U		GAAGGU		GAU
hsa-miR-4257	3087	CCAGAGGUGGGGACUGA	3088	CCAGAGGUGGGG	3089	GUCCCCACCUC
MIMAT0016878		G		ACUGAG		UGG
hsa-miR-4258	3090	CCCCGCCACCGCCUUGG	3091	CCCCGCCACCGC	3092	AGGCGGUGGCG
MIMAT0016879				CUUGG		GGG
hsa-miR-4259	3093	CAGUUGGGUCUAGGGGU	3094	CAGUUGGGUCUA	3095	CCUAGACCCAA
MIMAT0016880		CAGGA		GGGGUCAG		CUG
hsa-miR-4260	3096	CUUGGGGCAUGGAGUCC	3097	CUUGGGGCAUGG	3098	CUCCAUGCCCC
MIMAT0016881		CA		AGUCCCA		AAG
hsa-miR-4261	3099	AGGAAACAGGGACCCA	3100	AGGAAACAGGGA	3101	GGUCCCUGUUU
MIMAT0016890				CCCA		CCU
hsa-miR-4262	3102	GACAUUCAGACUACCUG	3103	GACAUUCAGACU	3104	GUAGUCUGAAU
MIMAT0016894				ACCUG		GUC
hsa-miR-4263	3105	AUUCUAAGUGCCUUGGC	3106	AUUCUAAGUGCC	3107	AAGGCACUUAG
MIMAT0016898		C		UUGGCC		AAU
hsa-miR-4264	3108	ACUCAGUCAUGGUCAUU	3109	ACUCAGUCAUGG	3110	GACCAUGACUG
MIMAT0016899				UCAUU		AGU
hsa-miR-4265	3111	CUGUGGGCUCAGCUCUG	3112	CUGUGGGCUCAG	3113	AGCUGAGCCCA
MIMAT0016891		GG		CUCUGGG		CAG
hsa-miR-4266	3114	CUAGGAGGCCUUGGCC	3115	CUAGGAGGCCUU	3116	CCAAGGCCUCC
MIMAT0016892				GGCC		UAG
hsa-miR-4267	3117	UCCAGCUCGGUGGCAC	3118	UCCAGCUCGGUG	3119	GCCACCGAGCU
MIMAT0016893				GCAC		GGA
hsa-miR-4268	3120	GGCUCCUCCUCUCAGGA	3121	GGCUCCUCCUCU	3122	UGAGAGGAGGA
MIMAT0016896		UGUG		CAGGAUGU		GCC
hsa-miR-4269	3123	GCAGGCACAGACAGCCC	3124	GCAGGCACAGAC	3125	CUGUCUGUGCC
MIMAT0016897		UGGC		AGCCCUGG		UGC
hsa-miR-4270	3126	UCAGGGAGUCAGGGGAG	3127	UCAGGGAGUCAG	3128	CCCUGACUCCC
MIMAT0016900		GGC		GGGAGGGC		UGA
hsa-miR-4271	3129	GGGGGAAGAAAAGGUGG	3130	GGGGGAAGAAAA	3131	CCUUUUCUUCC
MIMAT0016901		GG		GGUGGGG		CCC
hsa-miR-4272	3132	CAUUCAACUAGUGAUUG	3133	CAUUCAACUAGU	3134	UCACUAGUUGA
MIMAT0016902		U		GAUUGU		AUG
hsa-miR-4273	3135	GUGUUCUCUGAUGGACA	3136	GUGUUCUCUGAU	3137	CCAUCAGAGAA
MIMAT0016903		G		GGACAG		CAC
hsa-miR-4274	3138	CAGCAGUCCCUCCCCCU	3139	CAGCAGUCCCUC	3140	GGGAGGGACUG
MIMAT0016906		G		CCCCUG		CUG
hsa-miR-4275	3141	CCAAUUACCACUUCUUU	3142	CCAAUUACCACU	3143	GAAGUGGUAAU
MIMAT0016905				UCUUU		UGG
hsa-miR-4276	3144	CUCAGUGACUCAUGUGC	3145	CUCAGUGACUCA	3146	CAUGAGUCACU
MIMAT0016904				UGUGC		GAG
hsa-miR-4277	3147	GCAGUUCUGAGCACAGU	3148	GCAGUUCUGAGC	3149	GUGCUCAGAAC
MIMAT0016908		ACAC		ACAGUACA		UGC
hsa-miR-4278	3150	CUAGGGGGUUUGCCCUU	3151	CUAGGGGGUUUG	3152	GGCAAACCCCC
MIMAT0016910		G		CCCUUG		UAG
hsa-miR-4279	3153	CUCUCCUCCCGGCUUC	3154	CUCUCCUCCCGG	3155	AGCCGGGAGGA
MIMAT0016909				CUUC		GAG
hsa-miR-4280	3156	GAGUGUAGUUCUGAGCA	3157	GAGUGUAGUUCU	3158	UCAGAACUACA
MIMAT0016911		GAGC		GAGCAGAG		CUC
hsa-miR-4281	3159	GGGUCCCGGGGAGGGGG	3160	GGGUCCCGGGGA	3161	CCUCCCCGGGA
MIMAT0016907		G		GGGGGG		CCC
hsa-miR-4282	3162	UAAAAUUUGCAUCCAGG	3163	UAAAAUUUGCAU	3164	GGAUGCAAAUU
MIMAT0016912		A		CCAGGA		UUA
hsa-miR-4283	3165	UGGGGCUCAGCGAGUUU	3166	UGGGGCUCAGCG	3167	CUCGCUGAGCC
MIMAT0016914				AGUUU		CCA
hsa-miR-4284	3168	GGGCUCACAUCACCCCA	3169	GGGCUCACAUCA	3170	GGUGAUGUGAG
MIMAT0016915		U		CCCCAU		CCC
hsa-miR-4285	3171	GCGGCGAGUCCGACUCA	3172	GCGGCGAGUCCG	3173	GUCGGACUCGC
MIMAT0016913		U		ACUCAU		CGC
hsa-miR-4286	3174	ACCCCACUCCUGGUACC	3175	ACCCCACUCCUG	3176	ACCAGGAGUGG
MIMAT0016916				GUACC		GGU
hsa-miR-4287	3177	UCUCCCUUGAGGGCACU	3178	UCUCCCUUGAGG	3179	GCCCUCAAGGG
MIMAT0016917		UU		GCACUUU		AGA
hsa-miR-4288	3180	UUGUCUGCUGAGUUUCC	3181	UUGUCUGCUGAG	3182	AACUCAGCAGA
MIMAT0016918				UUUCC		CAA
hsa-miR-4289	3183	GCAUUGUGCAGGGCUAU	3184	GCAUUGUGCAGG	3185	GCCCUGCACAA
MIMAT0016920		CA		GCUAUCA		UGC
hsa-miR-429	3186	UAAUACUGUCUGGUAAA	3187	UAAUACUGUCUG	3188	ACCAGACAGUA
MIMAT0001536		ACCGU		GUAAAACC		UUA
hsa-miR-4290	3189	UGCCCUCCUUUCUUCCC	3190	UGCCCUCCUUUC	3191	AAGAAAGGAGG
MIMAT0016921		UC		UUCCCUC		GCA
hsa-miR-4291	3192	UUCAGCAGGAACAGCU	3193	UUCAGCAGGAAC	3194	CUGUUCCUGCU
MIMAT0016922				AGCU		GAA
hsa-miR-4292	3195	CCCCUGGGCCGGCCUUG	3196	CCCCUGGGCCGG	3197	GGCCGGCCCAG
MIMAT0016919		G		CCUUGG		GGG
hsa-miR-4293	3198	CAGCCUGACAGGAACAG	3199	CAGCCUGACAGG	3200	UUCCUGUCAGG
MIMAT0016848				AACAG		CUG
hsa-miR-4294	3201	GGGAGUCUACAGCAGGG	3202	GGGAGUCUACAG	3203	UGCUGUAGACU
MIMAT0016849				CAGGG		CCC
hsa-miR-4295	3204	CAGUGCAAUGUUUUCCU	3205	CAGUGCAAUGUU	3206	AAAACAUUGCA
MIMAT0016844		U		UUCCUU		CUG
hsa-miR-4296	3207	AUGUGGGCUCAGGCUCA	3208	AUGUGGGCUCAG	3209	GCCUGAGCCCA
MIMAT0016845				GCUCA		CAU
hsa-miR-4297	3210	UGCCUUCCUGUCUGUG	3211	UGCCUUCCUGUC	3212	CAGACAGGAAG
MIMAT0016846				UGUG		GCA
hsa-miR-4298	3213	CUGGGACAGGAGGAGGA	3214	CUGGGACAGGAG	3215	UCCUCCUGUCC
MIMAT0016852		GGCAG		GAGGAGGC		CAG
hsa-miR-4299	3216	GCUGGUGACAUGAGAGG	3217	GCUGGUGACAUG	3218	CUCAUGUCACC
MIMAT0016851		C		AGAGGC		AGC
hsa-miR-4300	3219	UGGGAGCUGGACUACUU	3220	UGGGAGCUGGAC	3221	UAGUCCAGCUC
MIMAT0016853		C		UACUUC		CCA
hsa-miR-4301	3222	UCCCACUACUUCACUUG	3223	UCCCACUACUUC	3224	GUGAAGUAGUG
MIMAT0016850		UGA		ACUUGUGA		GGA
hsa-miR-4302	3225	CCAGUGUGGCUCAGCGA	3226	CCAGUGUGGCUC	3227	CUGAGCCACAC
MIMAT0016855		G		AGCGAG		UGG
hsa-miR-4303	3228	UUCUGAGCUGAGGACAG	3229	UUCUGAGCUGAG	3230	UCCUCAGCUCA
MIMAT0016856				GACAG		GAA
hsa-miR-4304	3231	CCGGCAUGUCCAGGGCA	3232	CCGGCAUGUCCA	3233	CCUGGACAUGC
MIMAT0016854				GGGCA		CGG
hsa-miR-4305	3234	CCUAGACACCUCCAGUU	3235	CCUAGACACCUC	3236	UGGAGGUGUCU
MIMAT0016857		C		CAGUUC		AGG
hsa-miR-4306	3237	UGGAGAGAAAGGCAGUA	3238	UGGAGAGAAAGG	3239	UGCCUUUCUCU
MIMAT0016858				CAGUA		CCA
hsa-miR-4307	3240	AAUGUUUUUUCCUGUUU	3241	AAUGUUUUUUCC	3242	CAGGAAAAAAC
MIMAT0016860		CC		UGUUUCC		AUU
hsa-miR-4308	3243	UCCCUGGAGUUUCUUCU	3244	UCCCUGGAGUUU	3245	AGAAACUCCAG
MIMAT0016861		U		CUUCUU		GGA
hsa-miR-4309	3246	CUGGAGUCUAGGAUUCC	3247	CUGGAGUCUAGG	3248	AUCCUAGACUC
MIMAT0016859		A		AUUCCA		CAG
hsa-miR-431	3249	UGUCUUGCAGGCCGUCA	3250	UGUCUUGCAGGC	3251	CGGCCUGCAAG
MIMAT0001625		UGCA		CGUCAUGC		ACA
hsa-miR-431*	3252	CAGGUCGUCUUGCAGGG	3253	CAGGUCGUCUUG	3254	UGCAAGACGAC
MIMAT0004757		CUUCU		CAGGGCUU		CUG
hsa-miR-4310	3255	GCAGCAUUCAUGUCCC	3256	GCAGCAUUCAUG	3257	GACAUGAAUGC
MIMAT0016862				UCCC		UGC
hsa-miR-4311	3258	GAAAGAGAGCUGAGUGU	3259	GAAAGAGAGCUG	3260	CUCAGCUCUCU
MIMAT0016863		G		AGUGUG		UUC
hsa-miR-4312	3261	GGCCUUGUUCCUGUCCC	3262	GGCCUUGUUCCU	3263	ACAGGAACAAG
MIMAT0016864		CA		GUCCCCA		GCC
hsa-miR-4313	3264	AGCCCCCUGGCCCCAAA	3265	AGCCCCCUGGCC	3266	GGGGCCAGGGG
MIMAT0016865		CCC		CCAAACCC		GCU
hsa-miR-4314	3267	CUCUGGGAAAUGGGACA	3268	CUCUGGGAAAUG	3269	CCCAUUUCCCA
MIMAT0016868		G		GGACAG		GAG
hsa-miR-4315	3270	CCGCUUUCUGAGCUGGA	3271	CCGCUUUCUGAG	3272	AGCUCAGAAAG
MIMAT0016866		C		CUGGAC		CGG
hsa-miR-4316	3273	GGUGAGGCUAGCUGGUG	3274	GGUGAGGCUAGC	3275	CAGCUAGCCUC
MIMAT0016867				UGGUG		ACC
hsa-miR-4317	3276	ACAUUGCCAGGGAGUUU	3277	ACAUUGCCAGGG	3278	CUCCCUGGCAA
MIMAT0016872				AGUUU		UGU
hsa-miR-4318	3279	CACUGUGGGUACAUGCU	3280	CACUGUGGGUAC	3281	AUGUACCCACA
MIMAT0016869				AUGCU		GUG
hsa-miR-4319	3282	UCCCUGAGCAAAGCCAC	3283	UCCCUGAGCAAA	3284	GCUUUGCUCAG
MIMAT0016870				GCCAC		GGA
hsa-miR-432	3285	UCUUGGAGUAGGUCAUU	3286	UCUUGGAGUAGG	3287	GACCUACUCCA
MIMAT0002814		GGGUGG		UCAUUGGG		AGA
hsa-miR-432*	3288	CUGGAUGGCUCCUCCAU	3289	CUGGAUGGCUCC	3290	GAGGAGCCAUC
MIMAT0002815		GUCU		UCCAUGUC		CAG
hsa-miR-4320	3291	GGGAUUCUGUAGCUUCC	3292	GGGAUUCUGUAG	3293	AGCUACAGAAU
MIMAT0016871		U		CUUCCU		CCC
hsa-miR-4321	3294	UUAGCGGUGGACCGCCC	3295	UUAGCGGUGGAC	3296	CGGUCCACCGC
MIMAT0016874		UGCG		CGCCCUGC		UAA
hsa-miR-4322	3297	CUGUGGGCUCAGCGCGU	3298	CUGUGGGCUCAG	3299	CGCUGAGCCCA
MIMAT0016873		GGGG		CGCGUGGG		CAG
hsa-miR-4323	3300	CAGCCCCACAGCCUCAG	3301	CAGCCCCACAGC	3302	AGGCUGUGGGG
MIMAT0016875		A		CUCAGA		CUG
hsa-miR-4324	3303	CCCUGAGACCCUAACCU	3304	CCCUGAGACCCU	3305	UUAGGGUCUCA
MIMAT0016876		UAA		AACCUUAA		GGG
hsa-miR-4325	3306	UUGCACUUGUCUCAGUG	3307	UUGCACUUGUCU	3308	UGAGACAAGUG
MIMAT0016887		A		CAGUGA		CAA
hsa-miR-4326	3309	UGUUCCUCUGUCUCCCA	3310	UGUUCCUCUGUC	3311	GAGACAGAGGA
MIMAT0016888		GAC		UCCCAGAC		ACA
hsa-miR-4327	3312	GGCUUGCAUGGGGGACU	3313	GGCUUGCAUGGG	3314	CCCCCAUGCAA
MIMAT0016889		GG		GGACUGG		GCC
hsa-miR-4328	3315	CCAGUUUUCCCAGGAUU	3316	CCAGUUUUCCCA	3317	CCUGGGAAAAC
MIMAT0016926				GGAUU		UGG
hsa-miR-4329	3318	CCUGAGACCCUAGUUCC	3319	CCUGAGACCCUA	3320	ACUAGGGUCUC
MIMAT0016923		AC		GUUCCAC		AGG
hsa-miR-433	3321	AUCAUGAUGGGCUCCUC	3322	AUCAUGAUGGGC	3323	GAGCCCAUCAU
MIMAT0001627		GGUGU		UCCUCGGU		GAU
hsa-miR-4330	3324	CCUCAGAUCAGAGCCUU	3325	CCUCAGAUCAGA	3326	GCUCUGAUCUG
MIMAT0016924		GC		GCCUUGC		AGG
hsa-miR-448	3327	UUGCAUAUGUAGGAUGU	3328	UUGCAUAUGUAG	3329	UCCUACAUAUG
MIMAT0001532		CCCAU		GAUGUCCC		CAA
hsa-miR-449a	3330	UGGCAGUGUAUUGUUAG	3331	UGGCAGUGUAUU	3332	ACAAUACACUG
MIMAT0001541		CUGGU		GUUAGCUG		CCA
hsa-miR-449b	3333	AGGCAGUGUAUUGUUAG	3334	AGGCAGUGUAUU	3335	ACAAUACACUG
MIMAT0003327		CUGGC		GUUAGCUG		CCU
hsa-miR-449b*	3336	CAGCCACAACUACCCUG	3337	CAGCCACAACUA	3338	GGUAGUUGUGG
MIMAT0009203		CCACU		CCCUGCCA		CUG
hsa-miR-449c	3339	UAGGCAGUGUAUUGCUA	3340	UAGGCAGUGUAU	3341	CAAUACACUGC
MIMAT0010251		GCGGCUGU		UGCUAGCG		CUA
hsa-miR-449c*	3342	UUGCUAGUUGCACUCCU	3343	UUGCUAGUUGCA	3344	AGUGCAACUAG
MIMAT0013771		CUCUGU		CUCCUCUC		CAA
hsa-miR-450a	3345	UUUUGCGAUGUGUUCCU	3346	UUUUGCGAUGUG	3347	AACACAUCGCA
MIMAT0001545		AAUAU		UUCCUAAU		AAA
hsa-miR-450b-	3348	UUGGGAUCAUUUUGCAU	3349	UUGGGAUCAUUU	3350	CAAAAUGAUCC
3p		CCAUA		UGCAUCCA		CAA
MIMAT0004910
hsa-miR-450b-	3351	UUUUGCAAUAUGUUCCU	3352	UUUUGCAAUAUG	3353	AACAUAUUGCA
5p		GAAUA		UUCCUGAA		AAA
MIMAT0004909
hsa-miR-451	3354	AAACCGUUACCAUUACU	3355	AAACCGUUACCA	3356	AAUGGUAACGG
MIMAT0001631		GAGUU		UUACUGAG		UUU
hsa-miR-452	3357	AACUGUUUGCAGAGGAA	3358	AACUGUUUGCAG	3359	CUCUGCAAACA
MIMAT0001635		ACUGA		AGGAAACU		GUU
hsa-miR-452*	3360	CUCAUCUGCAAAGAAGU	3361	CUCAUCUGCAAA	3362	UCUUUGCAGAU
MIMAT0001636		AAGUG		GAAGUAAG		GAG
hsa-miR-454	3363	UAGUGCAAUAUUGCUUA	3364	UAGUGCAAUAUU	3365	GCAAUAUUGCA
MIMAT0003885		UAGGGU		GCUUAUAG		CUA
hsa-miR-454*	3366	ACCCUAUCAAUAUUGUC	3367	ACCCUAUCAAUA	3368	AAUAUUGAUAG
MIMAT0003884		UCUGC		UUGUCUCU		GGU
hsa-miR-455-3p	3369	GCAGUCCAUGGGCAUAU	3370	GCAGUCCAUGGG	3371	UGCCCAUGGAC
MIMAT0004784		ACAC		CAUAUACA		UGC
hsa-miR-455-5p	3372	UAUGUGCCUUUGGACUA	3373	UAUGUGCCUUUG	3374	UCCAAAGGCAC
MIMAT0003150		CAUCG		GACUACAU		AUA
hsa-miR-466	3375	AUACACAUACACGCAAC	3376	AUACACAUACAC	3377	GCGUGUAUGUG
MIMAT0015002		ACACAU		GCAACACA		UAU
hsa-miR-483-3p	3378	UCACUCCUCUCCUCCCG	3379	UCACUCCUCUCC	3380	GAGGAGAGGAG
MIMAT0002173		UCUU		UCCCGUCU		UGA
hsa-miR-483-5p	3381	AAGACGGGAGGAAAGAA	3382	AAGACGGGAGGA	3383	UUUCCUCCCGU
MIMAT0004761		GGGAG		AAGAAGGG		CUU
hsa-miR-484	3384	UCAGGCUCAGUCCCCUC	3385	UCAGGCUCAGUC	3386	GGGACUGAGCC
MIMAT0002174		CCGAU		CCCUCCCG		UGA
hsa-miR-485-3p	3387	GUCAUACACGGCUCUCC	3388	GUCAUACACGGC	3389	GAGCCGUGUAU
MIMAT0002176		UCUCU		UCUCCUCU		GAC
hsa-miR-485-5p	3390	AGAGGCUGGCCGUGAUG	3391	AGAGGCUGGCCG	3392	CACGGCCAGCC
MIMAT0002175		AAUUC		UGAUGAAU		UCU
hsa-miR-486-3p	3393	CGGGGCAGCUCAGUACA	3394	CGGGGCAGCUCA	3395	ACUGAGCUGCC
MIMAT0004762		GGAU		GUACAGGA		CCG
hsa-miR-486-5p	3396	UCCUGUACUGAGCUGCC	3397	UCCUGUACUGAG	3398	AGCUCAGUACA
MIMAT0002177		CCGAG		CUGCCCCG		GGA
hsa-miR-487a	3399	AAUCAUACAGGGACAUC	3400	AAUCAUACAGGG	3401	GUCCCUGUAUG
MIMAT0002178		CAGUU		ACAUCCAG		AUU
hsa-miR-487b	3402	AAUCGUACAGGGUCAUC	3403	AAUCGUACAGGG	3404	GACCCUGUACG
MIMAT0003180		CACUU		UCAUCCAC		AUU
hsa-miR-488	3405	UUGAAAGGCUAUUUCUU	3406	UUGAAAGGCUAU	3407	AAAUAGCCUUU
MIMAT0004763		GGUC		UUCUUGGU		CAA
hsa-miR-488*	3408	CCCAGAUAAUGGCACUC	3409	CCCAGAUAAUGG	3410	UGCCAUUAUCU
MIMAT0002804		UCAA		CACUCUCA		GGG
hsa-miR-489	3411	GUGACAUCACAUAUACG	3412	GUGACAUCACAU	3413	AUAUGUGAUGU
MIMAT0002805		GCAGC		AUACGGCA		CAC
hsa-miR-490-3p	3414	CAACCUGGAGGACUCCA	3415	CAACCUGGAGGA	3416	AGUCCUCCAGG
MIMAT0002806		UGCUG		CUCCAUGC		UUG
hsa-miR-490-5p	3417	CCAUGGAUCUCCAGGUG	3418	CCAUGGAUCUCC	3419	CUGGAGAUCCA
MIMAT0004764		GGU		AGGUGGGU		UGG
hsa-miR-491-3p	3420	CUUAUGCAAGAUUCCCU	3421	CUUAUGCAAGAU	3422	GAAUCUUGCAU
MIMAT0004765		UCUAC		UCCCUUCU		AAG
hsa-miR-491-5p	3423	AGUGGGGAACCCUUCCA	3424	AGUGGGGAACCC	3425	AAGGGUUCCCC
MIMAT0002807		UGAGG		UUCCAUGA		ACU
hsa-miR-492	3426	AGGACCUGCGGGACAAG	3427	AGGACCUGCGGG	3428	GUCCCGCAGGU
MIMAT0002812		AUUCUU		ACAAGAUU		CCU
hsa-miR-493	3429	UGAAGGUCUACUGUGUG	3430	UGAAGGUCUACU	3431	ACAGUAGACCU
MIMAT0003161		CCAGG		GUGUGCCA		UCA
hsa-miR-493*	3432	UUGUACAUGGUAGGCUU	3433	UUGUACAUGGUA	3434	CCUACCAUGUA
MIMAT0002813		UCAUU		GGCUUUCA		CAA
hsa-miR-494	3435	UGAAACAUACACGGGAA	3436	UGAAACAUACAC	3437	CCGUGUAUGUU
MIMAT0002816		ACCUC		GGGAAACC		UCA
hsa-miR-495	3438	AAACAAACAUGGUGCAC	3439	AAACAAACAUGG	3440	CACCAUGUUUG
MIMAT0002817		UUCUU		UGCACUUC		UUU
hsa-miR-496	3441	UGAGUAUUACAUGGCCA	3442	UGAGUAUUACAU	3443	CCAUGUAAUAC
MIMAT0002818		AUCUC		GGCCAAUC		UCA
hsa-miR-497	3444	CAGCAGCACACUGUGGU	3445	CAGCAGCACACU	3446	ACAGUGUGCUG
MIMAT0002820		UUGU		GUGGUUUG		CUG
hsa-miR-497*	3447	CAAACCACACUGUGGUG	3448	CAAACCACACUG	3449	CACAGUGUGGU
MIMAT0004768		UUAGA		UGGUGUUA		UUG
hsa-miR-498	3450	UUUCAAGCCAGGGGGCG	3451	UUUCAAGCCAGG	3452	CCCCUGGCUUG
MIMAT0002824		UUUUUC		GGGCGUUU		AAA
hsa-miR-499-3p	3453	AACAUCACAGCAAGUCU	3454	AACAUCACAGCA	3455	CUUGCUGUGAU
MIMAT0004772		GUGCU		AGUCUGUG		GUU
hsa-miR-499-5p	3456	UUAAGACUUGCAGUGAU	3457	UUAAGACUUGCA	3458	ACUGCAAGUCU
MIMAT0002870		GUUU		GUGAUGUU		UAA
hsa-miR-500a	3459	UAAUCCUUGCUACCUGG	3460	UAAUCCUUGCUA	3461	GGUAGCAAGGA
MIMAT0004773		GUGAGA		CCUGGGUG		UUA
hsa-miR-500a*	3462	AUGCACCUGGGCAAGGA	3463	AUGCACCUGGGC	3464	UUGCCCAGGUG
MIMAT0002871		UUCUG		AAGGAUUC		CAU
hsa-miR-500b	3465	AAUCCUUGCUACCUGGG	3466	AAUCCUUGCUAC	3467	AGGUAGCAAGG
MIMAT0016925		U		CUGGGU		AUU
hsa-miR-501-3p	3468	AAUGCACCCGGGCAAGG	3469	AAUGCACCCGGG	3470	UGCCCGGGUGC
MIMAT0004774		AUUCU		CAAGGAUU		AUU
hsa-miR-501-5p	3471	AAUCCUUUGUCCCUGGG	3472	AAUCCUUUGUCC	3473	AGGGACAAAGG
MIMAT0002872		UGAGA		CUGGGUGA		AUU
hsa-miR-502-3p	3474	AAUGCACCUGGGCAAGG	3475	AAUGCACCUGGG	3476	UGCCCAGGUGC
MIMAT0004775		AUUCA		CAAGGAUU		AUU
hsa-miR-502-5p	3477	AUCCUUGCUAUCUGGGU	3478	AUCCUUGCUAUC	3479	CAGAUAGCAAG
MIMAT0002873		GCUA		UGGGUGCU		GAU
hsa-miR-503	3480	UAGCAGCGGGAACAGUU	3481	UAGCAGCGGGAA	3482	UGUUCCCGCUG
MIMAT0002874		CUGCAG		CAGUUCUG		CUA
hsa-miR-504	3483	AGACCCUGGUCUGCACU	3484	AGACCCUGGUCU	3485	GCAGACCAGGG
MIMAT0002875		CUAUC		GCACUCUA		UCU
hsa-miR-505	3486	CGUCAACACUUGCUGGU	3487	CGUCAACACUUG	3488	AGCAAGUGUUG
MIMAT0002876		UUCCU		CUGGUUUC		ACG
hsa-miR-505*	3489	GGGAGCCAGGAAGUAUU	3490	GGGAGCCAGGAA	3491	ACUUCCUGGCU
MIMAT0004776		GAUGU		GUAUUGAU		CCC
hsa-miR-506	3492	UAAGGCACCCUUCUGAG	3493	UAAGGCACCCUU	3494	AGAAGGGUGCC
MIMAT0002878		UAGA		CUGAGUAG		UUA
hsa-miR-507	3495	UUUUGCACCUUUUGGAG	3496	UUUUGCACCUUU	3497	CAAAAGGUGCA
MIMAT0002879		UGAA		UGGAGUGA		AAA
hsa-miR-508-3p	3498	UGAUUGUAGCCUUUUGG	3499	UGAUUGUAGCCU	3500	AAAGGCUACAA
MIMAT0002880		AGUAGA		UUUGGAGU		UCA
hsa-miR-508-5p	3501	UACUCCAGAGGGCGUCA	3502	UACUCCAGAGGG	3503	CGCCCUCUGGA
MIMAT0004778		CUCAUG		CGUCACUC		GUA
hsa-miR-509-3-	3504	UACUGCAGACGUGGCAA	3505	UACUGCAGACGU	3506	CCACGUCUGCA
5p		UCAUG		GGCAAUCA		GUA
MIMAT0004975
hsa-miR-509-3p	3507	UGAUUGGUACGUCUGUG	3508	UGAUUGGUACGU	3509	AGACGUACCAA
MIMAT0002881		GGUAG		CUGUGGGU		UCA
hsa-miR-509-5p	3510	UACUGCAGACAGUGGCA	3511	UACUGCAGACAG	3512	CACUGUCUGCA
MIMAT0004779		AUCA		UGGCAAUC		GUA
hsa-miR-510	3513	UACUCAGGAGAGUGGCA	3514	UACUCAGGAGAG	3515	CACUCUCCUGA
MIMAT0002882		AUCAC		UGGCAAUC		GUA
hsa-miR-511	3516	GUGUCUUUUGCUCUGCA	3517	GUGUCUUUUGCU	3518	AGAGCAAAAGA
MIMAT0002808		GUCA		CUGCAGUC		CAC
hsa-miR-512-3p	3519	AAGUGCUGUCAUAGCUG	3520	AAGUGCUGUCAU	3521	CUAUGACAGCA
MIMAT0002823		AGGUC		AGCUGAGG		CUU
hsa-miR-512-5p	3522	CACUCAGCCUUGAGGGC	3523	CACUCAGCCUUG	3524	CUCAAGGCUGA
MIMAT0002822		ACUUUC		AGGGCACU		GUG
hsa-miR-513a-	3525	UAAAUUUCACCUUUCUG	3526	UAAAUUUCACCU	3527	AAAGGUGAAAU
3p		AGAAGG		UUCUGAGA		UUA
MIMAT0004777
hsa-miR-513a-	3528	UUCACAGGGAGGUGUCA	3529	UUCACAGGGAGG	3530	CACCUCCCUGU
5p		U		UGUCAU		GAA
MIMAT0002877
hsa-miR-513b	3531	UUCACAAGGAGGUGUCA	3532	UUCACAAGGAGG	3533	CACCUCCUUGU
MIMAT0005788		UUUAU		UGUCAUUU		GAA
hsa-miR-513c	3534	UUCUCAAGGAGGUGUCG	3535	UUCUCAAGGAGG	3536	CACCUCCUUGA
MIMAT0005789		UUUAU		UGUCGUUU		GAA
hsa-miR-514	3537	AUUGACACUUCUGUGAG	3538	AUUGACACUUCU	3539	ACAGAAGUGUC
MIMAT0002883		UAGA		GUGAGUAG		AAU
hsa-miR-514b-	3540	AUUGACACCUCUGUGAG	3541	AUUGACACCUCU	3542	ACAGAGGUGUC
3p		UGGA		GUGAGUGG		AAU
MIMAT0015088
hsa-miR-514b-	3543	UUCUCAAGAGGGAGGCA	3544	UUCUCAAGAGGG	3545	CUCCCUCUUGA
5p		AUCAU		AGGCAAUC		GAA
MIMAT0015087
hsa-miR-515-3p	3546	GAGUGCCUUCUUUUGGA	3547	GAGUGCCUUCUU	3548	AAAAGAAGGCA
MIMAT0002827		GCGUU		UUGGAGCG		CUC
hsa-miR-515-5p	3549	UUCUCCAAAAGAAAGCA	3550	UUCUCCAAAAGA	3551	UUUCUUUUGGA
MIMAT0002826		CUUUCUG		AAGCACUU		GAA
hsa-miR-516a-	3552	UGCUUCCUUUCAGAGGG	3553	UGCUUCCUUUCA	3554	UCUGAAAGGAA
3p		U		GAGGGU		GCA
MIMAT0006778
hsa-miR-516a-	3555	UUCUCGAGGAAAGAAGC	3556	UUCUCGAGGAAA	3557	UCUUUCCUCGA
5p		ACUUUC		GAAGCACU		GAA
MIMAT0004770
hsa-miR-516b	3558	AUCUGGAGGUAAGAAGC	3559	AUCUGGAGGUAA	3560	UCUUACCUCCA
MIMAT0002859		ACUUU		GAAGCACU		GAU
hsa-miR-516b*	3561	UGCUUCCUUUCAGAGGG	3562	UGCUUCCUUUCA	3563	UCUGAAAGGAA
MIMAT0002860		U		GAGGGU		GCA
hsa-miR-517*	3564	CCUCUAGAUGGAAGCAC	3565	CCUCUAGAUGGA	3566	CUUCCAUCUAG
MIMAT0002851		UGUCU		AGCACUGU		AGG
hsa-miR-517a	3567	AUCGUGCAUCCCUUUAG	3568	AUCGUGCAUCCC	3569	AAGGGAUGCAC
MIMAT0002852		AGUGU		UUUAGAGU		GAU
hsa-miR-517b	3570	UCGUGCAUCCCUUUAGA	3571	UCGUGCAUCCCU	3572	AAAGGGAUGCA
MIMAT0002857		GUGUU		UUAGAGUG		CGA
hsa-miR-517c	3573	AUCGUGCAUCCUUUUAG	3574	AUCGUGCAUCCU	3575	AAAGGAUGCAC
MIMAT0002866		AGUGU		UUUAGAGU		GAU
hsa-miR-518a-	3576	GAAAGCGCUUCCCUUUG	3577	GAAAGCGCUUCC	3578	AGGGAAGCGCU
3p		CUGGA		CUUUGCUG		UUC
MIMAT0002863
hsa-miR-518a-	3579	CUGCAAAGGGAAGCCCU	3580	CUGCAAAGGGAA	3581	GCUUCCCUUUG
5p		UUC		GCCCUUUC		CAG
MIMAT0005457
hsa-miR-518b	3582	CAAAGCGCUCCCCUUUA	3583	CAAAGCGCUCCC	3584	AGGGGAGCGCU
MIMAT0002844		GAGGU		CUUUAGAG		UUG
hsa-miR-518c	3585	CAAAGCGCUUCUCUUUA	3586	CAAAGCGCUUCU	3587	AGAGAAGCGCU
MIMAT0002848		GAGUGU		CUUUAGAG		UUG
hsa-miR-518c*	3588	UCUCUGGAGGGAAGCAC	3589	UCUCUGGAGGGA	3590	CUUCCCUCCAG
MIMAT0002847		UUUCUG		AGCACUUU		AGA
hsa-miR-518d-	3591	CAAAGCGCUUCCCUUUG	3592	CAAAGCGCUUCC	3593	AGGGAAGCGCU
3p		GAGC		CUUUGGAG		UUG
MIMAT0002864
hsa-miR-518d-	3594	CUCUAGAGGGAAGCACU	3595	CUCUAGAGGGAA	3596	GCUUCCCUCUA
5p		UUCUG		GCACUUUC		GAG
MIMAT0005456
hsa-miR-518e	3597	AAAGCGCUUCCCUUCAG	3598	AAAGCGCUUCCC	3599	AAGGGAAGCGC
MIMAT0002861		AGUG		UUCAGAGU		UUU
hsa-miR-518e*	3600	CUCUAGAGGGAAGCGCU	3601	CUCUAGAGGGAA	3602	GCUUCCCUCUA
MIMAT0005450		UUCUG		GCGCUUUC		GAG
hsa-miR-518f	3603	GAAAGCGCUUCUCUUUA	3604	GAAAGCGCUUCU	3605	AGAGAAGCGCU
MIMAT0002842		GAGG		CUUUAGAG		UUC
hsa-miR-518f*	3606	CUCUAGAGGGAAGCACU	3607	CUCUAGAGGGAA	3608	GCUUCCCUCUA
MIMAT0002841		UUCUC		GCACUUUC		GAG
hsa-miR-519a	3609	AAAGUGCAUCCUUUUAG	3610	AAAGUGCAUCCU	3611	AAAGGAUGCAC
MIMAT0002869		AGUGU		UUUAGAGU		UUU
hsa-miR-519a*	3612	CUCUAGAGGGAAGCGCU	3613	CUCUAGAGGGAA	3614	GCUUCCCUCUA
MIMAT0005452		UUCUG		GCGCUUUC		GAG
hsa-miR-519b-	3615	AAAGUGCAUCCUUUUAG	3616	AAAGUGCAUCCU	3617	AAAGGAUGCAC
3p		AGGUU		UUUAGAGG		UUU
MIMAT0002837
hsa-miR-519b-	3618	CUCUAGAGGGAAGCGCU	3619	CUCUAGAGGGAA	3620	GCUUCCCUCUA
5p		UUCUG		GCGCUUUC		GAG
MIMAT0005454
hsa-miR-519c-	3621	AAAGUGCAUCUUUUUAG	3622	AAAGUGCAUCUU	3623	AAAAGAUGCAC
3p		AGGAU		UUUAGAGG		UUU
MIMAT0002832
hsa-miR-519c-	3624	CUCUAGAGGGAAGCGCU	3625	CUCUAGAGGGAA	3626	GCUUCCCUCUA
5p		UUCUG		GCGCUUUC		GAG
MIMAT0002831
hsa-miR-519d	3627	CAAAGUGCCUCCCUUUA	3628	CAAAGUGCCUCC	3629	AGGGAGGCACU
MIMAT0002853		GAGUG		CUUUAGAG		UUG
hsa-miR-519e	3630	AAGUGCCUCCUUUUAGA	3631	AAGUGCCUCCUU	3632	AAAAGGAGGCA
MIMAT0002829		GUGUU		UUAGAGUG		CUU
hsa-miR-519e*	3633	UUCUCCAAAAGGGAGCA	3634	UUCUCCAAAAGG	3635	UCCCUUUUGGA
MIMAT0002828		CUUUC		GAGCACUU		GAA
hsa-miR-520a-	3636	AAAGUGCUUCCCUUUGG	3637	AAAGUGCUUCCC	3638	AAGGGAAGCAC
3p		ACUGU		UUUGGACU		UUU
MIMAT0002834
hsa-miR-520a-	3639	CUCCAGAGGGAAGUACU	3640	CUCCAGAGGGAA	3641	ACUUCCCUCUG
5p		UUCU		GUACUUUC		GAG
MIMAT0002833
hsa-miR-520b	3642	AAAGUGCUUCCUUUUAG	3643	AAAGUGCUUCCU	3644	AAAGGAAGCAC
MIMAT0002843		AGGG		UUUAGAGG		UUU
hsa-miR-520c-	3645	AAAGUGCUUCCUUUUAG	3646	AAAGUGCUUCCU	3647	AAAGGAAGCAC
3p		AGGGU		UUUAGAGG		UUU
MIMAT0002846
hsa-miR-520c-	3648	CUCUAGAGGGAAGCACU	3649	CUCUAGAGGGAA	3650	GCUUCCCUCUA
5p		UUCUG		GCACUUUC		GAG
MIMAT0005455
hsa-miR-520d-	3651	AAAGUGCUUCUCUUUGG	3652	AAAGUGCUUCUC	3653	AAGAGAAGCAC
3p		UGGGU		UUUGGUGG		UUU
MIMAT0002856
hsa-miR-520d-	3654	CUACAAAGGGAAGCCCU	3655	CUACAAAGGGAA	3656	GCUUCCCUUUG
5p		UUC		GCCCUUUC		UAG
MIMAT0002855
hsa-miR-520e	3657	AAAGUGCUUCCUUUUUG	3658	AAAGUGCUUCCU	3659	AAAGGAAGCAC
MIMAT0002825		AGGG		UUUUGAGG		UUU
hsa-miR-520f	3660	AAGUGCUUCCUUUUAGA	3661	AAGUGCUUCCUU	3662	AAAAGGAAGCA
MIMAT0002830		GGGUU		UUAGAGGG		CUU
hsa-miR-520g	3663	ACAAAGUGCUUCCCUUU	3664	ACAAAGUGCUUC	3665	GGGAAGCACUU
MIMAT0002858		AGAGUGU		CCUUUAGA		UGU
hsa-miR-520h	3666	ACAAAGUGCUUCCCUUU	3667	ACAAAGUGCUUC	3668	GGGAAGCACUU
MIMAT0002867		AGAGU		CCUUUAGA		UGU
hsa-miR-521	3669	AACGCACUUCCCUUUAG	3670	AACGCACUUCCC	3671	AAGGGAAGUGC
MIMAT0002854		AGUGU		UUUAGAGU		GUU
hsa-miR-522	3672	AAAAUGGUUCCCUUUAG	3673	AAAAUGGUUCCC	3674	AAGGGAACCAU
MIMAT0002868		AGUGU		UUUAGAGU		UUU
hsa-miR-522*	3675	CUCUAGAGGGAAGCGCU	3676	CUCUAGAGGGAA	3677	GCUUCCCUCUA
MIMAT0005451		UUCUG		GCGCUUUC		GAG
hsa-miR-523	3678	GAACGCGCUUCCCUAUA	3679	GAACGCGCUUCC	3680	AGGGAAGCGCG
MIMAT0002840		GAGGGU		CUAUAGAG		UUC
hsa-miR-523*	3681	CUCUAGAGGGAAGCGCU	3682	CUCUAGAGGGAA	3683	GCUUCCCUCUA
MIMAT0005449		UUCUG		GCGCUUUC		GAG
hsa-miR-524-3p	3684	GAAGGCGCUUCCCUUUG	3685	GAAGGCGCUUCC	3686	AGGGAAGCGCC
MIMAT0002850		GAGU		CUUUGGAG		UUC
hsa-miR-524-5p	3687	CUACAAAGGGAAGCACU	3688	CUACAAAGGGAA	3689	GCUUCCCUUUG
MIMAT0002849		UUCUC		GCACUUUC		UAG
hsa-miR-525-3p	3690	GAAGGCGCUUCCCUUUA	3691	GAAGGCGCUUCC	3692	AGGGAAGCGCC
MIMAT0002839		GAGCG		CUUUAGAG		UUC
hsa-miR-525-5p	3693	CUCCAGAGGGAUGCACU	3694	CUCCAGAGGGAU	3695	GCAUCCCUCUG
MIMAT0002838		UUCU		GCACUUUC		GAG
hsa-miR-526a	3696	CUCUAGAGGGAAGCACU	3697	CUCUAGAGGGAA	3698	GCUUCCCUCUA
MIMAT0002845		UUCUG		GCACUUUC		GAG
hsa-miR-526b	3699	CUCUUGAGGGAAGCACU	3700	CUCUUGAGGGAA	3701	GCUUCCCUCAA
MIMAT0002835		UUCUGU		GCACUUUC		GAG
hsa-miR-526b*	3702	GAAAGUGCUUCCUUUUA	3703	GAAAGUGCUUCC	3704	AAGGAAGCACU
MIMAT0002836		GAGGC		UUUUAGAG		UUC
hsa-miR-527	3705	CUGCAAAGGGAAGCCCU	3706	CUGCAAAGGGAA	3707	GCUUCCCUUUG
MIMAT0002862		UUC		GCCCUUUC		CAG
hsa-miR-532-3p	3708	CCUCCCACACCCAAGGC	3709	CCUCCCACACCC	3710	UUGGGUGUGGG
MIMAT0004780		UUGCA		AAGGCUUG		AGG
hsa-miR-532-5p	3711	CAUGCCUUGAGUGUAGG	3712	CAUGCCUUGAGU	3713	ACACUCAAGGC
MIMAT0002888		ACCGU		GUAGGACC		AUG
hsa-miR-539	3714	GGAGAAAUUAUCCUUGG	3715	GGAGAAAUUAUC	3716	AGGAUAAUUUC
MIMAT0003163		UGUGU		CUUGGUGU		UCC
hsa-miR-541	3717	UGGUGGGCACAGAAUCU	3718	UGGUGGGCACAG	3719	UUCUGUGCCCA
MIMAT0004920		GGACU		AAUCUGGA		CCA
hsa-miR-541*	3720	AAAGGAUUCUGCUGUCG	3721	AAAGGAUUCUGC	3722	CAGCAGAAUCC
MIMAT0004919		GUCCCACU		UGUCGGUC		UUU
hsa-miR-542-3p	3723	UGUGACAGAUUGAUAAC	3724	UGUGACAGAUUG	3725	AUCAAUCUGUC
MIMAT0003389		UGAAA		AUAACUGA		ACA
hsa-miR-542-5p	3726	UCGGGGAUCAUCAUGUC	3727	UCGGGGAUCAUC	3728	AUGAUGAUCCC
MIMAT0003340		ACGAGA		AUGUCACG		CGA
hsa-miR-543	3729	AAACAUUCGCGGUGCAC	3730	AAACAUUCGCGG	3731	CACCGCGAAUG
MIMAT0004954		UUCUU		UGCACUUC		UUU
hsa-miR-544	3732	AUUCUGCAUUUUUAGCA	3733	AUUCUGCAUUUU	3734	UAAAAAUGCAG
MIMAT0003164		AGUUC		UAGCAAGU		AAU
hsa-miR-544b	3735	ACCUGAGGUUGUGCAUU	3736	ACCUGAGGUUGU	3737	GCACAACCUCA
MIMAT0015004		UCUAA		GCAUUUCU		GGU
hsa-miR-545	3738	UCAGCAAACAUUUAUUG	3739	UCAGCAAACAUU	3740	UAAAUGUUUGC
MIMAT0003165		UGUGC		UAUUGUGU		UGA
hsa-miR-545*	3741	UCAGUAAAUGUUUAUUA	3742	UCAGUAAAUGUU	3743	UAAACAUUUAC
MIMAT0004785		GAUGA		UAUUAGAU		UGA
hsa-miR-548a-	3744	CAAAACUGGCAAUUACU	3745	CAAAACUGGCAA	3746	AAUUGCCAGUU
3p		UUUGC		UUACUUUU		UUG
MIMAT0003251
hsa-miR-548a-	3747	AAAAGUAAUUGCGAGUU	3748	AAAAGUAAUUGC	3749	UCGCAAUUACU
5p		UUACC		GAGUUUUA		UUU
MIMAT0004803
hsa-miR-548aa	3750	AAAAACCACAAUUACUU	3751	AAAAACCACAAU	3752	UAAUUGUGGUU
MIMAT0018447		UUGCACCA		UACUUUUG		UUU
hsa-miR-548b-	3753	CAAGAACCUCAGUUGCU	3754	CAAGAACCUCAG	3755	AACUGAGGUUC
3p		UUUGU		UUGCUUUU		UUG
MIMAT0003254
hsa-miR-548b-	3756	AAAAGUAAUUGUGGUUU	3757	AAAAGUAAUUGU	3758	CCACAAUUACU
5p		UGGCC		GGUUUUGG		UUU
MIMAT0004798
hsa-miR-548c-	3759	CAAAAAUCUCAAUUACU	3760	CAAAAAUCUCAA	3761	AAUUGAGAUUU
3p		UUUGC		UUACUUUU		UUG
MIMAT0003285
hsa-miR-548c-	3762	AAAAGUAAUUGCGGUUU	3763	AAAAGUAAUUGC	3764	CCGCAAUUACU
5p		UUGCC		GGUUUUUG		UUU
MIMAT0004806
hsa-miR-548d-	3765	CAAAAACCACAGUUUCU	3766	CAAAAACCACAG	3767	AACUGUGGUUU
3p		UUUGC		UUUCUUUU		UUG
MIMAT0003323
hsa-miR-548d-	3768	AAAAGUAAUUGUGGUUU	3769	AAAAGUAAUUGU	3770	CCACAAUUACU
5p		UUGCC		GGUUUUUG		UUU
MIMAT0004812
hsa-miR-548e	3771	AAAAACUGAGACUACUU	3772	AAAAACUGAGAC	3773	UAGUCUCAGUU
MIMAT0005874		UUGCA		UACUUUUG		UUU
hsa-miR-548f	3774	AAAAACUGUAAUUACUU	3775	AAAAACUGUAAU	3776	UAAUUACAGUU
MIMAT0005895		UU		UACUUUU		UUU
hsa-miR-548g	3777	AAAACUGUAAUUACUUU	3778	AAAACUGUAAUU	3779	GUAAUUACAGU
MIMAT0005912		UGUAC		ACUUUUGU		UUU
hsa-miR-548h	3780	AAAAGUAAUCGCGGUUU	3781	AAAAGUAAUCGC	3782	CCGCGAUUACU
MIMAT0005928		UUGUC		GGUUUUUG		UUU
hsa-miR-548i	3783	AAAAGUAAUUGCGGAUU	3784	AAAAGUAAUUGC	3785	CCGCAAUUACU
MIMAT0005935		UUGCC		GGAUUUUG		UUU
hsa-miR-548j	3786	AAAAGUAAUUGCGGUCU	3787	AAAAGUAAUUGC	3788	CCGCAAUUACU
MIMAT0005875		UUGGU		GGUCUUUG		UUU
hsa-miR-548k	3789	AAAAGUACUUGCGGAUU	3790	AAAAGUACUUGC	3791	CCGCAAGUACU
MIMAT0005882		UUGCU		GGAUUUUG		UUU
hsa-miR-548l	3792	AAAAGUAUUUGCGGGUU	3793	AAAAGUAUUUGC	3794	CCGCAAAUACU
MIMAT0005889		UUGUC		GGGUUUUG		UUU
hsa-miR-548m	3795	CAAAGGUAUUUGUGGUU	3796	CAAAGGUAUUUG	3797	CACAAAUACCU
MIMAT0005917		UUUG		UGGUUUUU		UUG
hsa-miR-548n	3798	CAAAAGUAAUUGUGGAU	3799	CAAAAGUAAUUG	3800	CACAAUUACUU
MIMAT0005916		UUUGU		UGGAUUUU		UUG
hsa-miR-548o	3801	CCAAAACUGCAGUUACU	3802	CCAAAACUGCAG	3803	AACUGCAGUUU
MIMAT0005919		UUUGC		UUACUUUU		UGG
hsa-miR-548p	3804	UAGCAAAAACUGCAGUU	3805	UAGCAAAAACUG	3806	UGCAGUUUUUG
MIMAT0005934		ACUUU		CAGUUACU		CUA
hsa-miR-548q	3807	GCUGGUGCAAAAGUAAU	3808	GCUGGUGCAAAA	3809	ACUUUUGCACC
MIMAT0011163		GGCGG		GUAAUGGC		AGC
hsa-miR-548s	3810	AUGGCCAAAACUGCAGU	3811	AUGGCCAAAACU	3812	GCAGUUUUGGC
MIMAT0014987		UAUUUU		GCAGUUAU		CAU
hsa-miR-548t	3813	CAAAAGUGAUCGUGGUU	3814	CAAAAGUGAUCG	3815	CACGAUCACUU
MIMAT0015009		UUUG		UGGUUUUU		UUG
hsa-miR-548u	3816	CAAAGACUGCAAUUACU	3817	CAAAGACUGCAA	3818	AAUUGCAGUCU
MIMAT0015013		UUUGCG		UUACUUUU		UUG
hsa-miR-548v	3819	AGCUACAGUUACUUUUG	3820	AGCUACAGUUAC	3821	AAGUAACUGUA
MIMAT0015020		CACCA		UUUUGCAC		GCU
hsa-miR-548w	3822	AAAAGUAACUGCGGUUU	3823	AAAAGUAACUGC	3824	CCGCAGUUACU
MIMAT0015060		UUGCCU		GGUUUUUG		UUU
hsa-miR-548x	3825	UAAAAACUGCAAUUACU	3826	UAAAAACUGCAA	3827	AAUUGCAGUUU
MIMAT0015081		UUCA		UUACUUUC		UUA
hsa-miR-548y	3828	AAAAGUAAUCACUGUUU	3829	AAAAGUAAUCAC	3830	CAGUGAUUACU
MIMAT0018354		UUGCC		UGUUUUUG		UUU
hsa-miR-548z	3831	CAAAAACCGCAAUUACU	3832	CAAAAACCGCAA	3833	AAUUGCGGUUU
MIMAT0018446		UUUGCA		UUACUUUU		UUG
hsa-miR-549	3834	UGACAACUAUGGAUGAG	3835	UGACAACUAUGG	3836	AUCCAUAGUUG
MIMAT0003333		CUCU		AUGAGCUC		UCA
hsa-miR-550a	3837	AGUGCCUGAGGGAGUAA	3838	AGUGCCUGAGGG	3839	CUCCCUCAGGC
MIMAT0004800		GAGCCC		AGUAAGAG		ACU
hsa-miR-550a*	3840	UGUCUUACUCCCUCAGG	3841	UGUCUUACUCCC	3842	GAGGGAGUAAG
MIMAT0003257		CACAU		UCAGGCAC		ACA
hsa-miR-550b	3843	UCUUACUCCCUCAGGCA	3844	UCUUACUCCCUC	3845	CUGAGGGAGUA
MIMAT0018445		CUG		AGGCACUG		AGA
hsa-miR-551a	3846	GCGACCCACUCUUGGUU	3847	GCGACCCACUCU	3848	CAAGAGUGGGU
MIMAT0003214		UCCA		UGGUUUCC		CGC
hsa-miR-551b	3849	GCGACCCAUACUUGGUU	3850	GCGACCCAUACU	3851	CAAGUAUGGGU
MIMAT0003233		UCAG		UGGUUUCA		CGC
hsa-miR-551b*	3852	GAAAUCAAGCGUGGGUG	3853	GAAAUCAAGCGU	3854	CCACGCUUGAU
MIMAT0004794		AGACC		GGGUGAGA		UUC
hsa-miR-552	3855	AACAGGUGACUGGUUAG	3856	AACAGGUGACUG	3857	ACCAGUCACCU
MIMAT0003215		ACAA		GUUAGACA		GUU
hsa-miR-553	3858	AAAACGGUGAGAUUUUG	3859	AAAACGGUGAGA	3860	AAUCUCACCGU
MIMAT0003216		UUUU		UUUUGUUU		UUU
hsa-miR-554	3861	GCUAGUCCUGACUCAGC	3862	GCUAGUCCUGAC	3863	GAGUCAGGACU
MIMAT0003217		CAGU		UCAGCCAG		AGC
hsa-miR-555	3864	AGGGUAAGCUGAACCUC	3865	AGGGUAAGCUGA	3866	GUUCAGCUUAC
MIMAT0003219		UGAU		ACCUCUGA		CCU
hsa-miR-556-3p	3867	AUAUUACCAUUAGCUCA	3868	AUAUUACCAUUA	3869	GCUAAUGGUAA
MIMAT0004793		UCUUU		GCUCAUCU		UAU
hsa-miR-556-5p	3870	GAUGAGCUCAUUGUAAU	3871	GAUGAGCUCAUU	3872	ACAAUGAGCUC
MIMAT0003220		AUGAG		GUAAUAUG		AUC
hsa-miR-557	3873	GUUUGCACGGGUGGGCC	3874	GUUUGCACGGGU	3875	CCACCCGUGCA
MIMAT0003221		UUGUCU		GGGCCUUG		AAC
hsa-miR-558	3876	UGAGCUGCUGUACCAAA	3877	UGAGCUGCUGUA	3878	GGUACAGCAGC
MIMAT0003222		AU		CCAAAAU		UCA
hsa-miR-559	3879	UAAAGUAAAUAUGCACC	3880	UAAAGUAAAUAU	3881	GCAUAUUUACU
MIMAT0003223		AAAA		GCACCAAA		UUA
hsa-miR-561	3882	CAAAGUUUAAGAUCCUU	3883	CAAAGUUUAAGA	3884	GAUCUUAAACU
MIMAT0003225		GAAGU		UCCUUGAA		UUG
hsa-miR-562	3885	AAAGUAGCUGUACCAUU	3886	AAAGUAGCUGUA	3887	GGUACAGCUAC
MIMAT0003226		UGC		CCAUUUGC		UUU
hsa-miR-563	3888	AGGUUGACAUACGUUUC	3889	AGGUUGACAUAC	3890	ACGUAUGUCAA
MIMAT0003227		CC		GUUUCCC		CCU
hsa-miR-564	3891	AGGCACGGUGUCAGCAG	3892	AGGCACGGUGUC	3893	CUGACACCGUG
MIMAT0003228		GC		AGCAGGC		CCU
hsa-miR-566	3894	GGGCGCCUGUGAUCCCA	3895	GGGCGCCUGUGA	3896	GAUCACAGGCG
MIMAT0003230		AC		UCCCAAC		CCC
hsa-miR-567	3897	AGUAUGUUCUUCCAGGA	3898	AGUAUGUUCUUC	3899	UGGAAGAACAU
MIMAT0003231		CAGAAC		CAGGACAG		ACU
hsa-miR-568	3900	AUGUAUAAAUGUAUACA	3901	AUGUAUAAAUGU	3902	AUACAUUUAUA
MIMAT0003232		CAC		AUACACAC		CAU
hsa-miR-569	3903	AGUUAAUGAAUCCUGGA	3904	AGUUAAUGAAUC	3905	AGGAUUCAUUA
MIMAT0003234		AAGU		CUGGAAAG		ACU
hsa-miR-570	3906	CGAAAACAGCAAUUACC	3907	CGAAAACAGCAA	3908	AAUUGCUGUUU
MIMAT0003235		UUUGC		UUACCUUU		UCG
hsa-miR-571	3909	UGAGUUGGCCAUCUGAG	3910	UGAGUUGGCCAU	3911	AGAUGGCCAAC
MIMAT0003236		UGAG		CUGAGUGA		UCA
hsa-miR-572	3912	GUCCGCUCGGCGGUGGC	3913	GUCCGCUCGGCG	3914	ACCGCCGAGCG
MIMAT0003237		CCA		GUGGCCCA		GAC
hsa-miR-573	3915	CUGAAGUGAUGUGUAAC	3916	CUGAAGUGAUGU	3917	ACACAUCACUU
MIMAT0003238		UGAUCAG		GUAACUGA		CAG
hsa-miR-574-3p	3918	CACGCUCAUGCACACAC	3919	CACGCUCAUGCA	3920	UGUGCAUGAGC
MIMAT0003239		CCACA		CACACCCA		GUG
hsa-miR-574-5p	3921	UGAGUGUGUGUGUGUGA	3922	UGAGUGUGUGUG	3923	CACACACACAC
MIMAT0004795		GUGUGU		UGUGAGUG		UCA
hsa-miR-575	3924	GAGCCAGUUGGACAGGA	3925	GAGCCAGUUGGA	3926	UGUCCAACUGG
MIMAT0003240		GC		CAGGAGC		CUC
hsa-miR-576-3p	3927	AAGAUGUGGAAAAAUUG	3928	AAGAUGUGGAAA	3929	UUUUUCCACAU
MIMAT0004796		GAAUC		AAUUGGAA		CUU
hsa-miR-576-5p	3930	AUUCUAAUUUCUCCACG	3931	AUUCUAAUUUCU	3932	GGAGAAAUUAG
MIMAT0003241		UCUUU		CCACGUCU		AAU
hsa-miR-577	3933	UAGAUAAAAUAUUGGUA	3934	UAGAUAAAAUAU	3935	CAAUAUUUUAU
MIMAT0003242		CCUG		UGGUACCU		CUA
hsa-miR-578	3936	CUUCUUGUGCUCUAGGA	3937	CUUCUUGUGCUC	3938	UAGAGCACAAG
MIMAT0003243		UUGU		UAGGAUUG		AAG
hsa-miR-579	3939	UUCAUUUGGUAUAAACC	3940	UUCAUUUGGUAU	3941	UUAUACCAAAU
MIMAT0003244		GCGAUU		AAACCGCG		GAA
hsa-miR-580	3942	UUGAGAAUGAUGAAUCA	3943	UUGAGAAUGAUG	3944	UUCAUCAUUCU
MIMAT0003245		UUAGG		AAUCAUUA		CAA
hsa-miR-581	3945	UCUUGUGUUCUCUAGAU	3946	UCUUGUGUUCUC	3947	UAGAGAACACA
MIMAT0003246		CAGU		UAGAUCAG		AGA
hsa-miR-582-3p	3948	UAACUGGUUGAACAACU	3949	UAACUGGUUGAA	3950	UGUUCAACCAG
MIMAT0004797		GAACC		CAACUGAA		UUA
hsa-miR-582-5p	3951	UUACAGUUGUUCAACCA	3952	UUACAGUUGUUC	3953	UUGAACAACUG
MIMAT0003247		GUUACU		AACCAGUU		UAA
hsa-miR-583	3954	CAAAGAGGAAGGUCCCA	3955	CAAAGAGGAAGG	3956	GACCUUCCUCU
MIMAT0003248		UUAC		UCCCAUUA		UUG
hsa-miR-584	3957	UUAUGGUUUGCCUGGGA	3958	UUAUGGUUUGCC	3959	CAGGCAAACCA
MIMAT0003249		CUGAG		UGGGACUG		UAA
hsa-miR-585	3960	UGGGCGUAUCUGUAUGC	3961	UGGGCGUAUCUG	3962	UACAGAUACGC
MIMAT0003250		UA		UAUGCUA		CCA
hsa-miR-586	3963	UAUGCAUUGUAUUUUUA	3964	UAUGCAUUGUAU	3965	AAAUACAAUGC
MIMAT0003252		GGUCC		UUUUAGGU		AUA
hsa-miR-587	3966	UUUCCAUAGGUGAUGAG	3967	UUUCCAUAGGUG	3968	AUCACCUAUGG
MIMAT0003253		UCAC		AUGAGUCA		AAA
hsa-miR-588	3969	UUGGCCACAAUGGGUUA	3970	UUGGCCACAAUG	3971	CCCAUUGUGGC
MIMAT0003255		GAAC		GGUUAGAA		CAA
hsa-miR-589	3972	UGAGAACCACGUCUGCU	3973	UGAGAACCACGU	3974	AGACGUGGUUC
MIMAT0004799		CUGAG		CUGCUCUG		UCA
hsa-miR-589*	3975	UCAGAACAAAUGCCGGU	3976	UCAGAACAAAUG	3977	GGCAUUUGUUC
MIMAT0003256		UCCCAGA		CCGGUUCC		UGA
hsa-miR-590-3p	3978	UAAUUUUAUGUAUAAGC	3979	UAAUUUUAUGUA	3980	UAUACAUAAAA
MIMAT0004801		UAGU		UAAGCUAG		UUA
hsa-miR-590-5p	3981	GAGCUUAUUCAUAAAAG	3982	GAGCUUAUUCAU	3983	UUAUGAAUAAG
MIMAT0003258		UGCAG		AAAAGUGC		CUC
hsa-miR-591	3984	AGACCAUGGGUUCUCAU	3985	AGACCAUGGGUU	3986	AGAACCCAUGG
MIMAT0003259		UGU		CUCAUUGU		UCU
hsa-miR-592	3987	UUGUGUCAAUAUGCGAU	3988	UUGUGUCAAUAU	3989	GCAUAUUGACA
MIMAT0003260		GAUGU		GCGAUGAU		CAA
hsa-miR-593	3990	UGUCUCUGCUGGGGUUU	3991	UGUCUCUGCUGG	3992	CCCCAGCAGAG
MIMAT0004802		CU		GGUUUCU		ACA
hsa-miR-593*	3993	AGGCACCAGCCAGGCAU	3994	AGGCACCAGCCA	3995	CCUGGCUGGUG
MIMAT0003261		UGCUCAGC		GGCAUUGC		CCU
hsa-miR-595	3996	GAAGUGUGCCGUGGUGU	3997	GAAGUGUGCCGU	3998	CCACGGCACAC
MIMAT0003263		GUCU		GGUGUGUC		UUC
hsa-miR-596	3999	AAGCCUGCCCGGCUCCU	4000	AAGCCUGCCCGG	4001	AGCCGGGCAGG
MIMAT0003264		CGGG		CUCCUCGG		CUU
hsa-miR-597	4002	UGUGUCACUCGAUGACC	4003	UGUGUCACUCGA	4004	CAUCGAGUGAC
MIMAT0003265		ACUGU		UGACCACU		ACA
hsa-miR-598	4005	UACGUCAUCGUUGUCAU	4006	UACGUCAUCGUU	4007	ACAACGAUGAC
MIMAT0003266		CGUCA		GUCAUCGU		GUA
hsa-miR-599	4008	GUUGUGUCAGUUUAUCA	4009	GUUGUGUCAGUU	4010	UAAACUGACAC
MIMAT0003267		AAC		UAUCAAAC		AAC
hsa-miR-600	4011	ACUUACAGACAAGAGCC	4012	ACUUACAGACAA	4013	UCUUGUCUGUA
MIMAT0003268		UUGCUC		GAGCCUUG		AGU
hsa-miR-601	4014	UGGUCUAGGAUUGUUGG	4015	UGGUCUAGGAUU	4016	ACAAUCCUAGA
MIMAT0003269		AGGAG		GUUGGAGG		CCA
hsa-miR-602	4017	GACACGGGCGACAGCUG	4018	GACACGGGCGAC	4019	CUGUCGCCCGU
MIMAT0003270		CGGCCC		AGCUGCGG		GUC
hsa-miR-603	4020	CACACACUGCAAUUACU	4021	CACACACUGCAA	4022	AAUUGCAGUGU
MIMAT0003271		UUUGC		UUACUUUU		GUG
hsa-miR-604	4023	AGGCUGCGGAAUUCAGG	4024	AGGCUGCGGAAU	4025	GAAUUCCGCAG
MIMAT0003272		AC		UCAGGAC		CCU
hsa-miR-605	4026	UAAAUCCCAUGGUGCCU	4027	UAAAUCCCAUGG	4028	CACCAUGGGAU
MIMAT0003273		UCUCCU		UGCCUUCU		UUA
hsa-miR-606	4029	AAACUACUGAAAAUCAA	4030	AAACUACUGAAA	4031	AUUUUCAGUAG
MIMAT0003274		AGAU		AUCAAAGA		UUU
hsa-miR-607	4032	GUUCAAAUCCAGAUCUA	4033	GUUCAAAUCCAG	4034	AUCUGGAUUUG
MIMAT0003275		UAAC		AUCUAUAA		AAC
hsa-miR-608	4035	AGGGGUGGUGUUGGGAC	4036	AGGGGUGGUGUU	4037	CCAACACCACC
MIMAT0003276		AGCUCCGU		GGGACAGC		CCU
hsa-miR-609	4038	AGGGUGUUUCUCUCAUC	4039	AGGGUGUUUCUC	4040	GAGAGAAACAC
MIMAT0003277		UCU		UCAUCUCU		CCU
hsa-miR-610	4041	UGAGCUAAAUGUGUGCU	4042	UGAGCUAAAUGU	4043	ACACAUUUAGC
MIMAT0003278		GGGA		GUGCUGGG		UCA
hsa-miR-611	4044	GCGAGGACCCCUCGGGG	4045	GCGAGGACCCCU	4046	CGAGGGGUCCU
MIMAT0003279		UCUGAC		CGGGGUCU		CGC
hsa-miR-612	4047	GCUGGGCAGGGCUUCUG	4048	GCUGGGCAGGGC	4049	AAGCCCUGCCC
MIMAT0003280		AGCUCCUU		UUCUGAGC		AGC
hsa-miR-613	4050	AGGAAUGUUCCUUCUUU	4051	AGGAAUGUUCCU	4052	GAAGGAACAUU
MIMAT0003281		GCC		UCUUUGCC		CCU
hsa-miR-614	4053	GAACGCCUGUUCUUGCC	4054	GAACGCCUGUUC	4055	AAGAACAGGCG
MIMAT0003282		AGGUGG		UUGCCAGG		UUC
hsa-miR-615-3p	4056	UCCGAGCCUGGGUCUCC	4057	UCCGAGCCUGGG	4058	GACCCAGGCUC
MIMAT0003283		CUCUU		UCUCCCUC		GGA
hsa-miR-615-5p	4059	GGGGGUCCCCGGUGCUC	4060	GGGGGUCCCCGG	4061	CACCGGGGACC
MIMAT0004804		GGAUC		UGCUCGGA		CCC
hsa-miR-616	4062	AGUCAUUGGAGGGUUUG	4063	AGUCAUUGGAGG	4064	ACCCUCCAAUG
MIMAT0004805		AGCAG		GUUUGAGC		ACU
hsa-miR-616*	4065	ACUCAAAACCCUUCAGU	4066	ACUCAAAACCCU	4067	GAAGGGUUUUG
MIMAT0003284		GACUU		UCAGUGAC		AGU
hsa-miR-617	4068	AGACUUCCCAUUUGAAG	4069	AGACUUCCCAUU	4070	CAAAUGGGAAG
MIMAT0003286		GUGGC		UGAAGGUG		UCU
hsa-miR-618	4071	AAACUCUACUUGUCCUU	4072	AAACUCUACUUG	4073	GACAAGUAGAG
MIMAT0003287		CUGAGU		UCCUUCUG		UUU
hsa-miR-619	4074	GACCUGGACAUGUUUGU	4075	GACCUGGACAUG	4076	AACAUGUCCAG
MIMAT0003288		GCCCAGU		UUUGUGCC		GUC
hsa-miR-620	4077	AUGGAGAUAGAUAUAGA	4078	AUGGAGAUAGAU	4079	AUAUCUAUCUC
MIMAT0003289		AAU		AUAGAAAU		CAU
hsa-miR-621	4080	GGCUAGCAACAGCGCUU	4081	GGCUAGCAACAG	4082	CGCUGUUGCUA
MIMAT0003290		ACCU		CGCUUACC		GCC
hsa-miR-622	4083	ACAGUCUGCUGAGGUUG	4084	ACAGUCUGCUGA	4085	CCUCAGCAGAC
MIMAT0003291		GAGC		GGUUGGAG		UGU
hsa-miR-623	4086	AUCCCUUGCAGGGGCUG	4087	AUCCCUUGCAGG	4088	CCCCUGCAAGG
MIMAT0003292		UUGGGU		GGCUGUUG		GAU
hsa-miR-624	4089	CACAAGGUAUUGGUAUU	4090	CACAAGGUAUUG	4091	ACCAAUACCUU
MIMAT0004807		ACCU		GUAUUACC		GUG
hsa-miR-624*	4092	UAGUACCAGUACCUUGU	4093	UAGUACCAGUAC	4094	AGGUACUGGUA
MIMAT0003293		GUUCA		CUUGUGUU		CUA
hsa-miR-625	4095	AGGGGGAAAGUUCUAUA	4096	AGGGGGAAAGUU	4097	AGAACUUUCCC
MIMAT0003294		GUCC		CUAUAGUC		CCU
hsa-miR-625*	4098	GACUAUAGAACUUUCCC	4099	GACUAUAGAACU	4100	AAAGUUCUAUA
MIMAT0004808		CCUCA		UUCCCCCU		GUC
hsa-miR-626	4101	AGCUGUCUGAAAAUGUC	4102	AGCUGUCUGAAA	4103	AUUUUCAGACA
MIMAT0003295		UU		AUGUCUU		GCU
hsa-miR-627	4104	GUGAGUCUCUAAGAAAA	4105	GUGAGUCUCUAA	4106	UCUUAGAGACU
MIMAT0003296		GAGGA		GAAAAGAG		CAC
hsa-miR-628-3p	4107	UCUAGUAAGAGUGGCAG	4108	UCUAGUAAGAGU	4109	CCACUCUUACU
MIMAT0003297		UCGA		GGCAGUCG		AGA
hsa-miR-628-5p	4110	AUGCUGACAUAUUUACU	4111	AUGCUGACAUAU	4112	AAAUAUGUCAG
MIMAT0004809		AGAGG		UUACUAGA		CAU
hsa-miR-629	4113	UGGGUUUACGUUGGGAG	4114	UGGGUUUACGUU	4115	CCAACGUAAAC
MIMAT0004810		AACU		GGGAGAAC		CCA
hsa-miR-629*	4116	GUUCUCCCAACGUAAGC	4117	GUUCUCCCAACG	4118	UACGUUGGGAG
MIMAT0003298		CCAGC		UAAGCCCA		AAC
hsa-miR-630	4119	AGUAUUCUGUACCAGGG	4120	AGUAUUCUGUAC	4121	UGGUACAGAAU
MIMAT0003299		AAGGU		CAGGGAAG		ACU
hsa-miR-631	4122	AGACCUGGCCCAGACCU	4123	AGACCUGGCCCA	4124	UCUGGGCCAGG
MIMAT0003300		CAGC		GACCUCAG		UCU
hsa-miR-632	4125	GUGUCUGCUUCCUGUGG	4126	GUGUCUGCUUCC	4127	CAGGAAGCAGA
MIMAT0003302		GA		UGUGGGA		CAC
hsa-miR-633	4128	CUAAUAGUAUCUACCAC	4129	CUAAUAGUAUCU	4130	GUAGAUACUAU
MIMAT0003303		AAUAAA		ACCACAAU		UAG
hsa-miR-634	4131	AACCAGCACCCCAACUU	4132	AACCAGCACCCC	4133	UUGGGGUGCUG
MIMAT0003304		UGGAC		AACUUUGG		GUU
hsa-miR-635	4134	ACUUGGGCACUGAAACA	4135	ACUUGGGCACUG	4136	UUCAGUGCCCA
MIMAT0003305		AUGUCC		AAACAAUG		AGU
hsa-miR-636	4137	UGUGCUUGCUCGUCCCG	4138	UGUGCUUGCUCG	4139	GACGAGCAAGC
MIMAT0003306		CCCGCA		UCCCGCCC		ACA
hsa-miR-637	4140	ACUGGGGGCUUUCGGGC	4141	ACUGGGGGCUUU	4142	CGAAAGCCCCC
MIMAT0003307		UCUGCGU		CGGGCUCU		AGU
hsa-miR-638	4143	AGGGAUCGCGGGCGGGU	4144	AGGGAUCGCGGG	4145	CGCCCGCGAUC
MIMAT0003308		GGCGGCCU		CGGGUGGC		CCU
hsa-miR-639	4146	AUCGCUGCGGUUGCGAG	4147	AUCGCUGCGGUU	4148	GCAACCGCAGC
MIMAT0003309		CGCUGU		GCGAGCGC		GAU
hsa-miR-640	4149	AUGAUCCAGGAACCUGC	4150	AUGAUCCAGGAA	4151	GGUUCCUGGAU
MIMAT0003310		CUCU		CCUGCCUC		CAU
hsa-miR-641	4152	AAAGACAUAGGAUAGAG	4153	AAAGACAUAGGA	4154	UAUCCUAUGUC
MIMAT0003311		UCACCUC		UAGAGUCA		UUU
hsa-miR-642a	4155	GUCCCUCUCCAAAUGUG	4156	GUCCCUCUCCAA	4157	AUUUGGAGAGG
MIMAT0003312		UCUUG		AUGUGUCU		GAC
hsa-miR-642b	4158	AGACACAUUUGGAGAGG	4159	AGACACAUUUGG	4160	CUCCAAAUGUG
MIMAT0018444		GACCC		AGAGGGAC		UCU
hsa-miR-643	4161	ACUUGUAUGCUAGCUCA	4162	ACUUGUAUGCUA	4163	GCUAGCAUACA
MIMAT0003313		GGUAG		GCUCAGGU		AGU
hsa-miR-644	4164	AGUGUGGCUUUCUUAGA	4165	AGUGUGGCUUUC	4166	AAGAAAGCCAC
MIMAT0003314		GC		UUAGAGC		ACU
hsa-miR-645	4167	UCUAGGCUGGUACUGCU	4168	UCUAGGCUGGUA	4169	AGUACCAGCCU
MIMAT0003315		GA		CUGCUGA		AGA
hsa-miR-646	4170	AAGCAGCUGCCUCUGAG	4171	AAGCAGCUGCCU	4172	AGAGGCAGCUG
MIMAT0003316		GC		CUGAGGC		CUU
hsa-miR-647	4173	GUGGCUGCACUCACUUC	4174	GUGGCUGCACUC	4175	GUGAGUGCAGC
MIMAT0003317		CUUC		ACUUCCUU		CAC
hsa-miR-648	4176	AAGUGUGCAGGGCACUG	4177	AAGUGUGCAGGG	4178	UGCCCUGCACA
MIMAT0003318		GU		CACUGGU		CUU
hsa-miR-649	4179	AAACCUGUGUUGUUCAA	4180	AAACCUGUGUUG	4181	AACAACACAGG
MIMAT0003319		GAGUC		UUCAAGAG		UUU
hsa-miR-650	4182	AGGAGGCAGCGCUCUCA	4183	AGGAGGCAGCGC	4184	GAGCGCUGCCU
MIMAT0003320		GGAC		UCUCAGGA		CCU
hsa-miR-651	4185	UUUAGGAUAAGCUUGAC	4186	UUUAGGAUAAGC	4187	AAGCUUAUCCU
MIMAT0003321		UUUUG		UUGACUUU		AAA
hsa-miR-652	4188	AAUGGCGCCACUAGGGU	4189	AAUGGCGCCACU	4190	CUAGUGGCGCC
MIMAT0003322		UGUG		AGGGUUGU		AUU
hsa-miR-653	4191	GUGUUGAAACAAUCUCU	4192	GUGUUGAAACAA	4193	GAUUGUUUCAA
MIMAT0003328		ACUG		UCUCUACU		CAC
hsa-miR-654-3p	4194	UAUGUCUGCUGACCAUC	4195	UAUGUCUGCUGA	4196	GGUCAGCAGAC
MIMAT0004814		ACCUU		CCAUCACC		AUA
hsa-miR-654-5p	4197	UGGUGGGCCGCAGAACA	4198	UGGUGGGCCGCA	4199	UCUGCGGCCCA
MIMAT0003330		UGUGC		GAACAUGU		CCA
hsa-miR-655	4200	AUAAUACAUGGUUAACC	4201	AUAAUACAUGGU	4202	UAACCAUGUAU
MIMAT0003331		UCUUU		UAACCUCU		UAU
hsa-miR-656	4203	AAUAUUAUACAGUCAAC	4204	AAUAUUAUACAG	4205	GACUGUAUAAU
MIMAT0003332		CUCU		UCAACCUC		AUU
hsa-miR-657	4206	GGCAGGUUCUCACCCUC	4207	GGCAGGUUCUCA	4208	GGUGAGAACCU
MIMAT0003335		UCUAGG		CCCUCUCU		GCC
hsa-miR-658	4209	GGCGGAGGGAAGUAGGU	4210	GGCGGAGGGAAG	4211	UACUUCCCUCC
MIMAT0003336		CCGUUGGU		UAGGUCCG		GCC
hsa-miR-659	4212	CUUGGUUCAGGGAGGGU	4213	CUUGGUUCAGGG	4214	CUCCCUGAACC
MIMAT0003337		CCCCA		AGGGUCCC		AAG
hsa-miR-660	4215	UACCCAUUGCAUAUCGG	4216	UACCCAUUGCAU	4217	AUAUGCAAUGG
MIMAT0003338		AGUUG		AUCGGAGU		GUA
hsa-miR-661	4218	UGCCUGGGUCUCUGGCC	4219	UGCCUGGGUCUC	4220	CAGAGACCCAG
MIMAT0003324		UGCGCGU		UGGCCUGC		GCA
hsa-miR-662	4221	UCCCACGUUGUGGCCCA	4222	UCCCACGUUGUG	4223	GCCACAACGUG
MIMAT0003325		GCAG		GCCCAGCA		GGA
hsa-miR-663	4224	AGGCGGGGCGCCGCGGG	4225	AGGCGGGGCGCC	4226	GCGGCGCCCCG
MIMAT0003326		ACCGC		GCGGGACC		CCU
hsa-miR-663b	4227	GGUGGCCCGGCCGUGCC	4228	GGUGGCCCGGCC	4229	ACGGCCGGGCC
MIMAT0005867		UGAGG		GUGCCUGA		ACC
hsa-miR-664	4230	UAUUCAUUUAUCCCCAG	4231	UAUUCAUUUAUC	4232	GGGAUAAAUGA
MIMAT0005949		CCUACA		CCCAGCCU		AUA
hsa-miR-664*	4233	ACUGGCUAGGGAAAAUG	4234	ACUGGCUAGGGA	4235	UUUCCCUAGCC
MIMAT0005948		AUUGGAU		AAAUGAUU		AGU
hsa-miR-665	4236	ACCAGGAGGCUGAGGCC	4237	ACCAGGAGGCUG	4238	CUCAGCCUCCU
MIMAT0004952		CCU		AGGCCCCU		GGU
hsa-miR-668	4239	UGUCACUCGGCUCGGCC	4240	UGUCACUCGGCU	4241	CGAGCCGAGUG
MIMAT0003881		CACUAC		CGGCCCAC		ACA
hsa-miR-670	4242	GUCCCUGAGUGUAUGUG	4243	GUCCCUGAGUGU	4244	AUACACUCAGG
MIMAT0010357		GUG		AUGUGGUG		GAC
hsa-miR-671-3p	4245	UCCGGUUCUCAGGGCUC	4246	UCCGGUUCUCAG	4247	CCCUGAGAACC
MIMAT0004819		CACC		GGCUCCAC		GGA
hsa-miR-671-5p	4248	AGGAAGCCCUGGAGGGG	4249	AGGAAGCCCUGG	4250	CUCCAGGGCUU
MIMAT0003880		CUGGAG		AGGGGCUG		CCU
hsa-miR-675	4251	UGGUGCGGAGAGGGCCC	4252	UGGUGCGGAGAG	4253	CCCUCUCCGCA
MIMAT0004284		ACAGUG		GGCCCACA		CCA
hsa-miR-675*	4254	CUGUAUGCCCUCACCGC	4255	CUGUAUGCCCUC	4256	GUGAGGGCAUA
MIMAT0006790		UCA		ACCGCUCA		CAG
hsa-miR-676	4257	CUGUCCUAAGGUUGUUG	4258	CUGUCCUAAGGU	4259	CAACCUUAGGA
MIMAT0018204		AGUU		UGUUGAGU		CAG
hsa-miR-676*	4260	UCUUCAACCUCAGGACU	4261	UCUUCAACCUCA	4262	CCUGAGGUUGA
MIMAT0018203		UGCA		GGACUUGC		AGA
hsa-miR-7	4263	UGGAAGACUAGUGAUUU	4264	UGGAAGACUAGU	4265	UCACUAGUCUU
MIMAT0000252		UGUUGU		GAUUUUGU		CCA
hsa-miR-708	4266	AAGGAGCUUACAAUCUA	4267	AAGGAGCUUACA	4268	AUUGUAAGCUC
MIMAT0004926		GCUGGG		AUCUAGCU		CUU
hsa-miR-708*	4269	CAACUAGACUGUGAGCU	4270	CAACUAGACUGU	4271	UCACAGUCUAG
MIMAT0004927		UCUAG		GAGCUUCU		UUG
hsa-miR-7-1*	4272	CAACAAAUCACAGUCUG	4273	CAACAAAUCACA	4274	ACUGUGAUUUG
MIMAT0004553		CCAUA		GUCUGCCA		UUG
hsa-miR-711	4275	GGGACCCAGGGAGAGAC	4276	GGGACCCAGGGA	4277	UCUCCCUGGGU
MIMAT0012734		GUAAG		GAGACGUA		CCC
hsa-miR-718	4278	CUUCCGCCCCGCCGGGC	4279	CUUCCGCCCCGC	4280	CGGCGGGGCGG
MIMAT0012735		GUCG		CGGGCGUC		AAG
hsa-miR-7-2*	4281	CAACAAAUCCCAGUCUA	4282	CAACAAAUCCCA	4283	ACUGGGAUUUG
MIMAT0004554		CCUAA		GUCUACCU		UUG
hsa-miR-720	4284	UCUCGCUGGGGCCUCCA	4285	UCUCGCUGGGGC	4286	AGGCCCCAGCG
MIMAT0005954				CUCCA		AGA
hsa-miR-744	4287	UGCGGGGCUAGGGCUAA	4288	UGCGGGGCUAGG	4289	GCCCUAGCCCC
MIMAT0004945		CAGCA		GCUAACAG		GCA
hsa-miR-744*	4290	CUGUUGCCACUAACCUC	4291	CUGUUGCCACUA	4292	GUUAGUGGCAA
MIMAT0004946		AACCU		ACCUCAAC		CAG
hsa-miR-758	4293	UUUGUGACCUGGUCCAC	4294	UUUGUGACCUGG	4295	GACCAGGUCAC
MIMAT0003879		UAACC		UCCACUAA		AAA
hsa-miR-759	4296	GCAGAGUGCAAACAAUU	4297	GCAGAGUGCAAA	4298	UGUUUGCACUC
MIMAT0010497		UUGAC		CAAUUUUG		UGC
hsa-miR-760	4299	CGGCUCUGGGUCUGUGG	4300	CGGCUCUGGGUC	4301	CAGACCCAGAG
MIMAT0004957		GGA		UGUGGGGA		CCG
hsa-miR-761	4302	GCAGCAGGGUGAAACUG	4303	GCAGCAGGGUGA	4304	UUUCACCCUGC
MIMAT0010364		ACACA		AACUGACA		UGC
hsa-miR-762	4305	GGGGCUGGGGCCGGGGC	4306	GGGGCUGGGGCC	4307	CCGGCCCCAGC
MIMAT0010313		CGAGC		GGGGCCGA		CCC
hsa-miR-764	4308	GCAGGUGCUCACUUGUC	4309	GCAGGUGCUCAC	4310	AAGUGAGCACC
MIMAT0010367		CUCCU		UUGUCCUC		UGC
hsa-miR-765	4311	UGGAGGAGAAGGAAGGU	4312	UGGAGGAGAAGG	4313	UUCCUUCUCCU
MIMAT0003945		GAUG		AAGGUGAU		CCA
hsa-miR-766	4314	ACUCCAGCCCCACAGCC	4315	ACUCCAGCCCCA	4316	UGUGGGGCUGG
MIMAT0003888		UCAGC		CAGCCUCA		AGU
hsa-miR-767-3p	4317	UCUGCUCAUACCCCAUG	4318	UCUGCUCAUACC	4319	GGGGUAUGAGC
MIMAT0003883		GUUUCU		CCAUGGUU		AGA
hsa-miR-767-5p	4320	UGCACCAUGGUUGUCUG	4321	UGCACCAUGGUU	4322	ACAACCAUGGU
MIMAT0003882		AGCAUG		GUCUGAGC		GCA
hsa-miR-769-3p	4323	CUGGGAUCUCCGGGGUC	4324	CUGGGAUCUCCG	4325	CCCGGAGAUCC
MIMAT0003887		UUGGUU		GGGUCUUG		CAG
hsa-miR-769-5p	4326	UGAGACCUCUGGGUUCU	4327	UGAGACCUCUGG	4328	ACCCAGAGGUC
MIMAT0003886		GAGCU		GUUCUGAG		UCA
hsa-miR-770-5p	4329	UCCAGUACCACGUGUCA	4330	UCCAGUACCACG	4331	CACGUGGUACU
MIMAT0003948		GGGCCA		UGUCAGGG		GGA
hsa-miR-802	4332	CAGUAACAAAGAUUCAU	4333	CAGUAACAAAGA	4334	AAUCUUUGUUA
MIMAT0004185		CCUUGU		UUCAUCCU		CUG
hsa-miR-873	4335	GCAGGAACUUGUGAGUC	4336	GCAGGAACUUGU	4337	UCACAAGUUCC
MIMAT0004953		UCCU		GAGUCUCC		UGC
hsa-miR-874	4338	CUGCCCUGGCCCGAGGG	4339	CUGCCCUGGCCC	4340	UCGGGCCAGGG
MIMAT0004911		ACCGA		GAGGGACC		CAG
hsa-miR-875-3p	4341	CCUGGAAACACUGAGGU	4342	CCUGGAAACACU	4343	UCAGUGUUUCC
MIMAT0004923		UGUG		GAGGUUGU		AGG
hsa-miR-875-5p	4344	UAUACCUCAGUUUUAUC	4345	UAUACCUCAGUU	4346	AAAACUGAGGU
MIMAT0004922		AGGUG		UUAUCAGG		AUA
hsa-miR-876-3p	4347	UGGUGGUUUACAAAGUA	4348	UGGUGGUUUACA	4349	UUUGUAAACCA
MIMAT0004925		AUUCA		AAGUAAUU		CCA
hsa-miR-876-5p	4350	UGGAUUUCUUUGUGAAU	4351	UGGAUUUCUUUG	4352	CACAAAGAAAU
MIMAT0004924		CACCA		UGAAUCAC		CCA
hsa-miR-877	4353	GUAGAGGAGAUGGCGCA	4354	GUAGAGGAGAUG	4355	GCCAUCUCCUC
MIMAT0004949		GGG		GCGCAGGG		UAC
hsa-miR-877*	4356	UCCUCUUCUCCCUCCUC	4357	UCCUCUUCUCCC	4358	GAGGGAGAAGA
MIMAT0004950		CCAG		UCCUCCCA		GGA
hsa-miR-885-3p	4359	AGGCAGCGGGGUGUAGU	4360	AGGCAGCGGGGU	4361	ACACCCCGCUG
MIMAT0004948		GGAUA		GUAGUGGA		CCU
hsa-miR-885-5p	4362	UCCAUUACACUACCCUG	4363	UCCAUUACACUA	4364	GGUAGUGUAAU
MIMAT0004947		CCUCU		CCCUGCCU		GGA
hsa-miR-887	4365	GUGAACGGGCGCCAUCC	4366	GUGAACGGGCGC	4367	UGGCGCCCGUU
MIMAT0004951		CGAGG		CAUCCCGA		CAC
hsa-miR-888	4368	UACUCAAAAAGCUGUCA	4369	UACUCAAAAAGC	4370	CAGCUUUUUGA
MIMAT0004916		GUCA		UGUCAGUC		GUA
hsa-miR-888*	4371	GACUGACACCUCUUUGG	4372	GACUGACACCUC	4373	AAGAGGUGUCA
MIMAT0004917		GUGAA		UUUGGGUG		GUC
hsa-miR-889	4374	UUAAUAUCGGACAACCA	4375	UUAAUAUCGGAC	4376	UUGUCCGAUAU
MIMAT0004921		UUGU		AACCAUUG		UAA
hsa-miR-890	4377	UACUUGGAAAGGCAUCA	4378	UACUUGGAAAGG	4379	UGCCUUUCCAA
MIMAT0004912		GUUG		CAUCAGUU		GUA
hsa-miR-891a	4380	UGCAACGAACCUGAGCC	4381	UGCAACGAACCU	4382	UCAGGUUCGUU
MIMAT0004902		ACUGA		GAGCCACU		GCA
hsa-miR-891b	4383	UGCAACUUACCUGAGUC	4384	UGCAACUUACCU	4385	UCAGGUAAGUU
MIMAT0004913		AUUGA		GAGUCAUU		GCA
hsa-miR-892a	4386	CACUGUGUCCUUUCUGC	4387	CACUGUGUCCUU	4388	GAAAGGACACA
MIMAT0004907		GUAG		UCUGCGUA		GUG
hsa-miR-892b	4389	CACUGGCUCCUUUCUGG	4390	CACUGGCUCCUU	4391	GAAAGGAGCCA
MIMAT0004918		GUAGA		UCUGGGUA		GUG
hsa-miR-9	4392	UCUUUGGUUAUCUAGCU	4393	UCUUUGGUUAUC	4394	UAGAUAACCAA
MIMAT0000441		GUAUGA		UAGCUGUA		AGA
hsa-miR-9*	4395	AUAAAGCUAGAUAACCG	4396	AUAAAGCUAGAU	4397	UUAUCUAGCUU
MIMAT0000442		AAAGU		AACCGAAA		UAU
hsa-miR-920	4398	GGGGAGCUGUGGAAGCA	4399	GGGGAGCUGUGG	4400	UUCCACAGCUC
MIMAT0004970		GUA		AAGCAGUA		CCC
hsa-miR-921	4401	CUAGUGAGGGACAGAAC	4402	CUAGUGAGGGAC	4403	CUGUCCCUCAC
MIMAT0004971		CAGGAUUC		AGAACCAG		UAG
hsa-miR-922	4404	GCAGCAGAGAAUAGGAC	4405	GCAGCAGAGAAU	4406	CUAUUCUCUGC
MIMAT0004972		UACGUC		AGGACUAC		UGC
hsa-miR-924	4407	AGAGUCUUGUGAUGUCU	4408	AGAGUCUUGUGA	4409	CAUCACAAGAC
MIMAT0004974		UGC		UGUCUUGC		UCU
hsa-miR-92a	4410	UAUUGCACUUGUCCCGG	4411	UAUUGCACUUGU	4412	GGACAAGUGCA
MIMAT0000092		CCUGU		CCCGGCCU		AUA
hsa-miR-92a-1*	4413	AGGUUGGGAUCGGUUGC	4414	AGGUUGGGAUCG	4415	ACCGAUCCCAA
MIMAT0004507		AAUGCU		GUUGCAAU		CCU
hsa-miR-92a-2*	4416	GGGUGGGGAUUUGUUGC	4417	GGGUGGGGAUUU	4418	ACAAAUCCCCA
MIMAT0004508		AUUAC		GUUGCAUU		CCC
hsa-miR-92b	4419	UAUUGCACUCGUCCCGG	4420	UAUUGCACUCGU	4421	GGACGAGUGCA
MIMAT0003218		CCUCC		CCCGGCCU		AUA
hsa-miR-92b*	4422	AGGGACGGGACGCGGUG	4423	AGGGACGGGACG	4424	CGCGUCCCGUC
MIMAT0004792		CAGUG		CGGUGCAG		CCU
hsa-miR-93	4425	CAAAGUGCUGUUCGUGC	4426	CAAAGUGCUGUU	4427	CGAACAGCACU
MIMAT0000093		AGGUAG		CGUGCAGG		UUG
hsa-miR-93*	4428	ACUGCUGAGCUAGCACU	4429	ACUGCUGAGCUA	4430	GCUAGCUCAGC
MIMAT0004509		UCCCG		GCACUUCC		AGU
hsa-miR-933	4431	UGUGCGCAGGGAGACCU	4432	UGUGCGCAGGGA	4433	UCUCCCUGCGC
MIMAT0004976		CUCCC		GACCUCUC		ACA
hsa-miR-934	4434	UGUCUACUACUGGAGAC	4435	UGUCUACUACUG	4436	UCCAGUAGUAG
MIMAT0004977		ACUGG		GAGACACU		ACA
hsa-miR-935	4437	CCAGUUACCGCUUCCGC	4438	CCAGUUACCGCU	4439	GAAGCGGUAAC
MIMAT0004978		UACCGC		UCCGCUAC		UGG
hsa-miR-936	4440	ACAGUAGAGGGAGGAAU	4441	ACAGUAGAGGGA	4442	CCUCCCUCUAC
MIMAT0004979		CGCAG		GGAAUCGC		UGU
hsa-miR-937	4443	AUCCGCGCUCUGACUCU	4444	AUCCGCGCUCUG	4445	GUCAGAGCGCG
MIMAT0004980		CUGCC		ACUCUCUG		GAU
hsa-miR-938	4446	UGCCCUUAAAGGUGAAC	4447	UGCCCUUAAAGG	4448	CACCUUUAAGG
MIMAT0004981		CCAGU		UGAACCCA		GCA
hsa-miR-939	4449	UGGGGAGCUGAGGCUCU	4450	UGGGGAGCUGAG	4451	GCCUCAGCUCC
MIMAT0004982		GGGGGUG		GCUCUGGG		CCA
hsa-miR-940	4452	AAGGCAGGGCCCCCGCU	4453	AAGGCAGGGCCC	4454	GGGGGCCCUGC
MIMAT0004983		CCCC		CCGCUCCC		CUU
hsa-miR-941	4455	CACCCGGCUGUGUGCAC	4456	CACCCGGCUGUG	4457	CACACAGCCGG
MIMAT0004984		AUGUGC		UGCACAUG		GUG
hsa-miR-942	4458	UCUUCUCUGUUUUGGCC	4459	UCUUCUCUGUUU	4460	CAAAACAGAGA
MIMAT0004985		AUGUG		UGGCCAUG		AGA
hsa-miR-943	4461	CUGACUGUUGCCGUCCU	4462	CUGACUGUUGCC	4463	ACGGCAACAGU
MIMAT0004986		CCAG		GUCCUCCA		CAG
hsa-miR-944	4464	AAAUUAUUGUACAUCGG	4465	AAAUUAUUGUAC	4466	AUGUACAAUAA
MIMAT0004987		AUGAG		AUCGGAUG		UUU
hsa-miR-95	4467	UUCAACGGGUAUUUAUU	4468	UUCAACGGGUAU	4469	AAAUACCCGUU
MIMAT0000094		GAGCA		UUAUUGAG		GAA
hsa-miR-96	4470	UUUGGCACUAGCACAUU	4471	UUUGGCACUAGC	4472	GUGCUAGUGCC
MIMAT0000095		UUUGCU		ACAUUUUU		AAA
hsa-miR-96*	4473	AAUCAUGUGCAGUGCCA	4474	AAUCAUGUGCAG	4475	CACUGCACAUG
MIMAT0004510		AUAUG		UGCCAAUA		AUU
hsa-miR-98	4476	UGAGGUAGUAAGUUGUA	4477	UGAGGUAGUAAG	4478	AACUUACUACC
MIMAT0000096		UUGUU		UUGUAUUG		UCA
hsa-miR-99a	4479	AACCCGUAGAUCCGAUC	4480	AACCCGUAGAUC	4481	CGGAUCUACGG
MIMAT0000097		UUGUG		CGAUCUUG		GUU
hsa-miR-99a*	4482	CAAGCUCGCUUCUAUGG	4483	CAAGCUCGCUUC	4484	UAGAAGCGAGC
MIMAT0004511		GUCUG		UAUGGGUC		UUG
hsa-miR-99b	4485	CACCCGUAGAACCGACC	4486	CACCCGUAGAAC	4487	CGGUUCUACGG
MIMAT0000689		UUGCG		CGACCUUG		GUG
hsa-miR-99b*	4488	CAAGCUCGUGUCUGUGG	4489	CAAGCUCGUGUC	4490	CAGACACGAGC
MIMAT0004678		GUCCG		UGUGGGUC		UUG

TABLE 5
Examples of chemical modification patterns
miRNA Name	Example of modified AS strand	Example of modified sense strand
hsa-let-7a	5′Pm0005f0f05f05f00f05f005f05f05m0*5m0*	m0m00m00m0m000m00m0*m0*m0TEGChol
MIMAT0000062	0*5m0*f0*5m0*0
hsa-let-7a*	5′Pm0005f0f05f005f05f05f0005f00*5m0*0*5	m0m0m0m00m00m00m00m0*m0*m0TEGChol
MIMAT0004481	m0*5m0*0*0
hsa-let-7a-2*	5′Pm05f05f05f05f005f05f05f00005f00*5m0*	m0m0m0m0m0m000m0m000*0*m0TEGChol
MIMAT0010195	5m0*0***
hsa-let-7b	5′Pm0000f0000f005f05f05f05m0*0*5m0*0*f	m0m000m0m0m0m0m0m0m0m0*m0*m0TEGChol
MIMAT0000063	0*5m0*0
hsa-let-7b*	5′Pm0005f0f0000f05f0005f00*0*5m0*5m0*f	m0m0m0m00m0m0m0m0m00m0*m0*m0TEGChol
MIMAT0004482	0*0*0
hsa-let-7c	5′Pm005f05f0f05f000f005f05f05f05m0*5m0*	m0m000m0m0m0m00m000*m0*m0TEGChol
MIMAT0000064	5m0*5m0*5m0*5m0*0
hsa-let-7c*	5′Pm0005f05f05f05f005f0005f05f00*0*0*5m	m0m00m0m0m0m000m00m0*m0*m0TEGChol
MIMAT0004483	0***
hsa-let-7d	5′Pm005f05f0f05f05f05f0f0000f05m0*0*5m0	m0m0m0m0m0m0000m000*m0*m0TEGChol
MIMAT0000065	*5m0*5m0*5m0*
hsa-let-7d*	5′Pm005f00f00005f05f000f05m0*0*5m0*5m	m0m0m0m00m0m0m0m0m0m00*m0*m0TEGChol
MIMAT0004484	0*5m0*0*0
hsa-let-7e	5′Pm0005f0f005f05f05f005f00f00*0*5m0*0*	m0m0m00m0m000m0m00m0*m0*m0TEGChol
MIMAT0000066	f0*5m0*0
hsa-let-7e*	5′Pm05f000f0000f00005f05m0*0*5m0*5m0	m0m0m0m0m0m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0004485	***
hsa-let-7f	5′Pm05f000f05f05f05f05f05f000f00*0*0*0*f	m0m0m0m00m0000m0m0m0*0*m0TEGChol
MIMAT0000067	0*0*0
hsa-let-7f-1*	5′Pm00005f005f05f0f005f005f05m0*5m0*0*	m0m0m00m0m000m0m0m0m0*m0*m0TEGChol
MIMAT0004486	5m0*5m0*5m0*0
hsa-let-7f-2*	5′Pm0005f0f05f005f05f05f0005f00*5m0*5m	m0m0m0m00m00m00m00m0*m0*m0TEGChol
MIMAT0004487	0*0*f0*0*0
hsa-let-7g	5′Pm00005f005f05f05f05f05f05f05f05m0*5m	m0m0000m000m0m0m0m0*m0*m0TEGChol
MIMAT0000414	0*0*0*f0*0*0
hsa-let-7g*	5′Pm0000f05f05f005f005f05f05f00*0*5m0*0	m0m000m0m0m000m0m0m0*m0*m0TEGChol
MIMAT0004584	*5m0*0*0
hsa-let-7i	5′Pm05f05f05f0f0000f0000f05m0*0*5m0*5	m0m0m0m0m0m0m0m0m0m000*0*m0TEGChol
MIMAT0000415	m0*5m0*5m0*0
hsa-let-7i*	5′Pm05f000f005f05f05f05f000f00*5m0*0*0*	m0m0m0m00m000m0m0m0m0*0*m0TEGChol
MIMAT0004585	f0*5m0*0
hsa-miR-1	5′Pm00005f05f05f05f05f05f05f005f00*0*0*5	m0m0m000m0000m0m0m0*m0*m0TEGChol
MIMAT0000416	m0*5m0*0*0
hsa-miR-100	5′Pm005f05f05f005f05f0f0005f05f00*0*0*0*	m0m00m0m0m000m0m000*m0*m0TEGChol
MIMAT0000098	5m0*0*0
hsa-miR-100*	5′Pm005f05f0f05f005f05f05f005f05f05m0*5	m0m00m00m00m00m000*m0*m0TEGChol
MIMAT0004512	m0*0*0*5m0*5m0*0
hsa-miR-101	5′Pm0000f005f05f05f05f05f005f00*5m0*0*5	m0m0m000m000m0m0m0m0*m0*m0TEGChol
MIMAT0000099	m0*5m0*5m0*0
hsa-miR-101*	5′Pm05f000f005f00f05f0005f05m0*5m0*0*5	m0m0m0m00m0m00m0m0m0m0*0*m0TEGChol
MIMAT0004513	m0*f0*5m0*0
hsa-miR-103	5′Pm005f05f0f05f000f0005f05f00*5m0*5m0	m0m00m0m0m0m0m00m000*m0*m0TEGChol
MIMAT0000101	*0*f0*0*0
hsa-miR-103-2*	5′Pm05f05f05f0f005f05f05f05f05f05f05f00*0	m0m0000m000m0m000*0*m0TEGChol
MIMAT0009196	*0*0*f0*5m0*0
hsa-miR-103-as	5′Pm0005f05f05f05f05f0f0000f05m0*0*5m0	m0m0m0m0m0m0000m00m0*m0*m0TEGChol
MIMAT0007402	*5m0*f0*5m0*0
hsa-miR-105	5′Pm0000f05f05f05f0f0005f0f05m0*5m0*5m	m0m00m0m0m0000m0m0m0*m0*m0TEGChol
MIMAT0000102	0*0*f0*0*
hsa-miR-105*	5′Pm0005f0f05f05f05f05f05f000f00*0*5m0*	m0m0m0m00m0000m00m0*m0*m0TEGChol
MIMAT0004516	5m0*5m0*5m0*0
hsa-miR-106a	5′Pm05f000f05f0005f05f005f0f00*5m0*0*0*	m0m00m00m0m0m00m0m0m0*0*m0TEGChol
MIMAT0000103	5m0*0*0
hsa-miR-106a*	5′Pm0005f0f005f005f005f05f0f05m0*5m0*0	m0m000m0m0m00m0m00m0*m0*m0TEGChol
MIMAT0004517	*0*5m0*5m0*0
hsa-miR-106b	5′Pm0000f05f005f05f05f05f05f05f05m0*5m0	m0m0000m00m00m0m0m0*m0*m0TEGChol
MIMAT0000680	*5m0*0*f0*0*0
hsa-miR-106b*	5′Pm0000f05f05f05f05f05f000f00*0*5m0*0*	m0m0m0m00m0000m0m0m0*m0*m0TEGChol
MIMAT0004672	f0*5m0*0
hsa-miR-107	5′Pm0005f0f05f005f05f05f005f0f00*0*0*5m	m0m00m00m00m00m00m0*m0*m0TEGChol
MIMAT0000104	0*5m0*5m0*
hsa-miR-10a	5′Pm0005f0f00005f05f05f05f0f00*0*0*0*5m	m0m0000m0m0m0m0m00m0*m0*m0TEGChol
MIMAT0000253	0*0*0
hsa-miR-10a*	5′Pm0005f0f0000f05f05f05f0f00*0*5m0*0*f	m0m0000m0m0m0m0m00m0*m0*m0TEGChol
MIMAT0004555	0*5m0*0
hsa-miR-10b	5′Pm0005f0f05f005f0f00005f05m0*5m0*0*5	m0m0m0m0m0m00m00m00m0*m0*m0TEGChol
MIMAT0000254	m0*f0*5m0*0
hsa-miR-10b*	5′Pm05f05f005f005f05f05f00005f05m0*5m0	m0m0m0m0m0m000m0m0m00*0*m0TEGChol
MIMAT0004556	*5m0*0*5m0*5m0*0
hsa-miR-1178	5′Pm00005f05f05f05f05f005f005f05m0*0*5	m0m0m00m0m0000m0m0m0*m0*m0TEGChol
MIMAT0005823	m0*5m0*5m0*5m0*0
hsa-miR-1179	5′Pm005f05f0f00005f05f000f05m0*5m0*0*5	m0m0m0m00m0m0m0m0m000*m0*m0TEGChol
MIMAT0005824	m0*f0*0*0
hsa-miR-1180	5′Pm05f000f05f000f005f05f05f05m0*5m0*0	m0m000m0m0m0m00m0m0m0*0*m0TEGChol
MIMAT0005825	*0*f0*0*0
hsa-miR-1181	5′Pm05f000f005f05f05f0000f00*0*5m0*5m0	m0m0m0m0m0m000m0m0m0m0*0*m0TEGChol
MIMAT0005826	*5m0*5m0*0
hsa-miR-1182	5′Pm0000f005f00f05f0005f05m0*0*5m0*5m	m0m0m0m00m0m00m0m0m0m0*m0*m0TEGChol
MIMAT0005827	0*5m0*5m0*0
hsa-miR-1183	5′Pm0005f05f005f00f05f05f005f05m0*5m0*	m0m0m000m0m00m0m00m0*m0*m0TEGChol
MIMAT0005828	5m0*0*5m0*5m0*0
hsa-miR-1184	5′Pm05f05f00f005f00f05f05f05f0f00*0*0*5m	m0m0000m0m00m0m0m00*0*m0TEGChol
MIMAT0005829	0*f0*0*0
hsa-miR-1185	5′Pm005f00f05f05f05f0f005f05f0f05m0*5m0	m0m000m0m0000m0m00*m0*m0TEGChol
MIMAT0005798	*0*0*5m0*0*0
hsa-miR-1193	5′Pm00005f05f0005f05f005f05f05m0*0*0*0	m0m00m00m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0015049	*5m0*0*0
hsa-miR-1197	5′Pm05f05f05f0f0000f0000f05m0*0*5m0*5	m0m0m0m0m0m0m0m0m0m000*0*m0TEGChol
MIMAT0005955	m0*5m0*5m0*0
hsa-miR-1200	5′Pm0000f0005f05f05f05f005f00*0*0*0*f0*	m0m0m000m00m0m0m0m0m0*m0*m0TEGChol
MIMAT0005863	5m0*0
hsa-miR-1202	5′Pm05f05f005f05f05f05f05f0005f05f00*5m0	m0m00m0m0m0000m0m00*0*m0TEGChol
MIMAT0005865	*5m0*5m0*f0*5m0*0
hsa-miR-1203	5′Pm00005f0005f0f05f005f05f00*5m0*5m0*	m0m00m00m00m0m0m0m0m0*m0*m0TEGChol
MIMAT0005866	0*f0*5m0*0
hsa-miR-1204	5′Pm05f0005f05f05f05f0f05f005f05f05m0*0*	m0m00m00m0000m0m0m0*0*m0TEGChol
MIMAT0005868	5m0*5m0*f0*5m0*0
hsa-miR-1205	5′Pm05f05f005f05f05f05f05f0005f05f00*5m0	m0m00m0m0m0000m0m00*0*m0TEGChol
MIMAT0005869	*5m0*5m0*f0*5m0*0
hsa-miR-1206	5′Pm0005f05f0000f005f005f00*0*0*0*f0**	m0m0m00m0m0m0m0m0m00m0*m0*m0TEGChol
MIMAT0005870
hsa-miR-1207-3p	5′Pm00005f005f05f0f05f05f005f00*5m0*5m	m0m0m000m000m0m0m0m0*m0*m0TEGChol
MIMAT0005872	0*5m0*f0*5m0*0
hsa-miR-1207-5p	5′Pm0005f0f05f000f0000f00*5m0*5m0*5m0	m0m0m0m0m0m0m0m00m00m0*m0*m0TEGChol
MIMAT0005871	*f0*5m0*0
hsa-miR-1208	5′Pm05f05f00f005f00f05f05f05f0f00*0*0*5m	m0m0000m0m00m0m0m00*0*m0TEGChol
MIMAT0005873	0*f0*0*0
hsa-miR-122	5′Pm05f05f05f0f05f05f05f0f005f00f05m0*0*	m0m0m00m0m0000m000*0*m0TEGChol
MIMAT0000421	0*5m0*5m0*5m0*0
hsa-miR-122*	5′Pm05f05f05f0f05f05f05f0f05f05f05f0f05m0	m0m0000m0000m000*0*m0TEGChol
MIMAT0004590	*5m0*5m0*5m0*f0*5m0*0
hsa-miR-1224-3p	5′Pm0000f05f000f00005f05m0*0*5m0*0*5	m0m0m0m0m0m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0005459	m0*0*0
hsa-miR-1224-5p	5′Pm00005f005f005f05f05f05f05f05m0*5m0	m0m0000m0m00m0m0m0m0*m0*m0TEGChol
MIMAT0005458	*0*0*f0*0*0
hsa-miR-1225-3p	5′Pm05f05f005f05f05f05f05f05f005f05f00*5	m0m00m00m0000m0m00*0*m0TEGChol
MIMAT0005573	m0*5m0*5m0*f0*0*0
hsa-miR-1225-5p	5′Pm05f000f00005f05f0005f05m0*0*0*0*f0	m0m0m0m00m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0005572	**
hsa-miR-1226	5′Pm05f05f00f05f005f0f00005f00*5m0*0*0*	m0m0m0m0m0m00m00m0m00*0*m0TEGChol
MIMAT0005577	f0*5m0*0
hsa-miR-1226*	5′Pm05f05f05f0f0000f0000f05m0*0*5m0*5	m0m0m0m0m0m0m0m0m0m000*0*m0TEGChol
MIMAT0005576	m0*5m0*5m0*0
hsa-miR-1227	5′Pm005f005f00005f005f005f00*5m0*0*5m	m0m0m00m0m0m0m0m0m0m00*m0*m0TEGChol
MIMAT0005580	0*f0*5m0*0
hsa-miR-1228	5′Pm0005f0f05f05f005f005f005f00*5m0*5m	m0m0m00m0m0m000m00m0*m0*m0TEGChol
MIMAT0005583	0*0*5m0*5m0*0
hsa-miR-1228*	5′Pm05f05f00f05f000f0005f0f00*5m0*0*0*5	m0m00m0m0m0m0m00m0m00*0*m0TEGChol
MIMAT0005582	m0*5m0*0
hsa-miR-1229	5′Pm05f000f05f005f0f005f05f05f00*0*5m0*	m0m000m0m00m00m0m0m0*0*m0TEGChol
MIMAT0005584	0*f0*0*0
hsa-miR-1231	5′Pm005f05f0f0005f0f0005f05f00*0*0*0*f0*	m0m00m0m0m00m0m0m000*m0*m0TEGChol
MIMAT0005586	0*
hsa-miR-1233	5′Pm005f05f0f0005f0f05f05f005f00*0*5m0*	m0m0m000m00m0m0m000*m0*m0TEGChol
MIMAT0005588	5m0*5m0*5m0*0
hsa-miR-1234	5′Pm005f05f05f0000f05f005f0f05m0*0*0*5	m0m00m00m0m0m0m0m000*m0*m0TEGChol
MIMAT0005589	m0*f0*5m0*0
hsa-miR-1236	5′Pm05f005f0f05f0005f05f05f05f05f05m0*0*	m0m0000m0m0m00m00m0*0*m0TEGChol
MIMAT0005591	0*5m0*5m0*5m0*0
hsa-miR-1237	5′Pm0000f05f005f05f05f005f0f00*5m0*0*5	m0m00m00m00m00m0m0m0*m0*m0TEGChol
MIMAT0005592	m0*f0*0*0
hsa-miR-1238	5′Pm05f005f0f005f005f00005f00*5m0*5m0*	m0m0m0m0m0m0m00m0m00m0*0*m0TEGChol
MIMAT0005593	5m0*5m0*5m0*0
hsa-miR-124	5′Pm05f000f005f00f05f005f0f05m0*0*0*5m	m0m00m00m0m00m0m0m0m0*0*m0TEGChol
MIMAT0000422	0*5m0*0*0
hsa-miR-124*	5′Pm0000f0000f0005f0f00*0*5m0*0*f0*0*0	m0m00m0m0m0m0m0m0m0m0m0*m0*m0TEGChol
MIMAT0004591
hsa-miR-1243	5′Pm005f05f05f05f05f05f05f005f00f00*5m0*	m0m0m00m0m0000m000*m0*m0TEGChol
MIMAT0005894	0*0*5m0*5m0*0
hsa-miR-1244	5′Pm005f005f005f00f005f05f0f05m0*0*0*0*	m0m000m0m0m00m0m0m00*m0*m0TEGChol
MIMAT0005896	f0*5m0*0
hsa-miR-1245	5′Pm00005f005f005f05f05f05f05f05m0*5m0	m0m0000m0m00m0m0m0m0*m0*m0TEGChol
MIMAT0005897	*0*0*f0*0*0
hsa-miR-1246	5′Pm05f05f05f0f05f05f005f05f005f0f00*5m0	m0m00m00m0m000m000*0*m0TEGChol
MIMAT0005898	*0*5m0*5m0*0*0
hsa-miR-1247	5′Pm05f005f05f0005f05f05f05f005f00*5m0*	m0m0m000m00m0m0m00m0*0*m0TEGChol
MIMAT0005899	5m0*5m0*5m0*5m0*0
hsa-miR-1248	5′Pm05f000f0005f0f05f005f0f00*0*5m0*5m	m0m00m00m00m0m0m0m0m0*0*m0TEGChol
MIMAT0005900	0*5m0*0*0
hsa-miR-1249	5′Pm0000f05f005f05f0005f0f00*5m0*0*5m0	m0m00m0m0m00m00m0m0m0*m0*m0TEGChol
MIMAT0005901	*f0*0*0
hsa-miR-1250	5′Pm005f00f005f005f0000f00*5m0*0*0***	m0m0m0m0m0m0m00m0m0m00*m0*m0TEGChol
MIMAT0005902
hsa-miR-1251	5′Pm05f005f0f05f05f005f05f05f05f05f05m0*	m0m0000m0m000m00m0*0*m0TEGChol
MIMAT0005903	5m0*5m0*5m0***
hsa-miR-1252	5′Pm05f000f0000f005f00f05m0*0*5m0*0*f0	m0m0m00m0m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0005944	*0*0
hsa-miR-1253	5′Pm05f05f005f05f000f05f05f00f05m0*0*5m	m0m0m000m0m0m00m0m00*0*m0TEGChol
MIMAT0005904	0*5m0*5m0*5m0*0
hsa-miR-1254	5′Pm0005f05f05f000f05f05f05f05f00*0*5m0	m0m0000m0m0m00m00m0*m0*m0TEGChol
MIMAT0005905	*5m0*5m0*0*0
hsa-miR-1255a	5′Pm05f05f05f05f05f05f05f05f05f05f05f05f0	m0m0000m0000m000*0*m0TEGChol
MIMAT0005906	5m0*5m0*5m0*5m0*5m0*5m0*0
hsa-miR-1255b	5′Pm0005f0f005f00f0005f0f05m0*0*0*5m0*	m0m00m0m0m0m00m0m00m0*m0*m0TEGChol
MIMAT0005945	f0*0*0
hsa-miR-1256	5′Pm05f05f005f05f05f05f05f05f05f05f0f05m	m0m0000m0000m0m00*0*m0TEGChol
MIMAT0005907	0*5m0*0*5m0*5m0*0*0
hsa-miR-1257	5′Pm005f005f05f05f005f005f005f00*5m0*0*	m0m0m00m0m0m000m0m00*m0*m0TEGChol
MIMAT0005908	5m0*5m0*5m0*0
hsa-miR-1258	5′Pm05f005f05f0005f05f005f005f05m0*5m0	m0m0m00m0m00m0m0m00m0*0*m0TEGChol
MIMAT0005909	*5m0*5m0*5m0*5m0*0
hsa-miR-125a-3p	5′Pm05f005f0f05f005f0f005f05f0f00*0*0*0*	m0m000m0m00m00m00m0*0*m0TEGChol
MIMAT0004602	5m0*5m0*0
hsa-miR-125a-5p	5′Pm05f005f0f005f00f005f05f0f00*5m0*5m0	m0m000m0m0m00m0m00m0*0*m0TEGChol
MIMAT0000443	*5m0*5m0*5m0*0
hsa-miR-125b	5′Pm0000f005f05f0f0005f05f05m0*5m0*0*5	m0m00m0m0m000m0m0m0m0*m0*m0TEGChol
MIMAT0000423	m0*f0*0*0
hsa-miR-125b-1*	5′Pm0005f0f0005f05f0000f00*5m0*0*5m0*f	m0m0m0m0m0m00m0m0m00m0*m0*m0TEGChol
MIMAT0004592	0*0*0
hsa-miR-125b-2*	5′Pm0005f0f005f005f05f005f05f00*5m0*5m	m0m00m00m0m00m0m00m0*m0*m0TEGChol
MIMAT0004603	0*5m0*f0*0*0
hsa-miR-126	5′Pm005f005f05f05f05f0f05f05f005f05m0*0*	m0m0m000m0000m0m00*m0*m0TEGChol
MIMAT0000445	0*5m0*f0*0*0
hsa-miR-126*	5′Pm05f05f05f05f0000f05f05f05f05f05m0*5	m0m0000m0m0m0m0m000*0*m0TEGChol
MIMAT0000444	m0*0*0*5m0*5m0*0
hsa-miR-1260	5′Pm0000f05f0005f00005f05m0*0*5m0*0*5	m0m0m0m0m0m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0005911	m0*0*0
hsa-miR-1260b	5′Pm005f005f05f005f05f05f05f05f05f05m0*5	m0m0000m00m00m0m00*m0*m0TEGChol
MIMAT0015041	m0*5m0*5m0*5m0*0*0
hsa-miR-1261	5′Pm0005f05f05f05f05f0f0005f05f05m0*5m0	m0m00m0m0m0000m00m0*m0*m0TEGChol
MIMAT0005913	*0*5m0*5m0*5m0*0
hsa-miR-1262	5′Pm05f05f00f0000f005f005f05m0*0*5m0*0	m0m0m00m0m0m0m0m0m0m00*0*m0TEGChol
MIMAT0005914	*f0*0*0
hsa-miR-1263	5′Pm05f05f005f0005f0f005f05f0f00*0*5m0*	m0m000m0m00m0m0m0m00*0*m0TEGChol
MIMAT0005915	5m0*5m0*5m0*0
hsa-miR-1264	5′Pm05f05f05f0f05f005f05f05f0005f05m0*5	m0m0m0m00m00m00m000*0*m0TEGChol
MIMAT0005791	m0*0*5m0*5m0*5m0*0
hsa-miR-1265	5′Pm05f05f05f0f0000f0000f05m0*0*5m0*5	m0m0m0m0m0m0m0m0m0m000*0*m0TEGChol
MIMAT0005918	m0*5m0*5m0*0
hsa-miR-1266	5′Pm0000f0000f0005f0f05m0*0*0*5m0*f0*	m0m00m0m0m0m0m0m0m0m0m0*m0*m0TEGChol
MIMAT0005920	0*0
hsa-miR-1267	5′Pm00005f005f05f0f05f05f05f0f05m0*0*0*	m0m0000m000m0m0m0m0*m0*m0TEGChol
MIMAT0005921	0*f0*0*0
hsa-miR-1268	5′Pm00005f005f005f005f005f00*5m0*0*0*f	m0m0m00m0m0m00m0m0m0m0*m0*m0TEGChol
MIMAT0005922	0*5m0*0
hsa-miR-1269	5′Pm05f05f00f05f000f0000f05m0*0*5m0*5	m0m0m0m0m0m0m0m00m0m00*0*m0TEGChol
MIMAT0005923	m0*5m0*5m0*0
hsa-miR-1270	5′Pm05f005f05f0005f0f05f005f05f05m0*0*5	m0m00m00m00m0m0m00m0*0*m0TEGChol
MIMAT0005924	m0*5m0*f0*0*0
hsa-miR-1271	5′Pm00005f05f05f00f05f05f005f05m0*5m0*	m0m0m000m0m000m0m0m0*m0*m0TEGChol
MIMAT0005796	0*5m0*f0*0*0
hsa-miR-1272	5′Pm00005f005f005f05f05f05f05f05m0*5m0	m0m0000m0m00m0m0m0m0*m0*m0TEGChol
MIMAT0005925	*0*0*f0*0*0
hsa-miR-1273	5′Pm00005f05f05f005f005f05f0f00*0*0*0*f0	m0m000m0m0m000m0m0m0*m0*m0TEGChol
MIMAT0005926	*0*0
hsa-miR-1273c	5′Pm05f05f05f05f05f05f05f0f005f005f00*0*	m0m0m00m0m0000m000*0*m0TEGChol
MIMAT0015017	0*5m0*5m0*5m0*0
hsa-miR-1273d	5′Pm05f05f00f005f05f0f005f05f05f00*5m0*5	m0m000m0m000m0m0m00*0*m0TEGChol
MIMAT0015090	m0*0*5m0*5m0*0
hsa-miR-1273e	5′Pm0000f0005f05f05f05f005f00*5m0*5m0*	m0m0m000m00m0m0m0m0m0*m0*m0TEGChol
MIMAT0018079	0*f0*0*0
hsa-miR-127-3p	5′Pm05f05f05f0f00005f0005f0f05m0*0*0*5	m0m00m0m0m0m0m0m0m000*0*m0TEGChol
MIMAT0000446	m0*f0*0*0
hsa-miR-1274a	5′Pm05f05f05f05f0000f05f05f05f05f00*0*5m	m0m0000m0m0m0m0m000*0*m0TEGChol
MIMAT0005927	0*5m0*5m0*0*0
hsa-miR-1274b	5′Pm05f05f05f05f0000f05f05f05f0f00*5m0*5	m0m0000m0m0m0m0m000*0*m0TEGChol
MIMAT0005938	m0*5m0*5m0*5m0*0
hsa-miR-1275	5′Pm05f05f005f05f005f0f05f05f005f05m0*5	m0m0m000m00m00m0m00*0*m0TEGChol
MIMAT0005929	m0*5m0*0*5m0*5m0*0
hsa-miR-127-5p	5′Pm05f05f05f0f0000f0000f05m0*0*5m0*5	m0m0m0m0m0m0m0m0m0m000*0*m0TEGChol
MIMAT0004604	m0*5m0*5m0*0
hsa-miR-1276	5′Pm05f05f05f0f05f0005f005f005f05m0*5m0	m0m0m00m0m0m0m00m000*0*m0TEGChol
MIMAT0005930	*5m0*5m0*f0*0*0
hsa-miR-1277	5′Pm05f000f005f05f0f05f05f05f05f00*5m0*0	m0m0000m000m0m0m0m0*0*m0TEGChol
MIMAT0005933	*5m0*5m0*5m0*0
hsa-miR-1278	5′Pm0005f05f05f000f005f05f05f00*0*0*5m0	m0m000m0m0m0m00m00m0*m0*m0TEGChol
MIMAT0005936	*f0*0*0
hsa-miR-1279	5′Pm05f005f0f05f05f05f0f05f05f05f05f00*5	m0m0000m0000m00m0*0*m0TEGChol
MIMAT0005937	m0*5m0*5m0*5m0*5m0*0
hsa-miR-128	5′Pm00005f005f00f0000f00*0*0*5m0*5m0*	m0m0m0m0m0m0m00m0m0m0m0*m0*m0TEGChol
MIMAT0000424	0*0
hsa-miR-1280	5′Pm05f000f05f05f00f005f05f05f05m0*5m0*	m0m000m0m0m000m0m0m0*0*m0TEGChol
MIMAT0005946	0*0*f0*0*0
hsa-miR-1281	5′Pm05f005f0f05f0005f05f05f005f05m0*0*5	m0m0m000m0m0m00m00m0*0*m0TEGChol
MIMAT0005939	m0*5m0*5m0*5m0*0
hsa-miR-1282	5′Pm05f005f0f05f0005f05f05f005f05m0*0*5	m0m0m000m0m0m00m00m0*0*m0TEGChol
MIMAT0005940	m0*5m0*5m0*5m0*0
hsa-miR-1283	5′Pm005f005f05f05f05f0f05f005f05f00*0*0*	m0m00m00m0000m0m00*m0*m0TEGChol
MIMAT0005799	0*f0*0*0
hsa-miR-1284	5′Pm05f05f05f05f005f05f05f05f005f05f00*5	m0m00m00m000m0m000*0*m0TEGChol
MIMAT0005941	m0*5m0*5m0*f0*0*0
hsa-miR-1285	5′Pm0000f05f005f05f05f05f05f05f05m0*5m0	m0m0000m00m00m0m0m0*m0*m0TEGChol
MIMAT0005876	*5m0*0*f0*0*0
hsa-miR-1286	5′Pm0005f05f0005f05f00005f00*0*0*0*f0*5	m0m0m0m0m0m00m0m0m00m0*m0*m0TEGChol
MIMAT0005877	m0*
hsa-miR-1287	5′Pm0005f0f05f05f005f05f05f00f05m0*0*0*	m0m0m000m0m000m00m0*m0*m0TEGChol
MIMAT0005878	0*5m0*5m0*0
hsa-miR-1288	5′Pm05f05f005f0005f0f005f05f0f00*0*5m0*	m0m000m0m00m0m0m0m00*0*m0TEGChol
MIMAT0005942	5m0*5m0*5m0*0
hsa-miR-1289	5′Pm05f05f05f05f0005f05f05f05f05f05f05m0	m0m0000m00m0m0m000*0*m0TEGChol
MIMAT0005879	*0*5m0*0*5m0*5m0*0
hsa-miR-129*	5′Pm05f005f0f0005f05f00005f05m0*5m0*5	m0m0m0m0m0m00m0m0m00m0*0*m0TEGChol
MIMAT0004548	m0*5m0*f0*0*0
hsa-miR-1290	5′Pm05f05f00f05f05f05f0f00005f05m0*0*5m	m0m0m0m0m0m0000m0m00*0*m0TEGChol
MIMAT0005880	0*5m0*f0*0*
hsa-miR-1291	5′Pm005f005f0005f0f05f05f00f00*0*0*5m0*	m0m0m000m00m0m0m0m00*m0*m0TEGChol
MIMAT0005881	f0*5m0*0
hsa-miR-1292	5′Pm0005f0f05f05f05f05f05f05f05f05f05m0*	m0m0000m0000m00m0*m0*m0TEGChol
MIMAT0005943	0*0*0*f0*5m0*0
hsa-miR-1293	5′Pm05f05f05f05f05f000f0000f00*0*5m0*0*	m0m0m0m0m0m0m0m00m000*0*m0TEGChol
MIMAT0005883	5m0*5m0*0
hsa-miR-129-3p	5′Pm05f005f0f05f05f005f00005f00*0*5m0*0	m0m0m0m0m0m0m000m00m0*0*m0TEGChol
MIMAT0004605	*f0*5m0*0
hsa-miR-1294	5′Pm05f05f05f0f05f0005f005f005f05m0*5m0	m0m0m00m0m0m0m00m000*0*m0TEGChol
MIMAT0005884	*5m0*5m0*f0*0*0
hsa-miR-1295	5′Pm0005f05f005f05f05f00005f00*0*5m0*5	m0m0m0m0m0m000m0m00m0*m0*m0TEGChol
MIMAT0005885	m0*5m0*5m0*0
hsa-miR-129-5p	5′Pm005f05f0f05f05f005f05f05f05f05f00*0*	m0m0000m0m000m000*m0*m0TEGChol
MIMAT0000242	5m0*0*5m0*0*0
hsa-miR-1296	5′Pm00005f005f00f05f05f00f00*5m0*5m0*0	m0m0m000m0m00m0m0m0m0*m0*m0TEGChol
MIMAT0005794	***
hsa-miR-1297	5′Pm0000f00005f0000f05m0*5m0*5m0*0*f	m0m0m0m0m0m0m0m0m0m0m0m0*m0*m0TEG
MIMAT0005886	0*0*0	Chol
hsa-miR-1298	5′Pm05f05f05f0f05f05f005f05f005f05f00*5m	m0m00m00m0m000m000*0*m0TEGChol
MIMAT0005800	0*5m0*5m0***
hsa-miR-1299	5′Pm005f05f05f05f005f0f0005f05f05m0*0*0	m0m00m0m0m00m00m000*m0*m0TEGChol
MIMAT0005887	*5m0*5m0*5m0*0
hsa-miR-1301	5′Pm05f0005f05f05f005f00005f05m0*0*0*5	m0m0m0m0m0m0m000m0m0m0*0*m0TEGChol
MIMAT0005797	m0*f0*0*0
hsa-miR-1302	5′Pm0000f05f0005f00005f00*0*5m0*0*f0*5	m0m0m0m0m0m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0005890	m0*0
hsa-miR-1303	5′Pm00005f0000f05f005f05f00*0*5m0*0*5	m0m00m00m0m0m0m0m0m0m0*m0*m0TEGChol
MIMAT0005891	m0*5m0*0
hsa-miR-1304	5′Pm00005f005f05f0f05f005f0f00*0*5m0*5	m0m00m00m000m0m0m0m0*m0*m0TEGChol
MIMAT0005892	m0*f0*0*0
hsa-miR-1305	5′Pm05f05f05f05f005f05f05f05f05f005f05m0	m0m0m000m000m0m000*0*m0TEGChol
MIMAT0005893	*0*5m0*5m0*f0**
hsa-miR-1306	5′Pm0000f005f05f0f0005f05f05m0*5m0*0*5	m0m00m0m0m000m0m0m0m0*m0*m0TEGChol
MIMAT0005950	m0*f0*0*0
hsa-miR-1307	5′Pm00005f05f05f00f05f05f00f05m0*5m0*0	m0m0m000m0m000m0m0m0*m0*m0TEGChol
MIMAT0005951	*0*5m0*0*0
hsa-miR-130a	5′Pm005f005f0005f0f05f000f05m0*0*0*5m0	m0m0m0m00m00m0m0m0m00*m0*m0TEGChol
MIMAT0000425	*5m0*5m0*0
hsa-miR-130a*	5′Pm05f005f0f05f000f0005f0f05m0*5m0*5m	m0m00m0m0m0m0m00m00m0*0*m0TEGChol
MIMAT0004593	0*5m0*5m0*0*0
hsa-miR-130b	5′Pm00005f005f05f05f05f05f05f05f05m0*5m	m0m0000m000m0m0m0m0*m0*m0TEGChol
MIMAT0000691	0*0*0*f0*5m0*0
hsa-miR-130b*	5′Pm05f005f0f05f0005f05f05f05f05f05m0*0*	m0m0000m0m0m00m00m0*0*m0TEGChol
MIMAT0004680	0*5m0*5m0*5m0*0
hsa-miR-132	5′Pm05f05f00f05f05f05f0f05f005f0f00*5m0*	m0m00m00m0000m0m00*0*m0TEGChol
MIMAT0000426	0*5m0*5m0*5m0*0
hsa-miR-132*	5′Pm05f005f05f05f05f05f05f05f05f05f05f05	m0m0000m0000m00m0*0*m0TEGChol
MIMAT0004594	m0*5m0*5m0*5m0***
hsa-miR-1321	5′Pm005f005f005f00f0000f00*5m0*5m0*5m	m0m0m0m0m0m0m00m0m0m00*m0*m0TEGChol
MIMAT0005952	0*5m0*5m0*0
hsa-miR-1322	5′Pm0000f05f000f005f05f05f05m0*5m0*0*0	m0m000m0m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0005953	*f0*0*
hsa-miR-1323	5′Pm0005f05f05f0005f05f05f00f00*5m0*5m	m0m0m000m0m0m00m00m0*m0*m0TEGChol
MIMAT0005795	0*5m0*5m0*0*0
hsa-miR-1324	5′Pm0005f0f0005f05f005f005f00*0*5m0*0*	m0m0m00m0m00m0m0m00m0*m0*m0TEGChol
MIMAT0005956	5m0*0*0
hsa-miR-133a	5′Pm05f005f0f05f05f005f00005f00*5m0*5m	m0m0m0m0m0m0m000m00m0*0*m0TEGChol
MIMAT0000427	0*5m0*f0*5m0*0
hsa-miR-133b	5′Pm005f00f05f005f05f005f005f00*0*0*0*5	m0m0m00m0m00m00m0m00*m0*m0TEGChol
MIMAT0000770	m0*5m0*0
hsa-miR-134	5′Pm005f05f05f05f005f05f05f05f05f0f05m0*	m0m0000m00m00m000*m0*m0TEGChol
MIMAT0000447	5m0*5m0*0*5m0*0*0
hsa-miR-135a	5′Pm05f005f05f05f005f05f05f05f05f05f05m0	m0m0000m00m00m00m0*0*m0TEGChol
MIMAT0000428	*5m0*5m0*0*5m0*5m0*0
hsa-miR-135a*	5′Pm05f005f05f05f005f05f05f05f05f05f00*5	m0m0000m00m00m00m0*0*m0TEGChol
MIMAT0004595	m0*0*0*f0*0*
hsa-miR-135b	5′Pm05f05f005f0000f0000f00*5m0*0*5m0*	m0m0m0m0m0m0m0m0m0m0m00*0*m0TEGChol
MIMAT0000758	5m0*5m0*0
hsa-miR-135b*	5′Pm05f05f05f0f0000f0000f05m0*0*5m0*5	m0m0m0m0m0m0m0m0m0m000*0*m0TEGChol
MIMAT0004698	m0*5m0*5m0*0
hsa-miR-136	5′Pm05f005f0f05f0005f05f05f005f05m0*0*5	m0m0m000m0m0m00m00m0*0*m0TEGChol
MIMAT0000448	m0*5m0*5m0*5m0*0
hsa-miR-136*	5′Pm05f05f005f005f00f005f05f05f05m0*0*0	m0m000m0m0m00m0m0m00*0*m0TEGChol
MIMAT0004606	*5m0*5m0*5m0*0
hsa-miR-137	5′Pm0000f05f000f005f05f05f05m0*5m0*0*0	m0m000m0m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0000429	*f0*0*0
hsa-miR-138	5′Pm05f05f05f05f00005f005f05f05f05m0*0*	m0m000m0m0m0m0m0m000*0*m0TEGChol
MIMAT0000430	5m0*5m0*5m0*5m0*0
hsa-miR-138-1*	5′Pm05f05f05f05f05f05f005f05f05f005f00*5	m0m0m000m0m000m000*0*m0TEGChol
MIMAT0004607	m0*0*5m0*5m0*5m0*0
hsa-miR-138-2*	5′Pm05f05f05f0f05f005f0f05f000f00*5m0*5	m0m0m0m00m00m00m000*0*m0TEGChol
MIMAT0004596	m0*0*f0*0*0
hsa-miR-139-3p	5′Pm005f005f0005f0f05f0005f05m0*5m0*0*	m0m0m0m00m00m0m0m0m00*m0*m0TEGChol
MIMAT0004552	5m0*5m0*0*0
hsa-miR-139-5p	5′Pm005f05f0f0005f05f005f00f00*5m0*5m0	m0m0m00m0m00m0m0m000*m0*m0TEGChol
MIMAT0000250	*5m0*5m0*5m0*0
hsa-miR-140-3p	5′Pm00005f005f05f05f05f05f05f05f05m0*5m	m0m0000m000m0m0m0m0*m0*m0TEGChol
MIMAT0004597	0*0*0*f0*0*0
hsa-miR-140-5p	5′Pm05f005f05f0005f05f05f05f005f00*0*0*5	m0m0m000m00m0m0m00m0*0*m0TEGChol
MIMAT0000431	m0*5m0*0*0
hsa-miR-141	5′Pm0000f005f05f05f005f00f05m0*5m0*5m	m0m0m00m0m000m0m0m0m0*m0*m0TEGChol
MIMAT0000432	0*0*5m0*5m0*0
hsa-miR-141*	5′Pm05f005f0f05f000f0005f0f05m0*5m0*5m	m0m00m0m0m0m0m00m00m0*0*m0TEGChol
MIMAT0004598	0*5m0*5m0*0*0
hsa-miR-142-3p	5′Pm05f0005f005f005f05f005f0f00*0*0*5m0	m0m00m00m0m00m0m0m0m0*0*m0TEGChol
MIMAT0000434	*5m0*5m0*0
hsa-miR-142-5p	5′Pm05f000f05f000f05f005f05f00*5m0*5m0	m0m00m00m0m0m00m0m0m0*0*m0TEGChol
MIMAT0000433	*5m0*5m0*0*0
hsa-miR-143	5′Pm05f0005f0005f0f05f05f05f0f05m0*5m0*	m0m0000m00m0m0m0m0m0*0*m0TEGChol
MIMAT0000435	0*5m0*f0*0*0
hsa-miR-143*	5′Pm005f00f005f005f0000f05m0*0*0*5m0*f	m0m0m0m0m0m0m00m0m0m00*m0*m0TEGChol
MIMAT0004599	0**
hsa-miR-144	5′Pm00005f005f05f05f05f05f05f05f05m0*5m	m0m0000m000m0m0m0m0*m0*m0TEGChol
MIMAT0000436	0*0*0*f0*0*0
hsa-miR-144*	5′Pm00005f05f05f00f05f0005f00*0*0*5m0*f	m0m0m0m00m0m000m0m0m0*m0*m0TEGChol
MIMAT0004600	0*0*
hsa-miR-145	5′Pm005f05f05f05f005f0f0005f05f05m0*0*0	m0m00m0m0m00m00m000*m0*m0TEGChol
MIMAT0000437	*0*5m0*5m0*0
hsa-miR-145*	5′Pm0005f0f05f000f05f005f0f00*0*5m0*0*5	m0m00m00m0m0m00m00m0*m0*m0TEGChol
MIMAT0004601	m0*5m0*0
hsa-miR-1468	5′Pm00005f05f05f005f005f05f05f00*0*0*0*f	m0m000m0m0m000m0m0m0*m0*m0TEGChol
MIMAT0006789	0*0*0
hsa-miR-1469	5′Pm0005f05f005f05f0f05f05f005f05m0*0*5	m0m0m000m000m0m00m0*m0*m0TEGChol
MIMAT0007347	m0*5m0*f0*0*0
hsa-miR-146a	5′Pm05f05f05f0f0000f0000f05m0*0*5m0*5	m0m0m0m0m0m0m0m0m0m000*0*m0TEGChol
MIMAT0000449	m0*5m0*5m0*0
hsa-miR-146a*	5′Pm005f05f0f005f05f05f005f00f00*0*5m0*	m0m0m00m0m000m0m000*m0*m0TEGChol
MIMAT0004608	5m0*5m0*5m0*0
hsa-miR-146b-3p	5′Pm00005f05f05f05f05f005f00f00*5m0*0*0	m0m0m00m0m0000m0m0m0*m0*m0TEGChol
MIMAT0004766	*f0*0*0
hsa-miR-146b-5p	5′Pm00005f005f05f05f05f05f05f05f05m0*5m	m0m0000m000m0m0m0m0*m0*m0TEGChol
MIMAT0002809	0*0*0*5m0*0*0
hsa-miR-147	5′Pm005f05f0f05f05f05f0f05f000f00*0*0*0*f	m0m0m0m00m0000m000*m0*m0TEGChol
MIMAT0000251	0*5m0*0
hsa-miR-1470	5′Pm005f05f05f05f005f0f00005f05m0*0*0*0	m0m0m0m0m0m00m00m000*m0*m0TEGChol
MIMAT0007348	*5m0*5m0*0
hsa-miR-1471	5′Pm05f05f00f005f05f05f05f05f00f05m0*0*5	m0m0m000m000m0m0m00*0*m0TEGChol
MIMAT0007349	m0*5m0*f0*0*
hsa-miR-147b	5′Pm05f05f005f05f05f005f0000f00*0*0*5m0	m0m0m0m0m0m0m000m0m00*0*m0TEGChol
MIMAT0004928	*f0*0*0
hsa-miR-148a	5′Pm05f05f05f05f05f005f0f005f005f00*0*5m	m0m0m00m0m00m00m000*0*m0TEGChol
MIMAT0000243	0*5m0***
hsa-miR-148a*	5′Pm0005f0f05f0005f005f05f0f05m0*5m0*5	m0m000m0m0m0m00m00m0*m0*m0TEGChol
MIMAT0004549	m0*0*5m0*0*0
hsa-miR-148b	5′Pm05f05f05f05f05f05f05f05f0000f05m0*5	m0m0m0m0m0m0000m000*0*m0TEGChol
MIMAT0000759	m0*0*5m0*5m0*5m0*0
hsa-miR-148b*	5′Pm00005f05f05f05f0f00005f00*5m0*5m0*	m0m0m0m0m0m0000m0m0m0*m0*m0TEGChol
MIMAT0004699	5m0*5m0*0*0
hsa-miR-149	5′Pm05f05f00f005f00f05f000f00*5m0*0*0*f	m0m0m0m00m0m00m0m0m00*0*m0TEGChol
MIMAT0000450	0*0*0
hsa-miR-149*	5′Pm005f05f05f0005f05f005f005f00*5m0*0*	m0m0m00m0m00m0m0m000*m0*m0TEGChol
MIMAT0004609	5m0*f0*5m0*0
hsa-miR-150	5′Pm05f000f05f05f05f0f005f05f05f05m0*0*0	m0m000m0m0000m0m0m0*0*m0TEGChol
MIMAT0000451	*0*f0*0*0
hsa-miR-150*	5′Pm05f05f05f05f05f05f05f05f05f05f05f0f05	m0m0000m0000m000*0*m0TEGChol
MIMAT0004610	m0*0*0*0*5m0*5m0*0
hsa-miR-151-3p	5′Pm05f05f05f05f005f05f05f0005f05f05m0*0	m0m00m0m0m000m0m000*0*m0TEGChol
MIMAT0000757	*5m0*5m0*f0*0*0
hsa-miR-151-5p	5′Pm05f05f05f05f005f05f0f005f005f05m0*0*	m0m0m00m0m000m0m000*0*m0TEGChol
MIMAT0004697	5m0*5m0*5m0*5m0*0
hsa-miR-152	5′Pm05f05f00f05f000f05f005f05f00*0*5m0*	m0m00m00m0m0m00m0m00*0*m0TEGChol
MIMAT0000438	5m0*f0*0*0
hsa-miR-153	5′Pm0000f0005f05f05f05f00f00*5m0*5m0*0	m0m0m000m00m0m0m0m0m0*m0*m0TEGChol
MIMAT0000439	*f0*0*0
hsa-miR-1537	5′Pm0000f0000f05f0005f05m0*0*0*5m0*5	m0m0m0m00m0m0m0m0m0m0m0*m0*m0TEGChol
MIMAT0007399	m0*5m0*0
hsa-miR-1538	5′Pm05f005f0f05f000f0000f05m0*0*0*5m0*	m0m0m0m0m0m0m0m00m00m0*0*m0TEGChol
MIMAT0007400	5m0*5m0*0
hsa-miR-1539	5′Pm05f05f05f05f005f05f0f05f05f005f05m0*	m0m0m000m000m0m000*0*m0TEGChol
MIMAT0007401	0*5m0*5m0*f0*5m0*
hsa-miR-154	5′Pm05f05f00f0005f05f0005f0f05m0*5m0*5	m0m00m0m0m00m0m0m0m00*0*m0TEGChol
MIMAT0000452	m0*5m0*5m0*5m0*0
hsa-miR-154*	5′Pm00005f005f05f05f005f05f05f00*5m0*0*	m0m000m0m000m0m0m0m0*m0*m0TEGChol
MIMAT0000453	5m0*f0*0*0
hsa-miR-155	5′Pm0000f05f05f00f005f00f00*0*0*5m0*5m	m0m0m00m0m0m000m0m0m0*m0*m0TEGChol
MIMAT0000646	0*5m0*0
hsa-miR-155*	5′Pm005f00f0005f05f0000f05m0*0*0*0*5m	m0m0m0m0m0m00m0m0m0m00*m0*m0TEGChol
MIMAT0004658	0*5m0*0
hsa-miR-15a	5′Pm05f0005f05f05f005f00005f00*5m0*0*5	m0m0m0m0m0m0m000m0m0m0*0*m0TEGChol
MIMAT0000068	m0*f0*5m0*0
hsa-miR-15a*	5′Pm0000f05f05f05f0f05f05f00f00*0*0*0*f0	m0m0m000m0000m0m0m0*m0*m0TEGChol
MIMAT0004488	*0*0
hsa-miR-15b	5′Pm005f005f0000f005f05f0f00*5m0*5m0*0	m0m000m0m0m0m0m0m0m00*m0*m0TEGChol
MIMAT0000417	*f0*0*0
hsa-miR-15b*	5′Pm00005f05f05f05f05f05f05f05f05f00*0*5	m0m0000m0000m0m0m0*m0*m0TEGChol
MIMAT0004586	m0*5m0*5m0*5m0*0
hsa-miR-16	5′Pm05f005f0f0000f0000f05m0*5m0*5m0*5	m0m0m0m0m0m0m0m0m0m00m0*0*m0TEGChol
MIMAT0000069	m0*5m0*5m0*0
hsa-miR-16-1*	5′Pm05f005f0f05f005f0f05f005f0f05m0*0*5	m0m00m00m00m00m00m0*0*m0TEGChol
MIMAT0004489	m0*0*5m0*0*0
hsa-miR-16-2*	5′Pm005f00f00005f0000f00*0*0*5m0*5m0*	m0m0m0m0m0m0m0m0m0m0m00*m0*m0TEGChol
MIMAT0004518	5m0*0
hsa-miR-17	5′Pm05f05f00f005f05f05f0000f05m0*5m0*0	m0m0m0m0m0m000m0m0m00*0*m0TEGChol
MIMAT0000070	*0*f0*0*0
hsa-miR-17*	5′Pm005f005f005f05f05f05f05f00f00*5m0*5	m0m0m000m000m0m0m00*m0*m0TEGChol
MIMAT0000071	m0*0*5m0*0*0
hsa-miR-181a	5′Pm005f005f0000f05f0005f00*0*0*5m0*5	m0m0m0m00m0m0m0m0m0m00*m0*m0TEGChol
MIMAT0000256	m0*0*0
hsa-miR-181a*	5′Pm05f0005f005f005f05f005f0f00*0*0*5m0	m0m00m00m0m00m0m0m0m0*0*m0TEGChol
MIMAT0000270	*5m0*5m0*0
hsa-miR-181a-2*	5′Pm0005f05f05f05f005f05f005f0f05m0*0*5	m0m00m00m0m000m00m0*m0*m0TEGChol
MIMAT0004558	m0*5m0*5m0*0*0
hsa-miR-181b	5′Pm05f05f00f05f05f05f05f005f005f05m0*5	m0m0m00m0m0000m0m00*0*m0TEGChol
MIMAT0000257	m0*5m0*5m0*f0*5m0*0
hsa-miR-181c	5′Pm0000f0000f05f000f00*0*5m0*5m0*f0*	m0m0m0m00m0m0m0m0m0m0m0*m0*m0TEGChol
MIMAT0000258	5m0*0
hsa-miR-181c*	5′Pm005f05f0f005f05f05f05f05f00f00*0*5m0	m0m0m000m000m0m000*m0*m0TEGChol
MIMAT0004559	*5m0*5m0*5m0*0
hsa-miR-181d	5′Pm05f05f05f05f05f0005f05f05f05f05f00*5	m0m0000m0m0m00m000*0*m0TEGChol
MIMAT0002821	m0*0*5m0*5m0*0*0
hsa-miR-182	5′Pm005f05f05f0005f05f05f000f00*5m0*5m	m0m0m0m00m00m0m0m000*m0*m0TEGChol
MIMAT0000259	0*5m0*5m0*5m0*0
hsa-miR-182*	5′Pm0005f05f05f005f05f005f05f05f05m0*0*	m0m000m0m00m00m00m0*m0*m0TEGChol
MIMAT0000260	5m0*0*5m0*0*0
hsa-miR-1825	5′Pm05f000f05f000f0005f0f00*0*5m0*0*5m	m0m00m0m0m0m0m00m0m0m0*0*m0TEGChol
MIMAT0006765	0*0*0
hsa-miR-1827	5′Pm005f05f0f005f005f05f05f05f0f00*5m0*5	m0m0000m0m00m0m000*m0*m0TEGChol
MIMAT0006767	m0*5m0*5m0*0*0
hsa-miR-183	5′Pm0000f0005f0f0000f00*5m0*0*0*f0*0*0	m0m0m0m0m0m00m0m0m0m0m0*m0*m0TEGChol
MIMAT0000261
hsa-miR-183*	5′Pm0005f0f005f00f05f05f05f0f05m0*0*5m0	m0m0000m0m00m0m00m0*m0*m0TEGChol
MIMAT0004560	*5m0*5m0*5m0*0
hsa-miR-184	5′Pm05f005f0f05f005f05f05f05f05f0f05m0*5	m0m0000m00m00m00m0*0*m0TEGChol
MIMAT0000454	m0*0*5m0*5m0*5m0*0
hsa-miR-185	5′Pm005f05f0f05f005f0f05f0005f00*5m0*5m	m0m0m0m00m00m00m000*m0*m0TEGChol
MIMAT0000455	0*0*f0*5m0*0
hsa-miR-185*	5′Pm05f0005f05f005f0f00005f05m0*0*5m0*	m0m0m0m0m0m00m00m0m0m0*0*m0TEGChol
MIMAT0004611	0*5m0*0*0
hsa-miR-186	5′Pm0000f05f05f05f05f005f005f00*0*0*5m0	m0m0m00m0m0000m0m0m0*m0*m0TEGChol
MIMAT0000456	*f0*5m0*0
hsa-miR-186*	5′Pm05f005f0f05f005f0f05f005f0f05m0*0*0*	m0m00m00m00m00m00m0*0*m0TEGChol
MIMAT0004612	5m0*f0*5m0*0
hsa-miR-187	5′Pm005f05f0f0005f05f0005f0f00*5m0*5m0	m0m00m0m0m00m0m0m000*m0*m0TEGChol
MIMAT0000262	*5m0*f0*0*0
hsa-miR-187*	5′Pm0000f05f005f0f00005f00*5m0*5m0*0*	m0m0m0m0m0m00m00m0m0m0*m0*m0TEGChol
MIMAT0004561	5m0*5m0*0
hsa-miR-188-3p	5′Pm0000f05f05f05f05f0000f00*5m0*0*0*f0	m0m0m0m0m0m0000m0m0m0*m0*m0TEGChol
MIMAT0004613	*0*0
hsa-miR-188-5p	5′Pm00005f05f005f05f05f05f00f05m0*5m0*	m0m0m000m00m00m0m0m0*m0*m0TEGChol
MIMAT0000457	5m0*0*f0*0*0
hsa-miR-18a	5′Pm005f00f05f005f0f005f05f0f05m0*5m0*5	m0m000m0m00m00m0m00*m0*m0TEGChol
MIMAT0000072	m0*5m0*5m0*0*0
hsa-miR-18a*	5′Pm05f0005f005f00f005f05f05f00*0*0*0*f0	m0m000m0m0m00m0m0m0m0*0*m0TEGChol
MIMAT0002891	*0*0
hsa-miR-18b	5′Pm05f05f00f00005f005f05f0f05m0*0*5m0	m0m000m0m0m0m0m0m0m00*0*m0TEGChol
MIMAT0001412	*5m0*5m0*0*0
hsa-miR-18b*	5′Pm005f00f05f0005f0005f05f05m0*5m0*0*	m0m00m0m0m0m0m00m0m00*m0*m0TEGChol
MIMAT0004751	5m0*f0*5m0*0
hsa-miR-190	5′Pm05f000f005f005f005f005f00*5m0*0*0*f	m0m0m00m0m0m00m0m0m0m0*0*m0TEGChol
MIMAT0000458	0*0*0
hsa-miR-1908	5′Pm05f005f05f05f05f00f0005f05f00*5m0*5	m0m00m0m0m0m000m00m0*0*m0TEGChol
MIMAT0007881	m0*0*f0*0*0
hsa-miR-1909	5′Pm05f05f05f05f05f005f0f05f05f05f05f00*0	m0m0000m00m00m000*0*m0TEGChol
MIMAT0007883	*0*0*5m0*5m0*0
hsa-miR-1909*	5′Pm05f05f00f0000f0000f05m0*5m0*0*0***	m0m0m0m0m0m0m0m0m0m0m00*0*m0TEGChol
MIMAT0007882
hsa-miR-190b	5′Pm005f05f0f05f005f05f05f05f00f05m0*0*0	m0m0m000m00m00m000*m0*m0TEGChol
MIMAT0004929	*5m0*f0*0*0
hsa-miR-191	5′Pm005f05f0f05f05f00f005f05f0f00*5m0*0*	m0m000m0m0m000m000*m0*m0TEGChol
MIMAT0000440	5m0*5m0*0*
hsa-miR-191*	5′Pm05f0005f0000f05f05f005f05m0*0*5m0*	m0m0m000m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0001618	5m0*f0*5m0*0
hsa-miR-1910	5′Pm0000f05f05f05f0f0000f05m0*5m0*5m0	m0m0m0m0m0m0000m0m0m0*m0*m0TEGChol
MIMAT0007884	*0*5m0*0*0
hsa-miR-1911	5′Pm05f05f005f05f005f05f0005f0f05m0*0*5	m0m00m0m0m00m00m0m00*0*m0TEGChol
MIMAT0007885	m0*0*f0*5m0*0
hsa-miR-1911*	5′Pm00005f05f05f005f0005f05f00*5m0*5m0	m0m00m0m0m0m000m0m0m0*m0*m0TEGChol
MIMAT0007886	*5m0*5m0*5m0*0
hsa-miR-1912	5′Pm05f05f00f005f00f00005f05m0*0*0*5m0	m0m0m0m0m0m0m00m0m0m00*0*m0TEGChol
MIMAT0007887	*5m0*5m0*0
hsa-miR-1913	5′Pm0000f05f05f005f005f05f05f05m0*0*0*0	m0m000m0m0m000m0m0m0*m0*m0TEGChol
MIMAT0007888	*f0*0*0
hsa-miR-1914	5′Pm0005f05f05f05f05f0f05f05f05f05f00*0*	m0m0000m0000m00m0*m0*m0TEGChol
MIMAT0007889	0*0*f0*0*0
hsa-miR-1914*	5′Pm05f005f05f05f05f05f05f05f05f05f05f05	m0m0000m0000m00m0*0*m0TEGChol
MIMAT0007890	m0*5m0*5m0*0*5m0*5m0*0
hsa-miR-1915	5′Pm05f000f005f05f05f005f005f00*0*0*0*5	m0m0m00m0m000m0m0m0m0*0*m0TEGChol
MIMAT0007892	m0*0*0
hsa-miR-1915*	5′Pm05f005f05f05f005f05f005f05f05f05m0*5	m0m000m0m00m00m00m0*0*m0TEGChol
MIMAT0007891	m0*5m0*5m0*5m0*5m0*0
hsa-miR-192	5′Pm05f05f05f05f00005f05f05f00f05m0*0*0	m0m0m000m0m0m0m0m000*0*m0TEGChol
MIMAT0000222	*0*f0*5m0*0
hsa-miR-192*	5′Pm05f000f05f05f00f0005f05f05m0*5m0*5	m0m00m0m0m0m000m0m0m0*0*m0TEGChol
MIMAT0004543	m0*5m0*f0*0*0
hsa-miR-193a-3p	5′Pm005f00f0000f05f000f05m0*0*0*5m0*5	m0m0m0m00m0m0m0m0m0m00*m0*m0TEGChol
MIMAT0000459	m0*0*0
hsa-miR-193a-5p	5′Pm0000f005f005f0005f05f00*0*5m0*5m0	m0m00m0m0m0m00m0m0m0m0*m0*m0TEGChol
MIMAT0004614	*f0*0*0
hsa-miR-193b	5′Pm0005f0f005f005f0000f00*5m0*0*5m0*	m0m0m0m0m0m0m00m0m00m0*m0*m0TEGChol
MIMAT0002819	5m0*0*0
hsa-miR-193b*	5′Pm00005f005f05f05f05f05f05f05f05m0*5m	m0m0000m000m0m0m0m0*m0*m0TEGChol
MIMAT0004767	0*5m0*0*f0*0*0
hsa-miR-194	5′Pm00005f005f005f05f05f00f00*0*0*0*5m	m0m0m000m0m00m0m0m0m0*m0*m0TEGChol
MIMAT0000460	0**
hsa-miR-194*	5′Pm05f05f05f0f00005f05f005f05f05m0*5m0	m0m00m00m0m0m0m0m000*0*m0TEGChol
MIMAT0004671	*0*5m0*5m0*0*0
hsa-miR-195	5′Pm05f05f05f0f0005f0f05f05f00f00*0*5m0*	m0m0m000m00m0m0m000*0*m0TEGChol
MIMAT0000461	0*f0*5m0*0
hsa-miR-195*	5′Pm0005f0f05f05f005f05f05f00f00*0*5m0*	m0m0m000m0m000m00m0*m0*m0TEGChol
MIMAT0004615	5m0*f0*0*0
hsa-miR-196a	5′Pm05f000f005f005f005f005f00*5m0*0*0*f	m0m0m00m0m0m00m0m0m0m0*0*m0TEGChol
MIMAT0000226	0*0*0
hsa-miR-196a*	5′Pm05f05f05f05f0005f05f05f05f00f00*0*5m	m0m0m000m00m0m0m000*0*m0TEGChol
MIMAT0004562	0*5m0*5m0*0*0
hsa-miR-196b	5′Pm05f05f00f05f05f05f05f05f05f05f05f00*0	m0m0000m0000m0m00*0*m0TEGChol
MIMAT0001080	*5m0*0*5m0*5m0*0
hsa-miR-196b*	5′Pm00005f0000f0000f00*0*0*0*f0*0*0	m0m0m0m0m0m0m0m0m0m0m0m0*m0*m0TEG
MIMAT0009201		Chol
hsa-miR-197	5′Pm0000f05f0005f0005f05f05m0*0*5m0*0	m0m00m0m0m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0000227	*5m0*0*0
hsa-miR-1972	5′Pm05f000f05f05f05f0f005f05f05f05m0*5m	m0m000m0m0000m0m0m0*0*m0TEGChol
MIMAT0009447	0*5m0*5m0*5m0*5m0*0
hsa-miR-1973	5′Pm05f05f005f005f005f0005f05f05m0*5m0	m0m00m0m0m0m00m0m0m00*0*m0TEGChol
MIMAT0009448	*5m0*5m0*5m0*5m0*0
hsa-miR-1976	5′Pm0000f05f0005f00005f05m0*0*5m0*0*5	m0m0m0m0m0m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0009451	m0*0*0
hsa-miR-198	5′Pm005f005f05f05f005f05f05f005f05m0*5m	m0m0m000m0m000m0m00*m0*m0TEGChol
MIMAT0000228	0*5m0*0*5m0*5m0*0
hsa-miR-199a-3p	5′Pm0005f0f05f05f005f05f05f00f00*0*5m0*	m0m0m000m0m000m00m0*m0*m0TEGChol
MIMAT0000232	5m0*f0*0*0
hsa-miR-199a-5p	5′Pm05f05f00f05f05f05f05f005f005f00*0*5m	m0m0m00m0m0000m0m00*0*m0TEGChol
MIMAT0000231	0*0*f0*5m0*0
hsa-miR-199b-3p	5′Pm05f0005f05f05f05f0f05f005f0f00*5m0*0	m0m00m00m0000m0m0m0*0*m0TEGChol
MIMAT0004563	*0*5m0*5m0*0
hsa-miR-199b-5p	5′Pm0005f0f05f05f005f05f05f00f00*0*5m0*	m0m0m000m0m000m00m0*m0*m0TEGChol
MIMAT0000263	5m0*f0*0*0
hsa-miR-19a	5′Pm05f05f005f0000f05f05f05f0f00*0*0*5m	m0m0000m0m0m0m0m0m00*0*m0TEGChol
MIMAT0000073	0*5m0*0*0
hsa-miR-19a*	5′Pm05f0005f005f05f0f005f05f0f05m0*0*5m	m0m000m0m000m0m0m0m0*0*m0TEGChol
MIMAT0004490	0*5m0*f0*5m0*0
hsa-miR-19b	5′Pm005f05f05f05f05f00f0000f05m0*5m0*5	m0m0m0m0m0m0m000m000*m0*m0TEGChol
MIMAT0000074	m0*5m0*5m0*5m0*0
hsa-miR-19b-1*	5′Pm00005f0005f05f05f05f005f00*5m0*5m0	m0m0m000m00m0m0m0m0m0*m0*m0TEGChol
MIMAT0004491	*0*5m0*5m0*0
hsa-miR-19b-2*	5′Pm0005f0f005f00f0000f05m0*5m0*0*5m0	m0m0m0m0m0m0m00m0m00m0*m0*m0TEGChol
MIMAT0004492	*5m0*5m0*0
hsa-miR-200a	5′Pm0005f05f0005f05f05f05f05f05f05m0*5m	m0m0000m00m0m0m00m0*m0*m0TEGChol
MIMAT0000682	0*0*0*5m0*0*0
hsa-miR-200a*	5′Pm005f005f0000f005f00f00*5m0*5m0*5m	m0m0m00m0m0m0m0m0m0m00*m0*m0TEGChol
MIMAT0001620	0*5m0*5m0*0
hsa-miR-200b	5′Pm0005f0f05f0005f0005f0f05m0*5m0*0*5	m0m00m0m0m0m0m00m00m0*m0*m0TEGChol
MIMAT0000318	m0*5m0*0*0
hsa-miR-200b*	5′Pm0005f0f05f0005f0005f0f05m0*5m0*0*5	m0m00m0m0m0m0m00m00m0*m0*m0TEGChol
MIMAT0004571	m0*5m0*0*0
hsa-miR-200c	5′Pm005f00f0005f05f05f05f05f0f05m0*0*0*	m0m0000m00m0m0m0m00*m0*m0TEGChol
MIMAT0000617	0*f0*0*0
hsa-miR-200c*	5′Pm05f000f00005f05f05f005f00*0*5m0*5m	m0m0m000m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0004657	0*5m0*0*0
hsa-miR-202	5′Pm0000f0005f05f0005f0f00*5m0*5m0*5m	m0m00m0m0m00m0m0m0m0m0*m0*m0TEGChol
MIMAT0002811	0*5m0*0*0
hsa-miR-202*	5′Pm05f0005f005f005f0005f0f00*0*0*5m0*	m0m00m0m0m0m00m0m0m0m0*0*m0TEGChol
MIMAT0002810	5m0*5m0*0
hsa-miR-203	5′Pm0005f0f05f05f05f0f0000f05m0*0*0*0***	m0m0m0m0m0m0000m00m0*m0*m0TEGChol
MIMAT0000264
hsa-miR-204	5′Pm05f005f0f05f000f05f05f005f05m0*0*5m	m0m0m000m0m0m00m00m0*0*m0TEGChol
MIMAT0000265	0*5m0*5m0*5m0*0
hsa-miR-205	5′Pm0000f05f0005f0005f05f05m0*0*5m0*0	m0m00m0m0m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0000266	*5m0*5m0*0
hsa-miR-205*	5′Pm05f005f0f05f05f05f05f05f05f05f05f00*5	m0m0000m0000m00m0*0*m0TEGChol
MIMAT0009197	m0*0*5m0*5m0*5m0*0
hsa-miR-2052	5′Pm05f05f00f0000f05f05f005f00*0*5m0*0*	m0m0m000m0m0m0m0m0m00*0*m0TEGChol
MIMAT0009977	f0*5m0*0
hsa-miR-2053	5′Pm05f05f05f0f05f005f0f00005f05m0*5m0*	m0m0m0m0m0m00m00m000*0*m0TEGChol
MIMAT0009978	0*0*f0*0*0
hsa-miR-2054	5′Pm05f05f05f0f005f05f05f0005f0f00*0*0*0	m0m00m0m0m000m0m000*0*m0TEGChol
MIMAT0009979	*5m0**
hsa-miR-206	5′Pm005f05f05f0000f0005f05f00*5m0*5m0*	m0m00m0m0m0m0m0m0m000*m0*m0TEGChol
MIMAT0000462	0*f0*5m0*0
hsa-miR-208a	5′Pm05f05f00f00005f05f05f05f05f00*0*0*5	m0m0000m0m0m0m0m0m00*0*m0TEGChol
MIMAT0000241	m0*5m0*5m0*0
hsa-miR-208b	5′Pm0000f05f05f005f00005f00*0*0*5m0*f0	m0m0m0m0m0m0m000m0m0m0*m0*m0TEGChol
MIMAT0004960	*0*0
hsa-miR-20a	5′Pm05f000f0005f0f0000f05m0*5m0*0*0*f0	m0m0m0m0m0m00m0m0m0m0m0*0*m0TEGChol
MIMAT0000075	**
hsa-miR-20a*	5′Pm00005f005f05f05f05f05f005f00*5m0*5	m0m0m000m000m0m0m0m0*m0*m0TEGChol
MIMAT0004493	m0*5m0*5m0*0*0
hsa-miR-20b	5′Pm05f05f05f0f05f05f005f05f005f05f05m0*	m0m00m00m0m000m000*0*m0TEGChol
MIMAT0001413	5m0*0*0***
hsa-miR-20b*	5′Pm05f05f005f00005f05f05f05f0f00*5m0*5	m0m0000m0m0m0m0m0m00*0*m0TEGChol
MIMAT0004752	m0*0*5m0*0*0
hsa-miR-21	5′Pm005f05f0f005f05f0f05f05f00f00*0*0*0*f	m0m0m000m000m0m000*m0*m0TEGChol
MIMAT0000076	0*5m0*0
hsa-miR-21*	5′Pm05f005f0f00005f05f05f005f00*5m0*0*0	m0m0m000m0m0m0m0m00m0*0*m0TEGChol
MIMAT0004494	*f0*5m0*0
hsa-miR-210	5′Pm05f05f005f005f00f005f05f05f05m0*0*5	m0m000m0m0m00m0m0m00*0*m0TEGChol
MIMAT0000267	m0*5m0*f0*5m0*0
hsa-miR-211	5′Pm05f005f0f05f000f05f05f005f05m0*0*5m	m0m0m000m0m0m00m00m0*0*m0TEGChol
MIMAT0000268	0*5m0*5m0*5m0*0
hsa-miR-2110	5′Pm05f05f005f05f005f0f005f05f0f05m0*0*0	m0m000m0m00m00m0m00*0*m0TEGChol
MIMAT0010133	*0*5m0*0*0
hsa-miR-2113	5′Pm00005f05f05f05f05f00005f05m0*0*0*0	m0m0m0m0m0m0000m0m0m0*m0*m0TEGChol
MIMAT0009206	*f0*0*
hsa-miR-2114	5′Pm0005f0f05f05f05f05f05f05f05f0f05m0*5	m0m0000m0000m00m0*m0*m0TEGChol
MIMAT0011156	m0*0*0*5m0*5m0*0
hsa-miR-2114*	5′Pm0005f05f00005f05f05f00f00*0*0*5m0*	m0m0m000m0m0m0m0m00m0*m0*m0TEGChol
MIMAT0011157	5m0*0*0
hsa-miR-2115	5′Pm0005f05f05f05f00f05f05f00f00*0*0*5m	m0m0m000m0m000m00m0*m0*m0TEGChol
MIMAT0011158	0*5m0*0*0
hsa-miR-2115*	5′Pm05f05f05f05f05f05f05f05f0005f0f00*5m	m0m00m0m0m0000m000*0*m0TEGChol
MIMAT0011159	0*5m0*5m0*5m0*5m0*0
hsa-miR-2116	5′Pm00005f0005f05f05f05f05f05f00*5m0*5	m0m0000m00m0m0m0m0m0*m0*m0TEGChol
MIMAT0011160	m0*0*5m0*5m0*0
hsa-miR-2116*	5′Pm0000f005f00f005f05f05f05m0*0*0*5m0	m0m000m0m0m00m0m0m0m0*m0*m0TEGChol
MIMAT0011161	*f0*0*0
hsa-miR-2117	5′Pm05f05f05f05f0005f05f05f005f0f05m0*0*	m0m00m00m00m0m0m000*0*m0TEGChol
MIMAT0011162	0*0*5m0*0*0
hsa-miR-212	5′Pm05f05f05f0f0005f0f05f000f05m0*0*5m0	m0m0m0m00m00m0m0m000*0*m0TEGChol
MIMAT0000269	*0*5m0*5m0*0
hsa-miR-214	5′Pm0005f0f05f05f05f05f05f05f05f05f05m0*	m0m0000m0000m00m0*m0*m0TEGChol
MIMAT0000271	0*0*0*f0*0*0
hsa-miR-214*	5′Pm00005f0005f05f05f000f00*0*5m0*5m0	m0m0m0m00m00m0m0m0m0m0*m0*m0TEGChol
MIMAT0004564	*5m0*0*0
hsa-miR-215	5′Pm005f005f05f000f05f05f05f0f00*0*5m0*	m0m0000m0m0m00m0m00*m0*m0TEGChol
MIMAT0000272	5m0***
hsa-miR-216a	5′Pm00005f005f05f05f05f05f005f00*5m0*5	m0m0m000m000m0m0m0m0*m0*m0TEGChol
MIMAT0000273	m0*5m0*5m0*0*0
hsa-miR-216b	5′Pm05f05f05f05f0005f0f05f000f00*0*5m0*	m0m0m0m00m00m0m0m000*0*m0TEGChol
MIMAT0004959	0*5m0*5m0*0
hsa-miR-217	5′Pm05f05f00f0005f0f05f000f00*5m0*5m0*	m0m0m0m00m00m0m0m0m00*0*m0TEGChol
MIMAT0000274	5m0*5m0*0*
hsa-miR-218	5′Pm05f005f0f05f0005f05f005f0f00*0*0*0*5	m0m00m00m0m0m00m00m0*0*m0TEGChol
MIMAT0000275	m0*0*0
hsa-miR-218-1*	5′Pm05f0005f0005f0f05f0005f00*5m0*5m0*	m0m0m0m00m00m0m0m0m0m0*0*m0TEGChol
MIMAT0004565	0*5m0*5m0*0
hsa-miR-218-2*	5′Pm05f05f005f05f005f05f05f05f05f05f05m0	m0m0000m00m00m0m00*0*m0TEGChol
MIMAT0004566	*5m0*0*5m0*5m0*5m0*0
hsa-miR-219-1-3p	5′Pm0000f005f00f00005f05m0*5m0*0****	m0m0m0m0m0m0m00m0m0m0m0*m0*m0TEGChol
MIMAT0004567
hsa-miR-219-2-3p	5′Pm005f005f05f05f00f005f05f0f05m0*5m0*	m0m000m0m0m000m0m00*m0*m0TEGChol
MIMAT0004675	5m0*0***
hsa-miR-219-5p	5′Pm0000f005f005f0005f0f00*0*0*0*f0*0*0	m0m00m0m0m0m00m0m0m0m0*m0*m0TEGChol
MIMAT0000276
hsa-miR-22	5′Pm0000f05f0005f0000f00*5m0*5m0*5m0	m0m0m0m0m0m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0000077	*5m0**
hsa-miR-22*	5′Pm00005f05f005f05f05f0005f05m0*0*5m0	m0m0m0m00m00m00m0m0m0*m0*m0TEGChol
MIMAT0004495	*0*f0*5m0*0
hsa-miR-221	5′Pm0005f05f05f000f05f05f005f05m0*0*5m	m0m0m000m0m0m00m00m0*m0*m0TEGChol
MIMAT0000278	0*5m0*f0*5m0*0
hsa-miR-221*	5′Pm00005f005f05f05f05f05f005f00*5m0*5	m0m0m000m000m0m0m0m0*m0*m0TEGChol
MIMAT0004568	m0*5m0*5m0*0*0
hsa-miR-222	5′Pm05f000f05f05f00f005f005f00*0*5m0*0*	m0m0m00m0m0m000m0m0m0*0*m0TEGChol
MIMAT0000279	f0*5m0*0
hsa-miR-222*	5′Pm005f05f05f005f05f05f005f00f00*0*5m0	m0m0m00m0m000m0m000*m0*m0TEGChol
MIMAT0004569	*5m0*f0*5m0*0
hsa-miR-223	5′Pm05f05f005f005f00f00005f00*0*5m0*0*	m0m0m0m0m0m0m00m0m0m00*0*m0TEGChol
MIMAT0000280	5m0*0*
hsa-miR-223*	5′Pm0000f05f005f0f0005f05f05m0*0*0*0*f0	m0m00m0m0m00m00m0m0m0*m0*m0TEGChol
MIMAT0004570	*0*0
hsa-miR-224	5′Pm05f05f05f05f00005f005f05f05f05m0*0*	m0m000m0m0m0m0m0m000*0*m0TEGChol
MIMAT0000281	0*5m0*5m0**
hsa-miR-224*	5′Pm05f05f05f0f05f005f0f005f05f05f05m0*0	m0m000m0m00m00m000*0*m0TEGChol
MIMAT0009198	*0*0*f0*0*0
hsa-miR-2276	5′Pm05f000f005f05f05f05f000f00*0*0*5m0*	m0m0m0m00m000m0m0m0m0*0*m0TEGChol
MIMAT0011775	f0*0*0
hsa-miR-2277-3p	5′Pm05f05f00f05f005f0f0000f05m0*0*5m0*	m0m0m0m0m0m00m00m0m00*0*m0TEGChol
MIMAT0011777	5m0*5m0*0*0
hsa-miR-2277-5p	5′Pm0000f05f05f00f05f05f005f00*0*5m0*0*	m0m0m000m0m000m0m0m0*m0*m0TEGChol
MIMAT0017352	f0*0*0
hsa-miR-2278	5′Pm05f05f005f05f05f00f05f005f0f00*0*5m0	m0m00m00m0m000m0m00*0*m0TEGChol
MIMAT0011778	*5m0*f0*5m0*0
hsa-miR-2355-3p	5′Pm05f005f05f005f05f0f05f05f005f05m0*5	m0m0m000m000m0m00m0*0*m0TEGChol
MIMAT0017950	m0*0*0*f0*5m0*0
hsa-miR-2355-5p	5′Pm05f05f05f05f05f005f05f05f05f05f05f05	m0m0000m00m00m000*0*m0TEGChol
MIMAT0016895	m0*5m0*0*5m0*5m0*0*0
hsa-miR-23a	5′Pm005f05f05f0000f0000f00*0*5m0*0*f0*	m0m0m0m0m0m0m0m0m0m000*m0*m0TEGChol
MIMAT0000078	0*0
hsa-miR-23a*	5′Pm05f05f05f0f005f05f0f05f0005f05m0*0*5	m0m0m0m00m000m0m000*0*m0TEGChol
MIMAT0004496	m0*5m0***
hsa-miR-23b	5′Pm05f0005f0005f05f05f005f0f05m0*0*5m	m0m00m00m00m0m0m0m0m0*0*m0TEGChol
MIMAT0000418	0*5m0*f0*0*0
hsa-miR-23b*	5′Pm00005f005f05f05f05f05f005f00*5m0*5	m0m0m000m000m0m0m0m0*m0*m0TEGChol
MIMAT0004587	m0*5m0*f0*0*0
hsa-miR-23c	5′Pm05f05f05f0f05f005f0f05f05f05f05f00*0*	m0m0000m00m00m000*0*m0TEGChol
MIMAT0018000	0*5m0*f0*5m0*0
hsa-miR-24	5′Pm05f05f05f05f0005f0f05f000f00*0*5m0*	m0m0m0m00m00m0m0m000*0*m0TEGChol
MIMAT0000080	0*5m0*5m0*0
hsa-miR-24-1*	5′Pm00005f005f05f05f05f05f005f00*5m0*5	m0m0m000m000m0m0m0m0*m0*m0TEGChol
MIMAT0000079	m0*5m0***
hsa-miR-24-2*	5′Pm0005f05f005f05f05f05f05f005f00*5m0*	m0m0m000m000m0m00m0*m0*m0TEGChol
MIMAT0004497	5m0*5m0***
hsa-miR-25	5′Pm0005f05f05f05f05f0f05f05f05f05f00*0*	m0m0000m0000m00m0*m0*m0TEGChol
MIMAT0000081	0*0*f0*0*0
hsa-miR-25*	5′Pm05f000f005f005f05f05f05f05f05m0*5m0	m0m0000m0m00m0m0m0m0*0*m0TEGChol
MIMAT0004498	*5m0*5m0*f0*0*0
hsa-miR-26a	5′Pm0000f05f05f005f05f05f05f0f00*0*0*0*f	m0m0000m0m000m0m0m0*m0*m0TEGChol
MIMAT0000082	0*0*0
hsa-miR-26a-1*	5′Pm05f000f05f000f005f05f05f05m0*0*0*5	m0m000m0m0m0m00m0m0m0*0*m0TEGChol
MIMAT0004499	m0*5m0*5m0*
hsa-miR-26a-2*	5′Pm05f000f05f000f05f05f05f0f05m0*0*0*0	m0m0000m0m0m00m0m0m0*0*m0TEGChol
MIMAT0004681	*f0*0*0
hsa-miR-26b	5′Pm005f05f0f05f005f0f05f05f005f05m0*0*0	m0m0m000m00m00m000*m0*m0TEGChol
MIMAT0000083	*0*5m0*5m0*0
hsa-miR-26b*	5′Pm0000f05f05f05f05f0000f00*0*0*0*5m0	m0m0m0m0m0m0000m0m0m0*m0*m0TEGChol
MIMAT0004500	*0*0
hsa-miR-27a	5′Pm0005f05f05f0005f005f005f00*5m0*0*0	m0m0m00m0m0m0m00m00m0*m0*m0TEGChol
MIMAT0000084	*5m0*0*0
hsa-miR-27a*	5′Pm005f05f05f05f005f0f05f05f005f05m0*5	m0m0m000m00m00m000*m0*m0TEGChol
MIMAT0004501	m0*0*0*f0*5m0*0
hsa-miR-27b	5′Pm005f05f05f0000f00005f00*5m0*0*5m0	m0m0m0m0m0m0m0m0m0m000*m0*m0TEGChol
MIMAT0000419	*f0*0*0
hsa-miR-27b*	5′Pm0005f0f0005f0f005f005f00*5m0*5m0*5	m0m0m00m0m00m0m0m00m0*m0*m0TEGChol
MIMAT0004588	m0*5m0*0*0
hsa-miR-28-3p	5′Pm05f005f0f0005f05f05f0005f05m0*5m0*	m0m0m0m00m00m0m0m00m0*0*m0TEGChol
MIMAT0004502	5m0*0*f0*0*
hsa-miR-28-5p	5′Pm0000f05f0005f05f05f00f05m0*0*5m0*0	m0m0m000m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0000085	*f0*0*0
hsa-miR-2861	5′Pm05f05f05f0f05f005f05f00005f05m0*0*5	m0m0m0m0m0m00m00m000*0*m0TEGChol
MIMAT0013802	m0*5m0*5m0*5m0*0
hsa-miR-2909	5′Pm05f005f0f005f005f05f05f05f0f05m0*5m	m0m0000m0m00m0m00m0*0*m0TEGChol
MIMAT0013863	0*5m0*0*5m0*5m0*0
hsa-miR-296-3p	5′Pm05f0005f05f05f00f00005f05m0*5m0*0*	m0m0m0m0m0m0m000m0m0m0*0*m0TEGChol
MIMAT0004679	5m0*5m0*5m0*0
hsa-miR-296-5p	5′Pm05f0005f005f05f05f05f0005f00*5m0*0*	m0m0m0m00m000m0m0m0m0*0*m0TEGChol
MIMAT0000690	5m0*5m0*0*0
hsa-miR-297	5′Pm05f0005f005f05f0f00005f00*5m0*5m0*	m0m0m0m0m0m000m0m0m0m0*0*m0TEGChol
MIMAT0004450	0*5m0*5m0*0
hsa-miR-298	5′Pm005f05f0f005f005f05f05f05f05f05m0*5	m0m0000m0m00m0m000*m0*m0TEGChol
MIMAT0004901	m0*0*0*f0*5m0*0
hsa-miR-299-3p	5′Pm05f000f0005f0f005f00f00*5m0*5m0*0*	m0m0m00m0m00m0m0m0m0m0*0*m0TEGChol
MIMAT0000687	5m0*5m0*0
hsa-miR-299-5p	5′Pm005f00f0005f05f0005f0f05m0*5m0*0*5	m0m00m0m0m00m0m0m0m00*m0*m0TEGChol
MIMAT0002890	m0*5m0*0*0
hsa-miR-29a	5′Pm00005f005f00f0000f00*0*0*5m0***	m0m0m0m0m0m0m00m0m0m0m0*m0*m0TEGChol
MIMAT0000086
hsa-miR-29a*	5′Pm005f05f0f05f000f05f0005f00*0*5m0*0*	m0m0m0m00m0m0m00m000*m0*m0TEGChol
MIMAT0004503	f0*0*0
hsa-miR-29b	5′Pm0000f0000f0000f00*0*5m0*5m0*5m0*	m0m0m0m0m0m0m0m0m0m0m0m0*m0*m0TEG
MIMAT0000100	5m0*0	Chol
hsa-miR-29b-1*	5′Pm00005f05f005f05f05f005f0f05m0*5m0*	m0m00m00m00m00m0m0m0*m0*m0TEGChol
MIMAT0004514	0*5m0*5m0*5m0*0
hsa-miR-29b-2*	5′Pm05f05f00f05f005f05f05f000f05m0*5m0*	m0m0m0m00m00m00m0m00*0*m0TEGChol
MIMAT0004515	0*5m0*5m0*5m0*0
hsa-miR-29c	5′Pm0000f05f05f00f005f05f0f00*0*0*0*f0*0	m0m000m0m0m000m0m0m0*m0*m0TEGChol
MIMAT0000681	*0
hsa-miR-29c*	5′Pm05f000f05f05f005f00005f05m0*5m0*0*	m0m0m0m0m0m0m000m0m0m0*0*m0TEGChol
MIMAT0004673	0*f0*5m0*0
hsa-miR-300	5′Pm0000f05f005f0f00005f00*0*0*0*5m0*5	m0m0m0m0m0m00m00m0m0m0*m0*m0TEGChol
MIMAT0004903	m0*0
hsa-miR-301a	5′Pm005f05f0f05f005f0f0000f05m0*0*5m0*	m0m0m0m0m0m00m00m000*m0*m0TEGChol
MIMAT0000688	5m0*5m0*0*0
hsa-miR-301b	5′Pm005f05f0f05f005f0f00005f05m0*0*5m0	m0m0m0m0m0m00m00m000*m0*m0TEGChol
MIMAT0004958	*5m0*5m0*0*0
hsa-miR-302a	5′Pm05f0005f0000f05f05f005f05m0*0*0*5m	m0m0m000m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0000684	0*f0*5m0*0
hsa-miR-302a*	5′Pm0005f0f005f005f00005f00*0*0*0*f0*5	m0m0m0m0m0m0m00m0m00m0*m0*m0TEGChol
MIMAT0000683	m0*0
hsa-miR-302b	5′Pm005f005f05f0005f05f05f00f05m0*0*0*0	m0m0m000m0m0m00m0m00*m0*m0TEGChol
MIMAT0000715	*5m0*0*0
hsa-miR-302b*	5′Pm0000f05f05f00f005f05f0f00*0*0*0*f0*0	m0m000m0m0m000m0m0m0*m0*m0TEGChol
MIMAT0000714	*0
hsa-miR-302c	5′Pm005f00f005f005f05f05f05f05f00*0*5m0	m0m0000m0m00m0m0m00*m0*m0TEGChol
MIMAT0000717	*5m0*f0*0*0
hsa-miR-302c*	5′Pm05f000f00005f05f005f05f05m0*5m0*5	m0m00m00m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0000716	m0*5m0*f0*0*0
hsa-miR-302d	5′Pm05f05f05f05f0005f05f00005f00*5m0*5	m0m0m0m0m0m00m0m0m000*0*m0TEGChol
MIMAT0000718	m0*5m0*f0*5m0*0
hsa-miR-302d*	5′Pm0000f05f05f00f005f05f0f00*0*0*0*f0*0	m0m000m0m0m000m0m0m0*m0*m0TEGChol
MIMAT0004685	*0
hsa-miR-302e	5′Pm005f00f005f005f05f05f05f0f05m0*0*5m	m0m0000m0m00m0m0m00*m0*m0TEGChol
MIMAT0005931	0*5m0*5m0*0*0
hsa-miR-302f	5′Pm005f05f0f05f005f0f05f0005f05m0*0*0*	m0m0m0m00m00m00m000*m0*m0TEGChol
MIMAT0005932	5m0*5m0*5m0*0
hsa-miR-3065-3p	5′Pm05f05f00f005f00f05f0005f00*5m0*5m0	m0m0m0m00m0m00m0m0m00*0*m0TEGChol
MIMAT0015378	*5m0*5m0*5m0*0
hsa-miR-3065-5p	5′Pm05f000f00005f05f05f05f0f00*5m0*5m0	m0m0000m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0015066	****
hsa-miR-3074	5′Pm05f000f00005f00005f00*5m0*5m0*5m	m0m0m0m0m0m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0015027	0*f0*5m0*0
hsa-miR-30a	5′Pm005f00f005f005f05f05f05f0f05m0*0*5m	m0m0000m0m00m0m0m00*m0*m0TEGChol
MIMAT0000087	0*5m0*5m0*5m0*0
hsa-miR-30a*	5′Pm05f000f0000f0005f05f00*5m0*5m0*5m	m0m00m0m0m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0000088	0*f0*5m0*0
hsa-miR-30b	5′Pm05f000f0000f0005f05f00*5m0*5m0*5m	m0m00m0m0m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0000420	0*f0*5m0*0
hsa-miR-30b*	5′Pm0000f005f05f05f005f00f05m0*5m0*5m	m0m0m00m0m000m0m0m0m0*m0*m0TEGChol
MIMAT0004589	0*0*f0*5m0*0
hsa-miR-30c	5′Pm005f00f005f005f05f05f05f05f00*0*5m0	m0m0000m0m00m0m0m00*m0*m0TEGChol
MIMAT0000244	*5m0*f0*0*0
hsa-miR-30c-1*	5′Pm0005f05f00005f05f005f0f00*0*5m0*5m	m0m00m00m0m0m0m0m00m0*m0*m0TEGChol
MIMAT0004674	0*5m0*5m0*0
hsa-miR-30c-2*	5′Pm0005f0f0005f05f005f00f05m0*5m0*5m	m0m0m00m0m00m0m0m00m0*m0*m0TEGChol
MIMAT0004550	0*0*5m0*5m0*0
hsa-miR-30d	5′Pm05f05f05f05f0005f05f00005f00*5m0*5	m0m0m0m0m0m00m0m0m000*0*m0TEGChol
MIMAT0000245	m0*5m0*f0*5m0*0
hsa-miR-30d*	5′Pm005f00f005f005f05f05f05f05f00*0*5m0	m0m0000m0m00m0m0m00*m0*m0TEGChol
MIMAT0004551	*5m0*f0*0*0
hsa-miR-30e	5′Pm05f05f05f05f0005f05f00005f00*5m0*5	m0m0m0m0m0m00m0m0m000*0*m0TEGChol
MIMAT0000692	m0*5m0*f0*5m0*0
hsa-miR-30e*	5′Pm0005f0f00005f005f05f0f00*5m0*0*5m0	m0m000m0m0m0m0m0m00m0*m0*m0TEGChol
MIMAT0000693	*f0*0*0
hsa-miR-31	5′Pm05f000f005f005f05f05f05f05f05m0*5m0	m0m0000m0m00m0m0m0m0*0*m0TEGChol
MIMAT0000089	*5m0*5m0*f0*0*0
hsa-miR-31*	5′Pm005f05f0f05f005f05f0005f0f05m0*0*5m	m0m00m0m0m00m00m000*m0*m0TEGChol
MIMAT0004504	0*5m0*f0*5m0*0
hsa-miR-3115	5′Pm05f005f0f0005f05f05f005f05f00*0*5m0	m0m00m00m00m0m0m00m0*0*m0TEGChol
MIMAT0014977	*5m0*f0*0*0
hsa-miR-3116	5′Pm05f05f00f05f05f05f0f005f00f05m0*0*5	m0m0m00m0m0000m0m00*0*m0TEGChol
MIMAT0014978	m0****
hsa-miR-3117	5′Pm005f00f05f005f05f0000f00*5m0*0*0*5	m0m0m0m0m0m00m00m0m00*m0*m0TEGChol
MIMAT0014979	m0*0*0
hsa-miR-3118	5′Pm005f05f05f0000f05f005f0f00*5m0*0*0*	m0m00m00m0m0m0m0m000*m0*m0TEGChol
MIMAT0014980	f0*0*0
hsa-miR-3119	5′Pm05f05f05f05f05f005f0f005f05f05f00*0*	m0m000m0m00m00m000*0*m0TEGChol
MIMAT0014981	0*5m0*5m0*5m0*0
hsa-miR-3120	5′Pm005f005f005f05f05f05f05f05f05f05m0*5	m0m0000m000m0m0m00*m0*m0TEGChol
MIMAT0014982	m0*0*0*f0*0*0
hsa-miR-3121	5′Pm00005f05f05f00f0000f00*0*0*5m0*f0*	m0m0m0m0m0m0m000m0m0m0*m0*m0TEGChol
MIMAT0014983	5m0*0
hsa-miR-3122	5′Pm05f05f05f05f05f05f05f05f05f000f05m0*	m0m0m0m00m0000m000*0*m0TEGChol
MIMAT0014984	0*5m0*0*5m0*5m0*0
hsa-miR-3123	5′Pm05f0005f005f05f0f05f005f0f05m0*0*5m	m0m00m00m000m0m0m0m0*0*m0TEGChol
MIMAT0014985	0*0*f0*5m0*0
hsa-miR-3124	5′Pm00005f0005f05f05f05f05f05f05m0*5m0	m0m0000m00m0m0m0m0m0*m0*m0TEGChol
MIMAT0014986	*0*0*f0*0*0
hsa-miR-3125	5′Pm05f05f05f05f005f05f05f05f005f05f00*0	m0m00m00m000m0m000*0*m0TEGChol
MIMAT0014988	*0*5m0*f0*5m0*0
hsa-miR-3126-3p	5′Pm05f0005f005f05f0f005f05f0f05m0*0*0*	m0m000m0m000m0m0m0m0*0*m0TEGChol
MIMAT0015377	5m0*f0*0*0
hsa-miR-3126-5p	5′Pm0005f0f0005f05f05f05f00f05m0*5m0*5	m0m0m000m00m0m0m00m0*m0*m0TEGChol
MIMAT0014989	m0*0*5m0*5m0*0
hsa-miR-3127	5′Pm0000f05f05f00f005f05f0f00*0*0*0*f0*0*	m0m000m0m0m000m0m0m0*m0*m0TEGChol
MIMAT0014990
hsa-miR-3128	5′Pm05f05f05f0f0000f0000f05m0*0*5m0*5	m0m0m0m0m0m0m0m0m0m000*0*m0TEGChol
MIMAT0014991	m0*5m0*5m0*0
hsa-miR-3129	5′Pm0005f0f05f005f05f05f05f05f05f05m0*0*	m0m0000m00m00m00m0*m0*m0TEGChol
MIMAT0014992	5m0*0*f0*0*0
hsa-miR-3130-3p	5′Pm05f000f05f05f05f0f005f005f00*5m0*0*	m0m0m00m0m0000m0m0m0*0*m0TEGChol
MIMAT0014994	5m0*5m0*5m0*0
hsa-miR-3130-5p	5′Pm05f000f005f05f05f05f0005f05m0*5m0*	m0m0m0m00m000m0m0m0m0*0*m0TEGChol
MIMAT0014995	5m0*0*5m0*5m0*0
hsa-miR-3131	5′Pm05f05f05f0f0000f0000f05m0*0*5m0*5	m0m0m0m0m0m0m0m0m0m000*0*m0TEGChol
MIMAT0014996	m0*5m0*5m0*0
hsa-miR-3132	5′Pm05f05f05f05f05f05f05f0f05f05f05f05f00	m0m0000m0000m000*0*m0TEGChol
MIMAT0014997	*0*5m0*5m0*f0*5m0*0
hsa-miR-3133	5′Pm005f05f05f05f05f05f05f05f05f05f05f00*	m0m0000m0000m000*m0*m0TEGChol
MIMAT0014998	0*0*0*5m0*0*0
hsa-miR-3134	5′Pm05f0005f005f05f0f0005f0f00*5m0*5m0	m0m00m0m0m000m0m0m0m0*0*m0TEGChol
MIMAT0015000	*0*5m0*5m0*0
hsa-miR-3135	5′Pm05f000f05f005f0f0005f0f00*5m0*5m0*	m0m00m0m0m00m00m0m0m0*0*m0TEGChol
MIMAT0015001	5m0*5m0*0*0
hsa-miR-3136	5′Pm0005f05f05f000f00005f05m0*5m0*5m0	m0m0m0m0m0m0m0m00m00m0*m0*m0TEGChol
MIMAT0015003	*0*5m0*0*0
hsa-miR-3137	5′Pm00005f05f000f05f05f00f00*0*0*0*f0**	m0m0m000m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0015005
hsa-miR-3138	5′Pm0005f0f05f005f05f05f000f00*0*0*0*f0*	m0m0m0m00m00m00m00m0*m0*m0TEGChol
MIMAT0015006	0*0
hsa-miR-3139	5′Pm0000f05f005f05f05f05f05f05f05m0*5m0	m0m0000m00m00m0m0m0*m0*m0TEGChol
MIMAT0015007	*5m0*0*f0*0*0
hsa-miR-3140	5′Pm005f005f05f005f0f05f0005f05m0*0*0*5	m0m0m0m00m00m00m0m00*m0*m0TEGChol
MIMAT0015008	m0*5m0*5m0*0
hsa-miR-3141	5′Pm005f05f05f0000f00005f00*5m0*5m0*0	m0m0m0m0m0m0m0m0m0m000*m0*m0TEGChol
MIMAT0015010	*f0*5m0*0
hsa-miR-3142	5′Pm05f0005f0005f05f05f005f0f05m0*0*5m	m0m00m00m00m0m0m0m0m0*0*m0TEGChol
MIMAT0015011	0*5m0*f0*0*0
hsa-miR-3143	5′Pm05f000f00005f05f000f00*0*0*0*f0*0*0	m0m0m0m00m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0015012
hsa-miR-3144-3p	5′Pm05f05f00f005f00f05f05f05f0f00*0*5m0*	m0m0000m0m00m0m0m00*0*m0TEGChol
MIMAT0015015	0***
hsa-miR-3144-5p	5′Pm005f00f05f000f05f05f05f0f00*0*5m0*5	m0m0000m0m0m00m0m00*m0*m0TEGChol
MIMAT0015014	m0*f0*5m0*0
hsa-miR-3145	5′Pm05f05f05f05f05f005f05f05f05f005f05m0	m0m0m000m00m00m000*0*m0TEGChol
MIMAT0015016	*5m0*0*0*f0*0*0
hsa-miR-3146	5′Pm05f005f0f0000f0000f05m0*0*5m0*5m0	m0m0m0m0m0m0m0m0m0m00m0*0*m0TEGChol
MIMAT0015018	*5m0*5m0*0
hsa-miR-3147	5′Pm0000f05f005f05f05f05f05f05f05m0*5m0	m0m0000m00m00m0m0m0*m0*m0TEGChol
MIMAT0015019	*5m0*0*f0*0*0
hsa-miR-3148	5′Pm05f05f05f0f05f05f00f0005f05f05m0*5m	m0m00m0m0m0m000m000*0*m0TEGChol
MIMAT0015021	0*5m0*0***
hsa-miR-3149	5′Pm05f05f05f0f05f000f0000f00*0*5m0*0*f	m0m0m0m0m0m0m0m00m000*0*m0TEGChol
MIMAT0015022	0*0*0
hsa-miR-3150	5′Pm0000f0000f0000f00*5m0*0*0*f0*0*	m0m0m0m0m0m0m0m0m0m0m0m0*m0*m0TEG
MIMAT0015023		Chol
hsa-miR-3150b	5′Pm05f05f05f0f05f005f05f05f05f05f05f00*0	m0m0000m00m00m000*0*m0TEGChol
MIMAT0018194	*0*5m0*5m0*0*0
hsa-miR-3151	5′Pm05f05f05f0f05f005f0f05f05f00f05m0*5	m0m0m000m00m00m000*0*m0TEGChol
MIMAT0015024	m0*5m0*0*f0*0*0
hsa-miR-3152	5′Pm05f05f05f0f0000f0005f0f05m0*0*5m0*	m0m00m0m0m0m0m0m0m000*0*m0TEGChol
MIMAT0015025	5m0*5m0*5m0*0
hsa-miR-3153	5′Pm005f05f05f005f05f0f05f05f00f00*0*0*5	m0m0m000m000m0m000*m0*m0TEGChol
MIMAT0015026	m0*f0*5m0*0
hsa-miR-3154	5′Pm05f0005f05f005f05f005f05f05f05m0*5m	m0m000m0m00m00m0m0m0*0*m0TEGChol
MIMAT0015028	0*0*5m0*5m0*0*0
hsa-miR-3155	5′Pm05f000f005f05f05f005f005f00*0*5m0*0	m0m0m00m0m000m0m0m0m0*0*m0TEGChol
MIMAT0015029	*5m0*5m0*0
hsa-miR-3156	5′Pm0005f05f0005f05f00005f00*0*5m0*5m	m0m0m0m0m0m00m0m0m00m0*m0*m0TEGChol
MIMAT0015030	0*f0*0*0
hsa-miR-3157	5′Pm0005f0f005f05f05f005f00f05m0*0*5m0	m0m0m00m0m000m0m00m0*m0*m0TEGChol
MIMAT0015031	*0*5m0*5m0*0
hsa-miR-3158	5′Pm05f05f005f05f05f00f05f05f005f05m0*5	m0m0m000m0m000m0m00*0*m0TEGChol
MIMAT0015032	m0*0*0*f0*5m0*0
hsa-miR-3159	5′Pm05f005f0f005f05f0f05f05f05f0f00*5m0*	m0m0000m000m0m00m0*0*m0TEGChol
MIMAT0015033	5m0*0*f0*5m0*0
hsa-miR-3160	5′Pm05f05f05f0f0000f0000f05m0*0*5m0*5	m0m0m0m0m0m0m0m0m0m000*0*m0TEGChol
MIMAT0015034	m0*5m0*5m0*0
hsa-miR-3161	5′Pm005f005f0005f05f05f05f05f05f05m0*0*	m0m0000m00m0m0m0m00*m0*m0TEGChol
MIMAT0015035	0*0*f0*5m0*
hsa-miR-3162	5′Pm005f00f05f05f05f0f05f05f05f0f00*0*5m	m0m0000m0000m0m00*m0*m0TEGChol
MIMAT0015036	0*5m0*f0*5m0*0
hsa-miR-3163	5′Pm005f00f0005f05f0000f05m0*5m0*0*0*	m0m0m0m0m0m00m0m0m0m00*m0*m0TEGChol
MIMAT0015037	5m0*0*0
hsa-miR-3164	5′Pm005f05f05f0005f05f0005f0f00*5m0*5m	m0m00m0m0m00m0m0m000*m0*m0TEGChol
MIMAT0015038	0*0*5m0**
hsa-miR-3165	5′Pm0000f0000f00005f05m0*5m0*5m0*0*5	m0m0m0m0m0m0m0m0m0m0m0m0*m0*m0TEG
MIMAT0015039	m0*5m0*0	Chol
hsa-miR-3166	5′Pm05f005f05f05f05f05f05f0005f0f00*0*5m	m0m00m0m0m0000m00m0*0*m0TEGChol
MIMAT0015040	0*0*f0**
hsa-miR-3167	5′Pm05f005f0f0005f05f05f05f05f0f00*0*5m0	m0m0000m00m0m0m00m0*0*m0TEGChol
MIMAT0015042	*0*f0*0*0
hsa-miR-3168	5′Pm005f00f05f05f005f005f05f0f05m0*0*0*	m0m000m0m0m000m0m00*m0*m0TEGChol
MIMAT0015043	0*f0*0*0
hsa-miR-3169	5′Pm05f05f00f005f00f005f005f05m0*5m0*0	m0m0m00m0m0m00m0m0m00*0*m0TEGChol
MIMAT0015044	*5m0*f0*5m0*0
hsa-miR-3170	5′Pm0005f0f005f05f05f05f05f05f05f05m0*5	m0m0000m000m0m00m0*m0*m0TEGChol
MIMAT0015045	m0*5m0*5m0*f0**
hsa-miR-3171	5′Pm05f05f05f05f0000f0000f05m0*0*5m0*5	m0m0m0m0m0m0m0m0m0m000*0*m0TEGChol
MIMAT0015046	m0*5m0*5m0*0
hsa-miR-3173	5′Pm05f0005f05f005f05f005f05f0f05m0*5m0	m0m000m0m00m00m0m0m0*0*m0TEGChol
MIMAT0015048	*5m0*5m0*5m0*5m0*0
hsa-miR-3174	5′Pm05f05f00f005f05f0f005f005f05m0*0*5m	m0m0m00m0m000m0m0m00*0*m0TEGChol
MIMAT0015051	0*5m0*f0*0*
hsa-miR-3175	5′Pm05f0005f0000f0000f00*0*0*5m0*5m0*	m0m0m0m0m0m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0015052	0*0
hsa-miR-3176	5′Pm05f05f00f05f005f0f05f0005f05m0*0*0*	m0m0m0m00m00m00m0m00*0*m0TEGChol
MIMAT0015053	5m0*5m0*5m0*0
hsa-miR-3177	5′Pm05f0005f05f005f05f005f05f05f05m0*5m	m0m000m0m00m00m0m0m0*0*m0TEGChol
MIMAT0015054	0*5m0*5m0***
hsa-miR-3178	5′Pm0000f05f005f05f05f05f05f05f05m0*5m0	m0m0000m00m00m0m0m0*m0*m0TEGChol
MIMAT0015055	*5m0*0*f0*0*0
hsa-miR-3179	5′Pm05f05f05f0f05f005f05f05f05f00f05m0*5	m0m0m000m00m00m000*0*m0TEGChol
MIMAT0015056	m0*5m0*5m0*5m0*5m0*0
hsa-miR-3180	5′Pm05f005f0f0000f0000f05m0*5m0*5m0*5	m0m0m0m0m0m0m0m0m0m00m0*0*m0TEGChol
MIMAT0018178	m0*5m0*5m0*0
hsa-miR-3180-3p	5′Pm05f05f05f05f05f005f0f05f05f05f0f00*0*	m0m0000m00m00m000*0*m0TEGChol
MIMAT0015058	0*5m0*5m0*5m0*0
hsa-miR-3180-5p	5′Pm05f05f05f0f00005f05f05f05f0f05m0*0*5	m0m0000m0m0m0m0m000*0*m0TEGChol
MIMAT0015057	m0*0*f0*0*0
hsa-miR-3181	5′Pm05f05f05f05f005f005f005f05f0f00*5m0*	m0m000m0m0m00m0m000*0*m0TEGChol
MIMAT0015061	0*5m0*5m0*0*0
hsa-miR-3182	5′Pm0005f0f005f005f005f00f05m0*0*0*5m0	m0m0m00m0m0m00m0m00m0*m0*m0TEGChol
MIMAT0015062	*5m0*5m0*0
hsa-miR-3183	5′Pm00005f05f05f05f0f05f05f05f0f00*0*5m0	m0m0000m0000m0m0m0*m0*m0TEGChol
MIMAT0015063	*0*5m0*5m0*0
hsa-miR-3184	5′Pm005f005f05f05f05f0f0005f0f05m0*0*0*	m0m00m0m0m0000m0m00*m0*m0TEGChol
MIMAT0015064	0*f0*5m0*0
hsa-miR-3185	5′Pm005f05f0f05f005f05f05f05f05f05f05m0*	m0m0000m00m00m000*m0*m0TEGChol
MIMAT0015065	5m0*0*5m0*f0*5m0*0
hsa-miR-3186-3p	5′Pm05f005f0f005f05f05f005f05f05f00*0*0*	m0m000m0m000m0m00m0*0*m0TEGChol
MIMAT0015068	0*5m0*5m0*0
hsa-miR-3186-5p	5′Pm0005f05f05f05f05f0f005f05f05f05m0*0*	m0m000m0m0000m00m0*m0*m0TEGChol
MIMAT0015067	0*5m0*f0*0*0
hsa-miR-3187	5′Pm05f05f00f05f0005f05f05f005f00*5m0*0	m0m0m000m0m0m00m0m00*0*m0TEGChol
MIMAT0015069	*5m0***
hsa-miR-3188	5′Pm005f00f0000f005f05f05f05m0*0*5m0*5	m0m000m0m0m0m0m0m0m00*m0*m0TEGChol
MIMAT0015070	m0*f0*5m0*0
hsa-miR-3189	5′Pm00005f05f005f0f05f05f005f00*5m0*5m	m0m0m000m00m00m0m0m0*m0*m0TEGChol
MIMAT0015071	0*0*5m0*5m0*0
hsa-miR-3190	5′Pm05f005f05f005f05f0f05f05f00f05m0*5m	m0m0m000m000m0m00m0*0*m0TEGChol
MIMAT0015073	0*5m0*5m0*f0*0*0
hsa-miR-3191	5′Pm00005f005f005f05f05f005f00*5m0*0*5	m0m0m000m0m00m0m0m0m0*m0*m0TEGChol
MIMAT0015075	m0*5m0*0*
hsa-miR-3192	5′Pm05f05f005f005f00f0005f05f05m0*5m0*	m0m00m0m0m0m00m0m0m00*0*m0TEGChol
MIMAT0015076	5m0*5m0*5m0*5m0*0
hsa-miR-3193	5′Pm0005f05f005f05f05f005f00f05m0*0*0*0	m0m0m00m0m000m0m00m0*m0*m0TEGChol
MIMAT0015077	*5m0*5m0*0
hsa-miR-3194	5′Pm05f05f005f05f05f05f0f0005f0f05m0*5m	m0m00m0m0m0000m0m00*0*m0TEGChol
MIMAT0015078	0*0*5m0*5m0*0*0
hsa-miR-3195	5′Pm005f005f05f05f05f05f05f000f00*5m0*0	m0m0m0m00m0000m0m00*m0*m0TEGChol
MIMAT0015079	*5m0*5m0*0*0
hsa-miR-3196	5′Pm005f05f0f005f05f05f05f05f05f05f05m0*	m0m0000m000m0m000*m0*m0TEGChol
MIMAT0015080	5m0*0*0*f0*5m0*0
hsa-miR-3197	5′Pm0000f0005f05f005f05f05f05m0*5m0*0*	m0m000m0m00m0m0m0m0m0*m0*m0TEGChol
MIMAT0015082	0*5m0*0*0
hsa-miR-3198	5′Pm05f0005f05f05f05f0f0005f0f05m0*0*0*	m0m00m0m0m0000m0m0m0*0*m0TEGChol
MIMAT0015083	5m0*f0*5m0*0
hsa-miR-3199	5′Pm05f05f00f05f000f05f005f05f05m0*0*0*	m0m00m00m0m0m00m0m00*0*m0TEGChol
MIMAT0015084	5m0*f0*0*0
hsa-miR-32	5′Pm05f05f00f05f005f05f05f000f05m0*5m0*	m0m0m0m00m00m00m0m00*0*m0TEGChol
MIMAT0000090	0*5m0*5m0*5m0*0
hsa-miR-32*	5′Pm05f000f00005f005f00f05m0*0*5m0*5m	m0m0m00m0m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0004505	0*f0*5m0*0
hsa-miR-3200-3p	5′Pm05f005f0f005f05f0f05f05f05f0f00*0*0*0	m0m0000m000m0m00m0*0*m0TEGChol
MIMAT0015085	*5m0*0*0
hsa-miR-3200-5p	5′Pm005f005f005f05f0f05f005f05f05m0*5m0	m0m00m00m000m0m0m00*m0*m0TEGChol
MIMAT0017392	*5m0*0*f0*0*0
hsa-miR-3201	5′Pm05f05f05f05f0005f05f005f05f05f00*0*5	m0m000m0m00m0m0m000*0*m0TEGChol
MIMAT0015086	m0*5m0*f0*5m0*0
hsa-miR-3202	5′Pm00005f05f05f005f05f05f05f05f00*5m0*	m0m0000m0m000m0m0m0*m0*m0TEGChol
MIMAT0015089	0*0*f0*5m0*0
hsa-miR-320a	5′Pm0005f0f0005f0f05f000f00*5m0*5m0*5	m0m0m0m00m00m0m0m00m0*m0*m0TEGChol
MIMAT0000510	m0*f0*0*0
hsa-miR-320b	5′Pm0000f005f05f05f05f005f05f00*5m0*5m	m0m00m00m000m0m0m0m0*m0*m0TEGChol
MIMAT0005792	0*0*f0*5m0*0
hsa-miR-320c	5′Pm005f00f05f000f05f05f00f05m0*0*0*5m	m0m0m000m0m0m00m0m00*m0*m0TEGChol
MIMAT0005793	0*5m0*0*0
hsa-miR-320d	5′Pm05f000f0005f05f005f05f0f05m0*0*5m0	m0m000m0m00m0m0m0m0m0*0*m0TEGChol
MIMAT0006764	*5m0*f0*5m0*0
hsa-miR-320e	5′Pm0005f0f05f05f05f0f05f0005f00*5m0*0*	m0m0m0m00m0000m00m0*m0*m0TEGChol
MIMAT0015072	5m0*5m0*5m0*0
hsa-miR-323-3p	5′Pm05f05f05f05f00005f05f05f05f05f05m0*5	m0m0000m0m0m0m0m000*0*m0TEGChol
MIMAT0000755	m0*5m0*5m0*5m0*0*0
hsa-miR-323-5p	5′Pm005f00f05f005f05f005f00f05m0*5m0*5	m0m0m00m0m00m00m0m00*m0*m0TEGChol
MIMAT0004696	m0*5m0*5m0*0*0
hsa-miR-323b-3p	5′Pm05f0005f05f05f05f05f05f05f05f0f05m0*	m0m0000m0000m0m0m0*0*m0TEGChol
MIMAT0015050	5m0*5m0*5m0*5m0*5m0*0
hsa-miR-323b-5p	5′Pm005f00f05f000f05f005f0f00*0*5m0*0*f	m0m00m00m0m0m00m0m00*m0*m0TEGChol
MIMAT0001630	0*0*0
hsa-miR-324-3p	5′Pm0005f0f005f005f005f05f0f05m0*0*0*5	m0m000m0m0m00m0m00m0*m0*m0TEGChol
MIMAT0000762	m0*5m0*5m0*0
hsa-miR-324-5p	5′Pm005f005f00005f05f05f005f00*5m0*0*0	m0m0m000m0m0m0m0m0m00*m0*m0TEGChol
MIMAT0000761	*f0*0*0
hsa-miR-325	5′Pm005f005f005f05f05f0005f05f00*0*5m0*	m0m00m0m0m000m0m0m00*m0*m0TEGChol
MIMAT0000771	5m0*5m0*5m0*0
hsa-miR-326	5′Pm05f05f05f05f005f05f0f05f05f005f05m0*	m0m0m000m000m0m000*0*m0TEGChol
MIMAT0000756	5m0*5m0*5m0*5m0*5m0*0
hsa-miR-328	5′Pm05f05f005f0005f0f005f05f05f00*0*5m0	m0m000m0m00m0m0m0m00*0*m0TEGChol
MIMAT0000752	*0*f0*5m0*0
hsa-miR-329	5′Pm00005f0000f05f000f05m0*0*0*0*f0*0*0	m0m0m0m00m0m0m0m0m0m0m0*m0*m0TEGChol
MIMAT0001629
hsa-miR-330-3p	5′Pm005f00f0000f05f05f05f05f05m0*5m0*5	m0m0000m0m0m0m0m0m00*m0*m0TEGChol
MIMAT0000751	m0*0*5m0*0*0
hsa-miR-330-5p	5′Pm00005f05f005f05f005f05f05f00*5m0*5	m0m000m0m00m00m0m0m0*m0*m0TEGChol
MIMAT0004693	m0*0*5m0*5m0*0
hsa-miR-331-3p	5′Pm0000f05f005f0f005f05f0f00*0*5m0*0*5	m0m000m0m00m00m0m0m0*m0*m0TEGChol
MIMAT0000760	m0*5m0*0
hsa-miR-331-5p	5′Pm05f000f005f005f005f00f05m0*5m0*5m	m0m0m00m0m0m00m0m0m0m0*0*m0TEGChol
MIMAT0004700	0*0*5m0*0*0
hsa-miR-335	5′Pm05f05f05f05f005f00f005f00f05m0*0*0*	m0m0m00m0m0m00m0m000*0*m0TEGChol
MIMAT0000765	0*5m0*5m0*0
hsa-miR-335*	5′Pm0000f005f005f05f05f05f05f05m0*0*5m	m0m0000m0m00m0m0m0m0*m0*m0TEGChol
MIMAT0004703	0*0*5m0*0*0
hsa-miR-337-3p	5′Pm0005f0f005f005f005f00f00*5m0*0*5m0	m0m0m00m0m0m00m0m00m0*m0*m0TEGChol
MIMAT0000754	*5m0*0*0
hsa-miR-337-5p	5′Pm05f05f00f0005f0f0000f00*0*5m0*0*f0*	m0m0m0m0m0m00m0m0m0m00*0*m0TEGChol
MIMAT0004695	5m0*0
hsa-miR-338-3p	5′Pm05f05f05f05f00005f05f05f005f00*5m0*	m0m0m000m0m0m0m0m000*0*m0TEGChol
MIMAT0000763	5m0*5m0*5m0*0*0
hsa-miR-338-5p	5′Pm0000f0005f05f005f05f05f00*0*5m0*5m	m0m000m0m00m0m0m0m0m0*m0*m0TEGChol
MIMAT0004701	0***
hsa-miR-339-3p	5′Pm005f00f05f005f05f005f00f05m0*5m0*5	m0m0m00m0m00m00m0m00*m0*m0TEGChol
MIMAT0004702	m0*5m0*5m0*0*0
hsa-miR-339-5p	5′Pm0000f05f005f0f0000f00*0*5m0*0*5m0	m0m0m0m0m0m00m00m0m0m0*m0*m0TEGChol
MIMAT0000764	*0*0
hsa-miR-33a	5′Pm05f05f005f00005f0000f00*5m0*0*0*f0	m0m0m0m0m0m0m0m0m0m0m00*0*m0TEGChol
MIMAT0000091	*0*0
hsa-miR-33a*	5′Pm005f05f05f05f005f0f05f0005f05m0*0*5	m0m0m0m00m00m00m000*m0*m0TEGChol
MIMAT0004506	m0*0*5m0*5m0*0
hsa-miR-33b	5′Pm05f0005f005f05f0f005f05f0f05m0*0*5m	m0m000m0m000m0m0m0m0*0*m0TEGChol
MIMAT0003301	0*5m0*f0*5m0*0
hsa-miR-33b*	5′Pm05f05f05f05f05f000f05f05f05f0f05m0*5	m0m0000m0m0m00m000*0*m0TEGChol
MIMAT0004811	m0*5m0*5m0*f0*0*0
hsa-miR-340	5′Pm05f05f05f05f005f005f05f05f05f05f00*0	m0m0000m0m00m0m000*0*m0TEGChol
MIMAT0004692	*5m0*0*f0*0*0
hsa-miR-340*	5′Pm05f05f05f0f00005f05f005f0f00*0*0*5m	m0m00m00m0m0m0m0m000*0*m0TEGChol
MIMAT0000750	0*f0*0*0
hsa-miR-342-3p	5′Pm05f000f00005f005f00f05m0*0*5m0*5m	m0m0m00m0m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0000753	0*f0*5m0*0
hsa-miR-342-5p	5′Pm05f05f05f0f0005f05f05f0005f00*5m0*0	m0m0m0m00m00m0m0m000*0*m0TEGChol
MIMAT0004694	*0*f0*5m0*0
hsa-miR-345	5′Pm05f000f005f005f005f05f05f00*5m0*0*5	m0m000m0m0m00m0m0m0m0*0*m0TEGChol
MIMAT0000772	m0*5m0*0*0
hsa-miR-346	5′Pm05f0005f005f05f0f05f05f005f00*5m0*5	m0m0m000m000m0m0m0m0*0*m0TEGChol
MIMAT0000773	m0*0*5m0*5m0*0
hsa-miR-34a	5′Pm05f000f05f005f0f005f05f05f05m0*0*0*	m0m000m0m00m00m0m0m0*0*m0TEGChol
MIMAT0000255	0*f0*0*0
hsa-miR-34a*	5′Pm00005f05f05f005f0000f05m0*0*0*0*f0	m0m0m0m0m0m0m000m0m0m0*m0*m0TEGChol
MIMAT0004557	*5m0*0
hsa-miR-34b	5′Pm005f005f00005f05f05f005f00*5m0*0*0	m0m0m000m0m0m0m0m0m00*m0*m0TEGChol
MIMAT0004676	*f0*0*0
hsa-miR-34b*	5′Pm05f000f00005f05f05f005f05m0*5m0*5	m0m0m000m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0000685	m0*5m0*f0**
hsa-miR-34c-3p	5′Pm0000f0000f05f05f005f00*0*0*0*f0*0*0	m0m0m000m0m0m0m0m0m0m0*m0*m0TEGChol
MIMAT0004677
hsa-miR-34c-5p	5′Pm0000f005f05f05f005f05f0f05m0*0*5m0	m0m000m0m000m0m0m0m0*m0*m0TEGChol
MIMAT0000686	*0*5m0*5m0*0
hsa-miR-3605-3p	5′Pm05f005f05f05f000f05f000f05m0*0*0*5	m0m0m0m00m0m0m00m00m0*0*m0TEGChol
MIMAT0017982	m0*5m0*0*0
hsa-miR-3605-5p	5′Pm05f05f005f0005f05f05f0005f05m0*5m0	m0m0m0m00m00m0m0m0m00*0*m0TEGChol
MIMAT0017981	*0*5m0*5m0*0*0
hsa-miR-3606	5′Pm05f005f0f05f005f0f005f00f00*5m0*5m0	m0m0m00m0m00m00m00m0*0*m0TEGChol
MIMAT0017983	*5m0*5m0*5m0*0
hsa-miR-3607-3p	5′Pm005f05f05f05f005f0f0005f05f05m0*0*5	m0m00m0m0m00m00m000*m0*m0TEGChol
MIMAT0017985	m0*0*5m0*5m0*0
hsa-miR-3607-5p	5′Pm0000f05f005f0f05f005f0f00*0*0*0*f0*5	m0m00m00m00m00m0m0m0*m0*m0TEGChol
MIMAT0017984	m0*0
hsa-miR-3609	5′Pm05f000f005f005f00005f00*0*5m0*5m0	m0m0m0m0m0m0m00m0m0m0m0*0*m0TEGChol
MIMAT0017986	*5m0*5m0*0
hsa-miR-3610	5′Pm05f000f005f05f0f0005f0f00*5m0*5m0*	m0m00m0m0m000m0m0m0m0*0*m0TEGChol
MIMAT0017987	0*f0*0*0
hsa-miR-3611	5′Pm0000f005f05f0f05f000f00*0*5m0*0*f0*	m0m0m0m00m000m0m0m0m0*m0*m0TEGChol
MIMAT0017988	5m0*0
hsa-miR-3612	5′Pm05f05f05f05f05f05f05f05f05f0005f05m0	m0m0m0m00m0000m000*0*m0TEGChol
MIMAT0017989	*5m0*5m0****
hsa-miR-3613-3p	5′Pm005f05f05f05f05f00f00005f00*0*0*5m0	m0m0m0m0m0m0m000m000*m0*m0TEGChol
MIMAT0017991	*5m0*5m0*0
hsa-miR-3613-5p	5′Pm00005f05f05f05f0f05f05f05f05f05m0*5	m0m0000m0000m0m0m0*m0*m0TEGChol
MIMAT0017990	m0*5m0*0*5m0*0*0
hsa-miR-361-3p	5′Pm005f05f05f05f005f0f0005f05f05m0*0*5	m0m00m0m0m00m00m000*m0*m0TEGChol
MIMAT0004682	m0*0*5m0*5m0*0
hsa-miR-3614-3p	5′Pm0005f0f05f05f005f05f05f00f05m0*0*0*	m0m0m000m0m000m00m0*m0*m0TEGChol
MIMAT0017993	5m0*f0*0*0
hsa-miR-3614-5p	5′Pm005f05f05f05f005f05f00005f00*0*5m0*	m0m0m0m0m0m00m00m000*m0*m0TEGChol
MIMAT0017992	0*5m0*5m0*0
hsa-miR-3615	5′Pm005f05f05f005f00f005f05f05f00*0*0*5	m0m000m0m0m00m0m000*m0*m0TEGChol
MIMAT0017994	m0*5m0*5m0*0
hsa-miR-361-5p	5′Pm0005f0f05f05f005f05f05f00f05m0*0*0*	m0m0m000m0m000m00m0*m0*m0TEGChol
MIMAT0000703	5m0*f0*0*0
hsa-miR-3616-3p	5′Pm005f00f005f00f05f000f00*0*5m0*5m0*	m0m0m0m00m0m00m0m0m00*m0*m0TEGChol
MIMAT0017996	5m0*0*0
hsa-miR-3616-5p	5′Pm05f05f05f05f005f005f05f0005f00*5m0*	m0m0m0m00m0m00m0m000*0*m0TEGChol
MIMAT0017995	5m0*0*5m0*0*0
hsa-miR-3617	5′Pm0005f0f0005f0f05f0005f00*5m0*0*5m0	m0m0m0m00m00m0m0m00m0*m0*m0TEGChol
MIMAT0017997	*5m0*5m0*0
hsa-miR-3618	5′Pm005f05f05f0005f0f05f05f05f0f05m0*5m	m0m0000m00m0m0m000*m0*m0TEGChol
MIMAT0017998	0*0*5m0*f0*5m0*0
hsa-miR-3619	5′Pm05f05f05f0f00005f05f005f0f05m0*0*5m	m0m00m00m0m0m0m0m000*0*m0TEGChol
MIMAT0017999	0*5m0*5m0*5m0*0
hsa-miR-3620	5′Pm05f0005f05f05f00f05f05f005f05m0*5m0	m0m0m000m0m000m0m0m0*0*m0TEGChol
MIMAT0018001	*0*5m0*5m0*5m0*0
hsa-miR-3621	5′Pm05f0005f00005f005f05f05f00*5m0*5m0	m0m000m0m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0018002	*0*5m0*0*0
hsa-miR-3622a-	5′Pm05f05f05f05f05f05f05f05f05f05f05f0f05	m0m0000m0000m000*0*m0TEGChol
3p	m0*5m0*5m0*5m0*5m0*5m0*0
MIMAT0018004
hsa-miR-3622a-	5′Pm0005f0f005f05f0f05f05f05f05f05m0*0*0	m0m0000m000m0m00m0*m0*m0TEGChol
5p	*0*f0*5m0*
MIMAT0018003
hsa-miR-3622b-	5′Pm05f05f00f00005f0000f05m0*5m0*5m0*	m0m0m0m0m0m0m0m0m0m0m00*0*m0TEGChol
3p	5m0*f0*5m0*0
MIMAT0018006
hsa-miR-3622b-	5′Pm05f0005f05f005f0f05f05f05f0f05m0*5m	m0m0000m00m00m0m0m0*0*m0TEGChol
5p	0*5m0*5m0*5m0*5m0*0
MIMAT0018005
hsa-miR-362-3p	5′Pm0000f05f005f05f05f005f0f00*5m0*0*5	m0m00m00m00m00m0m0m0*m0*m0TEGChol
MIMAT0004683	m0*f0*0*0
hsa-miR-362-5p	5′Pm005f05f05f05f005f05f00005f00*0*5m0*	m0m0m0m0m0m00m00m000*m0*m0TEGChol
MIMAT0000705	0*5m0*5m0*0
hsa-miR-363	5′Pm05f000f0005f0f005f00f05m0*0*0*0*f0*	m0m0m00m0m00m0m0m0m0m0*0*m0TEGChol
MIMAT0000707	0*0
hsa-miR-363*	5′Pm05f0005f00005f005f05f05f00*5m0*5m0	m0m000m0m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0003385	*0*f0*0*0
hsa-miR-3646	5′Pm0005f05f05f05f00f005f05f05f00*5m0*0	m0m000m0m0m000m00m0*m0*m0TEGChol
MIMAT0018065	*0*f0*0*0
hsa-miR-3647-3p	5′Pm05f05f005f05f0005f05f000f00*0*5m0*0	m0m0m0m00m0m0m00m0m00*0*m0TEGChol
MIMAT0018067	*f0*0*0
hsa-miR-3647-5p	5′Pm0000f05f05f00f05f0005f05m0*0*5m0*5	m0m0m0m00m0m000m0m0m0*m0*m0TEGChol
MIMAT0018066	m0*5m0*5m0*0
hsa-miR-3648	5′Pm00005f005f05f0f05f005f0f00*5m0*5m0	m0m00m00m000m0m0m0m0*m0*m0TEGChol
MIMAT0018068	*0*f0*5m0*0
hsa-miR-3649	5′Pm0005f0f005f005f005f05f0f05m0*0*0*5	m0m000m0m0m00m0m00m0*m0*m0TEGChol
MIMAT0018069	m0*5m0*5m0*0
hsa-miR-365	5′Pm05f05f05f05f05f005f05f005f05f0f05m0*	m0m000m0m00m00m000*0*m0TEGChol
MIMAT0000710	5m0*5m0*5m0*5m0*0*0
hsa-miR-365*	5′Pm0005f0f05f0005f05f05f05f0f00*0*5m0*	m0m0000m0m0m00m00m0*m0*m0TEGChol
MIMAT0009199	0*f0*0*0
hsa-miR-3650	5′Pm05f05f05f05f005f005f0005f0f05m0*5m0	m0m00m0m0m0m00m0m000*0*m0TEGChol
MIMAT0018070	*5m0*5m0*5m0*5m0*0
hsa-miR-3651	5′Pm0000f0005f0f0005f0f05m0*5m0*0*0*f0	m0m00m0m0m00m0m0m0m0m0*m0*m0TEGChol
MIMAT0018071	*0*0
hsa-miR-3652	5′Pm05f0005f05f005f0f005f00f00*5m0*5m0	m0m0m00m0m00m00m0m0m0*0*m0TEGChol
MIMAT0018072	*0*f0*0*0
hsa-miR-3653	5′Pm0000f05f0005f05f005f0f00*0*5m0*5m0	m0m00m00m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0018073	*5m0*5m0*0
hsa-miR-3654	5′Pm00005f05f005f0f05f05f005f00*0*5m0*0	m0m0m000m00m00m0m0m0*m0*m0TEGChol
MIMAT0018074	*5m0*5m0*0
hsa-miR-3655	5′Pm05f05f00f0005f05f005f00f05m0*0*0*0*	m0m0m00m0m00m0m0m0m00*0*m0TEGChol
MIMAT0018075	f0*5m0*0
hsa-miR-3656	5′Pm0005f0f05f005f0f00005f00*5m0*5m0*0	m0m0m0m0m0m00m00m00m0*m0*m0TEGChol
MIMAT0018076	*f0*5m0*
hsa-miR-3657	5′Pm05f05f05f05f0005f05f05f05f00f05m0*0*	m0m0m000m00m0m0m000*0*m0TEGChol
MIMAT0018077	0*0*f0*0*0
hsa-miR-3658	5′Pm0000f05f05f005f0005f05f00*5m0*5m0*	m0m00m0m0m0m000m0m0m0*m0*m0TEGChol
MIMAT0018078	5m0*5m0*5m0*0
hsa-miR-3659	5′Pm05f05f00f0005f05f05f005f0f00*0*0*5m	m0m00m00m00m0m0m0m00*0*m0TEGChol
MIMAT0018080	0*f0*0*0
hsa-miR-3660	5′Pm0000f005f05f0f05f005f05f05m0*0*5m0	m0m00m00m000m0m0m0m0*m0*m0TEGChol
MIMAT0018081	*5m0*5m0*5m0*0
hsa-miR-3661	5′Pm005f00f05f005f0f05f0005f05m0*0*0*5	m0m0m0m00m00m00m0m00*m0*m0TEGChol
MIMAT0018082	m0*5m0*5m0*0
hsa-miR-3662	5′Pm05f0005f0000f05f000f00*5m0*5m0*0*f	m0m0m0m00m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0018083	0*5m0*0
hsa-miR-3663-3p	5′Pm0005f05f05f05f00f0000f00*0*0*0*f0**	m0m0m0m0m0m0m000m00m0*m0*m0TEGChol
MIMAT0018085
hsa-miR-3663-5p	5′Pm0005f0f05f05f005f05f000f05m0*0*0*5	m0m0m0m00m0m000m00m0*m0*m0TEGChol
MIMAT0018084	m0*f0*0*0
hsa-miR-3664	5′Pm00005f0005f0f0005f05f00*0*5m0*0*f0	m0m00m0m0m00m0m0m0m0m0*m0*m0TEGChol
MIMAT0018086	*5m0*0
hsa-miR-3665	5′Pm05f000f005f00f005f005f05m0*0*0*5m0	m0m0m00m0m0m00m0m0m0m0*0*m0TEGChol
MIMAT0018087	*5m0*5m0*0
hsa-miR-3666	5′Pm0000f005f05f05f05f0005f05m0*0*5m0*	m0m0m0m00m000m0m0m0m0*m0*m0TEGChol
MIMAT0018088	5m0*5m0*5m0*0
hsa-miR-3667-3p	5′Pm0000f05f0005f00005f05m0*0*5m0*0*5	m0m0m0m0m0m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0018090	m0*0*0
hsa-miR-3667-5p	5′Pm0000f05f05f05f0f05f005f05f05m0*0*0*	m0m00m00m0000m0m0m0*m0*m0TEGChol
MIMAT0018089	0*f0**
hsa-miR-3668	5′Pm0000f05f0005f05f005f0f00*5m0*5m0*5	m0m00m00m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0018091	m0*5m0*0*0
hsa-miR-3669	5′Pm05f05f05f0f0005f05f0000f00*0*5m0*0*	m0m0m0m0m0m00m0m0m000*0*m0TEGChol
MIMAT0018092	5m0*5m0*0
hsa-miR-367	5′Pm05f05f005f0005f0f0000f05m0*0*5m0*5	m0m0m0m0m0m00m0m0m0m00*0*m0TEGChol
MIMAT0000719	m0*5m0*0*0
hsa-miR-367*	5′Pm005f005f05f05f00f05f005f05f00*5m0*5	m0m00m00m0m000m0m00*m0*m0TEGChol
MIMAT0004686	m0*0*f0*5m0*0
hsa-miR-3670	5′Pm0005f05f0005f05f005f005f05m0*0*5m0	m0m0m00m0m00m0m0m00m0*m0*m0TEGChol
MIMAT0018093	*0*5m0*5m0*0
hsa-miR-3671	5′Pm0000f005f05f05f05f0005f05m0*0*5m0*	m0m0m0m00m000m0m0m0m0*m0*m0TEGChol
MIMAT0018094	5m0*5m0*5m0*0
hsa-miR-3672	5′Pm05f05f05f0f05f05f00f0005f0f00*0*0*5m	m0m00m0m0m0m000m000*0*m0TEGChol
MIMAT0018095	0*5m0*5m0*0
hsa-miR-3673	5′Pm005f005f05f005f0f005f00f00*5m0*5m0	m0m0m00m0m00m00m0m00*m0*m0TEGChol
MIMAT0018096	*5m0*f0*5m0*0
hsa-miR-3674	5′Pm0005f0f005f05f05f05f005f0f05m0*0*0*	m0m00m00m000m0m00m0*m0*m0TEGChol
MIMAT0018097	0*f0*0*0
hsa-miR-3675-3p	5′Pm005f005f05f05f005f05f05f00f00*0*0*5	m0m0m000m0m000m0m00*m0*m0TEGChol
MIMAT0018099	m0*f0*0*0
hsa-miR-3675-5p	5′Pm05f05f00f05f000f05f000f00*0*0*5m0*5	m0m0m0m00m0m0m00m0m00*0*m0TEGChol
MIMAT0018098	m0*5m0*0
hsa-miR-3676	5′Pm0000f05f005f0f05f0005f05m0*5m0*0*5	m0m0m0m00m00m00m0m0m0*m0*m0TEGChol
MIMAT0018100	m0*5m0*5m0*0
hsa-miR-3677	5′Pm005f05f05f05f005f05f05f0005f00*0*5m	m0m0m0m00m00m00m000*m0*m0TEGChol
MIMAT0018101	0*0*5m0*5m0*0
hsa-miR-3678-3p	5′Pm0005f0f05f05f005f05f005f05f05m0*5m0	m0m00m00m0m000m00m0*m0*m0TEGChol
MIMAT0018103	*5m0*5m0*f0*0*0
hsa-miR-3678-5p	5′Pm0000f05f005f0f00005f00*5m0*0*0*f0*	m0m0m0m0m0m00m00m0m0m0*m0*m0TEGChol
MIMAT0018102	0*0
hsa-miR-3679-3p	5′Pm05f05f05f05f05f05f005f05f05f05f0f05m	m0m0000m0m000m000*0*m0TEGChol
MIMAT0018105	0*5m0*5m0*5m0*5m0*5m0*0
hsa-miR-3679-5p	5′Pm0005f05f05f005f0f05f05f005f05m0*5m0	m0m0m000m00m00m00m0*m0*m0TEGChol
MIMAT0018104	*0*0*f0*0*0
hsa-miR-3680	5′Pm05f05f05f05f005f005f005f005f00*5m0*	m0m0m00m0m0m00m0m000*0*m0TEGChol
MIMAT0018106	5m0*5m0*5m0*5m0*0
hsa-miR-3680*	5′Pm05f005f05f0005f05f05f05f00f05m0*0*0	m0m0m000m00m0m0m00m0*0*m0TEGChol
MIMAT0018107	*5m0*f0**
hsa-miR-3681	5′Pm0005f05f05f05f005f005f005f00*0*0*5m	m0m0m00m0m0m000m00m0*m0*m0TEGChol
MIMAT0018108	0*5m0*0*0
hsa-miR-3681*	5′Pm05f05f005f05f0005f05f005f05f00*0*5m	m0m00m00m0m0m00m0m00*0*m0TEGChol
MIMAT0018109	0*5m0*f0*5m0*0
hsa-miR-3682	5′Pm0005f05f05f005f05f05f005f0f00*0*0*0*	m0m00m00m00m00m00m0*m0*m0TEGChol
MIMAT0018110	5m0*0*0
hsa-miR-3683	5′Pm0000f05f0005f05f005f0f00*5m0*5m0*5	m0m00m00m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0018111	m0*5m0*5m0*0
hsa-miR-3684	5′Pm0000f05f0005f0005f0f05m0*5m0*5m0*	m0m00m0m0m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0018112	5m0*5m0*5m0*0
hsa-miR-3685	5′Pm00005f05f05f005f005f05f05f00*5m0*0*	m0m000m0m0m000m0m0m0*m0*m0TEGChol
MIMAT0018113	0*f0*5m0*0
hsa-miR-3686	5′Pm0000f005f05f0f05f0005f05m0*5m0*5m	m0m0m0m00m000m0m0m0m0*m0*m0TEGChol
MIMAT0018114	0*5m0*5m0*5m0*0
hsa-miR-3687	5′Pm0000f05f05f05f0f005f00f00*5m0*5m0*	m0m0m00m0m0000m0m0m0*m0*m0TEGChol
MIMAT0018115	5m0***
hsa-miR-3688	5′Pm0000f05f0005f05f005f0f00*5m0*5m0*5	m0m00m00m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0018116	m0*5m0*5m0*0
hsa-miR-3689a-	5′Pm0005f05f005f00f005f05f05f05m0*5m0*	m0m000m0m0m00m0m00m0*m0*m0TEGChol
3p	0*5m0*5m0*0*0
MIMAT0018118
hsa-miR-3689a-	5′Pm05f05f05f0f0005f05f005f00f00*0*0*5m	m0m0m00m0m00m0m0m000*0*m0TEGChol
5p	0*f0*5m0*0
MIMAT0018117
hsa-miR-3689b	5′Pm00005f005f05f0f05f0005f00*5m0*5m0*	m0m0m0m00m000m0m0m0m0*m0*m0TEGChol
MIMAT0018180	5m0*f0*0*0
hsa-miR-3689b*	5′Pm05f005f0f05f05f00f05f005f0f05m0*0*0*	m0m00m00m0m000m00m0*0*m0TEGChol
MIMAT0018181	5m0*f0*0*0
hsa-miR-3690	5′Pm05f0005f0005f0f05f000f00*0*5m0*5m0	m0m0m0m00m00m0m0m0m0m0*0*m0TEGChol
MIMAT0018119	*f0*0*0
hsa-miR-3691	5′Pm0000f005f00f05f005f05f05m0*5m0*5m	m0m00m00m0m00m0m0m0m0*m0*m0TEGChol
MIMAT0018120	0*0*f0*0*0
hsa-miR-3692	5′Pm05f05f005f05f0005f05f005f05f00*0*5m	m0m00m00m0m0m00m0m00*0*m0TEGChol
MIMAT0018122	0*5m0*f0*5m0*0
hsa-miR-3692*	5′Pm05f05f00f05f005f05f0005f0f00*5m0*5m	m0m00m0m0m00m00m0m00*0*m0TEGChol
MIMAT0018121	0*5m0*5m0*0*0
hsa-miR-369-3p	5′Pm0005f05f05f005f0f05f05f005f05m0*5m0	m0m0m000m00m00m00m0*m0*m0TEGChol
MIMAT0000721	*5m0*0*5m0**
hsa-miR-369-5p	5′Pm005f00f05f005f05f05f05f00f05m0*0*5m	m0m0m000m00m00m0m00*m0*m0TEGChol
MIMAT0001621	0*5m0*f0*0*0
hsa-miR-370	5′Pm00005f005f05f05f05f0005f00*0*5m0*0	m0m0m0m00m000m0m0m0m0*m0*m0TEGChol
MIMAT0000722	*f0*0*0
hsa-miR-3713	5′Pm05f000f005f005f05f05f00f00*0*5m0*5	m0m0m000m0m00m0m0m0m0*0*m0TEGChol
MIMAT0018164	m0*f0*5m0*0
hsa-miR-371-3p	5′Pm05f05f05f05f05f05f05f0f05f05f005f05m	m0m0m000m0000m000*0*m0TEGChol
MIMAT0000723	0*5m0*5m0*0*5m0*0*0
hsa-miR-3714	5′Pm005f05f05f05f05f005f05f000f00*5m0*5	m0m0m0m00m0m000m000*m0*m0TEGChol
MIMAT0018165	m0*5m0*5m0*5m0*
hsa-miR-371-5p	5′Pm05f05f05f05f005f05f05f05f05f05f0f00*0	m0m0000m000m0m000*0*m0TEGChol
MIMAT0004687	*0*0*5m0*5m0*0
hsa-miR-372	5′Pm05f000f005f05f05f005f00f05m0*0*0*5	m0m0m00m0m000m0m0m0m0*0*m0TEGChol
MIMAT0000724	m0*f0*5m0*0
hsa-miR-373	5′Pm05f005f0f05f05f005f0005f05f00*5m0*0	m0m00m0m0m0m000m00m0*0*m0TEGChol
MIMAT0000726	*5m0*5m0*0*0
hsa-miR-373*	5′Pm0000f05f05f00f0005f05f00*5m0*5m0*5	m0m00m0m0m0m000m0m0m0*m0*m0TEGChol
MIMAT0000725	m0*5m0*5m0*0
hsa-miR-374a	5′Pm0005f0f05f05f05f05f05f005f0f00*5m0*0	m0m00m00m0000m00m0*m0*m0TEGChol
MIMAT0000727	*5m0*f0*5m0*0
hsa-miR-374a*	5′Pm05f05f005f005f05f0f0000f05m0*5m0*0	m0m0m0m0m0m000m0m0m00*0*m0TEGChol
MIMAT0004688	*0*f0*5m0*0
hsa-miR-374b	5′Pm05f005f0f05f05f005f05f005f05f00*5m0*	m0m00m00m0m000m00m0*0*m0TEGChol
MIMAT0004955	0*5m0*5m0*0*0
hsa-miR-374b*	5′Pm00005f005f05f05f05f0005f05m0*5m0*5	m0m0m0m00m000m0m0m0m0*m0*m0TEGChol
MIMAT0004956	m0*0*f0*0*0
hsa-miR-374c	5′Pm005f05f05f0005f05f05f05f05f0f00*5m0*	m0m0000m00m0m0m000*m0*m0TEGChol
MIMAT0018443	0*5m0*f0*0*0
hsa-miR-375	5′Pm05f05f005f05f000f005f005f00*0*5m0*5	m0m0m00m0m0m0m00m0m00*0*m0TEGChol
MIMAT0000728	m0*5m0*5m0*0
hsa-miR-376a	5′Pm05f05f00f0005f0f0005f05f05m0*0*0*5	m0m00m0m0m00m0m0m0m00*0*m0TEGChol
MIMAT0000729	m0*5m0*5m0*0
hsa-miR-376a*	5′Pm05f05f05f05f05f05f005f05f05f005f05m0	m0m0m000m0m000m000*0*m0TEGChol
MIMAT0003386	*5m0*0*5m0*5m0*5m0*0
hsa-miR-376b	5′Pm005f00f05f005f05f005f05f0f00*0*0*5m	m0m000m0m00m00m0m00*m0*m0TEGChol
MIMAT0002172	0*5m0*0*0
hsa-miR-376c	5′Pm00005f05f000f005f05f0f00*0*0*5m0*5	m0m000m0m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0000720	m0*0*0
hsa-miR-377	5′Pm0005f05f05f05f05f0f05f05f005f05m0*5	m0m0m000m0000m00m0*m0*m0TEGChol
MIMAT0000730	m0*0*0*f0*5m0*0
hsa-miR-377*	5′Pm05f000f0005f05f0005f0f00*0*0*0*f0*0	m0m00m0m0m00m0m0m0m0m0*0*m0TEGChol
MIMAT0004689	*0
hsa-miR-378	5′Pm05f05f05f0f00005f0000f00*5m0*0*5m0	m0m0m0m0m0m0m0m0m0m000*0*m0TEGChol
MIMAT0000732	*5m0*5m0*0
hsa-miR-378*	5′Pm05f05f05f0f005f005f0005f0f05m0*5m0*	m0m00m0m0m0m00m0m000*0*m0TEGChol
MIMAT0000731	0*0*5m0*5m0*0
hsa-miR-378b	5′Pm05f0005f00005f05f05f00f05m0*5m0*5	m0m0m000m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0014999	m0*0*5m0**
hsa-miR-378c	5′Pm05f005f0f005f005f0005f05f05m0*0*0*5	m0m00m0m0m0m00m0m00m0*0*m0TEGChol
MIMAT0016847	m0*f0*0*0
hsa-miR-379	5′Pm0000f05f05f005f0005f05f00*5m0*5m0*	m0m00m0m0m0m000m0m0m0*m0*m0TEGChol
MIMAT0000733	5m0*5m0*5m0*
hsa-miR-379*	5′Pm05f05f05f05f005f05f05f05f05f00f05m0*	m0m0m000m000m0m000*0*m0TEGChol
MIMAT0004690	0*5m0*5m0***
hsa-miR-380	5′Pm05f05f05f05f05f05f05f0f0000f05m0*0*5	m0m0m0m0m0m0000m000*0*m0TEGChol
MIMAT0000735	m0*5m0*5m0*5m0*
hsa-miR-380*	5′Pm05f005f05f05f005f05f00005f05m0*5m0	m0m0m0m0m0m00m00m00m0*0*m0TEGChol
MIMAT0000734	*5m0*5m0***
hsa-miR-381	5′Pm05f005f05f0000f05f0005f05m0*5m0*5	m0m0m0m00m0m0m0m0m00m0*0*m0TEGChol
MIMAT0000736	m0*5m0*f0*5m0*0
hsa-miR-382	5′Pm0005f0f05f05f05f05f0005f0f00*5m0*0*	m0m00m0m0m0000m00m0*m0*m0TEGChol
MIMAT0000737	5m0*f0*0*0
hsa-miR-383	5′Pm005f005f05f05f005f05f0005f05m0*0*5	m0m0m0m00m0m000m0m00*m0*m0TEGChol
MIMAT0000738	m0*5m0*f0*5m0*0
hsa-miR-384	5′Pm00005f0000f0000f00*0*5m0*5m0*5m0	m0m0m0m0m0m0m0m0m0m0m0m0*m0*m0TEG
MIMAT0001075	*0*0	Chol
hsa-miR-3907	5′Pm05f005f0f00005f0005f0f00*0*0*5m0*5	m0m00m0m0m0m0m0m0m00m0*0*m0TEGChol
MIMAT0018179	m0*0*0
hsa-miR-3908	5′Pm0005f0f05f05f00f05f05f00f00*5m0*0*5	m0m0m000m0m000m00m0*m0*m0TEGChol
MIMAT0018182	m0*5m0*0*0
hsa-miR-3909	5′Pm05f05f05f05f05f005f05f05f05f005f05m0	m0m0m000m00m00m000*0*m0TEGChol
MIMAT0018183	*0*0*0*f0*5m0*0
hsa-miR-3910	5′Pm0005f0f0005f05f005f00f00*0*5m0*0*5	m0m0m00m0m00m0m0m00m0*m0*m0TEGChol
MIMAT0018184	m0*0*0
hsa-miR-3911	5′Pm05f05f005f05f05f05f0f005f05f0f05m0*5	m0m000m0m0000m0m00*0*m0TEGChol
MIMAT0018185	m0*5m0*5m0*f0*5m0*0
hsa-miR-3912	5′Pm05f005f0f05f05f05f0f0005f0f00*0*0*0*	m0m00m0m0m0000m00m0*0*m0TEGChol
MIMAT0018186	5m0*5m0*0
hsa-miR-3913	5′Pm05f05f05f0f05f005f0f0000f05m0*5m0*0	m0m0m0m0m0m00m00m000*0*m0TEGChol
MIMAT0018187	*5m0*f0*5m0*0
hsa-miR-3914	5′Pm05f0005f0000f0005f0f00*0*0*5m0*5m	m0m00m0m0m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0018188	0*0*0
hsa-miR-3915	5′Pm0000f0005f05f0000f05m0*5m0*5m0*5	m0m0m0m0m0m00m0m0m0m0m0*m0*m0TEGChol
MIMAT0018189	m0*f0*0*0
hsa-miR-3916	5′Pm0000f05f0005f00005f05m0*0*5m0*0*5	m0m0m0m0m0m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0018190	m0*5m0*0
hsa-miR-3917	5′Pm05f05f005f05f000f05f05f005f00*5m0*5	m0m0m000m0m0m00m0m00*0*m0TEGChol
MIMAT0018191	m0*0*5m0*0*0
hsa-miR-3918	5′Pm005f05f05f05f05f005f05f005f05f05m0*0	m0m00m00m0m000m000*m0*m0TEGChol
MIMAT0018192	*0*0*5m0**
hsa-miR-3919	5′Pm05f0005f0000f0005f0f00*0*0*5m0*5m	m0m00m0m0m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0018193	0*0*0
hsa-miR-3920	5′Pm0005f0f05f0005f005f05f0f00*0*0*0*f0*	m0m000m0m0m0m00m00m0*m0*m0TEGChol
MIMAT0018195	0*0
hsa-miR-3921	5′Pm005f005f05f05f005f05f005f05f00*5m0*	m0m00m00m0m000m0m00*m0*m0TEGChol
MIMAT0018196	5m0*0*f0*5m0*0
hsa-miR-3922	5′Pm05f05f005f005f05f0f05f005f05f00*5m0*	m0m00m00m000m0m0m00*0*m0TEGChol
MIMAT0018197	5m0*0*5m0*5m0*0
hsa-miR-3923	5′Pm05f005f0f005f005f0005f05f05m0*0*5m	m0m00m0m0m0m00m0m00m0*0*m0TEGChol
MIMAT0018198	0*5m0*f0*0*0
hsa-miR-3924	5′Pm0000f05f005f05f005f05f05f00*5m0*0*0	m0m000m0m00m00m0m0m0*m0*m0TEGChol
MIMAT0018199	*5m0*5m0*0
hsa-miR-3925	5′Pm00005f05f05f05f0f05f0005f00*5m0*5m	m0m0m0m00m0000m0m0m0*m0*m0TEGChol
MIMAT0018200	0*5m0*5m0*0*0
hsa-miR-3926	5′Pm05f0005f005f005f0005f05f00*0*5m0*5	m0m00m0m0m0m00m0m0m0m0*0*m0TEGChol
MIMAT0018201	m0*5m0*5m0*0
hsa-miR-3927	5′Pm005f005f005f05f05f00005f00*0*0*0*f0	m0m0m0m0m0m000m0m0m00*m0*m0TEGChol
MIMAT0018202	*5m0*0
hsa-miR-3928	5′Pm00005f05f005f0f005f05f0f05m0*5m0*5	m0m000m0m00m00m0m0m0*m0*m0TEGChol
MIMAT0018205	m0*5m0*5m0*0*0
hsa-miR-3929	5′Pm0000f05f0005f05f005f0f00*5m0*5m0*5	m0m00m00m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0018206	m0*5m0*5m0*0
hsa-miR-3934	5′Pm00005f005f005f05f005f0f00*5m0*0*5m	m0m00m00m0m00m0m0m0m0*m0*m0TEGChol
MIMAT0018349	0*f0*5m0*0
hsa-miR-3935	5′Pm0005f05f05f005f05f05f0005f05m0*5m0	m0m0m0m00m00m00m00m0*m0*m0TEGChol
MIMAT0018350	*5m0*5m0*5m0*0*0
hsa-miR-3936	5′Pm005f005f05f005f0f05f0005f05m0*0*0*5	m0m0m0m00m00m00m0m00*m0*m0TEGChol
MIMAT0018351	m0*5m0*5m0*0
hsa-miR-3937	5′Pm05f005f05f005f005f0000f05m0*5m0*0*	m0m0m0m0m0m0m00m0m00m0*0*m0TEGChol
MIMAT0018352	5m0*5m0*0*
hsa-miR-3938	5′Pm0005f0f05f0005f0005f0f00*0*0*0*f0*0	m0m00m0m0m0m0m00m00m0*m0*m0TEGChol
MIMAT0018353	*0
hsa-miR-3939	5′Pm05f05f00f05f000f05f05f005f00*5m0*5m	m0m0m000m0m0m00m0m00*0*m0TEGChol
MIMAT0018355	0*0*5m0*5m0*0
hsa-miR-3940	5′Pm0000f0005f05f05f05f05f0f00*0*0*5m0*	m0m0000m00m0m0m0m0m0*m0*m0TEGChol
MIMAT0018356	5m0*5m0*0
hsa-miR-3941	5′Pm05f05f00f05f05f05f05f05f0005f05m0*5	m0m0m0m00m0000m0m00*0*m0TEGChol
MIMAT0018357	m0*0*0*f0*0*0
hsa-miR-3942	5′Pm05f0005f005f00f05f05f05f0f05m0*5m0*	m0m0000m0m00m0m0m0m0*0*m0TEGChol
MIMAT0018358	0*0*f0*5m0*0
hsa-miR-3943	5′Pm005f05f05f05f0005f0000f05m0*0*0*0*f	m0m0m0m0m0m0m0m00m000*m0*m0TEGChol
MIMAT0018359	0*5m0*0
hsa-miR-3944	5′Pm0005f0f0005f0f0000f00*5m0*5m0*0*5	m0m0m0m0m0m00m0m0m00m0*m0*m0TEGChol
MIMAT0018360	m0*0*0
hsa-miR-3945	5′Pm005f05f0f05f005f05f05f005f05f05m0*5	m0m00m00m00m00m000*m0*m0TEGChol
MIMAT0018361	m0*0*0*5m0*5m0*0
hsa-miR-409-3p	5′Pm005f05f05f00005f05f000f00*5m0*5m0*	m0m0m0m00m0m0m0m0m000*m0*m0TEGChol
MIMAT0001639	0*5m0*0*0
hsa-miR-409-5p	5′Pm05f05f005f05f05f005f05f05f00f05m0*5	m0m0m000m0m000m0m00*0*m0TEGChol
MIMAT0001638	m0*5m0*0*5m0*0*0
hsa-miR-410	5′Pm005f05f05f05f05f05f0f05f05f05f05f05m	m0m0000m0000m000*m0*m0TEGChol
MIMAT0002171	0*0*0*0*5m0*0*0
hsa-miR-411	5′Pm005f005f005f05f05f00005f00*0*0*0*f0	m0m0m0m0m0m000m0m0m00*m0*m0TEGChol
MIMAT0003329	*5m0*0
hsa-miR-411*	5′Pm0005f0f05f05f005f05f05f00f05m0*0*0*	m0m0m000m0m000m00m0*m0*m0TEGChol
MIMAT0004813	0*f0*5m0*0
hsa-miR-412	5′Pm0000f05f005f0f05f0005f00*0*0*5m0*f0	m0m0m0m00m00m00m0m0m0*m0*m0TEGChol
MIMAT0002170	*5m0*0
hsa-miR-421	5′Pm05f05f005f0000f0000f00*5m0*5m0*5m	m0m0m0m0m0m0m0m0m0m0m00*0*m0TEGChol
MIMAT0003339	0*f0*5m0*0
hsa-miR-422a	5′Pm05f000f05f05f05f05f05f05f05f05f05m0*	m0m0000m0000m0m0m0*0*m0TEGChol
MIMAT0001339	5m0*0*5m0*f0*0*0
hsa-miR-423-3p	5′Pm005f05f05f005f05f05f005f005f00*5m0*	m0m0m00m0m000m0m000*m0*m0TEGChol
MIMAT0001340	5m0*5m0*f0*5m0*0
hsa-miR-423-5p	5′Pm0005f05f005f05f0f05f005f0f05m0*5m0*	m0m00m00m000m0m00m0*m0*m0TEGChol
MIMAT0004748	0*0*f0*5m0*0
hsa-miR-424	5′Pm05f05f005f0000f0000f00*5m0*5m0*5m	m0m0m0m0m0m0m0m0m0m0m00*0*m0TEGChol
MIMAT0001341	0*f0*5m0*0
hsa-miR-424*	5′Pm05f000f05f005f05f05f005f05f05m0*0*5	m0m00m00m00m00m0m0m0*0*m0TEGChol
MIMAT0004749	m0*5m0*5m0*5m0*0
hsa-miR-425	5′Pm005f005f0000f0000f05m0*5m0*5m0*5	m0m0m0m0m0m0m0m0m0m0m00*m0*m0TEGChol
MIMAT0003393	m0*f0*5m0*0
hsa-miR-425*	5′Pm05f05f005f005f00f00005f00*0*5m0*5m	m0m0m0m0m0m0m00m0m0m00*0*m0TEGChol
MIMAT0001343	0*5m0*5m0*0
hsa-miR-4251	5′Pm0000f0000f0000f00*0*0*5m0*f0*0*0	m0m0m0m0m0m0m0m0m0m0m0m0*m0*m0TEG
MIMAT0016883		Chol
hsa-miR-4252	5′Pm0005f0f005f005f05f05f05f0f00*5m0*5m	m0m0000m0m00m0m00m0*m0*m0TEGChol
MIMAT0016886	0*0*f0*5m0*0
hsa-miR-4253	5′Pm005f05f05f05f05f05f05f05f05f05f05f05	m0m0000m0000m000*m0*m0TEGChol
MIMAT0016882	m0*5m0*5m0*5m0*5m0*5m0*
hsa-miR-4254	5′Pm005f05f05f05f0005f0005f0f00*5m0*0*0	m0m00m0m0m0m0m00m000*m0*m0TEGChol
MIMAT0016884	*5m0*0*0
hsa-miR-4255	5′Pm05f05f05f05f05f005f05f005f05f05f00*0	m0m000m0m00m00m000*0*m0TEGChol
MIMAT0016885	*0*5m0*f0*5m0*0
hsa-miR-4256	5′Pm05f005f05f0005f05f00005f05m0*5m0*5	m0m0m0m0m0m00m0m0m00m0*0*m0TEGChol
MIMAT0016877	m0*5m0*f0*5m0*0
hsa-miR-4257	5′Pm05f05f05f05f0005f05f05f05f005f00*0*5	m0m0m000m00m0m0m000*0*m0TEGChol
MIMAT0016878	m0*5m0*5m0*5m0*0
hsa-miR-4258	5′Pm005f005f05f05f005f0005f0f00*0*5m0*5	m0m00m0m0m0m000m0m00*m0*m0TEGChol
MIMAT0016879	m0*5m0*5m0*0
hsa-miR-4259	5′Pm05f05f00f05f000f0005f0f00*5m0*5m0*	m0m00m0m0m0m0m00m0m00*0*m0TEGChol
MIMAT0016880	***
hsa-miR-4260	5′Pm0000f05f0005f05f005f0f00*0*5m0*5m0	m0m00m00m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0016881	*5m0*5m0*0
hsa-miR-4261	5′Pm0005f05f0000f05f05f00f05m0*5m0*0*5	m0m0m000m0m0m0m0m00m0*m0*m0TEGChol
MIMAT0016890	m0*f0*0*0
hsa-miR-4262	5′Pm05f0005f05f000f05f000f05m0*0*0*0*f0	m0m0m0m00m0m0m00m0m0m0*0*m0TEGChol
MIMAT0016894	*5m0*0
hsa-miR-4263	5′Pm05f05f05f05f05f05f05f05f05f05f005f05	m0m0m000m0000m000*0*m0TEGChol
MIMAT0016898	m0*0*5m0*0*5m0*5m0*0
hsa-miR-4264	5′Pm05f005f0f005f005f00005f05m0*5m0*0*	m0m0m0m0m0m0m00m0m00m0*0*m0TEGChol
MIMAT0016899	0*5m0*5m0*0
hsa-miR-4265	5′Pm0005f05f0005f0f0005f0f05m0*0*5m0*5	m0m00m0m0m00m0m0m00m0*m0*m0TEGChol
MIMAT0016891	m0*f0*5m0*0
hsa-miR-4266	5′Pm05f05f05f05f00005f05f0005f05m0*5m0	m0m0m0m00m0m0m0m0m000*0*m0TEGChol
MIMAT0016892	*5m0*0*f0**
hsa-miR-4267	5′Pm05f05f005f0005f05f05f000f00*0*5m0*0	m0m0m0m00m00m0m0m0m00*0*m0TEGChol
MIMAT0016893	*f0*5m0*0
hsa-miR-4268	5′Pm0000f05f0005f00005f05m0*0*5m0*0*5	m0m0m0m0m0m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0016896	m0*0*0
hsa-miR-4269	5′Pm0000f05f0005f05f005f0f00*5m0*5m0*5	m0m00m00m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0016897	m0*5m0*5m0*0
hsa-miR-4270	5′Pm005f00f005f05f05f05f05f005f05m0*5m0	m0m0m000m000m0m0m00*m0*m0TEGChol
MIMAT0016900	*5m0*5m0*5m0*5m0*0
hsa-miR-4271	5′Pm005f05f05f005f00f0005f05f00*0*5m0*5	m0m00m0m0m0m00m0m000*m0*m0TEGChol
MIMAT0016901	m0*5m0*5m0*0
hsa-miR-4272	5′Pm0005f05f005f05f0f005f05f05f05m0*0*5	m0m000m0m000m0m00m0*m0*m0TEGChol
MIMAT0016902	m0*5m0*f0*5m0*0
hsa-miR-4273	5′Pm0005f0f005f05f05f005f00f05m0*5m0*0	m0m0m00m0m000m0m00m0*m0*m0TEGChol
MIMAT0016903	*5m0*f0*0*0
hsa-miR-4274	5′Pm05f05f005f0005f05f05f05f05f0f00*5m0*	m0m0000m00m0m0m0m00*0*m0TEGChol
MIMAT0016906	5m0*0*5m0*5m0*0
hsa-miR-4275	5′Pm0000f00005f00005f00*5m0*0*0*5m0**	m0m0m0m0m0m0m0m0m0m0m0m0*m0*m0TEG
MIMAT0016905		Chol
hsa-miR-4276	5′Pm005f00f005f00f05f000f00*5m0*0*0*f0*	m0m0m0m00m0m00m0m0m00*m0*m0TEGChol
MIMAT0016904	0*0
hsa-miR-4277	5′Pm0000f005f05f05f0005f0f00*0*5m0*0*5	m0m00m0m0m000m0m0m0m0*m0*m0TEGChol
MIMAT0016908	m0*5m0*0
hsa-miR-4278	5′Pm0005f05f05f0005f0000f00*5m0*0*0***	m0m0m0m0m0m0m0m00m00m0*m0*m0TEGChol
MIMAT0016910
hsa-miR-4279	5′Pm005f00f05f005f05f005f00f05m0*0*0*5	m0m0m00m0m00m00m0m00*m0*m0TEGChol
MIMAT0016909	m0*5m0*0*0
hsa-miR-4280	5′Pm00005f0005f0f05f05f005f05m0*0*0*5m	m0m0m000m00m0m0m0m0m0*m0*m0TEGChol
MIMAT0016911	0*5m0*0*0
hsa-miR-4281	5′Pm0000f05f005f05f05f005f0f00*0*5m0*5	m0m00m00m00m00m0m0m0*m0*m0TEGChol
MIMAT0016907	m0*5m0*5m0*0
hsa-miR-4282	5′Pm005f05f0f05f05f00f05f05f005f00*5m0*0	m0m0m000m0m000m000*m0*m0TEGChol
MIMAT0016912	*0*5m0*5m0*0
hsa-miR-4283	5′Pm0000f05f005f05f05f005f0f00*0*5m0*5	m0m00m00m00m00m0m0m0*m0*m0TEGChol
MIMAT0016914	m0*5m0*5m0*0
hsa-miR-4284	5′Pm0000f05f005f0f0000f00*0*5m0*0*5m0	m0m0m0m0m0m00m00m0m0m0*m0*m0TEGChol
MIMAT0016915	*0*0
hsa-miR-4285	5′Pm0000f05f05f005f05f05f05f05f00*0*5m0	m0m0000m0m000m0m0m0*m0*m0TEGChol
MIMAT0016913	*0*f0*0*0
hsa-miR-4286	5′Pm05f05f05f05f00005f05f005f05f05m0*5m	m0m00m00m0m0m0m0m000*0*m0TEGChol
MIMAT0016916	0*0*0*f0*5m0*0
hsa-miR-4287	5′Pm005f005f05f05f00f05f05f05f0f05m0*5m	m0m0000m0m000m0m00*m0*m0TEGChol
MIMAT0016917	0*0*0*5m0*0*0
hsa-miR-4288	5′Pm05f000f005f00f005f00f00*0*0*0*5m0*	m0m0m00m0m0m00m0m0m0m0*0*m0TEGChol
MIMAT0016918	5m0*0
hsa-miR-4289	5′Pm05f05f00f005f05f05f0000f05m0*5m0*0	m0m0m0m0m0m000m0m0m00*0*m0TEGChol
MIMAT0016920	*0*f0*0*0
hsa-miR-429	5′Pm005f05f05f05f05f00f00005f05m0*5m0*	m0m0m0m0m0m0m000m000*m0*m0TEGChol
MIMAT0001536	0*0*f0*5m0*0
hsa-miR-4290	5′Pm05f005f0f05f0005f05f05f005f05m0*0*5	m0m0m000m0m0m00m00m0*0*m0TEGChol
MIMAT0016921	m0*5m0*5m0*5m0*0
hsa-miR-4291	5′Pm0000f005f005f05f05f005f00*0*5m0*5m	m0m0m000m0m00m0m0m0m0*m0*m0TEGChol
MIMAT0016922	0*5m0*5m0*0
hsa-miR-4292	5′Pm05f000f005f00f005f00f00*0*0*0*5m0*	m0m0m00m0m0m00m0m0m0m0*0*m0TEGChol
MIMAT0016919	5m0*0
hsa-miR-4293	5′Pm0000f005f00f05f05f005f00*0*0*5m0*5	m0m0m000m0m00m0m0m0m0*m0*m0TEGChol
MIMAT0016848	m0*5m0*0
hsa-miR-4294	5′Pm0005f0f005f00f00005f00*0*5m0*5m0*	m0m0m0m0m0m0m00m0m00m0*m0*m0TEGChol
MIMAT0016849	5m0*5m0*0
hsa-miR-4295	5′Pm0005f0f005f005f0005f05f00*0*5m0*5m	m0m00m0m0m0m00m0m00m0*m0*m0TEGChol
MIMAT0016844	0*f0*0*0
hsa-miR-4296	5′Pm05f05f05f05f0005f05f05f05f00f00*5m0*	m0m0m000m00m0m0m000*0*m0TEGChol
MIMAT0016845	5m0*5m0*5m0*0*0
hsa-miR-4297	5′Pm05f005f05f0005f05f005f00f05m0*0*0*0	m0m0m00m0m00m0m0m00m0*0*m0TEGChol
MIMAT0016846	*f0*0*0
hsa-miR-4298	5′Pm0005f0f0000f05f05f05f0f05m0*5m0*0*	m0m0000m0m0m0m0m00m0*m0*m0TEGChol
MIMAT0016852	5m0*f0*5m0*0
hsa-miR-4299	5′Pm0000f05f05f05f0f05f0005f00*0*0*0***	m0m0m0m00m0000m0m0m0*m0*m0TEGChol
MIMAT0016851
hsa-miR-4300	5′Pm005f005f05f005f05f05f0005f00*0*5m0*	m0m0m0m00m00m00m0m00*m0*m0TEGChol
MIMAT0016853	5m0*f0*5m0*0
hsa-miR-4301	5′Pm05f05f00f0005f05f0000f05m0*0*5m0*0	m0m0m0m0m0m00m0m0m0m00*0*m0TEGChol
MIMAT0016850	*f0*5m0*0
hsa-miR-4302	5′Pm05f05f05f05f005f005f05f005f05f05m0*0	m0m00m00m0m00m0m000*0*m0TEGChol
MIMAT0016855	*5m0*5m0*5m0*5m0*0
hsa-miR-4303	5′Pm0005f0f05f0005f005f05f05f05m0*5m0*	m0m000m0m0m0m00m00m0*m0*m0TEGChol
MIMAT0016856	5m0*5m0*5m0**
hsa-miR-4304	5′Pm0000f005f00f005f00f05m0*0*0*0*f0*0	m0m0m00m0m0m00m0m0m0m0*m0*m0TEGChol
MIMAT0016854	*0
hsa-miR-4305	5′Pm005f05f0f05f05f00f05f05f005f05m0*0*0	m0m0m000m0m000m000*m0*m0TEGChol
MIMAT0016857	*0*5m0*0*0
hsa-miR-4306	5′Pm005f05f05f005f00f005f05f05f00*0*5m0	m0m000m0m0m00m0m000*m0*m0TEGChol
MIMAT0016858	*5m0*5m0*5m0*0
hsa-miR-4307	5′Pm05f005f0f005f05f05f0005f05f05m0*5m0	m0m00m0m0m000m0m00m0*0*m0TEGChol
MIMAT0016860	*5m0*0*5m0*5m0*0
hsa-miR-4308	5′Pm005f00f05f005f05f005f05f0f00*5m0*0*	m0m000m0m00m00m0m00*m0*m0TEGChol
MIMAT0016861	5m0*5m0*0*
hsa-miR-4309	5′Pm0005f05f05f05f00f05f05f05f0f05m0*0*5	m0m0000m0m000m00m0*m0*m0TEGChol
MIMAT0016859	m0*5m0*5m0*5m0*0
hsa-miR-431	5′Pm0000f05f000f05f000f00*0*0*0*f0*0*	m0m0m0m00m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0001625
hsa-miR-431*	5′Pm00005f05f05f05f05f05f05f00f00*5m0*5	m0m0m000m0000m0m0m0*m0*m0TEGChol
MIMAT0004757	m0*5m0*5m0*5m0*0
hsa-miR-4310	5′Pm0000f05f005f05f05f005f0f00*5m0*0*5	m0m00m00m00m00m0m0m0*m0*m0TEGChol
MIMAT0016862	m0*f0*0*0
hsa-miR-4311	5′Pm005f05f0f05f005f05f05f005f05f05m0*5	m0m00m00m00m00m000*m0*m0TEGChol
MIMAT0016863	m0*0*0*5m0*5m0*0
hsa-miR-4312	5′Pm05f05f005f0000f05f05f05f0f05m0*5m0*	m0m0000m0m0m0m0m0m00*0*m0TEGChol
MIMAT0016864	5m0*5m0*f0*0*0
hsa-miR-4313	5′Pm005f05f0f0005f05f0005f05f00*5m0*0*0	m0m00m0m0m00m0m0m000*m0*m0TEGChol
MIMAT0016865	*f0*0*0
hsa-miR-4314	5′Pm05f000f005f05f0f05f0005f05m0*0*5m0	m0m0m0m00m000m0m0m0m0*0*m0TEGChol
MIMAT0016868	*5m0*5m0*5m0*0
hsa-miR-4315	5′Pm05f000f005f05f0f0000f00*5m0*0*5m0*	m0m0m0m0m0m000m0m0m0m0*0*m0TEGChol
MIMAT0016866	5m0*5m0*0
hsa-miR-4316	5′Pm005f05f0f005f005f05f05f005f05m0*0*0	m0m0m000m0m00m0m000*m0*m0TEGChol
MIMAT0016867	*5m0*5m0*5m0*0
hsa-miR-4317	5′Pm05f005f0f0005f05f05f000f05m0*5m0*5	m0m0m0m00m00m0m0m00m0*0*m0TEGChol
MIMAT0016872	m0*0***
hsa-miR-4318	5′Pm05f05f00f005f05f05f0000f00*5m0*0*0*	m0m0m0m0m0m000m0m0m00*0*m0TEGChol
MIMAT0016869	f0*0*
hsa-miR-4319	5′Pm05f05f00f005f05f05f0000f05m0*5m0*0	m0m0m0m0m0m000m0m0m00*0*m0TEGChol
MIMAT0016870	*0*f0*0*0
hsa-miR-432	5′Pm005f05f05f05f05f05f05f005f05f05f00*5	m0m000m0m0000m000*m0*m0TEGChol
MIMAT0002814	m0*0****
hsa-miR-432*	5′Pm05f05f005f005f05f0f05f000f05m0*0*5m	m0m0m0m00m000m0m0m00*0*m0TEGChol
MIMAT0002815	0*5m0*5m0*0*0
hsa-miR-4320	5′Pm05f0005f0000f005f05f0f05m0*5m0*5m	m0m000m0m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0016871	0*5m0*f0*0*0
hsa-miR-4321	5′Pm0000f05f05f00f0000f05m0*0*5m0*5m0	m0m0m0m0m0m0m000m0m0m0*m0*m0TEGChol
MIMAT0016874	*f0*0*0
hsa-miR-4322	5′Pm0005f0f0005f05f005f00f00*0*5m0*0*5	m0m0m00m0m00m0m0m00m0*m0*m0TEGChol
MIMAT0016873	m0*0*0
hsa-miR-4323	5′Pm0000f05f005f05f05f005f0f00*5m0*0*5	m0m00m00m00m00m0m0m0*m0*m0TEGChol
MIMAT0016875	m0*f0*0*0
hsa-miR-4324	5′Pm05f05f005f0005f0f05f000f05m0*0*5m0	m0m0m0m00m00m0m0m0m00*0*m0TEGChol
MIMAT0016876	*5m0*5m0*5m0*0
hsa-miR-4325	5′Pm00005f005f00f05f0005f00*0*0*0*f0**	m0m0m0m00m0m00m0m0m0m0*m0*m0TEGChol
MIMAT0016887
hsa-miR-4326	5′Pm0005f05f005f05f0f05f0005f00*5m0*5m	m0m0m0m00m000m0m00m0*m0*m0TEGChol
MIMAT0016888	0*0*f0*5m0*0
hsa-miR-4327	5′Pm05f000f005f00f0000f00*0*0*0*f0*0*0	m0m0m0m0m0m0m00m0m0m0m0*0*m0TEGChol
MIMAT0016889
hsa-miR-4328	5′Pm05f000f05f000f005f05f05f05m0*0*5m0	m0m000m0m0m0m00m0m0m0*0*m0TEGChol
MIMAT0016926	*0*5m0*0*0
hsa-miR-4329	5′Pm05f0005f005f05f0f05f000f00*5m0*0*5	m0m0m0m00m000m0m0m0m0*0*m0TEGChol
MIMAT0016923	m0*5m0*5m0*0
hsa-miR-433	5′Pm05f05f005f00005f005f05f05f05m0*5m0	m0m000m0m0m0m0m0m0m00*0*m0TEGChol
MIMAT0001627	*5m0*0*f0*5m0*0
hsa-miR-4330	5′Pm005f005f0005f0f05f0005f05m0*5m0*0*	m0m0m0m00m00m0m0m0m00*m0*m0TEGChol
MIMAT0016924	5m0*5m0*0*0
hsa-miR-448	5′Pm05f05f00f05f0005f005f00f00*0*0*0*5m	m0m0m00m0m0m0m00m0m00*0*m0TEGChol
MIMAT0001532	0**
hsa-miR-449a	5′Pm005f005f0005f0f05f0005f05m0*5m0*0*	m0m0m0m00m00m0m0m0m00*m0*m0TEGChol
MIMAT0001541	5m0*f0*5m0*0
hsa-miR-449b	5′Pm0005f05f0005f05f005f00f00*0*5m0*0*	m0m0m00m0m00m0m0m00m0*m0*m0TEGChol
MIMAT0003327	5m0*0*0
hsa-miR-449b*	5′Pm05f005f0f05f0005f0000f05m0*0*0*0*5	m0m0m0m0m0m0m0m00m00m0*0*m0TEGChol
MIMAT0009203	m0*5m0*0
hsa-miR-449c	5′Pm0000f05f005f05f05f05f05f05f05m0*0*0	m0m0000m00m00m0m0m0*m0*m0TEGChol
MIMAT0010251	*0*5m0*0*0
hsa-miR-449c*	5′Pm0005f05f05f005f05f00005f05m0*0*0*5	m0m0m0m0m0m00m00m00m0*m0*m0TEGChol
MIMAT0013771	m0*f0*5m0*0
hsa-miR-450a	5′Pm0005f0f05f05f00f05f05f00f05m0*0*0*0	m0m0m000m0m000m00m0*m0*m0TEGChol
MIMAT0001545	*5m0*5m0*0
hsa-miR-450b-3p	5′Pm05f005f0f05f05f05f0f05f05f05f0f00*5m	m0m0000m0000m00m0*0*m0TEGChol
MIMAT0004910	0*5m0*5m0*5m0*5m0*0
hsa-miR-450b-5p	5′Pm05f005f0f05f005f0f05f0005f00*0*5m0*	m0m0m0m00m00m00m00m0*0*m0TEGChol
MIMAT0004909	0*f0*5m0*0
hsa-miR-451	5′Pm05f05f05f05f05f05f05f0f05f05f005f05m	m0m0m000m0000m000*0*m0TEGChol
MIMAT0001631	0*5m0*5m0*5m0*5m0*0*0
hsa-miR-452	5′Pm0000f05f0005f00005f00*0*5m0*0*5m0	m0m0m0m0m0m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0001635	*5m0*0
hsa-miR-452*	5′Pm0005f05f0000f0000f00*0*5m0*0*5m0*	m0m0m0m0m0m0m0m0m0m00m0*m0*m0TEGChol
MIMAT0001636	5m0*0
hsa-miR-454	5′Pm005f005f0000f005f00f00*5m0*5m0*5m	m0m0m00m0m0m0m0m0m0m00*m0*m0TEGChol
MIMAT0003885	0*5m0*5m0*0
hsa-miR-454*	5′Pm05f05f00f05f05f05f05f05f05f05f05f00*0	m0m0000m0000m0m00*0*m0TEGChol
MIMAT0003884	*5m0*5m0*f0*0*0
hsa-miR-455-3p	5′Pm00005f05f005f05f05f005f0f00*5m0*0*0	m0m00m00m00m00m0m0m0*m0*m0TEGChol
MIMAT0004784	*f0*5m0*0
hsa-miR-455-5p	5′Pm05f000f0000f05f0005f05m0*0*5m0*5m	m0m0m0m00m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0003150	0*f0*0*0
hsa-miR-466	5′Pm0000f005f05f0f0000f00*0*5m0*0*5m0	m0m0m0m0m0m000m0m0m0m0*m0*m0TEGChol
MIMAT0015002	*0*0
hsa-miR-483-3p	5′Pm0000f05f0005f00005f05m0*0*5m0*0*5	m0m0m0m0m0m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0002173	m0*0*0
hsa-miR-483-5p	5′Pm05f05f00f05f000f05f005f05f05m0*0*5m	m0m00m00m0m0m00m0m00*0*m0TEGChol
MIMAT0004761	0*5m0*f0*0*0
hsa-miR-484	5′Pm05f05f05f0f05f005f05f05f0005f05m0*5	m0m0m0m00m00m00m000*0*m0TEGChol
MIMAT0002174	m0*5m0*0*5m0*5m0*0
hsa-miR-485-3p	5′Pm0005f05f05f05f05f05f05f05f05f05f00*0	m0m0000m0000m00m0*m0*m0TEGChol
MIMAT0002176	*0*0*5m0*0*0
hsa-miR-485-5p	5′Pm05f05f05f0f05f005f05f05f05f05f05f00*0	m0m0000m00m00m000*0*m0TEGChol
MIMAT0002175	*0*0*5m0*0*0
hsa-miR-486-3p	5′Pm0005f05f005f00f05f05f05f05f05m0*5m0	m0m0000m0m00m0m00m0*m0*m0TEGChol
MIMAT0004762	*0*0*f0*0*0
hsa-miR-486-5p	5′Pm00005f05f05f05f0f0005f0f00*0*0*0*f0*	m0m00m0m0m0000m0m0m0*m0*m0TEGChol
MIMAT0002177	5m0*0
hsa-miR-487a	5′Pm005f05f05f05f000f00005f00*5m0*5m0*	m0m0m0m0m0m0m0m00m000*m0*m0TEGChol
MIMAT0002178	0*5m0*5m0*0
hsa-miR-487b	5′Pm0000f005f05f0f0005f05f00*5m0*5m0*5	m0m00m0m0m000m0m0m0m0*m0*m0TEGChol
MIMAT0003180	m0*5m0**
hsa-miR-488	5′Pm05f05f05f0f05f05f005f05f05f05f0f05m0	m0m0000m0m000m000*0*m0TEGChol
MIMAT0004763	*5m0*5m0*0*5m0*0*0
hsa-miR-488*	5′Pm005f05f0f05f000f05f005f0f00*5m0*0*0	m0m00m00m0m0m00m000*m0*m0TEGChol
MIMAT0002804	*5m0*5m0*0
hsa-miR-489	5′Pm0005f0f05f05f05f05f00005f00*5m0*5m	m0m0m0m0m0m0000m00m0*m0*m0TEGChol
MIMAT0002805	0*5m0*f0*0*0
hsa-miR-490-3p	5′Pm0005f0f0000f05f05f005f00*0*5m0*5m0	m0m0m000m0m0m0m0m00m0*m0*m0TEGChol
MIMAT0002806	*f0*5m0*0
hsa-miR-490-5p	5′Pm005f05f05f05f05f005f0005f05f05m0*5m	m0m00m0m0m0m000m000*m0*m0TEGChol
MIMAT0004764	0*5m0*0*f0*5m0*0
hsa-miR-491-3p	5′Pm05f005f0f0000f0000f00*0*5m0*5m0*5	m0m0m0m0m0m0m0m0m0m00m0*0*m0TEGChol
MIMAT0004765	m0*5m0*0
hsa-miR-491-5p	5′Pm05f0005f005f00f05f05f05f0f00*5m0*0*	m0m0000m0m00m0m0m0m0*0*m0TEGChol
MIMAT0002807	0*f0**
hsa-miR-492	5′Pm0005f05f0005f0f05f005f05f05m0*0*5m	m0m00m00m00m0m0m00m0*m0*m0TEGChol
MIMAT0002812	0*0*f0*0*0
hsa-miR-493	5′Pm0005f05f0000f0005f0f00*5m0*5m0*0*	m0m00m0m0m0m0m0m0m00m0*m0*m0TEGChol
MIMAT0003161	5m0*0*0
hsa-miR-493*	5′Pm05f05f05f0f0005f05f0000f00*5m0*0*0*	m0m0m0m0m0m00m0m0m000*0*m0TEGChol
MIMAT0002813	**
hsa-miR-494	5′Pm05f05f00f05f005f0f0000f05m0*0*0*5m	m0m0m0m0m0m00m00m0m00*0*m0TEGChol
MIMAT0002816	0*f0*0*0
hsa-miR-495	5′Pm005f005f05f005f05f005f05f0f05m0*5m0	m0m000m0m00m00m0m00*m0*m0TEGChol
MIMAT0002817	*0*5m0*5m0*0*0
hsa-miR-496	5′Pm05f0005f005f005f05f05f00f00*0*5m0*0	m0m0m000m0m00m0m0m0m0*0*m0TEGChol
MIMAT0002818	***
hsa-miR-497	5′Pm05f05f05f05f05f000f0005f05f00*5m0*5	m0m00m0m0m0m0m00m000*0*m0TEGChol
MIMAT0002820	m0*5m0*f0*5m0*0
hsa-miR-497*	5′Pm0005f0f05f05f05f05f00005f05m0*0*0*5	m0m0m0m0m0m0000m00m0*m0*m0TEGChol
MIMAT0004768	m0*5m0*5m0*0
hsa-miR-498	5′Pm05f05f00f005f005f05f05f05f05f00*0*5m	m0m0000m0m00m0m0m00*0*m0TEGChol
MIMAT0002824	0*5m0*5m0**
hsa-miR-499-3p	5′Pm0000f0000f00005f00*0*5m0*0***	m0m0m0m0m0m0m0m0m0m0m0m0*m0*m0TEG
MIMAT0004772		Chol
hsa-miR-499-5p	5′Pm0005f0f005f005f00005f00*0*0*5m0*5	m0m0m0m0m0m0m00m0m00m0*m0*m0TEGChol
MIMAT0002870	m0*0*0
hsa-miR-500a	5′Pm05f05f00f05f05f05f05f05f05f05f05f00*0	m0m0000m0000m0m00*0*m0TEGChol
MIMAT0004773	*5m0*5m0*f0*0*0
hsa-miR-500a*	5′Pm0000f005f005f05f05f05f0f00*0*0*0*f0*	m0m0000m0m00m0m0m0m0*m0*m0TEGChol
MIMAT0002871	5m0*0
hsa-miR-500b	5′Pm0005f0f005f05f0f005f05f05f00*5m0*0*	m0m000m0m000m0m00m0*m0*m0TEGChol
MIMAT0016925	5m0*f0*0*0
hsa-miR-501-3p	5′Pm005f05f05f05f05f05f0f00005f05m0*5m0	m0m0m0m0m0m0000m000*m0*m0TEGChol
MIMAT0004774	*0*5m0*f0*0*0
hsa-miR-501-5p	5′Pm005f00f05f005f05f005f005f00*0*0*0*5	m0m0m00m0m00m00m0m00*m0*m0TEGChol
MIMAT0002872	m0*5m0*0
hsa-miR-502-3p	5′Pm0000f05f005f0f00005f05m0*0*0*0*f0*	m0m0m0m0m0m00m00m0m0m0*m0*m0TEGChol
MIMAT0004775	5m0*0
hsa-miR-502-5p	5′Pm005f05f05f005f005f00005f00*5m0*5m0	m0m0m0m0m0m0m00m0m000*m0*m0TEGChol
MIMAT0002873	*5m0*f0*0*0
hsa-miR-503	5′Pm05f05f005f05f05f005f005f05f05f05m0*0	m0m000m0m0m000m0m00*0*m0TEGChol
MIMAT0002874	*5m0*0*f0*5m0*0
hsa-miR-504	5′Pm005f005f05f05f005f05f005f05f00*5m0*	m0m00m00m0m000m0m00*m0*m0TEGChol
MIMAT0002875	5m0*0*f0*5m0*0
hsa-miR-505	5′Pm005f05f0f00005f05f05f005f00*0*0*0*f0	m0m0m000m0m0m0m0m000*m0*m0TEGChol
MIMAT0002876	*5m0*0
hsa-miR-505*	5′Pm005f005f05f005f0f005f05f0f05m0*5m0*	m0m000m0m00m00m0m00*m0*m0TEGChol
MIMAT0004776	5m0*0*f0*0*0
hsa-miR-506	5′Pm005f05f05f05f05f00f05f005f0f00*0*0*0	m0m00m00m0m000m000*m0*m0TEGChol
MIMAT0002878	*f0*5m0*0
hsa-miR-507	5′Pm05f0005f05f0005f05f05f05f05f00*5m0*	m0m0000m0m0m00m0m0m0*0*m0TEGChol
MIMAT0002879	5m0*5m0*5m0**
hsa-miR-508-3p	5′Pm05f05f05f05f05f005f0f05f05f00f00*0*0*	m0m0m000m00m00m000*0*m0TEGChol
MIMAT0002880	5m0*5m0*5m0*0
hsa-miR-508-5p	5′Pm005f05f0f05f000f05f0005f00*0*5m0*0*	m0m0m0m00m0m0m00m000*m0*m0TEGChol
MIMAT0004778	f0*5m0*0
hsa-miR-509-3-5p	5′Pm005f005f05f05f05f05f05f05f05f05f00*5	m0m0000m0000m0m00*m0*m0TEGChol
MIMAT0004975	m0*5m0*5m0*5m0*5m0*
hsa-miR-509-3p	5′Pm05f000f0000f0000f05m0*5m0*5m0*0*f	m0m0m0m0m0m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0002881	0*5m0*0
hsa-miR-509-5p	5′Pm005f05f05f0000f00005f00*0*5m0*0*f0	m0m0m0m0m0m0m0m0m0m000*m0*m0TEGChol
MIMAT0004779	*5m0*0
hsa-miR-510	5′Pm05f05f005f005f05f0f005f05f05f00*5m0*	m0m000m0m000m0m0m00*0*m0TEGChol
MIMAT0002882	5m0*0*f0*0*0
hsa-miR-511	5′Pm005f05f05f05f05f05f05f005f00f05m0*0*	m0m0m00m0m0000m000*m0*m0TEGChol
MIMAT0002808	5m0*5m0*f0*5m0*0
hsa-miR-512-3p	5′Pm005f05f0f05f005f05f05f05f05f05f05m0*	m0m0000m00m00m000*m0*m0TEGChol
MIMAT0002823	5m0*5m0*5m0*5m0*0*0
hsa-miR-512-5p	5′Pm005f05f05f05f05f05f05f05f005f05f00*0	m0m00m00m0000m000*m0*m0TEGChol
MIMAT0002822	*0*0*f0*5m0*0
hsa-miR-513a-3p	5′Pm005f00f05f05f00f05f05f00f05m0*5m0*0	m0m0m000m0m000m0m00*m0*m0TEGChol
MIMAT0004777	*0*f0*0*0
hsa-miR-513a-5p	5′Pm05f05f05f0f05f000f05f000f00*0*5m0*5	m0m0m0m00m0m0m00m000*0*m0TEGChol
MIMAT0002877	m0*5m0*5m0*0
hsa-miR-513b	5′Pm0005f05f05f000f005f05f0f05m0*5m0*0	m0m000m0m0m0m00m00m0*m0*m0TEGChol
MIMAT0005788	*0*f0*0*0
hsa-miR-513c	5′Pm05f005f05f05f05f05f05f005f05f05f05m0	m0m000m0m0000m00m0*0*m0TEGChol
MIMAT0005789	*0*5m0*0*f0*5m0*0
hsa-miR-514	5′Pm05f000f05f05f00f005f05f0f05m0*0*5m0	m0m000m0m0m000m0m0m0*0*m0TEGChol
MIMAT0002883	*5m0*f0*5m0*0
hsa-miR-514b-3p	5′Pm05f000f0005f0f05f000f00*0*0*0*5m0*	m0m0m0m00m00m0m0m0m0m0*0*m0TEGChol
MIMAT0015088	5m0*0
hsa-miR-514b-5p	5′Pm05f0005f05f000f005f05f0f05m0*0*0*5	m0m000m0m0m0m00m0m0m0*0*m0TEGChol
MIMAT0015087	m0*5m0*0*0
hsa-miR-515-3p	5′Pm0005f0f005f05f05f0000f00*5m0*5m0*5	m0m0m0m0m0m000m0m00m0*m0*m0TEGChol
MIMAT0002827	m0*f0*5m0*0
hsa-miR-515-5p	5′Pm05f05f05f05f0000f05f05f05f05f05m0*5	m0m0000m0m0m0m0m000*0*m0TEGChol
MIMAT0002826	m0*5m0*5m0*5m0**
hsa-miR-516a-3p	5′Pm005f00f005f05f05f05f05f00f00*0*5m0*	m0m0m000m000m0m0m00*m0*m0TEGChol
MIMAT0006778	0*f0*0*
hsa-miR-516a-5p	5′Pm0000f005f00f05f05f005f00*0*5m0*5m0	m0m0m000m0m00m0m0m0m0*m0*m0TEGChol
MIMAT0004770	*5m0*5m0*0
hsa-miR-516b	5′Pm0000f005f05f0f05f0005f05m0*0*5m0*5	m0m0m0m00m000m0m0m0m0*m0*m0TEGChol
MIMAT0002859	m0*5m0*5m0*0
hsa-miR-516b*	5′Pm05f05f05f0f05f05f05f05f005f05f05f00*5	m0m000m0m0000m000*0*m0TEGChol
MIMAT0002860	m0*5m0*5m0*5m0*5m0*0
hsa-miR-517*	5′Pm05f000f005f05f05f0000f05m0*5m0*5m	m0m0m0m0m0m000m0m0m0m0*0*m0TEGChol
MIMAT0002851	0*5m0*f0**
hsa-miR-517a	5′Pm05f05f05f05f05f05f05f0f05f005f0f00*0*	m0m00m00m0000m000*0*m0TEGChol
MIMAT0002852	5m0*0*5m0*5m0*0
hsa-miR-517b	5′Pm05f005f05f05f05f05f05f05f05f05f05f05	m0m0000m0000m00m0*0*m0TEGChol
MIMAT0002857	m0*5m0*5m0*5m0*5m0*5m0*0
hsa-miR-517c	5′Pm05f0005f005f05f0f0005f0f05m0*0*0*5	m0m00m0m0m000m0m0m0m0*0*m0TEGChol
MIMAT0002866	m0*5m0*5m0*0
hsa-miR-518a-3p	5′Pm0005f0f005f05f05f05f05f00f05m0*5m0*	m0m0m000m000m0m00m0*m0*m0TEGChol
MIMAT0002863	0*5m0*f0*0*0
hsa-miR-518a-5p	5′Pm05f000f005f05f05f05f05f00f00*0*5m0*	m0m0m000m000m0m0m0m0*0*m0TEGChol
MIMAT0005457	5m0*5m0*5m0*0
hsa-miR-518b	5′Pm05f0005f00005f005f00f00*5m0*0*0*f0	m0m0m00m0m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0002844	*5m0*0
hsa-miR-518c	5′Pm005f05f05f005f05f05f005f005f05m0*5m	m0m0m00m0m000m0m000*m0*m0TEGChol
MIMAT0002848	0*0*5m0*5m0*0*0
hsa-miR-518c*	5′Pm005f05f0f05f0005f05f005f05f05m0*5m0	m0m00m00m0m0m00m000*m0*m0TEGChol
MIMAT0002847	*5m0*0*5m0*0*0
hsa-miR-518d-3p	5′Pm05f0005f05f05f005f00005f05m0*0*0*5	m0m0m0m0m0m0m000m0m0m0*0*m0TEGChol
MIMAT0002864	m0*f0*0*0
hsa-miR-518d-5p	5′Pm005f005f00005f0005f0f00*5m0*5m0*0	m0m00m0m0m0m0m0m0m0m00*m0*m0TEGChol
MIMAT0005456	*5m0*0*0
hsa-miR-518e	5′Pm005f00f05f05f05f05f05f05f005f05m0*5	m0m0m000m0000m0m00*m0*m0TEGChol
MIMAT0002861	m0*5m0*5m0*f0*5m0*0
hsa-miR-518e*	5′Pm005f005f005f05f0f05f0005f05m0*0*5m	m0m0m0m00m000m0m0m00*m0*m0TEGChol
MIMAT0005450	0*5m0*5m0*5m0*0
hsa-miR-518f	5′Pm0005f05f05f05f00f05f05f00f05m0*0*0*	m0m0m000m0m000m00m0*m0*m0TEGChol
MIMAT0002842	5m0*5m0*0*0
hsa-miR-518f*	5′Pm0005f05f005f00f0005f05f05m0*0*0*0*f	m0m00m0m0m0m00m0m00m0*m0*m0TEGChol
MIMAT0002841	0*5m0*
hsa-miR-519a	5′Pm0005f05f05f05f05f0f05f000f05m0*0*0*	m0m0m0m00m0000m00m0*m0*m0TEGChol
MIMAT0002869	0*5m0*0*0
hsa-miR-519a*	5′Pm00005f05f05f05f0f05f0005f00*5m0*5m	m0m0m0m00m0000m0m0m0*m0*m0TEGChol
MIMAT0005452	0*5m0*5m0*5m0*0
hsa-miR-519b-3p	5′Pm005f05f0f05f005f05f0000f00*5m0*5m0	m0m0m0m0m0m00m00m000*m0*m0TEGChol
MIMAT0002837	*0*f0*5m0*0
hsa-miR-519b-5p	5′Pm0005f05f005f05f0f0000f05m0*5m0*0*0	m0m0m0m0m0m000m0m00m0*m0*m0TEGChol
MIMAT0005454	*f0*0*0
hsa-miR-519c-3p	5′Pm05f005f0f05f05f05f0f005f05f05f00*0*5	m0m000m0m0000m00m0*0*m0TEGChol
MIMAT0002832	m0*5m0*f0*5m0*0
hsa-miR-519c-5p	5′Pm05f05f05f0f0005f05f05f000f05m0*5m0*	m0m0m0m00m00m0m0m000*0*m0TEGChol
MIMAT0002831	5m0*0*5m0*0*0
hsa-miR-519d	5′Pm05f0005f05f05f05f0f05f05f00f00*5m0*0	m0m0m000m0000m0m0m0*0*m0TEGChol
MIMAT0002853	*5m0*5m0*0*0
hsa-miR-519e	5′Pm05f05f05f05f0005f05f005f05f0f00*0*0*	m0m000m0m00m0m0m000*0*m0TEGChol
MIMAT0002829	0*5m0*0*0
hsa-miR-519e*	5′Pm005f05f05f05f005f0f0005f05f00*5m0*5	m0m00m0m0m00m00m000*m0*m0TEGChol
MIMAT0002828	m0*0*5m0*0*0
hsa-miR-520a-3p	5′Pm005f00f00005f05f000f00*5m0*5m0*0*	m0m0m0m00m0m0m0m0m0m00*m0*m0TEGChol
MIMAT0002834	5m0*0*0
hsa-miR-520a-5p	5′Pm0000f05f0005f005f05f0f00*0*0*5m0*f0	m0m000m0m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0002833	*0*0
hsa-miR-520b	5′Pm005f00f05f05f05f05f05f05f005f05m0*5	m0m0m000m0000m0m00*m0*m0TEGChol
MIMAT0002843	m0*5m0*5m0*f0*5m0*0
hsa-miR-520c-3p	5′Pm05f005f0f00005f05f000f00*0*5m0*5m0	m0m0m0m00m0m0m0m0m00m0*0*m0TEGChol
MIMAT0002846	*f0*5m0*0
hsa-miR-520c-5p	5′Pm00005f005f05f05f05f05f05f05f05m0*0*	m0m0000m000m0m0m0m0*m0*m0TEGChol
MIMAT0005455	5m0*5m0*5m0*5m0*0
hsa-miR-520d-3p	5′Pm05f05f05f05f005f05f05f005f05f05f05m0	m0m000m0m000m0m000*0*m0TEGChol
MIMAT0002856	*0*0*5m0*f0*0*0
hsa-miR-520d-5p	5′Pm0000f05f05f05f05f05f000f05m0*5m0*5	m0m0m0m00m0000m0m0m0*m0*m0TEGChol
MIMAT0002855	m0*5m0*f0*0*0
hsa-miR-520e	5′Pm005f05f0f05f05f005f05f05f05f0f00*0*5	m0m0000m0m000m000*m0*m0TEGChol
MIMAT0002825	m0*0*f0*0*0
hsa-miR-520f	5′Pm0000f0000f05f05f00f00*5m0*5m0*5m0	m0m0m000m0m0m0m0m0m0m0*m0*m0TEGChol
MIMAT0002830	*f0*5m0*0
hsa-miR-520g	5′Pm005f00f05f05f05f05f005f05f0f00*0*5m0	m0m000m0m0000m0m00*m0*m0TEGChol
MIMAT0002858	*0*5m0*5m0*0
hsa-miR-520h	5′Pm00005f05f000f05f05f05f0f00*0*5m0*0*	m0m0000m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0002867	5m0*5m0*0
hsa-miR-521	5′Pm0000f0000f0005f05f00*0*5m0*5m0*5	m0m00m0m0m0m0m0m0m0m0m0*m0*m0TEGChol
MIMAT0002854	m0*0*0
hsa-miR-522	5′Pm00005f05f005f0f005f05f0f00*0*5m0*0*	m0m000m0m00m00m0m0m0*m0*m0TEGChol
MIMAT0002868	5m0*5m0*0
hsa-miR-522*	5′Pm00005f05f000f05f005f0f05m0*0*5m0*5	m0m00m00m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0005451	m0*f0*0*0
hsa-miR-523	5′Pm05f005f05f005f05f05f0000f00*5m0*0*5	m0m0m0m0m0m000m0m00m0*0*m0TEGChol
MIMAT0002840	m0*f0*5m0*0
hsa-miR-523*	5′Pm05f000f0005f05f05f05f05f05f00*0*0*0*	m0m0000m00m0m0m0m0m0*0*m0TEGChol
MIMAT0005449	5m0*5m0*0
hsa-miR-524-3p	5′Pm0005f05f005f05f05f00005f00*5m0*0*0	m0m0m0m0m0m000m0m00m0*m0*m0TEGChol
MIMAT0002850	*5m0*5m0*0
hsa-miR-524-5p	5′Pm05f05f00f05f005f05f005f005f00*5m0*5	m0m0m00m0m00m00m0m00*0*m0TEGChol
MIMAT0002849	m0*0*f0*0*0
hsa-miR-525-3p	5′Pm0005f05f005f05f0f005f05f0f00*0*0*0*f	m0m000m0m000m0m00m0*m0*m0TEGChol
MIMAT0002839	0*5m0*0
hsa-miR-525-5p	5′Pm0005f0f05f05f005f05f005f0f00*5m0*5m	m0m00m00m0m000m00m0*m0*m0TEGChol
MIMAT0002838	0*0*f0*0*0
hsa-miR-526a	5′Pm05f05f00f005f00f0005f05f05m0*5m0*5	m0m00m0m0m0m00m0m0m00*0*m0TEGChol
MIMAT0002845	m0*0*f0*0*0
hsa-miR-526b	5′Pm005f05f05f0005f05f05f05f00f00*0*0*5	m0m0m000m00m0m0m000*m0*m0TEGChol
MIMAT0002835	m0*f0*5m0*0
hsa-miR-526b*	5′Pm005f05f05f05f05f05f0f005f00f05m0*0*0	m0m0m00m0m0000m000*m0*m0TEGChol
MIMAT0002836	*0*5m0*5m0*0
hsa-miR-527	5′Pm0005f0f005f00f00005f05m0*5m0*0*5m	m0m0m0m0m0m0m00m0m00m0*m0*m0TEGChol
MIMAT0002862	0*5m0*5m0*0
hsa-miR-532-3p	5′Pm005f05f05f0000f005f05f0f00*0*0*5m0*	m0m000m0m0m0m0m0m000*m0*m0TEGChol
MIMAT0004780	5m0*5m0*0
hsa-miR-532-5p	5′Pm005f005f05f000f005f00f00*0*0*0*f0*0	m0m0m00m0m0m0m00m0m00*m0*m0TEGChol
MIMAT0002888	*0
hsa-miR-539	5′Pm00005f05f005f05f05f05f005f00*0*0*0*	m0m0m000m00m00m0m0m0*m0*m0TEGChol
MIMAT0003163	5m0*5m0*0
hsa-miR-541	5′Pm005f00f0000f00005f00*0*0*5m0*5m0*	m0m0m0m0m0m0m0m0m0m0m00*m0*m0TEGChol
MIMAT0004920	5m0*0
hsa-miR-541*	5′Pm005f005f00005f05f05f05f0f00*0*0*0*f0	m0m0000m0m0m0m0m0m00*m0*m0TEGChol
MIMAT0004919	*0*0
hsa-miR-542-3p	5′Pm00005f05f05f05f0f05f05f05f05f05m0*5	m0m0000m0000m0m0m0*m0*m0TEGChol
MIMAT0003389	m0*5m0*0*f0*0*0
hsa-miR-542-5p	5′Pm0005f0f05f005f0f005f005f00*0*0*5m0*	m0m0m00m0m00m00m00m0*m0*m0TEGChol
MIMAT0003340	f0*5m0*0
hsa-miR-543	5′Pm05f05f00f0005f05f0005f05f05m0*5m0*	m0m00m0m0m00m0m0m0m00*0*m0TEGChol
MIMAT0004954	0*0*5m0*0*0
hsa-miR-544	5′Pm0005f0f0000f0005f05f00*0*0*0*f0*0*0	m0m00m0m0m0m0m0m0m00m0*m0*m0TEGChol
MIMAT0003164
hsa-miR-544b	5′Pm005f05f0f0005f0f005f00f00*0*0*0*f0*0	m0m0m00m0m00m0m0m000*m0*m0TEGChol
MIMAT0015004	*0
hsa-miR-545	5′Pm0000f005f05f0f0000f00*5m0*0*0*f0*0	m0m0m0m0m0m000m0m0m0m0*m0*m0TEGChol
MIMAT0003165	*0
hsa-miR-545*	5′Pm05f000f0000f00005f00*0*5m0*5m0*5	m0m0m0m0m0m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0004785	m0*5m0*0
hsa-miR-548a-3p	5′Pm0000f05f0005f05f005f0f00*5m0*5m0*5	m0m00m00m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0003251	m0*5m0*5m0*0
hsa-miR-548a-5p	5′Pm0000f005f05f0f05f0005f05m0*0*5m0*5	m0m0m0m00m000m0m0m0m0*m0*m0TEGChol
MIMAT0004803	m0*5m0*5m0*0
hsa-miR-548aa	5′Pm05f05f005f0000f00005f00*5m0*5m0*0	m0m0m0m0m0m0m0m0m0m0m00*0*m0TEGChol
MIMAT0018447	*5m0**
hsa-miR-548b-3p	5′Pm05f0005f005f05f05f005f005f05m0*5m0	m0m0m00m0m000m0m0m0m0*0*m0TEGChol
MIMAT0003254	*5m0****
hsa-miR-548b-5p	5′Pm0000f05f0005f05f005f05f00*5m0*5m0*	m0m00m00m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0004798	5m0*5m0*5m0*0
hsa-miR-548c-3p	5′Pm0000f0000f05f05f00f00*5m0*0*5m0*f0	m0m0m000m0m0m0m0m0m0m0*m0*m0TEGChol
MIMAT0003285	**
hsa-miR-548c-5p	5′Pm0000f005f05f0f05f0005f05m0*0*5m0*5	m0m0m0m00m000m0m0m0m0*m0*m0TEGChol
MIMAT0004806	m0*5m0*5m0*0
hsa-miR-548d-3p	5′Pm0005f0f005f05f0f05f000f05m0*0*0*0*5	m0m0m0m00m000m0m00m0*m0*m0TEGChol
MIMAT0003323	m0*5m0*0
hsa-miR-548d-5p	5′Pm005f005f05f05f00f0000f00*5m0*0*0*f0	m0m0m0m0m0m0m000m0m00*m0*m0TEGChol
MIMAT0004812	*0*0
hsa-miR-548e	5′Pm0000f05f005f05f05f05f05f05f05m0*5m0	m0m0000m00m00m0m0m0*m0*m0TEGChol
MIMAT0005874	*5m0*5m0*f0*5m0*0
hsa-miR-548f	5′Pm05f05f005f0000f00005f00*5m0*5m0*0	m0m0m0m0m0m0m0m0m0m0m00*0*m0TEGChol
MIMAT0005895	*5m0*5m0*0
hsa-miR-548g	5′Pm0000f0000f00005f00*0*5m0*5m0*f0*0	m0m0m0m0m0m0m0m0m0m0m0m0*m0*m0TEG
MIMAT0005912	*0	Chol
hsa-miR-548h	5′Pm005f05f05f05f005f05f05f05f05f05f05m0	m0m0000m00m00m000*m0*m0TEGChol
MIMAT0005928	*0*0*0*5m0*0*0
hsa-miR-548i	5′Pm05f05f05f0f05f05f05f05f05f05f05f0f00*	m0m0000m0000m000*0*m0TEGChol
MIMAT0005935	0*5m0*0*5m0*5m0*0
hsa-miR-548j	5′Pm05f0005f05f05f005f05f05f05f05f00*0*5	m0m0000m0m000m0m0m0*0*m0TEGChol
MIMAT0005875	m0*5m0*5m0*5m0*0
hsa-miR-548k	5′Pm005f05f05f05f005f05f05f05f05f0f05m0*	m0m0000m00m00m000*m0*m0TEGChol
MIMAT0005882	5m0*5m0*5m0*5m0*0*
hsa-miR-548l	5′Pm005f05f05f05f05f05f0f005f05f05f05m0*	m0m000m0m0000m000*m0*m0TEGChol
MIMAT0005889	0*0*0*5m0*5m0*0
hsa-miR-548m	5′Pm05f05f05f05f0000f00005f00*5m0*5m0*	m0m0m0m0m0m0m0m0m0m000*0*m0TEGChol
MIMAT0005917	0*5m0*5m0*0
hsa-miR-548n	5′Pm0005f0f05f05f05f0f05f05f05f05f05m0*0	m0m0000m0000m00m0*m0*m0TEGChol
MIMAT0005916	*5m0*5m0*f0*0*0
hsa-miR-548o	5′Pm05f05f05f0f0000f005f00f00*0*5m0*0*f	m0m0m00m0m0m0m0m0m000*0*m0TEGChol
MIMAT0005919	0**
hsa-miR-548p	5′Pm05f05f00f005f05f05f00005f05m0*5m0*	m0m0m0m0m0m000m0m0m00*0*m0TEGChol
MIMAT0005934	5m0*5m0*5m0*5m0*0
hsa-miR-548q	5′Pm05f05f00f05f005f05f05f05f05f0f05m0*0	m0m0000m00m00m0m00*0*m0TEGChol
MIMAT0011163	*0*0*5m0*0*0
hsa-miR-548s	5′Pm05f05f05f0f0005f05f00005f00*0*0*5m0	m0m0m0m0m0m00m0m0m000*0*m0TEGChol
MIMAT0014987	*f0*0*0
hsa-miR-548t	5′Pm0000f05f05f05f05f05f0005f00*5m0*5m	m0m0m0m00m0000m0m0m0*m0*m0TEGChol
MIMAT0015009	0*5m0*f0*0*0
hsa-miR-548u	5′Pm05f0005f05f05f005f005f05f05f00*0*5m	m0m000m0m0m000m0m0m0*0*m0TEGChol
MIMAT0015013	0*5m0*5m0*5m0*0
hsa-miR-548v	5′Pm005f05f0f05f005f05f005f05f05f00*5m0*	m0m000m0m00m00m000*m0*m0TEGChol
MIMAT0015020	5m0*0*f0*0*0
hsa-miR-548w	5′Pm00005f05f000f05f005f0f00*0*5m0*0*f0	m0m00m00m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0015060	*0*0
hsa-miR-548x	5′Pm005f00f005f00f05f05f00f05m0*5m0*0*	m0m0m000m0m00m0m0m00*m0*m0TEGChol
MIMAT0015081	0*f0*5m0*0
hsa-miR-548y	5′Pm05f05f00f05f005f05f05f05f05f0f05m0*0	m0m0000m00m00m0m00*0*m0TEGChol
MIMAT0018354	*0*0*5m0*0*0
hsa-miR-548z	5′Pm00005f0005f0f00005f05m0*5m0*5m0*	m0m0m0m0m0m00m0m0m0m0m0*m0*m0TEGChol
MIMAT0018446	0*5m0*5m0*0
hsa-miR-549	5′Pm05f05f05f05f0000f0000f00*0*5m0*0*f0	m0m0m0m0m0m0m0m0m0m000*0*m0TEGChol
MIMAT0003333	*5m0*0
hsa-miR-550a	5′Pm05f05f00f05f05f05f05f0005f05f05m0*0*	m0m00m0m0m0000m0m00*0*m0TEGChol
MIMAT0004800	0*5m0*5m0*0*0
hsa-miR-550a*	5′Pm05f005f0f005f05f05f05f005f0f05m0*0*0	m0m00m00m000m0m00m0*0*m0TEGChol
MIMAT0003257	*5m0*f0*5m0*0
hsa-miR-550b	5′Pm05f000f05f005f05f05f000f05m0*5m0*5	m0m0m0m00m00m00m0m0m0*0*m0TEGChol
MIMAT0018445	m0*5m0*5m0*0*0
hsa-miR-551a	5′Pm05f05f00f05f005f05f05f0005f00*0*0*5	m0m0m0m00m00m00m0m00*0*m0TEGChol
MIMAT0003214	m0*f0*5m0*0
hsa-miR-551b	5′Pm05f05f00f05f0005f0005f0f00*0*0*5m0*	m0m00m0m0m0m0m00m0m00*0*m0TEGChol
MIMAT0003233	5m0*5m0*0
hsa-miR-551b*	5′Pm00005f00005f05f000f05m0*5m0*5m0*	m0m0m0m00m0m0m0m0m0m0m0*m0*m0TEGChol
MIMAT0004794	5m0*5m0*0*0
hsa-miR-552	5′Pm0005f0f05f05f05f05f05f05f05f05f05m0*	m0m0000m0000m00m0*m0*m0TEGChol
MIMAT0003215	0*0*0*f0*5m0*0
hsa-miR-553	5′Pm05f05f00f05f05f05f0f0000f00*0*0*5m0	m0m0m0m0m0m0000m0m00*0*m0TEGChol
MIMAT0003216	*5m0*5m0*0
hsa-miR-554	5′Pm005f05f0f005f005f05f005f0f00*0*5m0*	m0m00m00m0m00m0m000*m0*m0TEGChol
MIMAT0003217	5m0*f0*0*0
hsa-miR-555	5′Pm005f05f0f05f05f00f0000f05m0*5m0*5m	m0m0m0m0m0m0m000m000*m0*m0TEGChol
MIMAT0003219	0*0*f0*0*0
hsa-miR-556-3p	5′Pm0005f05f05f05f00f005f05f05f00*5m0*5	m0m000m0m0m000m00m0*m0*m0TEGChol
MIMAT0004793	m0*0*f0*5m0*0
hsa-miR-556-5p	5′Pm0000f0000f05f05f00f05m0*0*5m0*0*5	m0m0m000m0m0m0m0m0m0m0*m0*m0TEGChol
MIMAT0003220	m0*0*0
hsa-miR-557	5′Pm05f05f05f05f05f000f05f005f0f00*5m0*5	m0m00m00m0m0m00m000*0*m0TEGChol
MIMAT0003221	m0*5m0*5m0*0*0
hsa-miR-558	5′Pm0005f05f05f05f05f0f0005f05f05m0*5m0	m0m00m0m0m0000m00m0*m0*m0TEGChol
MIMAT0003222	*0*0*5m0*0*0
hsa-miR-559	5′Pm05f05f05f0f00005f05f05f05f05f05m0*0*	m0m0000m0m0m0m0m000*0*m0TEGChol
MIMAT0003223	0*5m0*f0*0*0
hsa-miR-561	5′Pm05f005f05f005f05f0f05f05f00f05m0*5m	m0m0m000m000m0m00m0*0*m0TEGChol
MIMAT0003225	0*5m0*0*5m0*5m0*0
hsa-miR-562	5′Pm05f005f05f05f05f05f05f00005f05m0*0*	m0m0m0m0m0m0000m00m0*0*m0TEGChol
MIMAT0003226	0*0*5m0**
hsa-miR-563	5′Pm05f000f005f05f0f05f000f05m0*0*0*0*f	m0m0m0m00m000m0m0m0m0*0*m0TEGChol
MIMAT0003227	0*0*0
hsa-miR-564	5′Pm005f00f0005f05f0005f05f00*0*5m0*0*	m0m00m0m0m00m0m0m0m00*m0*m0TEGChol
MIMAT0003228	**
hsa-miR-566	5′Pm05f005f05f05f000f05f05f05f0f00*0*0*0	m0m0000m0m0m00m00m0*0*m0TEGChol
MIMAT0003230	*5m0*5m0*0
hsa-miR-567	5′Pm005f00f05f0005f0005f0f00*5m0*0*0*f0	m0m00m0m0m0m0m00m0m00*m0*m0TEGChol
MIMAT0003231	*5m0*0
hsa-miR-568	5′Pm05f000f00005f0000f00*0*5m0*5m0*5	m0m0m0m0m0m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0003232	m0*0*0
hsa-miR-569	5′Pm05f05f05f05f05f0005f05f05f05f05f05m0	m0m0000m0m0m00m000*0*m0TEGChol
MIMAT0003234	*0*5m0*0*f0*5m0*0
hsa-miR-570	5′Pm005f05f05f005f05f0f05f005f0f05m0*5m	m0m00m00m000m0m000*m0*m0TEGChol
MIMAT0003235	0*0*0*f0*0*0
hsa-miR-571	5′Pm05f005f05f0000f05f05f05f05f05m0*0*0	m0m0000m0m0m0m0m00m0*0*m0TEGChol
MIMAT0003236	*0*f0*0*0
hsa-miR-572	5′Pm05f05f00f05f005f05f05f05f05f05f05m0*	m0m0000m00m00m0m00*0*m0TEGChol
MIMAT0003237	5m0*5m0*5m0*5m0**
hsa-miR-573	5′Pm05f05f05f05f05f000f0000f00*0*5m0*0*	m0m0m0m0m0m0m0m00m000*0*m0TEGChol
MIMAT0003238	5m0*5m0*0
hsa-miR-574-3p	5′Pm05f05f005f005f00f005f005f00*5m0*0*5	m0m0m00m0m0m00m0m0m00*0*m0TEGChol
MIMAT0003239	m0*f0*5m0*0
hsa-miR-574-5p	5′Pm005f05f05f05f05f05f05f05f05f00f00*0*	m0m0m000m0000m000*m0*m0TEGChol
MIMAT0004795	0*0*5m0**
hsa-miR-575	5′Pm05f05f05f05f0000f0000f00*0*0*5m0*f0	m0m0m0m0m0m0m0m0m0m000*0*m0TEGChol
MIMAT0003240	*5m0*0
hsa-miR-576-3p	5′Pm005f05f0f005f00f005f05f05f05m0*0*0*	m0m000m0m0m00m0m000*m0*m0TEGChol
MIMAT0004796	0*f0*0*0
hsa-miR-576-5p	5′Pm05f000f05f005f05f05f000f05m0*0*5m0	m0m0m0m00m00m00m0m0m0*0*m0TEGChol
MIMAT0003241	*0*5m0*0*0
hsa-miR-577	5′Pm0005f05f05f05f05f05f005f05f05f00*0*0	m0m000m0m0000m00m0*m0*m0TEGChol
MIMAT0003242	*0*f0*5m0*0
hsa-miR-578	5′Pm05f005f05f005f05f05f00005f00*0*0*5m	m0m0m0m0m0m000m0m00m0*0*m0TEGChol
MIMAT0003243	0*f0*0*0
hsa-miR-579	5′Pm05f05f05f0f005f005f005f00f05m0*0*5m	m0m0m00m0m0m00m0m000*0*m0TEGChol
MIMAT0003244	0*0*f0*0*0
hsa-miR-580	5′Pm005f05f05f00005f05f05f05f05f00*0*5m	m0m0000m0m0m0m0m000*m0*m0TEGChol
MIMAT0003245	0*5m0*5m0*0*0
hsa-miR-581	5′Pm0000f05f005f0f005f00f05m0*0*0*5m0*	m0m0m00m0m00m00m0m0m0*m0*m0TEGChol
MIMAT0003246	f0*5m0*0
hsa-miR-582-3p	5′Pm05f05f05f0f0000f05f000f00*0*0*5m0*f	m0m0m0m00m0m0m0m0m000*0*m0TEGChol
MIMAT0004797	0*5m0*0
hsa-miR-582-5p	5′Pm005f05f0f05f005f05f05f0005f05m0*0*5	m0m0m0m00m00m00m000*m0*m0TEGChol
MIMAT0003247	m0*5m0*f0*0*0
hsa-miR-583	5′Pm05f05f00f05f005f05f0005f0f05m0*0*5m	m0m00m0m0m00m00m0m00*0*m0TEGChol
MIMAT0003248	0*5m0*5m0*5m0*0
hsa-miR-584	5′Pm0000f05f0005f00005f05m0*0*0*0*5m0	m0m0m0m0m0m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0003249	**
hsa-miR-585	5′Pm05f05f00f05f05f005f05f05f05f0f00*5m0	m0m0000m0m000m0m00*0*m0TEGChol
MIMAT0003250	*5m0*5m0*5m0*5m0*0
hsa-miR-586	5′Pm05f05f00f05f0005f05f0005f00*5m0*0*0	m0m0m0m00m0m0m00m0m00*0*m0TEGChol
MIMAT0003252	*f0*5m0*0
hsa-miR-587	5′Pm05f000f0000f05f05f05f05f05m0*0*0*0*	m0m0000m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0003253	f0*5m0*0
hsa-miR-588	5′Pm05f005f05f005f05f0f0000f00*5m0*5m0	m0m0m0m0m0m000m0m00m0*0*m0TEGChol
MIMAT0003255	*5m0***
hsa-miR-589	5′Pm005f05f0f05f000f05f005f0f05m0*0*5m0	m0m00m00m0m0m00m000*m0*m0TEGChol
MIMAT0004799	*5m0***
hsa-miR-589*	5′Pm005f00f005f05f05f005f05f0f05m0*0*0*	m0m000m0m000m0m0m00*m0*m0TEGChol
MIMAT0003256	5m0*f0*5m0*0
hsa-miR-590-3p	5′Pm0000f00005f05f005f05f00*0*0*0*5m0*	m0m00m00m0m0m0m0m0m0m0*m0*m0TEGChol
MIMAT0004801	5m0*0
hsa-miR-590-5p	5′Pm005f05f0f005f05f05f005f05f0f00*0*5m0	m0m000m0m000m0m000*m0*m0TEGChol
MIMAT0003258	*0*5m0*5m0*0
hsa-miR-591	5′Pm0000f005f005f05f05f05f0f05m0*0*0*5	m0m0000m0m00m0m0m0m0*m0*m0TEGChol
MIMAT0003259	m0*f0*5m0*0
hsa-miR-592	5′Pm005f00f0005f0f005f00f00*0*5m0*5m0*	m0m0m00m0m00m0m0m0m00*m0*m0TEGChol
MIMAT0003260	f0*0*0
hsa-miR-593	5′Pm005f005f005f05f05f0005f0f00*0*5m0*5	m0m00m0m0m000m0m0m00*m0*m0TEGChol
MIMAT0004802	m0*f0*0*0
hsa-miR-593*	5′Pm05f05f05f05f00005f0000f05m0*5m0*0*	m0m0m0m0m0m0m0m0m0m000*0*m0TEGChol
MIMAT0003261	5m0***
hsa-miR-595	5′Pm05f05f05f0f00005f00005f05m0*0*5m0*	m0m0m0m0m0m0m0m0m0m000*0*m0TEGChol
MIMAT0003263	5m0*f0*0*0
hsa-miR-596	5′Pm00005f05f005f05f0005f0f00*5m0*5m0*	m0m00m0m0m00m00m0m0m0*m0*m0TEGChol
MIMAT0003264	5m0*5m0*0*0
hsa-miR-597	5′Pm005f005f05f000f005f00f00*0*0*5m0*f0	m0m0m00m0m0m0m00m0m00*m0*m0TEGChol
MIMAT0003265	*0*0
hsa-miR-598	5′Pm005f00f05f005f05f0005f0f00*0*0*5m0*	m0m00m0m0m00m00m0m00*m0*m0TEGChol
MIMAT0003266	5m0*5m0*0
hsa-miR-599	5′Pm05f000f05f05f005f05f000f00*0*0*5m0*	m0m0m0m00m0m000m0m0m0*0*m0TEGChol
MIMAT0003267	5m0*0*0
hsa-miR-600	5′Pm05f000f05f0005f05f05f05f05f05m0*5m0	m0m0000m0m0m00m0m0m0*0*m0TEGChol
MIMAT0003268	*0*5m0*f0*5m0*0
hsa-miR-601	5′Pm05f05f05f05f00005f005f05f0f05m0*0*5	m0m000m0m0m0m0m0m000*0*m0TEGChol
MIMAT0003269	m0*0*5m0*5m0*0
hsa-miR-602	5′Pm05f05f05f0f05f005f0f0005f0f00*0*5m0*	m0m00m0m0m00m00m000*0*m0TEGChol
MIMAT0003270	5m0*5m0*5m0*0
hsa-miR-603	5′Pm05f000f005f005f005f05f05f00*5m0*0*0	m0m000m0m0m00m0m0m0m0*0*m0TEGChol
MIMAT0003271	*5m0*0*0
hsa-miR-604	5′Pm00005f05f05f05f0f05f0005f05m0*5m0*	m0m0m0m00m0000m0m0m0*m0*m0TEGChol
MIMAT0003272	5m0*5m0*5m0**
hsa-miR-605	5′Pm05f05f00f05f05f05f05f0005f05f05m0*0*	m0m00m0m0m0000m0m00*0*m0TEGChol
MIMAT0003273	0*5m0*5m0*5m0*0
hsa-miR-606	5′Pm005f05f05f05f05f05f05f05f05f00f00*0*	m0m0m000m0000m000*m0*m0TEGChol
MIMAT0003274	0*0*5m0**
hsa-miR-607	5′Pm0000f00005f00005f00*0*0*0*f0*5m0*0	m0m0m0m0m0m0m0m0m0m0m0m0*m0*m0TEG
MIMAT0003275		Chol
hsa-miR-608	5′Pm00005f05f005f05f005f005f05m0*0*0*0	m0m0m00m0m00m00m0m0m0*m0*m0TEGChol
MIMAT0003276	*f0*5m0*
hsa-miR-609	5′Pm05f05f005f05f05f05f0f05f0005f00*5m0*	m0m0m0m00m0000m0m00*0*m0TEGChol
MIMAT0003277	5m0*0*f0*0*0
hsa-miR-610	5′Pm05f05f05f05f00005f0000f00*5m0*0*5m	m0m0m0m0m0m0m0m0m0m000*0*m0TEGChol
MIMAT0003278	0*5m0*0*0
hsa-miR-611	5′Pm0000f0000f0005f05f00*0*0*0*f0*5m0*0	m0m00m0m0m0m0m0m0m0m0m0*m0*m0TEGChol
MIMAT0003279
hsa-miR-612	5′Pm05f0005f0005f0f0005f05f00*5m0*5m0*	m0m00m0m0m00m0m0m0m0m0*0*m0TEGChol
MIMAT0003280	5m0*5m0*0*0
hsa-miR-613	5′Pm00005f0005f0f05f05f05f05f00*0*5m0*0	m0m0000m00m0m0m0m0m0*m0*m0TEGChol
MIMAT0003281	*f0*5m0*0
hsa-miR-614	5′Pm05f05f005f05f05f05f0f05f0005f00*5m0*	m0m0m0m00m0000m0m00*0*m0TEGChol
MIMAT0003282	5m0*0*f0*0*0
hsa-miR-615-3p	5′Pm0000f05f005f0f005f05f0f05m0*0*0*0*f	m0m000m0m00m00m0m0m0*m0*m0TEGChol
MIMAT0003283	0*5m0*0
hsa-miR-615-5p	5′Pm005f05f0f005f00f05f005f05f00*0*0*5m	m0m00m00m0m00m0m000*m0*m0TEGChol
MIMAT0004804	0*5m0*0*0
hsa-miR-616	5′Pm05f05f005f005f005f05f05f05f05f05m0*5	m0m0000m0m00m0m0m00*0*m0TEGChol
MIMAT0004805	m0*0*0*f0*0*0
hsa-miR-616*	5′Pm0000f05f005f0f005f05f05f05m0*0*5m0	m0m000m0m00m00m0m0m0*m0*m0TEGChol
MIMAT0003284	*5m0*f0*0*0
hsa-miR-617	5′Pm0005f0f005f00f0005f0f00*0*0*5m0*5m	m0m00m0m0m0m00m0m00m0*m0*m0TEGChol
MIMAT0003286	0*5m0*0
hsa-miR-618	5′Pm05f05f005f0005f0f05f005f0f05m0*0*5m	m0m00m00m00m0m0m0m00*0*m0TEGChol
MIMAT0003287	0*5m0*5m0*5m0*0
hsa-miR-619	5′Pm005f05f05f005f005f05f0005f00*0*0*0*f	m0m0m0m00m0m00m0m000*m0*m0TEGChol
MIMAT0003288	0*0*0
hsa-miR-620	5′Pm0005f05f05f05f005f05f05f005f05m0*5m	m0m0m000m0m000m00m0*m0*m0TEGChol
MIMAT0003289	0*5m0*5m0*5m0*5m0*0
hsa-miR-621	5′Pm05f005f0f05f005f05f05f05f05f05f05m0*	m0m0000m00m00m00m0*0*m0TEGChol
MIMAT0003290	0*0*0*f0*5m0*0
hsa-miR-622	5′Pm05f0005f00005f00005f05m0*0*0*5m0*	m0m0m0m0m0m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0003291	f0*5m0*0
hsa-miR-623	5′Pm05f05f005f00005f005f05f0f00*0*0*0*5	m0m000m0m0m0m0m0m0m00*0*m0TEGChol
MIMAT0003292	m0*0*0
hsa-miR-624	5′Pm05f05f005f005f005f05f05f05f05f05m0*5	m0m0000m0m00m0m0m00*0*m0TEGChol
MIMAT0004807	m0*0*0*f0*0*0
hsa-miR-624*	5′Pm05f005f05f05f05f005f005f05f05f05m0*0	m0m000m0m0m000m00m0*0*m0TEGChol
MIMAT0003293	*5m0*0*5m0*5m0*0
hsa-miR-625	5′Pm05f05f05f0f05f005f05f005f00f05m0*5m	m0m0m00m0m00m00m000*0*m0TEGChol
MIMAT0003294	0*5m0*0*f0*5m0*0
hsa-miR-625*	5′Pm005f00f005f05f0f00005f05m0*5m0*0*5	m0m0m0m0m0m000m0m0m00*m0*m0TEGChol
MIMAT0004808	m0*f0*0*0
hsa-miR-626	5′Pm05f005f0f05f005f0f05f005f0f00*5m0*5	m0m00m00m00m00m00m0*0*m0TEGChol
MIMAT0003295	m0*0*5m0*5m0*0
hsa-miR-627	5′Pm05f005f05f05f0005f05f05f05f05f05m0*0	m0m0000m0m0m00m00m0*0*m0TEGChol
MIMAT0003296	*5m0*0*5m0*5m0*0
hsa-miR-628-3p	5′Pm0000f05f000f05f005f0f05m0*0*5m0*5	m0m00m00m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0003297	m0*f0*0*0
hsa-miR-628-5p	5′Pm0005f0f005f005f05f05f05f0f05m0*5m0*	m0m0000m0m00m0m00m0*m0*m0TEGChol
MIMAT0004809	5m0*0*f0*5m0*0
hsa-miR-629	5′Pm00005f005f00f00005f05m0*5m0*0*0*f	m0m0m0m0m0m0m00m0m0m0m0*m0*m0TEGChol
MIMAT0004810	0*5m0*0
hsa-miR-629*	5′Pm005f00f05f000f005f00f00*0*5m0*5m0*	m0m0m00m0m0m0m00m0m00*m0*m0TEGChol
MIMAT0003298	5m0*5m0*0
hsa-miR-630	5′Pm00005f0000f0005f05f00*0*5m0*0*f0*0	m0m00m0m0m0m0m0m0m0m0m0*m0*m0TEGChol
MIMAT0003299	*0
hsa-miR-631	5′Pm05f005f05f05f000f05f05f05f05f05m0*0*	m0m0000m0m0m00m00m0*0*m0TEGChol
MIMAT0003300	5m0*0*5m0*5m0*0
hsa-miR-632	5′Pm005f005f05f005f05f005f05f0f05m0*0*5	m0m000m0m00m00m0m00*m0*m0TEGChol
MIMAT0003302	m0*5m0*f0*0*0
hsa-miR-633	5′Pm05f000f05f05f05f05f005f00f05m0*0*0*	m0m0m00m0m0000m0m0m0*0*m0TEGChol
MIMAT0003303	0*f0*0*0
hsa-miR-634	5′Pm005f005f00005f05f000f05m0*0*5m0*5	m0m0m0m00m0m0m0m0m0m00*m0*m0TEGChol
MIMAT0003304	m0*f0*5m0*0
hsa-miR-635	5′Pm0005f0f05f000f00005f05m0*0*0*0*5m	m0m0m0m0m0m0m0m00m00m0*m0*m0TEGChol
MIMAT0003305	0*0*0
hsa-miR-636	5′Pm005f05f0f05f000f005f00f00*0*5m0*5m	m0m0m00m0m0m0m00m000*m0*m0TEGChol
MIMAT0003306	0*f0*5m0*0
hsa-miR-637	5′Pm0000f05f05f05f0f0000f05m0*0*0*0*f0*	m0m0m0m0m0m0000m0m0m0*m0*m0TEGChol
MIMAT0003307	0*0
hsa-miR-638	5′Pm005f05f05f00005f005f005f05m0*5m0*0	m0m0m00m0m0m0m0m0m000*m0*m0TEGChol
MIMAT0003308	*5m0*f0*5m0*0
hsa-miR-639	5′Pm0000f0000f00005f00*0*5m0*5m0*5m0	m0m0m0m0m0m0m0m0m0m0m0m0*m0*m0TEG
MIMAT0003309	*5m0*0	Chol
hsa-miR-640	5′Pm05f005f0f0005f05f05f0005f00*5m0*0*5	m0m0m0m00m00m0m0m00m0*0*m0TEGChol
MIMAT0003310	m0*f0*0*0
hsa-miR-641	5′Pm05f000f0005f05f05f005f0f00*0*5m0*5	m0m00m00m00m0m0m0m0m0*0*m0TEGChol
MIMAT0003311	m0*5m0*5m0*0
hsa-miR-642a	5′Pm05f05f05f0f05f05f05f05f05f05f05f05f05	m0m0000m0000m000*0*m0TEGChol
MIMAT0003312	m0*5m0*5m0*5m0*5m0*5m0*0
hsa-miR-642b	5′Pm0005f05f05f05f005f0005f05f05m0*5m0	m0m00m0m0m0m000m00m0*m0*m0TEGChol
MIMAT0018444	*0*0*f0**
hsa-miR-643	5′Pm0000f05f05f00f05f05f05f05f05m0*5m0*	m0m0000m0m000m0m0m0*m0*m0TEGChol
MIMAT0003313	5m0*5m0*5m0*0*0
hsa-miR-644	5′Pm0005f0f005f05f05f05f005f05f05m0*5m0	m0m00m00m000m0m00m0*m0*m0TEGChol
MIMAT0003314	*0*5m0*f0*0*0
hsa-miR-645	5′Pm005f005f005f05f05f005f05f05f00*0*0*0	m0m000m0m000m0m0m00*m0*m0TEGChol
MIMAT0003315	*f0*5m0*0
hsa-miR-646	5′Pm0000f05f0005f005f005f00*5m0*5m0*0	m0m0m00m0m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0003316	*5m0*5m0*0
hsa-miR-647	5′Pm0000f0005f05f05f05f05f05f05m0*5m0*	m0m0000m00m0m0m0m0m0*m0*m0TEGChol
MIMAT0003317	5m0*5m0*f0*0*0
hsa-miR-648	5′Pm05f000f0005f0f0005f0f05m0*0*0*0*f0*	m0m00m0m0m00m0m0m0m0m0*0*m0TEGChol
MIMAT0003318	0*0
hsa-miR-649	5′Pm05f05f005f05f05f05f05f005f05f0f05m0*	m0m000m0m0000m0m00*0*m0TEGChol
MIMAT0003319	5m0*5m0*0*f0*0*0
hsa-miR-650	5′Pm0000f05f05f05f0f00005f05m0*5m0*5m	m0m0m0m0m0m0000m0m0m0*m0*m0TEGChol
MIMAT0003320	0*5m0*f0*0*0
hsa-miR-651	5′Pm05f05f05f0f00005f05f05f05f0f00*5m0*5	m0m0000m0m0m0m0m000*0*m0TEGChol
MIMAT0003321	m0*5m0*5m0*0*0
hsa-miR-652	5′Pm005f05f05f05f05f00f0005f05f05m0*0*0	m0m00m0m0m0m000m000*m0*m0TEGChol
MIMAT0003322	*0*5m0*0*0
hsa-miR-653	5′Pm05f005f0f05f05f05f0f05f05f05f05f00*0*	m0m0000m0000m00m0*0*m0TEGChol
MIMAT0003328	5m0*0*f0**
hsa-miR-654-3p	5′Pm05f05f05f05f05f000f05f005f0f00*5m0*0	m0m00m00m0m0m00m000*0*m0TEGChol
MIMAT0004814	*0*f0*5m0*0
hsa-miR-654-5p	5′Pm00005f0005f05f005f005f05m0*0*5m0*	m0m0m00m0m00m0m0m0m0m0*m0*m0TEGChol
MIMAT0003330	5m0*5m0*0*0
hsa-miR-655	5′Pm0000f0005f05f0000f00*5m0*0*0*f0*0*0	m0m0m0m0m0m00m0m0m0m0m0*m0*m0TEGChol
MIMAT0003331
hsa-miR-656	5′Pm005f05f0f05f005f0f005f005f05m0*5m0*	m0m0m00m0m00m00m000*m0*m0TEGChol
MIMAT0003332	0*5m0*5m0*5m0*0
hsa-miR-657	5′Pm05f05f005f005f05f0f05f05f00f00*0*0*5	m0m0m000m000m0m0m00*0*m0TEGChol
MIMAT0003335	m0*5m0*5m0*0
hsa-miR-658	5′Pm00005f0000f05f05f05f05f05m0*0*5m0*	m0m0000m0m0m0m0m0m0m0*m0*m0TEGChol
MIMAT0003336	5m0*5m0*5m0*0
hsa-miR-659	5′Pm005f05f05f05f05f05f05f005f05f05f05m0	m0m000m0m0000m000*m0*m0TEGChol
MIMAT0003337	*5m0*5m0*0*f0*0*0
hsa-miR-660	5′Pm05f05f05f0f0000f05f000f05m0*5m0*5m	m0m0m0m00m0m0m0m0m000*0*m0TEGChol
MIMAT0003338	0*5m0*5m0*5m0*0
hsa-miR-661	5′Pm05f005f0f05f05f05f05f005f005f05m0*0*	m0m0m00m0m0000m00m0*0*m0TEGChol
MIMAT0003324	5m0*0*f0*5m0*0
hsa-miR-662	5′Pm005f05f0f05f0005f005f00f00*0*5m0*5	m0m0m00m0m0m0m00m000*m0*m0TEGChol
MIMAT0003325	m0*5m0*0*0
hsa-miR-663	5′Pm0000f05f005f05f05f05f05f05f05m0*5m0	m0m0000m00m00m0m0m0*m0*m0TEGChol
MIMAT0003326	*5m0*0*5m0*5m0*0
hsa-miR-663b	5′Pm05f05f00f05f05f00f005f05f0f00*5m0*0*	m0m000m0m0m000m0m00*0*m0TEGChol
MIMAT0005867	5m0*f0*0*0
hsa-miR-664	5′Pm00005f00005f0000f00*0*0*0*5m0*0*0	m0m0m0m0m0m0m0m0m0m0m0m0*m0*m0TEG
MIMAT0005949		Chol
hsa-miR-664*	5′Pm0005f05f0005f0f05f005f0f05m0*5m0*5	m0m00m00m00m0m0m00m0*m0*m0TEGChol
MIMAT0005948	m0*5m0*5m0*5m0*
hsa-miR-665	5′Pm0005f0f05f0005f005f05f0f00*5m0*0*0*	m0m000m0m0m0m00m00m0*m0*m0TEGChol
MIMAT0004952	f0*5m0*
hsa-miR-668	5′Pm05f05f05f05f005f005f005f00f00*0*5m0	m0m0m00m0m0m00m0m000*0*m0TEGChol
MIMAT0003881	*5m0*5m0*0*0
hsa-miR-670	5′Pm005f05f05f05f05f05f0f05f005f0f00*5m0	m0m00m00m0000m000*m0*m0TEGChol
MIMAT0010357	*0*0*f0*0*0
hsa-miR-671-3p	5′Pm00005f05f05f05f05f0000f00*5m0*0*0*f	m0m0m0m0m0m0000m0m0m0*m0*m0TEGChol
MIMAT0004819	0*0*0
hsa-miR-671-5p	5′Pm0005f0f05f05f05f0f05f0005f05m0*5m0*	m0m0m0m00m0000m00m0*m0*m0TEGChol
MIMAT0003880	5m0*0*f0*5m0*
hsa-miR-675	5′Pm0000f05f000f005f005f00*0*5m0*0*5m	m0m0m00m0m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0004284	0*0*0
hsa-miR-675*	5′Pm0005f05f05f005f0f00005f05m0*0*0*0*f	m0m0m0m0m0m00m00m00m0*m0*m0TEGChol
MIMAT0006790	0*5m0*0
hsa-miR-676	5′Pm0000f05f05f05f05f05f05f05f05f05m0*5	m0m0000m0000m0m0m0*m0*m0TEGChol
MIMAT0018204	m0*0*5m0*f0*0*0
hsa-miR-676*	5′Pm0005f0f05f05f005f05f05f00f05m0*0*0*	m0m0m000m0m000m00m0*m0*m0TEGChol
MIMAT0018203	0*f0*0*0
hsa-miR-7	5′Pm0005f0f00005f005f05f0f05m0*0*0*0*f0	m0m000m0m0m0m0m0m00m0*m0*m0TEGChol
MIMAT0000252	*5m0*0
hsa-miR-708	5′Pm05f005f0f0000f0000f05m0*5m0*5m0*5	m0m0m0m0m0m0m0m0m0m00m0*0*m0TEGChol
MIMAT0004926	m0*5m0*5m0*0
hsa-miR-708*	5′Pm005f05f05f005f005f0000f00*0*5m0*5m	m0m0m0m0m0m0m00m0m000*m0*m0TEGChol
MIMAT0004927	0*f0*0*
hsa-miR-7-1*	5′Pm0000f05f005f05f05f05f05f05f05m0*5m0	m0m0000m00m00m0m0m0*m0*m0TEGChol
MIMAT0004553	*5m0*0*f0*0*0
hsa-miR-711	5′Pm005f00f05f05f05f0f005f05f0f05m0*0*5	m0m000m0m0000m0m00*m0*m0TEGChol
MIMAT0012734	m0*5m0*5m0*0*0
hsa-miR-718	5′Pm05f000f0005f05f05f000f00*0*0*5m0*f0	m0m0m0m00m00m0m0m0m0m0*0*m0TEGChol
MIMAT0012735	*0*
hsa-miR-7-2*	5′Pm0005f05f0000f0005f0f00*0*5m0*0*f0*	m0m00m0m0m0m0m0m0m00m0*m0*m0TEGChol
MIMAT0004554	0*0
hsa-miR-720	5′Pm05f05f005f005f05f0f05f05f00f00*0*0*5	m0m0m000m000m0m0m00*0*m0TEGChol
MIMAT0005954	m0*5m0*0*0
hsa-miR-744	5′Pm005f05f0f005f00f05f0005f00*5m0*5m0	m0m0m0m00m0m00m0m000*m0*m0TEGChol
MIMAT0004945	*5m0*f0*5m0*0
hsa-miR-744*	5′Pm0000f05f005f0f05f05f05f0f00*5m0*0*5	m0m0000m00m00m0m0m0*m0*m0TEGChol
MIMAT0004946	m0*f0*0*0
hsa-miR-758	5′Pm00005f05f05f05f05f0005f0f05m0*0*5m	m0m00m0m0m0000m0m0m0*m0*m0TEGChol
MIMAT0003879	0*5m0*f0*0*0
hsa-miR-759	5′Pm05f0005f05f05f005f05f000f00*5m0*5m	m0m0m0m00m0m000m0m0m0*0*m0TEGChol
MIMAT0010497	0*0*f0*0*0
hsa-miR-760	5′Pm0000f05f05f005f00005f00*5m0*5m0*0	m0m0m0m0m0m0m000m0m0m0*m0*m0TEGChol
MIMAT0004957	*f0*5m0*0
hsa-miR-761	5′Pm005f05f05f005f05f05f005f05f05f05m0*5	m0m000m0m000m0m000*m0*m0TEGChol
MIMAT0010364	m0*0*0*5m0*5m0*0
hsa-miR-762	5′Pm005f005f005f05f05f05f05f05f05f00*0*0	m0m0000m000m0m0m00*m0*m0TEGChol
MIMAT0010313	*0*5m0*0*0
hsa-miR-764	5′Pm05f05f005f005f05f0f05f05f00f05m0*0*0	m0m0m000m000m0m0m00*0*m0TEGChol
MIMAT0010367	*5m0*5m0*0*0
hsa-miR-765	5′Pm00005f05f05f005f005f05f05f00*5m0*0*	m0m000m0m0m000m0m0m0*m0*m0TEGChol
MIMAT0003945	0*f0*5m0*0
hsa-miR-766	5′Pm05f005f05f05f000f05f05f05f0f00*0*0*0	m0m0000m0m0m00m00m0*0*m0TEGChol
MIMAT0003888	*f0*5m0*0
hsa-miR-767-3p	5′Pm00005f00005f0000f00*0*0*0*5m0*0*0	m0m0m0m0m0m0m0m0m0m0m0m0*m0*m0TEG
MIMAT0003883		Chol
hsa-miR-767-5p	5′Pm00005f05f000f005f05f0f00*0*0*0*f0*5	m0m000m0m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0003882	m0*0
hsa-miR-769-3p	5′Pm00005f00005f05f005f0f00*5m0*0*5m0	m0m00m00m0m0m0m0m0m0m0*m0*m0TEGChol
MIMAT0003887	*f0*0*0
hsa-miR-769-5p	5′Pm00005f00005f005f05f05f00*0*5m0*0*f	m0m000m0m0m0m0m0m0m0m0*m0*m0TEGChol
MIMAT0003886	0*0*0
hsa-miR-770-5p	5′Pm05f0005f0000f005f00f00*0*0*5m0*5m	m0m0m00m0m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0003948	0*5m0*0
hsa-miR-802	5′Pm05f05f00f05f05f00f0000f00*0*5m0*0*f	m0m0m0m0m0m0m000m0m00*0*m0TEGChol
MIMAT0004185	0*5m0*0
hsa-miR-873	5′Pm05f0005f05f05f05f05f05f05f00f00*0*5m	m0m0m000m0000m0m0m0*0*m0TEGChol
MIMAT0004953	0*5m0***
hsa-miR-874	5′Pm005f05f05f05f05f05f0f005f005f00*0*5m	m0m0m00m0m0000m000*m0*m0TEGChol
MIMAT0004911	0*0*5m0*5m0*0
hsa-miR-875-3p	5′Pm05f05f00f0005f05f05f05f00f05m0*5m0*	m0m0m000m00m0m0m0m00*0*m0TEGChol
MIMAT0004923	5m0*5m0*f0*5m0*
hsa-miR-875-5p	5′Pm005f00f05f005f05f05f05f05f05f00*5m0*	m0m0000m00m00m0m00*m0*m0TEGChol
MIMAT0004922	5m0*5m0*5m0*0*0
hsa-miR-876-3p	5′Pm05f05f005f0005f0f0005f05f05m0*5m0*	m0m00m0m0m00m0m0m0m00*0*m0TEGChol
MIMAT0004925	5m0*5m0*f0*0*0
hsa-miR-876-5p	5′Pm05f05f005f05f05f05f0f0005f0f05m0*5m	m0m00m0m0m0000m0m00*0*m0TEGChol
MIMAT0004924	0*5m0*5m0*5m0*5m0*0
hsa-miR-877	5′Pm05f005f05f05f05f00f05f05f05f0f00*0*0*	m0m0000m0m000m00m0*0*m0TEGChol
MIMAT0004949	0*f0*5m0*0
hsa-miR-877*	5′Pm00005f005f00f0000f00*5m0*5m0*0*f0	m0m0m0m0m0m00m0m0m0m0*m0*m0TEGChol
MIMAT0004950	*0*0
hsa-miR-885-3p	5′Pm05f05f05f05f05f05f005f0000f00*5m0*5	m0m0m0m0m0m0m000m000*0*m0TEGChol
MIMAT0004948	m0*0*5m0*5m0*0
hsa-miR-885-5p	5′Pm005f00f0005f0f0000f00*5m0*0*5m0*5	m0m0m0m0m0m00m0m0m0m00*m0*m0TEGChol
MIMAT0004947	m0*0*0
hsa-miR-887	5′Pm0000f05f005f05f05f05f05f05f05m0*5m0	m0m0000m00m00m0m0m0*m0*m0TEGChol
MIMAT0004951	*5m0*0*f0*0*0
hsa-miR-888	5′Pm05f05f05f05f0000f0000f00*5m0*0*5m0	m0m0m0m0m0m0m0m0m0m000*0*m0TEGChol
MIMAT0004916	*5m0*5m0*0
hsa-miR-888*	5′Pm0000f05f000f005f005f05m0*0*5m0*0*f	m0m0m00m0m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0004917	0*5m0*0
hsa-miR-889	5′Pm05f05f05f0f0005f05f0000f05m0*5m0*5	m0m0m0m0m0m00m0m0m000*0*m0TEGChol
MIMAT0004921	m0*5m0*f0*5m0*
hsa-miR-890	5′Pm005f00f0005f0f05f05f00f05m0*0*5m0*	m0m0m000m00m0m0m0m00*m0*m0TEGChol
MIMAT0004912	5m0*f0*5m0*0
hsa-miR-891a	5′Pm05f005f0f05f005f0f05f000f00*5m0*0*5	m0m0m0m00m00m00m00m0*0*m0TEGChol
MIMAT0004902	m0*5m0*5m0*0
hsa-miR-891b	5′Pm0005f05f05f0005f05f05f00f05m0*0*0*0	m0m0m000m0m0m00m00m0*m0*m0TEGChol
MIMAT0004913	*f0*0*0
hsa-miR-892a	5′Pm0005f0f05f05f00f05f05f05f05f05m0*5m	m0m0000m0m000m00m0*m0*m0TEGChol
MIMAT0004907	0*0*5m0*5m0*0*0
hsa-miR-892b	5′Pm005f00f005f00f05f000f05m0*5m0*5m0	m0m0m0m00m0m00m0m0m00*m0*m0TEGChol
MIMAT0004918	*5m0*f0*0*0
hsa-miR-9	5′Pm05f000f05f05f05f0f05f05f05f0f00*0*5m	m0m0000m0000m0m0m0*0*m0TEGChol
MIMAT0000441	0*5m0*5m0*0*0
hsa-miR-9*	5′Pm05f005f0f05f000f05f005f0f05m0*0*5m0	m0m00m00m0m0m00m00m0*0*m0TEGChol
MIMAT0000442	*0*5m0*0*0
hsa-miR-920	5′Pm05f05f00f0000f05f05f00f00*0*5m0*5m	m0m0m000m0m0m0m0m0m00*0*m0TEGChol
MIMAT0004970	0*5m0*5m0*0
hsa-miR-921	5′Pm005f05f0f05f05f05f0f005f05f05f00*0*5	m0m000m0m0000m000*m0*m0TEGChol
MIMAT0004971	m0*5m0*5m0*0*0
hsa-miR-922	5′Pm05f05f05f05f05f000f05f005f0f05m0*0*5	m0m00m00m0m0m00m000*0*m0TEGChol
MIMAT0004972	m0*0*f0*5m0*0
hsa-miR-924	5′Pm0000f0005f05f05f05f00f00*0*5m0*5m0	m0m0m000m00m0m0m0m0m0*m0*m0TEGChol
MIMAT0004974	*5m0*5m0*0
hsa-miR-92a	5′Pm005f005f0005f0f05f05f005f00*5m0*5m	m0m0m000m00m0m0m0m00*m0*m0TEGChol
MIMAT0000092	0*5m0*5m0*5m0*0
hsa-miR-92a-1*	5′Pm0000f05f005f05f05f05f05f05f05m0*5m0	m0m0000m00m00m0m0m0*m0*m0TEGChol
MIMAT0004507	*5m0*0*f0*0*0
hsa-miR-92a-2*	5′Pm05f05f05f0f0000f0000f05m0*0*5m0*5	m0m0m0m0m0m0m0m0m0m000*0*m0TEGChol
MIMAT0004508	m0*5m0*5m0*0
hsa-miR-92b	5′Pm005f00f05f005f0f0005f0f00*5m0*0*5m	m0m00m0m0m00m00m0m00*m0*m0TEGChol
MIMAT0003218	0*f0*5m0*0
hsa-miR-92b*	5′Pm05f05f00f00005f005f05f0f00*0*0*5m0*	m0m000m0m0m0m0m0m0m00*0*m0TEGChol
MIMAT0004792	5m0*0*0
hsa-miR-93	5′Pm00005f05f0005f005f00f00*5m0*0*0*f0	m0m0m00m0m0m0m00m0m0m0*m0*m0TEGChol
MIMAT0000093	*5m0*0
hsa-miR-93*	5′Pm05f000f00005f0000f00*0*0*5m0*f0*0*0	m0m0m0m0m0m0m0m0m0m0m0m0*0*m0TEGChol
MIMAT0004509
hsa-miR-933	5′Pm05f05f00f05f05f05f05f05f000f00*5m0*5	m0m0m0m00m0000m0m00*0*m0TEGChol
MIMAT0004976	m0*5m0*5m0*0*0
hsa-miR-934	5′Pm005f05f05f005f05f0f0005f05f00*0*5m0	m0m00m0m0m000m0m000*m0*m0TEGChol
MIMAT0004977	*0*5m0*5m0*0
hsa-miR-935	5′Pm0005f0f05f05f005f05f005f0f05m0*0*5m	m0m00m00m0m000m00m0*m0*m0TEGChol
MIMAT0004978	0*5m0*f0*5m0*0
hsa-miR-936	5′Pm0000f05f005f05f005f05f05f00*5m0*0*5	m0m000m0m00m00m0m0m0*m0*m0TEGChol
MIMAT0004979	m0*f0*0*0
hsa-miR-937	5′Pm05f05f05f05f05f005f05f05f000f05m0*0*	m0m0m0m00m00m00m000*0*m0TEGChol
MIMAT0004980	5m0*5m0*f0**
hsa-miR-938	5′Pm05f000f05f005f0f0000f05m0*5m0*0*0*	m0m0m0m0m0m00m00m0m0m0*0*m0TEGChol
MIMAT0004981	f0*0*0
hsa-miR-939	5′Pm005f005f05f05f05f0f005f05f05f05m0*0*	m0m000m0m0000m0m00*m0*m0TEGChol
MIMAT0004982	5m0*5m0*f0*0*0
hsa-miR-940	5′Pm0005f0f005f005f005f05f0f05m0*5m0*0	m0m000m0m0m00m0m00m0*m0*m0TEGChol
MIMAT0004983	*0*5m0*5m0*0
hsa-miR-941	5′Pm005f00f0005f0f0000f05m0*0*0*5m0*f0	m0m0m0m0m0m00m0m0m0m00*m0*m0TEGChol
MIMAT0004984	*0*0
hsa-miR-942	5′Pm05f005f0f05f0005f05f05f005f05m0*0*5	m0m0m000m0m0m00m00m0*0*m0TEGChol
MIMAT0004985	m0*5m0*5m0*5m0*0
hsa-miR-943	5′Pm0000f05f005f0f05f05f05f0f00*5m0*0*5	m0m0000m00m00m0m0m0*m0*m0TEGChol
MIMAT0004986	m0*f0*0*0
hsa-miR-944	5′Pm005f00f05f05f05f05f0000f00*0*0*0*5m	m0m0m0m0m0m0000m0m00*m0*m0TEGChol
MIMAT0004987	0*0*0
hsa-miR-95	5′Pm00005f0000f05f000f05m0*5m0*5m0*0	m0m0m0m00m0m0m0m0m0m0m0*m0*m0TEGChol
MIMAT0000094	*f0*5m0*0
hsa-miR-96	5′Pm0005f0f0005f0f05f0005f00*5m0*0*0*5	m0m0m0m00m00m0m0m00m0*m0*m0TEGChol
MIMAT0000095	m0*5m0*0
hsa-miR-96*	5′Pm005f00f005f005f00005f00*5m0*5m0*0	m0m0m0m0m0m0m00m0m0m00*m0*m0TEGChol
MIMAT0004510	*f0*5m0*0
hsa-miR-98	5′Pm0000f005f05f05f05f000f00*0*0*0*5m0	m0m0m0m00m000m0m0m0m0*m0*m0TEGChol
MIMAT0000096	*5m0*0
hsa-miR-99a	5′Pm005f00f005f00f05f005f05f05m0*0*5m0	m0m00m00m0m00m0m0m00*m0*m0TEGChol
MIMAT0000097	*5m0*f0*0*0
hsa-miR-99a*	5′Pm005f05f05f05f000f05f005f05f05m0*5m0	m0m00m00m0m0m00m000*m0*m0TEGChol
MIMAT0004511	*5m0*5m0*5m0*5m0*0
hsa-miR-99b	5′Pm0000f0005f0f05f005f0f00*5m0*0*0*f0*	m0m00m00m00m0m0m0m0m0*m0*m0TEGChol
MIMAT0000689	5m0*0
hsa-miR-99b*	5′Pm00005f05f05f05f0f0000f05m0*0*5m0*5	m0m0m0m0m0m0000m0m0m0*m0*m0TEGChol
MIMAT0004678	m0*f0*0*0

Having thus described several aspects of at least one embodiment of this invention, it is to be appreciated various alterations, modifications, and improvements will readily occur to those skilled in the art. Such alterations, modifications, and improvements are intended to be part of this disclosure, and are intended to be within the spirit and scope of the invention. Accordingly, the foregoing description and drawings are by way of example only.

EQUIVALENTS

Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. Such equivalents are intended to be encompassed by the following claims.

All references, including patent documents, disclosed herein are incorporated by reference in their entirety. This application incorporates by reference the entire contents, including all the drawings and all parts of the specification.

Claims

1. An isolated nucleic acid molecule comprising a guide strand of 18-23 nucleotides in length that has complementarity to a miRNA sequence, anda passenger strand of 8-16 nucleotides in length,wherein the guide strand and the passenger strand form the nucleic acid molecule such that the nucleic acid has a double stranded region and a single stranded region, wherein the single stranded region is the 3′ end of the guide strand and comprises at least two phosphorothioate modifications, and wherein at least 50% of the pyrimidines in the nucleic acid molecule are modified.

2. The nucleic acid molecule of claim 1, wherein the nucleotide in position one of the guide strand has a 2′-O-methyl modification.

3. The nucleic acid molecule of claim 2, wherein the nucleotide in position one of the guide strand is a 5P-2′O-methyl U.

4. The nucleic acid molecule of claim 1, wherein at least 60%, at least 80%, at least 90%, or 100% of the pyrimidines in the nucleic acid molecule are modified.

5. The nucleic acid molecule of claim 1, wherein modified pyrimidines are 2′fluoro or 2′O methyl modified.

6. The nucleic acid molecule of claim 1, wherein at least one U or C includes a hydrophobic modification.

7. The nucleic acid molecule of claim 6, wherein the hydrophobic modification is a methyl or ethyl hydrophobic base modification.

8. The nucleic acid molecule of claim 1, wherein the guide strand contains 6-8 phosphorothioate modifications.

9. The nucleic acid molecule of claim 1, wherein the 3′ terminal 10 nucleotides of the guide strand include at least eight phosphorothioate modifications.

10. The nucleic acid molecule of claim 1 wherein the guide strand includes 4-14 phosphate modifications.

11. The nucleic acid molecule of claim 1, wherein the single stranded region of the guide strand is 6 nucleotides long.

12. The nucleic acid molecule of claim 1, wherein the double stranded region is 16 nucleotides long.

13. The nucleic acid molecule of claim 1, wherein the nucleic acid molecule has one end that is blunt or includes a one nucleotide overhang.

14. The nucleic acid molecule of claim 1, wherein the passenger strand is linked at the 3′ end to a lipophilic group.

15. The nucleic acid molecule of claim 14, wherein the lipophilic group is a sterol.

16. The nucleic acid molecule of claim 1, wherein the nucleic acid molecule is an miRNA mimic and wherein the miRNA sequence to which the guide strand is complementary is a miRNA recognition element.

17. The nucleic acid molecule of claim 16, wherein the miRNA mimic is a mimic of an miRNA selected from the group consisting of miR21, miR 139, miR 7, miR29, miR 122, miR 302-367 cluster, miR 221, miR-96, miR 126, miR 225 and miR 206.

18. A method of modulating miRNA-mediated gene expression in a subject comprising: administering to a subject an effective amount for modulating miRNA-mediated gene expression of the isolated nucleic acid molecule of claim 1.

19. The method of claim 18, wherein the administration is systemic, intravenous, intraperitoneal, intradermal, topical, or intraocular.

20. The method of claim 18, wherein the subject is a human.